<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:BNZI="http://banzai.io/20240630"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="bnzi-20240630.xsd" xlink:type="simple"/>
    <context id="From2024-01-01to2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CPBFLendingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CPBFLendingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2024-04-012024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_CommonStockMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_CommonStockMember_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_custom_GemMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:GemMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_CommonStockMember_custom_GemMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:GemMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_GemMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:GemMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember_custom_GemMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:GemMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-03-31_custom_GemMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:GemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_CommonStockMember_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_custom_GemMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:GemMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_CommonStockMember_custom_GemMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:GemMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember_custom_GemMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:GemMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember_custom_GemMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:GemMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_GemMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:GemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_CommonStockMember_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_CommonStockMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_CommonStockMember_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_custom_YorkvilleMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:YorkvilleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_BanzaiInternationalIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_BanzaiInternationalIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-12-012022-12-31_custom_HyrosIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:HyrosIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-08-04_custom_SevenGCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BNZI:SevenGCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-04</instant>
        </period>
    </context>
    <context id="From2023-08-042023-08-04_custom_SevenGCCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BNZI:SevenGCCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-04</startDate>
            <endDate>2023-08-04</endDate>
        </period>
    </context>
    <context id="From2024-09-192024-09-19_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-19</startDate>
            <endDate>2024-09-19</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">BNZI:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">BNZI:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CustomerConcentrationRiskMember_custom_CustomerThreeMember_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">BNZI:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">BNZI:ThreeCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ThreeCustomersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">BNZI:ThreeCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">BNZI:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">BNZI:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_GemWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">BNZI:GemWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_custom_GemWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">BNZI:GemWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">BNZI:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_custom_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">BNZI:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_PlacementAgentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">BNZI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_custom_PlacementAgentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">BNZI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">BNZI:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">BNZI:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_GemWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">BNZI:GemWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_GemWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">BNZI:GemWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_BanzaiInternationalIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_custom_BanzaiInternationalIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_SevenGCClassACommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BNZI:SevenGCClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_us-gaap_CommonClassAMember_custom_BanzaiInternationalIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_us-gaap_CommonClassBMember_custom_BanzaiInternationalIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember5435062">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_custom_BanzaiInternationalIncMember5435078">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_BanzaiInternationalIncMember5435093">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="From2023-08-042023-08-04_custom_ForfeitedPrivatePlacementWarrantsMember_custom_SponsorForfeitureAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:ForfeitedPrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:SponsorForfeitureAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-04</startDate>
            <endDate>2023-08-04</endDate>
        </period>
    </context>
    <context id="AsOf2023-08-04_custom_ForfeitedPrivatePlacementWarrantsMember_custom_SponsorForfeitureAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:ForfeitedPrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:SponsorForfeitureAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-04</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-10-03_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember_custom_SevenGCClassBCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BNZI:SevenGCClassBCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:ShareTransferAgreementsAndAlcoPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-03</instant>
        </period>
    </context>
    <context id="AsOf2023-11-16_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember_custom_SevenGCClassBCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BNZI:SevenGCClassBCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:ShareTransferAgreementsAndAlcoPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-16</instant>
        </period>
    </context>
    <context id="From2023-10-032023-10-03_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:ShareTransferAgreementsAndAlcoPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-03</startDate>
            <endDate>2023-10-03</endDate>
        </period>
    </context>
    <context id="From2023-11-162023-11-16_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:ShareTransferAgreementsAndAlcoPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-16</startDate>
            <endDate>2023-11-16</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:ShareTransferAgreementsAndAlcoPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-13_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:ShareTransferAgreementsAndAlcoPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-13</instant>
        </period>
    </context>
    <context id="AsOf2023-09-13_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:ShareTransferAgreementsAndAlcoPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-13</instant>
        </period>
    </context>
    <context id="AsOf2023-12-13_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember_custom_SevenGCClassBCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BNZI:SevenGCClassBCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:ShareTransferAgreementsAndAlcoPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-13</instant>
        </period>
    </context>
    <context id="From2023-12-132023-12-13_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:ShareTransferAgreementsAndAlcoPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-13</startDate>
            <endDate>2023-12-13</endDate>
        </period>
    </context>
    <context id="AsOf2022-05-27_custom_GemAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:GemAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-27</instant>
        </period>
    </context>
    <context id="From2022-05-272022-05-27_custom_GemAgreementsMember_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:GemAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-27</startDate>
            <endDate>2022-05-27</endDate>
        </period>
    </context>
    <context id="From2022-05-272022-05-27_custom_GemAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:GemAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-27</startDate>
            <endDate>2022-05-27</endDate>
        </period>
    </context>
    <context id="From2023-12-132023-12-13_custom_GemAgreementsMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:GemAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-13</startDate>
            <endDate>2023-12-13</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-13_custom_GemAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:GemAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-13</instant>
        </period>
    </context>
    <context id="From2023-12-132023-12-13_custom_GemAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:GemAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-13</startDate>
            <endDate>2023-12-13</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-12_custom_SevenGCPromissoryNotesMemberMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:SevenGCPromissoryNotesMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-12</instant>
        </period>
    </context>
    <context id="From2023-12-122023-12-12_custom_SevenGCPromissoryNotesMemberMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:SevenGCPromissoryNotesMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-12</startDate>
            <endDate>2023-12-12</endDate>
        </period>
    </context>
    <context id="From2023-12-122023-12-12_custom_SevenGCPromissoryNotesMemberMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:SevenGCPromissoryNotesMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-12</startDate>
            <endDate>2023-12-12</endDate>
        </period>
    </context>
    <context id="AsOf2021-02-19_custom_CpBfSeniorConvertibleNotesMember_custom_FirstSeniorConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:FirstSeniorConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:CpBfSeniorConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-19</instant>
        </period>
    </context>
    <context id="AsOf2022-10-10_custom_CpBfSeniorConvertibleNotesMember_custom_FirstSeniorConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:FirstSeniorConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:CpBfSeniorConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-10</instant>
        </period>
    </context>
    <context id="From2023-08-242023-08-24_custom_CpBfSeniorConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:CpBfSeniorConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-24</startDate>
            <endDate>2023-08-24</endDate>
        </period>
    </context>
    <context id="AsOf2023-08-24_custom_CpBfSeniorConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:CpBfSeniorConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-24</instant>
        </period>
    </context>
    <context id="AsOf2023-11-08_custom_CantorFeeAgreementMember_custom_GcCoHoldingsIncMember_custom_CantorFitzgeraldMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GcCoHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:CantorFeeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-08</instant>
        </period>
    </context>
    <context id="From2023-12-282023-12-28_custom_CantorFeeAgreementMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:CantorFeeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-28</startDate>
            <endDate>2023-12-28</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2022-01-01_custom_BanzaiInternationalIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="From2022-01-012022-01-01_custom_BanzaiInternationalIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-01</endDate>
        </period>
    </context>
    <context id="AsOf2022-01-01_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="From2022-01-012022-01-01_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-01</endDate>
        </period>
    </context>
    <context id="AsOf2022-01-01_custom_BanzaiInternationalIncMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="From2022-01-012022-01-01_custom_BanzaiInternationalIncMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-01</endDate>
        </period>
    </context>
    <context id="AsOf2022-01-01_custom_BanzaiInternationalIncMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="From2022-01-012022-01-01_custom_BanzaiInternationalIncMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-01</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-01-01_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-01</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-21_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalDrawdownsAndExtensionDrawdownsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">BNZI:WorkingCapitalDrawdownsAndExtensionDrawdownsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-21</instant>
        </period>
    </context>
    <context id="AsOf2022-12-21_custom_SevenGcCoHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-21</instant>
        </period>
    </context>
    <context id="AsOf2023-10-03_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalLoansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:WorkingCapitalLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-03</instant>
        </period>
    </context>
    <context id="AsOf2024-02-02_custom_SevenGcCoHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-02</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SevenGcCoHoldingsIncMember_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-21_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalDrawdownsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">BNZI:WorkingCapitalDrawdownsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-21</instant>
        </period>
    </context>
    <context id="AsOf2022-12-21_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_ExtensionDrawdownsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">BNZI:ExtensionDrawdownsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-21</instant>
        </period>
    </context>
    <context id="From2022-12-212022-12-21_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalDrawdownsAndExtensionDrawdownsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">BNZI:WorkingCapitalDrawdownsAndExtensionDrawdownsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-21</startDate>
            <endDate>2022-12-21</endDate>
        </period>
    </context>
    <context id="From2022-12-212022-12-21_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalDrawdownsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">BNZI:WorkingCapitalDrawdownsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-21</startDate>
            <endDate>2022-12-21</endDate>
        </period>
    </context>
    <context id="From2022-12-212022-12-21_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_ExtensionDrawdownsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">BNZI:ExtensionDrawdownsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-21</startDate>
            <endDate>2022-12-21</endDate>
        </period>
    </context>
    <context id="From2023-02-092023-02-09_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalDrawdownsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">BNZI:WorkingCapitalDrawdownsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-09</startDate>
            <endDate>2023-02-09</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalDrawdownsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">BNZI:WorkingCapitalDrawdownsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalDrawdownsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">BNZI:WorkingCapitalDrawdownsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_ExtensionDrawdownsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">BNZI:ExtensionDrawdownsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_ExtensionDrawdownsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">BNZI:ExtensionDrawdownsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SevenGcCoHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_DemioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">BNZI:DemioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_ReachMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">BNZI:ReachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_DemioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">BNZI:DemioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ReachMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">BNZI:ReachMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_srt_AmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_srt_AmericasMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_srt_AmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_srt_AmericasMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_EMEAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_EMEAMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_EMEAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_EMEAMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_srt_AsiaPacificMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_srt_AsiaPacificMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_srt_AsiaPacificMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_srt_AsiaPacificMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_srt_AmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_srt_AmericasMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_srt_AmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_srt_AmericasMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_us-gaap_EMEAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_us-gaap_EMEAMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_us-gaap_EMEAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_us-gaap_EMEAMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_srt_AsiaPacificMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_srt_AsiaPacificMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_srt_AsiaPacificMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_srt_AsiaPacificMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_AmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_AmericasMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_AmericasMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_AmericasMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_EMEAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_EMEAMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_EMEAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_EMEAMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_AsiaPacificMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_AsiaPacificMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_AsiaPacificMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_AsiaPacificMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_PublicWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_GemWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:GemWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PublicWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_GemWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:GemWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_PublicWarrantsMember5441250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SimpleAgreementsForFutureEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SimpleAgreementsForFutureEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:SimpleAgreementsForFutureEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PublicWarrantsMember5441437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PublicWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_PublicWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_PublicWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_GemWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:GemWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_GemWarrantsLiabilityMember_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:GemWarrantsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_GemWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:GemWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_GemWarrantsLiabilityMember_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:GemWarrantsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_GemWarrantsLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:GemWarrantsLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_ThirdPartyConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:ThirdPartyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_ThirdPartyConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:ThirdPartyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_ThirdPartyConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:ThirdPartyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_ThirdPartyConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:ThirdPartyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_ThirdPartyConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:ThirdPartyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ThirdPartyConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:ThirdPartyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ThirdPartyConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:ThirdPartyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ThirdPartyConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:ThirdPartyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ThirdPartyConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:ThirdPartyConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_AlcoMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AlcoMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_DNXMember_us-gaap_SeriesAPreferredStockMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:DNXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_DNXMember_us-gaap_SeriesAPreferredStockMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:DNXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_RelatedPartyConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_RelatedPartyConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_RelatedPartyConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_custom_RelatedPartyConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_ThirdPartyConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:ThirdPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_custom_ThirdPartyConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:ThirdPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-08-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoAugustPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-30</instant>
        </period>
    </context>
    <context id="AsOf2023-08-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoAugustPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-30</instant>
        </period>
    </context>
    <context id="From2023-08-302023-08-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoAugustPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-30</startDate>
            <endDate>2023-08-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoAugustPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoAugustPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoAugustPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoAugustPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-13_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-13</instant>
        </period>
    </context>
    <context id="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-13</startDate>
            <endDate>2023-09-13</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-11-16_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-16</instant>
        </period>
    </context>
    <context id="AsOf2023-11-16_custom_AlcoMember_custom_AlcoNovemberPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-16</instant>
        </period>
    </context>
    <context id="From2023-11-162023-11-16_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-16</startDate>
            <endDate>2023-11-16</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-13_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoDecemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-13</instant>
        </period>
    </context>
    <context id="AsOf2023-12-13_custom_AlcoMember_custom_AlcoDecemberPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoDecemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-13</instant>
        </period>
    </context>
    <context id="From2023-12-132023-12-13_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoDecemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-13</startDate>
            <endDate>2023-12-13</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoDecemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoDecemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoDecemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoDecemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_AlcoShareTransferAgreementsMember_custom_GcCoHoldingsIncMember_custom_AlcoNovemberPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:AlcoShareTransferAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:GcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-13_custom_AlcoShareTransferAgreementsMember_custom_GcCoHoldingsIncMember_custom_AlcoSeptemberPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:AlcoShareTransferAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:GcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-13</instant>
        </period>
    </context>
    <context id="From2023-12-132023-12-13_custom_AlcoShareTransferAgreementsMember_custom_GcCoHoldingsIncMember_custom_AlcoSeptemberPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:AlcoShareTransferAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:GcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-13</startDate>
            <endDate>2023-12-13</endDate>
        </period>
    </context>
    <context id="From2023-12-132023-12-13_custom_AlcoShareTransferAgreementsMember_custom_GcCoHoldingsIncMember_custom_AlcoNovemberPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:AlcoShareTransferAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:GcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-13</startDate>
            <endDate>2023-12-13</endDate>
        </period>
    </context>
    <context id="From2023-12-132023-12-13_custom_AlcoShareTransferAgreementsMember_custom_GcCoHoldingsIncMember_custom_AlcoDecemberPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:AlcoShareTransferAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoDecemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:GcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-13</startDate>
            <endDate>2023-12-13</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-13</instant>
        </period>
    </context>
    <context id="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-13</startDate>
            <endDate>2023-09-13</endDate>
        </period>
    </context>
    <context id="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-13</startDate>
            <endDate>2023-09-13</endDate>
        </period>
    </context>
    <context id="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-13</startDate>
            <endDate>2023-09-13</endDate>
        </period>
    </context>
    <context id="AsOf2023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-03</instant>
        </period>
    </context>
    <context id="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-03</startDate>
            <endDate>2023-10-03</endDate>
        </period>
    </context>
    <context id="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-03</startDate>
            <endDate>2023-10-03</endDate>
        </period>
    </context>
    <context id="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-03</startDate>
            <endDate>2023-10-03</endDate>
        </period>
    </context>
    <context id="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-16</startDate>
            <endDate>2023-11-16</endDate>
        </period>
    </context>
    <context id="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-16</startDate>
            <endDate>2023-11-16</endDate>
        </period>
    </context>
    <context id="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-16</startDate>
            <endDate>2023-11-16</endDate>
        </period>
    </context>
    <context id="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-13</startDate>
            <endDate>2023-12-13</endDate>
        </period>
    </context>
    <context id="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-13</startDate>
            <endDate>2023-12-13</endDate>
        </period>
    </context>
    <context id="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-13</startDate>
            <endDate>2023-12-13</endDate>
        </period>
    </context>
    <context id="From2024-05-302024-05-30_custom_AlcoAugustPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoAugustPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-30</startDate>
            <endDate>2024-05-30</endDate>
        </period>
    </context>
    <context id="From2024-05-302024-05-30_custom_AlcoNovemberPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-30</startDate>
            <endDate>2024-05-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-09_custom_SevenGCPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:SevenGCPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-09</instant>
        </period>
    </context>
    <context id="From2024-02-092024-02-09_custom_ConversionOf7GcPromissoryNotesMember_us-gaap_CommonClassAMember_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:ConversionOf7GcPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BNZI:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-09</startDate>
            <endDate>2024-02-09</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_GemAgreementMember_srt_MaximumMember_custom_SharePurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:SharePurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_GemAgreementMember_custom_GemTermSheetMember_us-gaap_CommonClassAMember_custom_GemWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BNZI:GemWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:GemTermSheetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_GemAgreementMember_custom_GemTermSheetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:GemTermSheetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_custom_GemAgreementMember_custom_GemTermSheetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:GemTermSheetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_GemAgreementMember_custom_GemTermSheetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:GemTermSheetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-02-052024-02-05_custom_GemAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-05</startDate>
            <endDate>2024-02-05</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-05_custom_GemAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-05</instant>
        </period>
    </context>
    <context id="From2024-02-052024-02-05_custom_GemAgreementMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-05</startDate>
            <endDate>2024-02-05</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_GemAgreementMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_GemAgreementMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleConvertibleNoteMember_custom_YorkvilleAdvisorsGlobalLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:YorkvilleConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-05_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-05</instant>
        </period>
    </context>
    <context id="From2024-02-052024-02-05_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-05</startDate>
            <endDate>2024-02-05</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-26_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-26</instant>
        </period>
    </context>
    <context id="From2024-03-262024-03-26_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-26</startDate>
            <endDate>2024-03-26</endDate>
        </period>
    </context>
    <context id="AsOf2024-05-03_custom_OriginalDebtRepaymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:OriginalDebtRepaymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-03</instant>
        </period>
    </context>
    <context id="From2024-05-032024-05-03_custom_OriginalDebtRepaymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:OriginalDebtRepaymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-03</startDate>
            <endDate>2024-05-03</endDate>
        </period>
    </context>
    <context id="AsOf2024-05-03_custom_OriginalDebtRepaymentAgreementMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:OriginalDebtRepaymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-03</instant>
        </period>
    </context>
    <context id="AsOf2024-05-22_custom_AmendedDebtRepaymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:AmendedDebtRepaymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="From2024-05-222024-05-22_custom_AmendedDebtRepaymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:AmendedDebtRepaymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-22</startDate>
            <endDate>2024-05-22</endDate>
        </period>
    </context>
    <context id="AsOf2024-05-31_custom_AmendedDebtRepaymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:AmendedDebtRepaymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="From2024-05-222024-05-22_custom_AmendedDebtRepaymentAgreementMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:AmendedDebtRepaymentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-22</startDate>
            <endDate>2024-05-22</endDate>
        </period>
    </context>
    <context id="From2024-05-222024-05-22_custom_YorkvilleAdvisorsGlobalLPMember_custom_AmendedDebtRepaymentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:AmendedDebtRepaymentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-22</startDate>
            <endDate>2024-05-22</endDate>
        </period>
    </context>
    <context id="AsOf2024-05-22_custom_YorkvilleAdvisorsGlobalLPMember_custom_AmendedDebtRepaymentAgreementMember_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:AmendedDebtRepaymentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="AsOf2024-05-22_custom_AmendedDebtRepaymentAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:AmendedDebtRepaymentAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="From2024-05-222024-05-22_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-22</startDate>
            <endDate>2024-05-22</endDate>
        </period>
    </context>
    <context id="AsOf2024-05-22_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="From2024-05-222024-05-22_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember_custom_YorkvilleConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:YorkvilleConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-22</startDate>
            <endDate>2024-05-22</endDate>
        </period>
    </context>
    <context id="AsOf2024-05-22_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember_custom_YorkvilleConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:YorkvilleConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="AsOf2024-01-31_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-31</instant>
        </period>
    </context>
    <context id="AsOf2024-02-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-14</instant>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_YorkvilleConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:YorkvilleConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_YorkvilleConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:YorkvilleConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_YorkvilleConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:YorkvilleConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_YorkvilleConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:YorkvilleConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_YorkvilleConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:YorkvilleConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CPBFLendingLLCMember_custom_TermNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:TermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CPBFLendingLLCMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_CPBFLendingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_CPBFLendingLLCMember_us-gaap_MediumTermNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_CPBFLendingLLCMember_us-gaap_MediumTermNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:TermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:TermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:TermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:TermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_CPBFLendingLLCMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_custom_CPBFLendingLLCMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_us-gaap_MediumTermNotesMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_us-gaap_MediumTermNotesMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-06-30_custom_TermNoteMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:TermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_TermNoteMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:TermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_us-gaap_MediumTermNotesMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_us-gaap_MediumTermNotesMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_TermNoteMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:TermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_custom_TermNoteMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:TermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-03-21_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-21</instant>
        </period>
    </context>
    <context id="AsOf2022-03-21_custom_AlcoMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-21</instant>
        </period>
    </context>
    <context id="From2022-03-212022-03-21_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-21</startDate>
            <endDate>2022-03-21</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-07-19_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-19</instant>
        </period>
    </context>
    <context id="From2022-07-192022-07-19_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-19</startDate>
            <endDate>2022-07-19</endDate>
        </period>
    </context>
    <context id="AsOf2022-07-31_custom_AlcoMansonWardAndDNXMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMansonWardAndDNXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_custom_AlcoMansonWardAndDNXMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMansonWardAndDNXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_AlcoMansonWardDNXAndWilliamBryantMember_custom_RelatedPartyConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMansonWardDNXAndWilliamBryantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_AlcoMansonWardDNXAndWilliamBryantMember_custom_RelatedPartyConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMansonWardDNXAndWilliamBryantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_DNXMember_custom_RelatedPartyConvertibleNotesMember_us-gaap_SeriesAPreferredStockMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:DNXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2023-04-012023-09-30_custom_RelatedPartyConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_custom_RelatedPartyConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_RelatedPartyConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_RelatedPartyConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_RelatedPartyConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_custom_RelatedPartyConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:RelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-30_custom_ThirdPartyCreditorsMember_custom_TwoThousandTwentyTwoThirdPartyConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:TwoThousandTwentyTwoThirdPartyConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:ThirdPartyCreditorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_custom_ThirdPartyCreditorsMember_custom_ThirdPartyConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:ThirdPartyConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:ThirdPartyCreditorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="From2023-04-012023-09-30_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-30_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AdditionalSubordinatedConvertibleNotesTwoThousandAndTwentyTwoMember_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:AdditionalSubordinatedConvertibleNotesTwoThousandAndTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AdditionalSubordinatedConvertibleNotesTwoThousandAndTwentyTwoMember_us-gaap_NonrelatedPartyMember_custom_BifurcatedDerivativePortionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:BifurcatedDerivativePortionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:AdditionalSubordinatedConvertibleNotesTwoThousandAndTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AdditionalSubordinatedConvertibleNotesTwoThousandAndTwentyTwoMember_us-gaap_NonrelatedPartyMember_custom_DebtPortionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:DebtPortionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:AdditionalSubordinatedConvertibleNotesTwoThousandAndTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AdditionalSubordinatedConvertibleNotesTwoThousandAndTwentyTwoMember_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:AdditionalSubordinatedConvertibleNotesTwoThousandAndTwentyTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwoThousandAndTwentyTwoConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:TwoThousandAndTwentyTwoConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-08-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember5467515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoAugustPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-30</instant>
        </period>
    </context>
    <context id="From2023-08-302023-08-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember5467531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoAugustPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-30</startDate>
            <endDate>2023-08-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoAugustPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember5467578">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoAugustPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-13_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoAugustPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-13</instant>
        </period>
    </context>
    <context id="AsOf2023-09-13_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember5467625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-13</instant>
        </period>
    </context>
    <context id="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember5467640">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-13</startDate>
            <endDate>2023-09-13</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember5467687">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AlcoOctoberShareTransferAgreementMember_custom_AlcoSeptemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:AlcoOctoberShareTransferAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-13_custom_AlcoOctoberShareTransferAgreementMember_custom_AlcoSeptemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:AlcoOctoberShareTransferAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-13</instant>
        </period>
    </context>
    <context id="From2023-09-132023-09-13_custom_AlcoOctoberShareTransferAgreementMember_custom_AlcoSeptemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:AlcoOctoberShareTransferAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-13</startDate>
            <endDate>2023-09-13</endDate>
        </period>
    </context>
    <context id="AsOf2023-11-16_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoAugustPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-16</instant>
        </period>
    </context>
    <context id="AsOf2023-11-16_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-16</instant>
        </period>
    </context>
    <context id="From2023-11-162023-11-16_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember5467796">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-16</startDate>
            <endDate>2023-11-16</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember5467843">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AlcoNovemberShareTransferAgreementMember_custom_AlcoNovemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:AlcoNovemberShareTransferAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-13_custom_AlcoNovemberShareTransferAgreementMember_custom_AlcoNovemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:AlcoNovemberShareTransferAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-13</instant>
        </period>
    </context>
    <context id="From2023-09-132023-09-13_custom_AlcoNovemberShareTransferAgreementMember_custom_AlcoNovemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:AlcoNovemberShareTransferAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-13</startDate>
            <endDate>2023-09-13</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-13_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoDecemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-13</instant>
        </period>
    </context>
    <context id="From2023-12-132023-12-13_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember5467953">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoDecemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-13</startDate>
            <endDate>2023-12-13</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoDecemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember5467984">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">BNZI:AlcoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoDecemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_December2023ShareTransferAgreementMember_custom_AlcoNovemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:December2023ShareTransferAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-13_custom_December2023ShareTransferAgreementMember_custom_AlcoNovemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:December2023ShareTransferAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-13</instant>
        </period>
    </context>
    <context id="From2023-09-132023-09-13_custom_December2023ShareTransferAgreementMember_custom_AlcoNovemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:ComponentsAxis">BNZI:December2023ShareTransferAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoNovemberPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-13</startDate>
            <endDate>2023-09-13</endDate>
        </period>
    </context>
    <context id="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_srt_WeightedAverageMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-13</startDate>
            <endDate>2023-09-13</endDate>
        </period>
    </context>
    <context id="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_srt_WeightedAverageMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-03</startDate>
            <endDate>2023-10-03</endDate>
        </period>
    </context>
    <context id="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_srt_WeightedAverageMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-16</startDate>
            <endDate>2023-11-16</endDate>
        </period>
    </context>
    <context id="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_srt_WeightedAverageMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-13</startDate>
            <endDate>2023-12-13</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AlcoSeptemberPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:AlcoSeptemberPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-21_custom_DecemberTwoThousandTwentyTwoSevenGCNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:DecemberTwoThousandTwentyTwoSevenGCNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-21</instant>
        </period>
    </context>
    <context id="AsOf2023-10-03_custom_DecemberTwoThousandTwentyTwoSevenGCNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:DecemberTwoThousandTwentyTwoSevenGCNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-03</instant>
        </period>
    </context>
    <context id="AsOf2023-10-03_custom_SevenGCPromissoryNotesMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:SevenGCPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-03</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SevenGCPromissoryNotesMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:SevenGCPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SevenGCPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:SevenGCPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_SevenGCPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:SevenGCPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-12-122023-12-12_custom_SevenGCPromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:SevenGCPromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-12</startDate>
            <endDate>2023-12-12</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_srt_MaximumMember_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_YorkvilleConvertibleNoteMember_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:YorkvilleConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2024-02-14_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember_srt_MaximumMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-14</instant>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:YorkvilleConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:StandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:YorkvilleAdvisorsGlobalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_YorkvilleConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:YorkvilleConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_YorkvilleConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:YorkvilleConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_YorkvilleConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:YorkvilleConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_custom_YorkvilleConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:YorkvilleConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="AsOf2021-02-19_custom_CPBFLendingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-19</instant>
        </period>
    </context>
    <context id="AsOf2021-02-19_custom_CPBFLendingLLCMember_custom_TermNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:TermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-19</instant>
        </period>
    </context>
    <context id="AsOf2021-02-19_custom_CPBFLendingLLCMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-19</instant>
        </period>
    </context>
    <context id="From2021-02-192021-02-19_custom_CPBFLendingLLCMember_custom_TermNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:TermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-19</startDate>
            <endDate>2021-02-19</endDate>
        </period>
    </context>
    <context id="From2021-02-192021-02-19_custom_CPBFLendingLLCMember_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-19</startDate>
            <endDate>2021-02-19</endDate>
        </period>
    </context>
    <context id="From2021-02-192021-02-19_custom_CPBFLendingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-19</startDate>
            <endDate>2021-02-19</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_CPBFLendingLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-10-10_custom_CPBFLendingLLCMember_custom_FirstAmendmentConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:FirstAmendmentConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-10</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_ConvertibleDebtMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CPBFLendingLLCMember_custom_TermNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:TermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_CPBFLendingLLCMember_custom_TermNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">BNZI:CPBFLendingLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:TermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_ConvertibleDebtMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_ConvertibleDebtMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_ConvertibleDebtMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_custom_FirstAmendmentConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">BNZI:FirstAmendmentConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_RelatedPartyAndThirdPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:RelatedPartyAndThirdPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_ConvertibleNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BNZI:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_ConvertibleNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BNZI:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BNZI:TermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BNZI:TermNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_LoanAgreementWithCpbfLendingLlcMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BNZI:LoanAgreementWithCpbfLendingLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_PublicWarrantsMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_PublicWarrantsMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-15_custom_GemAgreementMember_custom_GemWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BNZI:GemWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_GemAgreementMember_custom_GemWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BNZI:GemWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_PublicWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_PublicWarrantsMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_PublicWarrantsMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-05-31_custom_GemAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="AsOf2022-05-31_custom_GemAgreementMember_custom_GemWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BNZI:GemWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-13_custom_GemAgreementMember_custom_GemWarrantMember_us-gaap_CommonClassAMember_custom_GemTermSheetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BNZI:GemWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:GemTermSheetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-13</instant>
        </period>
    </context>
    <context id="AsOf2023-12-13_custom_GemAgreementMember_custom_GemTermSheetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:GemTermSheetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-13</instant>
        </period>
    </context>
    <context id="From2023-12-132023-12-13_custom_GemAgreementMember_custom_GemTermSheetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:GemTermSheetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-13</startDate>
            <endDate>2023-12-13</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-15_custom_GemAgreementMember_custom_GemWarrantMember_custom_GEMFinancingArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BNZI:GemWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:GEMFinancingArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-15</instant>
        </period>
    </context>
    <context id="From2023-12-152023-12-15_custom_GemAgreementMember_custom_GemWarrantMember_custom_GEMFinancingArrangementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BNZI:GemWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:GEMFinancingArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-15</startDate>
            <endDate>2023-12-15</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_AlcoDNXAndWilliamBryantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:AlcoDNXAndWilliamBryantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_AlcoDNXAndWilliamBryantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:AlcoDNXAndWilliamBryantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_AlcoDNXAndWilliamBryantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:AlcoDNXAndWilliamBryantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_custom_AlcoDNXAndWilliamBryantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:AlcoDNXAndWilliamBryantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_AlcoDNXAndWilliamBryantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:AlcoDNXAndWilliamBryantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_custom_AlcoDNXAndWilliamBryantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:AlcoDNXAndWilliamBryantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ThirdPartySafesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">BNZI:ThirdPartySafesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ThirdPartySafesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">BNZI:ThirdPartySafesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2023-04-012023-06-30_custom_ThirdPartySafesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">BNZI:ThirdPartySafesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_custom_ThirdPartySafesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">BNZI:ThirdPartySafesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_ThirdPartySafesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">BNZI:ThirdPartySafesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_custom_ThirdPartySafesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">BNZI:ThirdPartySafesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AlcoDNXAndWilliamBryantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:AlcoDNXAndWilliamBryantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AlcoDNXAndWilliamBryantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:AlcoDNXAndWilliamBryantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-09-022022-09-02_custom_AlcoDNXAndWilliamBryantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:AlcoDNXAndWilliamBryantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-02</startDate>
            <endDate>2022-09-02</endDate>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_custom_AlcoDNXAndWilliamBryantMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:AlcoDNXAndWilliamBryantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ThirdPartySafesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">BNZI:ThirdPartySafesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ThirdPartySafesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">BNZI:ThirdPartySafesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-09-022022-09-02_custom_ThirdPartySafesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">BNZI:ThirdPartySafesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-02</startDate>
            <endDate>2022-09-02</endDate>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_custom_ThirdPartySafesMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">BNZI:ThirdPartySafesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_CantorFeeAgreementMember_custom_GcCoHoldingsIncMember_custom_CantorFitzgeraldMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:CantorFeeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:GcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-11-08_custom_CantorFeeAgreementMember_custom_GcCoHoldingsIncMember_custom_CantorFitzgeraldMember5486640">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:CantorFeeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:GcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-08</instant>
        </period>
    </context>
    <context id="From2023-12-082023-12-08_custom_RothAddendumToLetterAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:RothAddendumToLetterAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-08</startDate>
            <endDate>2023-12-08</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_RothAddendumToLetterAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:RothAddendumToLetterAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-02-022024-02-02_custom_RothAddendumToLetterAgreementsMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:RothAddendumToLetterAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-02</startDate>
            <endDate>2024-02-02</endDate>
        </period>
    </context>
    <context id="From2024-05-152024-05-15_custom_RothAddendumToLetterAgreementsMember_us-gaap_CommonClassAMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:RothAddendumToLetterAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-15</startDate>
            <endDate>2024-05-15</endDate>
        </period>
    </context>
    <context id="From2024-02-022024-02-02_custom_RothAddendumToLetterAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:RothAddendumToLetterAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-02</startDate>
            <endDate>2024-02-02</endDate>
        </period>
    </context>
    <context id="From2024-02-022024-02-02_custom_RothAddendumToLetterAgreementsMember_us-gaap_CommonClassAMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:RothAddendumToLetterAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-02</startDate>
            <endDate>2024-02-02</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_RothAddendumToLetterAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:RothAddendumToLetterAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_RothAddendumToLetterAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:RothAddendumToLetterAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CantorFeeAgreementMember_custom_GcCoHoldingsIncMember_custom_CantorFitzgeraldMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:CantorFeeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:GcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-11-08_custom_CantorFeeAgreementMember_custom_SevenGcCoHoldingsIncMember_custom_CantorFitzgeraldMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:CantorFeeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-08</instant>
        </period>
    </context>
    <context id="AsOf2023-11-08_custom_NewBanzaiClassASharesMember_custom_SevenGcCoHoldingsIncMember_custom_CantorFitzgeraldMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BNZI:NewBanzaiClassASharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-08</instant>
        </period>
    </context>
    <context id="From2023-12-282023-12-28_custom_CantorFitzgeraldMember_us-gaap_CommonClassAMember_custom_SevenGcCoHoldingsIncMember_custom_CantorFeeAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:CantorFeeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-28</startDate>
            <endDate>2023-12-28</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-28_custom_CantorFitzgeraldMember_custom_SevenGcCoHoldingsIncMember_custom_CantorFeeAgreementMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:CantorFeeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-28</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_CantorFitzgeraldMember_custom_SevenGcCoHoldingsIncMember_custom_CantorFeeAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:CantorFeeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">BNZI:CantorFitzgeraldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:SevenGcCoHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_CommonStockMember5488218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonStockMember5488265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-05-222024-05-22_us-gaap_CommonClassAMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-22</startDate>
            <endDate>2024-05-22</endDate>
        </period>
    </context>
    <context id="AsOf2024-05-22_custom_PrefundedWarrantsMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PrefundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="AsOf2024-05-22_custom_CommonWarrantsMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="AsOf2024-05-22_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="From2024-05-222024-05-22_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-22</startDate>
            <endDate>2024-05-22</endDate>
        </period>
    </context>
    <context id="From2024-05-222024-05-22_custom_AllianceGlobalPartnersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BNZI:AllianceGlobalPartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-22</startDate>
            <endDate>2024-05-22</endDate>
        </period>
    </context>
    <context id="From2024-05-222024-05-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <startDate>2024-05-22</startDate>
            <endDate>2024-05-22</endDate>
        </period>
    </context>
    <context id="AsOf2024-05-22_us-gaap_MeasurementInputSharePriceMember_custom_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="AsOf2024-05-22_us-gaap_MeasurementInputExercisePriceMember_custom_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="AsOf2024-05-22_us-gaap_MeasurementInputPriceVolatilityMember_custom_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="AsOf2024-05-22_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="AsOf2024-05-22_us-gaap_MeasurementInputExpectedDividendRateMember_custom_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:CommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="AsOf2024-05-22_custom_CommonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="AsOf2024-05-22_custom_PrefundedWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PrefundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="AsOf2024-05-22_custom_PlacementAgentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="AsOf2024-05-22_us-gaap_MeasurementInputSharePriceMember_custom_PlacementAgentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="AsOf2024-05-22_us-gaap_MeasurementInputExercisePriceMember_custom_PlacementAgentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="AsOf2024-05-22_us-gaap_MeasurementInputPriceVolatilityMember_custom_PlacementAgentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="AsOf2024-05-22_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_PlacementAgentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="AsOf2024-05-22_us-gaap_MeasurementInputExpectedDividendRateMember_custom_PlacementAgentWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">BNZI:PlacementAgentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-03-012024-03-31_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember_custom_ClassACommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BNZI:ClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_us-gaap_CommonClassAMember_custom_BanzaiInternationalIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_us-gaap_CommonClassAMember_custom_BanzaiInternationalIncMember5493359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:BanzaiInternationalIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="From2021-02-192021-02-19_us-gaap_CommonClassAMember_custom_ShareholdersAndFoundersMember_us-gaap_RestrictedStockMember_custom_DemioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BNZI:ShareholdersAndFoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:DemioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-19</startDate>
            <endDate>2021-02-19</endDate>
        </period>
    </context>
    <context id="From2021-02-192021-02-19_us-gaap_CommonClassAMember_custom_ShareholdersAndFoundersMember_us-gaap_RestrictedStockMember_custom_HighAttendanceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BNZI:ShareholdersAndFoundersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:HighAttendanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-19</startDate>
            <endDate>2021-02-19</endDate>
        </period>
    </context>
    <context id="From2023-02-142023-02-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-14</startDate>
            <endDate>2023-02-14</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_YorkvilleStandbyEquityPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-14</instant>
        </period>
    </context>
    <context id="AsOf2023-02-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember5493562">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="From2023-12-282023-12-28_custom_CantorFeeAgreementMember_us-gaap_CommonClassAMember5494328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:CantorFeeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-28</startDate>
            <endDate>2023-12-28</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BNZI:TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BNZI:TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BNZI:TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BNZI:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BNZI:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BNZI:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_us-gaap_RestrictedStockUnitsRSUMember5495062">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_us-gaap_GeneralAndAdministrativeExpenseMember_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2016-04-26_custom_TwoThousandAndSixteenEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BNZI:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-04-26</instant>
        </period>
    </context>
    <context id="From2017-07-192017-07-19_custom_TwoThousandAndSixteenEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BNZI:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-07-19</startDate>
            <endDate>2017-07-19</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BNZI:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BNZI:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-12-032023-12-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <startDate>2023-12-03</startDate>
            <endDate>2023-12-03</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_SubstituteOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BNZI:SubstituteOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-06-30_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-06-30_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-06-30_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-30_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-30</instant>
        </period>
    </context>
    <context id="From2021-12-312021-12-31_srt_ScenarioPreviouslyReportedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-30_srt_RestatementAdjustmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-30</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_StateAndLocalJurisdictionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-07-052024-07-05_custom_GemAgreementMember_us-gaap_CommonClassAMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-05</startDate>
            <endDate>2024-07-05</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-22_custom_SubordinatedBusinessLoanAndSecurityAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:SubordinatedBusinessLoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-22</instant>
        </period>
    </context>
    <context id="From2024-07-222024-07-22_custom_SubordinatedBusinessLoanAndSecurityAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BNZI:SubordinatedBusinessLoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-22</startDate>
            <endDate>2024-07-22</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-05_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-05</instant>
        </period>
    </context>
    <context id="From2024-02-052024-02-05_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-05</startDate>
            <endDate>2024-02-05</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-27_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-27</instant>
        </period>
    </context>
    <context id="From2024-03-272024-03-27_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleStandbyEquityPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-27</startDate>
            <endDate>2024-03-27</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_YorkvilleConvertibleNoteAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleConvertibleNoteAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-242024-01-24_custom_YorkvilleConvertibleNoteAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleConvertibleNoteAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-24</startDate>
            <endDate>2024-01-24</endDate>
        </period>
    </context>
    <context id="From2024-02-012024-02-29_custom_YorkvilleSEPAAdvancePurchaseNoticesMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleSEPAAdvancePurchaseNoticesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_YorkvilleSEPAAdvancePurchaseNoticesMember_us-gaap_SubsequentEventMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleSEPAAdvancePurchaseNoticesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_YorkvilleSEPAAdvancePurchaseNoticesMember_us-gaap_SubsequentEventMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleSEPAAdvancePurchaseNoticesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="From2024-03-012024-03-31_custom_PrePaidYorkvilleConvertibleNotesMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:PrePaidYorkvilleConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-03-31_custom_YorkvilleDeferredFeeSettlementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleDeferredFeeSettlementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_YorkvilleDeferredFeeSettlementMember_us-gaap_SubsequentEventMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleDeferredFeeSettlementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_YorkvilleDeferredFeeSettlementMember_us-gaap_SubsequentEventMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:YorkvilleDeferredFeeSettlementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-02-022024-02-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
        </entity>
        <period>
            <startDate>2024-02-02</startDate>
            <endDate>2024-02-02</endDate>
        </period>
    </context>
    <context id="From2024-02-022024-02-02_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-02</startDate>
            <endDate>2024-02-02</endDate>
        </period>
    </context>
    <context id="From2024-03-292024-03-29_custom_RothAddendumToLetterAgreementsMember_us-gaap_CommonClassAMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:RothAddendumToLetterAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-29</startDate>
            <endDate>2024-03-29</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-05_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-05</instant>
        </period>
    </context>
    <context id="From2024-02-052024-02-05_us-gaap_SubsequentEventMember_custom_GemAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-05</startDate>
            <endDate>2024-02-05</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-05_us-gaap_SubsequentEventMember_custom_GemAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-05</instant>
        </period>
    </context>
    <context id="From2024-02-052024-02-05_custom_GemAgreementMember_us-gaap_CommonClassAMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:GemAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-05</startDate>
            <endDate>2024-02-05</endDate>
        </period>
    </context>
    <context id="From2024-02-022024-02-02_custom_ConversionOf7GcPromissoryNotesMember_us-gaap_SubsequentEventMember_custom_SponsorMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:ConversionOf7GcPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BNZI:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-02</startDate>
            <endDate>2024-02-02</endDate>
        </period>
    </context>
    <context id="AsOf2024-01-31_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-31</instant>
        </period>
    </context>
    <context id="From2024-02-192024-02-19_us-gaap_SubsequentEventMember_custom_MarketingServicesAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="BNZI:AgreementAxis">BNZI:MarketingServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-19</startDate>
            <endDate>2024-02-19</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_SPACRelatedLegalFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">BNZI:SPACRelatedLegalFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_SPACRelatedLegalFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">BNZI:SPACRelatedLegalFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_InvestmentBankAdvisoryServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">BNZI:InvestmentBankAdvisoryServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_InvestmentBankAdvisoryServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">BNZI:InvestmentBankAdvisoryServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-14_custom_FederalTradeCommissionFilingFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">BNZI:FederalTradeCommissionFilingFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-14</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_FederalTradeCommissionFilingFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">BNZI:FederalTradeCommissionFilingFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="From2023-12-142023-12-14_custom_RecapitalizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">BNZI:RecapitalizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-14</startDate>
            <endDate>2023-12-14</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-07-01_custom_HighAttendanceMember_us-gaap_CommonClassAMember_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:HighAttendanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-01</endDate>
        </period>
    </context>
    <context id="AsOf2022-07-01_custom_HighAttendanceMember_us-gaap_CommonClassAMember_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:HighAttendanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-01</instant>
        </period>
    </context>
    <context id="From2022-07-012022-07-01_custom_HighAttendanceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">BNZI:HighAttendanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-01</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001826011</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Integer">
        <measure>BNZI:Integer</measure>
    </unit>
    <unit id="Tradingday">
        <measure>BNZI:Tradingday</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-01-01to2024-06-30" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2024-01-01to2024-06-30" id="Fact000004">0001826011</dei:EntityCentralIndexKey>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2024-06-30_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0095"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0098"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0101"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0107"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0113"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0116"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent
      contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0119"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:DeferredFeeCurrent
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0134"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:GemCommitmentFeeLiability
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0152"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0173"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0174"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0198"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0199"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SettlementFeeExpense
      contextRef="From2024-04-012024-06-30"
      id="xdx2ixbrl0284"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SettlementFeeExpense
      contextRef="From2023-04-012023-06-30"
      id="xdx2ixbrl0285"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SettlementFeeExpense
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0287"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2024-04-012024-06-30"
      id="xdx2ixbrl0309"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2023-04-012023-06-30"
      id="xdx2ixbrl0310"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2024-04-012024-06-30"
      id="xdx2ixbrl0344"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2023-04-012023-06-30"
      id="xdx2ixbrl0345"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0347"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:GainsLossesOnDebtIssuance
      contextRef="From2024-04-012024-06-30"
      id="xdx2ixbrl0349"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:GainsLossesOnDebtIssuance
      contextRef="From2023-04-012023-06-30"
      id="xdx2ixbrl0350"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:GainsLossesOnDebtIssuance
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0352"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-04-012023-06-30_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0355"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-06-30_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0357"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-04-012023-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0360"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0362"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-04-012023-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0365"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0367"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2024-04-012024-06-30_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0369"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2024-01-012024-06-30_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0371"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2024-04-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0374"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0376"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2024-04-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0379"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0381"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2024-04-012024-06-30_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0384"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2024-01-012024-06-30_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0386"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2024-04-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0389"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0391"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2024-04-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0394"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0396"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="From2023-04-012023-06-30"
      id="xdx2ixbrl0400"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0402"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:PrepaymentPremiumExpense
      contextRef="From2023-04-012023-06-30"
      id="xdx2ixbrl0405"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:PrepaymentPremiumExpense
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0407"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0461"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0467"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0471"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0474"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_custom_YorkvilleMember"
      id="xdx2ixbrl0479"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember_custom_YorkvilleMember"
      id="xdx2ixbrl0482"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SharesIssuedToYorkvilleForCommitmentFee
      contextRef="From2024-01-012024-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_custom_YorkvilleMember"
      id="xdx2ixbrl0487"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SharesIssuedToYorkvilleForCommitmentFee
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember_custom_YorkvilleMember"
      id="xdx2ixbrl0490"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ShareIssuedToRothForAdvisoryFee
      contextRef="From2024-01-012024-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0495"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ShareIssuedToRothForAdvisoryFee
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0498"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_custom_GemMember"
      id="xdx2ixbrl0503"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember_custom_GemMember"
      id="xdx2ixbrl0506"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:StockIssuedDuringPeriodSharesissuedFormarketingExpenses
      contextRef="From2024-01-012024-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0511"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:StockIssuedDuringPeriodSharesissuedFormarketingExpenses
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0514"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ForfeitureOfSponsorSharesValue
      contextRef="From2024-01-012024-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0519"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ForfeitureOfSponsorSharesValue
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0522"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ForfeitureOfSponsorSharesValue
      contextRef="From2024-01-012024-03-31"
      id="xdx2ixbrl0523"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0527"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0528"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0530"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0533"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0534"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0535"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0539"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0545"
      unitRef="Shares"
      xsi:nil="true"/>
    <BNZI:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndWarrantsNetOfIssuanceCosts
      contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0549"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndWarrantsNetOfIssuanceCosts
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0552"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:StockIssuedDuringPeriodValueStockWarrantsExercised
      contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0557"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:StockIssuedDuringPeriodValueStockWarrantsExercised
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0560"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_custom_YorkvilleMember"
      id="xdx2ixbrl0565"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember_custom_YorkvilleMember"
      id="xdx2ixbrl0568"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:StockIssuedDuringPeriodValueRedemptionPremium
      contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_custom_YorkvilleMember"
      id="xdx2ixbrl0573"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:StockIssuedDuringPeriodValueRedemptionPremium
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember_custom_YorkvilleMember"
      id="xdx2ixbrl0576"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_custom_GemMember"
      id="xdx2ixbrl0581"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember_custom_GemMember"
      id="xdx2ixbrl0584"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:StockIssuedDuringPeriodSharesissuedFormarketingExpenses
      contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0589"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:StockIssuedDuringPeriodSharesissuedFormarketingExpenses
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0592"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0597"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0598"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0600"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0603"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0604"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0605"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0609"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0615"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0619"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0625"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0629"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0630"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0632"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0637"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0638"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0640"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0643"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0644"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0645"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0649"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0655"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0659"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0665"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-04-012023-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0669"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0670"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0672"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0677"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0678"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0680"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0683"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      id="xdx2ixbrl0684"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0685"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0689"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0695"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0699"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0705"
      unitRef="Shares"
      xsi:nil="true"/>
    <BNZI:NonCashSharesIssuedToYorkvilleForAggregateCommitmentFee
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0724"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:NonCashSharesIssuedToYorkvilleForAggregateCommitmentFee
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0725"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:NonCashIssuanceOfWarrantsAccountedForAsLiabilities
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0727"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:NonCashIssuanceOfWarrantsAccountedForAsLiabilities
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0728"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:NonCashShareIssuanceForMarketingExpenses
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0731"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:NonCashSettlementOfGemCommitmentFee
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0734"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:NoncashShareIssuanceForRedemptionPremium
      contextRef="From2023-01-012023-06-30_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0737"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0757"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0764"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ExciseTax
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0766"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ExciseTax
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0767"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:GainsLossesOnDebtIssuance
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0770"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-06-30_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0773"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0776"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0779"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:LossOnModificationOfSimpleAgreementForFutureEquity
      contextRef="From2024-01-012024-06-30_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0781"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:LossOnModificationOfSimpleAgreementForFutureEquity
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0784"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:LossOnModificationOfSimpleAgreementForFutureEquity
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0787"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2024-01-012024-06-30_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0790"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0793"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0796"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ChangeInFairValueOfBifurcatedEmbeddedDerivativeLiabilities
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0799"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0802"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0805"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ChangeInFairValueOfConvertiblePromissoryNotes
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0809"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:DeferredOfferingCostsOperatingActivities
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0820"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0823"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0824"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0829"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0830"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0835"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0836"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDeferredLeasingFees
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0847"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDeferredLeasingFees
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0848"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0850"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0851"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0859"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0862"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:EffectOfMergerNetOfTransactionCosts
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0868"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:EffectOfMergerNetOfTransactionCosts
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0869"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:PaymentsOfDeferredOfferingCosts
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0871"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:PaymentsOfDeferredOfferingCosts
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0872"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0874"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0875"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:PaymentOfGemCommitmentFee
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0878"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0881"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ProceedsFromRedemptionPremium
      contextRef="From2023-01-012023-06-30_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0884"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0889"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0892"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0896"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:IssuanceOfCantorFeeShares
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0926"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ModificationOfConvertibleNotesPayable
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0929"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SharesIssuedToRothForAdvisoryFeeAmount
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0932"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssued1
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0935"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SharesIssuedForMarketingExpenses
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0938"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SettlementOfGemCommitmentFee
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0941"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SharesIssuedToYorkvilleForAggregateCommitmentFee
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0944"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SharesIssuedUnderShareTransferAgreement
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0947"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:IssuanceOfWarrantsAccountedForAsALiability
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0950"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:GemCommitmentFee
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0953"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-06-30_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0959"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0962"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0965"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConversionOfConvertibleNotes
      contextRef="From2023-01-012023-06-30_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0968"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0973"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesAtIssuance
      contextRef="From2024-01-012024-06-30_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0976"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesAtIssuance
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0979"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl0982"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:IssuanceOfConvertiblePromissoryNote
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl0992"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConversionOfConvertibleNotes
      contextRef="From2023-01-012023-06-30_custom_YorkvilleMember"
      id="xdx2ixbrl0995"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConversionOfConvertibleNotes
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl0998"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConversionOfConvertibleNotes
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl1001"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-06-30_us-gaap_RestrictedStockUnitsRSUMember"
      id="xdx2ixbrl1071"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-06-30_custom_PublicWarrantsMember"
      id="xdx2ixbrl1074"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-06-30_custom_GemWarrantsMember"
      id="xdx2ixbrl1077"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-06-30_custom_CommonWarrantsMember"
      id="xdx2ixbrl1080"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-06-30_custom_PlacementAgentWarrantsMember"
      id="xdx2ixbrl1083"
      unitRef="Shares"
      xsi:nil="true"/>
    <BNZI:IssuanceOfConvertibleNotes
      contextRef="From2023-01-012023-03-31_custom_ThirdPartyConvertibleDebtMember"
      id="xdx2ixbrl1365"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:AccruedOfferingCosts
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl1469"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:AccruedOfferingCosts
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl1470"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConvertibleDebtIncludingAccruedInterest
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl1568"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConvertibleDebtIncludingAccruedInterest
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl1569"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2023-12-142023-12-14_custom_GemAgreementMember_custom_GemTermSheetMember"
      id="xdx2ixbrl1788">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2024-04-012024-06-30"
      id="xdx2ixbrl2114"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2023-04-012023-06-30"
      id="xdx2ixbrl2115"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl2126"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2023-01-012023-06-30"
      id="xdx2ixbrl2127"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2156"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl2180"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl2460"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl2462"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl2464"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-01-01to2024-06-30"
      id="xdx2ixbrl2466"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2023-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      id="xdx2ixbrl2508"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2023-12-31_us-gaap_RestrictedStockUnitsRSUMember"
      id="xdx2ixbrl2510"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:DeferredCosts
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2588"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl2606"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2609"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2612"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl2627"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2630"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2633"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2640"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2643"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:DeferredUnderwritingFeesCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2646"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:DeferredFeeCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2649"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:WarrantLiabilityCurrent
      contextRef="AsOf2022-12-31_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl2652"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:WarrantLiabilityCurrent
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2655"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:WarrantLiabilityCurrent
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2658"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:DueToRelatedPartyCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2664"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:GemCommitmentFeeLiability
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2667"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2681"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2690"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2691"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2742"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2743"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl2761"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl2762"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl2797"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:StandByEquityPurchaseAgreementCommitmentFeeAndDeferredFeeExpense
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2810"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:GEMWarrantExpense
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2813"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:GemCommitmentFeeExpense
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2816"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2825"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl2836"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl2840"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2843"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2846"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:LossOnModificationOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl2848"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:LossOnModificationOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2851"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:LossOnModificationOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2854"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2876"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl2884"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2885"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:RetroactiveApplicationOfRecapitalization
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2919"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:RetroactiveApplicationOfRecapitalization
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2920"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:StockholdersEquityAdjustedBalance
      contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl2926"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl2934"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2937"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl2942"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2945"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl2946"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl2950"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2951"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2953"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl2956"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl2957"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl2958"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl2962"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl2968"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl2972"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl2978"
      unitRef="Shares"
      xsi:nil="true"/>
    <BNZI:ReverseRecapitalization
      contextRef="From2023-01-012023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl2982"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ReverseRecapitalization
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl2985"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl2990"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl2993"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl2998"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3001"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl3006"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl3009"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3014"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3017"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ModificationOfConvertibleNotesPayable
      contextRef="From2023-01-012023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3022"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ModificationOfConvertibleNotesPayable
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3023"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ModificationOfConvertibleNotesPayable
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3025"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SharesIssuedToYorkvilleForCommitmentFee
      contextRef="From2023-01-012023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_custom_YorkvilleMember"
      id="xdx2ixbrl3028"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SharesIssuedToYorkvilleForCommitmentFee
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember_custom_YorkvilleMember"
      id="xdx2ixbrl3031"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SharesIssuedUnderShareTransferAgreement
      contextRef="From2023-01-012023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3036"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SharesIssuedUnderShareTransferAgreement
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3037"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SharesIssuedUnderShareTransferAgreement
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3039"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:StockIssuedDuringPeriodValueIssuanceOfCantorFeeShares
      contextRef="From2023-01-012023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl3042"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:StockIssuedDuringPeriodValueIssuanceOfCantorFeeShares
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3045"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:StockIssuedDuringPeriodValueIssuanceOfCantorFeeShares
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3046"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl3050"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3053"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl3058"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3059"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3061"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:AdjustmentsToAdditionalPaidInCapitalExciseTax
      contextRef="From2023-01-012023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl3064"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:AdjustmentsToAdditionalPaidInCapitalExciseTax
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3065"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:AdjustmentsToAdditionalPaidInCapitalExciseTax
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl3067"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl3070"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl3071"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl3072"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl3076"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl3082"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl3086"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl3092"
      unitRef="Shares"
      xsi:nil="true"/>
    <BNZI:NonCashSharesIssuedToYorkvilleForAggregateCommitmentFee
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3112"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:NonCashIssuanceOfWarrantsAccountedForAsLiabilities
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3115"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:NonCashSettlementOfGemCommitmentFee
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3118"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3141"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3147"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ExciseTax
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3151"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl3154"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3157"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3160"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:LossOnModificationOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl3162"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:LossOnModificationOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3165"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:LossOnModificationOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3168"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ChangeInFairValueOfConvertiblePromissoryNotes
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3190"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:DeferredOfferingCostsOperatingActivities
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3202"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3204"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3211"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDeferredLeasingFees
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3226"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3228"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3237"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3240"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:EffectOfMergerNetOfTransactionCosts
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3247"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:PaymentsOfDeferredOfferingCosts
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3249"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3253"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:IssuanceOfCantorFeeShares
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3292"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ModificationOfConvertibleNotesPayable
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3295"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SharesIssuedToYorkvilleForAggregateCommitmentFee
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3298"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SharesIssuedUnderShareTransferAgreement
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3301"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:IssuanceOfWarrantsAccountedForAsALiability
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3304"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:GemCommitmentFee
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl3307"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl3313"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3316"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3319"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConversionOfConvertibleNotes
      contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl3322"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConversionOfConvertibleNotes
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3325"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConversionOfConvertibleNotes
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3328"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConvertibleNoteIssuedInSettlementOfAccruedInterest
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl3330"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConvertibleNoteIssuedInSettlementOfAccruedInterest
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3333"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConvertibleNoteIssuedInSettlementOfAccruedInterest
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3336"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3339"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesAtIssuance
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl3342"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesAtIssuance
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3345"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesAtIssuance
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3348"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl3351"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredCosts
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl3441"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_custom_PublicWarrantsMember"
      id="xdx2ixbrl3488"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_custom_GemWarrantsMember"
      id="xdx2ixbrl3491"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2023-12-132023-12-13_custom_GemAgreementsMember"
      id="xdx2ixbrl3607">P5Y</us-gaap:DebtInstrumentTerm>
    <BNZI:WarrantLiabilitiesPublic
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl3877"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:GEMWarrantLiabilities
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl3880"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl3883"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl3885"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3888"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SimpleAgreementForFutureEquity
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl3891"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SimpleAgreementForFutureEquity
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3894"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:PublicWarrantsLiability
      contextRef="AsOf2022-12-31_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl3902"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:PublicWarrantsLiability
      contextRef="AsOf2022-12-31_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl3913"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember"
      id="xdx2ixbrl3925"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="AsOf2021-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3935"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="From2022-01-012022-12-31_custom_ThirdPartyConvertibleDebtMember"
      id="xdx2ixbrl3949"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl3967"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="AsOf2023-12-31_custom_ThirdPartyConvertibleDebtMember"
      id="xdx2ixbrl3969"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl4001"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2023-12-31_custom_ThirdPartyConvertibleDebtMember"
      id="xdx2ixbrl4003"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ExciseTaxPayableCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl4092"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DepositLiabilityCurrent
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl4098"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:AccruedStreamingServiceCosts
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl4101"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:AccruedOfferingCosts
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl4106"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConvertibleDebtIncludingAccruedInterest
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      id="xdx2ixbrl4237"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:ConvertibleDebtIncludingAccruedInterest
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl4238"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2023-12-132023-12-13_custom_GemAgreementMember_custom_GemTermSheetMember"
      id="xdx2ixbrl4603">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl4675"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl4692"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl4698"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl4709"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:IncomeTaxReconciliationNondeductibleInterest
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl5039"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl5047"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:IncomeTaxReconciliationNondeductibleWarrantIssuanceExpense
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl5055"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl5067"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl5071"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl5077"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl5078"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl5080"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl5081"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl5083"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl5084"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl5086"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl5087"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-12-31"
      id="xdx2ixbrl5089"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-12-31"
      id="xdx2ixbrl5090"
      unitRef="USD"
      xsi:nil="true"/>
    <BNZI:DeferredTaxAssetsTaxStartupCosts
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl5110"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl5130"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2022-12-31"
      id="xdx2ixbrl5131"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2024-01-01to2024-06-30" id="Fact000012">S-1</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2024-01-01to2024-06-30" id="Fact000013">Banzai International, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-01-01to2024-06-30" id="Fact000014">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityPrimarySicNumber contextRef="From2024-01-01to2024-06-30" id="Fact000015">7372</dei:EntityPrimarySicNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-01-01to2024-06-30" id="Fact000016">85-3118980</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-01-01to2024-06-30" id="Fact000017">435 Ericksen Ave</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2024-01-01to2024-06-30" id="Fact000018">Suite 250</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2024-01-01to2024-06-30" id="Fact000019">Bainbridge Island</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-01-01to2024-06-30" id="Fact000020">WA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-01-01to2024-06-30" id="Fact000021">98110</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-01-01to2024-06-30" id="Fact000022">206</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-01-01to2024-06-30" id="Fact000023">414-1777</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName
      contextRef="From2024-01-012024-06-30_dei_BusinessContactMember"
      id="Fact000024">Joseph Davy</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="From2024-01-012024-06-30_dei_BusinessContactMember"
      id="Fact000025">435 Ericksen Ave</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2024-01-012024-06-30_dei_BusinessContactMember"
      id="Fact000026">Suite 250</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="From2024-01-012024-06-30_dei_BusinessContactMember"
      id="Fact000027">Bainbridge Island</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="From2024-01-012024-06-30_dei_BusinessContactMember"
      id="Fact000028">WA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="From2024-01-012024-06-30_dei_BusinessContactMember"
      id="Fact000029">98110</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="From2024-01-012024-06-30_dei_BusinessContactMember"
      id="Fact000030">206</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="From2024-01-012024-06-30_dei_BusinessContactMember"
      id="Fact000031">414-1777</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2024-01-01to2024-06-30" id="Fact000032">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2024-01-01to2024-06-30" id="Fact000033">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-01-01to2024-06-30" id="Fact000034">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2024-01-01to2024-06-30" id="Fact000035">false</dei:EntityExTransitionPeriod>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000043"
      unitRef="USD">471747</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000044"
      unitRef="USD">2093718</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000047"
      unitRef="USD">110797</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000050"
      unitRef="USD">5748</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <BNZI:AllowanceForCreditLosses
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000055"
      unitRef="USD">6713</BNZI:AllowanceForCreditLosses>
    <BNZI:AllowanceForCreditLosses
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000057"
      unitRef="USD">5748</BNZI:AllowanceForCreditLosses>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000052"
      unitRef="USD">26161</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000053"
      unitRef="USD">105049</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000059"
      unitRef="USD">1080936</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000060"
      unitRef="USD">741155</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000062"
      unitRef="USD">1578844</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000063"
      unitRef="USD">2939922</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000065"
      unitRef="USD">1819</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000066"
      unitRef="USD">4644</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000068"
      unitRef="USD">2171526</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000069"
      unitRef="USD">2171526</us-gaap:Goodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000071"
      unitRef="USD">46434</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000072"
      unitRef="USD">134013</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000077"
      unitRef="USD">38381</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000078"
      unitRef="USD">38381</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000080"
      unitRef="USD">3837004</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000081"
      unitRef="USD">5288486</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000089"
      unitRef="USD">9429803</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000090"
      unitRef="USD">6439863</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000092"
      unitRef="USD">4264028</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000093"
      unitRef="USD">5194240</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2024-06-30_custom_YorkvilleMember"
      decimals="0"
      id="Fact000104"
      unitRef="USD">2013000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-12-31_custom_YorkvilleMember"
      decimals="0"
      id="Fact000105"
      unitRef="USD">1766000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000108"
      unitRef="USD">2540091</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2024-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000110"
      unitRef="USD">3530571</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000111"
      unitRef="USD">2693841</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000122"
      unitRef="USD">7088209</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000123"
      unitRef="USD">6659787</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000125"
      unitRef="USD">3468124</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000126"
      unitRef="USD">2505137</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000128"
      unitRef="USD">3468124</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000129"
      unitRef="USD">2505137</us-gaap:NotesPayableCurrent>
    <BNZI:DeferredUnderwritingFeesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000131"
      unitRef="USD">4000000</BNZI:DeferredUnderwritingFeesCurrent>
    <BNZI:DeferredUnderwritingFeesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000132"
      unitRef="USD">4000000</BNZI:DeferredUnderwritingFeesCurrent>
    <BNZI:DeferredFeeCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000135"
      unitRef="USD">500000</BNZI:DeferredFeeCurrent>
    <BNZI:WarrantLiabilityCurrent
      contextRef="AsOf2024-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000137"
      unitRef="USD">79000</BNZI:WarrantLiabilityCurrent>
    <BNZI:WarrantLiabilityCurrent
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000138"
      unitRef="USD">641000</BNZI:WarrantLiabilityCurrent>
    <BNZI:WarrantLiabilityCurrent
      contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000140"
      unitRef="USD">230000</BNZI:WarrantLiabilityCurrent>
    <BNZI:WarrantLiabilityCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000141"
      unitRef="USD">575000</BNZI:WarrantLiabilityCurrent>
    <BNZI:WarrantLiabilityCurrent
      contextRef="AsOf2024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000143"
      unitRef="USD">230000</BNZI:WarrantLiabilityCurrent>
    <BNZI:WarrantLiabilityCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000144"
      unitRef="USD">575000</BNZI:WarrantLiabilityCurrent>
    <BNZI:EarnoutLiabilityCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000146"
      unitRef="USD">37125</BNZI:EarnoutLiabilityCurrent>
    <BNZI:EarnoutLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000147"
      unitRef="USD">59399</BNZI:EarnoutLiabilityCurrent>
    <BNZI:DueToRelatedPartyCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000149"
      unitRef="USD">67118</BNZI:DueToRelatedPartyCurrent>
    <BNZI:DueToRelatedPartyCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000150"
      unitRef="USD">67118</BNZI:DueToRelatedPartyCurrent>
    <BNZI:GemCommitmentFeeLiability
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000153"
      unitRef="USD">2000000</BNZI:GemCommitmentFeeLiability>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000155"
      unitRef="USD">1322238</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000156"
      unitRef="USD">1214096</us-gaap:DeferredRevenueCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000158"
      unitRef="USD">81708</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000159"
      unitRef="USD">234043</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000161"
      unitRef="USD">35610924</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000162"
      unitRef="USD">37089615</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000167"
      unitRef="USD">75000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000168"
      unitRef="USD">75000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000170"
      unitRef="USD">35685924</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000171"
      unitRef="USD">37164615</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000182"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000184"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000186"
      unitRef="Shares">275000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000188"
      unitRef="Shares">275000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000190"
      unitRef="Shares">3003810</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000192"
      unitRef="Shares">3003810</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000194"
      unitRef="Shares">2585296</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000196"
      unitRef="Shares">2585296</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000179"
      unitRef="USD">300</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000180"
      unitRef="USD">259</us-gaap:CommonStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000201"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000203"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000205"
      unitRef="Shares">75000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000207"
      unitRef="Shares">75000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000209"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact000211"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000213"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000215"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000217"
      unitRef="USD">23582484</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000218"
      unitRef="USD">14889936</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000220"
      unitRef="USD">-55431704</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000221"
      unitRef="USD">-46766324</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000223"
      unitRef="USD">-31848920</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000224"
      unitRef="USD">-31876129</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000226"
      unitRef="USD">3837004</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000227"
      unitRef="USD">5288486</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000234"
      unitRef="USD">1068197</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000235"
      unitRef="USD">1193321</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000236"
      unitRef="USD">2147669</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000237"
      unitRef="USD">2370382</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000239"
      unitRef="USD">330008</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000240"
      unitRef="USD">379294</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000241"
      unitRef="USD">711388</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000242"
      unitRef="USD">791520</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000244"
      unitRef="USD">738189</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000245"
      unitRef="USD">814027</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000246"
      unitRef="USD">1436281</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000247"
      unitRef="USD">1578862</us-gaap:GrossProfit>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000254"
      unitRef="USD">4319014</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000255"
      unitRef="USD">2929150</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000256"
      unitRef="USD">8627943</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000257"
      unitRef="USD">6099213</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:Depreciation
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000259"
      unitRef="USD">1261</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000260"
      unitRef="USD">1621</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000261"
      unitRef="USD">2825</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000262"
      unitRef="USD">4025</us-gaap:Depreciation>
    <us-gaap:OperatingExpenses
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000269"
      unitRef="USD">4320275</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000270"
      unitRef="USD">2930771</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000271"
      unitRef="USD">8630768</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000272"
      unitRef="USD">6103238</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000274"
      unitRef="USD">-3582086</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000275"
      unitRef="USD">-2116744</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000276"
      unitRef="USD">-7194487</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000277"
      unitRef="USD">-4524376</us-gaap:OperatingIncomeLoss>
    <BNZI:SettlementFeeExpense
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000286"
      unitRef="USD">200000</BNZI:SettlementFeeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000289"
      unitRef="USD">-64145</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000290"
      unitRef="USD">22145</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000291"
      unitRef="USD">-60027</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000292"
      unitRef="USD">84683</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000311"
      unitRef="USD">10</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000312"
      unitRef="USD">111</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-04-012024-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000329"
      unitRef="USD">396019</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-04-012023-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000330"
      unitRef="USD">521420</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-01-012024-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000331"
      unitRef="USD">847418</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-01-012023-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000332"
      unitRef="USD">1059298</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-04-012024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000334"
      unitRef="USD">385474</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-04-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000335"
      unitRef="USD">552403</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000336"
      unitRef="USD">962987</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000337"
      unitRef="USD">935687</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-04-012024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000339"
      unitRef="USD">385474</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-04-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000340"
      unitRef="USD">552403</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000341"
      unitRef="USD">962987</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000342"
      unitRef="USD">935687</us-gaap:InterestExpenseNonoperating>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000346"
      unitRef="USD">527980</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <BNZI:GainsLossesOnDebtIssuance
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000351"
      unitRef="USD">171000</BNZI:GainsLossesOnDebtIssuance>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-04-012024-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000354"
      unitRef="USD">-154000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-012024-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000356"
      unitRef="USD">-562000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-04-012024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000359"
      unitRef="USD">-230000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000361"
      unitRef="USD">-345000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-04-012024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000364"
      unitRef="USD">-230000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000366"
      unitRef="USD">-345000</us-gaap:FairValueAdjustmentOfWarrants>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-04-012023-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000370"
      unitRef="USD">68582</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000372"
      unitRef="USD">91443</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-04-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000375"
      unitRef="USD">909418</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000377"
      unitRef="USD">1212557</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-04-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000380"
      unitRef="USD">909418</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000382"
      unitRef="USD">1212557</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2023-04-012023-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000385"
      unitRef="USD">194643</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2023-01-012023-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000387"
      unitRef="USD">162228</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2023-04-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000390"
      unitRef="USD">478198</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000392"
      unitRef="USD">340913</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2023-04-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000395"
      unitRef="USD">478198</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000397"
      unitRef="USD">340913</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000399"
      unitRef="USD">-34000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000401"
      unitRef="USD">-578000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <BNZI:PrepaymentPremiumExpense
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000404"
      unitRef="USD">80760</BNZI:PrepaymentPremiumExpense>
    <BNZI:PrepaymentPremiumExpense
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000406"
      unitRef="USD">80760</BNZI:PrepaymentPremiumExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000409"
      unitRef="USD">-576398</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000410"
      unitRef="USD">-1356837</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000411"
      unitRef="USD">-1465202</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000412"
      unitRef="USD">-2711050</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000414"
      unitRef="USD">-4158484</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000415"
      unitRef="USD">-3473581</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000416"
      unitRef="USD">-8659689</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000417"
      unitRef="USD">-7235426</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000419"
      unitRef="USD">6624</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000420"
      unitRef="USD">12472</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000421"
      unitRef="USD">5691</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000422"
      unitRef="USD">15749</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000424"
      unitRef="USD">-4165108</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000425"
      unitRef="USD">-3486053</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000426"
      unitRef="USD">-8665380</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000427"
      unitRef="USD">-7251175</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-04-012024-06-30"
      decimals="INF"
      id="Fact000429"
      unitRef="USDPShares">-7.69</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-04-012024-06-30"
      decimals="INF"
      id="Fact000431"
      unitRef="USDPShares">-7.69</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-04-012023-06-30"
      decimals="INF"
      id="Fact000433"
      unitRef="USDPShares">-26.98</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-04-012023-06-30"
      decimals="INF"
      id="Fact000435"
      unitRef="USDPShares">-26.98</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact000437"
      unitRef="USDPShares">-19.50</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact000439"
      unitRef="USDPShares">-19.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-06-30"
      decimals="INF"
      id="Fact000441"
      unitRef="USDPShares">-56.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-06-30"
      decimals="INF"
      id="Fact000443"
      unitRef="USDPShares">-56.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-04-012024-06-30"
      decimals="INF"
      id="Fact000445"
      unitRef="Shares">541836</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2024-04-012024-06-30"
      decimals="INF"
      id="Fact000447"
      unitRef="Shares">541836</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-04-012023-06-30"
      decimals="INF"
      id="Fact000449"
      unitRef="Shares">129193</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2023-04-012023-06-30"
      decimals="INF"
      id="Fact000451"
      unitRef="Shares">129193</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact000453"
      unitRef="Shares">444474</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact000455"
      unitRef="Shares">444474</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-06-30"
      decimals="INF"
      id="Fact000457"
      unitRef="Shares">129127</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2023-01-012023-06-30"
      decimals="INF"
      id="Fact000459"
      unitRef="Shares">129127</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000469"
      unitRef="Shares">2585296</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000462"
      unitRef="USD">259</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000463"
      unitRef="USD">14889936</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000464"
      unitRef="USD">-46766324</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000465"
      unitRef="USD">-31876129</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember_us-gaap_RelatedPartyMember"
      decimals="INF"
      id="Fact000477"
      unitRef="Shares">17812</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000472"
      unitRef="USD">2</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000473"
      unitRef="USD">2540089</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-03-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000475"
      unitRef="USD">2540091</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember_custom_YorkvilleMember"
      decimals="INF"
      id="Fact000485"
      unitRef="Shares">44675</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember_custom_YorkvilleMember"
      decimals="0"
      id="Fact000480"
      unitRef="USD">4</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_YorkvilleMember"
      decimals="0"
      id="Fact000481"
      unitRef="USD">1666996</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-01-012024-03-31_custom_YorkvilleMember"
      decimals="0"
      id="Fact000483"
      unitRef="USD">1667000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <BNZI:SharesIssuedToYorkvilleForCommitmentFeeShares
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember_custom_YorkvilleMember"
      decimals="INF"
      id="Fact000493"
      unitRef="Shares">14201</BNZI:SharesIssuedToYorkvilleForCommitmentFeeShares>
    <BNZI:SharesIssuedToYorkvilleForCommitmentFee
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember_custom_YorkvilleMember"
      decimals="0"
      id="Fact000488"
      unitRef="USD">1</BNZI:SharesIssuedToYorkvilleForCommitmentFee>
    <BNZI:SharesIssuedToYorkvilleForCommitmentFee
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_YorkvilleMember"
      decimals="0"
      id="Fact000489"
      unitRef="USD">499999</BNZI:SharesIssuedToYorkvilleForCommitmentFee>
    <BNZI:SharesIssuedToYorkvilleForCommitmentFee
      contextRef="From2024-01-012024-03-31_custom_YorkvilleMember"
      decimals="0"
      id="Fact000491"
      unitRef="USD">500000</BNZI:SharesIssuedToYorkvilleForCommitmentFee>
    <BNZI:SharesIssuedToRothForAdvisoryFee
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000501"
      unitRef="Shares">35000</BNZI:SharesIssuedToRothForAdvisoryFee>
    <BNZI:ShareIssuedToRothForAdvisoryFee
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000496"
      unitRef="USD">0</BNZI:ShareIssuedToRothForAdvisoryFee>
    <BNZI:ShareIssuedToRothForAdvisoryFee
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000497"
      unitRef="USD">278333</BNZI:ShareIssuedToRothForAdvisoryFee>
    <BNZI:ShareIssuedToRothForAdvisoryFee
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000499"
      unitRef="USD">278833</BNZI:ShareIssuedToRothForAdvisoryFee>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember_custom_GemMember"
      decimals="INF"
      id="Fact000509"
      unitRef="Shares">2789</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember_custom_GemMember"
      decimals="0"
      id="Fact000504"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember_custom_GemMember"
      decimals="0"
      id="Fact000505"
      unitRef="USD">100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-03-31_custom_GemMember"
      decimals="0"
      id="Fact000507"
      unitRef="USD">100000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <BNZI:StockissuedDuringPeriodSharesOfSharesIssuedForMarketingExpenses
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000517"
      unitRef="Shares">3070</BNZI:StockissuedDuringPeriodSharesOfSharesIssuedForMarketingExpenses>
    <BNZI:StockIssuedDuringPeriodSharesissuedFormarketingExpenses
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000512"
      unitRef="USD">0</BNZI:StockIssuedDuringPeriodSharesissuedFormarketingExpenses>
    <BNZI:StockIssuedDuringPeriodSharesissuedFormarketingExpenses
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000513"
      unitRef="USD">194935</BNZI:StockIssuedDuringPeriodSharesissuedFormarketingExpenses>
    <BNZI:StockIssuedDuringPeriodSharesissuedFormarketingExpenses
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000515"
      unitRef="USD">194935</BNZI:StockIssuedDuringPeriodSharesissuedFormarketingExpenses>
    <BNZI:ForfeitureOfSponsorShares
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000525"
      unitRef="Shares">-2000</BNZI:ForfeitureOfSponsorShares>
    <BNZI:ForfeitureOfSponsorSharesValue
      contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000520"
      unitRef="USD">-0</BNZI:ForfeitureOfSponsorSharesValue>
    <BNZI:ForfeitureOfSponsorSharesValue
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000521"
      unitRef="USD">0</BNZI:ForfeitureOfSponsorSharesValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000529"
      unitRef="USD">252967</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000531"
      unitRef="USD">252967</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000536"
      unitRef="USD">-4500272</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact000537"
      unitRef="USD">-4500272</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000547"
      unitRef="Shares">2669343</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000540"
      unitRef="USD">267</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000541"
      unitRef="USD">20423754</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000542"
      unitRef="USD">-51266596</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="Fact000543"
      unitRef="USD">-30842575</us-gaap:StockholdersEquity>
    <BNZI:StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndWarrantsNetOfIssuanceCosts
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000555"
      unitRef="Shares">104556</BNZI:StockIssuedDuringPeriodSharesIssuanceOfCommonStockAndWarrantsNetOfIssuanceCosts>
    <BNZI:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndWarrantsNetOfIssuanceCosts
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000550"
      unitRef="USD">10</BNZI:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndWarrantsNetOfIssuanceCosts>
    <BNZI:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndWarrantsNetOfIssuanceCosts
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000551"
      unitRef="USD">1854808</BNZI:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndWarrantsNetOfIssuanceCosts>
    <BNZI:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndWarrantsNetOfIssuanceCosts
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000553"
      unitRef="USD">1854818</BNZI:StockIssuedDuringPeriodValueIssuanceOfCommonStockAndWarrantsNetOfIssuanceCosts>
    <BNZI:StockIssuedDuringPeriodSharesStockWarrantsExercised
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000563"
      unitRef="Shares">173222</BNZI:StockIssuedDuringPeriodSharesStockWarrantsExercised>
    <BNZI:StockIssuedDuringPeriodValueStockWarrantsExercised
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000558"
      unitRef="USD">17</BNZI:StockIssuedDuringPeriodValueStockWarrantsExercised>
    <BNZI:StockIssuedDuringPeriodValueStockWarrantsExercised
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000559"
      unitRef="USD">849</BNZI:StockIssuedDuringPeriodValueStockWarrantsExercised>
    <BNZI:StockIssuedDuringPeriodValueStockWarrantsExercised
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000561"
      unitRef="USD">866</BNZI:StockIssuedDuringPeriodValueStockWarrantsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember_custom_YorkvilleMember"
      decimals="INF"
      id="Fact000571"
      unitRef="Shares">20176</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember_custom_YorkvilleMember"
      decimals="0"
      id="Fact000566"
      unitRef="USD">2</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember_custom_YorkvilleMember"
      decimals="0"
      id="Fact000567"
      unitRef="USD">334998</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-04-012024-06-30_custom_YorkvilleMember"
      decimals="0"
      id="Fact000569"
      unitRef="USD">335000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <BNZI:StockIssuedDuringPeriodSharesRedemptionPremium
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember_custom_YorkvilleMember"
      decimals="0"
      id="Fact000579"
      unitRef="USD">12000</BNZI:StockIssuedDuringPeriodSharesRedemptionPremium>
    <BNZI:StockIssuedDuringPeriodValueRedemptionPremium
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember_custom_YorkvilleMember"
      decimals="0"
      id="Fact000574"
      unitRef="USD">1</BNZI:StockIssuedDuringPeriodValueRedemptionPremium>
    <BNZI:StockIssuedDuringPeriodValueRedemptionPremium
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember_custom_YorkvilleMember"
      decimals="0"
      id="Fact000575"
      unitRef="USD">115799</BNZI:StockIssuedDuringPeriodValueRedemptionPremium>
    <BNZI:StockIssuedDuringPeriodValueRedemptionPremium
      contextRef="From2024-04-012024-06-30_custom_YorkvilleMember"
      decimals="0"
      id="Fact000577"
      unitRef="USD">115800</BNZI:StockIssuedDuringPeriodValueRedemptionPremium>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember_custom_GemMember"
      decimals="INF"
      id="Fact000587"
      unitRef="Shares">18113</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember_custom_GemMember"
      decimals="0"
      id="Fact000582"
      unitRef="USD">2</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember_custom_GemMember"
      decimals="0"
      id="Fact000583"
      unitRef="USD">299998</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-04-012024-06-30_custom_GemMember"
      decimals="0"
      id="Fact000585"
      unitRef="USD">300000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <BNZI:StockissuedDuringPeriodSharesOfSharesIssuedForMarketingExpenses
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000595"
      unitRef="Shares">6400</BNZI:StockissuedDuringPeriodSharesOfSharesIssuedForMarketingExpenses>
    <BNZI:StockIssuedDuringPeriodSharesissuedFormarketingExpenses
      contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000590"
      unitRef="USD">1</BNZI:StockIssuedDuringPeriodSharesissuedFormarketingExpenses>
    <BNZI:StockIssuedDuringPeriodSharesissuedFormarketingExpenses
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000591"
      unitRef="USD">139836</BNZI:StockIssuedDuringPeriodSharesissuedFormarketingExpenses>
    <BNZI:StockIssuedDuringPeriodSharesissuedFormarketingExpenses
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000593"
      unitRef="USD">139837</BNZI:StockIssuedDuringPeriodSharesissuedFormarketingExpenses>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000599"
      unitRef="USD">412442</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000601"
      unitRef="USD">412442</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000606"
      unitRef="USD">-4165108</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact000607"
      unitRef="USD">-4165108</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000617"
      unitRef="Shares">3003810</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000610"
      unitRef="USD">300</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000611"
      unitRef="USD">23582484</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000612"
      unitRef="USD">-55431704</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000613"
      unitRef="USD">-31848920</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000627"
      unitRef="Shares">3935892</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000620"
      unitRef="USD">394</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000621"
      unitRef="USD">8245610</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000622"
      unitRef="USD">-32360062</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000623"
      unitRef="USD">-24114058</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000635"
      unitRef="Shares">171</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000631"
      unitRef="USD">5543</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-03-31"
      decimals="0"
      id="Fact000633"
      unitRef="USD">5543</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000639"
      unitRef="USD">402448</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-03-31"
      decimals="0"
      id="Fact000641"
      unitRef="USD">402448</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000646"
      unitRef="USD">-3765122</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31"
      decimals="0"
      id="Fact000647"
      unitRef="USD">-3765122</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000657"
      unitRef="Shares">3936063</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000650"
      unitRef="USD">394</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000651"
      unitRef="USD">8653601</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000652"
      unitRef="USD">-36125184</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact000653"
      unitRef="USD">-27471189</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000667"
      unitRef="Shares">3936063</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000660"
      unitRef="USD">394</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000661"
      unitRef="USD">8653601</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000662"
      unitRef="USD">-36125184</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact000663"
      unitRef="USD">-27471189</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-04-012023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000675"
      unitRef="Shares">126</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000671"
      unitRef="USD">7820</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000673"
      unitRef="USD">7820</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000679"
      unitRef="USD">218539</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000681"
      unitRef="USD">218539</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000686"
      unitRef="USD">-3486053</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact000687"
      unitRef="USD">-3486053</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000697"
      unitRef="Shares">3936189</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000690"
      unitRef="USD">394</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000691"
      unitRef="USD">8879960</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000692"
      unitRef="USD">-39611237</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000693"
      unitRef="USD">-30730883</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000707"
      unitRef="Shares">3936189</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000700"
      unitRef="USD">394</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000701"
      unitRef="USD">8879960</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000702"
      unitRef="USD">-39611237</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000703"
      unitRef="USD">-30730883</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000712"
      unitRef="USD">-8665380</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000713"
      unitRef="USD">-7251175</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000718"
      unitRef="USD">2825</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000719"
      unitRef="USD">4025</us-gaap:Depreciation>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000721"
      unitRef="USD">-2191</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000722"
      unitRef="USD">-68285</us-gaap:ProvisionForDoubtfulAccounts>
    <BNZI:NonCashShareIssuanceForMarketingExpenses
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000730"
      unitRef="USD">175334</BNZI:NonCashShareIssuanceForMarketingExpenses>
    <BNZI:NonCashSettlementOfGemCommitmentFee
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000733"
      unitRef="USD">200000</BNZI:NonCashSettlementOfGemCommitmentFee>
    <BNZI:NoncashShareIssuanceForRedemptionPremium
      contextRef="From2024-01-012024-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000736"
      unitRef="USD">80760</BNZI:NoncashShareIssuanceForRedemptionPremium>
    <BNZI:NonCashInterestExpense
      contextRef="From2024-01-012024-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000739"
      unitRef="USD">596693</BNZI:NonCashInterestExpense>
    <BNZI:NonCashInterestExpense
      contextRef="From2023-01-012023-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000740"
      unitRef="USD">471076</BNZI:NonCashInterestExpense>
    <BNZI:NonCashInterestExpense
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000742"
      unitRef="USD">175517</BNZI:NonCashInterestExpense>
    <BNZI:NonCashInterestExpense
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000743"
      unitRef="USD">214830</BNZI:NonCashInterestExpense>
    <BNZI:NonCashInterestExpense
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000745"
      unitRef="USD">175517</BNZI:NonCashInterestExpense>
    <BNZI:NonCashInterestExpense
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000746"
      unitRef="USD">214830</BNZI:NonCashInterestExpense>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2024-01-012024-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000748"
      unitRef="USD">68459</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2023-01-012023-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000749"
      unitRef="USD">272670</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000751"
      unitRef="USD">787470</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000752"
      unitRef="USD">719913</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000754"
      unitRef="USD">87579</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000755"
      unitRef="USD">86320</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000760"
      unitRef="USD">665409</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000761"
      unitRef="USD">620987</us-gaap:ShareBasedCompensation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000763"
      unitRef="USD">527980</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <BNZI:GainsLossesOnDebtIssuance
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000769"
      unitRef="USD">171000</BNZI:GainsLossesOnDebtIssuance>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-012024-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000772"
      unitRef="USD">-562000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000775"
      unitRef="USD">-345000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000778"
      unitRef="USD">-345000</us-gaap:FairValueAdjustmentOfWarrants>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000791"
      unitRef="USD">91443</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000794"
      unitRef="USD">1212557</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000797"
      unitRef="USD">1212557</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfBifurcatedEmbeddedDerivativeLiabilities
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000800"
      unitRef="USD">-162228</BNZI:ChangeInFairValueOfBifurcatedEmbeddedDerivativeLiabilities>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000803"
      unitRef="USD">340913</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000806"
      unitRef="USD">340913</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <BNZI:ChangeInFairValueOfConvertiblePromissoryNotes
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000808"
      unitRef="USD">578000</BNZI:ChangeInFairValueOfConvertiblePromissoryNotes>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000814"
      unitRef="USD">-81079</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000815"
      unitRef="USD">-27168</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000817"
      unitRef="USD">180343</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000818"
      unitRef="USD">93137</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <BNZI:DeferredOfferingCostsOperatingActivities
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000821"
      unitRef="USD">427664</BNZI:DeferredOfferingCostsOperatingActivities>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000826"
      unitRef="USD">2989940</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000827"
      unitRef="USD">1218775</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000832"
      unitRef="USD">108142</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000833"
      unitRef="USD">32124</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000838"
      unitRef="USD">-123399</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000839"
      unitRef="USD">-336332</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000841"
      unitRef="USD">-152335</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000842"
      unitRef="USD">-138804</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <BNZI:IncreaseDecreaseInEarnoutLiability
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000844"
      unitRef="USD">-22274</BNZI:IncreaseDecreaseInEarnoutLiability>
    <BNZI:IncreaseDecreaseInEarnoutLiability
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000845"
      unitRef="USD">-200000</BNZI:IncreaseDecreaseInEarnoutLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000853"
      unitRef="USD">-3812695</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000854"
      unitRef="USD">-4046650</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <BNZI:PaymentOfGemCommitmentFee
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000877"
      unitRef="USD">1200000</BNZI:PaymentOfGemCommitmentFee>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000880"
      unitRef="USD">750000</us-gaap:RepaymentsOfConvertibleDebt>
    <BNZI:ProceedsFromRedemptionPremium
      contextRef="From2024-01-012024-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000883"
      unitRef="USD">35040</BNZI:ProceedsFromRedemptionPremium>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2024-01-012024-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000886"
      unitRef="USD">2250000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-01-012023-06-30_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000887"
      unitRef="USD">850000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000890"
      unitRef="USD">2583000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-01-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000893"
      unitRef="USD">2583000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000895"
      unitRef="USD">866</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000898"
      unitRef="USD">1854818</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000899"
      unitRef="USD">13362</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000901"
      unitRef="USD">2190724</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000902"
      unitRef="USD">3446362</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000904"
      unitRef="USD">-1621971</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000905"
      unitRef="USD">-600288</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000907"
      unitRef="USD">2093718</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact000908"
      unitRef="USD">1023499</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000910"
      unitRef="USD">471747</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000911"
      unitRef="USD">423211</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000916"
      unitRef="USD">158518</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000917"
      unitRef="USD">313813</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000919"
      unitRef="USD">5075</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact000920"
      unitRef="USD">8825</us-gaap:IncomeTaxesPaidNet>
    <BNZI:SharesIssuedToRothForAdvisoryFeeAmount
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000931"
      unitRef="USD">278833</BNZI:SharesIssuedToRothForAdvisoryFeeAmount>
    <us-gaap:StockIssued1
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000934"
      unitRef="USD">400000</us-gaap:StockIssued1>
    <BNZI:SharesIssuedForMarketingExpenses
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000937"
      unitRef="USD">334772</BNZI:SharesIssuedForMarketingExpenses>
    <BNZI:SettlementOfGemCommitmentFee
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000940"
      unitRef="USD">200000</BNZI:SettlementOfGemCommitmentFee>
    <BNZI:SharesIssuedToYorkvilleForAggregateCommitmentFee
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000943"
      unitRef="USD">500000</BNZI:SharesIssuedToYorkvilleForAggregateCommitmentFee>
    <BNZI:SharesIssuedRedemptionPremium
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000985"
      unitRef="USD">115800</BNZI:SharesIssuedRedemptionPremium>
    <BNZI:SharesIssuedForExerciseOfPrefundedWarrants
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000988"
      unitRef="USD">866</BNZI:SharesIssuedForExerciseOfPrefundedWarrants>
    <BNZI:IssuanceOfConvertiblePromissoryNote
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact000991"
      unitRef="USD">1000000</BNZI:IssuanceOfConvertiblePromissoryNote>
    <BNZI:ConversionOfConvertibleNotes
      contextRef="From2024-01-012024-06-30_custom_YorkvilleMember"
      decimals="0"
      id="Fact000994"
      unitRef="USD">2002000</BNZI:ConversionOfConvertibleNotes>
    <BNZI:ConversionOfConvertibleNotes
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000997"
      unitRef="USD">2540091</BNZI:ConversionOfConvertibleNotes>
    <BNZI:ConversionOfConvertibleNotes
      contextRef="From2024-01-012024-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001000"
      unitRef="USD">2540091</BNZI:ConversionOfConvertibleNotes>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001003">&lt;p id="xdx_80D_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zK2CvWYRuZI6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;1.
&lt;span id="xdx_827_zWL9f5NNxfKa"&gt;Organization&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;The
Business&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Banzai
International, Inc. (the &#x201c;Company&#x201d; or &#x201c;Banzai&#x201d;) was incorporated in Delaware on &lt;span id="xdx_905_edei--EntityIncorporationDateOfIncorporation_c20240101__20240630_zdJSdZ1Ei5mb"&gt;September 30, 2015&lt;/span&gt;. Banzai is
a leading enterprise SaaS Video Engagement platform used by marketers to power webinars, trainings, virtual events, and on-demand video
content.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Close
of the Merger&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2023 (the &#x201c;Closing Date&#x201d;), 7GC &amp;amp; Co. Holdings Inc. (&#x201c;7GC&#x201d;), our predecessor company, consummated
the business combination pursuant to the Agreement and Plan of Merger and Reorganization, dated as of December 8, 2022 (the &#x201c;Original
Merger Agreement&#x201d;), by and among 7GC, Banzai International, Inc. (&#x201c;Legacy Banzai&#x201d;), 7GC Merger Sub I, Inc., an indirect
wholly owned subsidiary of 7GC (&#x201c;First Merger Sub&#x201d;), and 7GC Merger Sub II, LLC, a direct wholly owned subsidiary of 7GC
(&#x201c;Second Merger Sub&#x201d;), as amended by the Amendment to Agreement and Plan of Merger, dated as of August 4, 2023 (the &#x201c;Merger
Agreement Amendment&#x201d; and, together with the Original Merger Agreement, the &#x201c;Merger Agreement&#x201d;), by and between 7GC
and Legacy Banzai.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the terms of the Merger Agreement, a business combination between 7GC and Legacy Banzai was effected through (a) the merger of First
Merger Sub with and into Legacy Banzai, with Legacy Banzai surviving as a wholly-owned subsidiary of 7GC (Legacy Banzai, in its capacity
as the surviving corporation of the merger, the &#x201c;Surviving Corporation&#x201d;) (the &#x201c;First Merger&#x201d;) and (b) the subsequent
merger of the Surviving Corporation with and into Second Merger Sub, with Second Merger Sub being the surviving entity of the Second
Merger, which ultimately resulted in Legacy Banzai becoming a wholly-owned direct subsidiary of 7GC (the &#x201c;Second Merger&#x201d;
and, together with the First Merger, the &#x201c;Mergers&#x201d; and, collectively with the other transactions described in the Merger
Agreement, the &#x201c;Merger&#x201d;). On the Closing Date, and in connection with the closing of the Merger (the &#x201c;Closing&#x201d;),
7GC changed its name to Banzai International, Inc.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Although
7GC was the legal acquirer of Legacy Banzai in the merger, Legacy Banzai is deemed to be the accounting acquirer, and the historical
financial statements of Legacy Banzai became the basis for the historical financial statements of the Company upon the closing of the
merger.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
a result, the financial statements included here reflect (i) the historical operating results of Legacy Banzai prior to the merger; (ii)
the combined results of 7GC and Legacy Banzai following the close of the merger; (iii) the assets and liabilities of Legacy Banzai at
their historical cost and (iv) the Legacy Banzai&#x2019;s equity structure for all periods presented, as affected by the recapitalization
presentation after completion of the merger.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aggregate consideration payable to securityholders of Legacy Banzai at the Closing consisted of a number of shares of Class A Common
Stock or shares of Class B Common Stock, and cash in lieu of any fractional shares of Class A Common Stock or shares of Class B Common
Stock that would otherwise have been payable to any Legacy Banzai securityholders, equal to $&lt;span id="xdx_908_eus-gaap--AssetAcquisitionConsiderationTransferred_c20240101__20240630__dei--LegalEntityAxis__custom--BanzaiInternationalIncMember_zS38jz4jxfQf" title="Asset acquisition, consideration transferred"&gt;100,000,000&lt;/span&gt;. See &lt;i&gt;Note 4 - Reverse Merger
Capitalization with 7GC &amp;amp; Co. Holdings Inc. &lt;/i&gt;for further details of the merger.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Emerging
Growth Company&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
closure of the Merger, the Company became an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act
of 1933, as amended, (the &#x201c;Securities Act&#x201d;), as modified by the Jumpstart our Business Startups Act of 2012, (the &#x201c;JOBS
Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to public companies
that are not emerging growth companies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Section
102(b) (1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards
until private companies are required to comply. Private companies are those companies that have not had a Securities Act registration
statement declared effective or do not have a class of securities registered under the Exchange Act of 1934, as amended (the &#x201c;Exchange
Act&#x201d;). The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies. Any such election to opt out is irrevocable. The Company has elected not to opt out of such
extended transition period, which means that when a standard is issued or revised, it adopts the new or revised standard at the time
private companies adopt the new or revised standard. Therefore, the Company&#x2019;s financial statements may not be comparable to certain
public companies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <dei:EntityIncorporationDateOfIncorporation contextRef="From2024-01-01to2024-06-30" id="Fact001004">2015-09-30</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="From2024-01-012024-06-30_custom_BanzaiInternationalIncMember"
      decimals="0"
      id="Fact001006"
      unitRef="USD">100000000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001008">&lt;p id="xdx_807_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zMrp0y81ZMtd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
&lt;span id="xdx_828_zLs1YMGn1Iv1"&gt;Going Concern&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2024 the Company had cash of approximately $&lt;span id="xdx_909_eus-gaap--Cash_iI_pn5n6_c20240630_z8jwvpazvwmk" title="Cash"&gt;0.5&lt;/span&gt; million. For the six months ended June 30, 2024, the Company used approximately
$&lt;span id="xdx_906_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20240101__20240630_zN9Fzx6S0yl" title="Net cash used in operating activities"&gt;3.8&lt;/span&gt; million in cash for operating activities. The Company has incurred recurring net losses from operations and negative cash flows
from operating activities since inception. As of June 30, 2024, the Company had an accumulated deficit of approximately $&lt;span id="xdx_902_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20240630_zbxKTXK2zl9a" title="Accumulated deficit"&gt;55.4&lt;/span&gt; million.
These factors raise substantial doubt regarding the Company&#x2019;s ability to continue as a going concern within one year of the date
these financial statements were issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
continuation of the Company as a going concern is dependent upon the continued financial support from its stockholders and debt holders.
Specifically, continuation is contingent on the Company&#x2019;s ability to obtain necessary equity or debt financing to continue operations,
and ultimately the Company&#x2019;s ability to generate profit from sales and positive operating cash flows, which is not assured.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s plans include obtaining future debt and equity financings associated with the close of the Merger described in &lt;i&gt;Note
4 - Reverse Merger Capitalization with 7GC &amp;amp; Co. Holdings Inc..&lt;/i&gt; If the Company is unsuccessful in completing these planned transactions,
it may be required to reduce its spending rate to align with expected revenue levels and cash reserves, although there can be no guarantee
that it will be successful in doing so. Accordingly, the Company may be required to raise additional cash through debt or equity transactions.
It may not be able to secure financing in a timely manner or on favorable terms, if at all. As a result, management&#x2019;s plans cannot
be considered probable and thus do not alleviate substantial doubt about the Company&#x2019;s ability to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going
concern and do not include any adjustments that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:Cash
      contextRef="AsOf2024-06-30"
      decimals="-5"
      id="Fact001010"
      unitRef="USD">500000</us-gaap:Cash>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-01-01to2024-06-30"
      decimals="-5"
      id="Fact001012"
      unitRef="USD">-3800000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-06-30"
      decimals="-5"
      id="Fact001014"
      unitRef="USD">-55400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001016">&lt;p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zD8R6gJioWCj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3.
&lt;span id="xdx_82C_zfzUdPeKZPFa"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zIoDitdguHg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zDTD3u1847Z2"&gt;Basis
of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally
accepted in the United States of America (&#x201c;GAAP&#x201d;) as determined by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;)
Accounting Standards Codification (&#x201c;ASC&#x201d;) and applicable regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;)
for interim financial information and with the instructions to Form 10-Q of Regulation S-X. Certain information and note disclosures
normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such rules and regulations
of the SEC relating to interim financial statements. The December 31, 2023 balance sheet information was derived from the audited financial
statements as of that date. Except as disclosed herein, there has been no material change in the information disclosed in the notes to
the consolidated financial statements for the year ended December 31, 2023 included in the Company&#x2019;s Annual Report on Form 10-K,
as filed with the Securities and Exchange Commission on April 1, 2024. The interim unaudited condensed consolidated financial statements
should be read in conjunction with those consolidated financial statements included in the Form 10-K. In the opinion of management, all
adjustments considered necessary for a fair statement of the financial statements, consisting solely of normal recurring adjustments,
have been made. Operating results for the periods ended June 30, 2024 are not necessarily indicative of the results that may be expected
for the year ending December 31, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;Effective September 19, 2024,
the Company completed a &lt;span id="xdx_906_eus-gaap--StockholdersEquityReverseStockSplit_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMpcMLC8vT8k" title="Reverse stock split"&gt;one-for-fifty (1-for-50) reverse stock split&lt;/span&gt; of our issued and outstanding shares of Class A Common Stock without
a corresponding reduction in the total number of authorized shares of our Class A Common Stock (the &#x201c;Reverse Stock Split&#x201d;).
All references to shares of the Company&#x2019;s Class A Common Stock in these financial statements refer to the number of shares of Class
A Common Stock after giving effect to the Reverse Stock Split and are presented as if the Reverse Stock Split had occurred at the beginning
of the earliest period presented.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--WarrantLiabilitiesPolicyTextBlock_z2xSJd6nXNZi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zs3bpJIjbB8k"&gt;Warrant
Liabilities&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates
all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain
features that qualify as embedded derivatives. The classification of derivative instruments, including whether such instruments should
be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Warrant
Liability - related party&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
warrants originally issued in 7GC&#x2019;s initial public offering (the &#x201c;Public Warrants&#x201d;) are recognized as derivative liabilities
in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the
instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercise
or expiration, and any change in fair value is recognized in the Company&#x2019;s consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Public Warrants were initially measured at fair value using a Monte Carlo simulation model and have subsequently been measured based
on the listed market price of such warrants. Warrant liabilities are classified as current liabilities on the Company&#x2019;s consolidated
balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Warrant
Liability &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
GEM Warrants were not considered indexed to the issuer&#x2019;s stock pursuant to ASC 815, as the holder&#x2019;s ability to receive in
lieu of the Warrant one percent of the total consideration received by the Company&#x2019;s stockholders in connection with a Change of
Control, where the surviving corporation is not publicly traded, adjusts the settlement value based on items outside the Company&#x2019;s
control in violation of the fixed-for-fixed option pricing model. As such, the Company recorded the Warrants as liabilities initially
measured at fair value with subsequent changes in fair value recognized in earnings each reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
measurement of fair value was determined utilizing a Monte Carlo simulation considering all relevant assumptions current at the date
of issuance (i.e., share price, exercise price, term, volatility, risk-free rate, probability of dilutive term of three years, and expected
time to conversion).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--EarningsPerSharePolicyTextBlock_zfyk6CCbRHHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zri4fEuSQf27"&gt;Loss
Per Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of
shares of common stock outstanding during the period. Diluted net loss per share excludes, when applicable, the potential impact of stock
options and convertible preferred stock because their effect would be anti-dilutive due to the net loss. Since the Company had a net
loss in each of the periods presented, basic and diluted net loss per common share are the same.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zc7YYuwG5Ht6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of basic and diluted net loss per share attributable to common stock was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B9_zUR6Jfh7dcFb" style="display: none"&gt;Schedule
of Basic and Diluted Net Loss Per Share&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240401__20240630_zFHluK3S3nhb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20230401__20230630_z95r4DCevc87" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20240101__20240630_z1GrZhbtMKgg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230101__20230630_zzvsbz8z3fVd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;For
                                            the Three Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;June 30,&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;For
                                            the Six Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;June 30,&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_zyGIlvDn8ocl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Net loss attributable to common stock&#x2014;basic and diluted&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(4,165,108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(3,486,053&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(8,665,380&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(7,251,175&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average shares&#x2014;basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240401__20240630_zJFwkcqfFJkh" title="Weighted average shares-basic"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630_zhDeDJjqMtU9" title="Weighted average shares-diluted"&gt;541,836&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230401__20230630_znWJT4nPCTI4" title="Weighted average shares-basic"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630_zfYw1FWQhUo1" title="Weighted average shares-diluted"&gt;129,193&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20240630_zJM8G4gUjFD4" title="Weighted average shares-basic"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630_zfF10j7cI0b3" title="Weighted average shares-diluted"&gt;444,474&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20230630_zMYMimW3cqw3" title="Weighted average shares-basic"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230630_zsxvB5qf63df" title="Weighted average shares-diluted"&gt;129,127&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net loss per share attributable to common stock&#x2014;basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_c20240401__20240630_zvdIRacGfQH1" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_c20240401__20240630_zdgWOxCMndf" title="Net loss per share attributable to common stock-diluted"&gt;(7.69&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EarningsPerShareBasic_c20230401__20230630_znUOjf8hFgwb" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareDiluted_c20230401__20230630_zXWJZiNEMM08" title="Net loss per share attributable to common stock-diluted"&gt;(26.98&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20240101__20240630_zdKqgfpwsu36" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20240101__20240630_zarPfXLHIXU2" title="Net loss per share attributable to common stock-diluted"&gt;(19.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareBasic_c20230101__20230630_zxAn5WU0dPp4" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_c20230101__20230630_zKRUevcbtUG4" title="Net loss per share attributable to common stock-diluted"&gt;(56.16&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zfa4Cv4Y9RF2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zmNdZYwyy4wh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Securities
that were excluded from loss per share as their effect would be anti-dilutive due to the net loss position that could potentially be
dilutive in future periods are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B6_ztFWPeT0dtHf" style="display: none"&gt;Schedule
of Antidilutive Securities Excluded from Computation of Earnings Per Share&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240101__20240630_zboRhNaduUKg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230101__20230630_zGcHZFC5fQH8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zXm1IgQ80S29" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Options&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;33,649&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;13,405&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zd26bB93nAd3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;RSUs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,558&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1071"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublicWarrantsMember_z072X9VKbHfl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Public warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;230,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1074"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--GemWarrantsMember_zytUPdfe1JX3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;GEM warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,571&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1077"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonWarrantsMember_z8O50dwo2PUi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Common warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;277,778&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1080"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PlacementAgentWarrantsMember_zI5leMAqobK9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Placement agent warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,667&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1083"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zesNnvEDkC6c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;592,222&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;13,405&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zGDWDB6KbAA8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Antidilutive Securities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;592,222&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;13,405&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zhBaP5j2fI41" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--DerivativesPolicyTextBlock_zK4BRhSMMxll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zKuqd4cqBsFg"&gt;Derivative
Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates all its financial instruments to determine if such instruments contain features that qualify as embedded derivatives.
Embedded derivatives must be separately measured from the host contract if all the requirements for bifurcation are met. The assessment
of the conditions surrounding the bifurcation of embedded derivatives depends on the nature of the host contract. Bifurcated embedded
derivatives are recognized at fair value, with changes in fair value recognized in the statement of operations each period. Bifurcated
embedded derivatives are classified with the related host contract in the Company&#x2019;s balance sheet. Refer to &lt;i&gt;Note 7 - Fair Value
Measurements&lt;/i&gt; and &lt;i&gt;Note 11 - Debt&lt;/i&gt; for further detail.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zsvtdzWDa5Kh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_z6OvQFY6DfO2"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with FASB ASC 820 &lt;i&gt;Fair Value Measurements and Disclosures&lt;/i&gt;, the Company uses a three-level hierarchy for fair value
measurements of certain assets and liabilities for financial reporting purposes that distinguishes between market participant assumptions
developed from market data obtained from outside sources (observable inputs) and the Company&#x2019;s own assumptions about market participant
assumptions developed from the best information available to us in the circumstances (unobservable inputs). The fair value hierarchy
is divided into three levels based on the source of inputs as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1: Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2: Inputs other than Level 1 prices for similar assets or liabilities that are directly or indirectly observable in the marketplace.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3: Unobservable inputs which are supported by little or no market activity and values determined using pricing models, discounted cash
flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment
or estimation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management
during the three and six months ended June 30, 2024 and 2023. The carrying amount of cash, accounts receivable, prepaid expenses and
other current assets, accounts payable, accrued expenses, deferred revenue, and other current liabilities approximated their fair values
as of June 30, 2024 and December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zUtziDHX7iA" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zHmuiTLsgJH8"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Recent
accounting pronouncements not yet effective&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09 (Topic 740), Improvements to income tax disclosures, which enhances the disclosure requirements
for the income tax rate reconciliation, domestic and foreign income taxes paid, requiring disclosure of disaggregated income taxes paid
by jurisdiction, unrecognized tax benefits, and modifies other income tax-related disclosures. The amendments are effective for annual
periods beginning after December 15, 2024. Early adoption is permitted and should be applied prospectively. The Company is currently
evaluating the effect of adopting this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments
in this update intend to improve reportable segment disclosure requirements primarily through enhanced disclosures about significant
segment expenses. This ASU requires disclosure of significant segment expenses that are regularly provided to the chief operating decision
maker, the addition of a category for other segment items by reportable segment, that all annual segment disclosures be disclosed in
interim periods, and other related segment disclosures. The ASU is effective for fiscal years beginning after December 15, 2023, and
interim periods within fiscal years beginning after December 15, 2024. The Company is currently evaluating the effect of adopting this
guidance on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;
&lt;p id="xdx_853_zKNpsvhqR5q9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001018">&lt;p id="xdx_849_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zIoDitdguHg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zDTD3u1847Z2"&gt;Basis
of Presentation&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally
accepted in the United States of America (&#x201c;GAAP&#x201d;) as determined by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;)
Accounting Standards Codification (&#x201c;ASC&#x201d;) and applicable regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;)
for interim financial information and with the instructions to Form 10-Q of Regulation S-X. Certain information and note disclosures
normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such rules and regulations
of the SEC relating to interim financial statements. The December 31, 2023 balance sheet information was derived from the audited financial
statements as of that date. Except as disclosed herein, there has been no material change in the information disclosed in the notes to
the consolidated financial statements for the year ended December 31, 2023 included in the Company&#x2019;s Annual Report on Form 10-K,
as filed with the Securities and Exchange Commission on April 1, 2024. The interim unaudited condensed consolidated financial statements
should be read in conjunction with those consolidated financial statements included in the Form 10-K. In the opinion of management, all
adjustments considered necessary for a fair statement of the financial statements, consisting solely of normal recurring adjustments,
have been made. Operating results for the periods ended June 30, 2024 are not necessarily indicative of the results that may be expected
for the year ending December 31, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;Effective September 19, 2024,
the Company completed a &lt;span id="xdx_906_eus-gaap--StockholdersEquityReverseStockSplit_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMpcMLC8vT8k" title="Reverse stock split"&gt;one-for-fifty (1-for-50) reverse stock split&lt;/span&gt; of our issued and outstanding shares of Class A Common Stock without
a corresponding reduction in the total number of authorized shares of our Class A Common Stock (the &#x201c;Reverse Stock Split&#x201d;).
All references to shares of the Company&#x2019;s Class A Common Stock in these financial statements refer to the number of shares of Class
A Common Stock after giving effect to the Reverse Stock Split and are presented as if the Reverse Stock Split had occurred at the beginning
of the earliest period presented.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:StockholdersEquityReverseStockSplit
      contextRef="From2024-09-192024-09-19_us-gaap_SubsequentEventMember"
      id="Fact001020">one-for-fifty (1-for-50) reverse stock split</us-gaap:StockholdersEquityReverseStockSplit>
    <BNZI:WarrantLiabilitiesPolicyTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001022">&lt;p id="xdx_84B_ecustom--WarrantLiabilitiesPolicyTextBlock_z2xSJd6nXNZi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zs3bpJIjbB8k"&gt;Warrant
Liabilities&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates
all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain
features that qualify as embedded derivatives. The classification of derivative instruments, including whether such instruments should
be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Warrant
Liability - related party&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
warrants originally issued in 7GC&#x2019;s initial public offering (the &#x201c;Public Warrants&#x201d;) are recognized as derivative liabilities
in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the
instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercise
or expiration, and any change in fair value is recognized in the Company&#x2019;s consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Public Warrants were initially measured at fair value using a Monte Carlo simulation model and have subsequently been measured based
on the listed market price of such warrants. Warrant liabilities are classified as current liabilities on the Company&#x2019;s consolidated
balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Warrant
Liability &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
GEM Warrants were not considered indexed to the issuer&#x2019;s stock pursuant to ASC 815, as the holder&#x2019;s ability to receive in
lieu of the Warrant one percent of the total consideration received by the Company&#x2019;s stockholders in connection with a Change of
Control, where the surviving corporation is not publicly traded, adjusts the settlement value based on items outside the Company&#x2019;s
control in violation of the fixed-for-fixed option pricing model. As such, the Company recorded the Warrants as liabilities initially
measured at fair value with subsequent changes in fair value recognized in earnings each reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
measurement of fair value was determined utilizing a Monte Carlo simulation considering all relevant assumptions current at the date
of issuance (i.e., share price, exercise price, term, volatility, risk-free rate, probability of dilutive term of three years, and expected
time to conversion).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BNZI:WarrantLiabilitiesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001024">&lt;p id="xdx_843_eus-gaap--EarningsPerSharePolicyTextBlock_zfyk6CCbRHHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zri4fEuSQf27"&gt;Loss
Per Share&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of
shares of common stock outstanding during the period. Diluted net loss per share excludes, when applicable, the potential impact of stock
options and convertible preferred stock because their effect would be anti-dilutive due to the net loss. Since the Company had a net
loss in each of the periods presented, basic and diluted net loss per common share are the same.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zc7YYuwG5Ht6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of basic and diluted net loss per share attributable to common stock was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B9_zUR6Jfh7dcFb" style="display: none"&gt;Schedule
of Basic and Diluted Net Loss Per Share&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240401__20240630_zFHluK3S3nhb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20230401__20230630_z95r4DCevc87" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20240101__20240630_z1GrZhbtMKgg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230101__20230630_zzvsbz8z3fVd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;For
                                            the Three Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;June 30,&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;For
                                            the Six Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;June 30,&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_zyGIlvDn8ocl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Net loss attributable to common stock&#x2014;basic and diluted&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(4,165,108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(3,486,053&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(8,665,380&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(7,251,175&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average shares&#x2014;basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240401__20240630_zJFwkcqfFJkh" title="Weighted average shares-basic"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630_zhDeDJjqMtU9" title="Weighted average shares-diluted"&gt;541,836&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230401__20230630_znWJT4nPCTI4" title="Weighted average shares-basic"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630_zfYw1FWQhUo1" title="Weighted average shares-diluted"&gt;129,193&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20240630_zJM8G4gUjFD4" title="Weighted average shares-basic"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630_zfF10j7cI0b3" title="Weighted average shares-diluted"&gt;444,474&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20230630_zMYMimW3cqw3" title="Weighted average shares-basic"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230630_zsxvB5qf63df" title="Weighted average shares-diluted"&gt;129,127&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net loss per share attributable to common stock&#x2014;basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_c20240401__20240630_zvdIRacGfQH1" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_c20240401__20240630_zdgWOxCMndf" title="Net loss per share attributable to common stock-diluted"&gt;(7.69&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EarningsPerShareBasic_c20230401__20230630_znUOjf8hFgwb" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareDiluted_c20230401__20230630_zXWJZiNEMM08" title="Net loss per share attributable to common stock-diluted"&gt;(26.98&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20240101__20240630_zdKqgfpwsu36" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20240101__20240630_zarPfXLHIXU2" title="Net loss per share attributable to common stock-diluted"&gt;(19.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareBasic_c20230101__20230630_zxAn5WU0dPp4" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_c20230101__20230630_zKRUevcbtUG4" title="Net loss per share attributable to common stock-diluted"&gt;(56.16&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zfa4Cv4Y9RF2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zmNdZYwyy4wh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Securities
that were excluded from loss per share as their effect would be anti-dilutive due to the net loss position that could potentially be
dilutive in future periods are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B6_ztFWPeT0dtHf" style="display: none"&gt;Schedule
of Antidilutive Securities Excluded from Computation of Earnings Per Share&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240101__20240630_zboRhNaduUKg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230101__20230630_zGcHZFC5fQH8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zXm1IgQ80S29" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Options&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;33,649&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;13,405&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zd26bB93nAd3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;RSUs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,558&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1071"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublicWarrantsMember_z072X9VKbHfl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Public warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;230,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1074"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--GemWarrantsMember_zytUPdfe1JX3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;GEM warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,571&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1077"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonWarrantsMember_z8O50dwo2PUi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Common warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;277,778&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1080"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PlacementAgentWarrantsMember_zI5leMAqobK9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Placement agent warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,667&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1083"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zesNnvEDkC6c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;592,222&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;13,405&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zGDWDB6KbAA8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Antidilutive Securities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;592,222&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;13,405&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zhBaP5j2fI41" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001026">&lt;p id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zc7YYuwG5Ht6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of basic and diluted net loss per share attributable to common stock was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B9_zUR6Jfh7dcFb" style="display: none"&gt;Schedule
of Basic and Diluted Net Loss Per Share&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240401__20240630_zFHluK3S3nhb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20230401__20230630_z95r4DCevc87" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20240101__20240630_z1GrZhbtMKgg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230101__20230630_zzvsbz8z3fVd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;For
                                            the Three Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;June 30,&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;For
                                            the Six Months Ended&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;June 30,&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_zyGIlvDn8ocl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Net loss attributable to common stock&#x2014;basic and diluted&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(4,165,108&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(3,486,053&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(8,665,380&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(7,251,175&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average shares&#x2014;basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240401__20240630_zJFwkcqfFJkh" title="Weighted average shares-basic"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240401__20240630_zhDeDJjqMtU9" title="Weighted average shares-diluted"&gt;541,836&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230401__20230630_znWJT4nPCTI4" title="Weighted average shares-basic"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230401__20230630_zfYw1FWQhUo1" title="Weighted average shares-diluted"&gt;129,193&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20240630_zJM8G4gUjFD4" title="Weighted average shares-basic"&gt;&lt;span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240630_zfF10j7cI0b3" title="Weighted average shares-diluted"&gt;444,474&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20230630_zMYMimW3cqw3" title="Weighted average shares-basic"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20230101__20230630_zsxvB5qf63df" title="Weighted average shares-diluted"&gt;129,127&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Net loss per share attributable to common stock&#x2014;basic and diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--EarningsPerShareBasic_c20240401__20240630_zvdIRacGfQH1" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_c20240401__20240630_zdgWOxCMndf" title="Net loss per share attributable to common stock-diluted"&gt;(7.69&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--EarningsPerShareBasic_c20230401__20230630_znUOjf8hFgwb" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareDiluted_c20230401__20230630_zXWJZiNEMM08" title="Net loss per share attributable to common stock-diluted"&gt;(26.98&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareBasic_c20240101__20240630_zdKqgfpwsu36" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareDiluted_c20240101__20240630_zarPfXLHIXU2" title="Net loss per share attributable to common stock-diluted"&gt;(19.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--EarningsPerShareBasic_c20230101__20230630_zxAn5WU0dPp4" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_c20230101__20230630_zKRUevcbtUG4" title="Net loss per share attributable to common stock-diluted"&gt;(56.16&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact001028"
      unitRef="USD">-4165108</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact001029"
      unitRef="USD">-3486053</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact001030"
      unitRef="USD">-8665380</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact001031"
      unitRef="USD">-7251175</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-04-012024-06-30"
      decimals="INF"
      id="Fact001033"
      unitRef="Shares">541836</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-04-012024-06-30"
      decimals="INF"
      id="Fact001035"
      unitRef="Shares">541836</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-04-012023-06-30"
      decimals="INF"
      id="Fact001037"
      unitRef="Shares">129193</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-04-012023-06-30"
      decimals="INF"
      id="Fact001039"
      unitRef="Shares">129193</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact001041"
      unitRef="Shares">444474</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact001043"
      unitRef="Shares">444474</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-06-30"
      decimals="INF"
      id="Fact001045"
      unitRef="Shares">129127</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-06-30"
      decimals="INF"
      id="Fact001047"
      unitRef="Shares">129127</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-04-012024-06-30"
      decimals="INF"
      id="Fact001049"
      unitRef="USDPShares">-7.69</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-04-012024-06-30"
      decimals="INF"
      id="Fact001051"
      unitRef="USDPShares">-7.69</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-04-012023-06-30"
      decimals="INF"
      id="Fact001053"
      unitRef="USDPShares">-26.98</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-04-012023-06-30"
      decimals="INF"
      id="Fact001055"
      unitRef="USDPShares">-26.98</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact001057"
      unitRef="USDPShares">-19.50</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact001059"
      unitRef="USDPShares">-19.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-06-30"
      decimals="INF"
      id="Fact001061"
      unitRef="USDPShares">-56.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-06-30"
      decimals="INF"
      id="Fact001063"
      unitRef="USDPShares">-56.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001065">&lt;p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zmNdZYwyy4wh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Securities
that were excluded from loss per share as their effect would be anti-dilutive due to the net loss position that could potentially be
dilutive in future periods are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B6_ztFWPeT0dtHf" style="display: none"&gt;Schedule
of Antidilutive Securities Excluded from Computation of Earnings Per Share&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240101__20240630_zboRhNaduUKg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20230101__20230630_zGcHZFC5fQH8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;As of June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zXm1IgQ80S29" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Options&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;33,649&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;13,405&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockUnitsRSUMember_zd26bB93nAd3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;RSUs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,558&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1071"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublicWarrantsMember_z072X9VKbHfl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Public warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;230,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1074"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--GemWarrantsMember_zytUPdfe1JX3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;GEM warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;16,571&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1077"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonWarrantsMember_z8O50dwo2PUi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Common warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;277,778&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1080"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PlacementAgentWarrantsMember_zI5leMAqobK9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Placement agent warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;16,667&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1083"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zesNnvEDkC6c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;592,222&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;13,405&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zGDWDB6KbAA8" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Antidilutive Securities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;592,222&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;13,405&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-06-30_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001067"
      unitRef="Shares">33649</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-06-30_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001068"
      unitRef="Shares">13405</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-06-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact001070"
      unitRef="Shares">17558</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-06-30_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact001073"
      unitRef="Shares">230000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-06-30_custom_GemWarrantsMember"
      decimals="INF"
      id="Fact001076"
      unitRef="Shares">16571</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-06-30_custom_CommonWarrantsMember"
      decimals="INF"
      id="Fact001079"
      unitRef="Shares">277778</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-012024-06-30_custom_PlacementAgentWarrantsMember"
      decimals="INF"
      id="Fact001082"
      unitRef="Shares">16667</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact001085"
      unitRef="Shares">592222</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-06-30"
      decimals="INF"
      id="Fact001086"
      unitRef="Shares">13405</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact001088"
      unitRef="Shares">592222</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-06-30"
      decimals="INF"
      id="Fact001089"
      unitRef="Shares">13405</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001091">&lt;p id="xdx_84C_eus-gaap--DerivativesPolicyTextBlock_zK4BRhSMMxll" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zKuqd4cqBsFg"&gt;Derivative
Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates all its financial instruments to determine if such instruments contain features that qualify as embedded derivatives.
Embedded derivatives must be separately measured from the host contract if all the requirements for bifurcation are met. The assessment
of the conditions surrounding the bifurcation of embedded derivatives depends on the nature of the host contract. Bifurcated embedded
derivatives are recognized at fair value, with changes in fair value recognized in the statement of operations each period. Bifurcated
embedded derivatives are classified with the related host contract in the Company&#x2019;s balance sheet. Refer to &lt;i&gt;Note 7 - Fair Value
Measurements&lt;/i&gt; and &lt;i&gt;Note 11 - Debt&lt;/i&gt; for further detail.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2024-01-01to2024-06-30" id="Fact001093">&lt;p id="xdx_84E_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zsvtdzWDa5Kh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_z6OvQFY6DfO2"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with FASB ASC 820 &lt;i&gt;Fair Value Measurements and Disclosures&lt;/i&gt;, the Company uses a three-level hierarchy for fair value
measurements of certain assets and liabilities for financial reporting purposes that distinguishes between market participant assumptions
developed from market data obtained from outside sources (observable inputs) and the Company&#x2019;s own assumptions about market participant
assumptions developed from the best information available to us in the circumstances (unobservable inputs). The fair value hierarchy
is divided into three levels based on the source of inputs as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1: Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2: Inputs other than Level 1 prices for similar assets or liabilities that are directly or indirectly observable in the marketplace.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3: Unobservable inputs which are supported by little or no market activity and values determined using pricing models, discounted cash
flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment
or estimation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management
during the three and six months ended June 30, 2024 and 2023. The carrying amount of cash, accounts receivable, prepaid expenses and
other current assets, accounts payable, accrued expenses, deferred revenue, and other current liabilities approximated their fair values
as of June 30, 2024 and December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001095">&lt;p id="xdx_844_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zUtziDHX7iA" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86C_zHmuiTLsgJH8"&gt;Recent
Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Recent
accounting pronouncements not yet effective&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09 (Topic 740), Improvements to income tax disclosures, which enhances the disclosure requirements
for the income tax rate reconciliation, domestic and foreign income taxes paid, requiring disclosure of disaggregated income taxes paid
by jurisdiction, unrecognized tax benefits, and modifies other income tax-related disclosures. The amendments are effective for annual
periods beginning after December 15, 2024. Early adoption is permitted and should be applied prospectively. The Company is currently
evaluating the effect of adopting this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments
in this update intend to improve reportable segment disclosure requirements primarily through enhanced disclosures about significant
segment expenses. This ASU requires disclosure of significant segment expenses that are regularly provided to the chief operating decision
maker, the addition of a category for other segment items by reportable segment, that all annual segment disclosures be disclosed in
interim periods, and other related segment disclosures. The ASU is effective for fiscal years beginning after December 15, 2023, and
interim periods within fiscal years beginning after December 15, 2024. The Company is currently evaluating the effect of adopting this
guidance on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001097">&lt;p id="xdx_807_eus-gaap--MergersAcquisitionsAndDispositionsDisclosuresTextBlock_zgAkb7HQ1ntb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;4.
&lt;span id="xdx_82F_zHEvM0xUUqSa"&gt;Reverse Merger Capitalization with 7GC &amp;amp; Co. Holdings Inc.&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2023 (the &#x201c;Closing Date&#x201d;), Banzai consummated the previously announced Merger with 7GC, as a result of which
Banzai became a wholly-owned subsidiary of 7GC. While 7GC was the legal acquirer of Banzai in the merger, for accounting purposes, Legacy
Banzai was deemed to be the accounting acquirer in the merger. The determination was primarily based on Legacy Banzai&#x2019;s stockholders
having a majority of the voting power in the combined Company, Legacy Banzai having the ability to appoint a majority of the Board of
Directors of the Company, Legacy Banzai&#x2019;s existing management team comprising the senior management of the combined Company, Legacy
Banzai comprising the ongoing operations of the combined Company and the combined Company assumed the name &#x201c;Banzai International,
Inc.&#x201d;. Accordingly, for accounting purposes, the merger was treated as the equivalent of Legacy Banzai issuing stock for the net
assets of 7GC, accompanied by a recapitalization. The net assets of 7GC are stated at historical cost, with no goodwill or other intangible
assets recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Retroactive
Restatement for Conversion of Common Stock and Series A Preferred Stock by Applying Exchange Ratio&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
the closing of the merger, holders of Legacy Banzai common stock and Series A preferred stock received shares of common stock in an amount
determined by application of the Exchange Ratio. In accordance with guidance applicable to these circumstances, the equity structure
has been restated in all comparable periods, prior to the merger, up to December 14, 2023, to reflect the number of shares of the Company&#x2019;s
common stock, $&lt;span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231214__dei--LegalEntityAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zicefzMYVzee" title="Common stock par value"&gt;0.0001&lt;/span&gt; par value per share, issued to Legacy Banzai&#x2019;s stockholders in connection with the merger. As such, the shares
and corresponding capital amounts and earnings per share related to Legacy Banzai&#x2019;s outstanding Series A preferred stock and Legacy
Banzai&#x2019;s common stock prior to the merger have been retroactively restated as shares reflecting the exchange ratio of approximately
&lt;span id="xdx_90A_ecustom--ExchangeRatio_iI_uPure_c20231214__dei--LegalEntityAxis__custom--BanzaiInternationalIncMember_z4uqHzIClyp7" title="Exchange ratio"&gt;0.6147&lt;/span&gt; established in the merger. Legacy Banzai&#x2019;s Series A preferred stock previously classified as temporary equity was retroactively
adjusted, converted into common stock and reclassified to permanent equity as a result of the reverse recapitalization. The consolidated
assets, liabilities, and results of operations prior to the merger are those of Legacy Banzai.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aggregate consideration payable to securityholders of Banzai at the Closing Date was equal to $&lt;span id="xdx_90A_ecustom--BusinessCombinationProvisionalInformationInitialAccountingIncompleteReductionConsiderationTransferred_c20231214__20231214__dei--LegalEntityAxis__custom--BanzaiInternationalIncMember_zGfdGx7Qztch" title="Aggregate consideration payable to security holders"&gt;100,000,000&lt;/span&gt;. Holders of &lt;span id="xdx_903_ecustom--NumberOfSharesHeldBySecurityHolders_iI_c20231214__us-gaap--StatementClassOfStockAxis__custom--SevenGCClassACommonStockMember_z70bDpRMsGTa" title="Number of shares held by security holders"&gt;3,207,428&lt;/span&gt; shares
of 7GC&#x2019;s Class A common stock, par value $&lt;span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231214__us-gaap--StatementClassOfStockAxis__custom--SevenGCClassACommonStockMember_za4kf4W3Xrfl" title="Common stock par value"&gt;0.0001&lt;/span&gt; per share (&#x201c;7GC Class A Common Stock&#x201d;), exercised their right to redeem
their shares for cash at a redemption price of approximately $&lt;span id="xdx_905_ecustom--RedemptionPricePerShare_iI_c20231214__us-gaap--StatementClassOfStockAxis__custom--SevenGCClassACommonStockMember_zYfLLC3F1Jf9" title="Redemption price per share"&gt;10.76&lt;/span&gt; per share, for an aggregate redemption amount of $&lt;span id="xdx_90F_ecustom--AggregateRedemptionAmount_iI_c20231214__us-gaap--StatementClassOfStockAxis__custom--SevenGCClassACommonStockMember_zxSmx2LXO7Ga" title="Aggregate redemption amount"&gt;34,524,065&lt;/span&gt;. Immediately
prior to the Closing Date, each share of Banzai&#x2019;s Preferred Stock that was issued and outstanding was automatically converted into
one share of Banzai&#x2019;s Class A Common Stock, par value $&lt;span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--BanzaiInternationalIncMember_zldGEsaABHta" title="Common stock par value"&gt;0.0001&lt;/span&gt; per share. Each share of Banzai&#x2019;s Class B Common Stock that
was not held by the Chief Executive Officer of the Company converted to &lt;span id="xdx_90D_ecustom--CommonStockConvertibleConversionRatio_iI_pdp0_dc_uPure_c20231214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__dei--LegalEntityAxis__custom--BanzaiInternationalIncMember_zeJJ3vYG4kx8" title="Common stock, convertible, conversion ratio"&gt;one&lt;/span&gt; share of Banzai&#x2019;s Class A Common Stock, while the Chief
Executive Officer received Class B Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
the terms and subject to the conditions set forth in the Merger Agreement, at the Second Effective Time, each share of common stock of
the Surviving Corporation issued and outstanding immediately prior to the Second Effective Time was cancelled and no consideration was
delivered therefore.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;Upon
the closing of the merger, the Company&#x2019;s certificate of incorporation was amended and restated to, among other things, increase
the total number of authorized shares of all classes of capital stock to &lt;span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20231214_zqGkOdmAhsa1" title="Common stock, shares authorized"&gt;350,000,000&lt;/span&gt; shares, consisting of &lt;span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_c20231214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z9a0rilNMP71" title="Common stock, shares authorized"&gt;5,000,000&lt;/span&gt; shares of Class
A Common Stock, &lt;span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_c20231214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z9WhUK3XfCli" title="Common stock, shares authorized"&gt;25,000,000&lt;/span&gt; shares of Class B Common Stock, and &lt;span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20231214_zFG4iL3M6AO8" title="Preferred stock, shares authorized"&gt;75,000,000&lt;/span&gt; shares of Preferred Stock, all having a par value of $&lt;span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231214_zd5suJD6JgNg" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt;
per share. As of June 30, 2024, there were &lt;span id="xdx_907_eus-gaap--CommonStockSharesIssued_iI_c20240630_zB6UaYwmW7tj" title="Common stock, shares issued"&gt;&lt;span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_c20240630_zEQT4u1t1Cnf" title="Common stock, shares outstanding"&gt;3,003,810&lt;/span&gt;&lt;/span&gt; shares of Common Stock and &lt;span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20240630_z8ZJHuyUuEs9" title="Preferred stock, shares outstanding"&gt;no&lt;/span&gt; shares of Preferred Stock outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Effect
of Merger on Class A and Class B Common Stock&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
the Close of the Merger, holders of Legacy Banzai common stock and Series A preferred stock were converted into shares of common stock
in an amount determined by application of the Exchange Ratio. As noted above, the equity structure has been restated in all comparable
periods, prior to the Merger, up to December 14, 2023, to reflect the number of shares of the Company&#x2019;s common stock, $&lt;span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231214__dei--LegalEntityAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zrn45ks2ubW" title="Common stock, par value"&gt;0.0001&lt;/span&gt; par
value per share, issued to Legacy Banzai&#x2019;s stockholders in connection with the Merger.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_ecustom--ScheduleOfReconciliationOfTheMergerToTheCompanysConsolidatedCashFlowsTableTextBlock_zHi3mCSwV4Ek" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_ziVVanBZSrld"&gt;Schedule
of Reconciliation of the Merger to the Company's Consolidated Cash Flows&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8AE_zTkIHKCvgqX3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001099"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <BNZI:ExchangeRatio
      contextRef="AsOf2023-12-14_custom_BanzaiInternationalIncMember"
      decimals="INF"
      id="Fact001101"
      unitRef="Pure">0.6147</BNZI:ExchangeRatio>
    <BNZI:BusinessCombinationProvisionalInformationInitialAccountingIncompleteReductionConsiderationTransferred
      contextRef="From2023-12-142023-12-14_custom_BanzaiInternationalIncMember"
      decimals="0"
      id="Fact001103"
      unitRef="USD">100000000</BNZI:BusinessCombinationProvisionalInformationInitialAccountingIncompleteReductionConsiderationTransferred>
    <BNZI:NumberOfSharesHeldBySecurityHolders
      contextRef="AsOf2023-12-14_custom_SevenGCClassACommonStockMember"
      decimals="INF"
      id="Fact001105"
      unitRef="Shares">3207428</BNZI:NumberOfSharesHeldBySecurityHolders>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14_custom_SevenGCClassACommonStockMember"
      decimals="INF"
      id="Fact001107"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <BNZI:RedemptionPricePerShare
      contextRef="AsOf2023-12-14_custom_SevenGCClassACommonStockMember"
      decimals="INF"
      id="Fact001109"
      unitRef="USDPShares">10.76</BNZI:RedemptionPricePerShare>
    <BNZI:AggregateRedemptionAmount
      contextRef="AsOf2023-12-14_custom_SevenGCClassACommonStockMember"
      decimals="0"
      id="Fact001111"
      unitRef="USD">34524065</BNZI:AggregateRedemptionAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14_us-gaap_CommonClassAMember_custom_BanzaiInternationalIncMember"
      decimals="INF"
      id="Fact001113"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <BNZI:CommonStockConvertibleConversionRatio
      contextRef="AsOf2023-12-14_us-gaap_CommonClassBMember_custom_BanzaiInternationalIncMember"
      decimals="INF"
      id="Fact001115"
      unitRef="Pure">1</BNZI:CommonStockConvertibleConversionRatio>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-14"
      decimals="INF"
      id="Fact001117"
      unitRef="Shares">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-14_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact001119"
      unitRef="Shares">5000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-14_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact001121"
      unitRef="Shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-14"
      decimals="INF"
      id="Fact001123"
      unitRef="Shares">75000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14"
      decimals="INF"
      id="Fact001125"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001127"
      unitRef="Shares">3003810</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001129"
      unitRef="Shares">3003810</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact001131"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001133"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <BNZI:ScheduleOfReconciliationOfTheMergerToTheCompanysConsolidatedCashFlowsTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001135">&lt;p id="xdx_891_ecustom--ScheduleOfReconciliationOfTheMergerToTheCompanysConsolidatedCashFlowsTableTextBlock_zHi3mCSwV4Ek" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_ziVVanBZSrld"&gt;Schedule
of Reconciliation of the Merger to the Company's Consolidated Cash Flows&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span&gt;&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BNZI:ScheduleOfReconciliationOfTheMergerToTheCompanysConsolidatedCashFlowsTableTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001137">&lt;p id="xdx_801_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z2auRARvWy0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;5.
&lt;span id="xdx_82E_zSa1YVJyCUbf"&gt;Related Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;7GC
Related Party Promissory Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 21, 2022, 7GC issued an unsecured promissory note (the &#x201c;December 2022 7GC Note&#x201d;) to the Sponsor, 7GC &amp;amp; Co. Holdings
LLC, which provides for borrowings from time to time of up to an aggregate of $&lt;span id="xdx_905_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20221221__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalDrawdownsAndExtensionDrawdownsMember_zOLVv3xmo28j" title="Aggregate redemption amount"&gt;2,300,000&lt;/span&gt;. The December 2022 7GC Note does not bear interest.
Upon the consummation of a Business Combination, the Sponsor shall have the option, but not the obligation, to convert the principal
balance of the December 2022 7GC Note, in whole or in part, into that number of shares of Class A common stock, $&lt;span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221221__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalDrawdownsAndExtensionDrawdownsMember_z1t0benbRftk" title="Common stock par value"&gt;0.0001&lt;/span&gt; par value per
share, of 7GC (the &#x201c;Converted Shares&#x201d;) equal to the principal amount of the December 2022 7GC Note so converted divided by
$&lt;span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20221221__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember_zikMamB0wFQl" title="Debt instrument conversion price per share"&gt;10.00&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 3, 2023, 7GC issued an additional unsecured promissory note (the &#x201c;October 2023 7GC Note&#x201d;, together with the December
2022 7GC Note, the &#x201c; 7GC Promissory Notes&#x201d;) to the Sponsor, which provides for borrowings from time to time of up to an aggregate
of $&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20231003__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--DebtInstrumentAxis__custom--WorkingCapitalLoansMember_zqleWSNT9ndc" title="Aggregate principal amount"&gt;500,000&lt;/span&gt; for working capital purposes. The October 2023 7GC Note does &lt;span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dpo_c20231003__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--DebtInstrumentAxis__custom--WorkingCapitalLoansMember_zSNZZkBLGcX2" title="Debt instrument, interest rate"&gt;no&lt;/span&gt;t bear interest. Upon the consummation of a Business Combination,
the Sponsor shall have the option, but not the obligation, to convert the principal balance of the October 2023 7GC Note, in whole or
in part, into that number of the Converted Shares, equal to the principal amount of the October 2023 7GC Note so converted divided by
$&lt;span id="xdx_901_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20231003__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--DebtInstrumentAxis__custom--WorkingCapitalLoansMember_z3ZPIjBtkoV8" title="Debt instrument conversion price per share"&gt;10.00&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
Closing of the Merger, Banzai assumed the 7GC Promissory Notes which subsequently converted on February 2, 2024. At the date of conversion,
the total balance of the Notes converted was $&lt;span id="xdx_90F_eus-gaap--ConvertibleDebtCurrent_iI_c20240202__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember_z6DuWKaoSVhk" title="Convertible notes"&gt;2,540,092&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Due
to Related Party of 7GC&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2023, the Sponsor paid certain expenses on behalf of 7GC. Upon Closing of the Merger, Banzai assumed the
$&lt;span id="xdx_909_eus-gaap--OtherLiabilitiesCurrent_iI_c20231231__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zRvAZuAODOHd" title="Other current liabilities"&gt;67,118&lt;/span&gt; liability. As of June 30, 2024, the entire balance remained outstanding and is included within due to related party under current
liabilities on the accompanying unaudited condensed consolidated balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Legacy
Banzai Related Party Transactions&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2023, Legacy Banzai issued Promissory Notes and Convertible Notes to related parties. See &lt;i&gt;Note 11 - Debt &lt;/i&gt;for further details related
to these transactions and associated balances.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2022-12-21_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalDrawdownsAndExtensionDrawdownsMember"
      decimals="0"
      id="Fact001139"
      unitRef="USD">2300000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-21_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalDrawdownsAndExtensionDrawdownsMember"
      decimals="INF"
      id="Fact001141"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2022-12-21_custom_SevenGcCoHoldingsIncMember"
      decimals="INF"
      id="Fact001143"
      unitRef="USDPShares">10.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-10-03_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalLoansMember"
      decimals="0"
      id="Fact001145"
      unitRef="USD">500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-10-03_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalLoansMember"
      decimals="INF"
      id="Fact001147"
      unitRef="Pure">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2023-10-03_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalLoansMember"
      decimals="INF"
      id="Fact001149"
      unitRef="USDPShares">10.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2024-02-02_custom_SevenGcCoHoldingsIncMember"
      decimals="0"
      id="Fact001151"
      unitRef="USD">2540092</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_SevenGcCoHoldingsIncMember_custom_SponsorMember"
      decimals="0"
      id="Fact001153"
      unitRef="USD">67118</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001155">&lt;p id="xdx_803_eus-gaap--RevenueFromContractWithCustomerTextBlock_z2t9m2hDLXji" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;6.
&lt;span id="xdx_82D_z3OCrjC0X0il"&gt;Revenue&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
ASC 606, revenue is recognized throughout the life of the executed agreement. The Company measures revenue based on considerations specified
in terms and conditions agreed to by a customer. Furthermore, the Company recognizes revenue when a performance obligation is satisfied
by transferring control of the service to the customer, which occurs over time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s services include providing end-to-end video engagement solutions that provide a fast, intuitive and powerful platform
of marketing tools that create more intent-driven videos, webinars, virtual events and other digital and in-person marketing campaigns.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
noted within the SOW&#x2019;s and invoices, agreements range from monthly to annual and Banzai generally provides for net &lt;span id="xdx_903_ecustom--PaymentTerm_dtD_c20240101__20240630_zTHVCzaBavak" title="Payment Term"&gt;30&lt;/span&gt;-day payment
terms with the payment made directly through check or electronic means.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Banzai&#x2019;s
Management believes its exposure to credit risk is sufficiently mitigated by collection through credit card sales or direct payment from
established clients.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Nature
of Products and Services&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a description of the Company&#x2019;s products and services from which the Company generates revenue, as well as the nature,
timing of satisfaction of performance obligations, and significant payment terms for each, as applicable:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Demio&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Demio product is a full-stack technology that marketers can leverage live and automated for video marketing content such as webinars
and virtual events. Software products are provided to Demio customers for a range of attendees and hosts within a specified time frame
at a specified established price. &lt;span id="xdx_906_eus-gaap--RevenuePerformanceObligationDescriptionOfTiming_c20240101__20240630__srt--ProductOrServiceAxis__custom--DemioMember_z0BGh3or0lai" title="Performance obligations, timing"&gt;The performance obligations identified include access to the suite and platform, within the parameters
established, and within the standards established in the agreement. Contracts include a standalone selling price for the number of webinars
and hosts as a performance obligation. There are no financing components and payments are typically net 30 of date or receipt of invoice.
It is nearly 100% certain that a significant revenue reversal will not occur. The Company recognizes revenue for its sale of Demio services
over time which corresponds with the period of time that access to the service is provided.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Reach&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;While
the Reach product is in the process of being phased out, the Company continues to generate revenues from the product. The Reach product
provides a multi-channel targeted audience acquisition (via Reach) to bolster engagement and Return on Investment (ROI). Banzai enables
marketing teams to create winning webinars and virtual and in-person events that increase marketing efficiency and drive additional revenue.
Software products are provided to Reach customers for a range of simultaneous events and registrations within a specified time frame
at a specified established price. &lt;span id="xdx_90F_eus-gaap--RevenuePerformanceObligationDescriptionOfTiming_c20240101__20240630__srt--ProductOrServiceAxis__custom--ReachMember_ztzD4I8KsxMi" title="Performance obligations, timing"&gt;The performance obligations identified include access to the suite and platform, within the parameters
established, and within the standards established in the agreement. Contracts include a standalone selling price for the number of simultaneous
published events as a performance obligation. There are no financing components and payments are typically net 30 of date or receipt
of invoice. It is nearly 100% certain that a significant revenue reversal will not occur. The Company recognizes revenue for its sale
of Reach services over time which corresponds with the timing the service is rendered.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Disaggregation
of Revenue&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_zUHzjlmJSsWd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes revenue by region based on the billing address of customers for the three months ended June 30, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zmMlXRvNh7N2"&gt;Summary
of Revenue by Region&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Percentage of Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Percentage of Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 36%"&gt;Americas&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240401__20240630__srt--StatementGeographicalAxis__srt--AmericasMember_zk3IqVit9aMg" style="width: 12%; text-align: right" title="Revenue"&gt;587,712&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_dp_c20240401__20240630__srt--StatementGeographicalAxis__srt--AmericasMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zxQeBQ9vRBGa" style="width: 12%; text-align: right" title="Percentage of Revenue"&gt;55&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230401__20230630__srt--StatementGeographicalAxis__srt--AmericasMember_z32Gp7ET9rLe" style="width: 12%; text-align: right" title="Revenue"&gt;704,626&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20230630__srt--StatementGeographicalAxis__srt--AmericasMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_z03T5l0VFbFd" style="width: 12%; text-align: right" title="Percentage of Revenue"&gt;59&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Europe, Middle East and Africa (EMEA)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240401__20240630__srt--StatementGeographicalAxis__us-gaap--EMEAMember_zh3G4GPjv2u2" style="text-align: right" title="Revenue"&gt;360,666&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_dp_c20240401__20240630__srt--StatementGeographicalAxis__us-gaap--EMEAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zBj9NftGmwPa" style="text-align: right" title="Percentage of Revenue"&gt;34&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230401__20230630__srt--StatementGeographicalAxis__us-gaap--EMEAMember_zWsP6kjLfdwh" style="text-align: right" title="Revenue"&gt;389,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20230630__srt--StatementGeographicalAxis__us-gaap--EMEAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zMKCuGBsPVW2" style="text-align: right" title="Percentage of Revenue"&gt;33&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Asia Pacific&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240401__20240630__srt--StatementGeographicalAxis__srt--AsiaPacificMember_zUz1aRschYSa" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;119,819&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20240401__20240630__srt--StatementGeographicalAxis__srt--AsiaPacificMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_ztUcdBwIeJ5j" style="border-bottom: Black 1pt solid; text-align: right" title="Percentage of Revenue"&gt;11&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230401__20230630__srt--StatementGeographicalAxis__srt--AsiaPacificMember_znz9nDZET727" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;99,377&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20230630__srt--StatementGeographicalAxis__srt--AsiaPacificMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_ziGyexzH4Yt4" style="border-bottom: Black 1pt solid; text-align: right" title="Percentage of Revenue"&gt;8&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240401__20240630_zYojN6Jyays3" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount"&gt;1,068,197&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_dp_c20240401__20240630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_za1GTVmcaHjc" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of Revenue"&gt;100&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230401__20230630_zX1N6DNLTIPe" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount"&gt;1,193,321&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zrIlQH15Un8j" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of Revenue"&gt;100&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes revenue by region based on the billing address of customers for the six months ended June 30, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Six Months Ended June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Percentage of Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Percentage of Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 36%"&gt;Americas&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240101__20240630__srt--StatementGeographicalAxis__srt--AmericasMember_z3u6E7y8ijxa" style="width: 12%; text-align: right" title="Revenue"&gt;1,170,539&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__srt--StatementGeographicalAxis__srt--AmericasMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zoCcIJQfG9w2" style="width: 12%; text-align: right" title="Percentage of Revenue"&gt;55&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20230630__srt--StatementGeographicalAxis__srt--AmericasMember_zh01HYHR3W62" style="width: 12%; text-align: right" title="Revenue"&gt;1,374,401&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--StatementGeographicalAxis__srt--AmericasMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_z99hSG6mBscl" style="width: 12%; text-align: right" title="Percentage of Revenue"&gt;62&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Europe, Middle East and Africa (EMEA)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240101__20240630__srt--StatementGeographicalAxis__us-gaap--EMEAMember_zt3YMdk6xKU5" style="text-align: right" title="Revenue"&gt;746,916&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__srt--StatementGeographicalAxis__us-gaap--EMEAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zWRmY4BVvE8g" style="text-align: right" title="Percentage of Revenue"&gt;34&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20230630__srt--StatementGeographicalAxis__us-gaap--EMEAMember_zPPI8FOM1qLa" style="text-align: right" title="Revenue"&gt;797,228&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--StatementGeographicalAxis__us-gaap--EMEAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_z9dDGyRkcjb8" style="text-align: right" title="Percentage of Revenue"&gt;30&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Asia Pacific&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240101__20240630__srt--StatementGeographicalAxis__srt--AsiaPacificMember_z6Ra6knbhJfe" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;230,214&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__srt--StatementGeographicalAxis__srt--AsiaPacificMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zoXp6VkMRd81" style="border-bottom: Black 1pt solid; text-align: right" title="Percentage of Revenue"&gt;11&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20230630__srt--StatementGeographicalAxis__srt--AsiaPacificMember_zp4GO5u4bUH8" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;198,753&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--StatementGeographicalAxis__srt--AsiaPacificMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zKeSvofj7R03" style="border-bottom: Black 1pt solid; text-align: right" title="Percentage of Revenue"&gt;8&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240101__20240630_zdDZOB25sdc7" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount"&gt;2,147,669&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zPuNGWzcKD52" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of Revenue"&gt;100&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20230630_zQmGSAgXc5p8" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount"&gt;2,370,382&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_z2WmO1svwwT8" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of Revenue"&gt;100&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zSLOfZGacl3c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Contract
Balances&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Accounts
Receivable, Net&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
receivable is recorded when an unconditional right to invoice and receive payment exists, such that only the passage of time is required
before payment of consideration is due. &lt;span id="xdx_90B_ecustom--AccountsReceivableContractualTerm_c20240101__20240630_zTHTu3HGLdU4" title="Accounts receivable contractual term"&gt;The Company receives payments from customers based upon agreed-upon contractual terms, typically
within 30 days of invoicing the customer.&lt;/span&gt; The timing of revenue recognition may differ from the timing of invoicing to customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zRqHR0whY0Ma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_zP259Qx5CsV9"&gt;Summary
of Accounts Receivable, Net&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Opening Balance&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Closing Balance&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Opening Balance&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Closing Balance&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;1/1/2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;6/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;1/1/2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;6/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Accounts receivable, net&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AccountsReceivableNetCurrent_iS_c20240101__20240630_zFi0cmPLVlz5" style="width: 10%; text-align: right" title="Opening Balance"&gt;105,049&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccountsReceivableNetCurrent_iE_c20240101__20240630_zE3EG3Yx5l37" style="width: 10%; text-align: right" title="Closing Balance"&gt;26,161&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccountsReceivableNetCurrent_iS_c20230101__20230630_zDm0ejfKnPBk" style="width: 10%; text-align: right" title="Opening Balance"&gt;68,416&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccountsReceivableNetCurrent_iE_c20230101__20230630_zGibCTWUato7" style="width: 10%; text-align: right" title="Closing Balance"&gt;109,533&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zRugHAnYTTjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Costs
to Obtain a Contract&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sales
commissions, the principal costs incurred to obtain a contract, are earned when the contract is executed. Management has capitalized
these costs and amortized the commission expense over time in accordance with the related contract&#x2019;s term. For the three and six
months ended June 30, 2024, commission expenses were $&lt;span id="xdx_904_eus-gaap--SalesCommissionsAndFees_c20240401__20240630_zZmfZamqaWi7" title="Commission expenses"&gt;61,146&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--SalesCommissionsAndFees_c20240101__20240630_zIT2ZI81I79k" title="Commission expenses"&gt;143,288&lt;/span&gt;, respectively. For the three and six months ended June 30,
2023, commission expenses were $&lt;span id="xdx_90E_eus-gaap--SalesCommissionsAndFees_c20230401__20230630_zzKgBT5i2pSj" title="Commission expenses"&gt;91,243&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--SalesCommissionsAndFees_c20230101__20230630_zzAHMLcDsx7h" title="Commission expenses"&gt;190,619&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Capitalized
commissions at June 30, 2024 and December 31, 2023 were $&lt;span id="xdx_904_eus-gaap--CapitalizedContractCostNetCurrent_iI_c20240630_z5a1RqIlXXYa" title="Capitalized commissions"&gt;39,144&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--CapitalizedContractCostNetCurrent_iI_c20231231_zRKSeVaKGt13" title="Capitalized commissions"&gt;51,472&lt;/span&gt;, respectively, and are included within prepaid expenses and
other current assets on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--CapitalizedContractCostTableTextBlock_z1Tq5ogXfT6f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following summarizes the Costs to obtain a contract activity during the three and six months ended June 30, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zkxft3JAS228"&gt;Summary
of Costs to Obtain Contract Activity&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_4BA_z7mMiCNWKhhl" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_434_c20240101__20240331_eus-gaap--CapitalizedContractCostNetCurrent_iS_zoRFa9ORbU85" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Balance - December 31, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;51,472&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--CommissionsIncurred_zfrmV527Ha16" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Commissions Incurred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,610&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DeferredCommissionsRecognized_iN_di_zUwpfkenLil5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Deferred Commissions Recognized&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44,620&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20240401__20240630_eus-gaap--CapitalizedContractCostNetCurrent_iS_zFdzFEfuobS6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Balance - March 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38,462&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--CommissionsIncurred_zQ62dHRQeBJl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Commissions Incurred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48,316&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DeferredCommissionsRecognized_iN_di_zjw2ODN1yUq8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Deferred Commissions Recognized&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(47,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20240401__20240630_eus-gaap--CapitalizedContractCostNetCurrent_iE_zmXBPcStrKz3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance - June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;39,144&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following summarizes the Costs to obtain a contract activity during the three and six months ended June 30, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_4BA_z7lGeASb8oP5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_434_c20230101__20230331_eus-gaap--CapitalizedContractCostNetCurrent_iS_zqgZNzxN6ao8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Balance - December 31, 2022&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;69,737&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--CommissionsIncurred_zr6tIWagcbkb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Commissions Incurred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;88,928&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DeferredCommissionsRecognized_iN_di_zusu4fEuftig" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Deferred Commissions Recognized&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(104,289&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_432_c20230401__20230630_eus-gaap--CapitalizedContractCostNetCurrent_iS_zyXfQZLwCxpk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Balance - March 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54,376&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--CommissionsIncurred_zbdHzDnSYHA8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Commissions Incurred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;60,777&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DeferredCommissionsRecognized_iN_di_zmGdwyJ5p8O1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Deferred Commissions Recognized&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(75,001&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20230401__20230630_eus-gaap--CapitalizedContractCostNetCurrent_iE_zSYk5nI26598" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance - June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;40,152&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zyOY9jYWy1rj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <BNZI:PaymentTerm contextRef="From2024-01-01to2024-06-30" id="Fact001157">P30D</BNZI:PaymentTerm>
    <us-gaap:RevenuePerformanceObligationDescriptionOfTiming
      contextRef="From2024-01-012024-06-30_custom_DemioMember"
      id="Fact001159">The performance obligations identified include access to the suite and platform, within the parameters
established, and within the standards established in the agreement. Contracts include a standalone selling price for the number of webinars
and hosts as a performance obligation. There are no financing components and payments are typically net 30 of date or receipt of invoice.
It is nearly 100% certain that a significant revenue reversal will not occur. The Company recognizes revenue for its sale of Demio services
over time which corresponds with the period of time that access to the service is provided.</us-gaap:RevenuePerformanceObligationDescriptionOfTiming>
    <us-gaap:RevenuePerformanceObligationDescriptionOfTiming
      contextRef="From2024-01-012024-06-30_custom_ReachMember"
      id="Fact001161">The performance obligations identified include access to the suite and platform, within the parameters
established, and within the standards established in the agreement. Contracts include a standalone selling price for the number of simultaneous
published events as a performance obligation. There are no financing components and payments are typically net 30 of date or receipt
of invoice. It is nearly 100% certain that a significant revenue reversal will not occur. The Company recognizes revenue for its sale
of Reach services over time which corresponds with the timing the service is rendered.</us-gaap:RevenuePerformanceObligationDescriptionOfTiming>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001163">&lt;p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_zUHzjlmJSsWd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes revenue by region based on the billing address of customers for the three months ended June 30, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zmMlXRvNh7N2"&gt;Summary
of Revenue by Region&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Three Months Ended June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Percentage of Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Percentage of Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 36%"&gt;Americas&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240401__20240630__srt--StatementGeographicalAxis__srt--AmericasMember_zk3IqVit9aMg" style="width: 12%; text-align: right" title="Revenue"&gt;587,712&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_dp_c20240401__20240630__srt--StatementGeographicalAxis__srt--AmericasMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zxQeBQ9vRBGa" style="width: 12%; text-align: right" title="Percentage of Revenue"&gt;55&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230401__20230630__srt--StatementGeographicalAxis__srt--AmericasMember_z32Gp7ET9rLe" style="width: 12%; text-align: right" title="Revenue"&gt;704,626&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20230630__srt--StatementGeographicalAxis__srt--AmericasMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_z03T5l0VFbFd" style="width: 12%; text-align: right" title="Percentage of Revenue"&gt;59&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Europe, Middle East and Africa (EMEA)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240401__20240630__srt--StatementGeographicalAxis__us-gaap--EMEAMember_zh3G4GPjv2u2" style="text-align: right" title="Revenue"&gt;360,666&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_dp_c20240401__20240630__srt--StatementGeographicalAxis__us-gaap--EMEAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zBj9NftGmwPa" style="text-align: right" title="Percentage of Revenue"&gt;34&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230401__20230630__srt--StatementGeographicalAxis__us-gaap--EMEAMember_zWsP6kjLfdwh" style="text-align: right" title="Revenue"&gt;389,318&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20230630__srt--StatementGeographicalAxis__us-gaap--EMEAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zMKCuGBsPVW2" style="text-align: right" title="Percentage of Revenue"&gt;33&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Asia Pacific&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240401__20240630__srt--StatementGeographicalAxis__srt--AsiaPacificMember_zUz1aRschYSa" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;119,819&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20240401__20240630__srt--StatementGeographicalAxis__srt--AsiaPacificMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_ztUcdBwIeJ5j" style="border-bottom: Black 1pt solid; text-align: right" title="Percentage of Revenue"&gt;11&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230401__20230630__srt--StatementGeographicalAxis__srt--AsiaPacificMember_znz9nDZET727" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;99,377&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20230630__srt--StatementGeographicalAxis__srt--AsiaPacificMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_ziGyexzH4Yt4" style="border-bottom: Black 1pt solid; text-align: right" title="Percentage of Revenue"&gt;8&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240401__20240630_zYojN6Jyays3" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount"&gt;1,068,197&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_dp_c20240401__20240630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_za1GTVmcaHjc" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of Revenue"&gt;100&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230401__20230630_zX1N6DNLTIPe" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount"&gt;1,193,321&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zrIlQH15Un8j" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of Revenue"&gt;100&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes revenue by region based on the billing address of customers for the six months ended June 30, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Six Months Ended June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Percentage of Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Percentage of Revenue&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; width: 36%"&gt;Americas&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240101__20240630__srt--StatementGeographicalAxis__srt--AmericasMember_z3u6E7y8ijxa" style="width: 12%; text-align: right" title="Revenue"&gt;1,170,539&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__srt--StatementGeographicalAxis__srt--AmericasMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zoCcIJQfG9w2" style="width: 12%; text-align: right" title="Percentage of Revenue"&gt;55&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20230630__srt--StatementGeographicalAxis__srt--AmericasMember_zh01HYHR3W62" style="width: 12%; text-align: right" title="Revenue"&gt;1,374,401&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--StatementGeographicalAxis__srt--AmericasMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_z99hSG6mBscl" style="width: 12%; text-align: right" title="Percentage of Revenue"&gt;62&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Europe, Middle East and Africa (EMEA)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240101__20240630__srt--StatementGeographicalAxis__us-gaap--EMEAMember_zt3YMdk6xKU5" style="text-align: right" title="Revenue"&gt;746,916&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__srt--StatementGeographicalAxis__us-gaap--EMEAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zWRmY4BVvE8g" style="text-align: right" title="Percentage of Revenue"&gt;34&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20230630__srt--StatementGeographicalAxis__us-gaap--EMEAMember_zPPI8FOM1qLa" style="text-align: right" title="Revenue"&gt;797,228&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--StatementGeographicalAxis__us-gaap--EMEAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_z9dDGyRkcjb8" style="text-align: right" title="Percentage of Revenue"&gt;30&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Asia Pacific&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240101__20240630__srt--StatementGeographicalAxis__srt--AsiaPacificMember_z6Ra6knbhJfe" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;230,214&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__srt--StatementGeographicalAxis__srt--AsiaPacificMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zoXp6VkMRd81" style="border-bottom: Black 1pt solid; text-align: right" title="Percentage of Revenue"&gt;11&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20230630__srt--StatementGeographicalAxis__srt--AsiaPacificMember_zp4GO5u4bUH8" style="border-bottom: Black 1pt solid; text-align: right" title="Revenue"&gt;198,753&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--StatementGeographicalAxis__srt--AsiaPacificMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zKeSvofj7R03" style="border-bottom: Black 1pt solid; text-align: right" title="Percentage of Revenue"&gt;8&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20240101__20240630_zdDZOB25sdc7" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount"&gt;2,147,669&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zPuNGWzcKD52" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of Revenue"&gt;100&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20230630_zQmGSAgXc5p8" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount"&gt;2,370,382&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_z2WmO1svwwT8" style="border-bottom: Black 2.5pt double; text-align: right" title="Percentage of Revenue"&gt;100&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-04-012024-06-30_srt_AmericasMember"
      decimals="0"
      id="Fact001165"
      unitRef="USD">587712</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-04-012024-06-30_srt_AmericasMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact001167"
      unitRef="Pure">0.55</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-04-012023-06-30_srt_AmericasMember"
      decimals="0"
      id="Fact001169"
      unitRef="USD">704626</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-04-012023-06-30_srt_AmericasMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact001171"
      unitRef="Pure">0.59</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-04-012024-06-30_us-gaap_EMEAMember"
      decimals="0"
      id="Fact001173"
      unitRef="USD">360666</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-04-012024-06-30_us-gaap_EMEAMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact001175"
      unitRef="Pure">0.34</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-04-012023-06-30_us-gaap_EMEAMember"
      decimals="0"
      id="Fact001177"
      unitRef="USD">389318</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-04-012023-06-30_us-gaap_EMEAMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact001179"
      unitRef="Pure">0.33</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-04-012024-06-30_srt_AsiaPacificMember"
      decimals="0"
      id="Fact001181"
      unitRef="USD">119819</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-04-012024-06-30_srt_AsiaPacificMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact001183"
      unitRef="Pure">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-04-012023-06-30_srt_AsiaPacificMember"
      decimals="0"
      id="Fact001185"
      unitRef="USD">99377</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-04-012023-06-30_srt_AsiaPacificMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact001187"
      unitRef="Pure">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact001189"
      unitRef="USD">1068197</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-04-012024-06-30_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact001191"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact001193"
      unitRef="USD">1193321</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-04-012023-06-30_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact001195"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-01-012024-06-30_srt_AmericasMember"
      decimals="0"
      id="Fact001197"
      unitRef="USD">1170539</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-01-012024-06-30_srt_AmericasMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact001199"
      unitRef="Pure">0.55</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-06-30_srt_AmericasMember"
      decimals="0"
      id="Fact001201"
      unitRef="USD">1374401</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-06-30_srt_AmericasMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact001203"
      unitRef="Pure">0.62</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-01-012024-06-30_us-gaap_EMEAMember"
      decimals="0"
      id="Fact001205"
      unitRef="USD">746916</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-01-012024-06-30_us-gaap_EMEAMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact001207"
      unitRef="Pure">0.34</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-06-30_us-gaap_EMEAMember"
      decimals="0"
      id="Fact001209"
      unitRef="USD">797228</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-06-30_us-gaap_EMEAMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact001211"
      unitRef="Pure">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-01-012024-06-30_srt_AsiaPacificMember"
      decimals="0"
      id="Fact001213"
      unitRef="USD">230214</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-01-012024-06-30_srt_AsiaPacificMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact001215"
      unitRef="Pure">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-06-30_srt_AsiaPacificMember"
      decimals="0"
      id="Fact001217"
      unitRef="USD">198753</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-06-30_srt_AsiaPacificMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact001219"
      unitRef="Pure">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact001221"
      unitRef="USD">2147669</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-01-012024-06-30_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact001223"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact001225"
      unitRef="USD">2370382</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-06-30_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact001227"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <BNZI:AccountsReceivableContractualTerm contextRef="From2024-01-01to2024-06-30" id="Fact001229">The Company receives payments from customers based upon agreed-upon contractual terms, typically
within 30 days of invoicing the customer.</BNZI:AccountsReceivableContractualTerm>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001231">&lt;p id="xdx_897_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zRqHR0whY0Ma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_zP259Qx5CsV9"&gt;Summary
of Accounts Receivable, Net&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Opening Balance&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Closing Balance&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Opening Balance&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Closing Balance&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;1/1/2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;6/30/2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;1/1/2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;6/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Accounts receivable, net&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AccountsReceivableNetCurrent_iS_c20240101__20240630_zFi0cmPLVlz5" style="width: 10%; text-align: right" title="Opening Balance"&gt;105,049&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccountsReceivableNetCurrent_iE_c20240101__20240630_zE3EG3Yx5l37" style="width: 10%; text-align: right" title="Closing Balance"&gt;26,161&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccountsReceivableNetCurrent_iS_c20230101__20230630_zDm0ejfKnPBk" style="width: 10%; text-align: right" title="Opening Balance"&gt;68,416&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AccountsReceivableNetCurrent_iE_c20230101__20230630_zGibCTWUato7" style="width: 10%; text-align: right" title="Closing Balance"&gt;109,533&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001233"
      unitRef="USD">105049</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001235"
      unitRef="USD">26161</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001237"
      unitRef="USD">68416</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001239"
      unitRef="USD">109533</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:SalesCommissionsAndFees
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact001241"
      unitRef="USD">61146</us-gaap:SalesCommissionsAndFees>
    <us-gaap:SalesCommissionsAndFees
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact001243"
      unitRef="USD">143288</us-gaap:SalesCommissionsAndFees>
    <us-gaap:SalesCommissionsAndFees
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact001245"
      unitRef="USD">91243</us-gaap:SalesCommissionsAndFees>
    <us-gaap:SalesCommissionsAndFees
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact001247"
      unitRef="USD">190619</us-gaap:SalesCommissionsAndFees>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001249"
      unitRef="USD">39144</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001251"
      unitRef="USD">51472</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:CapitalizedContractCostTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001253">&lt;p id="xdx_890_eus-gaap--CapitalizedContractCostTableTextBlock_z1Tq5ogXfT6f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following summarizes the Costs to obtain a contract activity during the three and six months ended June 30, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zkxft3JAS228"&gt;Summary
of Costs to Obtain Contract Activity&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_4BA_z7mMiCNWKhhl" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_434_c20240101__20240331_eus-gaap--CapitalizedContractCostNetCurrent_iS_zoRFa9ORbU85" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Balance - December 31, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;51,472&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--CommissionsIncurred_zfrmV527Ha16" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Commissions Incurred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,610&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DeferredCommissionsRecognized_iN_di_zUwpfkenLil5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Deferred Commissions Recognized&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(44,620&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20240401__20240630_eus-gaap--CapitalizedContractCostNetCurrent_iS_zFdzFEfuobS6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Balance - March 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;38,462&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--CommissionsIncurred_zQ62dHRQeBJl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Commissions Incurred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48,316&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DeferredCommissionsRecognized_iN_di_zjw2ODN1yUq8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Deferred Commissions Recognized&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(47,634&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20240401__20240630_eus-gaap--CapitalizedContractCostNetCurrent_iE_zmXBPcStrKz3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance - June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;39,144&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following summarizes the Costs to obtain a contract activity during the three and six months ended June 30, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_4BA_z7lGeASb8oP5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_434_c20230101__20230331_eus-gaap--CapitalizedContractCostNetCurrent_iS_zqgZNzxN6ao8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Balance - December 31, 2022&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;69,737&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--CommissionsIncurred_zr6tIWagcbkb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Commissions Incurred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;88,928&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DeferredCommissionsRecognized_iN_di_zusu4fEuftig" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Deferred Commissions Recognized&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(104,289&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_432_c20230401__20230630_eus-gaap--CapitalizedContractCostNetCurrent_iS_zyXfQZLwCxpk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Balance - March 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54,376&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--CommissionsIncurred_zbdHzDnSYHA8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Commissions Incurred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;60,777&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DeferredCommissionsRecognized_iN_di_zmGdwyJ5p8O1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Deferred Commissions Recognized&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(75,001&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20230401__20230630_eus-gaap--CapitalizedContractCostNetCurrent_iE_zSYk5nI26598" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance - June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;40,152&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:CapitalizedContractCostTableTextBlock>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001255"
      unitRef="USD">51472</us-gaap:CapitalizedContractCostNetCurrent>
    <BNZI:CommissionsIncurred
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact001257"
      unitRef="USD">31610</BNZI:CommissionsIncurred>
    <BNZI:DeferredCommissionsRecognized
      contextRef="From2024-01-012024-03-31"
      decimals="0"
      id="Fact001259"
      unitRef="USD">44620</BNZI:DeferredCommissionsRecognized>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="Fact001261"
      unitRef="USD">38462</us-gaap:CapitalizedContractCostNetCurrent>
    <BNZI:CommissionsIncurred
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact001263"
      unitRef="USD">48316</BNZI:CommissionsIncurred>
    <BNZI:DeferredCommissionsRecognized
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact001265"
      unitRef="USD">47634</BNZI:DeferredCommissionsRecognized>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001267"
      unitRef="USD">39144</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001269"
      unitRef="USD">69737</us-gaap:CapitalizedContractCostNetCurrent>
    <BNZI:CommissionsIncurred
      contextRef="From2023-01-012023-03-31"
      decimals="0"
      id="Fact001271"
      unitRef="USD">88928</BNZI:CommissionsIncurred>
    <BNZI:DeferredCommissionsRecognized
      contextRef="From2023-01-012023-03-31"
      decimals="0"
      id="Fact001273"
      unitRef="USD">104289</BNZI:DeferredCommissionsRecognized>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="AsOf2023-03-31"
      decimals="0"
      id="Fact001275"
      unitRef="USD">54376</us-gaap:CapitalizedContractCostNetCurrent>
    <BNZI:CommissionsIncurred
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact001277"
      unitRef="USD">60777</BNZI:CommissionsIncurred>
    <BNZI:DeferredCommissionsRecognized
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact001279"
      unitRef="USD">75001</BNZI:DeferredCommissionsRecognized>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact001281"
      unitRef="USD">40152</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001283">&lt;p id="xdx_808_eus-gaap--FairValueDisclosuresTextBlock_z1bmFrE9WJYk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;7.
&lt;span id="xdx_829_zqfZjmdGhm9b"&gt;Fair Value Measurements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management
as of and during the periods ended June 30, 2024 and the year ended December 31, 2023. The carrying amount of accounts payable approximated
fair value as they are short term in nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
Value on a Non-recurring Basis&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of non-financial assets measured at fair value on a non-recurring basis, classified as Level 3 in the fair value hierarchy,
is determined based on using market-based approaches, or estimates of discounted expected future cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
Value on a Recurring Basis&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the guidance in ASC 820 &lt;i&gt;Fair Value Measurements and Disclosures&lt;/i&gt; for its financial assets and liabilities that
are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and
reported at fair value at least annually. The estimated fair value of the Public Warrants liabilities represent Level 1 measurements.
The estimated fair value of the convertible notes bifurcated embedded derivative liabilities, GEM warrant liabilities, Yorkville convertible
note, and SAFE represent Level 3 measurements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zx9rO4XFHukj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents information about the Company&#x2019;s financial instruments that are measured at fair value on a recurring basis
at June 30, 2024 and December 31, 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine
such fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B1_ztpxYhD8hqJl"&gt;Schedule
of Fair Value on Recurring Basis&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Description&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20240630_zhkkxPlowkF1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20231231_zGhiHbO5KZae" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LiabilitiesAbstract_iB_z5l1yObrpDwk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--WarrantLiabilitiesPublic_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znME1UT4ZkXj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Warrant liabilities - public&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: center"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;230,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;575,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--GEMWarrantLiabilities_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zaaZ89k9jKyc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;GEM warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;79,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;641,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ConvertibleDebt_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZRVsSVrhtSg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Yorkville convertible note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,013,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,766,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8A2_zgERAeQxdJ07" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrant
Liability - Public Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company assumed &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z8kjBLczpHIl" title="Warrants outstanding"&gt;&lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_ziO5qguL4fB8" title="Warrants outstanding"&gt;230,000&lt;/span&gt;&lt;/span&gt; Public Warrants in the Merger which were outstanding as of June 30, 2024 and December 31, 2023. The fair values
of the Public Warrants are measured based on the listed market price of such warrants through June 30, 2024. See &lt;i&gt;Note 12 - Warrant
Liabilities &lt;/i&gt;for further details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2024, the Company recognized a benefit of approximately $&lt;span id="xdx_90A_eus-gaap--FairValueAdjustmentOfWarrants_pid_c20240101__20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z3deAVSHurN1" title="Benefit (loss) resulting from a decrease/(increase) in fair value of derivative warrant liabilities"&gt;345,000&lt;/span&gt; resulting from changes in the fair value of the derivative
warrant liabilities, presented as change in fair value of warrant liabilities - related party in the accompanying condensed consolidated
statements of operations. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_ecustom--SummaryOfChangesInTheFairValueOfTheWarrantsLiabilityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsLiabilityMember_z82y8F7IbN03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the changes in the fair value of the Public Warrants liability which are Level 1 financial liabilities
that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zWjGlBovYByc"&gt;Summary
of Changes in the Fair Value of the Warrants Liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B4_us-gaap--ClassOfWarrantOrRightAxis_custom--PublicWarrantsLiabilityMember_zq9zSvn6rV69" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20240101__20240630_ecustom--PublicWarrantsLiability_iS_zuhWJmZkv9X1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;575,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ChangeInFairValueOfPublicWarrantsLiability_iN_di_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zrGlQYypxXC1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(115,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20240401__20240630_ecustom--PublicWarrantsLiability_iS_zwmowYcgyr67" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Balance at March 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;460,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ChangeInFairValueOfPublicWarrantsLiability_iN_di_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zmq7TtN8tei1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(230,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20240401__20240630_ecustom--PublicWarrantsLiability_iE_zXDCTbCFy1y9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance at June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;230,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zyCuw1s9Z5i1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrant
Liability - GEM Warrants&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
measurement of fair value of the GEM Warrants were determined utilizing a Monte Carlo simulation considering all relevant assumptions
current at the date of issuance (i.e., share price, exercise price, term, volatility, risk-free rate, probability of dilutive term of
three years, and expected time to conversion). Refer to &lt;i&gt;Note 12 - Warrant Liabilities&lt;/i&gt; for further details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2024, the Company recognized a benefit of approximately $&lt;span id="xdx_900_eus-gaap--FairValueAdjustmentOfWarrants_c20240101__20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--GemWarrantsLiabilityMember_zGUitb2MAS7h" title="Benefit (loss) resulting from a decrease/(increase) in fair value of derivative warrant liabilities"&gt;562,000&lt;/span&gt;, resulting from changes in the fair value of the derivative
warrant liabilities, presented as change in fair value of warrant liabilities in the accompanying condensed consolidated statements of
operations.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_ecustom--SummaryOfChangesInTheFairValueOfTheWarrantsLiabilityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--GemWarrantsLiabilityMember_z2RPV2eGWqK2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the changes in the fair value of the GEM Warrants liability which are Level 3 financial liabilities
that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zbKGmMx6DSob"&gt;Summary
of Changes in the Fair Value of the Warrants Liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BA_us-gaap--ClassOfWarrantOrRightAxis_custom--GemWarrantsLiabilityMember_zecNEJNuZea2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20240101__20240630_ecustom--PublicWarrantsLiability_iS_zHRQdBSG1Qh2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;641,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ChangeInFairValueOfPublicWarrantsLiability_iN_di_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zT3IHWPrgUa7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(408,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20240401__20240630_ecustom--PublicWarrantsLiability_iS_zIVpX2L8NxS9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Balance at March 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;233,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ChangeInFairValueOfPublicWarrantsLiability_iN_di_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z7HYY6HdSO99" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(154,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20240401__20240630_ecustom--PublicWarrantsLiability_iE_zlcmdhUbfP8k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance at June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;79,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zKauPythk0Kf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Yorkville
Convertible Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
measurement of fair value of the Yorkville convertible notes were determined utilizing a Monte Carlo simulation considering all relevant
assumptions current at the date of issuance (i.e., share price, term, volatility, risk-free rate, and probability of optional redemption).
Refer to &lt;i&gt;Note 11 - Debt&lt;/i&gt; for further details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2024, the Company recognized a loss of approximately $&lt;span id="xdx_902_ecustom--FairValueAdjustmentOfConvertibleNote_iN_di_c20240101__20240630__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zaP4io96FMlb" title="Benefit (loss) of changes in the fair value of the Yorkville convertible note"&gt;578,000&lt;/span&gt; resulting from changes in the fair value of the Yorkville convertible
notes, presented as change in fair value of convertible promissory notes in the accompanying condensed consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_ecustom--SummaryOfChangesInFairValueOfConvertibleNoteTableTextBlock_zSIIUbGkQUze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the changes in the fair value of the Yorkville convertible notes which is a Level 3 financial
liability measured at fair value on a recurring basis:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zlcykgrrg65j"&gt;Summary
of Changes in Fair Value of Yorkville Convertible Note&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BB_us-gaap--FairValueByFairValueHierarchyLevelAxis_us-gaap--FairValueInputsLevel3Member_us-gaap--ShortTermDebtTypeAxis_us-gaap--ConvertibleDebtMember_zNMfKM8E2td6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_432_c20240101__20240630_eus-gaap--ConvertibleDebt_iS_zekDExvyE36l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,766,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--IssuanceOfYorkvilleConvertibleNote_zpXgjQtFUXLe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of Yorkville convertible note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,250,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--GainsLossesOnDebtIssuance_z41gBKs7xDOf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loss on debt issuance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;171,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--PaymentInSharesToSettleYorkvilleConvertibleNotes_zU2LSqMG49Rg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Payment in shares to settle Yorkville convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,667,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ChangeInFairValueOfYorkvilleConvertibleNote_zmQ8QXnJbd0a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;544,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20240401__20240630_eus-gaap--ConvertibleDebt_iS_zwGlTP7AJaUe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Balance at March 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,064,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--PaymentInSharesToSettleYorkvilleConvertibleNotes_zvuQFKo27ROl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Payment in shares to settle Yorkville convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(335,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--RepaymentInCashOfYorkvilleConvertibleNotes_zgDOKwQOco2e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Repayment in cash of Yorkville convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(750,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ChangeInFairValueOfYorkvilleConvertibleNote_z7KkxrTnBRxg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;34,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20240401__20240630_eus-gaap--ConvertibleDebt_iE_z8DJLJS39jSl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance at June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,013,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zYwBNQ27cj49" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Bifurcated
Embedded Derivative Liabilities&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the embedded put options, relating to the Convertible Notes - Related Party, Convertible Notes, and Term and Convertible
Notes (CP BF)&lt;i&gt;,&lt;/i&gt; was determined using a Black Scholes option pricing model. Estimating fair values of embedded conversion features
requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument
with related changes in internal and external market factors. Because the embedded conversion features are initially and subsequently
carried at fair values, the Company&#x2019;s consolidated statements of operations will reflect the volatility in these estimate and assumption
changes. On December 14, 2023, all outstanding principal and accrued interest, including the carrying value of any related embedded derivative,
related to the Related Party Convertible Notes and Third Party Convertible Notes converted into the Company&#x2019;s Class A Common Stock
pursuant to the close of the Merger Agreement. Upon the conversion described above, the bifurcated embedded derivative liabilities were
$&lt;span id="xdx_904_ecustom--BifurcatedEmbeddedDerivativeLiabilitiesCurrent_iI_c20240630_zQ8tAkOD5C96" title="Bifurcated embedded derivative liabilities"&gt;&lt;span id="xdx_90E_ecustom--BifurcatedEmbeddedDerivativeLiabilitiesCurrent_iI_c20231231_zLPVISh8hPk9" title="Bifurcated embedded derivative liabilities"&gt;0&lt;/span&gt;&lt;/span&gt; as of June 30, 2024 and December 31, 2023, respectively. Refer to &lt;i&gt;Note 11 - Debt&lt;/i&gt; for further details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zSF83T55NYq1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table sets forth a summary of the changes in the fair value of the bifurcated embedded derivative liabilities for the six months
ended June 30, 2023, related to the Related Party and Third Party Convertible Debt, respectively, which are Level 3 financial liabilities
that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zJg6WBEFcwMi"&gt;Schedule
of Derivative Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BA_us-gaap--RelatedPartyTransactionsByRelatedPartyAxis_us-gaap--RelatedPartyMember_zE1OYJDsCa87" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B5_us-gaap--RelatedPartyTransactionsByRelatedPartyAxis_custom--ThirdPartyConvertibleDebtMember_znvA5KbiArS3" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20230101__20230331_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iS_zNQR7zxp9yef" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Balance at December 31, 2022&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,936,827&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;845,473&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--IssuanceOfConvertibleNotes_zaLWWbPlmiFf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of convertible notes with bifurcated embedded derivative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;707,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1365"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_iN_di_zt3bKYwWFey7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;137,285&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;32,415&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20230401__20230630_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iS_zao5AK0YaBS5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Balance at March 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,781,112&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;877,888&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--IssuanceOfConvertibleNotes_zVBqLMQpIVA1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of convertible notes with bifurcated embedded derivative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;419,451&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;330,390&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_iN_di_zcoGJgW44sWe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(478,198&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(194,643&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20230401__20230630_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iE_zA5aumlcynA8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance at June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,722,365&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,013,635&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zDHWgSuhjoN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Simple
Agreements for Future Equity (SAFE)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2021, the Company entered into Simple Agreements for Future Equity (SAFE) arrangements (the &#x201c;SAFEs&#x201d;). In the event of an
Equity Financing (as defined in the SAFEs agreements), the SAFEs will automatically convert into shares of the Company&#x2019;s common
or preferred stock at a discount of &lt;span id="xdx_909_ecustom--PercentageOfDiscountPricePerShare_dp_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SimpleAgreementsForFutureEquityMember_zmRUFgzGVfhh" title="Discount price"&gt;15&lt;/span&gt;% of the per share price of the shares offered in the Equity Financing (the &#x201c;Discount Price&#x201d;).
In the event of a Liquidity Event, SPAC Transaction or Dissolution Event (all terms as defined in the SAFEs agreements), the holders
of the SAFEs will be entitled to receive cash or shares of the Company&#x2019;s common or preferred stock. The number of shares required
to be issued to settle the SAFEs at the equity financing is variable, because that number will be determined by the discounted fair value
of the Company&#x2019;s equity shares on the date of settlement (i.e., Discount Price). Regardless of the fair value of the shares on
the date of settlement, the holder will receive a fixed monetary value based on the Purchase Amount of the SAFE. If there is a Liquidity
Event or SPAC Transaction before the settlement or termination of the SAFEs, the SAFEs will automatically be entitled to receive a portion
of Proceeds, due and payable immediately prior to, or concurrent with, the consummation of such Liquidity Event or SPAC Transaction,
equal to the greater of (i) two times (2x) the Purchase Amount (the &#x201c;Cash-Out Amount&#x201d;) or (ii) the amount payable on the
number of shares of Common Stock equal to the Purchase Amount divided by the Liquidity Price (as defined in the SAFEs agreements). Refer
to &lt;i&gt;Note 13 - Simple Agreements for Future Equity&lt;/i&gt; for additional information related to the Company&#x2019;s SAFEs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the SAFEs was determined using a scenario-based method for the pre-modification SAFE&#x2019;s and a Monte Carlo simulation
method for the post-modification SAFEs. The value of the SAFE liability as of December 31, 2023 is based on significant inputs not observable
in the market, which represents a Level 3 measurement within the fair value hierarchy. The fair value of the SAFEs on the date of issuance
was determined to be $&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SimpleAgreementsForFutureEquityMember_zeUBvr5fTQg1" title="Face value of the convertible notes"&gt;3,836,000&lt;/span&gt;. On December 14, 2023, all outstanding principal related to the Third Party SAFEs and Related Party SAFEs
converted into the Company&#x2019;s Class A Common Stock pursuant to the close of the Merger Agreement. Upon the conversion described
above, the SAFEs were $&lt;span id="xdx_90F_ecustom--ConversionUponSimpleAgreementsForFutureEquity_iI_c20240630_zmLtFnk29KF3" title="Conversion upon simple agreements for future equity"&gt;&lt;span id="xdx_90B_ecustom--ConversionUponSimpleAgreementsForFutureEquity_iI_c20231231_zvMESGQk9TRf" title="Conversion upon simple agreements for future equity"&gt;0&lt;/span&gt;&lt;/span&gt; as of June 30, 2024 and December 31, 2023, respectively. Refer to &lt;i&gt;Note 13 - Simple Agreements for Future
Equity&lt;/i&gt; for further details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--FairValueConcentrationOfRiskTextBlock_zvOkjteJv0Ra" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the activity of the Related Party and Third Party SAFE liabilities, respectively (See &lt;i&gt;Note
13 - Simple Agreements for Future Equity&lt;/i&gt; for further detail), which represents a recurring fair value measurement at the end of the
relevant reporting period:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zIRJXlor64Wg"&gt;Schedule
of Fair Value Measurements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B1_us-gaap--RelatedPartyTransactionsByRelatedPartyAxis_us-gaap--RelatedPartyMember_zHg5XphLFzXg" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B4_us-gaap--RelatedPartyTransactionsByRelatedPartyAxis_custom--ThirdPartyConvertibleDebtMember_zqOqm5T1Ftqc" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20230101__20230331_ecustom--SimpleAgreementForFutureEquityCurrent_iS_z4GQAMTu0lh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Balance at December 31, 2022&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;8,802,196&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;663,804&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--ChangeInFairValueOfSimpleAgreementForFutureEquity_zJBOuVGfM9Ua" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;303,139&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;22,861&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20230401__20230630_ecustom--SimpleAgreementForFutureEquityCurrent_iS_zHut71q3vU4f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Balance at March 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,105,335&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;686,665&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ChangeInFairValueOfSimpleAgreementForFutureEquity_zfd5svMNN0F1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;909,418&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;68,582&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20230401__20230630_ecustom--SimpleAgreementForFutureEquityCurrent_iE_z717Ar7WFEjg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance at June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;10,014,753&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;755,247&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_z4aS9YJn8C2c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001285">&lt;p id="xdx_891_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zx9rO4XFHukj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents information about the Company&#x2019;s financial instruments that are measured at fair value on a recurring basis
at June 30, 2024 and December 31, 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine
such fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B1_ztpxYhD8hqJl"&gt;Schedule
of Fair Value on Recurring Basis&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Description&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20240630_zhkkxPlowkF1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20231231_zGhiHbO5KZae" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LiabilitiesAbstract_iB_z5l1yObrpDwk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--WarrantLiabilitiesPublic_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_znME1UT4ZkXj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Warrant liabilities - public&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: center"&gt;1&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;230,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;575,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--GEMWarrantLiabilities_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zaaZ89k9jKyc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;GEM warrant liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;79,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;641,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ConvertibleDebt_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zZRVsSVrhtSg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Yorkville convertible note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,013,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,766,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <BNZI:WarrantLiabilitiesPublic
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel2Member"
      decimals="0"
      id="Fact001290"
      unitRef="USD">230000</BNZI:WarrantLiabilitiesPublic>
    <BNZI:WarrantLiabilitiesPublic
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member"
      decimals="0"
      id="Fact001291"
      unitRef="USD">575000</BNZI:WarrantLiabilitiesPublic>
    <BNZI:GEMWarrantLiabilities
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact001293"
      unitRef="USD">79000</BNZI:GEMWarrantLiabilities>
    <BNZI:GEMWarrantLiabilities
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact001294"
      unitRef="USD">641000</BNZI:GEMWarrantLiabilities>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact001296"
      unitRef="USD">2013000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact001297"
      unitRef="USD">1766000</us-gaap:ConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-30_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact001299"
      unitRef="Shares">230000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact001301"
      unitRef="Shares">230000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-012024-06-30_custom_PublicWarrantsMember5441250"
      decimals="INF"
      id="Fact001303"
      unitRef="USD">345000</us-gaap:FairValueAdjustmentOfWarrants>
    <BNZI:SummaryOfChangesInTheFairValueOfTheWarrantsLiabilityTableTextBlock
      contextRef="From2024-01-012024-06-30_custom_PublicWarrantsLiabilityMember"
      id="Fact001305">&lt;p id="xdx_897_ecustom--SummaryOfChangesInTheFairValueOfTheWarrantsLiabilityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsLiabilityMember_z82y8F7IbN03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the changes in the fair value of the Public Warrants liability which are Level 1 financial liabilities
that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zWjGlBovYByc"&gt;Summary
of Changes in the Fair Value of the Warrants Liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B4_us-gaap--ClassOfWarrantOrRightAxis_custom--PublicWarrantsLiabilityMember_zq9zSvn6rV69" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20240101__20240630_ecustom--PublicWarrantsLiability_iS_zuhWJmZkv9X1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;575,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ChangeInFairValueOfPublicWarrantsLiability_iN_di_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zrGlQYypxXC1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(115,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20240401__20240630_ecustom--PublicWarrantsLiability_iS_zwmowYcgyr67" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Balance at March 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;460,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ChangeInFairValueOfPublicWarrantsLiability_iN_di_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zmq7TtN8tei1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(230,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20240401__20240630_ecustom--PublicWarrantsLiability_iE_zXDCTbCFy1y9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance at June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;230,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BNZI:SummaryOfChangesInTheFairValueOfTheWarrantsLiabilityTableTextBlock>
    <BNZI:PublicWarrantsLiability
      contextRef="AsOf2023-12-31_custom_PublicWarrantsLiabilityMember"
      decimals="0"
      id="Fact001307"
      unitRef="USD">575000</BNZI:PublicWarrantsLiability>
    <BNZI:ChangeInFairValueOfPublicWarrantsLiability
      contextRef="From2024-01-012024-06-30_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact001309"
      unitRef="USD">115000</BNZI:ChangeInFairValueOfPublicWarrantsLiability>
    <BNZI:PublicWarrantsLiability
      contextRef="AsOf2024-03-31_custom_PublicWarrantsLiabilityMember"
      decimals="0"
      id="Fact001311"
      unitRef="USD">460000</BNZI:PublicWarrantsLiability>
    <BNZI:ChangeInFairValueOfPublicWarrantsLiability
      contextRef="From2024-04-012024-06-30_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact001313"
      unitRef="USD">230000</BNZI:ChangeInFairValueOfPublicWarrantsLiability>
    <BNZI:PublicWarrantsLiability
      contextRef="AsOf2024-06-30_custom_PublicWarrantsLiabilityMember"
      decimals="0"
      id="Fact001315"
      unitRef="USD">230000</BNZI:PublicWarrantsLiability>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2024-01-012024-06-30_custom_GemWarrantsLiabilityMember"
      decimals="0"
      id="Fact001317"
      unitRef="USD">562000</us-gaap:FairValueAdjustmentOfWarrants>
    <BNZI:SummaryOfChangesInTheFairValueOfTheWarrantsLiabilityTableTextBlock
      contextRef="From2024-01-012024-06-30_custom_GemWarrantsLiabilityMember"
      id="Fact001319">&lt;p id="xdx_89C_ecustom--SummaryOfChangesInTheFairValueOfTheWarrantsLiabilityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--GemWarrantsLiabilityMember_z2RPV2eGWqK2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the changes in the fair value of the GEM Warrants liability which are Level 3 financial liabilities
that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zbKGmMx6DSob"&gt;Summary
of Changes in the Fair Value of the Warrants Liability&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BA_us-gaap--ClassOfWarrantOrRightAxis_custom--GemWarrantsLiabilityMember_zecNEJNuZea2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20240101__20240630_ecustom--PublicWarrantsLiability_iS_zHRQdBSG1Qh2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;641,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ChangeInFairValueOfPublicWarrantsLiability_iN_di_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zT3IHWPrgUa7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(408,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20240401__20240630_ecustom--PublicWarrantsLiability_iS_zIVpX2L8NxS9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Balance at March 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;233,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ChangeInFairValueOfPublicWarrantsLiability_iN_di_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z7HYY6HdSO99" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(154,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20240401__20240630_ecustom--PublicWarrantsLiability_iE_zlcmdhUbfP8k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance at June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;79,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BNZI:SummaryOfChangesInTheFairValueOfTheWarrantsLiabilityTableTextBlock>
    <BNZI:PublicWarrantsLiability
      contextRef="AsOf2023-12-31_custom_GemWarrantsLiabilityMember"
      decimals="0"
      id="Fact001321"
      unitRef="USD">641000</BNZI:PublicWarrantsLiability>
    <BNZI:ChangeInFairValueOfPublicWarrantsLiability
      contextRef="From2024-01-012024-06-30_custom_GemWarrantsLiabilityMember_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact001323"
      unitRef="USD">408000</BNZI:ChangeInFairValueOfPublicWarrantsLiability>
    <BNZI:PublicWarrantsLiability
      contextRef="AsOf2024-03-31_custom_GemWarrantsLiabilityMember"
      decimals="0"
      id="Fact001325"
      unitRef="USD">233000</BNZI:PublicWarrantsLiability>
    <BNZI:ChangeInFairValueOfPublicWarrantsLiability
      contextRef="From2024-04-012024-06-30_custom_GemWarrantsLiabilityMember_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact001327"
      unitRef="USD">154000</BNZI:ChangeInFairValueOfPublicWarrantsLiability>
    <BNZI:PublicWarrantsLiability
      contextRef="AsOf2024-06-30_custom_GemWarrantsLiabilityMember"
      decimals="0"
      id="Fact001329"
      unitRef="USD">79000</BNZI:PublicWarrantsLiability>
    <BNZI:FairValueAdjustmentOfConvertibleNote
      contextRef="From2024-01-012024-06-30_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001331"
      unitRef="USD">-578000</BNZI:FairValueAdjustmentOfConvertibleNote>
    <BNZI:SummaryOfChangesInFairValueOfConvertibleNoteTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001333">&lt;p id="xdx_898_ecustom--SummaryOfChangesInFairValueOfConvertibleNoteTableTextBlock_zSIIUbGkQUze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the changes in the fair value of the Yorkville convertible notes which is a Level 3 financial
liability measured at fair value on a recurring basis:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zlcykgrrg65j"&gt;Summary
of Changes in Fair Value of Yorkville Convertible Note&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BB_us-gaap--FairValueByFairValueHierarchyLevelAxis_us-gaap--FairValueInputsLevel3Member_us-gaap--ShortTermDebtTypeAxis_us-gaap--ConvertibleDebtMember_zNMfKM8E2td6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_432_c20240101__20240630_eus-gaap--ConvertibleDebt_iS_zekDExvyE36l" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,766,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--IssuanceOfYorkvilleConvertibleNote_zpXgjQtFUXLe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of Yorkville convertible note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,250,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--GainsLossesOnDebtIssuance_z41gBKs7xDOf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loss on debt issuance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;171,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--PaymentInSharesToSettleYorkvilleConvertibleNotes_zU2LSqMG49Rg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Payment in shares to settle Yorkville convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,667,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ChangeInFairValueOfYorkvilleConvertibleNote_zmQ8QXnJbd0a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;544,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20240401__20240630_eus-gaap--ConvertibleDebt_iS_zwGlTP7AJaUe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Balance at March 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,064,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--PaymentInSharesToSettleYorkvilleConvertibleNotes_zvuQFKo27ROl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Payment in shares to settle Yorkville convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(335,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--RepaymentInCashOfYorkvilleConvertibleNotes_zgDOKwQOco2e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Repayment in cash of Yorkville convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(750,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ChangeInFairValueOfYorkvilleConvertibleNote_z7KkxrTnBRxg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;34,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20240401__20240630_eus-gaap--ConvertibleDebt_iE_z8DJLJS39jSl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance at June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,013,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BNZI:SummaryOfChangesInFairValueOfConvertibleNoteTableTextBlock>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001335"
      unitRef="USD">1766000</us-gaap:ConvertibleDebt>
    <BNZI:IssuanceOfYorkvilleConvertibleNote
      contextRef="From2024-01-012024-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001337"
      unitRef="USD">2250000</BNZI:IssuanceOfYorkvilleConvertibleNote>
    <BNZI:GainsLossesOnDebtIssuance
      contextRef="From2024-01-012024-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001339"
      unitRef="USD">171000</BNZI:GainsLossesOnDebtIssuance>
    <BNZI:PaymentInSharesToSettleYorkvilleConvertibleNotes
      contextRef="From2024-01-012024-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001341"
      unitRef="USD">-1667000</BNZI:PaymentInSharesToSettleYorkvilleConvertibleNotes>
    <BNZI:ChangeInFairValueOfYorkvilleConvertibleNote
      contextRef="From2024-01-012024-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001343"
      unitRef="USD">544000</BNZI:ChangeInFairValueOfYorkvilleConvertibleNote>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2024-03-31_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001345"
      unitRef="USD">3064000</us-gaap:ConvertibleDebt>
    <BNZI:PaymentInSharesToSettleYorkvilleConvertibleNotes
      contextRef="From2024-04-012024-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001347"
      unitRef="USD">-335000</BNZI:PaymentInSharesToSettleYorkvilleConvertibleNotes>
    <BNZI:RepaymentInCashOfYorkvilleConvertibleNotes
      contextRef="From2024-04-012024-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001349"
      unitRef="USD">-750000</BNZI:RepaymentInCashOfYorkvilleConvertibleNotes>
    <BNZI:ChangeInFairValueOfYorkvilleConvertibleNote
      contextRef="From2024-04-012024-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001351"
      unitRef="USD">34000</BNZI:ChangeInFairValueOfYorkvilleConvertibleNote>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2024-06-30_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001353"
      unitRef="USD">2013000</us-gaap:ConvertibleDebt>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001355"
      unitRef="USD">0</BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001357"
      unitRef="USD">0</BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001359">&lt;p id="xdx_895_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zSF83T55NYq1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table sets forth a summary of the changes in the fair value of the bifurcated embedded derivative liabilities for the six months
ended June 30, 2023, related to the Related Party and Third Party Convertible Debt, respectively, which are Level 3 financial liabilities
that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zJg6WBEFcwMi"&gt;Schedule
of Derivative Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BA_us-gaap--RelatedPartyTransactionsByRelatedPartyAxis_us-gaap--RelatedPartyMember_zE1OYJDsCa87" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B5_us-gaap--RelatedPartyTransactionsByRelatedPartyAxis_custom--ThirdPartyConvertibleDebtMember_znvA5KbiArS3" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20230101__20230331_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iS_zNQR7zxp9yef" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Balance at December 31, 2022&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,936,827&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;845,473&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--IssuanceOfConvertibleNotes_zaLWWbPlmiFf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of convertible notes with bifurcated embedded derivative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;707,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1365"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_iN_di_zt3bKYwWFey7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;137,285&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;32,415&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20230401__20230630_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iS_zao5AK0YaBS5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Balance at March 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,781,112&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;877,888&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--IssuanceOfConvertibleNotes_zVBqLMQpIVA1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of convertible notes with bifurcated embedded derivative&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;419,451&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;330,390&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_iN_di_zcoGJgW44sWe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(478,198&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(194,643&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20230401__20230630_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iE_zA5aumlcynA8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance at June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,722,365&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,013,635&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001361"
      unitRef="USD">1936827</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="AsOf2022-12-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact001362"
      unitRef="USD">845473</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <BNZI:IssuanceOfConvertibleNotes
      contextRef="From2023-01-012023-03-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001364"
      unitRef="USD">707000</BNZI:IssuanceOfConvertibleNotes>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2023-01-012023-03-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001367"
      unitRef="USD">-137285</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2023-01-012023-03-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact001368"
      unitRef="USD">-32415</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001370"
      unitRef="USD">2781112</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="AsOf2023-03-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact001371"
      unitRef="USD">877888</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <BNZI:IssuanceOfConvertibleNotes
      contextRef="From2023-04-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001373"
      unitRef="USD">419451</BNZI:IssuanceOfConvertibleNotes>
    <BNZI:IssuanceOfConvertibleNotes
      contextRef="From2023-04-012023-06-30_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact001374"
      unitRef="USD">330390</BNZI:IssuanceOfConvertibleNotes>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2023-04-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001376"
      unitRef="USD">478198</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2023-04-012023-06-30_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact001377"
      unitRef="USD">194643</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="AsOf2023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001379"
      unitRef="USD">2722365</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="AsOf2023-06-30_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact001380"
      unitRef="USD">1013635</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <BNZI:PercentageOfDiscountPricePerShare
      contextRef="From2021-01-012021-12-31_custom_SimpleAgreementsForFutureEquityMember"
      decimals="INF"
      id="Fact001382"
      unitRef="Pure">0.15</BNZI:PercentageOfDiscountPricePerShare>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-12-31_custom_SimpleAgreementsForFutureEquityMember"
      decimals="0"
      id="Fact001384"
      unitRef="USD">3836000</us-gaap:DebtInstrumentFaceAmount>
    <BNZI:ConversionUponSimpleAgreementsForFutureEquity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001386"
      unitRef="USD">0</BNZI:ConversionUponSimpleAgreementsForFutureEquity>
    <BNZI:ConversionUponSimpleAgreementsForFutureEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001388"
      unitRef="USD">0</BNZI:ConversionUponSimpleAgreementsForFutureEquity>
    <us-gaap:FairValueConcentrationOfRiskTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001390">&lt;p id="xdx_896_eus-gaap--FairValueConcentrationOfRiskTextBlock_zvOkjteJv0Ra" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the activity of the Related Party and Third Party SAFE liabilities, respectively (See &lt;i&gt;Note
13 - Simple Agreements for Future Equity&lt;/i&gt; for further detail), which represents a recurring fair value measurement at the end of the
relevant reporting period:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zIRJXlor64Wg"&gt;Schedule
of Fair Value Measurements&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B1_us-gaap--RelatedPartyTransactionsByRelatedPartyAxis_us-gaap--RelatedPartyMember_zHg5XphLFzXg" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B4_us-gaap--RelatedPartyTransactionsByRelatedPartyAxis_custom--ThirdPartyConvertibleDebtMember_zqOqm5T1Ftqc" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20230101__20230331_ecustom--SimpleAgreementForFutureEquityCurrent_iS_z4GQAMTu0lh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Balance at December 31, 2022&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;8,802,196&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;663,804&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--ChangeInFairValueOfSimpleAgreementForFutureEquity_zJBOuVGfM9Ua" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;303,139&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;22,861&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20230401__20230630_ecustom--SimpleAgreementForFutureEquityCurrent_iS_zHut71q3vU4f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Balance at March 31, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,105,335&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;686,665&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ChangeInFairValueOfSimpleAgreementForFutureEquity_zfd5svMNN0F1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;909,418&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;68,582&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20230401__20230630_ecustom--SimpleAgreementForFutureEquityCurrent_iE_z717Ar7WFEjg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance at June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;10,014,753&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;755,247&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueConcentrationOfRiskTextBlock>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001392"
      unitRef="USD">8802196</BNZI:SimpleAgreementForFutureEquityCurrent>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2022-12-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact001393"
      unitRef="USD">663804</BNZI:SimpleAgreementForFutureEquityCurrent>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-03-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001395"
      unitRef="USD">303139</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-03-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact001396"
      unitRef="USD">22861</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001398"
      unitRef="USD">9105335</BNZI:SimpleAgreementForFutureEquityCurrent>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2023-03-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact001399"
      unitRef="USD">686665</BNZI:SimpleAgreementForFutureEquityCurrent>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-04-012023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001401"
      unitRef="USD">909418</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-04-012023-06-30_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact001402"
      unitRef="USD">68582</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2023-06-30_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001404"
      unitRef="USD">10014753</BNZI:SimpleAgreementForFutureEquityCurrent>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2023-06-30_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact001405"
      unitRef="USD">755247</BNZI:SimpleAgreementForFutureEquityCurrent>
    <BNZI:PrepaidExpensesAndOtherCurrentAssetsTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001407">&lt;p id="xdx_80D_ecustom--PrepaidExpensesAndOtherCurrentAssetsTextBlock_zjINs9vp51jh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;8.
&lt;span id="xdx_828_z5O7xApv9tKg"&gt;Prepaid Expenses and Other Current Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zyWf8kh2XGz1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
expenses and other current assets consisted of the following at the dates indicated:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zumMVySAXOii"&gt;Summary
of Prepaid Expenses and Other Current Assets&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240630_zandxZGUGsJ5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20231231_z4258fNkZ3Xh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Prepaid expenses and other current assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ServiceTrade_iI_maPEAOAzwvC_z98NomZz2Qpd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Service Trade&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;302,055&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;364,384&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--PrepaidInsurance_iI_maPEAOAzwvC_z80eghUuUSkl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Prepaid insurance costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;282,265&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,661&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--PrepaidAdvertising_iI_maPEAOAzwvC_zH03npFdKXGj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Prepaid advertising and marketing costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;259,438&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,074&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--PrepaidSoftwareCosts_iI_maPEAOAzwvC_znpS0cpNNXf3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Prepaid software costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;97,912&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,887&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--PrepaidCommissions_iI_maPEAOAzwvC_zlKeyEI7thPl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Prepaid commissions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39,144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,472&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--PrepaidDataLicenseAndSubscriptionCosts_iI_maPEAOAzwvC_zQvxIOq2sXpd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Prepaid data license and subscription costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,375&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;53,124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--PrepaidMerchantFees_iI_maPEAOAzwvC_zktBPaMBVLw4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Prepaid merchant fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,488&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,224&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--PrepaidConsultingCosts_maPEAOAzwvC_z0UKn5LPbLqa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Prepaid consulting costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,539&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;120,332&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--OtherAssetsCurrent_iI_maPEAOAzwvC_znB6cfQrGLQ7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Other current assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;10,720&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;66,997&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzwvC_zuMURJ0tkv1b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total prepaid expenses and other current assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,080,936&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;741,155&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zIHTyZzXldkh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BNZI:PrepaidExpensesAndOtherCurrentAssetsTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001409">&lt;p id="xdx_892_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zyWf8kh2XGz1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
expenses and other current assets consisted of the following at the dates indicated:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zumMVySAXOii"&gt;Summary
of Prepaid Expenses and Other Current Assets&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240630_zandxZGUGsJ5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20231231_z4258fNkZ3Xh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Prepaid expenses and other current assets:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ServiceTrade_iI_maPEAOAzwvC_z98NomZz2Qpd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Service Trade&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;302,055&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;364,384&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--PrepaidInsurance_iI_maPEAOAzwvC_z80eghUuUSkl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Prepaid insurance costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;282,265&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,661&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--PrepaidAdvertising_iI_maPEAOAzwvC_zH03npFdKXGj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Prepaid advertising and marketing costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;259,438&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,074&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--PrepaidSoftwareCosts_iI_maPEAOAzwvC_znpS0cpNNXf3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Prepaid software costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;97,912&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,887&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--PrepaidCommissions_iI_maPEAOAzwvC_zlKeyEI7thPl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Prepaid commissions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39,144&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,472&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--PrepaidDataLicenseAndSubscriptionCosts_iI_maPEAOAzwvC_zQvxIOq2sXpd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Prepaid data license and subscription costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,375&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;53,124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--PrepaidMerchantFees_iI_maPEAOAzwvC_zktBPaMBVLw4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Prepaid merchant fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,488&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,224&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--PrepaidConsultingCosts_maPEAOAzwvC_z0UKn5LPbLqa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Prepaid consulting costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,539&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;120,332&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--OtherAssetsCurrent_iI_maPEAOAzwvC_znB6cfQrGLQ7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Other current assets&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;10,720&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;66,997&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzwvC_zuMURJ0tkv1b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total prepaid expenses and other current assets&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,080,936&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;741,155&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <BNZI:ServiceTrade
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001411"
      unitRef="USD">302055</BNZI:ServiceTrade>
    <BNZI:ServiceTrade
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001412"
      unitRef="USD">364384</BNZI:ServiceTrade>
    <us-gaap:PrepaidInsurance
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001414"
      unitRef="USD">282265</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001415"
      unitRef="USD">17661</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidAdvertising
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001417"
      unitRef="USD">259438</us-gaap:PrepaidAdvertising>
    <us-gaap:PrepaidAdvertising
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001418"
      unitRef="USD">11074</us-gaap:PrepaidAdvertising>
    <BNZI:PrepaidSoftwareCosts
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001420"
      unitRef="USD">97912</BNZI:PrepaidSoftwareCosts>
    <BNZI:PrepaidSoftwareCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001421"
      unitRef="USD">29887</BNZI:PrepaidSoftwareCosts>
    <BNZI:PrepaidCommissions
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001423"
      unitRef="USD">39144</BNZI:PrepaidCommissions>
    <BNZI:PrepaidCommissions
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001424"
      unitRef="USD">51472</BNZI:PrepaidCommissions>
    <BNZI:PrepaidDataLicenseAndSubscriptionCosts
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001426"
      unitRef="USD">34375</BNZI:PrepaidDataLicenseAndSubscriptionCosts>
    <BNZI:PrepaidDataLicenseAndSubscriptionCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001427"
      unitRef="USD">53124</BNZI:PrepaidDataLicenseAndSubscriptionCosts>
    <BNZI:PrepaidMerchantFees
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001429"
      unitRef="USD">28488</BNZI:PrepaidMerchantFees>
    <BNZI:PrepaidMerchantFees
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001430"
      unitRef="USD">26224</BNZI:PrepaidMerchantFees>
    <BNZI:PrepaidConsultingCosts
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001432"
      unitRef="USD">26539</BNZI:PrepaidConsultingCosts>
    <BNZI:PrepaidConsultingCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001433"
      unitRef="USD">120332</BNZI:PrepaidConsultingCosts>
    <us-gaap:OtherAssetsCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001435"
      unitRef="USD">10720</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001436"
      unitRef="USD">66997</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001438"
      unitRef="USD">1080936</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001439"
      unitRef="USD">741155</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001441">&lt;p id="xdx_809_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_z0iszU4Rn576" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;9.
&lt;span id="xdx_82D_z4HNq5Hu5fei"&gt;Accrued Expenses and Other Current Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zVt8FiGXCDFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
expenses and other current liabilities consisted of the following at the dates indicated:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zySJ5m5f4wBg"&gt;Summary
of Accrued Expenses and Other Current Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240630_zfu7pQtE2bPi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20231231_zrUJUbvsNIgf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued expenses and other current liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--AccruedAccountingAndProfessionalServicesCosts_iI_maALAOLzQvM_z7HJuxLlCl8f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Accrued accounting and professional services costs&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,458,192&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,511,889&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--AccruedSubscriptionCosts_iI_maALAOLzQvM_zcsotDQpSxC" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Accrued subscription costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;510,549&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,110&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--SalesTaxPayableCurrent_iI_maALAOLzQvM_zY6pV4Q63sda" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Sales tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;363,883&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;314,873&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--ExciseTaxPayableCurrent_iI_maALAOLzQvM_znVK2Y9gNFcg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Excise tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;223,717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;223,717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--AccruedLegalCosts_iI_maALAOLzQvM_zocG4dPHooyc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Accrued legal costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;159,417&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,694,439&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AccruedPayrollAndBenefitCosts_iI_maALAOLzQvM_zDapnX1gcNal" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Accrued payroll and benefit costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;123,335&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;185,504&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DepositLiabilityCurrent_iI_maALAOLzQvM_zfdLnVj2HYQg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Deposits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;52,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54,102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--AccruedStreamingServiceCosts_iI_maALAOLzQvM_zQouLoatPUy6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Accrued streaming service costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48,218&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,765&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccruedOfferingCosts_iI_maALAOLzQvM_zBz4jtQaUqua" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Accrued offering costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1469"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1470"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherLiabilitiesCurrent_iI_maALAOLzQvM_zsja988TSZ31" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;324,717&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;149,841&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iTI_mtALAOLzQvM_zU7O6BcQJk95" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total accrued expenses and other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,264,028&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,194,240&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zK7CCPJULEN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001443">&lt;p id="xdx_899_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zVt8FiGXCDFl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
expenses and other current liabilities consisted of the following at the dates indicated:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zySJ5m5f4wBg"&gt;Summary
of Accrued Expenses and Other Current Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240630_zfu7pQtE2bPi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20231231_zrUJUbvsNIgf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued expenses and other current liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--AccruedAccountingAndProfessionalServicesCosts_iI_maALAOLzQvM_z7HJuxLlCl8f" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; width: 60%; text-align: left"&gt;Accrued accounting and professional services costs&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;2,458,192&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,511,889&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--AccruedSubscriptionCosts_iI_maALAOLzQvM_zcsotDQpSxC" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Accrued subscription costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;510,549&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,110&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--SalesTaxPayableCurrent_iI_maALAOLzQvM_zY6pV4Q63sda" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Sales tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;363,883&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;314,873&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--ExciseTaxPayableCurrent_iI_maALAOLzQvM_znVK2Y9gNFcg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Excise tax payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;223,717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;223,717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--AccruedLegalCosts_iI_maALAOLzQvM_zocG4dPHooyc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Accrued legal costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;159,417&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,694,439&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AccruedPayrollAndBenefitCosts_iI_maALAOLzQvM_zDapnX1gcNal" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Accrued payroll and benefit costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;123,335&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;185,504&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DepositLiabilityCurrent_iI_maALAOLzQvM_zfdLnVj2HYQg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Deposits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;52,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54,102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--AccruedStreamingServiceCosts_iI_maALAOLzQvM_zQouLoatPUy6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Accrued streaming service costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;48,218&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37,765&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccruedOfferingCosts_iI_maALAOLzQvM_zBz4jtQaUqua" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Accrued offering costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1469"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1470"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--OtherLiabilitiesCurrent_iI_maALAOLzQvM_zsja988TSZ31" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;324,717&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;149,841&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iTI_mtALAOLzQvM_zU7O6BcQJk95" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total accrued expenses and other current liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;4,264,028&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,194,240&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <BNZI:AccruedAccountingAndProfessionalServicesCosts
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001445"
      unitRef="USD">2458192</BNZI:AccruedAccountingAndProfessionalServicesCosts>
    <BNZI:AccruedAccountingAndProfessionalServicesCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001446"
      unitRef="USD">1511889</BNZI:AccruedAccountingAndProfessionalServicesCosts>
    <BNZI:AccruedSubscriptionCosts
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001448"
      unitRef="USD">510549</BNZI:AccruedSubscriptionCosts>
    <BNZI:AccruedSubscriptionCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001449"
      unitRef="USD">22110</BNZI:AccruedSubscriptionCosts>
    <BNZI:SalesTaxPayableCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001451"
      unitRef="USD">363883</BNZI:SalesTaxPayableCurrent>
    <BNZI:SalesTaxPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001452"
      unitRef="USD">314873</BNZI:SalesTaxPayableCurrent>
    <BNZI:ExciseTaxPayableCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001454"
      unitRef="USD">223717</BNZI:ExciseTaxPayableCurrent>
    <BNZI:ExciseTaxPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001455"
      unitRef="USD">223717</BNZI:ExciseTaxPayableCurrent>
    <BNZI:AccruedLegalCosts
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001457"
      unitRef="USD">159417</BNZI:AccruedLegalCosts>
    <BNZI:AccruedLegalCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001458"
      unitRef="USD">2694439</BNZI:AccruedLegalCosts>
    <BNZI:AccruedPayrollAndBenefitCosts
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001460"
      unitRef="USD">123335</BNZI:AccruedPayrollAndBenefitCosts>
    <BNZI:AccruedPayrollAndBenefitCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001461"
      unitRef="USD">185504</BNZI:AccruedPayrollAndBenefitCosts>
    <us-gaap:DepositLiabilityCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001463"
      unitRef="USD">52000</us-gaap:DepositLiabilityCurrent>
    <us-gaap:DepositLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001464"
      unitRef="USD">54102</us-gaap:DepositLiabilityCurrent>
    <BNZI:AccruedStreamingServiceCosts
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001466"
      unitRef="USD">48218</BNZI:AccruedStreamingServiceCosts>
    <BNZI:AccruedStreamingServiceCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001467"
      unitRef="USD">37765</BNZI:AccruedStreamingServiceCosts>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001472"
      unitRef="USD">324717</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001473"
      unitRef="USD">149841</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001475"
      unitRef="USD">4264028</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001476"
      unitRef="USD">5194240</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <BNZI:DeferredRevenueTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001478">&lt;p id="xdx_80F_ecustom--DeferredRevenueTextBlock_zB5Bk2YCFb2a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;10.
&lt;span id="xdx_820_zcenpVsT4JEg"&gt;Deferred Revenue&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
revenue represents amounts that have been collected in advance of revenue recognition and is recognized as revenue when transfer of control
to customers has occurred or services have been provided. The deferred revenue balance does not represent the total contract value of
annual or multi-year, non-cancelable revenue agreements. Differences between the revenue recognized per the below schedule, and the revenue
recognized per the consolidated statement of operations, reflect amounts not recognized through the deferred revenue process, and which
have been determined to be insignificant. For the six months ended June 30, 2024 and 2023, the Company recognized $&lt;span id="xdx_905_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20240101__20240630_zc2iTFeEIdE8" title="Recognition of deferred revenue"&gt;861,496&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230101__20230630_z8tF3edknz3g" title="Recognition of deferred revenue"&gt;887,219&lt;/span&gt;
in revenue that was included in the prior year deferred revenue balance, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_ze7qrqSuy2Fa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
change in deferred revenue was as follows for the periods indicated:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_zdeVDwtNWK1b"&gt;Summary of Changes in Deferred Revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20240101__20240630_zxF9s6BLfaVd" style="font-weight: bold; text-align: center"&gt;Six Months Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20230101__20231231_zpboZHXatZPe" style="font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ContractWithCustomerLiability_iS_zUHqvTaYkoJb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Deferred revenue, beginning of period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,214,096&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;930,436&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ContractWithCustomerLiabilityBillings_zrSPnutvBZQj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Billings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,255,811&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,781,924&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenuePriorYear_iN_di_z2NgayQRWtgk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Revenue recognized (prior year deferred revenue)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(861,496&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(930,436&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenueCurrentYear_iN_di_zWGmal5IB5z4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Revenue recognized (current year deferred revenue)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,286,173&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,567,828&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ContractWithCustomerLiability_iE_zFQlRtf64ue7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Deferred revenue, end of period&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,322,238&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,214,096&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zx9b215T0X5i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
deferred revenue balance is short-term and included under current liabilities on the accompanying unaudited condensed consolidated balance
sheet.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BNZI:DeferredRevenueTextBlock>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact001480"
      unitRef="USD">861496</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact001482"
      unitRef="USD">887219</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001484">&lt;p id="xdx_89F_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_ze7qrqSuy2Fa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
change in deferred revenue was as follows for the periods indicated:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_zdeVDwtNWK1b"&gt;Summary of Changes in Deferred Revenue&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20240101__20240630_zxF9s6BLfaVd" style="font-weight: bold; text-align: center"&gt;Six Months Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20230101__20231231_zpboZHXatZPe" style="font-weight: bold; text-align: center"&gt;Year Ended&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ContractWithCustomerLiability_iS_zUHqvTaYkoJb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Deferred revenue, beginning of period&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,214,096&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;930,436&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ContractWithCustomerLiabilityBillings_zrSPnutvBZQj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;Billings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,255,811&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,781,924&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenuePriorYear_iN_di_z2NgayQRWtgk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Revenue recognized (prior year deferred revenue)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(861,496&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(930,436&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenueCurrentYear_iN_di_zWGmal5IB5z4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Revenue recognized (current year deferred revenue)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,286,173&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,567,828&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ContractWithCustomerLiability_iE_zFQlRtf64ue7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Deferred revenue, end of period&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,322,238&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,214,096&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001486"
      unitRef="USD">1214096</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact001487"
      unitRef="USD">930436</us-gaap:ContractWithCustomerLiability>
    <BNZI:ContractWithCustomerLiabilityBillings
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact001489"
      unitRef="USD">2255811</BNZI:ContractWithCustomerLiabilityBillings>
    <BNZI:ContractWithCustomerLiabilityBillings
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001490"
      unitRef="USD">4781924</BNZI:ContractWithCustomerLiabilityBillings>
    <BNZI:ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenuePriorYear
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact001492"
      unitRef="USD">861496</BNZI:ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenuePriorYear>
    <BNZI:ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenuePriorYear
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001493"
      unitRef="USD">930436</BNZI:ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenuePriorYear>
    <BNZI:ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenueCurrentYear
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact001495"
      unitRef="USD">1286173</BNZI:ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenueCurrentYear>
    <BNZI:ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenueCurrentYear
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact001496"
      unitRef="USD">3567828</BNZI:ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenueCurrentYear>
    <us-gaap:ContractWithCustomerLiability
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001498"
      unitRef="USD">1322238</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact001499"
      unitRef="USD">1214096</us-gaap:ContractWithCustomerLiability>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001501">&lt;p id="xdx_801_eus-gaap--DebtDisclosureTextBlock_z0e7uFgpbovl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;11.
&lt;span id="xdx_825_zrXaBFvnkDq9"&gt;Debt&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Convertible
Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Convertible
Notes - Related Party&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2022 and 2023, the Company issued subordinated convertible promissory notes to related parties Alco Investment Company (&#x201c;Alco&#x201d;),
Mason Ward, DNX, and William Bryant. Alco held approximately &lt;span id="xdx_90C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20221231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z0ldv4x4qJTg" title="Equity percentage owned percentage"&gt;&lt;span id="xdx_907_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zP2iByhGbnM1" title="Equity percentage owned percentage"&gt;5&lt;/span&gt;&lt;/span&gt;% of the issued equity of the Company, through its ownership of Series
A preferred stock. DNX held in excess of &lt;span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DNXMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__srt--RangeAxis__srt--MinimumMember_zgwZmZRWZ9T2" title="Equity percentage owned percentage"&gt;&lt;span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20221231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DNXMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__srt--RangeAxis__srt--MinimumMember_zqTIqPfCOty9" title="Equity percentage owned percentage"&gt;5&lt;/span&gt;&lt;/span&gt;% of the issued equity of the Company, through its ownership of Series A preferred stock. William
Bryant became a member of the Board of Directors upon completion of the Merger. The Related Party Convertible Notes bear interest at
a rate of &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_znR9ccwhzUl1" title="Debt instrument, interest rate"&gt;&lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zemmxBkEcL0k" title="Debt instrument, interest rate"&gt;8&lt;/span&gt;&lt;/span&gt;% per annum, and are convertible into the same series of capital stock of the Company to be issued to other investors upon
a Qualified Financing (as defined in the agreement).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the three and six months ended June 30, 2023, the Company recorded a $&lt;span id="xdx_902_eus-gaap--AmortizationOfDebtDiscountPremium_c20230401__20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_ztWhKjP8HPOc" title="Debt discount upon issuance"&gt;707,000&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--AmortizationOfDebtDiscountPremium_c20230101__20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zDRI75oTDR52" title="Debt discount upon issuance"&gt;1,126,451&lt;/span&gt;, respectively, debt discount upon issuance
of additional Related Party Convertible Notes. For the three months ended June 30, 2023, interest expense on the Related Party Convertible
Notes totaled $&lt;span id="xdx_90B_eus-gaap--InterestExpense_c20230401__20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zdYe41ywj0Ia" title="Interest expense"&gt;552,403&lt;/span&gt;, comprised of $&lt;span id="xdx_900_eus-gaap--InterestExpenseDebt_c20230401__20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zqHdcsU3Rd44" title="Interest expense debt"&gt;125,352&lt;/span&gt; of contractual interest and $&lt;span id="xdx_90F_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20230401__20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zxxOFz5Mubo8" title="Debt related commitement fees and debt issuance costs"&gt;427,051&lt;/span&gt; for the amortization of the discount. For the six
months ended June 30, 2023, interest expense on the Related Party Convertible Notes totaled $&lt;span id="xdx_902_eus-gaap--InterestExpense_c20230101__20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zaeQT2uULUZd" title="Interest expense"&gt;935,687&lt;/span&gt;, comprised of $&lt;span id="xdx_908_eus-gaap--InterestExpenseDebt_c20230101__20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zOJO29TwhJs3" title="Interest expense debt"&gt;215,774&lt;/span&gt; of contractual
interest and $&lt;span id="xdx_90F_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20230101__20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zbtJ8meRLO7" title="Debt related commitement fees and debt issuance costs"&gt;719,913&lt;/span&gt; for the amortization of the discount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;March
2023 Amendment&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2023, the Related Party Convertible Notes were amended to extend the maturity to December 31, 2023. The Company evaluated the terms
of the First Amendment in accordance with ASC 470-60, Troubled Debt Restructurings, and ASC 470-50, Debt Modifications and Extinguishments.
The Company determined that the Company was granted a concession by the lender based on the decrease of the effective borrowing rate
on the First Amendment. Accordingly, the Company accounted for the First Amendment as a troubled debt restructuring. As a result, the
Company accounted for the troubled debt restructuring by calculating a new effective interest rate for the First Amendment based on the
carrying amount of the debt and the present value of the revised future cash flow payment stream. The troubled debt restructuring did
not result in recognition of a gain or loss in the consolidated statement of operations but does impact interest expense recognized in
the future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Convertible
Notes - Third Party&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2022 and 2023, the Company issued additional subordinated convertible notes (the &#x201c;Third Party Convertible Notes&#x201d;). &lt;span id="xdx_903_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zq1swhR3TWYh" title="Debt instrument, convertible terms"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zGZ6QrFjJThh" title="Debt instrument, convertible terms"&gt;The Third
Party Convertible Notes bear interest at a rate of 8% per annum, and are convertible into the same series of capital stock of the Company
to be issued to other investors upon a Qualified Financing (as defined in the agreement).&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the three and six months ended June 30, 2023, the Company recorded a $&lt;span id="xdx_901_eus-gaap--AmortizationOfDebtDiscountPremium_c20230401__20230630__us-gaap--DebtInstrumentAxis__custom--ThirdPartyConvertibleNotesMember_z6afQHx57lij" title="Debt discount upon issuance"&gt;0&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--AmortizationOfDebtDiscountPremium_c20230101__20230630__us-gaap--DebtInstrumentAxis__custom--ThirdPartyConvertibleNotesMember_zC1l1j2BIFqi" title="Debt discount upon issuance"&gt;330,390&lt;/span&gt;, respectively, debt discount upon issuance of additional
Third Party Convertible Notes. For the three months ended June 30, 2023, interest expense on the Third Party Convertible Notes totaled
$&lt;span id="xdx_900_eus-gaap--InterestExpense_c20230401__20230630__us-gaap--DebtInstrumentAxis__custom--ThirdPartyConvertibleNotesMember_zX63mUHXL6pl" title="Interest expense"&gt;142,353&lt;/span&gt;, comprised of $&lt;span id="xdx_90D_eus-gaap--InterestExpenseDebt_c20230401__20230630__us-gaap--DebtInstrumentAxis__custom--ThirdPartyConvertibleNotesMember_zWFO62GvTT3i" title="Interest expense debt"&gt;37,845&lt;/span&gt; of contractual interest and $&lt;span id="xdx_90D_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20230401__20230630__us-gaap--DebtInstrumentAxis__custom--ThirdPartyConvertibleNotesMember_zMOOmFKqBll5" title="Debt related commitement fees and debt issuance costs"&gt;104,508&lt;/span&gt; for the amortization of the discount. For the six months ended June
30, 2023, interest expense on the Third Party Convertible Notes totaled $&lt;span id="xdx_90D_eus-gaap--InterestExpense_c20230101__20230630__us-gaap--DebtInstrumentAxis__custom--ThirdPartyConvertibleNotesMember_zPsoSKSteoe7" title="Interest expense"&gt;293,977&lt;/span&gt;, comprised of $&lt;span id="xdx_905_eus-gaap--InterestExpenseDebt_c20230101__20230630__us-gaap--DebtInstrumentAxis__custom--ThirdPartyConvertibleNotesMember_zeMfYeI5f6W" title="Interest expense debt"&gt;72,562&lt;/span&gt; of contractual interest and $&lt;span id="xdx_909_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20230101__20230630__us-gaap--DebtInstrumentAxis__custom--ThirdPartyConvertibleNotesMember_zAIRGspwFBaa" title="Debt related commitement fees and debt issuance costs"&gt;221,415&lt;/span&gt;
for the amortization of the discount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;March
2023 Amendment&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2023, the Third Party Convertible Notes were amended to extend the maturity to December 31, 2023. The Company evaluated the terms
of the First Amendment in accordance with ASC 470-60, Troubled Debt Restructurings, and ASC 470-50, Debt Modifications and Extinguishments.
The Company determined that the Company was granted a concession by the lender based on the decrease of the effective borrowing rate
on the First Amendment. Accordingly, the Company accounted for the First Amendment as a troubled debt restructuring. As a result, the
Company accounted for the troubled debt restructuring by calculating a new effective interest rate for the First Amendment based on the
carrying amount of the debt and the present value of the revised future cash flow payment stream. The troubled debt restructuring did
not result in recognition of a gain or loss in the consolidated statement of operations but does impact interest expense recognized in
the future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ConvertibleDebtTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyAndThirdPartyMember_zmlgDYmRW4Ui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the Related Party and Third Party Convertible Notes, respectively, as of December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B7_zYgACGyhAoAc" style="display: none"&gt;Summary
of Related Party  and Third Party Convertible Notes&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_ziUGMH93byT" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zHTt8aWsY0Te" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_zWoNcpXIhX8b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Face value of the convertible notes&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6,783,538&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;3,196,206&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--UnamortizedDebtDiscountOnConvertibleNotesPayable_iI_zG6ER3VfyCf1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Debt discount, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(131,867&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(83,688&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ConvertibleNotesPayable_iI_z8maFHu0bmi2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Carrying value of the convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,651,671&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,112,518&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--InterestPayableOnConvertibleDebt_iI_zMYYequKM0Oa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;619,697&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;233,714&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ConversionOfConvertibleNote_iI_zahMoMzD3ZD4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Conversion of convertible notes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(7,271,368&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,346,232&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ConvertibleDebtIncludingAccruedInterest_zMWAkYc6cB4e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total convertible notes and accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1568"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1569"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zjkrv0fhbKz4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Promissory
Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Promissory
Notes - Related Party&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 30, 2023, the Company issued a subordinate promissory note (&#x201c;Alco August Promissory Note&#x201d;) in the aggregate principal
amount of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20230830__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zSBQiFPTDEgf" title="Aggregate principal amount"&gt;150,000&lt;/span&gt; to Alco Investment Company, a related party. Alco held its ownership of over &lt;span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230830__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zIEOwjZcbIS7" title="Equity percentage owned percentage"&gt;10&lt;/span&gt;% of the issued equity of the Company,
through its ownership of Series A preferred stock. The Alco August Promissory Note bears interest at a rate of &lt;span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20230830__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember_zbNPQikV6uue" title="Debt instrument, interest rate"&gt;8&lt;/span&gt;% per annum. The outstanding
principal and accrued interest are due and payable on &lt;span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_dd_c20230830__20230830__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zWmUvUGwvWY9" title="Debt instrument, maturity date"&gt;April 29, 2024&lt;/span&gt;. The Company recorded a $&lt;span id="xdx_909_eus-gaap--DeferredFinanceCostsGross_iI_c20230830__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zIBm6MJcTqR4" title="Debt instrument unamortized debt issuance costs gross"&gt;3,711&lt;/span&gt; debt discount upon issuance of the
Alco August Promissory Note. For the three months ended June 30, 2024, interest expense on the Alco August Promissory Note totaled $&lt;span id="xdx_908_eus-gaap--InterestExpense_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zgQF1F69R3zd" title="Interest expense"&gt;2,908&lt;/span&gt;,
comprised of $&lt;span id="xdx_905_eus-gaap--InterestExpenseDebt_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zm3qd5tOVVG2" title="Interest expense debt"&gt;2,992&lt;/span&gt; of contractual accrued interest and ($&lt;span id="xdx_903_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zXtNT456Jpci" title="Debt related commitement fees and debt issuance costs"&gt;84&lt;/span&gt;) for the amortization of the discount. For the six months ended June 30,
2024, interest expense on the Alco August Promissory Note totaled $&lt;span id="xdx_90C_eus-gaap--InterestExpense_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zNJ8QaugfvWf" title="Interest expense"&gt;8,357&lt;/span&gt;, comprised of $&lt;span id="xdx_908_eus-gaap--InterestExpenseDebt_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zlMM41V8bkja" title="Interest expense debt"&gt;5,983&lt;/span&gt; of contractual accrued interest and $&lt;span id="xdx_90D_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_z1QCWFWEvEKf" title="Debt related commitement fees and debt issuance costs"&gt;2,374&lt;/span&gt;
for the amortization of the discount. As of June 30, 2024 and December 31, 2023, $&lt;span id="xdx_90B_eus-gaap--OtherNotesPayableCurrent_iI_c20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zE2fAxKPezEj" title="Principal amount outstanding"&gt;&lt;span id="xdx_905_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zF8wpRUGbex5" title="Principal amount outstanding"&gt;150,000&lt;/span&gt;&lt;/span&gt; of principal and $&lt;span id="xdx_900_ecustom--InterestPayableOnOtherNotesPayableCurrent_iI_c20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zaefJfGlK9si" title="Accrued interest outstanding"&gt;10,027&lt;/span&gt; and $&lt;span id="xdx_901_ecustom--InterestPayableOnOtherNotesPayableCurrent_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_z6qH2ssm8E82" title="Accrued interest outstanding"&gt;4,044&lt;/span&gt;, respectively,
of accrued interest is outstanding under the Alco August Promissory Note recorded in note payable - related party on the balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 13, 2023, the Company issued a subordinate promissory note (&#x201c;Alco September Promissory Note&#x201d;) in the aggregate
principal amount of up to $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zNIcbuyjVfaj" title="Aggregate principal amount"&gt;1,500,000&lt;/span&gt; to Alco Investment Company, a related party. The Alco September Promissory Note bears interest at
a rate of &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20230913__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember_zIN4c0vvSINa" title="Debt instrument, interest rate"&gt;8&lt;/span&gt;% per annum. The outstanding principal and accrued interest are due and payable on &lt;span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20230913__20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_znoiRZbfuE3f" title="Debt instrument, maturity date"&gt;September 30, 2024&lt;/span&gt;. The Company recorded
$&lt;span id="xdx_905_eus-gaap--DeferredFinanceCostsNet_iI_c20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zSgzoW77XuZ" title="Debt issuance costs"&gt;8,588&lt;/span&gt; of debt issuance costs and a $&lt;span id="xdx_904_eus-gaap--AmortizationOfDebtDiscountPremium_c20230913__20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zxvcLeRmF0H1" title="Debt discount upon issuance"&gt;638,808&lt;/span&gt; debt discount upon issuance of the Alco September Promissory Note, relating to the share
transfer agreements, see below. For the three months ended June 30, 2024, interest expense on the Alco September Promissory Note totaled
$&lt;span id="xdx_909_eus-gaap--InterestExpense_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zLLrIU6AlQs7" title="Interest expense"&gt;95,935&lt;/span&gt;, comprised of $&lt;span id="xdx_90A_eus-gaap--InterestExpenseDebt_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zcPfyWga7zd1" title="Interest expense debt"&gt;29,918&lt;/span&gt; of contractual accrued interest and $&lt;span id="xdx_90C_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zj0H4t5LRHYe" title="Debt related commitement fees and debt issuance costs"&gt;66,017&lt;/span&gt; for the amortization of the discount. For the six months ended
June 30, 2024, interest expense on the Alco September Promissory Note totaled $&lt;span id="xdx_90F_eus-gaap--InterestExpense_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zyhIbkotBC17" title="Interest expense"&gt;187,498&lt;/span&gt;, comprised of $&lt;span id="xdx_902_eus-gaap--InterestExpenseDebt_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zhLUDFtlhrif" title="Interest expense debt"&gt;59,836&lt;/span&gt; of contractual accrued interest
and $&lt;span id="xdx_90B_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zyjZrjBwtts5" title="Debt related commitement fees and debt issuance costs"&gt;127,662&lt;/span&gt; for the amortization of the discount. As of June 30, 2024 and December 31, 2023, $&lt;span id="xdx_90E_eus-gaap--OtherNotesPayableCurrent_iI_c20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zpjBujjgq3f5" title="Principal amount outstanding"&gt;&lt;span id="xdx_908_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zgXwnsUv3xA7" title="Principal amount outstanding"&gt;1,500,000&lt;/span&gt;&lt;/span&gt; of principal and $&lt;span id="xdx_904_ecustom--InterestPayableOnOtherNotesPayableCurrent_iI_c20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zB8W0ORRdm52" title="Accrued interest outstanding"&gt;90,411&lt;/span&gt; and
$&lt;span id="xdx_904_ecustom--InterestPayableOnOtherNotesPayableCurrent_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zgcxqiUDQ3L" title="Accrued interest outstanding"&gt;30,575&lt;/span&gt;, respectively, of accrued interest is outstanding under the Alco September Promissory Note recorded in note payable - related
party on the balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 16, 2023, the Company issued a subordinate promissory note (&#x201c;Alco November Promissory Note&#x201d;) in the aggregate principal
amount of up to $&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20231116__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember__srt--RangeAxis__srt--MaximumMember_zOjKoPlZm44i" title="Aggregate principal amount"&gt;750,000&lt;/span&gt; to Alco Investment Company, a related party. The Alco November Promissory Note bears interest at a rate of &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20231116__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember_z5w02VCxQ8n6" title="Debt instrument, interest rate"&gt;8&lt;/span&gt;%
per annum. The outstanding principal and accrued interest are due and payable on &lt;span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20231116__20231116__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zNjoP4kBX05h" title="Debt instrument, maturity date"&gt;April 13, 2024&lt;/span&gt;. The Company recorded a $&lt;span id="xdx_904_eus-gaap--DeferredFinanceCostsGross_iI_c20231116__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zqRjXDSPSYB7" title="Debt instrument unamortized debt issuance costs gross"&gt;363,905&lt;/span&gt; debt
discount upon issuance of the Alco November Promissory Note relating to the share transfer agreements, see below. For the three months
ended June 30, 2024, interest expense on the Alco November Promissory Note totaled ($&lt;span id="xdx_908_eus-gaap--InterestExpense_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_z44HG54oiwe1" title="Interest expense"&gt;31,036&lt;/span&gt;), comprised of $&lt;span id="xdx_908_eus-gaap--InterestExpenseDebt_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_z3mSLeTksh3h" title="Interest expense debt"&gt;14,959&lt;/span&gt; of contractual accrued
interest and ($&lt;span id="xdx_904_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_z3fArkEmGWla" title="Debt related commitement fees and debt issuance costs"&gt;45,995&lt;/span&gt;) for the amortization of the discount. For the six months ended June 30, 2024, interest expense on the Alco November
Promissory Note totaled $&lt;span id="xdx_903_eus-gaap--InterestExpense_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zNV43RCVFAK1" title="Interest expense"&gt;217,249&lt;/span&gt;, comprised of $&lt;span id="xdx_908_eus-gaap--InterestExpenseDebt_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zCRxG3Qkdf22" title="Interest expense debt"&gt;29,918&lt;/span&gt; of contractual accrued interest and $&lt;span id="xdx_90F_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_z67DltiF5qf8" title="Debt related commitement fees and debt issuance costs"&gt;187,331&lt;/span&gt; for the amortization of the discount.
As of June 30, 2024 and December 31, 2023, $&lt;span id="xdx_905_eus-gaap--OtherNotesPayableCurrent_iI_c20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zi70mDr9ikhc" title="Principal amount outstanding"&gt;&lt;span id="xdx_906_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zeAzaEAUTKNd" title="Principal amount outstanding"&gt;750,000&lt;/span&gt;&lt;/span&gt; of principal and $&lt;span id="xdx_90C_ecustom--InterestPayableOnOtherNotesPayableCurrent_iI_c20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_z0uBWSuTiSvc" title="Accrued interest outstanding"&gt;37,315&lt;/span&gt; and $&lt;span id="xdx_901_ecustom--InterestPayableOnOtherNotesPayableCurrent_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zH64a4WUtrGg" title="Accrued interest outstanding"&gt;7,397&lt;/span&gt;, respectively, of accrued interest is outstanding
under the Alco November Promissory Note recorded in note payable - related party on the consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 13, 2023, the Company issued a subordinate promissory note (&#x201c;Alco December Promissory Note&#x201d;) in the aggregate principal
amount of up to $&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20231213__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember__srt--RangeAxis__srt--MaximumMember_zr6RQoghVu05" title="Aggregate principal amount"&gt;2,000,000&lt;/span&gt; to Alco Investment Company, a related party. The Alco December Promissory Note bears interest at a rate of
&lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20231213__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember_zgDj0g0rD4rb" title="Debt instrument, interest rate"&gt;8&lt;/span&gt;% per annum. The outstanding principal and accrued interest are due and payable on &lt;span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20231213__20231213__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zEz0FYxihPZb" title="Debt instrument, maturity date"&gt;December 31, 2024&lt;/span&gt;. The Company recorded a $&lt;span id="xdx_90B_eus-gaap--DeferredFinanceCostsGross_iI_c20231213__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zRoB0BrdCJb5" title="Debt instrument unamortized debt issuance costs gross"&gt;1,496,252&lt;/span&gt;
debt discount upon issuance of the Alco December Promissory Note, relating to the share transfer agreements, see below. For the three
months ended June 30, 2024, interest expense on the Alco December Promissory Note totaled $&lt;span id="xdx_90D_eus-gaap--InterestExpense_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zxm5bCJl9USf" title="Interest expense"&gt;317,667&lt;/span&gt;, comprised of $&lt;span id="xdx_90F_eus-gaap--InterestExpenseDebt_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zglvUnvJ5hN3" title="Interest expense debt"&gt;39,890&lt;/span&gt; of contractual
accrued interest and $&lt;span id="xdx_907_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zKGGAOCfm85" title="Debt issuance costs"&gt;277,777&lt;/span&gt; for the amortization of the discount. For the six months ended June 30, 2024, interest expense on the Alco
December Promissory Note totaled $&lt;span id="xdx_908_eus-gaap--InterestExpense_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zu00jGVPdbia" title="Interest expense"&gt;549,883&lt;/span&gt;, comprised of $&lt;span id="xdx_908_eus-gaap--InterestExpenseDebt_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_z4Q5oOHdmoKk" title="Interest expense debt"&gt;79,780&lt;/span&gt; of contractual accrued interest and $&lt;span id="xdx_902_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_ztAlWLlX5Dml" title="Debt issuance costs"&gt;470,103&lt;/span&gt; for the amortization of
the discount. As of June 30, 2024 and December 31, 2023, $&lt;span id="xdx_904_eus-gaap--OtherNotesPayableCurrent_iI_c20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zyKtcesZ9uKb" title="Principal amount outstanding"&gt;&lt;span id="xdx_905_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zgxtQqEUIhK4" title="Principal amount outstanding"&gt;2,000,000&lt;/span&gt;&lt;/span&gt; of principal and $&lt;span id="xdx_902_ecustom--InterestPayableOnOtherNotesPayableCurrent_iI_c20240630__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zB59Ln5dEoH2" title="Accrued interest outstanding"&gt;87,670&lt;/span&gt; and $&lt;span id="xdx_90B_ecustom--InterestPayableOnOtherNotesPayableCurrent_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__us-gaap--EquityMethodInvestmentNonconsolidatedInvesteeAxis__custom--AlcoMember_zvvlJB8Dn1Zi" title="Accrued interest outstanding"&gt;7,890&lt;/span&gt;, respectively, of accrued interest
is outstanding under the Alco December Promissory Note recorded in note payable &#x2013; related party on the consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the issuances of the Alco September, November, and December Promissory Notes, the Company, 7GC and the Sponsor entered
into share transfer agreements (the &#x201c;Alco Share Transfer Agreements&#x201d;) with Alco Investment Company. Pursuant to which &lt;span id="xdx_90A_eus-gaap--DebtConversionDescription_c20240101__20240630__custom--ComponentsAxis__custom--AlcoShareTransferAgreementsMember__dei--LegalEntityAxis__custom--GcCoHoldingsIncMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember_zljyG1ml9hg7"&gt;for
each $&lt;span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20231213__custom--ComponentsAxis__custom--AlcoShareTransferAgreementsMember__dei--LegalEntityAxis__custom--GcCoHoldingsIncMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember_z0e28J39Ysci" title="Debt Instrument, Convertible, Conversion Price"&gt;500.00&lt;/span&gt; in principal borrowed under the Alco September and November Promissory Notes, the Sponsor agreed to forfeit one share of
7GC Class B Common Stock held by the Sponsor, in exchange for the right of Alco to receive one New Banzai Class A Share. For each $&lt;span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20231213__custom--ComponentsAxis__custom--AlcoShareTransferAgreementsMember__dei--LegalEntityAxis__custom--GcCoHoldingsIncMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember_z8Df75Wbkvmh" title="Debt Instrument, Convertible, Conversion Price"&gt;500.00&lt;/span&gt;
in principal borrowed under the December Note, the Sponsor agreed to forfeit three shares of 7GC Class B Common Stock held by the Sponsor,
in exchange for the right of Alco to receive three New Banzai Class A Shares. Such forfeited and issued shares under the Alco September,
November, and December Promissory Notes are capped at an amount equal to &lt;span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20231213__20231213__custom--ComponentsAxis__custom--AlcoShareTransferAgreementsMember__dei--LegalEntityAxis__custom--GcCoHoldingsIncMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember_zo4AwvGxOcd5" title="Debt Conversion, Converted Instrument, Shares Issued"&gt;3,000&lt;/span&gt;, &lt;span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20231213__20231213__custom--ComponentsAxis__custom--AlcoShareTransferAgreementsMember__dei--LegalEntityAxis__custom--GcCoHoldingsIncMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember_zIWy3TO64NMl" title="Debt Conversion, Converted Instrument, Shares Issued"&gt;1,500&lt;/span&gt;, and &lt;span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20231213__20231213__custom--ComponentsAxis__custom--AlcoShareTransferAgreementsMember__dei--LegalEntityAxis__custom--GcCoHoldingsIncMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember_z26PeBFhRCP8" title="Debt Conversion, Converted Instrument, Shares Issued"&gt;12,000&lt;/span&gt;, respectively&lt;/span&gt;. Pursuant to the
Alco Share Transfer Agreements, the shares are subject to an &lt;span id="xdx_901_ecustom--LockUpPeriod_dtD_c20231213__20231213__custom--ComponentsAxis__custom--AlcoShareTransferAgreementsMember__dei--LegalEntityAxis__custom--GcCoHoldingsIncMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember_zDIwyOsCCNxb" title="Debt conversion, description"&gt;180&lt;/span&gt;-day lock-up period upon issuance of the shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the Alco Share Transfer Agreements, the Company considered the guidance under ASC 815, Derivatives and Hedging, and determined that the
Investor Shares underlying each of the Share Transfer Agreements described above, met the definition of a freestanding financial instrument
and are not precluded from being considered indexed to the Company&#x2019;s common stock. The Company determined that these shares represent
a freestanding equity contract issued to the lender, resulting in a discount recorded on the notes when they are issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity-classified
contracts are initially measured at fair value (or allocated value). Subsequent changes in fair value are not recognized if the contracts
continue to be classified in equity. The measurement of fair value was determined utilizing various put option models in estimating the
discount lack of marketability (the &#x201c;DLOM&#x201d;) applied to the public share price as the shares underlying each of the Share
Transfer Agreements are subject to a lock-up period pursuant to each agreement, to estimate the fair value of the shares transferred.
Option pricing models assume that the cost to purchase a stock option relates directly to the measurement of the DLOM. The logic behind
these models is that investors may be able to quantify this price risk, due to lack of marketability, over a particular holding period
where price volatility is usually estimated as a proxy for risk. The inputs and assumptions utilized in the fair value estimation included
the Company&#x2019;s stock price on the measurement date, a DLOM as described above, the number of shares pursuant to each Share Transfer
Agreement, and a probability weighted factor for the Company&#x2019;s expected percentage of completing its Business Combination, at each
Share Transfer Agreement date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the Alco September Promissory Note, of which $&lt;span id="xdx_909_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zihZ4CNegiL1" title="Maximum borrowing capacity"&gt;1,000,000&lt;/span&gt; was drawn on September 13, 2023, the DLOM was estimated using the put option
models described above and the following assumptions: a holding period for the shares of 272 days (approximately &lt;span id="xdx_901_ecustom--HoldingPeriodForShares_dtY_c20230913__20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zXy3SREDqtj1" title="Holding period for shares"&gt;0.77&lt;/span&gt; years) measured
from the date of issuance of the $&lt;span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfDebt_c20230913__20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zkHOgrdfnG1e" title="Proceeds from Issuance of Debt"&gt;1,000,000&lt;/span&gt; of proceeds under the September Note through the issuance of the shares under the Alco October
Share Transfer Agreement on December 14, 2023 at which time the &lt;span id="xdx_908_ecustom--LockUpPeriod_dtD_c20230913__20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_z6sS9CkzEoGf" title="Lock up period"&gt;180&lt;/span&gt;-day lock-up period commenced; a re-levered equity volatility estimated
using guideline public companies of &lt;span id="xdx_90E_ecustom--EstimatedReLeveredEquityVolatilityRate_dp_uPure_c20230913__20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zf3g01pdR6V1" title="Estimated re-levered equity volatility rate"&gt;54.0&lt;/span&gt;%; and a risk-free rate commensurate with the term of &lt;span id="xdx_90E_ecustom--CommensurateRiskFreeRate_pid_dp_uPure_c20230913__20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zyF6eXiSRRga" title="Commensurate risk-free rate"&gt;5.3&lt;/span&gt;%. The put option models provided a
DLOM range of &lt;span id="xdx_902_ecustom--PercentageOfDiscountLackOfMarketability_dp_uPure_c20230913__20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__srt--RangeAxis__srt--MinimumMember_zCN1kluDpyad" title="Percentage of discount lack of marketability"&gt;10.7&lt;/span&gt;% to &lt;span id="xdx_900_ecustom--PercentageOfDiscountLackOfMarketability_dp_uPure_c20230913__20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__srt--RangeAxis__srt--MaximumMember_zezlPALPGtX" title="Percentage of discount lack of marketability"&gt;16.0&lt;/span&gt;% and the concluded DLOM was estimated to be &lt;span id="xdx_902_ecustom--PercentageOfDiscountLackOfMarketability_dp_uPure_c20230913__20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_za2MiaBvXQv1" title="Percentage of discount lack of marketability"&gt;12.5&lt;/span&gt;%. The Company&#x2019;s expected percentage of completing
the Merger on this date was &lt;span id="xdx_902_ecustom--ExpectedPercentageOfCompletingTheMerger_dp_uPure_c20230913__20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zpCNXe9d97Ek" title="Expected percentage of completing the Merger"&gt;80&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the remaining $&lt;span id="xdx_904_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20231003__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_z8PjixvvVZZf" title="Maximum borrowing capacity"&gt;500,000&lt;/span&gt; drawn on the Alco September Promissory Note on October 3, 2023, the DLOM was estimated using the put option models
described above and the following assumptions: a holding period for the shares of 252 days (approximately &lt;span id="xdx_90A_ecustom--HoldingPeriodForShares_dtY_c20231003__20231003__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zzE3NUfoJaG2" title="Holding period for shares"&gt;0.72&lt;/span&gt; years) measured from the
date of issuance of the remaining $&lt;span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfDebt_c20231003__20231003__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zzpG6pq3NeXl" title="Proceeds from Issuance of Debt"&gt;500,000&lt;/span&gt; of proceeds under the September Note through the issuance of the shares under the Alco October
Share Transfer Agreement on December 14, 2023 at which time the &lt;span id="xdx_902_ecustom--LockUpPeriod_dtD_c20231003__20231003__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zH4ZNTn79mTf" title="Lock up period"&gt;180&lt;/span&gt;-day lock-up period commenced; a re-levered equity volatility estimated
using guideline public companies of &lt;span id="xdx_901_ecustom--EstimatedReLeveredEquityVolatilityRate_dp_uPure_c20231003__20231003__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_ztsjNKUaDwlk" title="Estimated re-levered equity volatility rate"&gt;52.0&lt;/span&gt;%; and a risk-free rate commensurate with the term of &lt;span id="xdx_905_ecustom--CommensurateRiskFreeRate_pid_dp_uPure_c20231003__20231003__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_znaQ98hvsoD3" title="Commensurate risk-free rate"&gt;5.4&lt;/span&gt;%. The put option models provided a
DLOM range of &lt;span id="xdx_906_ecustom--PercentageOfDiscountLackOfMarketability_dp_uPure_c20231003__20231003__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__srt--RangeAxis__srt--MinimumMember_zrt4GaMUww8e" title="Percentage of discount lack of marketability"&gt;10.0&lt;/span&gt;% to &lt;span id="xdx_906_ecustom--PercentageOfDiscountLackOfMarketability_dp_uPure_c20231003__20231003__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__srt--RangeAxis__srt--MaximumMember_zejPEzklJLxe" title="Percentage of discount lack of marketability"&gt;15.0&lt;/span&gt;% and the concluded DLOM was estimated to be &lt;span id="xdx_900_ecustom--PercentageOfDiscountLackOfMarketability_dp_uPure_c20231003__20231003__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zQSGXWEt80Ja" title="Percentage of discount lack of marketability"&gt;11.5&lt;/span&gt;%. The Company&#x2019;s expected percentage of completing
the Merger on this date was &lt;span id="xdx_90B_ecustom--ExpectedPercentageOfCompletingTheMerger_dp_uPure_c20231003__20231003__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zBocgTjJLZQ2" title="Expected percentage of completing the Merger"&gt;80&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the Alco November Promissory Note, the DLOM was estimated using the put option models described above and the following assumptions:
a holding period for the shares of 208 days (approximately &lt;span id="xdx_901_ecustom--HoldingPeriodForShares_dtY_c20231116__20231116__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zA1hLDpQE9X8" title="Holding period for shares"&gt;0.60&lt;/span&gt; years) measured from the issuance date of the November Note through the
issuance of the shares under the November 2023 Share Transfer Agreement on December 14, 2023 at which time the &lt;span id="xdx_90F_ecustom--LockUpPeriod_dtD_c20231116__20231116__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zI6LpiSF8hEg" title="Lock up period"&gt;180&lt;/span&gt;-day lock-up period
commenced; a re-levered equity volatility estimated using guideline public companies of &lt;span id="xdx_900_ecustom--EstimatedReLeveredEquityVolatilityRate_dp_uPure_c20231116__20231116__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zyPVe838D1T7" title="Estimated re-levered equity volatility rate"&gt;54.0&lt;/span&gt;%; and a risk-free rate commensurate with
the term of &lt;span id="xdx_90A_ecustom--CommensurateRiskFreeRate_pid_dp_uPure_c20231116__20231116__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zfzxuTNnRqGh" title="Commensurate risk-free rate"&gt;5.2&lt;/span&gt;%. The put option models provided a DLOM range of &lt;span id="xdx_907_ecustom--PercentageOfDiscountLackOfMarketability_dp_uPure_c20231116__20231116__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__srt--RangeAxis__srt--MinimumMember_zDOT0UZ8WaF7" title="Percentage of discount lack of marketability"&gt;9.5&lt;/span&gt;% to &lt;span id="xdx_90A_ecustom--PercentageOfDiscountLackOfMarketability_dp_uPure_c20231116__20231116__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__srt--RangeAxis__srt--MaximumMember_zjXdi1vjF4L7" title="Percentage of discount lack of marketability"&gt;15.0&lt;/span&gt;% and the concluded DLOM was estimated to be &lt;span id="xdx_90C_ecustom--PercentageOfDiscountLackOfMarketability_dp_uPure_c20231116__20231116__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zU7Ngf2VhCV2" title="Percentage of discount lack of marketability"&gt;11.5&lt;/span&gt;%. The
Company&#x2019;s expected percentage of completing the Merger on this date was &lt;span id="xdx_90B_ecustom--ExpectedPercentageOfCompletingTheMerger_dp_uPure_c20231116__20231116__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_znAUi4Q34lYc" title="Expected percentage of completing the Merger"&gt;100&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the Alco December Promissory Note, the DLOM was estimated using the put option models described above and the following assumptions:
a holding period for the shares of 180 days (approximately &lt;span id="xdx_909_ecustom--HoldingPeriodForShares_dtY_c20231213__20231213__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zaebcpjtdXza" title="Holding period for shares"&gt;0.49&lt;/span&gt; years) measured from the issuance date of the December Note through the
issuance of the shares under the December 2023 Share Transfer Agreement on December 14, 2023 at which time the &lt;span id="xdx_903_ecustom--LockUpPeriod_dtD_c20231213__20231213__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zhiB0HmU49V1" title="Lock-up period"&gt;180&lt;/span&gt;-day lock-up period
commenced; a re-levered equity volatility estimated using guideline public companies of &lt;span id="xdx_902_ecustom--EstimatedReLeveredEquityVolatilityRate_dp_uPure_c20231213__20231213__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zId1RPTyYMrb" title="Estimated re-levered equity volatility rate"&gt;47.0&lt;/span&gt;%; and a risk-free rate commensurate with
the term of &lt;span id="xdx_90D_ecustom--CommensurateRiskFreeRate_pid_dp_uPure_c20231213__20231213__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zD7SndaiYwt3" title="Commensurate risk-free rate"&gt;5.2&lt;/span&gt;%. The put option models provided a DLOM range of &lt;span id="xdx_904_ecustom--PercentageOfDiscountLackOfMarketability_dp_uPure_c20231213__20231213__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__srt--RangeAxis__srt--MinimumMember_ziotSPnaF507" title="Percentage of discount lack of marketability"&gt;7.5&lt;/span&gt;% to &lt;span id="xdx_90E_ecustom--PercentageOfDiscountLackOfMarketability_dp_uPure_c20231213__20231213__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__srt--RangeAxis__srt--MaximumMember_zW1vNxet6VFg" title="Percentage of discount lack of marketability"&gt;12.0&lt;/span&gt;% and the concluded DLOM was estimated to be &lt;span id="xdx_905_ecustom--PercentageOfDiscountLackOfMarketability_dp_uPure_c20231213__20231213__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_zJLDjD3EH1fa" title="Percentage of discount lack of marketability"&gt;9.0&lt;/span&gt;%. The Company&#x2019;s
expected percentage of completing its Business Combination on this date was &lt;span id="xdx_901_ecustom--ExpectedPercentageOfCompletingTheMerger_dp_uPure_c20231213__20231213__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember_ztxD9JpUUaQ5" title="Expected percentage of completing the Merger"&gt;100&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;April
2024 and May 2024 Amendment&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 18, 2024, the Company amended the Alco August Promissory Note and Alco November Promissory Note to extend the maturity dates of
each note to May 31, 2024 (the &#x201c;Alco April 2024 Amendment&#x201d;). On May 30, 2024, both parties agreed to again amend the Alco
August Promissory Note and Alco November Promissory Note to further amend the maturity date to the earlier of (a) August 29, 2024 or
(b) the closing of the next transaction (an &#x201c;Offering&#x201d;) in which the Company sells any of its Common Stock for cash with
net proceeds of $&lt;span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20240530__20240530__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember_zu1gdSEuXoP3" title="Proceeds from sale of common stock"&gt;&lt;span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20240530__20240530__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember_zWf9XhOGoRXl" title="Proceeds from sale of common stock"&gt;4,000,000&lt;/span&gt;&lt;/span&gt; or greater or if the holder acquires Common Stock in an amount not less than the then outstanding balance
of the Alco August Promissory Note and Alco November Promissory Note (the &#x201c;Alco May 2024 Amendment&#x201d;). The Company evaluated
the terms of both the Alco April 2024 Amendment and Alco May 2024 Amendment (the &#x201c;Alco 2024 Amendments&#x201d;) in accordance with
ASC 470-60, Troubled Debt Restructurings, and ASC 470-50, Debt Modifications and Extinguishments. The Company determined that the Company
was granted a concession by the lender based on the decrease of the effective borrowing rate on the Alco 2024 Amendments. Accordingly,
the Company accounted for the Alco 2024 Amendments as troubled debt restructurings. As a result, the Company accounted for the troubled
debt restructurings by calculating a new effective interest rate for the Alco 2024 Amendments based on the carrying amount of the debt
and the present value of the revised future cash flows payment streams. The troubled debt restructurings did not result in recognition
of a gain or loss in the consolidated statement of operations but does impact interest expense recognized in the future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Promissory
Notes - 7GC&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company assumed &lt;span id="xdx_902_ecustom--NumberOfPromissoryNotesInConnectionWithMerger_iI_pid_dc_uPure_c20231231_zkQIgD6zVwic" title="Number of promissory notes In connection with merger"&gt;two&lt;/span&gt; promissory notes in connection with the Merger which remained outstanding as of December 31, 2023. On February 9,
2024, the $&lt;span id="xdx_904_eus-gaap--LoansPayableCurrent_iI_c20240209__us-gaap--LongtermDebtTypeAxis__custom--SevenGCPromissoryNotesMember_zEixXtTj7bw6" title="Loans payable current"&gt;2,540,091&lt;/span&gt; balance was converted into &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240209__20240209__custom--AgreementAxis__custom--ConversionOf7GcPromissoryNotesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__srt--TitleOfIndividualAxis__custom--SponsorMember_zB3haJjc3yqk" title="Stock Issued During Period, Shares, New Issues"&gt;17,812&lt;/span&gt; shares the Company&#x2019;s Class A Common Stock pursuant to the terms in the
7GC Promissory Notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Promissory
Note - GEM&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2023, the Company and GEM Global Yield LLC SCS and GEM Yield Bahamas Limited (collectively, &#x201c;GEM&#x201d;) agreed to
terminate in its entirety the GEM Agreement, pursuant to which GEM was to purchase from the Company shares of common stock having an
aggregate value up to $&lt;span id="xdx_907_eus-gaap--CommonStockValue_iI_c20231214__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementMember_zGQjGNKHBCgg" title="Common stock, value issued"&gt;100,000,000&lt;/span&gt; and the Company was required to make and execute a warrant (&#x201c;GEM Warrant&#x201d;). The Company&#x2019;s
obligation to issue the GEM Warrant remained, granting GEM the right to purchase Class A Common Stock in an amount equal to &lt;span id="xdx_90C_ecustom--PercentageOfRightToConvertWarrantToCommonShares_iI_dp_uPure_c20231214__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--TypeOfArrangementAxis__custom--GemTermSheetMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--StatementEquityComponentsAxis__custom--GemWarrantMember_ziaURQ5mzZGg" title="Percentage of right to convert warrant to common shares"&gt;3&lt;/span&gt;% of the
total number of equity interests outstanding as of the Closing, calculated on a fully diluted basis, at an exercise price on the terms
and conditions set forth therein, in exchange for issuance of a $&lt;span id="xdx_906_eus-gaap--ConvertibleDebt_iI_pn5n6_c20231214__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--TypeOfArrangementAxis__custom--GemTermSheetMember_zwfB6TxCccUl" title="Convertible debt"&gt;2.0&lt;/span&gt; million convertible debenture with a &lt;span id="xdx_90E_eus-gaap--DebtInstrumentTerm_dxL_c20231214__20231214__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--TypeOfArrangementAxis__custom--GemTermSheetMember_z5YIR2gIQYGk" title="Debt Instrument term::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1788"&gt;five&lt;/span&gt;&lt;/span&gt;-year maturity and &lt;span id="xdx_906_ecustom--CouponRate_iI_dp_uPure_c20231214__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--TypeOfArrangementAxis__custom--GemTermSheetMember_zNU43ucVPR69" title="Coupon rate"&gt;0&lt;/span&gt;% coupon.
Due to the determination of the final terms of the planned $&lt;span id="xdx_90D_eus-gaap--CommonStockValue_iI_pn5n6_c20231214__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--TypeOfArrangementAxis__custom--GemTermSheetMember_zeHyl2pDNmC" title="Common stock, value issued"&gt;2.0&lt;/span&gt; million convertible debenture having not been finalized, nor the final
agreement related to the convertible debenture having been executed, as of December 31, 2023, the Company recognized, concurrent with
the close of the merger, a liability for the GEM commitment fee, along with a corresponding GEM commitment fee expense, in the amount
of $&lt;span id="xdx_909_eus-gaap--DebtInstrumentFeeAmount_iI_pn5n6_c20231231__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--TypeOfArrangementAxis__custom--GemTermSheetMember_zrfajo0FK4Y" title="Debt instrument fee amount"&gt;2.0&lt;/span&gt; million.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 5, 2024, the Company and GEM entered into a settlement agreement (the &#x201c;GEM Settlement Agreement&#x201d;), pursuant to which
(a) the Company and GEM agreed to (i) settle the Company&#x2019;s obligations under and terminate the binding term sheet entered into
between Legacy Banzai and GEM, dated December 13, 2023, and (ii) terminate the share repurchase agreement, dated May 27, 2022, by and
among the Company and GEM, and (b) the Company (i) agreed to pay GEM $&lt;span id="xdx_90E_ecustom--DebtInstrumentCashAgreedToPay_pn5n6_c20240205__20240205__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember_zHgTOq1cLRP6" title="Cash agreed to pay"&gt;1.2&lt;/span&gt; million in cash within three business days of the GEM Settlement
Agreement and (ii) issued to GEM, on February 5, 2024, an unsecured promissory zero coupon note in the amount of $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20240205__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember_zQ2NsTFhPit9" title="principal amount"&gt;1.0&lt;/span&gt; million, payable
in monthly installments of $&lt;span id="xdx_906_eus-gaap--DebtInstrumentPeriodicPayment_c20240205__20240205__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember_z7gwWrOqSyfg" title="Monthly installments"&gt;100,000&lt;/span&gt; beginning on March 1, 2024, with the final payment to be made on December 1, 2024 (the &#x201c;GEM
Promissory Note&#x201d;). The Company paid GEM the $&lt;span id="xdx_903_eus-gaap--RepaymentsOfLongTermDebt_pn5n6_c20240205__20240205__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember_zvNEYCQ3Elk5" title="Payment of debt"&gt;1.2&lt;/span&gt; million in cash in February 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
GEM Promissory Note provides that, in the event the Company fails to make a required monthly payment when due, the Company shall issue
to GEM a number of shares of Class A Common Stock equal to the monthly payment amount divided by the VWAP of the Class A Common Stock
for the trading day immediately preceding the applicable payment due date. In addition, the Company agreed to register on a registration
statement &lt;span id="xdx_907_ecustom--SharesIssuableUnderPromissoryNote_c20240205__20240205__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z2jccO9fXI9b" title="Shares issuable under the terms of promissory note"&gt;40,000&lt;/span&gt; shares of Class A Common Stock that may be issuable under the terms of the GEM Promissory Note. The GEM Promissory
Note contains customary events of default. If an event of default occurs, GEM may, at its option, demand from the Company immediate payment
of any outstanding balance under the GEM Promissory Note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As
of June 30, 2024, the Company has issued an aggregate of &lt;span id="xdx_90E_ecustom--SharesIssuedUnderPromissoryNote_c20240101__20240630__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zA5RhPxo5Ay7" title="Shares issued under the terms of promissory note"&gt;20,902&lt;/span&gt; shares of Class A Common Stock to GEM in lieu of monthly payment obligations
and the remaining balance of the GEM Promissory Note as of June 30, 2024 is $&lt;span id="xdx_90A_eus-gaap--ConvertibleDebt_iI_c20240630__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zJrTE9Hnzkt2" title="Convertible Debt"&gt;600,000&lt;/span&gt; recorded in the convertible notes line on the unaudited
consolidated balance sheet.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Convertible
Promissory Notes (Yorkville)&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2023, in connection with and pursuant to the terms of its Standby Equity Purchase Agreement (&#x201c;SEPA&#x201d;) with YA
II PN, LTD, a Cayman Islands exempt limited partnership managed by Yorkville Advisors Global, LP (&#x201c;Yorkville&#x201d;), (refer to
&lt;i&gt;Note 15 - Equity&lt;/i&gt; for further details), Yorkville agreed to advance to the Company, in exchange for convertible promissory notes,
an aggregate principal amount of up to $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20231214_zfPG0WRGHM2f" title="Debt Instrument, Face Amount"&gt;3,500,000&lt;/span&gt;, $&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20231214__custom--ComponentsAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember_zRAM2K3k7GOh" title="Debt Instrument, Face Amount"&gt;2,000,000&lt;/span&gt; of which was funded at the Closing in exchange for the issuance by the
Company of a Convertible Promissory Note (the &#x201c;December Yorkville Convertible Note&#x201d;). The Company received net proceeds of
$&lt;span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_c20231214__20231214__custom--ComponentsAxis__custom--StandbyEquityPurchaseAgreementMember__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember_z5F5jgJ8bgu7" title="Debt Instrument, Face Amount"&gt;1,800,000&lt;/span&gt; after a non-cash original issue discount of $&lt;span id="xdx_908_eus-gaap--AmortizationOfDebtDiscountPremium_c20231214__20231214__custom--ComponentsAxis__custom--StandbyEquityPurchaseAgreementMember__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember_z7vAmS3r2THk" title="Debt discount upon issuance"&gt;200,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 5, 2024, the Company and Yorkville entered into a supplemental agreement (the &#x201c;SEPA Supplemental Agreement&#x201d;) to
increase the amount of convertible promissory notes allowed to be issued under SEPA by $&lt;span id="xdx_908_ecustom--IncreasedPrincipalAmountAgreedToAdvance_iI_c20240205__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zlEh4GJyGyWl" title="Increased Principal Amount Agreed to Advance"&gt;1,000,000&lt;/span&gt; (the &#x201c;Additional Pre-Paid Advance
Amount&#x201d;), for an aggregate principal amount of $&lt;span id="xdx_901_ecustom--AggregatePrincipalAmount_iI_c20240205__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_z3LPxiNL3O3c" title="Aggregate principal amount"&gt;4,500,000&lt;/span&gt; to be advanced by Yorkville to the Company in the form of convertible
promissory notes. On February 5, 2024 in exchange for a promissory note in the principal amount of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20240205__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zU9DgX9sMvYa" title="Debt Instrument, Face Amount"&gt;1,000,000&lt;/span&gt; (the &#x201c;February Yorkville
Promissory Note&#x201d;), with the same terms as the December Yorkville Convertible Note, the Company received net proceeds of $&lt;span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfDebt_c20240205__20240205__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zEUjhq71o9sd" title="Proceeds from Issuance of Debt"&gt;900,000&lt;/span&gt;
after a non-cash original issue discount of $&lt;span id="xdx_90F_eus-gaap--AmortizationOfDebtDiscountPremium_c20240205__20240205__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zRalZVZ0wVvf" title="Debt discount upon issuance"&gt;100,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 26, 2024, the Company, in exchange for a convertible promissory note with a principal amount of $&lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20240326__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zITjipek4ZAf" title="Debt Instrument, Face Amount"&gt;1,500,000&lt;/span&gt; (the &#x201c;March Yorkville
Promissory Note&#x201d; and, together with the December Yorkville Convertible Note and February Yorkville Promissory Note the&#x201d; Yorkville
Promissory Notes&#x201d;), received net proceeds of $&lt;span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfDebt_c20240326__20240326__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zyBqRT001gOg" title="Proceeds from Issuance of Debt"&gt;1,250,000&lt;/span&gt; after a non-cash original issue discount of $&lt;span id="xdx_90A_eus-gaap--AmortizationOfDebtDiscountPremium_c20240326__20240326__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zRkNeM5zANU8" title="Debt discount upon issuance"&gt;250,000&lt;/span&gt; from Yorkville.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 3, 2024, the Company and Yorkville entered into a Debt Repayment Agreement (the &#x201c;Original Debt Repayment Agreement&#x201d;)
with respect to the Yorkville Promissory Notes. Under the Original Debt Repayment Agreement, Yorkville agreed that, upon completion of
a Company registered offering and repayment of an aggregate $&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20240503__us-gaap--TypeOfArrangementAxis__custom--OriginalDebtRepaymentAgreementMember_zY2habxQib2" title="Debt Instrument, Face Amount"&gt;2,000,000&lt;/span&gt; outstanding under the Yorkville Promissory Notes (the &#x201c;Original
Repayment Amount&#x201d;), Yorkville would not deliver to the Company any Investor Notice (as defined in the SEPA) and would not exercise
its right to convert the remainder of the amount outstanding under the Promissory Notes for a period commencing on the date of the closing
of the offering and ending on the date that is 90 days thereafter. Under the Original Debt Repayment Agreement, the Company and Yorkville
also agreed to extend the maturity date of the Promissory Notes to the date that is 120 days after the closing of the offering and to
satisfy the $&lt;span id="xdx_909_eus-gaap--RepaymentsOfDebt_c20240503__20240503__us-gaap--TypeOfArrangementAxis__custom--OriginalDebtRepaymentAgreementMember_zzWzqoTonrc5" title="Premium payment"&gt;200,000&lt;/span&gt; payment premium due in connection with an early redemption through the issuance of an Advance Notice (as defined
in the SEPA) for shares of the Company&#x2019;s Class A common stock, par value $&lt;span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240503__us-gaap--TypeOfArrangementAxis__custom--OriginalDebtRepaymentAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zX6lVzZGHrF4" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share. The Debt Repayment Agreement was conditioned
on the completion of the offering by June 2, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 22, 2024, the Company and Yorkville entered into an Amended and Restated Debt Repayment Agreement (the &#x201c;Amended Debt Repayment
Agreement&#x201d;) with respect to the Yorkville Promissory Notes, which amends and restates the Original Debt Repayment Agreement. Under
the Amended Debt Repayment Agreement, Yorkville has agreed that, upon completion of a registered offering and repayment of an aggregate
$&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20240522__us-gaap--TypeOfArrangementAxis__custom--AmendedDebtRepaymentAgreementMember_zN81lWFrYVxk" title="Debt Instrument, Face Amount"&gt;750,000&lt;/span&gt; outstanding under the Yorkville Promissory Notes (the &#x201c;Amended Repayment Amount&#x201d;), Yorkville will not deliver to
the Company any Investor Notice (as defined in the SEPA) and will not exercise its right to convert the remainder of the amount outstanding
under the Promissory Notes for a period commencing on the date of the closing of the offering and ending on the date that is 90 days
thereafter (the &#x201c;Stand-still Period&#x201d;); provided that the Company will seek any consents necessary to allow Yorkville to issue
Investor Notices or exercise its right to convert the remainder of the amount outstanding under the Promissory Notes after a period of
60 days following the closing of the offering. Under the Amended Debt Repayment Agreement, the Company and Yorkville also agreed to extend
the maturity date of the Promissory Notes to the date that is 120 days after the closing of the offering and to satisfy the $&lt;span id="xdx_906_eus-gaap--RepaymentsOfDebt_c20240522__20240522__us-gaap--TypeOfArrangementAxis__custom--AmendedDebtRepaymentAgreementMember_z3ofwQzhYQb5" title="Premium payment"&gt;75,000&lt;/span&gt; payment
premium due in connection with an early redemption through the issuance of an Advance Notice for shares of Class A Common Stock (the
&#x201c;Q2 Prepayment Premium&#x201d;). The Amended Debt Repayment Agreement was conditioned on the completion of the offering by May 29,
2024, which condition was satisfied upon the closing of the offering on May 28, 2024 (the &#x201c;May 2024 Offering&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the terms of the Amended Repayment Agreement, the Company made a cash principal payment of $&lt;span id="xdx_908_ecustom--AggregatePrincipalAmount_iI_c20240531__us-gaap--TypeOfArrangementAxis__custom--AmendedDebtRepaymentAgreementMember_zqtVyAnWLctg" title="Aggregate principal amount"&gt;750,000&lt;/span&gt; on May 31, 2024 (the &#x201c;Repayment
Date&#x201d;), and issued an Advance Notice for the purchase of &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20240522__20240522__us-gaap--TypeOfArrangementAxis__custom--AmendedDebtRepaymentAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zHMdMTvMoCqf" title="Share purchase"&gt;12,000&lt;/span&gt; shares of Class A Common Stock (the &#x201c;Premium Advance Shares&#x201d;)
(representing the number of shares the Company reasonably believed would be sufficient to result in net proceeds of $&lt;span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfDebt_c20240522__20240522__us-gaap--TypeOfArrangementAxis__custom--AmendedDebtRepaymentAgreementMember_zNjJzU2Ce8eh" title="Proceeds from Issuance of Debt"&gt;75,000&lt;/span&gt; as of the
Repayment Date) (the &#x201c;Premium Advance&#x201d;). The total purchase price for the Premium Advance was $&lt;span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedPremium_iI_c20240522__us-gaap--TypeOfArrangementAxis__custom--AmendedDebtRepaymentAgreementMember_zUt6WJGtuPV3" title="Premium advance"&gt;110,040&lt;/span&gt;, of which $&lt;span id="xdx_909_eus-gaap--RepaymentsOfDebt_c20240522__20240522__us-gaap--TypeOfArrangementAxis__custom--AmendedDebtRepaymentAgreementMember_zA6LRniSCjj1" title="Premium payment"&gt;75,000&lt;/span&gt;
was applied in satisfaction of the Payment Premium, and the remaining $&lt;span id="xdx_900_eus-gaap--ProceedsFromRepaymentsOfDebt_c20240522__20240522__us-gaap--TypeOfArrangementAxis__custom--AmendedDebtRepaymentAgreementMember_zEDWGpO8FfY7" title="Premium remaining payment"&gt;35,040&lt;/span&gt; was paid by Yorkville to the Company in cash (the &#x201c;Cash
Surplus&#x201d;). The Premium Advance Shares were recorded at fair value totaling $&lt;span id="xdx_905_eus-gaap--DebtInstrumentFairValue_iI_c20240522__us-gaap--TypeOfArrangementAxis__custom--AmendedDebtRepaymentAgreementMember_zt7DCTTnu5wh" title="Premium fair value"&gt;115,800&lt;/span&gt; on the Repayment Date, and the excess of fair
value over the Cash Surplus was recorded to the consolidated statement of operations in line Yorkville prepayment premium expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Yorkville Promissory Notes have a maturity date (as modified by the Amended Debt Repayment Agreement) of &lt;span id="xdx_907_eus-gaap--DebtInstrumentMaturityDate_c20240522__20240522__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--TypeOfArrangementAxis__custom--AmendedDebtRepaymentAgreementMember_zvn9PwnwQlF2" title="Debt Instrument, Maturity Date"&gt;September 25, 2024&lt;/span&gt;, and accrue
interest at &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240522__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--TypeOfArrangementAxis__custom--AmendedDebtRepaymentAgreementMember__custom--ComponentsAxis__custom--StandbyEquityPurchaseAgreementMember_zcUrNUvmkEEi" title="Debt instrument, interest rate"&gt;0&lt;/span&gt;% per annum, subject to an increase to &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240522__us-gaap--TypeOfArrangementAxis__custom--AmendedDebtRepaymentAgreementMember__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember_zfa692n797R4" title="Debt instrument, interest rate"&gt;18&lt;/span&gt;% per annum upon events of default as defined in the agreement. As of June 30,
2024, no events of default have occurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Yorkville
has the right to convert any portion of the outstanding principal into shares of Class A common stock at any time subsequent to the Stand-still
Period through maturity. The number of shares issuable upon conversion is equal to the amount of principal to be converted (as specified
by Yorkville) divided by the Conversion Price (as defined in the Standby Equity Purchase Agreement disclosure in Note 15). Yorkville
will not have the right to convert any portion of the principal to the extent that after giving effect to such conversion, Yorkville
would beneficially own in excess of &lt;span id="xdx_906_eus-gaap--DebtConversionConvertedInstrumentRate_dp_uPure_c20240522__20240522__custom--ComponentsAxis__custom--StandbyEquityPurchaseAgreementMember__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zG33ukfFJ8n6" title="Conversion rate percentage of common stock outstanding"&gt;9.99&lt;/span&gt;% of the total number of shares of Class A common stock outstanding after giving effect to such
conversion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additionally,
the Company, at its option, shall have the right, but not the obligation, to redeem early a portion or all amounts outstanding under
the Promissory Notes at a redemption amount equal to the outstanding principal balance being repaid or redeemed, plus a &lt;span id="xdx_900_ecustom--PercentageOfPrepaymentPremium_iI_pid_dp_uPure_c20240522__custom--ComponentsAxis__custom--StandbyEquityPurchaseAgreementMember__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember_zTgWzMCfFRi4" title="Prepayment premium"&gt;10&lt;/span&gt;% prepayment
premium, plus all accrued and unpaid interest; provided that (i) the Company provides Yorkville with no less than ten trading days&#x2019;
prior written notice thereof and (ii) on the date such notice is issued, the VWAP of the Class A common stock is less than the Fixed
Price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
the occurrence of certain triggering events, as defined in the Yorkville Promissory Notes agreement (each an &#x201c;Amortization Event&#x201d;),
the Company may be required to make monthly repayments of amounts outstanding under the Yorkville Promissory Notes, with each monthly
repayment to be in an amount equal to the sum of (x) $&lt;span id="xdx_905_eus-gaap--RepaymentsOfConvertibleDebt_c20240522__20240522__custom--ComponentsAxis__custom--StandbyEquityPurchaseAgreementMember__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_zYCO6tGijDhe" title="Prepayment premium"&gt;1,000,000&lt;/span&gt;, plus (y) &lt;span id="xdx_902_ecustom--PercentageOfRepaymentOfConvertibleDebtAmount_iI_dp_uPure_c20240522__custom--ComponentsAxis__custom--StandbyEquityPurchaseAgreementMember__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_zTsD02K5u0P7" title="Percentage of repayment of convertible debt, amount"&gt;10&lt;/span&gt;% in respect of such amount, and (z) all outstanding accrued
and unpaid interest as of each payment date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
January 2024, the Company&#x2019;s stock price per share fell below the then in effect Floor Price (as defined in the Standby Equity Purchase
Agreement disclosure in Note 15) of $&lt;span id="xdx_903_ecustom--MaximumFloorPrice_iI_c20240131__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zunwpwBjwb47" title="Maximum floor price"&gt;2.00&lt;/span&gt; for five trading days during a period of seven consecutive trading days (an Amortization Event
under the terms of the December Yorkville Convertible Note agreement), thus triggering amortization payments under the terms of the December
Yorkville Convertible Note. On January 24, 2024, Yorkville agreed to waive the Amortization Event trigger, prior to the date upon which
any amortization payment would have been required. As discussed in the definitions below, the Floor Price was reset on February 14, 2024,
in conjunction with the effective date of the Company&#x2019;s Registration Statement, at a price of $&lt;span id="xdx_90A_ecustom--FloorPrice_iI_pid_c20240214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zCChHkeOsZ4f" title="Floor price"&gt;14.70&lt;/span&gt; per share of Common Stock,
thus curing the Amortization Event condition.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the three and six months ended June 30, 2024, $&lt;span id="xdx_903_eus-gaap--ProceedsFromRepaymentsOfDebt_c20240401__20240630__custom--ComponentsAxis__custom--StandbyEquityPurchaseAgreementMember__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember_zVWldtANqZk5" title="Debt Instrument, Face Amount"&gt;300,000&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--ProceedsFromRepaymentsOfDebt_c20240101__20240630__custom--ComponentsAxis__custom--StandbyEquityPurchaseAgreementMember__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember_zB5lGQA9uBB2" title="Debt Instrument, Face Amount"&gt;800,000&lt;/span&gt; of principal under the December Yorkville Convertible Note, respectively,
was converted into &lt;span id="xdx_909_eus-gaap--ConversionOfStockSharesConverted1_c20240401__20240630__custom--ComponentsAxis__custom--StandbyEquityPurchaseAgreementMember__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z4SobiyIkaWj" title="Conversion of Stock, Shares Converted"&gt;20,176&lt;/span&gt; and &lt;span id="xdx_908_eus-gaap--ConversionOfStockSharesConverted1_c20240101__20240630__custom--ComponentsAxis__custom--StandbyEquityPurchaseAgreementMember__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zOAYYHg7Ugxk" title="Conversion of Stock, Shares Converted"&gt;35,940&lt;/span&gt; shares of Class A Common stock of the Company, respectively. During the six months ended June
30, 2024, the full principal amount of $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20240630__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zKPzNq7uht6e" title="Face amount"&gt;1,000,000&lt;/span&gt; under the February Yorkville Promissory Note was converted into &lt;span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_c20240101__20240630__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zFGlgxWCkYdh" title="Conversion of stock shares converted"&gt;28,910&lt;/span&gt; Class A Common
stock of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2024 and December 31, 2023, the principal amount outstanding under the Yorkville Promissory Notes was $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_z7iZSIlFzg9j" title="Debt instrument carrying amount"&gt;1,950,000&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--DebtInstrumentCarryingAmount_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_zy2SwgF6BVti" title="Debt instrument carrying amount"&gt;2,000,000&lt;/span&gt;,
respectively. During the three and six months ended June 30, 2024, the Company recorded interest expense of $&lt;span id="xdx_908_eus-gaap--InterestExpense_c20240401__20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_zYOk3moAlnuh" title="Interest expense"&gt;&lt;span id="xdx_906_eus-gaap--InterestExpense_c20240101__20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_zbcHYt57rrFk" title="Interest expense"&gt;80,760&lt;/span&gt;&lt;/span&gt; in connection with
the Yorkville Promissory Notes, all of which was related to the Premium Advance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Yorkville Promissory Notes are required to be measured at fair value pursuant to ASC 480 &lt;i&gt;Distinguishing Liabilities from Equity&lt;/i&gt;
(&#x201c;ASC 480&#x201d;) at the date of issuances and in subsequent reporting periods, due to the variable share-settled feature described
above in which, if converted, the value to be received by Yorkville fluctuates based on something other than the fair value of the Company&#x2019;s
common stock. The fair value of the Yorkville Promissory Notes as of June 30, 2024 and December 31, 2023 was $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_z5L57U96lbt" title="Debt Instrument, Face Amount"&gt;2,013,000&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_z2EIReeLsgh8" title="Debt Instrument, Face Amount"&gt;1,766,000&lt;/span&gt;,
respectively. The Company used a Monte Carlo simulation model in order to determine the Yorkville Promissory Note&#x2019;s fair value
at December 31, 2023, with the following inputs: the fair value of the Company&#x2019;s common stock of $&lt;span id="xdx_900_eus-gaap--SharePrice_iI_pid_c20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_z8HN3m0f4eHe" title="Share price"&gt;1.88&lt;/span&gt; on December 31, 2023, estimated
equity volatility of &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_z0IjG8bnRAef" title="volatility"&gt;71&lt;/span&gt;%, the time to maturity of &lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_zvCAPP8iKTag" title="Time to maturity"&gt;0.46&lt;/span&gt; years, a discounted market interest rate of &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_dp_uPure_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_zpc3WZPj984f" title="Market interest rate"&gt;14&lt;/span&gt;%, a risk free rate of &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_zseIKyxfBElc" title="Risk free rate"&gt;5.28&lt;/span&gt;%, and
probability of optional redemption &lt;span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsProbabilityOptionalRedemptionRate_dp_uPure_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_zn9GWmnDShKa" title="Probability of optional redemption rate"&gt;10.0&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the three and six months ended June 30, 2024, the Company recorded a loss of $&lt;span id="xdx_904_ecustom--GainLossOnChangeInFairValueOfConvertibleNotesLiability_c20240401__20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_zH0dJSt98VA6" title="Gain (loss) on change in fair value of convertible notes liability"&gt;34,000&lt;/span&gt; and $&lt;span id="xdx_900_ecustom--GainLossOnChangeInFairValueOfConvertibleNotesLiability_c20240101__20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_zZhw4J5vOQm2" title="Gain (loss) on change in fair value of convertible notes liability"&gt;578,000&lt;/span&gt;, respectively, related to the change
in fair value of the Yorkville Promissory Notes liability, respectively. The Company used Monte Carlo simulation models in order to determine
the Yorkville Promissory Note&#x2019;s fair value at June 30, 2024, with the following inputs: the fair value of the Company&#x2019;s common
stock of $&lt;span id="xdx_908_eus-gaap--SharePrice_iI_pid_c20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_z1HNe2xRcN3e" title="Share price"&gt;0.17&lt;/span&gt; on June 30, 2024, estimated equity volatility of &lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20240101__20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_zFX74FBfLch4" title="volatility"&gt;125&lt;/span&gt;%, the time to maturity of &lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240101__20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_zDwXo7BTfmLk" title="Time to maturity"&gt;0.24&lt;/span&gt; years, a discounted market interest
rate of &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_pid_dp_uPure_c20240101__20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_zp1kzbvVfng9" title="Market interest rate"&gt;20.6&lt;/span&gt;%, a risk free rate of &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240101__20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_zQGMIRLnZRob" title="Risk free rate"&gt;5.48&lt;/span&gt;%, and probability of optional redemption &lt;span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsProbabilityOptionalRedemptionRate_dp_uPure_c20240101__20240630__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNotesMember_zTPRSPtgRAVf" title="Probability of optional redemption rate"&gt;75.0&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Term
and Convertible Notes (CP BF)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2021, the Company entered into a loan agreement with CP BF Lending, LLC (&#x201c;CP BF&#x201d;) comprised of a Term Note and a Convertible
Note. The Term Note bears cash interest at a rate of &lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember_z0qEKXp5tkbg" title="Debt instrument, interest rate"&gt;14&lt;/span&gt;% per annum paid monthly and accrued interest payable-in-kind (&#x201c;PIK&#x201d;)
cumulatively at &lt;span id="xdx_901_ecustom--PaidInKindInterestPercentage_iI_dp_uPure_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember_zvcN4m1SCRd9" title="Paid In Kind Interest percentage"&gt;1.5&lt;/span&gt;% per annum. The outstanding principal balance of the Term Note together with accrued and unpaid interest thereon,
unpaid fees and expenses and any other Obligations then due, shall be paid on February 19, 2025 (&#x201c;Loan Maturity Date&#x201d;). The
Convertible Note accrues PIK interest cumulatively at a rate of &lt;span id="xdx_900_ecustom--PaidInKindInterestPercentage_iI_dp_uPure_c20211231__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z0HPqmV4vYhh" title="Paid in kind interest"&gt;15.5&lt;/span&gt;% per annum, and is convertible into Class A Common Stock upon Qualified
Financing (as defined in the agreement), upon a Change of Control (as defined in the agreement), upon Prepayment, or at Maturity at a
fixed conversion price. If not sooner converted or prepaid, the Convertible Note principal together with accrued and unpaid interest
thereon, unpaid fees and expenses and any other Obligations then due, shall be paid on the Loan Maturity Date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--DebtInstrumentCovenantCompliance_c20240101__20240630__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember_zuhOYk3oWT7g" title="Debt Instrument, covenant compliance description"&gt;For
all respective periods presented, the Company was not in compliance with the Minimum Gross Profit Margin covenant in section 7.14.1 of
the Loan Agreement, the Minimum ARR Growth covenant in section 7.14.2 of the Loan Agreement, and the Fixed Charge Coverage Ratio covenant
in section 7.14.3 of the Loan Agreement. As a result of the Company&#x2019;s noncompliance with the financial covenants, the entire principal
amount and all unpaid and accrued interest will be classified as current on the Company&#x2019;s consolidated balance sheets.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
effective interest rate for the Term Note was &lt;span id="xdx_905_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20230630__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember_zGUwmBliIgc" title="Effective interest rate percentage"&gt;&lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20240630__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember_zLqRSYQKsBni" title="Effective interest rate percentage"&gt;16&lt;/span&gt;&lt;/span&gt;% for three and six months ended June 30, 2024 and 2023. For the three and six months
ended June 30, 2024, interest expense on the Term Note totaled $&lt;span id="xdx_90A_eus-gaap--InterestExpense_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zSoGruwo6TU6" title="Interest expense"&gt;294,613&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--InterestExpense_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zQKjXVYym97l" title="Interest expense"&gt;586,940&lt;/span&gt;, respectively, comprised of $&lt;span id="xdx_907_eus-gaap--InterestExpenseDebt_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_z4rpoCdVsZm2" title="Interest expense debt"&gt;267,359&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--InterestExpenseDebt_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zVYtXpnEeLCk" title="Interest expense debt"&gt;533,707&lt;/span&gt;,
respectively, of contractual interest and $&lt;span id="xdx_90B_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zr6R7dRxU0t6" title="Interest expense debt"&gt;27,254&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zkiWw6pyrUTb" title="Interest expense debt"&gt;53,233&lt;/span&gt;, respectively, for the amortization of the discount. For the three and
six months ended June 30, 2023, interest expense on the Term Note totaled $&lt;span id="xdx_903_eus-gaap--InterestExpense_c20230401__20230630__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zTN1SDRe2K7k" title="Interest expense"&gt;284,097&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--InterestExpense_c20230101__20230630__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_ziiRL4UaYlM5" title="Interest expense"&gt;562,261&lt;/span&gt;, respectively, comprised of $&lt;span id="xdx_901_eus-gaap--InterestExpenseDebt_c20230401__20230630__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zNmiWGZTJBc9" title="Interest expense debt"&gt;264,320&lt;/span&gt;
and $&lt;span id="xdx_90E_eus-gaap--InterestExpenseDebt_c20230101__20230630__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zCnHdTR5wVpi" title="Interest expense debt"&gt;523,763&lt;/span&gt;, respectively, of contractual interest and $&lt;span id="xdx_90A_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20230401__20230630__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zSE0Yy3Zxg2j" title="Interest expense debt"&gt;19,777&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20230101__20230630__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zH1BlmU1PAo8" title="Interest expense debt"&gt;38,498&lt;/span&gt; respectively, for the amortization of the discount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
effective interest rate for the CP BF Convertible Note and First Amendment Convertible Note was &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20240630__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zq7uToqPhYZ3" title="Effective interest rate percentage"&gt;&lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_uPure_c20230630__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zelAutmQBB3" title="Effective interest rate percentage"&gt;16&lt;/span&gt;&lt;/span&gt;% for the three and six months ended
June 30, 2024 and 2023. For the three and six months ended June 30, 2024, interest expense on the Convertible Notes totaled $&lt;span id="xdx_906_eus-gaap--InterestExpense_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleDebtMember_zOVOmcEos9xf" title="Interest expense"&gt;121,448&lt;/span&gt;
and $&lt;span id="xdx_907_eus-gaap--InterestExpense_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleDebtMember_zBZn7sw9XOE" title="Interest expense"&gt;237,859&lt;/span&gt;, respectively, comprised of $&lt;span id="xdx_902_eus-gaap--InterestExpenseDebt_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleDebtMember_zPV0FbDErI29" title="Interest expense debt"&gt;112,908&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--InterestExpenseDebt_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleDebtMember_zLFS30ab5jhc" title="Interest expense debt"&gt;221,504&lt;/span&gt;, respectively, of contractual interest and $&lt;span id="xdx_901_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20240401__20240630__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleDebtMember_z2EE2f57CtRg" title="Interest expense debt"&gt;8,540&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20240101__20240630__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleDebtMember_zb8QkesfW0I8" title="Interest expense debt"&gt;16,355&lt;/span&gt;, respectively,
for the amortization of the discount. For the three and six months ended June 30, 2023, interest expense on the Convertible Notes totaled
$&lt;span id="xdx_908_eus-gaap--InterestExpense_c20230401__20230630__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleDebtMember_z59HDzPGh0u" title="Interest expense"&gt;101,719&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--InterestExpense_c20230101__20230630__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleDebtMember_zfVHI56MKmak" title="Interest expense"&gt;200,151&lt;/span&gt;, respectively, comprised of $&lt;span id="xdx_904_eus-gaap--InterestExpenseDebt_c20230401__20230630__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleDebtMember_zrbsKRo9bhq8" title="Interest expense debt"&gt;95,534&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--InterestExpenseDebt_c20230101__20230630__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleDebtMember_zYWL10F4B0Ec" title="Interest expense debt"&gt;187,394&lt;/span&gt;, respectively, of contractual interest and $&lt;span id="xdx_906_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20230401__20230630__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleDebtMember_zxEa0yqUIfPi" title="Interest expense debt"&gt;6,185&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20230101__20230630__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__us-gaap--ConvertibleDebtMember_zIGpgQCSqVXh" title="Interest expense debt"&gt;12,757&lt;/span&gt;,
respectively, for the amortization of the discount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes a combination of scenario-based methods and Black-Scholes option pricing models to determine the average share count
outstanding at conversion and the simulated price per share for the Company as of the valuation date. Key inputs into these models included
the timing and probability of the identified scenarios, and for Black-Scholes option pricing models used for notes that included a valuation
cap, equity values, risk-free rate and volatility.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ConvertibleDebtTableTextBlock_zUg8MmqBkU2e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the CP BF convertible notes as of June 30, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zi28tYs4VmMl" style="display: none"&gt;Summary
of Convertible Notes&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20240630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesMember_zTD3K9PJq0w3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maCNPzpbq_zbH6lPzcwcw8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Face value of the CB BF convertible notes&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,821,345&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--UnamortizedDebtDiscountOnConvertibleNotesPayable_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maCNPzpbq_zGi1VRpcgoEb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Debt discount, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(26,757&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ConvertibleNotesPayable_iTI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_mtCNPzpbq_maCDIAIzlB2_zGwXGUHJKxLh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Carrying value of the CB BF convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,794,588&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--InterestPayableOnConvertibleDebt_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maCDIAIzlB2_zGdoDOn1Wl9k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,135,983&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ConvertibleDebtIncludingAccruedInterest_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_mtCDIAIzlB2_zEEdG8o1CmP9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total CB BF convertible notes and accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,930,571&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the CP BF convertible notes as of December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20231231__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesMember_zLKVesy85ZP4" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maCNPz84e_z9VRLviS9OY5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Face value of the CB BF convertible notes&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,821,345&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--UnamortizedDebtDiscountOnConvertibleNotesPayable_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maCNPz84e_zUXSO8mwUiS1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Debt discount, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(41,983&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ConvertibleNotesPayable_iTI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_mtCNPz84e_maCDIAIz7Jz_zGe9CaIN9qS3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Carrying value of the CB BF convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,779,362&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--InterestPayableOnConvertibleDebt_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maCDIAIz7Jz_zIGhV5DMTLZg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;914,479&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--ConvertibleDebtIncludingAccruedInterest_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_mtCDIAIz7Jz_zJ11fDGfpaik" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total CB BF convertible notes and accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,693,841&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the CP BF term note as of June 30, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20240630__us-gaap--ShortTermDebtTypeAxis__custom--TermNoteMember_zxC1HznVHr9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OtherNotesPayableCurrent_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maNPFVDzDF9_z08nSQH3sEIl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Face value of the CB BF term note&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6,500,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--UnamortizedDebtDiscountOnOtherNotesPayable_iNI_di_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_msNPFVDzDF9_zQwJzlJky6u7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Debt discount, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(76,353&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NotesPayableFairValueDisclosure_iTI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_mtNPFVDzDF9_maNPIAIzcLA_z2TcFVuJM2oa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Carrying value of the CB BF term note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,423,647&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--AccruedInterestOnNotesPayableCurrent_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maNPIAIzcLA_zBJH4xoDiODf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;664,562&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NotesPayableIncludingAccruedInterest_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_mtNPIAIzcLA_zsOhVMRI19zb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total CB BF term note and accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;7,088,209&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the CP BF term note as of December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20231231__us-gaap--ShortTermDebtTypeAxis__custom--TermNoteMember_z7QggMLZj2Pj" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OtherNotesPayableCurrent_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maNPFVDzyNE_zOsi7Gw2Hrh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Face value of the CB BF term note&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6,500,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--UnamortizedDebtDiscountOnOtherNotesPayable_iNI_di_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_msNPFVDzyNE_z2v12D6Hx8gg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Debt discount, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(129,586&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--NotesPayableFairValueDisclosure_iTI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_mtNPFVDzyNE_maNPIAIzkCu_z3sBHECaP942" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Carrying value of the CB BF term note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,370,414&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--AccruedInterestOnNotesPayableCurrent_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maNPIAIzkCu_z8IK6g1Mkkqe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;289,373&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--NotesPayableIncludingAccruedInterest_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_mtNPIAIzkCu_zhPvn6ZFzyT4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total CB BF term note and accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,659,787&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A1_zti5zA2kG304" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2022-12-31_custom_AlcoMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001503"
      unitRef="Pure">0.05</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2023-12-31_custom_AlcoMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001505"
      unitRef="Pure">0.05</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2023-12-31_custom_DNXMember_us-gaap_SeriesAPreferredStockMember_srt_MinimumMember"
      decimals="INF"
      id="Fact001507"
      unitRef="Pure">0.05</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2022-12-31_custom_DNXMember_us-gaap_SeriesAPreferredStockMember_srt_MinimumMember"
      decimals="INF"
      id="Fact001509"
      unitRef="Pure">0.05</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-12-31_custom_RelatedPartyConvertibleNotesMember"
      decimals="INF"
      id="Fact001511"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2022-12-31_custom_RelatedPartyConvertibleNotesMember"
      decimals="INF"
      id="Fact001513"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-04-012023-06-30_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact001515"
      unitRef="USD">707000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-01-012023-06-30_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact001517"
      unitRef="USD">1126451</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestExpense
      contextRef="From2023-04-012023-06-30_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact001519"
      unitRef="USD">552403</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-04-012023-06-30_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact001521"
      unitRef="USD">125352</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2023-04-012023-06-30_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact001523"
      unitRef="USD">427051</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:InterestExpense
      contextRef="From2023-01-012023-06-30_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact001525"
      unitRef="USD">935687</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-01-012023-06-30_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact001527"
      unitRef="USD">215774</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2023-01-012023-06-30_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact001529"
      unitRef="USD">719913</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature
      contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember"
      id="Fact001531">The Third
Party Convertible Notes bear interest at a rate of 8% per annum, and are convertible into the same series of capital stock of the Company
to be issued to other investors upon a Qualified Financing (as defined in the agreement).</us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature>
    <us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      id="Fact001533">The Third
Party Convertible Notes bear interest at a rate of 8% per annum, and are convertible into the same series of capital stock of the Company
to be issued to other investors upon a Qualified Financing (as defined in the agreement).</us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-04-012023-06-30_custom_ThirdPartyConvertibleNotesMember"
      decimals="0"
      id="Fact001535"
      unitRef="USD">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-01-012023-06-30_custom_ThirdPartyConvertibleNotesMember"
      decimals="0"
      id="Fact001537"
      unitRef="USD">330390</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestExpense
      contextRef="From2023-04-012023-06-30_custom_ThirdPartyConvertibleNotesMember"
      decimals="0"
      id="Fact001539"
      unitRef="USD">142353</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-04-012023-06-30_custom_ThirdPartyConvertibleNotesMember"
      decimals="0"
      id="Fact001541"
      unitRef="USD">37845</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2023-04-012023-06-30_custom_ThirdPartyConvertibleNotesMember"
      decimals="0"
      id="Fact001543"
      unitRef="USD">104508</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:InterestExpense
      contextRef="From2023-01-012023-06-30_custom_ThirdPartyConvertibleNotesMember"
      decimals="0"
      id="Fact001545"
      unitRef="USD">293977</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-01-012023-06-30_custom_ThirdPartyConvertibleNotesMember"
      decimals="0"
      id="Fact001547"
      unitRef="USD">72562</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2023-01-012023-06-30_custom_ThirdPartyConvertibleNotesMember"
      decimals="0"
      id="Fact001549"
      unitRef="USD">221415</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:ConvertibleDebtTableTextBlock
      contextRef="From2024-01-012024-06-30_custom_RelatedPartyAndThirdPartyMember"
      id="Fact001551">&lt;p id="xdx_89A_eus-gaap--ConvertibleDebtTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyAndThirdPartyMember_zmlgDYmRW4Ui" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the Related Party and Third Party Convertible Notes, respectively, as of December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B7_zYgACGyhAoAc" style="display: none"&gt;Summary
of Related Party  and Third Party Convertible Notes&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_ziUGMH93byT" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zHTt8aWsY0Te" style="border-bottom: Black 1pt solid; font-style: italic; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-style: italic"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_zWoNcpXIhX8b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Face value of the convertible notes&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6,783,538&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;3,196,206&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--UnamortizedDebtDiscountOnConvertibleNotesPayable_iI_zG6ER3VfyCf1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Debt discount, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(131,867&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(83,688&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ConvertibleNotesPayable_iI_z8maFHu0bmi2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Carrying value of the convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,651,671&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,112,518&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--InterestPayableOnConvertibleDebt_iI_zMYYequKM0Oa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;619,697&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;233,714&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ConversionOfConvertibleNote_iI_zahMoMzD3ZD4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Conversion of convertible notes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(7,271,368&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,346,232&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ConvertibleDebtIncludingAccruedInterest_zMWAkYc6cB4e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total convertible notes and accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1568"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1569"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001553"
      unitRef="USD">6783538</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact001554"
      unitRef="USD">3196206</us-gaap:ConvertibleDebtFairValueDisclosures>
    <BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001556"
      unitRef="USD">-131867</BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable>
    <BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact001557"
      unitRef="USD">-83688</BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001559"
      unitRef="USD">6651671</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact001560"
      unitRef="USD">3112518</us-gaap:ConvertibleNotesPayable>
    <BNZI:InterestPayableOnConvertibleDebt
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001562"
      unitRef="USD">619697</BNZI:InterestPayableOnConvertibleDebt>
    <BNZI:InterestPayableOnConvertibleDebt
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact001563"
      unitRef="USD">233714</BNZI:InterestPayableOnConvertibleDebt>
    <BNZI:ConversionOfConvertibleNote
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001565"
      unitRef="USD">-7271368</BNZI:ConversionOfConvertibleNote>
    <BNZI:ConversionOfConvertibleNote
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact001566"
      unitRef="USD">-3346232</BNZI:ConversionOfConvertibleNote>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-08-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001571"
      unitRef="USD">150000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2023-08-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001573"
      unitRef="Pure">0.10</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-08-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="INF"
      id="Fact001575"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-08-302023-08-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      id="Fact001577">2024-04-29</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="AsOf2023-08-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001579"
      unitRef="USD">3711</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:InterestExpense
      contextRef="From2024-04-012024-06-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001581"
      unitRef="USD">2908</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-04-012024-06-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001583"
      unitRef="USD">2992</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2024-04-012024-06-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001585"
      unitRef="USD">84</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:InterestExpense
      contextRef="From2024-01-012024-06-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001587"
      unitRef="USD">8357</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-01-012024-06-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001589"
      unitRef="USD">5983</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2024-01-012024-06-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001591"
      unitRef="USD">2374</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="AsOf2024-06-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001593"
      unitRef="USD">150000</us-gaap:OtherNotesPayableCurrent>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001595"
      unitRef="USD">150000</us-gaap:OtherNotesPayableCurrent>
    <BNZI:InterestPayableOnOtherNotesPayableCurrent
      contextRef="AsOf2024-06-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001597"
      unitRef="USD">10027</BNZI:InterestPayableOnOtherNotesPayableCurrent>
    <BNZI:InterestPayableOnOtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001599"
      unitRef="USD">4044</BNZI:InterestPayableOnOtherNotesPayableCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-09-13_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001601"
      unitRef="USD">1500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-09-13_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      decimals="INF"
      id="Fact001603"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      id="Fact001605">2024-09-30</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="AsOf2023-09-13_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001607"
      unitRef="USD">8588</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001609"
      unitRef="USD">638808</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestExpense
      contextRef="From2024-04-012024-06-30_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001611"
      unitRef="USD">95935</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-04-012024-06-30_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001613"
      unitRef="USD">29918</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2024-04-012024-06-30_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001615"
      unitRef="USD">66017</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:InterestExpense
      contextRef="From2024-01-012024-06-30_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001617"
      unitRef="USD">187498</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-01-012024-06-30_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001619"
      unitRef="USD">59836</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2024-01-012024-06-30_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001621"
      unitRef="USD">127662</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="AsOf2024-06-30_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001623"
      unitRef="USD">1500000</us-gaap:OtherNotesPayableCurrent>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001625"
      unitRef="USD">1500000</us-gaap:OtherNotesPayableCurrent>
    <BNZI:InterestPayableOnOtherNotesPayableCurrent
      contextRef="AsOf2024-06-30_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001627"
      unitRef="USD">90411</BNZI:InterestPayableOnOtherNotesPayableCurrent>
    <BNZI:InterestPayableOnOtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001629"
      unitRef="USD">30575</BNZI:InterestPayableOnOtherNotesPayableCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-11-16_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember_srt_MaximumMember"
      decimals="0"
      id="Fact001631"
      unitRef="USD">750000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-11-16_custom_AlcoMember_custom_AlcoNovemberPromissoryNoteMember"
      decimals="INF"
      id="Fact001633"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-11-162023-11-16_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember"
      id="Fact001635">2024-04-13</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="AsOf2023-11-16_custom_AlcoMember_custom_AlcoNovemberPromissoryNoteMember"
      decimals="0"
      id="Fact001637"
      unitRef="USD">363905</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:InterestExpense
      contextRef="From2024-04-012024-06-30_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001639"
      unitRef="USD">31036</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-04-012024-06-30_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001641"
      unitRef="USD">14959</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2024-04-012024-06-30_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001643"
      unitRef="USD">45995</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:InterestExpense
      contextRef="From2024-01-012024-06-30_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001645"
      unitRef="USD">217249</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-01-012024-06-30_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001647"
      unitRef="USD">29918</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2024-01-012024-06-30_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001649"
      unitRef="USD">187331</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="AsOf2024-06-30_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001651"
      unitRef="USD">750000</us-gaap:OtherNotesPayableCurrent>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001653"
      unitRef="USD">750000</us-gaap:OtherNotesPayableCurrent>
    <BNZI:InterestPayableOnOtherNotesPayableCurrent
      contextRef="AsOf2024-06-30_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001655"
      unitRef="USD">37315</BNZI:InterestPayableOnOtherNotesPayableCurrent>
    <BNZI:InterestPayableOnOtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001657"
      unitRef="USD">7397</BNZI:InterestPayableOnOtherNotesPayableCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-13_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember_srt_MaximumMember"
      decimals="0"
      id="Fact001659"
      unitRef="USD">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-12-13_custom_AlcoMember_custom_AlcoDecemberPromissoryNoteMember"
      decimals="INF"
      id="Fact001661"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-12-132023-12-13_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember"
      id="Fact001663">2024-12-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="AsOf2023-12-13_custom_AlcoMember_custom_AlcoDecemberPromissoryNoteMember"
      decimals="0"
      id="Fact001665"
      unitRef="USD">1496252</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:InterestExpense
      contextRef="From2024-04-012024-06-30_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001667"
      unitRef="USD">317667</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-04-012024-06-30_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001669"
      unitRef="USD">39890</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2024-04-012024-06-30_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001671"
      unitRef="USD">277777</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:InterestExpense
      contextRef="From2024-01-012024-06-30_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001673"
      unitRef="USD">549883</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-01-012024-06-30_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001675"
      unitRef="USD">79780</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2024-01-012024-06-30_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001677"
      unitRef="USD">470103</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="AsOf2024-06-30_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001679"
      unitRef="USD">2000000</us-gaap:OtherNotesPayableCurrent>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001681"
      unitRef="USD">2000000</us-gaap:OtherNotesPayableCurrent>
    <BNZI:InterestPayableOnOtherNotesPayableCurrent
      contextRef="AsOf2024-06-30_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001683"
      unitRef="USD">87670</BNZI:InterestPayableOnOtherNotesPayableCurrent>
    <BNZI:InterestPayableOnOtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact001685"
      unitRef="USD">7890</BNZI:InterestPayableOnOtherNotesPayableCurrent>
    <us-gaap:DebtConversionDescription
      contextRef="From2024-01-012024-06-30_custom_AlcoShareTransferAgreementsMember_custom_GcCoHoldingsIncMember_custom_AlcoNovemberPromissoryNoteMember"
      id="Fact001686">for
each $500.00 in principal borrowed under the Alco September and November Promissory Notes, the Sponsor agreed to forfeit one share of
7GC Class B Common Stock held by the Sponsor, in exchange for the right of Alco to receive one New Banzai Class A Share. For each $500.00
in principal borrowed under the December Note, the Sponsor agreed to forfeit three shares of 7GC Class B Common Stock held by the Sponsor,
in exchange for the right of Alco to receive three New Banzai Class A Shares. Such forfeited and issued shares under the Alco September,
November, and December Promissory Notes are capped at an amount equal to 3,000, 1,500, and 12,000, respectively</us-gaap:DebtConversionDescription>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2023-12-13_custom_AlcoShareTransferAgreementsMember_custom_GcCoHoldingsIncMember_custom_AlcoSeptemberPromissoryNoteMember"
      decimals="INF"
      id="Fact001688"
      unitRef="USDPShares">500.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2023-12-13_custom_AlcoShareTransferAgreementsMember_custom_GcCoHoldingsIncMember_custom_AlcoSeptemberPromissoryNoteMember"
      decimals="INF"
      id="Fact001690"
      unitRef="USDPShares">500.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2023-12-132023-12-13_custom_AlcoShareTransferAgreementsMember_custom_GcCoHoldingsIncMember_custom_AlcoSeptemberPromissoryNoteMember"
      decimals="INF"
      id="Fact001692"
      unitRef="Shares">3000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2023-12-132023-12-13_custom_AlcoShareTransferAgreementsMember_custom_GcCoHoldingsIncMember_custom_AlcoNovemberPromissoryNoteMember"
      decimals="INF"
      id="Fact001694"
      unitRef="Shares">1500</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2023-12-132023-12-13_custom_AlcoShareTransferAgreementsMember_custom_GcCoHoldingsIncMember_custom_AlcoDecemberPromissoryNoteMember"
      decimals="INF"
      id="Fact001696"
      unitRef="Shares">12000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <BNZI:LockUpPeriod
      contextRef="From2023-12-132023-12-13_custom_AlcoShareTransferAgreementsMember_custom_GcCoHoldingsIncMember_custom_AlcoDecemberPromissoryNoteMember"
      id="Fact001698">P180D</BNZI:LockUpPeriod>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="0"
      id="Fact001700"
      unitRef="USD">1000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <BNZI:HoldingPeriodForShares
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      id="Fact001702">P0Y9M7D</BNZI:HoldingPeriodForShares>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="0"
      id="Fact001704"
      unitRef="USD">1000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <BNZI:LockUpPeriod
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      id="Fact001706">P180D</BNZI:LockUpPeriod>
    <BNZI:EstimatedReLeveredEquityVolatilityRate
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001708"
      unitRef="Pure">0.540</BNZI:EstimatedReLeveredEquityVolatilityRate>
    <BNZI:CommensurateRiskFreeRate
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001710"
      unitRef="Pure">0.053</BNZI:CommensurateRiskFreeRate>
    <BNZI:PercentageOfDiscountLackOfMarketability
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MinimumMember"
      decimals="INF"
      id="Fact001712"
      unitRef="Pure">0.107</BNZI:PercentageOfDiscountLackOfMarketability>
    <BNZI:PercentageOfDiscountLackOfMarketability
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001714"
      unitRef="Pure">0.160</BNZI:PercentageOfDiscountLackOfMarketability>
    <BNZI:PercentageOfDiscountLackOfMarketability
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001716"
      unitRef="Pure">0.125</BNZI:PercentageOfDiscountLackOfMarketability>
    <BNZI:ExpectedPercentageOfCompletingTheMerger
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001718"
      unitRef="Pure">0.80</BNZI:ExpectedPercentageOfCompletingTheMerger>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="0"
      id="Fact001720"
      unitRef="USD">500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <BNZI:HoldingPeriodForShares
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      id="Fact001722">P0Y8M19D</BNZI:HoldingPeriodForShares>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="0"
      id="Fact001724"
      unitRef="USD">500000</us-gaap:ProceedsFromIssuanceOfDebt>
    <BNZI:LockUpPeriod
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      id="Fact001726">P180D</BNZI:LockUpPeriod>
    <BNZI:EstimatedReLeveredEquityVolatilityRate
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001728"
      unitRef="Pure">0.520</BNZI:EstimatedReLeveredEquityVolatilityRate>
    <BNZI:CommensurateRiskFreeRate
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001730"
      unitRef="Pure">0.054</BNZI:CommensurateRiskFreeRate>
    <BNZI:PercentageOfDiscountLackOfMarketability
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MinimumMember"
      decimals="INF"
      id="Fact001732"
      unitRef="Pure">0.100</BNZI:PercentageOfDiscountLackOfMarketability>
    <BNZI:PercentageOfDiscountLackOfMarketability
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001734"
      unitRef="Pure">0.150</BNZI:PercentageOfDiscountLackOfMarketability>
    <BNZI:PercentageOfDiscountLackOfMarketability
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001736"
      unitRef="Pure">0.115</BNZI:PercentageOfDiscountLackOfMarketability>
    <BNZI:ExpectedPercentageOfCompletingTheMerger
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001738"
      unitRef="Pure">0.80</BNZI:ExpectedPercentageOfCompletingTheMerger>
    <BNZI:HoldingPeriodForShares
      contextRef="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      id="Fact001740">P0Y7M6D</BNZI:HoldingPeriodForShares>
    <BNZI:LockUpPeriod
      contextRef="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      id="Fact001742">P180D</BNZI:LockUpPeriod>
    <BNZI:EstimatedReLeveredEquityVolatilityRate
      contextRef="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001744"
      unitRef="Pure">0.540</BNZI:EstimatedReLeveredEquityVolatilityRate>
    <BNZI:CommensurateRiskFreeRate
      contextRef="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001746"
      unitRef="Pure">0.052</BNZI:CommensurateRiskFreeRate>
    <BNZI:PercentageOfDiscountLackOfMarketability
      contextRef="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MinimumMember"
      decimals="INF"
      id="Fact001748"
      unitRef="Pure">0.095</BNZI:PercentageOfDiscountLackOfMarketability>
    <BNZI:PercentageOfDiscountLackOfMarketability
      contextRef="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001750"
      unitRef="Pure">0.150</BNZI:PercentageOfDiscountLackOfMarketability>
    <BNZI:PercentageOfDiscountLackOfMarketability
      contextRef="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001752"
      unitRef="Pure">0.115</BNZI:PercentageOfDiscountLackOfMarketability>
    <BNZI:ExpectedPercentageOfCompletingTheMerger
      contextRef="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001754"
      unitRef="Pure">1</BNZI:ExpectedPercentageOfCompletingTheMerger>
    <BNZI:HoldingPeriodForShares
      contextRef="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      id="Fact001756">P0Y5M26D</BNZI:HoldingPeriodForShares>
    <BNZI:LockUpPeriod
      contextRef="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      id="Fact001758">P180D</BNZI:LockUpPeriod>
    <BNZI:EstimatedReLeveredEquityVolatilityRate
      contextRef="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001760"
      unitRef="Pure">0.470</BNZI:EstimatedReLeveredEquityVolatilityRate>
    <BNZI:CommensurateRiskFreeRate
      contextRef="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001762"
      unitRef="Pure">0.052</BNZI:CommensurateRiskFreeRate>
    <BNZI:PercentageOfDiscountLackOfMarketability
      contextRef="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MinimumMember"
      decimals="INF"
      id="Fact001764"
      unitRef="Pure">0.075</BNZI:PercentageOfDiscountLackOfMarketability>
    <BNZI:PercentageOfDiscountLackOfMarketability
      contextRef="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001766"
      unitRef="Pure">0.120</BNZI:PercentageOfDiscountLackOfMarketability>
    <BNZI:PercentageOfDiscountLackOfMarketability
      contextRef="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001768"
      unitRef="Pure">0.090</BNZI:PercentageOfDiscountLackOfMarketability>
    <BNZI:ExpectedPercentageOfCompletingTheMerger
      contextRef="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact001770"
      unitRef="Pure">1</BNZI:ExpectedPercentageOfCompletingTheMerger>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-05-302024-05-30_custom_AlcoAugustPromissoryNoteMember"
      decimals="0"
      id="Fact001772"
      unitRef="USD">4000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-05-302024-05-30_custom_AlcoNovemberPromissoryNoteMember"
      decimals="0"
      id="Fact001774"
      unitRef="USD">4000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <BNZI:NumberOfPromissoryNotesInConnectionWithMerger
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact001776"
      unitRef="Pure">2</BNZI:NumberOfPromissoryNotesInConnectionWithMerger>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2024-02-09_custom_SevenGCPromissoryNotesMember"
      decimals="0"
      id="Fact001778"
      unitRef="USD">2540091</us-gaap:LoansPayableCurrent>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-02-092024-02-09_custom_ConversionOf7GcPromissoryNotesMember_us-gaap_CommonClassAMember_custom_SponsorMember"
      decimals="INF"
      id="Fact001780"
      unitRef="Shares">17812</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-14_custom_GemAgreementMember_srt_MaximumMember_custom_SharePurchaseAgreementMember"
      decimals="0"
      id="Fact001782"
      unitRef="USD">100000000</us-gaap:CommonStockValue>
    <BNZI:PercentageOfRightToConvertWarrantToCommonShares
      contextRef="AsOf2023-12-14_custom_GemAgreementMember_custom_GemTermSheetMember_us-gaap_CommonClassAMember_custom_GemWarrantMember"
      decimals="INF"
      id="Fact001784"
      unitRef="Pure">0.03</BNZI:PercentageOfRightToConvertWarrantToCommonShares>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2023-12-14_custom_GemAgreementMember_custom_GemTermSheetMember"
      decimals="-5"
      id="Fact001786"
      unitRef="USD">2000000.0</us-gaap:ConvertibleDebt>
    <BNZI:CouponRate
      contextRef="AsOf2023-12-14_custom_GemAgreementMember_custom_GemTermSheetMember"
      decimals="INF"
      id="Fact001790"
      unitRef="Pure">0</BNZI:CouponRate>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-14_custom_GemAgreementMember_custom_GemTermSheetMember"
      decimals="-5"
      id="Fact001792"
      unitRef="USD">2000000.0</us-gaap:CommonStockValue>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="AsOf2023-12-31_custom_GemAgreementMember_custom_GemTermSheetMember"
      decimals="-5"
      id="Fact001794"
      unitRef="USD">2000000.0</us-gaap:DebtInstrumentFeeAmount>
    <BNZI:DebtInstrumentCashAgreedToPay
      contextRef="From2024-02-052024-02-05_custom_GemAgreementMember"
      decimals="-5"
      id="Fact001796"
      unitRef="USD">1200000</BNZI:DebtInstrumentCashAgreedToPay>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-02-05_custom_GemAgreementMember"
      decimals="-5"
      id="Fact001798"
      unitRef="USD">1000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2024-02-052024-02-05_custom_GemAgreementMember"
      decimals="0"
      id="Fact001800"
      unitRef="USD">100000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="From2024-02-052024-02-05_custom_GemAgreementMember"
      decimals="-5"
      id="Fact001802"
      unitRef="USD">1200000</us-gaap:RepaymentsOfLongTermDebt>
    <BNZI:SharesIssuableUnderPromissoryNote
      contextRef="From2024-02-052024-02-05_custom_GemAgreementMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact001804"
      unitRef="Shares">40000</BNZI:SharesIssuableUnderPromissoryNote>
    <BNZI:SharesIssuedUnderPromissoryNote
      contextRef="From2024-01-012024-06-30_custom_GemAgreementMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact001806"
      unitRef="Shares">20902</BNZI:SharesIssuedUnderPromissoryNote>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2024-06-30_custom_GemAgreementMember_us-gaap_CommonClassAMember"
      decimals="0"
      id="Fact001808"
      unitRef="USD">600000</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-14"
      decimals="0"
      id="Fact001810"
      unitRef="USD">3500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-14_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleConvertibleNoteMember_custom_YorkvilleAdvisorsGlobalLPMember"
      decimals="0"
      id="Fact001812"
      unitRef="USD">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2023-12-142023-12-14_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember"
      decimals="0"
      id="Fact001814"
      unitRef="USD">1800000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-12-142023-12-14_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember"
      decimals="0"
      id="Fact001816"
      unitRef="USD">200000</us-gaap:AmortizationOfDebtDiscountPremium>
    <BNZI:IncreasedPrincipalAmountAgreedToAdvance
      contextRef="AsOf2024-02-05_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact001818"
      unitRef="USD">1000000</BNZI:IncreasedPrincipalAmountAgreedToAdvance>
    <BNZI:AggregatePrincipalAmount
      contextRef="AsOf2024-02-05_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact001820"
      unitRef="USD">4500000</BNZI:AggregatePrincipalAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-02-05_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact001822"
      unitRef="USD">1000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2024-02-052024-02-05_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact001824"
      unitRef="USD">900000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2024-02-052024-02-05_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact001826"
      unitRef="USD">100000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-03-26_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact001828"
      unitRef="USD">1500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2024-03-262024-03-26_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact001830"
      unitRef="USD">1250000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2024-03-262024-03-26_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact001832"
      unitRef="USD">250000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-05-03_custom_OriginalDebtRepaymentAgreementMember"
      decimals="0"
      id="Fact001834"
      unitRef="USD">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2024-05-032024-05-03_custom_OriginalDebtRepaymentAgreementMember"
      decimals="0"
      id="Fact001836"
      unitRef="USD">200000</us-gaap:RepaymentsOfDebt>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-05-03_custom_OriginalDebtRepaymentAgreementMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact001838"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-05-22_custom_AmendedDebtRepaymentAgreementMember"
      decimals="0"
      id="Fact001840"
      unitRef="USD">750000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2024-05-222024-05-22_custom_AmendedDebtRepaymentAgreementMember"
      decimals="0"
      id="Fact001842"
      unitRef="USD">75000</us-gaap:RepaymentsOfDebt>
    <BNZI:AggregatePrincipalAmount
      contextRef="AsOf2024-05-31_custom_AmendedDebtRepaymentAgreementMember"
      decimals="0"
      id="Fact001844"
      unitRef="USD">750000</BNZI:AggregatePrincipalAmount>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2024-05-222024-05-22_custom_AmendedDebtRepaymentAgreementMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact001846"
      unitRef="Shares">12000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2024-05-222024-05-22_custom_AmendedDebtRepaymentAgreementMember"
      decimals="0"
      id="Fact001848"
      unitRef="USD">75000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="AsOf2024-05-22_custom_AmendedDebtRepaymentAgreementMember"
      decimals="0"
      id="Fact001850"
      unitRef="USD">110040</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2024-05-222024-05-22_custom_AmendedDebtRepaymentAgreementMember"
      decimals="0"
      id="Fact001852"
      unitRef="USD">75000</us-gaap:RepaymentsOfDebt>
    <us-gaap:ProceedsFromRepaymentsOfDebt
      contextRef="From2024-05-222024-05-22_custom_AmendedDebtRepaymentAgreementMember"
      decimals="0"
      id="Fact001854"
      unitRef="USD">35040</us-gaap:ProceedsFromRepaymentsOfDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="AsOf2024-05-22_custom_AmendedDebtRepaymentAgreementMember"
      decimals="0"
      id="Fact001856"
      unitRef="USD">115800</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-05-222024-05-22_custom_YorkvilleAdvisorsGlobalLPMember_custom_AmendedDebtRepaymentAgreementMember"
      id="Fact001858">2024-09-25</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-05-22_custom_YorkvilleAdvisorsGlobalLPMember_custom_AmendedDebtRepaymentAgreementMember_custom_StandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact001860"
      unitRef="Pure">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-05-22_custom_AmendedDebtRepaymentAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember"
      decimals="INF"
      id="Fact001862"
      unitRef="Pure">0.18</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="From2024-05-222024-05-22_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact001864"
      unitRef="Pure">0.0999</us-gaap:DebtConversionConvertedInstrumentRate>
    <BNZI:PercentageOfPrepaymentPremium
      contextRef="AsOf2024-05-22_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember"
      decimals="INF"
      id="Fact001866"
      unitRef="Pure">0.10</BNZI:PercentageOfPrepaymentPremium>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="From2024-05-222024-05-22_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember_custom_YorkvilleConvertibleNotesMember"
      decimals="0"
      id="Fact001868"
      unitRef="USD">1000000</us-gaap:RepaymentsOfConvertibleDebt>
    <BNZI:PercentageOfRepaymentOfConvertibleDebtAmount
      contextRef="AsOf2024-05-22_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember_custom_YorkvilleConvertibleNotesMember"
      decimals="INF"
      id="Fact001870"
      unitRef="Pure">0.10</BNZI:PercentageOfRepaymentOfConvertibleDebtAmount>
    <BNZI:MaximumFloorPrice
      contextRef="AsOf2024-01-31_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact001872"
      unitRef="USDPShares">2.00</BNZI:MaximumFloorPrice>
    <BNZI:FloorPrice
      contextRef="AsOf2024-02-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact001874"
      unitRef="USDPShares">14.70</BNZI:FloorPrice>
    <us-gaap:ProceedsFromRepaymentsOfDebt
      contextRef="From2024-04-012024-06-30_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember"
      decimals="0"
      id="Fact001876"
      unitRef="USD">300000</us-gaap:ProceedsFromRepaymentsOfDebt>
    <us-gaap:ProceedsFromRepaymentsOfDebt
      contextRef="From2024-01-012024-06-30_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember"
      decimals="0"
      id="Fact001878"
      unitRef="USD">800000</us-gaap:ProceedsFromRepaymentsOfDebt>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-04-012024-06-30_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact001880"
      unitRef="Shares">20176</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-01-012024-06-30_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleAdvisorsGlobalLPMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact001882"
      unitRef="Shares">35940</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-06-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact001884"
      unitRef="USD">1000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-01-012024-06-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact001886"
      unitRef="Shares">28910</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2024-06-30_custom_YorkvilleConvertibleNotesMember"
      decimals="0"
      id="Fact001888"
      unitRef="USD">1950000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-12-31_custom_YorkvilleConvertibleNotesMember"
      decimals="0"
      id="Fact001890"
      unitRef="USD">2000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:InterestExpense
      contextRef="From2024-04-012024-06-30_custom_YorkvilleConvertibleNotesMember"
      decimals="0"
      id="Fact001892"
      unitRef="USD">80760</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2024-01-012024-06-30_custom_YorkvilleConvertibleNotesMember"
      decimals="0"
      id="Fact001894"
      unitRef="USD">80760</us-gaap:InterestExpense>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-06-30_custom_YorkvilleConvertibleNotesMember"
      decimals="0"
      id="Fact001896"
      unitRef="USD">2013000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-31_custom_YorkvilleConvertibleNotesMember"
      decimals="0"
      id="Fact001898"
      unitRef="USD">1766000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:SharePrice
      contextRef="AsOf2023-12-31_custom_YorkvilleConvertibleNotesMember"
      decimals="INF"
      id="Fact001900"
      unitRef="USDPShares">1.88</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-01-012023-12-31_custom_YorkvilleConvertibleNotesMember"
      decimals="INF"
      id="Fact001902"
      unitRef="Pure">0.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-12-31_custom_YorkvilleConvertibleNotesMember"
      id="Fact001904">P0Y5M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
      contextRef="From2023-01-012023-12-31_custom_YorkvilleConvertibleNotesMember"
      decimals="INF"
      id="Fact001906"
      unitRef="Pure">0.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-01-012023-12-31_custom_YorkvilleConvertibleNotesMember"
      decimals="INF"
      id="Fact001908"
      unitRef="Pure">0.0528</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <BNZI:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsProbabilityOptionalRedemptionRate
      contextRef="From2023-01-012023-12-31_custom_YorkvilleConvertibleNotesMember"
      decimals="INF"
      id="Fact001910"
      unitRef="Pure">0.100</BNZI:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsProbabilityOptionalRedemptionRate>
    <BNZI:GainLossOnChangeInFairValueOfConvertibleNotesLiability
      contextRef="From2024-04-012024-06-30_custom_YorkvilleConvertibleNotesMember"
      decimals="0"
      id="Fact001912"
      unitRef="USD">34000</BNZI:GainLossOnChangeInFairValueOfConvertibleNotesLiability>
    <BNZI:GainLossOnChangeInFairValueOfConvertibleNotesLiability
      contextRef="From2024-01-012024-06-30_custom_YorkvilleConvertibleNotesMember"
      decimals="0"
      id="Fact001914"
      unitRef="USD">578000</BNZI:GainLossOnChangeInFairValueOfConvertibleNotesLiability>
    <us-gaap:SharePrice
      contextRef="AsOf2024-06-30_custom_YorkvilleConvertibleNotesMember"
      decimals="INF"
      id="Fact001916"
      unitRef="USDPShares">0.17</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-01-012024-06-30_custom_YorkvilleConvertibleNotesMember"
      decimals="INF"
      id="Fact001918"
      unitRef="Pure">1.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-01-012024-06-30_custom_YorkvilleConvertibleNotesMember"
      id="Fact001920">P0Y2M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
      contextRef="From2024-01-012024-06-30_custom_YorkvilleConvertibleNotesMember"
      decimals="INF"
      id="Fact001922"
      unitRef="Pure">0.206</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-01-012024-06-30_custom_YorkvilleConvertibleNotesMember"
      decimals="INF"
      id="Fact001924"
      unitRef="Pure">0.0548</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <BNZI:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsProbabilityOptionalRedemptionRate
      contextRef="From2024-01-012024-06-30_custom_YorkvilleConvertibleNotesMember"
      decimals="INF"
      id="Fact001926"
      unitRef="Pure">0.750</BNZI:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsProbabilityOptionalRedemptionRate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-12-31_custom_CPBFLendingLLCMember_custom_TermNoteMember"
      decimals="INF"
      id="Fact001928"
      unitRef="Pure">0.14</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <BNZI:PaidInKindInterestPercentage
      contextRef="AsOf2021-12-31_custom_CPBFLendingLLCMember_custom_TermNoteMember"
      decimals="INF"
      id="Fact001930"
      unitRef="Pure">0.015</BNZI:PaidInKindInterestPercentage>
    <BNZI:PaidInKindInterestPercentage
      contextRef="AsOf2021-12-31_custom_CPBFLendingLLCMember_us-gaap_ConvertibleDebtMember"
      decimals="INF"
      id="Fact001932"
      unitRef="Pure">0.155</BNZI:PaidInKindInterestPercentage>
    <us-gaap:DebtInstrumentCovenantCompliance
      contextRef="From2024-01-012024-06-30_custom_CPBFLendingLLCMember"
      id="Fact001934">For
all respective periods presented, the Company was not in compliance with the Minimum Gross Profit Margin covenant in section 7.14.1 of
the Loan Agreement, the Minimum ARR Growth covenant in section 7.14.2 of the Loan Agreement, and the Fixed Charge Coverage Ratio covenant
in section 7.14.3 of the Loan Agreement. As a result of the Company&#x2019;s noncompliance with the financial covenants, the entire principal
amount and all unpaid and accrued interest will be classified as current on the Company&#x2019;s consolidated balance sheets.</us-gaap:DebtInstrumentCovenantCompliance>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2023-06-30_custom_CPBFLendingLLCMember_us-gaap_MediumTermNotesMember"
      decimals="INF"
      id="Fact001936"
      unitRef="Pure">0.16</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2024-06-30_custom_CPBFLendingLLCMember_us-gaap_MediumTermNotesMember"
      decimals="INF"
      id="Fact001938"
      unitRef="Pure">0.16</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestExpense
      contextRef="From2024-04-012024-06-30_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact001940"
      unitRef="USD">294613</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2024-01-012024-06-30_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact001942"
      unitRef="USD">586940</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-04-012024-06-30_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact001944"
      unitRef="USD">267359</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-01-012024-06-30_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact001946"
      unitRef="USD">533707</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2024-04-012024-06-30_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact001948"
      unitRef="USD">27254</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2024-01-012024-06-30_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact001950"
      unitRef="USD">53233</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:InterestExpense
      contextRef="From2023-04-012023-06-30_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact001952"
      unitRef="USD">284097</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2023-01-012023-06-30_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact001954"
      unitRef="USD">562261</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-04-012023-06-30_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact001956"
      unitRef="USD">264320</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-01-012023-06-30_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact001958"
      unitRef="USD">523763</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2023-04-012023-06-30_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact001960"
      unitRef="USD">19777</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2023-01-012023-06-30_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact001962"
      unitRef="USD">38498</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2024-06-30_custom_CPBFLendingLLCMember_us-gaap_ConvertibleDebtMember"
      decimals="INF"
      id="Fact001964"
      unitRef="Pure">0.16</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2023-06-30_custom_CPBFLendingLLCMember_us-gaap_ConvertibleDebtMember"
      decimals="INF"
      id="Fact001966"
      unitRef="Pure">0.16</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestExpense
      contextRef="From2024-04-012024-06-30_us-gaap_MediumTermNotesMember_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001968"
      unitRef="USD">121448</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2024-01-012024-06-30_us-gaap_MediumTermNotesMember_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001970"
      unitRef="USD">237859</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-04-012024-06-30_custom_TermNoteMember_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001972"
      unitRef="USD">112908</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-01-012024-06-30_custom_TermNoteMember_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001974"
      unitRef="USD">221504</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2024-04-012024-06-30_us-gaap_MediumTermNotesMember_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001976"
      unitRef="USD">8540</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2024-01-012024-06-30_us-gaap_MediumTermNotesMember_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001978"
      unitRef="USD">16355</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:InterestExpense
      contextRef="From2023-04-012023-06-30_us-gaap_MediumTermNotesMember_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001980"
      unitRef="USD">101719</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2023-01-012023-06-30_us-gaap_MediumTermNotesMember_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001982"
      unitRef="USD">200151</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-04-012023-06-30_custom_TermNoteMember_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001984"
      unitRef="USD">95534</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-01-012023-06-30_custom_TermNoteMember_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001986"
      unitRef="USD">187394</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2023-04-012023-06-30_us-gaap_MediumTermNotesMember_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001988"
      unitRef="USD">6185</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2023-01-012023-06-30_us-gaap_MediumTermNotesMember_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001990"
      unitRef="USD">12757</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact001992">&lt;p id="xdx_897_eus-gaap--ConvertibleDebtTableTextBlock_zUg8MmqBkU2e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the CP BF convertible notes as of June 30, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zi28tYs4VmMl" style="display: none"&gt;Summary
of Convertible Notes&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20240630__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesMember_zTD3K9PJq0w3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maCNPzpbq_zbH6lPzcwcw8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Face value of the CB BF convertible notes&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,821,345&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--UnamortizedDebtDiscountOnConvertibleNotesPayable_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maCNPzpbq_zGi1VRpcgoEb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Debt discount, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(26,757&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ConvertibleNotesPayable_iTI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_mtCNPzpbq_maCDIAIzlB2_zGwXGUHJKxLh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Carrying value of the CB BF convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,794,588&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--InterestPayableOnConvertibleDebt_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maCDIAIzlB2_zGdoDOn1Wl9k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,135,983&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--ConvertibleDebtIncludingAccruedInterest_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_mtCDIAIzlB2_zEEdG8o1CmP9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total CB BF convertible notes and accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,930,571&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the CP BF convertible notes as of December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20231231__us-gaap--ShortTermDebtTypeAxis__custom--ConvertibleNotesMember_zLKVesy85ZP4" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maCNPz84e_z9VRLviS9OY5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Face value of the CB BF convertible notes&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,821,345&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--UnamortizedDebtDiscountOnConvertibleNotesPayable_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maCNPz84e_zUXSO8mwUiS1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Debt discount, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(41,983&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--ConvertibleNotesPayable_iTI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_mtCNPz84e_maCDIAIz7Jz_zGe9CaIN9qS3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Carrying value of the CB BF convertible notes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,779,362&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--InterestPayableOnConvertibleDebt_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maCDIAIz7Jz_zIGhV5DMTLZg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;914,479&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--ConvertibleDebtIncludingAccruedInterest_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_mtCDIAIz7Jz_zJ11fDGfpaik" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total CB BF convertible notes and accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,693,841&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the CP BF term note as of June 30, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20240630__us-gaap--ShortTermDebtTypeAxis__custom--TermNoteMember_zxC1HznVHr9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OtherNotesPayableCurrent_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maNPFVDzDF9_z08nSQH3sEIl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Face value of the CB BF term note&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6,500,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--UnamortizedDebtDiscountOnOtherNotesPayable_iNI_di_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_msNPFVDzDF9_zQwJzlJky6u7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Debt discount, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(76,353&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--NotesPayableFairValueDisclosure_iTI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_mtNPFVDzDF9_maNPIAIzcLA_z2TcFVuJM2oa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Carrying value of the CB BF term note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,423,647&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--AccruedInterestOnNotesPayableCurrent_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maNPIAIzcLA_zBJH4xoDiODf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;664,562&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--NotesPayableIncludingAccruedInterest_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_mtNPIAIzcLA_zsOhVMRI19zb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total CB BF term note and accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;7,088,209&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the CP BF term note as of December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20231231__us-gaap--ShortTermDebtTypeAxis__custom--TermNoteMember_z7QggMLZj2Pj" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--OtherNotesPayableCurrent_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maNPFVDzyNE_zOsi7Gw2Hrh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Face value of the CB BF term note&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6,500,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--UnamortizedDebtDiscountOnOtherNotesPayable_iNI_di_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_msNPFVDzyNE_z2v12D6Hx8gg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Debt discount, net&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(129,586&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--NotesPayableFairValueDisclosure_iTI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_mtNPFVDzyNE_maNPIAIzkCu_z3sBHECaP942" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Carrying value of the CB BF term note&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,370,414&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--AccruedInterestOnNotesPayableCurrent_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_maNPIAIzkCu_z8IK6g1Mkkqe" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;289,373&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--NotesPayableIncludingAccruedInterest_iI_hus-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_mtNPIAIzkCu_zhPvn6ZFzyT4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total CB BF term note and accrued interest&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,659,787&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="AsOf2024-06-30_custom_ConvertibleNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact001994"
      unitRef="USD">1821345</us-gaap:ConvertibleDebtFairValueDisclosures>
    <BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable
      contextRef="AsOf2024-06-30_custom_ConvertibleNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact001996"
      unitRef="USD">-26757</BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2024-06-30_custom_ConvertibleNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact001998"
      unitRef="USD">1794588</us-gaap:ConvertibleNotesPayable>
    <BNZI:InterestPayableOnConvertibleDebt
      contextRef="AsOf2024-06-30_custom_ConvertibleNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact002000"
      unitRef="USD">1135983</BNZI:InterestPayableOnConvertibleDebt>
    <BNZI:ConvertibleDebtIncludingAccruedInterest
      contextRef="AsOf2024-06-30_custom_ConvertibleNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact002002"
      unitRef="USD">2930571</BNZI:ConvertibleDebtIncludingAccruedInterest>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="AsOf2023-12-31_custom_ConvertibleNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact002004"
      unitRef="USD">1821345</us-gaap:ConvertibleDebtFairValueDisclosures>
    <BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable
      contextRef="AsOf2023-12-31_custom_ConvertibleNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact002006"
      unitRef="USD">-41983</BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2023-12-31_custom_ConvertibleNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact002008"
      unitRef="USD">1779362</us-gaap:ConvertibleNotesPayable>
    <BNZI:InterestPayableOnConvertibleDebt
      contextRef="AsOf2023-12-31_custom_ConvertibleNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact002010"
      unitRef="USD">914479</BNZI:InterestPayableOnConvertibleDebt>
    <BNZI:ConvertibleDebtIncludingAccruedInterest
      contextRef="AsOf2023-12-31_custom_ConvertibleNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact002012"
      unitRef="USD">2693841</BNZI:ConvertibleDebtIncludingAccruedInterest>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="AsOf2024-06-30_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact002014"
      unitRef="USD">6500000</us-gaap:OtherNotesPayableCurrent>
    <BNZI:UnamortizedDebtDiscountOnOtherNotesPayable
      contextRef="AsOf2024-06-30_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact002016"
      unitRef="USD">76353</BNZI:UnamortizedDebtDiscountOnOtherNotesPayable>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="AsOf2024-06-30_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact002018"
      unitRef="USD">6423647</us-gaap:NotesPayableFairValueDisclosure>
    <BNZI:AccruedInterestOnNotesPayableCurrent
      contextRef="AsOf2024-06-30_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact002020"
      unitRef="USD">664562</BNZI:AccruedInterestOnNotesPayableCurrent>
    <BNZI:NotesPayableIncludingAccruedInterest
      contextRef="AsOf2024-06-30_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact002022"
      unitRef="USD">7088209</BNZI:NotesPayableIncludingAccruedInterest>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact002024"
      unitRef="USD">6500000</us-gaap:OtherNotesPayableCurrent>
    <BNZI:UnamortizedDebtDiscountOnOtherNotesPayable
      contextRef="AsOf2023-12-31_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact002026"
      unitRef="USD">129586</BNZI:UnamortizedDebtDiscountOnOtherNotesPayable>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="AsOf2023-12-31_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact002028"
      unitRef="USD">6370414</us-gaap:NotesPayableFairValueDisclosure>
    <BNZI:AccruedInterestOnNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact002030"
      unitRef="USD">289373</BNZI:AccruedInterestOnNotesPayableCurrent>
    <BNZI:NotesPayableIncludingAccruedInterest
      contextRef="AsOf2023-12-31_custom_TermNoteMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact002032"
      unitRef="USD">6659787</BNZI:NotesPayableIncludingAccruedInterest>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact002034">&lt;p id="xdx_809_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zf9wZCqYUbgk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12.
&lt;span id="xdx_82A_zPOtC8tMqon8"&gt;Warrant Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Public
Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The
Company assumed &lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zlO2lIvOq0C3" title="Warrants outstanding"&gt;230,000&lt;/span&gt; Public Warrants in the Merger which remained outstanding as of June 30, 2024. &lt;span id="xdx_908_ecustom--WarrantsExercisePriceDescription_c20240101__20240630_zsWk20L6UXCe" title="Warrants exercise price, description"&gt;The Public Warrants have an
exercise price of $&lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSHRVyprBlM6" title="Warrants price per share"&gt;575.00&lt;/span&gt; per share, subject to adjustments, and will expire &lt;span id="xdx_903_ecustom--WarrantExpirationPeriod_iI_dc_c20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zFhzrU7RwcSj" title="Warrant expiration period"&gt;five years&lt;/span&gt; from the Merger Closing Date. The exercise price
and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including
in the event of a share dividend, or recapitalization, reorganization, merger or consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a Public Warrant and will have
no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the shares
of Class A Common Stock underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the
Company&#x2019;s satisfying its obligations described below with respect to registration, or a valid exemption from registration is available.
&lt;span id="xdx_90B_ecustom--WarrantsExercisable_iI_do_c20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zZd6ZxlhdS59" title="Warrants exercisable"&gt;No&lt;/span&gt; Public Warrant will be exercisable and the Company will not be obligated to issue a share of Class A Common Stock upon exercise of
a Public Warrant unless the shares of Class A Common Stock issuable upon such Public Warrant exercise has been registered, qualified,
or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Public Warrants. In the event
that the conditions in the two immediately preceding sentences are not satisfied with respect to a Public Warrant, the holder of such
Public Warrant will not be entitled to exercise such Public Warrant and such Public Warrant may have no value and expire worthless. In
no event will the Company be required to net cash settle any Public Warrant. The Resale Registration statement went effective on February
14, 2024. As the Resale Registration Statement was declared effective within the contractual &lt;span id="xdx_90D_ecustom--ContractualTerm_dtD_c20240101__20240630_zKlKZW5Hfyz7" title="Contractual term"&gt;60&lt;/span&gt;-day term upon closing of the Merger,
no &#x201c;cashless basis&#x201d; exercises were triggered during the period ended June 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Redemption
of Public Warrants When the price per Share of Class A Common Stock Equals or Exceeds $&lt;span id="xdx_905_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_pid_c20240101__20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z3iUnUeWYSjh" title="Redemption trigger price"&gt;900.00&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Once
the Public Warrants become exercisable, the Company may redeem the outstanding Public Warrants:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
                                            whole and not in part;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-align: justify; text-indent: -24.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at
                                            a price of $&lt;span id="xdx_90F_eus-gaap--SharePrice_iI_c20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zMQSmpRv2UVa" title="Share price warrants"&gt;0.01&lt;/span&gt; per Warrant;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-align: justify; text-indent: -24.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;upon
                                            a minimum of 30 days&#x2019; prior written notice of redemption (the &#x201c;30-day redemption
                                            period&#x201d;); and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-align: justify; text-indent: -24.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if,
                                            and only if, the closing price per share of Class A Common Stock equals or exceeds $&lt;span id="xdx_902_eus-gaap--SharePrice_iI_c20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zCuf26UAWpia" title="Share price"&gt;900.00&lt;/span&gt;
                                            per share (as adjusted for adjustments to the number of shares issuable upon exercise or
                                            the exercise price of a Public Warrant as described under the heading &#x201c;- Warrants&#x2014;Public
                                            Stockholder Warrants&#x2014;Anti-dilution Adjustments&#x201d;) for any 20 trading days within
                                            a 30-trading day period ending three trading days before the Company sends the notice of
                                            redemption to the warrant holders.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will not redeem the Public Warrants as described above unless a registration statement under the Securities Act covering the
issuance of shares of Class A Common Stock issuable upon exercise of the Public Warrants is then effective and a current prospectus relating
to those shares of Class A Common Stock is available throughout the 30-day redemption period. If and when the Public Warrants become
redeemable by the Company, the Company may not exercise its redemption right if the Company is unable to register or qualify the underlying
securities for sale under all applicable state securities laws.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time
of the call a significant premium to the Public Warrant exercise price. If the foregoing conditions are satisfied and the Company issues
a notice of redemption of the Public Warrants, each warrant holder will be entitled to exercise his, her or its Public Warrant prior
to the scheduled redemption date. However, the price per share of Class A Common Stock may fall below the $&lt;span id="xdx_909_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_pid_c20240101__20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zSATy0Fjos8h" title="Redemption trigger price"&gt;900.00&lt;/span&gt; redemption trigger price
(as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a Public Warrant as described under
the heading &#x201c;-Warrants&#x2014;Public Stockholder Warrants&#x2014;Anti-dilution Adjustments&#x201d;) as well as the $&lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zU9aazr16Qdk" title="Redemption trigger price"&gt;575.00&lt;/span&gt; (for whole
shares) Public Warrant exercise price after the redemption notice is issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--FractionalSharesIssuedUponExerciseOfCommonStock_iI_do_c20240630__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z8Qp0gDh27af" title="Warrants price per share"&gt;No&lt;/span&gt;
fractional shares of Class A Common Stock will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional
interest in a share, the Company will round down to the nearest whole number of the number of shares of Class A Common Stock to be issued
to the holder.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;GEM
Financing Arrangement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
association with the GEM Letter, see &lt;i&gt;Note 11 - Debt&lt;/i&gt; for further details, at Closing, the GEM Warrant automatically became an obligation
of the Company, and on December 15, 2023, the Company issued the GEM Warrant granting GEM the right to purchase &lt;span id="xdx_90C_ecustom--WarrantsPurchased_iI_c20231215__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--GemWarrantMember_zNEND6ySByS" title="Warrants purchased"&gt;16,571&lt;/span&gt; shares at an
exercise price of $&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231215__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--GemWarrantMember_zOt9EpZOkIo5" title="Warrants price per share"&gt;324.50&lt;/span&gt; per share. &lt;span id="xdx_90B_ecustom--WarrantsExercisePriceDescription_c20230101__20231231__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--GemWarrantMember_zRZ7Za7uZGEa" title="Warrants exercise price, description"&gt;The exercise price will be adjusted to 105% of the then-current exercise price if on the one-year
anniversary date of the Effective Time, the GEM Warrant has not been exercised in full and the average closing price per share of Class
A Common Stock for the 10 days preceding the anniversary date is less than 90% of the initial exercise price. GEM may exercise the GEM
Warrant at any time and from time to time until December 14, 2026. The terms of the GEM Warrant provide that the exercise price of the
GEM Warrant, and the number of shares of Class A Common Stock for which the GEM Warrant may be exercised, are subject to adjustment to
account for increases or decreases in the number of outstanding shares of New Banzai Common Stock resulting from stock splits, reverse
stock splits, consolidations, combinations and reclassifications. Additionally, the GEM Warrant contains weighted average anti-dilution
provisions that provide that if the Company issues shares of common stock, or securities convertible into or exercisable or exchange
for, shares of common stock at a price per share that is less than 90% of the exercise price then in effect or without consideration,
then the exercise price of the GEM Warrant upon each such issuance will be adjusted to the price equal to 105% of the consideration per
share paid for such common stock or other securities. In the event of a Change of Control, if the Surviving Corporation does not have
registered class of equity securities and common shares listed on a U.S. national securities exchange, then the Holder is entitled to
receive one percent of the total consideration received by the Company&#x2019;s stockholders and the GEM Warrants will expire upon payment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Warrants were not considered indexed to the issuer&#x2019;s stock pursuant to ASC 815, as the holder&#x2019;s ability to receive in lieu
of the Warrant one percent of the total consideration received by the Company&#x2019;s stockholders in connection with a Change of Control,
where the surviving corporation is not publicly traded, adjusts the settlement value based on items outside the Company&#x2019;s control
in violation of the fixed-for-fixed option pricing model. As such, the Company recorded the Warrants as liabilities initially measured
at fair value with subsequent changes in fair value recognized in earnings each reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
measurement of fair value was determined utilizing a Monte Carlo simulation considering all relevant assumptions current at the date
of issuance (i.e., share price, exercise price, term, volatility, risk-free rate, probability of dilutive term of three years, and expected
time to conversion). As of June 30, 2024 and December 31, 2023, the fair value of the Warrants, as determined by the Monte Carlo simulation
option pricing model, were $&lt;span id="xdx_90C_ecustom--FairValueOfWarrants_iI_c20240630_zLahLb0tD7uh" title="Fair value of warrants"&gt;79,000&lt;/span&gt; and $&lt;span id="xdx_90D_ecustom--FairValueOfWarrants_iI_c20231231_zjRvG4EgIhQ5" title="Fair value of warrants"&gt;641,000&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the per share market value of one share of Class A Common Stock is greater than the then-current exercise price, then GEM will have the
option to exercise the GEM Warrant on a cashless basis and receive a number of shares of Class A Common Stock equal to (x) the number
of shares of Class A Common Stock purchasable upon exercise of all of the GEM Warrant or, if only a portion of the GEM Warrant is being
exercised, the portion of the GEM Warrant being exercised, less (y) the product of the then-current exercise price and the number of
shares of Class A Common Stock purchasable upon exercise of all of the GEM Warrant or, if only a portion of the GEM Warrant is being
exercised, the portion of the GEM Warrant being exercised, divided by the per share market value of one share of Class A Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
GEM Warrant may not be exercised if such exercise would result in the beneficial ownership of the holder and its affiliates in excess
of &lt;span id="xdx_90A_ecustom--ClassOfWarrantsOrRightsThresholdLimitForTheThenIssuedAndOutstandingSharesOfCommonStock_iI_dp_uPure_c20231215_zjmrCd3zA0Hh" title="Class of warrants or rights threshold limit for the then issued and outstanding shares of Common Stock"&gt;9.99&lt;/span&gt;% of the then-issued and outstanding shares of Common Stock.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-06-30_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact002036"
      unitRef="Shares">230000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <BNZI:WarrantsExercisePriceDescription contextRef="From2024-01-01to2024-06-30" id="Fact002038">The Public Warrants have an
exercise price of $575.00 per share, subject to adjustments, and will expire five years from the Merger Closing Date. The exercise price
and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including
in the event of a share dividend, or recapitalization, reorganization, merger or consolidation.</BNZI:WarrantsExercisePriceDescription>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-06-30_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact002040"
      unitRef="USDPShares">575.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <BNZI:WarrantExpirationPeriod
      contextRef="AsOf2024-06-30_custom_PublicWarrantsMember"
      id="Fact002042">P5Y</BNZI:WarrantExpirationPeriod>
    <BNZI:WarrantsExercisable
      contextRef="AsOf2024-06-30_custom_PublicWarrantsMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002044"
      unitRef="Shares">0</BNZI:WarrantsExercisable>
    <BNZI:ContractualTerm contextRef="From2024-01-01to2024-06-30" id="Fact002046">P60D</BNZI:ContractualTerm>
    <BNZI:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="From2024-01-012024-06-30_custom_PublicWarrantsMember5441250"
      decimals="INF"
      id="Fact002048"
      unitRef="USDPShares">900.00</BNZI:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <us-gaap:SharePrice
      contextRef="AsOf2024-06-30_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact002050"
      unitRef="USDPShares">0.01</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-06-30_custom_PublicWarrantsMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002052"
      unitRef="USDPShares">900.00</us-gaap:SharePrice>
    <BNZI:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="From2024-01-012024-06-30_custom_PublicWarrantsMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002054"
      unitRef="USDPShares">900.00</BNZI:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-06-30_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact002056"
      unitRef="USDPShares">575.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <BNZI:FractionalSharesIssuedUponExerciseOfCommonStock
      contextRef="AsOf2024-06-30_custom_PublicWarrantsMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002058"
      unitRef="Shares">0</BNZI:FractionalSharesIssuedUponExerciseOfCommonStock>
    <BNZI:WarrantsPurchased
      contextRef="AsOf2023-12-15_custom_GemAgreementMember_custom_GemWarrantMember"
      decimals="INF"
      id="Fact002060"
      unitRef="Shares">16571</BNZI:WarrantsPurchased>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-12-15_custom_GemAgreementMember_custom_GemWarrantMember"
      decimals="INF"
      id="Fact002062"
      unitRef="USDPShares">324.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <BNZI:WarrantsExercisePriceDescription
      contextRef="From2023-01-012023-12-31_custom_GemAgreementMember_custom_GemWarrantMember"
      id="Fact002064">The exercise price will be adjusted to 105% of the then-current exercise price if on the one-year
anniversary date of the Effective Time, the GEM Warrant has not been exercised in full and the average closing price per share of Class
A Common Stock for the 10 days preceding the anniversary date is less than 90% of the initial exercise price. GEM may exercise the GEM
Warrant at any time and from time to time until December 14, 2026. The terms of the GEM Warrant provide that the exercise price of the
GEM Warrant, and the number of shares of Class A Common Stock for which the GEM Warrant may be exercised, are subject to adjustment to
account for increases or decreases in the number of outstanding shares of New Banzai Common Stock resulting from stock splits, reverse
stock splits, consolidations, combinations and reclassifications. Additionally, the GEM Warrant contains weighted average anti-dilution
provisions that provide that if the Company issues shares of common stock, or securities convertible into or exercisable or exchange
for, shares of common stock at a price per share that is less than 90% of the exercise price then in effect or without consideration,
then the exercise price of the GEM Warrant upon each such issuance will be adjusted to the price equal to 105% of the consideration per
share paid for such common stock or other securities. In the event of a Change of Control, if the Surviving Corporation does not have
registered class of equity securities and common shares listed on a U.S. national securities exchange, then the Holder is entitled to
receive one percent of the total consideration received by the Company&#x2019;s stockholders and the GEM Warrants will expire upon payment.</BNZI:WarrantsExercisePriceDescription>
    <BNZI:FairValueOfWarrants
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact002066"
      unitRef="USD">79000</BNZI:FairValueOfWarrants>
    <BNZI:FairValueOfWarrants
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002068"
      unitRef="USD">641000</BNZI:FairValueOfWarrants>
    <BNZI:ClassOfWarrantsOrRightsThresholdLimitForTheThenIssuedAndOutstandingSharesOfCommonStock
      contextRef="AsOf2023-12-15"
      decimals="INF"
      id="Fact002070"
      unitRef="Pure">0.0999</BNZI:ClassOfWarrantsOrRightsThresholdLimitForTheThenIssuedAndOutstandingSharesOfCommonStock>
    <BNZI:SimpleAgreementsForFutureEquityTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact002072">&lt;p id="xdx_80F_ecustom--SimpleAgreementsForFutureEquityTextBlock_zSKlMkoF0Wr8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;13.
&lt;span id="xdx_820_zWt1wuc39hdj"&gt;Simple Agreements for Future Equity&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Simple
Agreements for Future Equity - Related Party&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2021, the Company entered into Simple Agreements for Future Equity (SAFE) arrangements with related parties Alco, DNX and William Bryant
(See &lt;i&gt;Note 11 - Debt&lt;/i&gt;, for a description of the related party relationship with these entities) (the &#x201c;Related Party SAFEs&#x201d;)
pursuant to which the Company received gross proceeds in the amount of $&lt;span id="xdx_907_ecustom--ProceedsFromSimpleAgreementForFutureEquity_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlcoDNXAndWilliamBryantMember_zVlgSWF7zc2k" title="Received gross proceeds"&gt;3,567,000&lt;/span&gt;. In the event of an Equity Financing (as defined in
the SAFEs agreements), the Related Party SAFEs will automatically convert into shares of the Company&#x2019;s common or preferred stock
at a discount of &lt;span id="xdx_900_ecustom--CommonAndPreferredStockDiscountPercentage_pid_dp_uPure_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlcoDNXAndWilliamBryantMember_z4kcvkZJNXy6" title="Common or preferred stock discount"&gt;15&lt;/span&gt;% of the per share price of the shares offered in the Equity Financing (the &#x201c;Discount Price&#x201d;). In the
event of a Liquidity Event, SPAC Transaction or Dissolution Event (all terms as defined in the SAFEs agreements), the holders of the
Related Party SAFEs will be entitled to receive cash or shares of the Company&#x2019;s common or preferred stock. The Related Party SAFEs
were recorded as a liability in accordance with the applicable accounting guidance as they are redeemable for cash upon contingent events
that are outside of the Company&#x2019;s control. The initial fair value of the Related Party SAFE liability was $&lt;span id="xdx_90A_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlcoDNXAndWilliamBryantMember_zuw73mlM5yld" title="Fair value of SAFE liability"&gt;3,567,000&lt;/span&gt;. Subsequent
changes in fair value at each reporting period are recognized in the consolidated statement of operations. For the three and six months
ended June 30, 2023, the Company recognized a loss of $&lt;span id="xdx_909_ecustom--GainLossOnCahngeInFairValueOfSafeLiability_c20230401__20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlcoDNXAndWilliamBryantMember_zwIJ51rhnWy5" title="Loss on change in fair value of SAFE liability"&gt;909,418&lt;/span&gt; and $&lt;span id="xdx_909_ecustom--GainLossOnCahngeInFairValueOfSafeLiability_c20230101__20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlcoDNXAndWilliamBryantMember_zdzXwf2JgVAb" title="Loss on change in fair value of SAFE liability"&gt;1,212,557&lt;/span&gt; for the change in fair value of the Related Party SAFE
liability, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes a combination of scenario-based methods and Monte Carlo simulation to determine the fair value of the Related Party
SAFE liability as of the valuation dates. Key inputs into these models included the timing and probability of the identified scenarios,
and for Black-Scholes option pricing models used for notes that included a valuation cap, equity values, risk-free rate and volatility.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2023, all outstanding principal related to the Related Party SAFEs at a carrying value of $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentCarryingAmount_iI_c20231214__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlcoDNXAndWilliamBryantMember_zyFD1Ux4WU7c" title="Outstanding principal amount"&gt;6,049,766&lt;/span&gt; converted into &lt;span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20231214__20231214__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlcoDNXAndWilliamBryantMember_ztZO1LTxuTWl" title="Debt outstanding converted to common stock"&gt;11,039&lt;/span&gt;
shares the Company&#x2019;s Class A Common Stock pursuant to the close of the Merger Agreement and application of the exchange ratio.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Simple
Agreements for Future Equity - Third Party&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2021, the Company entered into Simple Agreements for Future Equity (SAFE) arrangements with third party investors (the &#x201c;Third Party
SAFEs&#x201d;) pursuant to which the Company received gross proceeds in the amount of $&lt;span id="xdx_909_ecustom--ProceedsFromSimpleAgreementForFutureEquity_c20210101__20211231__srt--CounterpartyNameAxis__custom--ThirdPartySafesMember_zikLLassSYrh" title="Received gross proceeds"&gt;269,000&lt;/span&gt;. In the event of an Equity Financing (as
defined in the SAFEs agreements), the Third Party SAFEs will automatically convert into shares of the Company&#x2019;s common or preferred
stock at a discount of &lt;span id="xdx_90F_ecustom--CommonAndPreferredStockDiscountPercentage_pid_dp_uPure_c20210101__20211231__srt--CounterpartyNameAxis__custom--ThirdPartySafesMember_zK1ScV3bc9U2" title="Common or preferred stock discount"&gt;15&lt;/span&gt;% of the per share price of the shares offered in the Equity Financing (the &#x201c;Discount Price&#x201d;). In
the event of a Liquidity Event, SPAC Transaction or Dissolution Event (all terms as defined in the SAFEs agreements), the holders of
the Third Party SAFEs will be entitled to receive cash or shares of the Company&#x2019;s common or preferred stock. The Third Party SAFEs
were recorded as a liability in accordance with the applicable accounting guidance as they are redeemable for cash upon contingent events
that are outside of the Company&#x2019;s control. The initial fair value of the Third Party SAFE liability was $&lt;span id="xdx_904_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20211231__srt--CounterpartyNameAxis__custom--ThirdPartySafesMember_zIDqxRZr5DT5" title="Fair value of SAFE liability"&gt;269,000&lt;/span&gt;. Subsequent changes
in fair value at each reporting period are recognized in the Consolidated Statement of Operations. For the three and six months ended
June 30, 2023, the Company recognized a loss of $&lt;span id="xdx_901_ecustom--GainLossOnCahngeInFairValueOfSafeLiability_c20230401__20230630__srt--CounterpartyNameAxis__custom--ThirdPartySafesMember_zRKV8MMwGUfk" title="Loss on change in fair value of SAFE liability"&gt;68,582&lt;/span&gt; and $&lt;span id="xdx_902_ecustom--GainLossOnCahngeInFairValueOfSafeLiability_c20230101__20230630__srt--CounterpartyNameAxis__custom--ThirdPartySafesMember_zeMMReCuVf2b" title="Loss on change in fair value of SAFE liability"&gt;91,443&lt;/span&gt; for the change in fair value of the Third Party SAFE liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes a combination of scenario-based methods and Monte Carlo simulation to determine the fair value of the Third Party SAFE
liability as of the valuation dates. Key inputs into these models included the timing and probability of the identified scenarios, and
for Black-Scholes option pricing models used for notes that included a valuation cap, equity values, risk-free rate and volatility.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2023, all outstanding principal related to the Third Party SAFEs at a carrying value of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentCarryingAmount_iI_c20231214__srt--CounterpartyNameAxis__custom--ThirdPartySafesMember_zj6py04WedTa" title="Outstanding principal amount"&gt;456,234&lt;/span&gt; converted into &lt;span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20231214__20231214__srt--CounterpartyNameAxis__custom--ThirdPartySafesMember_zoAAGCVkyFWj" title="Debt instrument carrying amount"&gt;833&lt;/span&gt; shares
the Company&#x2019;s Class A Common Stock pursuant to the close of the Merger Agreement and application of the exchange ratio.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BNZI:SimpleAgreementsForFutureEquityTextBlock>
    <BNZI:ProceedsFromSimpleAgreementForFutureEquity
      contextRef="From2021-01-012021-12-31_custom_AlcoDNXAndWilliamBryantMember"
      decimals="0"
      id="Fact002074"
      unitRef="USD">3567000</BNZI:ProceedsFromSimpleAgreementForFutureEquity>
    <BNZI:CommonAndPreferredStockDiscountPercentage
      contextRef="From2021-01-012021-12-31_custom_AlcoDNXAndWilliamBryantMember"
      decimals="INF"
      id="Fact002076"
      unitRef="Pure">0.15</BNZI:CommonAndPreferredStockDiscountPercentage>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2021-12-31_custom_AlcoDNXAndWilliamBryantMember"
      decimals="0"
      id="Fact002078"
      unitRef="USD">3567000</us-gaap:LiabilitiesFairValueDisclosure>
    <BNZI:GainLossOnCahngeInFairValueOfSafeLiability
      contextRef="From2023-04-012023-06-30_custom_AlcoDNXAndWilliamBryantMember"
      decimals="0"
      id="Fact002080"
      unitRef="USD">909418</BNZI:GainLossOnCahngeInFairValueOfSafeLiability>
    <BNZI:GainLossOnCahngeInFairValueOfSafeLiability
      contextRef="From2023-01-012023-06-30_custom_AlcoDNXAndWilliamBryantMember"
      decimals="0"
      id="Fact002082"
      unitRef="USD">1212557</BNZI:GainLossOnCahngeInFairValueOfSafeLiability>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-12-14_custom_AlcoDNXAndWilliamBryantMember"
      decimals="0"
      id="Fact002084"
      unitRef="USD">6049766</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2023-12-142023-12-14_custom_AlcoDNXAndWilliamBryantMember"
      decimals="INF"
      id="Fact002086"
      unitRef="Shares">11039</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <BNZI:ProceedsFromSimpleAgreementForFutureEquity
      contextRef="From2021-01-012021-12-31_custom_ThirdPartySafesMember"
      decimals="0"
      id="Fact002088"
      unitRef="USD">269000</BNZI:ProceedsFromSimpleAgreementForFutureEquity>
    <BNZI:CommonAndPreferredStockDiscountPercentage
      contextRef="From2021-01-012021-12-31_custom_ThirdPartySafesMember"
      decimals="INF"
      id="Fact002090"
      unitRef="Pure">0.15</BNZI:CommonAndPreferredStockDiscountPercentage>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2021-12-31_custom_ThirdPartySafesMember"
      decimals="0"
      id="Fact002092"
      unitRef="USD">269000</us-gaap:LiabilitiesFairValueDisclosure>
    <BNZI:GainLossOnCahngeInFairValueOfSafeLiability
      contextRef="From2023-04-012023-06-30_custom_ThirdPartySafesMember"
      decimals="0"
      id="Fact002094"
      unitRef="USD">68582</BNZI:GainLossOnCahngeInFairValueOfSafeLiability>
    <BNZI:GainLossOnCahngeInFairValueOfSafeLiability
      contextRef="From2023-01-012023-06-30_custom_ThirdPartySafesMember"
      decimals="0"
      id="Fact002096"
      unitRef="USD">91443</BNZI:GainLossOnCahngeInFairValueOfSafeLiability>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-12-14_custom_ThirdPartySafesMember"
      decimals="0"
      id="Fact002098"
      unitRef="USD">456234</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2023-12-142023-12-14_custom_ThirdPartySafesMember"
      decimals="INF"
      id="Fact002100"
      unitRef="Shares">833</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact002102">&lt;p id="xdx_808_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zYDzcqqIp5h6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;14.
&lt;span id="xdx_820_zF1VskMtXVgl"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Leases&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has operating leases for its real estate across multiple states. The operating leases have remaining lease terms of approximately
&lt;span id="xdx_906_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtY_c20240630_zCDpIt9mIRz" title="Operating leases have remaining lease terms"&gt;0.26&lt;/span&gt; years as of June 30, 2024 and consist primarily of office space.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
lease agreements generally do not provide an implicit borrowing rate. Therefore, the Company used a benchmark approach to derive an appropriate
incremental borrowing rate to discount remaining lease payments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leases
with an initial term of twelve months or less are not recorded on the balance sheet. There are no material residual guarantees associated
with any of the Company&#x2019;s leases, and there are no significant restrictions or covenants included in the Company&#x2019;s lease
agreements. Certain leases include variable payments related to common area maintenance and property taxes, which are billed by the landlord,
as is customary with these types of charges for office space. The Company has not entered into any lease arrangements with related parties.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s existing leases contain escalation clauses and renewal options. The Company is not reasonably certain that renewal options
will be exercised upon expiration of the initial terms of its existing leases.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company entered into a sublease which it has identified as an operating lease prior to the adoption of ASC 842 &lt;i&gt;Leases&lt;/i&gt;. The Company
remains the primary obligor to the head lease lessor, making rental payments directly to the lessor and separately billing the sublessee.
The sublease is subordinate to the master lease, and the sublessee must comply with all applicable terms of the master lease. The Company
subleased the real estate to a third-party at a monthly rental payment amount that was less than the monthly cost that it pays on the
headlease with the lessor.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--LeaseCostTableTextBlock_zvNuniQWK2Fg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of lease expense for the three months ended June 30, 2024 and 2023, are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BB_zBzEhhbez7i4" style="display: none"&gt;Schedule of Components of Lease Expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Components of lease expense:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240401__20240630_zl8g045Z1Yuh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230401__20230630_zEIITZ12MYm6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the Three Months Ended June
    30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LeaseCostAbstract_iB_zhMh9vkxeTq5" style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Components of lease expense:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingLeaseCost_i01_zFlJbtymNSGe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Operating lease cost&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;46,140&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;50,440&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingLeaseImpairmentLoss_i01_zlgVTRwPWtFd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Lease impairment cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2114"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2115"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--SubleaseIncome_i01N_di_zJrQySxehtNg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Sublease income&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(52,542&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(51,082&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LeaseCost_i01T_z9uwgew7EuR7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total lease (income) cost&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(6,402&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(642&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of lease expense for the six months ended June 30, 2024 and 2023, are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Components of lease expense:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240101__20240630_zIv8oAE6t1p7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230101__20230630_zrktYU2OWqib" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the Six Months Ended June
    30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Components of lease expense:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingLeaseCost_i01_zRa1SL6I2c4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Operating lease cost&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;93,384&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;101,888&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingLeaseImpairmentLoss_i01_znOmoB9A5HS1" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Lease impairment cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2126"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2127"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--SubleaseIncome_i01N_di_zpgG53y8waU5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Sublease income&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(105,084&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(102,165&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--LeaseCost_i01T_z6lAsuEhfYpl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total lease (income) cost&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(11,700&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(277&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zEiyjBWUfqd7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_zz5HX7FZIsjj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Supplemental
cash flow information related to leases are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zlp0a66vLjhk" style="display: none"&gt;Schedule of Supplemental Cash Flow Information Related to Leases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Supplemental cash flow information:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240101__20240630_zIjndKBJCYXg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230101__20230630_z4EeFsHOu8Hj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the Six Months Ended June
    30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Supplemental cash flow information:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CashFlowOperatingActivitiesLesseeAbstract_iB_zLYAv67SdgUk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i01_zCDNfvMm09W3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Non-cash lease expense (operating cash flow)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;87,579&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;86,320&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i01_zRrkQwxC3IE9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Change in lease liabilities (operating cash flow)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(152,335&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(138,804&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zu9NZOtlzqka" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock_zYIBh6Lmo1Te" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Supplemental
balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zn7B0qmvVF2" style="display: none"&gt;Schedule of Supplemental Balance Sheet Information Related to Leases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr id="xdx_400_eus-gaap--LeasesOperatingAbstract_iB_zVEjWojPWQ01" style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Operating leases:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240630_z5DPNuEish1h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20231231_zlTyQpAOc5L3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_zQnW2vyddfbl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 1pt"&gt;Operating lease right-of-use assets&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;46,434&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;134,013&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_zMzGgsXTeJDg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Operating lease liability, current&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;81,708&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;234,043&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_zfWNlqwawjOb" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Operating lease liability, non-current&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2156"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--OperatingLeaseLiability_i01I_zpRfuChxpggl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total operating lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;81,708&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;234,043&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr id="xdx_401_ecustom--WeightedAverageRemainingLeaseTermAbstract_iB_zmt9stkUvg11" style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Weighted-average remaining lease term:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Operating leases (in years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_i01I_dtY_c20240630_zCg3qXc9qP32" style="width: 16%; text-align: right" title="Operating leases (in years)"&gt;0.26&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20231231_z7SgSVSOrwv2" title="Operating leases (in years)"&gt;0.76&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr id="xdx_404_ecustom--WeightedAverageDiscountRateAbstract_iB_zeTpGIqJ86D3" style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Weighted-average discount rate:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Operating leases&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_pid_dp_uPure_c20240630_zqPoo9gHZUn6" style="width: 16%; text-align: right" title="Operating leases"&gt;6.83&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_pid_dp_uPure_c20231231_z2uAi1kFmhBg" style="width: 16%; text-align: right" title="Operating leases"&gt;6.76&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_z8QcxEni2kLa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zVPh0842bHxe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
minimum lease payments under non-cancellable lease as of June 30, 2024, are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_z7480fmBTXF3" style="display: none"&gt;Schedule of Future Minimum Lease Payments Under Non-Cancellable Lease&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilitiesPaymentsDueAbstract_iB_z3ndHzJitXzh" style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Maturities of lease liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20240630_zz7CQax4Ykk2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Year Ending December 31,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_i01I_maLOLLPzVN7_zDuVNjjyHE8i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; padding-bottom: 1pt"&gt;Remainder of 2024&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;82,679&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzVN7_zOm5GfW0Q27e" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt; text-align: left"&gt;Year Ending December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2180"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_i01TI_mtLOLLPzVN7_zkq6rB6PV8x7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total undiscounted cash flows&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;82,679&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_i01NI_di_zsPHW49NtlDb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less discounting&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(971&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OperatingLeaseLiability_i01I_zp6RzqSRN2k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Present value of lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;81,708&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_z4CKEAkudgZe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Cantor
Fee Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Merger, 7GC previously agreed to pay Cantor Fitzgerald &amp;amp; Co. (&#x201c;Cantor&#x201d; or &#x201c;CF&amp;amp;CO&#x201d;)
an Original Deferred Fee of $&lt;span id="xdx_905_ecustom--DeferredUnderwritingFeesPayable_iI_c20240630__custom--AgreementAxis__custom--CantorFeeAgreementMember__dei--LegalEntityAxis__custom--GcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember_zgHTgHcPRYAb" title="Deferred underwriting fees payable"&gt;8,050,000&lt;/span&gt; as deferred underwriting commissions. On November 8, 2023, Cantor and 7GC entered into a Fee Reduction
Agreement, pursuant to which Cantor agreed to forfeit $&lt;span id="xdx_902_ecustom--DeferredUnderwritingFeesForfeit_iI_c20231108__custom--AgreementAxis__custom--CantorFeeAgreementMember__dei--LegalEntityAxis__custom--GcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember_zOVToGGhHev3" title="Deferred underwriting fees forfeit"&gt;4,050,000&lt;/span&gt; of the $&lt;span id="xdx_90C_ecustom--DeferredUnderwritingFeesPayable_iI_c20231108__custom--AgreementAxis__custom--CantorFeeAgreementMember__dei--LegalEntityAxis__custom--GcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember_zkhAnTWBcdj9" title="Deferred underwriting fees payable"&gt;8,050,000&lt;/span&gt; Original Deferred Fee, with the remaining $&lt;span id="xdx_901_ecustom--IncreaseDecreaseInDeferredUnderwritingFees_iI_c20231108__custom--AgreementAxis__custom--CantorFeeAgreementMember__dei--LegalEntityAxis__custom--GcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember_ztEa2DD7PKmj" title="Increase Decrease In Deferred Underwriting Fees"&gt;4,000,000&lt;/span&gt;
Reduced Deferred Fee payable by Banzai to Cantor following the Closing of the Merger.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Fee Reduction Agreement, the Company agreed to use its reasonable best efforts to have the registration statement declared effective
by the SEC by the 120th calendar day after December 29, 2023, the date of the initial filing thereof, and to maintain the effectiveness
of such registration statement until the earliest to occur of (i) the second anniversary of the date of the effectiveness thereof, (ii)
the Cantor Fee Shares shall have been sold, transferred, disposed of or exchanged by Cantor, and (iii) the Cantor Fee Shares issued to
Cantor may be sold without registration pursuant to Rule 144 under the Securities Act (such obligations, the &#x201c;Cantor Registration
Rights Obligations&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Although
the Company issued the Cantor Fee Shares, as of June 30, 2024, the Company has not satisfied its Cantor Registration Rights Obligations.
As such, the Company cannot conclude that it has settled its outstanding obligations to Cantor. Therefore, neither criteria under ASC
405 for extinguishment and derecognition of the liability were satisfied and the $&lt;span id="xdx_901_ecustom--IncreaseDecreaseInDeferredUnderwritingFees_iI_c20240630__custom--AgreementAxis__custom--CantorFeeAgreementMember__dei--LegalEntityAxis__custom--GcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember_zTIFHt5WxQE3" title="Increase Decrease In Deferred Underwriting Fees"&gt;4,000,000&lt;/span&gt; Reduced Deferred Fee remained outstanding
as a current liability on the Company&#x2019;s June 30, 2024 condensed consolidated balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
each interim and annual period after December 31, 2023, the Company will monitor its compliance with the Cantor Registration Rights Obligations
to determine whether the entire amount of the Reduced Deferred Fee has become due and payable in cash, or the Company&#x2019;s obligations
have been satisfied and the remaining liability should be derecognized. At such time as the Company&#x2019;s obligations under the Fee
Reduction Agreement have been satisfied the relief of the liability will be recorded through equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Roth
Addendum to Letter Agreements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 13, 2022, Roth Capital Partners, LLC (&#x201c;Roth&#x201d;) and Legacy Banzai entered into the Roth Engagement Letter, pursuant
to which Legacy Banzai engaged Roth as a financial advisor in connection with the Merger and, on October 14, 2022, MKM and 7GC entered
into the MKM Engagement Letter, pursuant to which 7GC engaged MKM as a financial advisor in connection with the Merger. In February 2023,
Roth acquired MKM. On December 8, 2023, the Company received an invoice from Roth for an advisory fee in the amount of $&lt;span id="xdx_90A_ecustom--AdvisoryFee_c20231208__20231208__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember_zbXBFuOZbs5e" title="Advisory fee"&gt;1,100,000&lt;/span&gt; as
well as transaction expenses reimbursable to Roth amounting to $&lt;span id="xdx_90A_ecustom--AdvisorTransactionExpenses_c20231208__20231208__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember_zkOJj8Sm9ay2" title="Advisor transaction expenses"&gt;6,813&lt;/span&gt;. As of December 31, 2023, the Company recorded a liability for
the total advisory fee of $&lt;span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrent_iI_c20231231__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember_zem7erhkYHW" title="Accrued expenses"&gt;1,106,813&lt;/span&gt; to accrued expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 2, 2024, the Company and Roth entered into an addendum to (i) the engagement letter, dated October 13, 2022, by and between
Roth and Legacy Banzai, and (ii) the engagement letter, dated October 14, 2022, by and between Roth (as successor to MKM Partners, LLC)
and 7GC (such engagement agreements, collectively, the &#x201c;Roth Engagement Agreements,&#x201d; and such addendum, the &#x201c;Roth Addendum&#x201d;).
&lt;span id="xdx_90E_ecustom--AddendumToLetterAgreementsDescription_c20240101__20240630_zZvrPz2z57L9" title="Addendum To Letter Agreements Description"&gt;Pursuant to the Roth Addendum, in lieu of payment in cash of the full amount of any advisory fees or other fees or expenses, incurred
in 2024, and owed under the Roth Engagement Agreements (collectively, the &#x201c;Roth Fee&#x201d;), the Company (i) issued to Roth &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240202__20240202__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zKFWXJP1aI55" title="Shares issued, shares"&gt;3,500&lt;/span&gt;
shares (the &#x201c;Roth Shares&#x201d;) of the Company&#x2019;s Class A Common Stock on February 2, 2024, and (ii) on or before June 30,
2024, will pay to Roth an amount in cash equal to $&lt;span id="xdx_90E_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20240202__20240202__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zRGwF6WeQi4l" title="Payment amount"&gt;300,000&lt;/span&gt; or, if the Company determines that such payment should not be made in cash
due to the Company&#x2019;s cash position at such time, issue to Roth a number of shares of Class A Common Stock equal to $&lt;span id="xdx_90E_ecustom--StockIssueValueIfPaymentNotMadeInCash_c20240202__20240202__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zOOsaDEOwjA" title="Shares issued, cash"&gt;300,000&lt;/span&gt; divided
by the daily VWAP for the trading day immediately preceding June 30, 2024 (any such shares, the &#x201c;Additional Roth Shares&#x201d;).
The Company registered the Roth Shares and &lt;span id="xdx_903_ecustom--StockIssuedDuringPeriodSharesAdditionalShares_c20240202__20240202__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zjNizAjCA4Da" title="Shares issued, shares"&gt;12,000&lt;/span&gt; shares of Class A Common Stock (in addition to the Roth Shares) on a registration
statement to cover any issuances of Additional Roth Shares&lt;/span&gt; (which may be more or less than &lt;span id="xdx_909_ecustom--StockIssuedDuringPeriodSharesAdditionalShares_c20240202__20240202__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zXs74CMNyJJ4" title="Stock issued during period shares additional shares"&gt;12,000&lt;/span&gt;) that may occur pursuant to the Roth
Addendum. This registration statement became effective on February 14, 2024. The $&lt;span id="xdx_902_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20240515__20240515__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z6Y4qWfhESp4" title="Cash payment"&gt;300,000&lt;/span&gt; cash payment has not yet been made as of the
date of filing of these condensed consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 2, 2024, the Company issued the &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240202__20240202__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember_zykDTqE1zslf" title="Shares issued, shares"&gt;3,500&lt;/span&gt; Roth Shares with a fair value of $&lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240202__20240202__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember_zik2dWLCF7nj" title="Shares issued, value"&gt;278,833&lt;/span&gt; on the date of issuance. As neither the remaining
$&lt;span id="xdx_903_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20240202__20240202__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zM0tuMYUS7ga" title="Shares issued, shares"&gt;300,000&lt;/span&gt; cash payment, nor any Additional Roth Shares had been paid or issued to Roth, as of June 30, 2024, $&lt;span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrent_iI_c20240630__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember_zjaUt2ojOjA" title="Accrued expenses"&gt;300,000&lt;/span&gt; will remain as an
accrued expense on the Company&#x2019;s condensed consolidated balance sheet, payable to Roth on or before June 30, 2024. Therefore, the
&lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240202__20240202__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember_zEpqlZ4pPxy7" title="Shares issued, shares"&gt;3,500&lt;/span&gt; shares are determined to settle $&lt;span id="xdx_902_eus-gaap--ContractualObligation_iI_c20231231__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember_z09Cfflv54Sb" title="Contractual obligation"&gt;806,813&lt;/span&gt; of the obligation recognized as of December 31, 2023, resulting in gain of $&lt;span id="xdx_909_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20240101__20240630__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember_zxk521OaqNw9" title="Gain on extinguishment of liability"&gt;577,513&lt;/span&gt;
that has been recognized as a gain on extinguishment of liability on the Company&#x2019;s condensed consolidated statement of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Legal
Matters&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the regular course of business affairs and operations, the Company is subject to possible loss contingencies arising from third-party
litigation and federal, state, and local environmental, labor, health and safety laws and regulations. The Company assesses the probability
that they may incur a liability in connection with certain of these lawsuits. The Company&#x2019;s assessments are made in accordance
with generally accepted accounting principles, as codified in ASC 450-20, and is not an admission of any liability on the part of the
Company or any of its subsidiaries. In certain cases that are in the early stages and in light of the uncertainties surrounding them,
the Company does not currently possess sufficient information to determine a range of reasonably possible liability. &lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="AsOf2024-06-30" id="Fact002104">P0Y3M3D</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact002106">&lt;p id="xdx_89A_eus-gaap--LeaseCostTableTextBlock_zvNuniQWK2Fg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of lease expense for the three months ended June 30, 2024 and 2023, are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BB_zBzEhhbez7i4" style="display: none"&gt;Schedule of Components of Lease Expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Components of lease expense:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240401__20240630_zl8g045Z1Yuh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20230401__20230630_zEIITZ12MYm6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the Three Months Ended June
    30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LeaseCostAbstract_iB_zhMh9vkxeTq5" style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Components of lease expense:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingLeaseCost_i01_zFlJbtymNSGe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Operating lease cost&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;46,140&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;50,440&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingLeaseImpairmentLoss_i01_zlgVTRwPWtFd" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Lease impairment cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2114"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2115"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--SubleaseIncome_i01N_di_zJrQySxehtNg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Sublease income&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(52,542&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(51,082&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LeaseCost_i01T_z9uwgew7EuR7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total lease (income) cost&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(6,402&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(642&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of lease expense for the six months ended June 30, 2024 and 2023, are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Components of lease expense:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240101__20240630_zIv8oAE6t1p7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230101__20230630_zrktYU2OWqib" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the Six Months Ended June
    30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Components of lease expense:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--OperatingLeaseCost_i01_zRa1SL6I2c4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Operating lease cost&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;93,384&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;101,888&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingLeaseImpairmentLoss_i01_znOmoB9A5HS1" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; text-align: left"&gt;Lease impairment cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2126"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2127"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--SubleaseIncome_i01N_di_zpgG53y8waU5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Sublease income&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(105,084&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(102,165&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--LeaseCost_i01T_z6lAsuEhfYpl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total lease (income) cost&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(11,700&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(277&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact002111"
      unitRef="USD">46140</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact002112"
      unitRef="USD">50440</us-gaap:OperatingLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact002117"
      unitRef="USD">52542</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact002118"
      unitRef="USD">51082</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="From2024-04-012024-06-30"
      decimals="0"
      id="Fact002120"
      unitRef="USD">-6402</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="From2023-04-012023-06-30"
      decimals="0"
      id="Fact002121"
      unitRef="USD">-642</us-gaap:LeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact002123"
      unitRef="USD">93384</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact002124"
      unitRef="USD">101888</us-gaap:OperatingLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact002129"
      unitRef="USD">105084</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact002130"
      unitRef="USD">102165</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact002132"
      unitRef="USD">-11700</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact002133"
      unitRef="USD">-277</us-gaap:LeaseCost>
    <BNZI:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact002135">&lt;p id="xdx_89A_ecustom--ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_zz5HX7FZIsjj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Supplemental
cash flow information related to leases are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zlp0a66vLjhk" style="display: none"&gt;Schedule of Supplemental Cash Flow Information Related to Leases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Supplemental cash flow information:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240101__20240630_zIjndKBJCYXg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230101__20230630_z4EeFsHOu8Hj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the Six Months Ended June
    30,&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Supplemental cash flow information:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CashFlowOperatingActivitiesLesseeAbstract_iB_zLYAv67SdgUk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i01_zCDNfvMm09W3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Non-cash lease expense (operating cash flow)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;87,579&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;86,320&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i01_zRrkQwxC3IE9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Change in lease liabilities (operating cash flow)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(152,335&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(138,804&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BNZI:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact002140"
      unitRef="USD">87579</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact002141"
      unitRef="USD">86320</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2024-01-01to2024-06-30"
      decimals="0"
      id="Fact002143"
      unitRef="USD">-152335</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2023-01-012023-06-30"
      decimals="0"
      id="Fact002144"
      unitRef="USD">-138804</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <BNZI:ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact002146">&lt;p id="xdx_895_ecustom--ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock_zYIBh6Lmo1Te" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Supplemental
balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zn7B0qmvVF2" style="display: none"&gt;Schedule of Supplemental Balance Sheet Information Related to Leases&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr id="xdx_400_eus-gaap--LeasesOperatingAbstract_iB_zVEjWojPWQ01" style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Operating leases:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20240630_z5DPNuEish1h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20231231_zlTyQpAOc5L3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_zQnW2vyddfbl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 1pt"&gt;Operating lease right-of-use assets&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;46,434&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;134,013&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_zMzGgsXTeJDg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Operating lease liability, current&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;81,708&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;234,043&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_zfWNlqwawjOb" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt"&gt;Operating lease liability, non-current&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2156"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--OperatingLeaseLiability_i01I_zpRfuChxpggl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total operating lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;81,708&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;234,043&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr id="xdx_401_ecustom--WeightedAverageRemainingLeaseTermAbstract_iB_zmt9stkUvg11" style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Weighted-average remaining lease term:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Operating leases (in years)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_i01I_dtY_c20240630_zCg3qXc9qP32" style="width: 16%; text-align: right" title="Operating leases (in years)"&gt;0.26&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20231231_z7SgSVSOrwv2" title="Operating leases (in years)"&gt;0.76&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr id="xdx_404_ecustom--WeightedAverageDiscountRateAbstract_iB_zeTpGIqJ86D3" style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;Weighted-average discount rate:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Operating leases&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_pid_dp_uPure_c20240630_zqPoo9gHZUn6" style="width: 16%; text-align: right" title="Operating leases"&gt;6.83&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_pid_dp_uPure_c20231231_z2uAi1kFmhBg" style="width: 16%; text-align: right" title="Operating leases"&gt;6.76&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BNZI:ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact002149"
      unitRef="USD">46434</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002150"
      unitRef="USD">134013</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact002152"
      unitRef="USD">81708</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002153"
      unitRef="USD">234043</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact002158"
      unitRef="USD">81708</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002159"
      unitRef="USD">234043</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2024-06-30" id="Fact002164">P0Y3M3D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2023-12-31" id="Fact002166">P0Y9M3D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002171"
      unitRef="Pure">0.0683</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002173"
      unitRef="Pure">0.0676</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact002175">&lt;p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zVPh0842bHxe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
minimum lease payments under non-cancellable lease as of June 30, 2024, are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_z7480fmBTXF3" style="display: none"&gt;Schedule of Future Minimum Lease Payments Under Non-Cancellable Lease&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilitiesPaymentsDueAbstract_iB_z3ndHzJitXzh" style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Maturities of lease liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20240630_zz7CQax4Ykk2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Year Ending December 31,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_i01I_maLOLLPzVN7_zDuVNjjyHE8i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; padding-bottom: 1pt"&gt;Remainder of 2024&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 16%; text-align: right"&gt;82,679&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzVN7_zOm5GfW0Q27e" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; padding-bottom: 1pt; text-align: left"&gt;Year Ending December 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2180"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_i01TI_mtLOLLPzVN7_zkq6rB6PV8x7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total undiscounted cash flows&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;82,679&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_i01NI_di_zsPHW49NtlDb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less discounting&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(971&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OperatingLeaseLiability_i01I_zp6RzqSRN2k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Present value of lease liabilities&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;81,708&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact002178"
      unitRef="USD">82679</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact002182"
      unitRef="USD">82679</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact002184"
      unitRef="USD">971</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact002186"
      unitRef="USD">81708</us-gaap:OperatingLeaseLiability>
    <BNZI:DeferredUnderwritingFeesPayable
      contextRef="AsOf2024-06-30_custom_CantorFeeAgreementMember_custom_GcCoHoldingsIncMember_custom_CantorFitzgeraldMember"
      decimals="0"
      id="Fact002188"
      unitRef="USD">8050000</BNZI:DeferredUnderwritingFeesPayable>
    <BNZI:DeferredUnderwritingFeesForfeit
      contextRef="AsOf2023-11-08_custom_CantorFeeAgreementMember_custom_GcCoHoldingsIncMember_custom_CantorFitzgeraldMember5486640"
      decimals="0"
      id="Fact002190"
      unitRef="USD">4050000</BNZI:DeferredUnderwritingFeesForfeit>
    <BNZI:DeferredUnderwritingFeesPayable
      contextRef="AsOf2023-11-08_custom_CantorFeeAgreementMember_custom_GcCoHoldingsIncMember_custom_CantorFitzgeraldMember5486640"
      decimals="0"
      id="Fact002192"
      unitRef="USD">8050000</BNZI:DeferredUnderwritingFeesPayable>
    <BNZI:IncreaseDecreaseInDeferredUnderwritingFees
      contextRef="AsOf2023-11-08_custom_CantorFeeAgreementMember_custom_GcCoHoldingsIncMember_custom_CantorFitzgeraldMember5486640"
      decimals="0"
      id="Fact002194"
      unitRef="USD">4000000</BNZI:IncreaseDecreaseInDeferredUnderwritingFees>
    <BNZI:IncreaseDecreaseInDeferredUnderwritingFees
      contextRef="AsOf2024-06-30_custom_CantorFeeAgreementMember_custom_GcCoHoldingsIncMember_custom_CantorFitzgeraldMember"
      decimals="0"
      id="Fact002196"
      unitRef="USD">4000000</BNZI:IncreaseDecreaseInDeferredUnderwritingFees>
    <BNZI:AdvisoryFee
      contextRef="From2023-12-082023-12-08_custom_RothAddendumToLetterAgreementsMember"
      decimals="0"
      id="Fact002198"
      unitRef="USD">1100000</BNZI:AdvisoryFee>
    <BNZI:AdvisorTransactionExpenses
      contextRef="From2023-12-082023-12-08_custom_RothAddendumToLetterAgreementsMember"
      decimals="0"
      id="Fact002200"
      unitRef="USD">6813</BNZI:AdvisorTransactionExpenses>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_RothAddendumToLetterAgreementsMember"
      decimals="0"
      id="Fact002202"
      unitRef="USD">1106813</us-gaap:AccruedLiabilitiesCurrent>
    <BNZI:AddendumToLetterAgreementsDescription contextRef="From2024-01-01to2024-06-30" id="Fact002204">Pursuant to the Roth Addendum, in lieu of payment in cash of the full amount of any advisory fees or other fees or expenses, incurred
in 2024, and owed under the Roth Engagement Agreements (collectively, the &#x201c;Roth Fee&#x201d;), the Company (i) issued to Roth 3,500
shares (the &#x201c;Roth Shares&#x201d;) of the Company&#x2019;s Class A Common Stock on February 2, 2024, and (ii) on or before June 30,
2024, will pay to Roth an amount in cash equal to $300,000 or, if the Company determines that such payment should not be made in cash
due to the Company&#x2019;s cash position at such time, issue to Roth a number of shares of Class A Common Stock equal to $300,000 divided
by the daily VWAP for the trading day immediately preceding June 30, 2024 (any such shares, the &#x201c;Additional Roth Shares&#x201d;).
The Company registered the Roth Shares and 12,000 shares of Class A Common Stock (in addition to the Roth Shares) on a registration
statement to cover any issuances of Additional Roth Shares</BNZI:AddendumToLetterAgreementsDescription>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-02-022024-02-02_custom_RothAddendumToLetterAgreementsMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002206"
      unitRef="Shares">3500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="From2024-02-022024-02-02_custom_RothAddendumToLetterAgreementsMember_us-gaap_CommonClassAMember"
      decimals="0"
      id="Fact002208"
      unitRef="USD">300000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <BNZI:StockIssueValueIfPaymentNotMadeInCash
      contextRef="From2024-02-022024-02-02_custom_RothAddendumToLetterAgreementsMember_us-gaap_CommonClassAMember"
      decimals="0"
      id="Fact002210"
      unitRef="USD">300000</BNZI:StockIssueValueIfPaymentNotMadeInCash>
    <BNZI:StockIssuedDuringPeriodSharesAdditionalShares
      contextRef="From2024-02-022024-02-02_custom_RothAddendumToLetterAgreementsMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002212"
      unitRef="Shares">12000</BNZI:StockIssuedDuringPeriodSharesAdditionalShares>
    <BNZI:StockIssuedDuringPeriodSharesAdditionalShares
      contextRef="From2024-02-022024-02-02_custom_RothAddendumToLetterAgreementsMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002214"
      unitRef="Shares">12000</BNZI:StockIssuedDuringPeriodSharesAdditionalShares>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="From2024-05-152024-05-15_custom_RothAddendumToLetterAgreementsMember_us-gaap_CommonClassAMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002216"
      unitRef="USD">300000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-02-022024-02-02_custom_RothAddendumToLetterAgreementsMember"
      decimals="INF"
      id="Fact002218"
      unitRef="Shares">3500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-02-022024-02-02_custom_RothAddendumToLetterAgreementsMember"
      decimals="0"
      id="Fact002220"
      unitRef="USD">278833</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="From2024-02-022024-02-02_custom_RothAddendumToLetterAgreementsMember_us-gaap_CommonClassAMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002222"
      unitRef="USD">300000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-06-30_custom_RothAddendumToLetterAgreementsMember"
      decimals="0"
      id="Fact002224"
      unitRef="USD">300000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-02-022024-02-02_custom_RothAddendumToLetterAgreementsMember"
      decimals="INF"
      id="Fact002226"
      unitRef="Shares">3500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ContractualObligation
      contextRef="AsOf2023-12-31_custom_RothAddendumToLetterAgreementsMember"
      decimals="0"
      id="Fact002228"
      unitRef="USD">806813</us-gaap:ContractualObligation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2024-01-012024-06-30_custom_RothAddendumToLetterAgreementsMember"
      decimals="0"
      id="Fact002230"
      unitRef="USD">577513</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact002232">&lt;p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zdkAb54cSb3f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;15.
&lt;span id="xdx_828_zbfBiVyiddth"&gt;Equity&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Class
A and B Common Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is authorized to issue up to &lt;span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20240630__srt--RangeAxis__srt--MaximumMember_zHIcCpr8NFlh" title="Common stock, shares authorized"&gt;275,000,000&lt;/span&gt; shares, consisting of &lt;span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zMQ5l6dB7Joe" title="Common stock, shares authorized"&gt;25,000,000&lt;/span&gt; Class A Common Stock, and &lt;span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zf90ckTdESJ2" title="Common stock, shares authorized"&gt;25,000,000&lt;/span&gt; shares of Class
B Common Stock par value $&lt;span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240630_zRNZw8RL83Ai" title="Common stock par value"&gt;0.0001&lt;/span&gt; per share. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
discussed in &lt;i&gt;Note 4 - Reverse Merger Capitalization with 7GC &amp;amp; Co. Holdings Inc.&lt;/i&gt;, the Company has retroactively adjusted the
shares issued and outstanding prior to December 14, 2023 to give effect to the Exchange Ratio to determine the number of shares of Company
Common Stock into which they were converted.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--CommonStockVotingRights_c20240101__20240630_zvXWfNNIZuqg" title="Common stock voting rights"&gt;The
Class A Common Stock and Class B Common Stock entitle their holders to one vote per share and ten votes per share, respectively, on each
matter properly submitted to the stockholders entitled to vote thereon.&lt;/span&gt; The holders of shares of Common Stock shall be entitled to receive
dividends declared by the Board of Directors, on a pro rata basis based on the number of shares of Common Stock held by each such holder,
assuming conversion of all Class B Common Stock into Class A Common Stock at a one to one conversion ratio.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were &lt;span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_pid_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ziV8pBaLF7T5" title="Common stock, shares issued"&gt;&lt;span id="xdx_907_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zLyw705tzwkd" title="Common stock, shares outstanding"&gt;3,003,810&lt;/span&gt;&lt;/span&gt; shares (&lt;span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zDwKubyT9o5" title="Common stock, shares outstanding"&gt;&lt;span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zLqFkvrHH971" title="Common stock shares issued"&gt;692,676&lt;/span&gt;&lt;/span&gt; Class A common stock and &lt;span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zKwudnOocc0c" title="Common stock, shares outstanding"&gt;&lt;span id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_pid_c20240630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z7sS5J1JqQ2b" title="Common stock, shares issued"&gt;2,311,134&lt;/span&gt;&lt;/span&gt; Class B common stock) issued and outstanding at June 30, 2024 and
&lt;span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zbf7H8Nnhtu3" title="Common stock, shares issued"&gt;&lt;span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zGb0uJ7jMVBj" title="Common stock, shares outstanding"&gt;2,585,296&lt;/span&gt;&lt;/span&gt; shares (&lt;span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zLttB8Bdgona" title="Common stock, shares issued"&gt;&lt;span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zywNMmS8CpT5" title="Common stock, shares outstanding"&gt;274,162&lt;/span&gt;&lt;/span&gt; Class A common stock and &lt;span id="xdx_904_eus-gaap--CommonStockSharesIssued_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z80m3ykMyX2i" title="Common stock, shares issued"&gt;&lt;span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zY2nAXNp9kye" title="Common stock, shares outstanding"&gt;2,311,134 &lt;/span&gt;&lt;/span&gt;Class B common stock) issued and outstanding at December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;May
22, 2024 Equity Financing&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 22, 2024, Banzai entered into a securities purchase agreement with accredited investors, providing for the issuance and sale of &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240522__20240522__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zjLhmT58Iypi" title="Issuane of stock, shares"&gt;104,556&lt;/span&gt;
shares of the Company&#x2019;s Class A common stock (&#x201c;Common Stock&#x201d;) &lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240522__us-gaap--ClassOfWarrantOrRightAxis__custom--PrefundedWarrantsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zRLvpxaQ4hPj" title="Issuane of warrants"&gt;173,222&lt;/span&gt; pre-funded warrants (the &#x201c;Pre-Funded
Warrants&#x201d;), and &lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240522__us-gaap--ClassOfWarrantOrRightAxis__custom--CommonWarrantsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zdoDcU9d65Sd" title="Issuane of warrants"&gt;277,778&lt;/span&gt; common warrants (the &#x201c;Common Warrants&#x201d;) in a registered direct offering priced at-the-market
under Nasdaq rules for a purchase price of $&lt;span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20240522__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zmRWwyMh2u78" title="Share price"&gt;9.00&lt;/span&gt; per share (the &#x201c; May 2024 Offering&#x201d;). The Common Warrants have an exercise
price of $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240522__us-gaap--ClassOfWarrantOrRightAxis__custom--CommonWarrantsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zi4KXkhoBO3b" title="Warrants exercise price"&gt;9.00&lt;/span&gt; per share and the Pre-Funded Warrants have an exercise price of $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20240522__us-gaap--ClassOfWarrantOrRightAxis__custom--PrefundedWarrantsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zgvDof97n4ph" title="Warrants exercise price"&gt;0.0050&lt;/span&gt; per share, are initially exercisable immediately
on the date of issuance (the &#x201c;Initial Exercise Date&#x201d;). The Common Warrants expire five years from the Initial Exercise Date
while the Pre-Funded Warrants do not expire. The aggregate gross proceeds to the Company from the May 2024 Offering were approximately
$&lt;span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfWarrants_pn5n6_c20240522__20240522__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zHqubxEykdp9" title="Proceeds from issuance of warrants"&gt;2.5&lt;/span&gt; million. The Company used the net proceeds from the May 2024 Offering for working capital and general corporate purposes. The closing
of the sale of these securities occurred on May 28, 2024. The securities were issued pursuant to the Company&#x2019;s registration statement
on Form S-1/A filed with the SEC on May 16, 2024 (File No. 333-278871) and became effective on May 21, 2024. As of June 30, 2024 all
Pre-Funded warrants were exercised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A.G.P./Alliance
Global Partners (&#x201c;AGP&#x201d;) acted as placement agent for the May 2024 Offering, pursuant to a placement agency agreement, dated
May 22, 2024, between the Company and AGP (the &#x201c;Placement Agency Agreement&#x201d;). Under the Placement Agency Agreement, AGP received
a fee in the form of &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_c20240522__20240522__dei--LegalEntityAxis__custom--AllianceGlobalPartnersMember_z6pPn2Uy1Uqk" title="Securities purchase price and percentage description"&gt;(a) a cash fee equal to 7.0% of the aggregate purchase price paid by each purchaser of securities that were sold
in the May 2024 Offering (the &#x201c;Cash Fee&#x201d;); provided, however, that the Cash Fee was reduced by an amount equal to $&lt;span id="xdx_90E_eus-gaap--LegalFees_c20240522__20240522_zm1tlm0FYFT3" title="Cash fee payments"&gt;25,000&lt;/span&gt;
to be paid to the Company&#x2019;s financial advisor, and (b) warrants (the &#x201c;Placement Agent Warrants&#x201d;) to purchase Class
A Common Stock equal to 6% of the aggregate number of shares of Class A Common Stock sold in the May 2024 Offering at an exercise price
per share equal to 110% of the price per share of Class A Common Stock sold in the May 2024 Offering. The Company recognized the Placement
Agent Warrants as a stock issuance cost as they are issued for services in connection with an offering.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company additionally incurred approximately $&lt;span id="xdx_90D_eus-gaap--LegalFees_c20240522__20240522__dei--LegalEntityAxis__custom--AllianceGlobalPartnersMember_zUOUYBQWKaZa" title="Cash fee payments"&gt;409,000&lt;/span&gt; of legal fees associated with the May 2024 Offering which is recognized as a stock
issuance cost and reflected as a reduction within additional paid-in capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;May
22, 2024 Common Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
discussed above, on May 22, 2024, in conjunction with the issuance and sale of &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240522__20240522__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zMQff4HHtE86" title="Issuane of stock, shares"&gt;104,556&lt;/span&gt; shares of the Company&#x2019;s Class A common
stock, the Company issued &lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240522__us-gaap--ClassOfWarrantOrRightAxis__custom--CommonWarrantsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z3SiPonKM4x6" title="Issuane of warrants"&gt;277,778&lt;/span&gt; Common Warrants which did not meet the definition of a liability pursuant to ASC 480 and met all
of the requirements for equity classification under ASC 815 as such were classified in stockholder&#x2019;s equity. The measurement of
fair value of the Common Warrants were determined utilizing a Black-Scholes model considering all relevant assumptions current at the
date of issuance (i.e., share price of $&lt;span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240522__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--CommonWarrantsMember_zOiCcS9EeZk6"&gt;9.00&lt;/span&gt;, exercise price of $&lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240522__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--CommonWarrantsMember_zXXaMsIdtcj2"&gt;9.00&lt;/span&gt;, term of &lt;span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240522__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--CommonWarrantsMember_zkfPCBT91bM7"&gt;five years&lt;/span&gt;, volatility of &lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240522__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--CommonWarrantsMember_z4YTWG8P2nT5"&gt;87&lt;/span&gt;%, risk-free rate of &lt;span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240522__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--CommonWarrantsMember_zwggixQF2DWj"&gt;4.6&lt;/span&gt;%,
and expected dividend rate of &lt;span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240522__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--CommonWarrantsMember_zFGQmohCa29e"&gt;0&lt;/span&gt;%). The relative fair value of these Common Warrants, net of issuance costs, on date of issuance was estimated
to be approximately $&lt;span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240522__us-gaap--ClassOfWarrantOrRightAxis__custom--CommonWarrantsMember_zriQXtRE8HX1" title="Net of issuance costs"&gt;722,000&lt;/span&gt; and is reflected within additional paid-in capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;May
22, 2024 Pre-Funded Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
discussed above, on May 22, 2024, in conjunction with the issuance and sale of &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240522__20240522__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zOSjRlMwZo9l" title="Issuane of stock, shares"&gt;104,556&lt;/span&gt; shares of the Company&#x2019;s Class A common
stock, the Company issued &lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240522__us-gaap--ClassOfWarrantOrRightAxis__custom--PrefundedWarrantsMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zcVTi0XeMCw" title="Issuane of warrants"&gt;173,222&lt;/span&gt; Pre-Funded Warrants which did not meet the definition of a liability pursuant to ASC 480 and met
all of the requirements for equity classification under ASC 815 as such were classified in stockholder&#x2019;s equity. were classified
in stockholder&#x2019;s equity. The measurement of fair value of the Pre-Funded Warrants were determined as the intrinsic value calculated
as the common stock price on the issuance date minus the exercise price. The relative fair value of these Pre-Funded Warrants, net of
issuance costs, on date of issuance was estimated to be approximately $&lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240522__us-gaap--ClassOfWarrantOrRightAxis__custom--PrefundedWarrantsMember_zG4QYtLHPgFl" title="Net of issuance costs"&gt;660,000&lt;/span&gt; and is reflected within additional paid-in capital. On
May 28, 2024 the Pre-Funded warrants were exercised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;May
22, 2024 Placement Agent Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
discussed above, on May 22, 2024, in conjunction with the issuance and sale of &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240522__20240522__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zs1b8vEdF2sb" title="Issuane of stock, shares"&gt;104,556&lt;/span&gt; shares of the Company&#x2019;s Class A common
stock and Pre-Funded Warrants, the Company issued &lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240522__us-gaap--ClassOfWarrantOrRightAxis__custom--PlacementAgentWarrantsMember_z9v5dtT17eO4" title="Issuane of warrants"&gt;16,667&lt;/span&gt; Placement Agent Warrants. As the Placement Agent Warrants were issued for services
provided in facilitating the May 2024 Offering, the Company recorded the fair value of such Placement Agent Warrants of approximately
$&lt;span id="xdx_902_eus-gaap--WarrantsAndRightsOutstanding_iI_c20240522__us-gaap--ClassOfWarrantOrRightAxis__custom--PlacementAgentWarrantsMember_zwNxnPP0FlD1" title="Net of issuance costs"&gt;100,000&lt;/span&gt; as a cost of capital on the issuance date. The measurement of fair value was determined utilizing a Black-Scholes model considering
all relevant assumptions current at the date of issuance (i.e., share price of $&lt;span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240522__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PlacementAgentWarrantsMember_zwT19QRUkD1k" title="Warrants and rights outstanding measurement input"&gt;9.00&lt;/span&gt;, exercise price of $&lt;span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240522__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PlacementAgentWarrantsMember_zw7XVL33a4Ai" title="Warrants and rights outstanding measurement input"&gt;9.00&lt;/span&gt;, term of &lt;span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240522__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PlacementAgentWarrantsMember_z2zmhnhVMrX8" title="Warrants and rights outstanding measurement input"&gt;five years&lt;/span&gt;, volatility
of &lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240522__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PlacementAgentWarrantsMember_zs7V8B2Wjwrf" title="Warrants and rights outstanding measurement input"&gt;87&lt;/span&gt;%, risk-free rate of &lt;span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240522__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PlacementAgentWarrantsMember_zyZR1uepe8dg" title="Warrants and rights outstanding measurement input"&gt;4.6&lt;/span&gt;%, and expected dividend rate of &lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20240522__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--ClassOfWarrantOrRightAxis__custom--PlacementAgentWarrantsMember_zgpFYEsXufr4" title="Warrants and rights outstanding measurement input"&gt;0&lt;/span&gt;%).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Preferred
Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is authorized to issue &lt;span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240630_zcRNfvNm40D" title="Preferred stock, shares authorized"&gt;75,000,000&lt;/span&gt; shares of preferred stock with a par value of $&lt;span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240630_zFCh5Xt76zog" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share. The board of directors of
the Company (the &#x201c;Board&#x201d;) has the authority to issue preferred stock and to determine the rights, privileges, preferences,
restrictions, and voting rights of those shares. As of June 30, 2024 and December 31, 2023, &lt;span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20240630_zJvPpLmDdUl1" title="Preferred stock, shares outstanding"&gt;&lt;span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20231231_z8xd1QFqkCCi" title="Preferred stock, shares outstanding"&gt;no&lt;/span&gt;&lt;/span&gt; shares of preferred stock were outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Yorkville
Standby Equity Purchase Agreement (&#x201c;SEPA&#x201d;) &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December&#x202f;14, 2023, the Company entered into the SEPA with YA II PN, LTD, a Cayman Islands exempt limited partnership managed by
Yorkville Advisors Global, LP (&#x201c;Yorkville&#x201d;) in connection with the Merger. Pursuant to the SEPA, subject to certain conditions,
the Company shall have the option, but not the obligation, to sell to Yorkville, and Yorkville shall subscribe for, an aggregate amount
of up to up to $&lt;span id="xdx_909_eus-gaap--AssetAcquisitionConsiderationTransferred_c20231214__20231214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zI8wFQ23YhJa" title="Total consideration payable in shares of class A common stock"&gt;100,000,000&lt;/span&gt; of the Company&#x2019;s shares of Class A common stock, par value $&lt;span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zETWEDmclH8l" title="Common stock par value"&gt;0.0001&lt;/span&gt; per share, at the Company&#x2019;s
request any time during the commitment period commencing on December 14, 2023 and terminating on the 36-month anniversary of the SEPA
(the &#x201c;SEPA Option&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
advance (each, an &#x201c;Advance&#x201d;) the Company requests under the SEPA (notice of such request, an &#x201c;Advance Notice&#x201d;)
may be for a number of shares of Class A common stock up to the greater of (i) &lt;span id="xdx_904_eus-gaap--InvestmentCompanyExpenseLimitationAgreementDescription_c20240101__20240630__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zuRHk1On7Oi9" title="Description of equity facility financing agreement"&gt;10,000&lt;/span&gt; shares or (ii) such amount as is equal to 100%
of the average daily volume traded of the Class A common stock during the five trading days immediately prior to the date the Company
requests each Advance; provided, in no event shall the number of shares of Class A common stock issued cause the aggregate shares of
Class A common stock held by Yorkville and its affiliates as of any such date to exceed &lt;span id="xdx_90C_ecustom--PercentageOfSharesOutstandingAtTheDateOfAdvanceNotice_pid_dp_uPure_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zPlKgDwj679f" title="Description of equity facility financing agreement"&gt;9.99&lt;/span&gt;% of the total number of shares of Class
A common stock outstanding as of the date of the Advance Notice (less any such shares held by Yorkville and its affiliates as of such
date) (the &#x201c;Exchange Cap&#x201d;). The shares would be purchased, at the Company&#x2019;s election, at a purchase price equal to
either:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--PercentageOfAverageDailyVolumeWeightedAveragePrice_pid_dp_uPure_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zl9nCdFSwEx3" title="Percentage of average daily Volume Weighted Average Price"&gt;95&lt;/span&gt;%
                                            of the average daily Volume Weighted Average Price (&#x201c;VWAP&#x201d;) of the Class A Common
                                            Stock on the Nasdaq Stock Market (&#x201c;Nasdaq&#x201d;), subject to certain conditions per
                                            the SEPA (the &#x201c;Option 1 Pricing Period; or&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48.95pt; text-align: justify; text-indent: -24.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--PercentageOfLowestDailyVolumeWeightedAveragePrice_pid_dp_uPure_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zfKkSTYIUP73" title="Percentage of lowest daily Volume Weighted Average Price"&gt;96&lt;/span&gt;%
                                            of the lowest daily VWAP of the Class A Common Stock during the three trading days commencing
                                            on the Advance Notice date, subject to certain conditions per the SEPA (the &#x201c;Option
                                            2 Pricing Period&#x201d;).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Any
purchase under an Advance would be subject to certain limitations, including that Yorkville shall not purchase or acquire any shares
that would result in it and its affiliates beneficially owning more than &lt;span id="xdx_906_ecustom--PurchaseOfStockPercentageOfVotingPowerOwnershipLimitation_iI_pid_dp_uPure_c20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zFg70kai65Yh" title="Percentage of voting power"&gt;9.99&lt;/span&gt;% of the then outstanding voting power or number of shares
of Class A common stock or any shares that, aggregated with shares issued under all other earlier Advances, would exceed &lt;span id="xdx_90C_ecustom--PurchaseOfStockPercentageOfOutstandingSharesOwnershipLimitation_iI_pid_dp_uPure_c20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zKDuMgke1B2f" title="Percentage of outstanding shares"&gt;&lt;span id="xdx_90D_ecustom--PurchaseOfStockPercentageOfOutstandingSharesOwnershipLimitation_iI_pid_dp_uPure_c20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z7nFL5B9gGjb" title="Percentage of outstanding shares"&gt;19.99&lt;/span&gt;&lt;/span&gt;% of all
shares of Class A common stock and Class B common stock of the Company, par value $&lt;span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zQG1DeOmYK48" title="Common stock par value"&gt;&lt;span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zT3M1FzQhuZh" title="Common stock par value"&gt;0.0001&lt;/span&gt;&lt;/span&gt; per share, outstanding on the date of the SEPA,
unless Company securityholder approval was obtained allowing for issuances in excess of such amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
SEPA Option was determined to be a freestanding financial instrument which did not meet the criteria to be accounted for as a derivative
instrument or to be recognized within equity. Pursuant to ASC 815 &lt;i&gt;Derivatives and Hedging &lt;/i&gt;(&#x201c;ASC 815&#x201d;), the Company
will therefore recognize the SEPA Option as an asset or liability, measured at fair value at the date of issuance, December 14, 2023,
and in subsequent reporting periods, with changes in fair value recognized in earnings. The SEPA Option was determined to have a fair
value of $&lt;span id="xdx_90B_ecustom--FairValueOfStandbyEquityPurchaseAgreement_iI_c20231231__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zDHXLDLGs5c4" title="Fair Value Of Standby Equity Purchase Agreement"&gt;&lt;span id="xdx_90C_ecustom--FairValueOfStandbyEquityPurchaseAgreement_iI_c20240630__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zWId5XHje9oc" title="Fair Value Of Standby Equity Purchase Agreement"&gt;0&lt;/span&gt;&lt;/span&gt; on the date of issuance as well as at December 31, 2023 and June 30, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the execution of the SEPA, the Company agreed to pay a commitment fee of $&lt;span id="xdx_900_ecustom--CommitmentFeePayable_iI_c20240630__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zVJ49MRzXIHl" title="Stock issued during period value acquisitions"&gt;500,000&lt;/span&gt; to Yorkville at the earlier of (i)
March 14, 2024 or (ii) the termination of the SEPA, which will be payable, at the option of the Company, in cash or shares of Class A
common stock through an Advance (the &#x201c;Deferred Fee&#x201d;). In March 2024 the Company issued &lt;span id="xdx_908_ecustom--SharesIssuedAsPaymentOfDeferredFee_c20240301__20240331__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zre4o7xFIghb" title="Stock issued during period value acquisitions"&gt;14,201&lt;/span&gt; Class A common stock as payment
for the Deferred Fee.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the terms of the SEPA, at any time that there is a balance outstanding under the Yorkville Promissory Notes, Yorkville has the right
to receive shares to pay down the principal balance, and may select the timing and delivery of such shares (via an &#x201c;Investor Notice&#x201d;),
in an amount up to the outstanding principal balance on the Yorkville Promissory Notes at a purchase price equal to the lower of (i)
$&lt;span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_zUnDw4LoKLfa" title="Common stock price per share"&gt;500.00&lt;/span&gt; per share of Class A common stock (the &#x201c;Fixed Price&#x201d;), or (ii) &lt;span id="xdx_90A_ecustom--PercentageOfLowestDailyVolumeWeightedAveragePrice_pid_dp_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zK1eRrlAE2j2" title="Percentage of lowest daily Volume Weighted Average Price"&gt;90&lt;/span&gt;% of the lowest daily Volume Weighted Average Price
(&#x201c;VWAP&#x201d;) of the Class A common stock on Nasdaq during the 10 consecutive Trading Days immediately preceding the Investor
Notice date or other date of determination (the &#x201c;Variable Price&#x201d;). The Variable Price shall not be lower than $&lt;span id="xdx_90C_ecustom--MaximumFloorPrice_iI_pid_c20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zhdx7KGdDHk7" title="Maximum floor price"&gt;100.00&lt;/span&gt; per share
(the &#x201c;Floor Price&#x201d;). &lt;span id="xdx_90F_ecustom--FloorPriceAdjustment_pid_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zCYqyOMp8NRc" title="Floor price adjustment"&gt;The Floor Price shall be adjusted (downwards only) to equal 20% of the average VWAP for the five trading
days immediately prior to the date of effectiveness of the initial Registration Statement.&lt;/span&gt; Notwithstanding the foregoing, the Company
may reduce the Floor Price to any amount via written notice to Yorkville, provided that such amount is no more than &lt;span id="xdx_901_ecustom--MaximumPercentageOfClosingPriceOnTradingDay_pid_dp_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zTL8XBNvClx4" title="Maximum percentage of closing price on trading day"&gt;75&lt;/span&gt;% of the closing
price on the Trading Day immediately prior to the time of such reduction and no greater than $&lt;span id="xdx_90A_eus-gaap--CommonStockConvertibleConversionPriceIncrease_pid_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zI6bWscffJXh" title="Maximum conversion price"&gt;100.00&lt;/span&gt; per share of Class A common stock
(the &#x201c;Conversion Price&#x201d;). At any time that there is a balance outstanding under the Yorkville Promissory Notes, the Company
is not permitted to issue Advance Notices under the SEPA unless an Amortization Event has occurred under the terms of the Yorkville Promissory
Notes agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were no Advance Notices issued pursuant to the SEPA during the period ended June 30, 2024 or as of the date that these financial statements
were issued, apart from the Premium Advance which was issued pursuant to the terms of the Amended Debt Agreement (see &lt;i&gt;Note 11 - Debt&lt;/i&gt;)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-06-30_srt_MaximumMember"
      decimals="INF"
      id="Fact002234"
      unitRef="Shares">275000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002236"
      unitRef="Shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact002238"
      unitRef="Shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002240"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockVotingRights contextRef="From2024-01-01to2024-06-30" id="Fact002242">The
Class A Common Stock and Class B Common Stock entitle their holders to one vote per share and ten votes per share, respectively, on each
matter properly submitted to the stockholders entitled to vote thereon.</us-gaap:CommonStockVotingRights>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember5488218"
      decimals="INF"
      id="Fact002244"
      unitRef="Shares">3003810</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonStockMember5488218"
      decimals="INF"
      id="Fact002246"
      unitRef="Shares">3003810</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002248"
      unitRef="Shares">692676</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-06-30_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002250"
      unitRef="Shares">692676</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact002252"
      unitRef="Shares">2311134</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact002254"
      unitRef="Shares">2311134</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember5488265"
      decimals="INF"
      id="Fact002256"
      unitRef="Shares">2585296</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember5488265"
      decimals="INF"
      id="Fact002258"
      unitRef="Shares">2585296</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002260"
      unitRef="Shares">274162</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002262"
      unitRef="Shares">274162</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact002264"
      unitRef="Shares">2311134</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact002266"
      unitRef="Shares">2311134</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-05-222024-05-22_us-gaap_CommonClassAMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002268"
      unitRef="Shares">104556</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-05-22_custom_PrefundedWarrantsMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002270"
      unitRef="Shares">173222</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-05-22_custom_CommonWarrantsMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002272"
      unitRef="Shares">277778</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SharePrice
      contextRef="AsOf2024-05-22_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002274"
      unitRef="USDPShares">9.00</us-gaap:SharePrice>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-05-22_custom_CommonWarrantsMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002276"
      unitRef="USDPShares">9.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-05-22_custom_PrefundedWarrantsMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002278"
      unitRef="USDPShares">0.0050</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2024-05-222024-05-22_custom_SecuritiesPurchaseAgreementMember"
      decimals="-5"
      id="Fact002280"
      unitRef="USD">2500000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
      contextRef="From2024-05-222024-05-22_custom_AllianceGlobalPartnersMember"
      id="Fact002282">(a) a cash fee equal to 7.0% of the aggregate purchase price paid by each purchaser of securities that were sold
in the May 2024 Offering (the &#x201c;Cash Fee&#x201d;); provided, however, that the Cash Fee was reduced by an amount equal to $25,000
to be paid to the Company&#x2019;s financial advisor, and (b) warrants (the &#x201c;Placement Agent Warrants&#x201d;) to purchase Class
A Common Stock equal to 6% of the aggregate number of shares of Class A Common Stock sold in the May 2024 Offering at an exercise price
per share equal to 110% of the price per share of Class A Common Stock sold in the May 2024 Offering. The Company recognized the Placement
Agent Warrants as a stock issuance cost as they are issued for services in connection with an offering.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <us-gaap:LegalFees
      contextRef="From2024-05-222024-05-22"
      decimals="0"
      id="Fact002284"
      unitRef="USD">25000</us-gaap:LegalFees>
    <us-gaap:LegalFees
      contextRef="From2024-05-222024-05-22_custom_AllianceGlobalPartnersMember"
      decimals="0"
      id="Fact002286"
      unitRef="USD">409000</us-gaap:LegalFees>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-05-222024-05-22_us-gaap_CommonClassAMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002288"
      unitRef="Shares">104556</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-05-22_custom_CommonWarrantsMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002290"
      unitRef="Shares">277778</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-05-22_us-gaap_MeasurementInputSharePriceMember_custom_CommonWarrantsMember"
      decimals="INF"
      id="Fact002291"
      unitRef="Pure">9.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-05-22_us-gaap_MeasurementInputExercisePriceMember_custom_CommonWarrantsMember"
      decimals="INF"
      id="Fact002292"
      unitRef="Pure">9.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-05-22_us-gaap_MeasurementInputPriceVolatilityMember_custom_CommonWarrantsMember"
      decimals="INF"
      id="Fact002294"
      unitRef="Pure">87</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-05-22_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_CommonWarrantsMember"
      decimals="INF"
      id="Fact002295"
      unitRef="Pure">4.6</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-05-22_us-gaap_MeasurementInputExpectedDividendRateMember_custom_CommonWarrantsMember"
      decimals="INF"
      id="Fact002296"
      unitRef="Pure">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-05-22_custom_CommonWarrantsMember"
      decimals="0"
      id="Fact002298"
      unitRef="USD">722000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-05-222024-05-22_us-gaap_CommonClassAMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002300"
      unitRef="Shares">104556</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-05-22_custom_PrefundedWarrantsMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002302"
      unitRef="Shares">173222</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-05-22_custom_PrefundedWarrantsMember"
      decimals="0"
      id="Fact002304"
      unitRef="USD">660000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-05-222024-05-22_us-gaap_CommonClassAMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002306"
      unitRef="Shares">104556</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-05-22_custom_PlacementAgentWarrantsMember"
      decimals="INF"
      id="Fact002308"
      unitRef="Shares">16667</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2024-05-22_custom_PlacementAgentWarrantsMember"
      decimals="0"
      id="Fact002310"
      unitRef="USD">100000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-05-22_us-gaap_MeasurementInputSharePriceMember_custom_PlacementAgentWarrantsMember"
      decimals="INF"
      id="Fact002312"
      unitRef="Pure">9.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-05-22_us-gaap_MeasurementInputExercisePriceMember_custom_PlacementAgentWarrantsMember"
      decimals="INF"
      id="Fact002314"
      unitRef="Pure">9.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-05-22_us-gaap_MeasurementInputPriceVolatilityMember_custom_PlacementAgentWarrantsMember"
      decimals="INF"
      id="Fact002318"
      unitRef="Pure">87</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-05-22_us-gaap_MeasurementInputRiskFreeInterestRateMember_custom_PlacementAgentWarrantsMember"
      decimals="INF"
      id="Fact002320"
      unitRef="Pure">4.6</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2024-05-22_us-gaap_MeasurementInputExpectedDividendRateMember_custom_PlacementAgentWarrantsMember"
      decimals="INF"
      id="Fact002322"
      unitRef="Pure">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002324"
      unitRef="Shares">75000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002326"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002328"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002330"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="From2023-12-142023-12-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact002332"
      unitRef="USD">100000000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact002334"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:InvestmentCompanyExpenseLimitationAgreementDescription
      contextRef="From2024-01-012024-06-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      id="Fact002336">10,000</us-gaap:InvestmentCompanyExpenseLimitationAgreementDescription>
    <BNZI:PercentageOfSharesOutstandingAtTheDateOfAdvanceNotice
      contextRef="From2023-12-142023-12-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact002338"
      unitRef="Pure">0.0999</BNZI:PercentageOfSharesOutstandingAtTheDateOfAdvanceNotice>
    <BNZI:PercentageOfAverageDailyVolumeWeightedAveragePrice
      contextRef="From2023-12-142023-12-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact002340"
      unitRef="Pure">0.95</BNZI:PercentageOfAverageDailyVolumeWeightedAveragePrice>
    <BNZI:PercentageOfLowestDailyVolumeWeightedAveragePrice
      contextRef="From2023-12-142023-12-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact002342"
      unitRef="Pure">0.96</BNZI:PercentageOfLowestDailyVolumeWeightedAveragePrice>
    <BNZI:PurchaseOfStockPercentageOfVotingPowerOwnershipLimitation
      contextRef="AsOf2023-12-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact002344"
      unitRef="Pure">0.0999</BNZI:PurchaseOfStockPercentageOfVotingPowerOwnershipLimitation>
    <BNZI:PurchaseOfStockPercentageOfOutstandingSharesOwnershipLimitation
      contextRef="AsOf2023-12-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact002346"
      unitRef="Pure">0.1999</BNZI:PurchaseOfStockPercentageOfOutstandingSharesOwnershipLimitation>
    <BNZI:PurchaseOfStockPercentageOfOutstandingSharesOwnershipLimitation
      contextRef="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact002348"
      unitRef="Pure">0.1999</BNZI:PurchaseOfStockPercentageOfOutstandingSharesOwnershipLimitation>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact002350"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact002352"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <BNZI:FairValueOfStandbyEquityPurchaseAgreement
      contextRef="AsOf2023-12-31_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact002354"
      unitRef="USD">0</BNZI:FairValueOfStandbyEquityPurchaseAgreement>
    <BNZI:FairValueOfStandbyEquityPurchaseAgreement
      contextRef="AsOf2024-06-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact002356"
      unitRef="USD">0</BNZI:FairValueOfStandbyEquityPurchaseAgreement>
    <BNZI:CommitmentFeePayable
      contextRef="AsOf2024-06-30_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact002358"
      unitRef="USD">500000</BNZI:CommitmentFeePayable>
    <BNZI:SharesIssuedAsPaymentOfDeferredFee
      contextRef="From2024-03-012024-03-31_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002360"
      unitRef="Shares">14201</BNZI:SharesIssuedAsPaymentOfDeferredFee>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember_custom_ClassACommonStockMember"
      decimals="INF"
      id="Fact002362"
      unitRef="USDPShares">500.00</us-gaap:SharesIssuedPricePerShare>
    <BNZI:PercentageOfLowestDailyVolumeWeightedAveragePrice
      contextRef="From2023-12-142023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact002364"
      unitRef="Pure">0.90</BNZI:PercentageOfLowestDailyVolumeWeightedAveragePrice>
    <BNZI:MaximumFloorPrice
      contextRef="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember_srt_MaximumMember"
      decimals="INF"
      id="Fact002366"
      unitRef="USDPShares">100.00</BNZI:MaximumFloorPrice>
    <BNZI:FloorPriceAdjustment
      contextRef="From2023-12-142023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      id="Fact002368">The Floor Price shall be adjusted (downwards only) to equal 20% of the average VWAP for the five trading
days immediately prior to the date of effectiveness of the initial Registration Statement.</BNZI:FloorPriceAdjustment>
    <BNZI:MaximumPercentageOfClosingPriceOnTradingDay
      contextRef="From2023-12-142023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact002370"
      unitRef="Pure">0.75</BNZI:MaximumPercentageOfClosingPriceOnTradingDay>
    <us-gaap:CommonStockConvertibleConversionPriceIncrease
      contextRef="From2023-12-142023-12-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact002372"
      unitRef="USDPShares">100.00</us-gaap:CommonStockConvertibleConversionPriceIncrease>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact002374">&lt;p id="xdx_800_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zTqPyVtDtqT2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;16.
&lt;span id="xdx_82B_znswe4VnJuKb"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2023, the Company adopted the 2023 Employee Stock Purchase Plan (the &#x201c;Purchase Plan&#x201d;). The Purchase Plan permits eligible
employees of the Company and certain designated companies as determined by the Board of Directors, to purchase shares of the Company&#x2019;s
Common Stock. &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_c20240101__20240630__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember_zrqfCK7M9DC5" title="Equity incentive plan, description"&gt;The aggregate number of shares of common stock that may be purchased pursuant to the Purchase Plan is equal to 2% of the
fully diluted common stock determined at the Close of the Merger Agreement, determined to be &lt;span id="xdx_90B_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20240630__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6sGGBtPnep2" title="Common stock reserved for future issuance"&gt;11,443&lt;/span&gt;. In addition, the aggregate number
of shares of common stock that remain available to be awarded under the Purchase Plan, will automatically increase on January 1 of each
year for a period of &lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dtY_c20240101__20240630__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember_zlIIfcSmaMa9" title="Expiration period"&gt;10&lt;/span&gt; years commencing on January 1, 2024 and ending on &lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20240101__20240630__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember_zylxhunz8z2j" title="Expiration date"&gt;January 1, 2033&lt;/span&gt;, in an amount equal to the lesser of one percent
(1%) of the total number of shares of the fully diluted common stock determined as of December 31 of the preceding year, or a number
of shares of common stock equal to two hundred percent (200%) of the initial share reserve of &lt;span id="xdx_909_ecustom--InitialShareReserve_iI_c20240630__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zPVtTrovjhZ5" title="Initial share reserve"&gt;11,443&lt;/span&gt;&lt;/span&gt;. As of June 30, 2024 and December
31, 2023, &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20240630__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNh9Qz4RtAC6" title="Stock options awarded"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjOqbCgiCNLe" title="Stock options awarded"&gt;11,443&lt;/span&gt;&lt;/span&gt; shares of common stock remain available to be purchased under the Purchase Plan, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2023, the Company adopted the 2023 Equity Incentive Plan (the &#x201c;Plan&#x201d;). The Plan permits the granting of incentive stock options,
nonstatutory stock options, SARs, restricted stock awards, RSU awards, performance awards, and other awards. to employees, directors,
and consultants. &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_c20240101__20240630__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityIncentivePlanMember_zicLlOyNZ8fl" title="Equity incentive plan, description"&gt;The aggregate number of shares of common stock that may be issued will not exceed approximately 12.5% of the fully diluted
common stock determined at the Close of the Merger, determined to be &lt;span id="xdx_90E_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20240630__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityIncentivePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhj5R78tjvjj" title="Common stock reserved for future issuance"&gt;71,522&lt;/span&gt;. In addition, the aggregate number of shares of common
stock that remain available to be awarded under the Plan, will automatically increase on January 1 of each year for a period of &lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c20240101__20240630__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityIncentivePlanMember_zyXWqhQXqXff" title="Expiration period"&gt;ten years&lt;/span&gt;
commencing on January 1, 2024 and ending on &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20240101__20240630__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityIncentivePlanMember_zUXPYO0Aa8f8" title="Expiration date"&gt;January 1, 2033&lt;/span&gt;, in an amount equal to 5% of the total number of shares of the fully diluted
common stock determined as of the day prior to such increase. The aggregate maximum number of shares of common stock that may be issued
pursuant to the exercise of incentive stock options is approximately three times the total number of shares of common stock initially
reserved for issuance, which were &lt;span id="xdx_902_ecustom--InitialShareReserve_iI_c20240630__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityIncentivePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwbSch5zBs5" title="Initial share reserve"&gt;71,522&lt;/span&gt;.&lt;/span&gt; As of June 30, 2024 and December 31, 2023, &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20240630__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityIncentivePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKTs4TbhTP3i" title="Stock options awarded"&gt;35,276&lt;/span&gt; and &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityIncentivePlanMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxI7HiyuGM75" title="Stock options awarded"&gt;71,522&lt;/span&gt; stock options remain
available to be awarded under the Plan, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for stock-based payments pursuant to ASC 718 &lt;i&gt;Stock Compensation&lt;/i&gt; and, accordingly, the Company records compensation
expense for stock-based awards based upon an assessment of the grant date fair value for options using the Black-Scholes option pricing
model. The Company has concluded that its historical share option exercise experience does not provide a reasonable basis upon which
to estimate expected term. Therefore, the expected term was determined according to the simplified method, which is the average of the
vesting tranche dates and the contractual term. Due to the lack of company specific historical and implied volatility data, the estimate
of expected volatility is primarily based on the historical volatility of a group of similar companies that are publicly traded. For
these analyses, companies with comparable characteristics were selected, including enterprise value and position within the industry,
and with historical share price information sufficient to meet the expected life of the share-based awards. The Company computes the
historical volatility data using the daily closing prices for the selected companies&#x2019; shares during the equivalent periods of the
calculated expected term of its share-based awards. The risk-free interest rate is determined by reference to the U.S. Treasury zero-coupon
issues with remaining maturities similar to the expected term of the options. Expected dividend yield is zero based on the fact that
the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zcBZyKZItnZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes assumptions used to compute the fair value of options granted:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B6_z8eQEuIZYhre"&gt;Summary
of Assumptions Used to Compute Fair Value&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Stock price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90B_eus-gaap--SharePrice_iI_pid_c20240630__srt--RangeAxis__srt--MinimumMember_zKnVSsTJ3p3h" title="Stock price"&gt;0.29&lt;/span&gt;
                                            - &lt;span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20240630__srt--RangeAxis__srt--MaximumMember_zC1uihqzflk6" title="Stock price"&gt;0.61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_901_eus-gaap--SharePrice_iI_pid_c20230630__srt--RangeAxis__srt--MinimumMember_zDPEvcLFqj38" title="Stock price"&gt;8.22&lt;/span&gt;
                                            - &lt;span id="xdx_908_eus-gaap--SharePrice_iI_pid_c20230630__srt--RangeAxis__srt--MaximumMember_z9hzqgL7ZZ43" title="Stock price"&gt;9.56&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%"&gt;Exercise price&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20240630__srt--RangeAxis__srt--MinimumMember_zDkSErL7se55" title="Exercise price"&gt;0.29&lt;/span&gt;
                                            - &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20240630__srt--RangeAxis__srt--MaximumMember_zWgqRPnwZjW3" title="Exercise price"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20230630_zAq6pJIPCpRc" title="Exercise price"&gt;11.98&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20240101__20240630_zmLwpcYhAyvi" title="Expected volatility"&gt;75.00&lt;/span&gt;
                                            - &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20240101__20240630_zBbOPcTrPb6e" title="Expected volatility"&gt;85.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20230630_ztU2OrJtNMkb" title="Expected volatility"&gt;80.00&lt;/span&gt;
                                            - &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20230630_zD26RurgFh45" title="Expected volatility"&gt;99.03&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pid_dtY_c20240101__20240630__srt--RangeAxis__srt--MinimumMember_zAyKCJ8htZgg" title="Expected term (in years)"&gt;5.75&lt;/span&gt;
                                            - &lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pid_dtY_c20240101__20240630__srt--RangeAxis__srt--MaximumMember_zzIhM7YJ3Bla" title="Expected term (in years)"&gt;10.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pid_dtY_c20230101__20230630__srt--RangeAxis__srt--MinimumMember_zGfbXH3RdF08" title="Expected term (in years)"&gt;5.25&lt;/span&gt;
                                            - &lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pid_dtY_c20230101__20230630__srt--RangeAxis__srt--MaximumMember_zs49WzWRsND4" title="Expected term (in years)"&gt;6.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20240630_z52UaMDeDmJg" title="Risk-free interest rate"&gt;4.20&lt;/span&gt;
                                            - &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20240630_zCWv7c5xvbd8" title="Risk-free interest rate maximum"&gt;4.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20230630_zkH1MeiO33E2" title="Risk-free interest rate"&gt;3.46&lt;/span&gt;
                                            - &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20230630_zzA9zXVHeeql" title="Risk-free interest rate maximum"&gt;4.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zfyjogYqmo43" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zRi7V4xxubLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of stock option activity under the Plan is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_z2xXNhYxB3l9"&gt;Summary
of Stock Option Activity&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;br/&gt;
    Underlying&lt;br/&gt;
    Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt;
    Average&lt;br/&gt;
    Exercise &lt;br/&gt;
    Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt;
    Average&lt;br/&gt;
    Remaining&lt;br/&gt;
    Contractual&lt;br/&gt;
    Term&lt;br/&gt;
    (in years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Intrinsic&lt;br/&gt;
    Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; padding-bottom: 1pt"&gt;Outstanding at December 31, 2023&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240630_ztFvXyTUkkEh" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Shares Underlying Options, Beginning balanceShares Underlying Options, Beginning balance"&gt;14,962&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;p id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20240630_zcZbv8jfXCC7" style="margin: 0" title="Weighted Average Exercise Price, Beginning BalanceWeighted Average Exercise Price, Beginning Balance"&gt;293.50&lt;/p&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zvNfdpNyqkY1" title="Weighted Average Remaining Contractual Term (in years), Outstanding"&gt;8.43&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20240101__20240630_zRQpN65h5urh" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Intrinsic Value, Outstanding, Beginning balanceIntrinsic Value, Outstanding, Ending balance"&gt;103,662&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240630_zwkMAEfjeuP1" style="text-align: right" title="Shares Underlying Options, Granted"&gt;27,970&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240630_zPwx85o7rHpe" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;145.70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_dtY_c20240101__20240630_zQ7eoCRP4ai6" style="text-align: right" title="Weighted Average Remaining Contractual Term (in years), Granted"&gt;9.87&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240101__20240630_z47M5JFpyxOi" style="text-align: right" title="Shares Underlying Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2460"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240101__20240630_zOQ0e3fT0EVg" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2462"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20240101__20240630_zM0FaLfxBEu8" style="text-align: right" title="Shares Underlying Options, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2464"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240630_zM4R3CUA0DE2" style="text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2466"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20240101__20240630_zePYQvmI77Ej" style="border-bottom: Black 1pt solid; text-align: right" title="Shares Underlying Options, Forfeited"&gt;(9,283&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20240101__20240630_zvHUgT2WbE2j" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;239.11&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding at June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20240630_zsolsl68yANa" style="border-bottom: Black 1pt solid; text-align: right" title="Shares Underlying Options, Ending balance"&gt;33,649&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20240630_zLFbwQaEisH8" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Ending Balance"&gt;185.69&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240630_zl6iSIxevtXf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Remaining Contractual Term (in years), Outstanding"&gt;9.17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20240101__20240630_z2Qh7MYuIga2" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic Value, Outstanding, Ending balance"&gt;1,807&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Exercisable at June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240630_zFhHoXXnZrMk" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares Underlying Options, Exercisable"&gt;8,675&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20240630_zwQkFeP31cM9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable"&gt;248.23&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20240630_zdGlF7RP2ovb" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Remaining Contractual Term (in years), Exercisable"&gt;8.34&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20240630_z643nuIkXzV1" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic Value, Exercisable"&gt;1,807&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zct2ZpzojBE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with issuances under the Plan, the Company recorded stock-based compensation expense of $&lt;span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_c20240101__20240630__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zmSPeQ9U2y2f" title="Stock-based compensation expense"&gt;457,231&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20230630__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zm8KO38t0pdh" title="Stock-based compensation expense"&gt;620,987&lt;/span&gt;, which is included
in general and administrative expense for the six months ended June 30, 2024 and 2023, respectively. The weighted-average grant-date
fair value per option granted during the six months ended June 30, 2024 and 2023 was $&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240101__20240630_zx6pR0Z31TNj" title="Weighted average grant date fair value"&gt;8.60&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20230630_zqWL0nyiGWwl" title="Weighted average grant date fair value"&gt;426.61&lt;/span&gt;, respectively. As of June 30, 2024
and 2023, $&lt;span id="xdx_902_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20240630_zvtI79aihtla" title="Unrecognized compensation expense related to unvested options"&gt;1,262,655&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20230630_z9RUpZmElDaf" title="Unrecognized compensation expense related to unvested options"&gt;2,575,808&lt;/span&gt; of unrecognized compensation expense related to non-vested awards is expected to be recognized over
the weighted average period of &lt;span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20240101__20240630_zosGKmxhiMFd" title="Unrecognized compensation expense related to unvested options"&gt;3.80&lt;/span&gt; and &lt;span id="xdx_90B_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20230630_zo87KZsbIHxf" title="Unrecognized compensation expense related to unvested options"&gt;2.97&lt;/span&gt; years, respectively. The aggregate intrinsic value is calculated as the difference between
the fair value of the Company&#x2019;s stock price and the exercise price of the options.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;RSUs&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the three and six months ended June 30, 2024, the Company began issuing RSUs to employees and to non-employee directors. Each RSU entitles
the recipient to one share of Class A Common Stock upon vesting. We measure the fair value of RSUs using the stock price on the date
of grant. Stock-based compensation expense for employee-granted RSUs is recorded ratably over their vesting period of &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zDo4LX5DEgjb" title="Vesting period"&gt;four years&lt;/span&gt;. 25%
of the RSUs will vest on each anniversary of the vesting commencement date until the RSU is fully vested. Stock-based compensation expense
for non-employee director-granted RSUs is recorded ratably over their vesting period which is the earlier to occur of the one (1) year
anniversary of the respective grant date, or the next annual meeting of stockholders following the respective grant date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zcTlA4XasXGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the activity with respect to, and status of, RSUs during the six months ended June 30, 2024 is presented below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B8_z8pQSnAc30ee"&gt;Summary
of Activity with Respect Status of, RSUs&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Units&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted Average&lt;br/&gt;
    Grant Date &lt;br/&gt;
    Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding at December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHEzkZvRXUcd" style="border-bottom: Black 1pt solid; text-align: right" title="Units, Outstanding Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2508"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zFcfbUvIBGfi" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Beginning balance Outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2510"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%"&gt;Granted&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7ccu5Rb8gb6" style="width: 16%; text-align: right" title="Granted"&gt;17,851&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ziDCLAG2AbW8" style="width: 16%; text-align: right" title="Weighted Average Grant Date Fair Value, Granted"&gt;26.64&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQiNv5EWSxk4" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited"&gt;(293&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z15EJTNWn0V4" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited"&gt;14.65&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding at June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6bl6e9B6Imj" style="border-bottom: Black 2.5pt double; text-align: right" title="Units, Outstanding Ending Balance"&gt;17,558&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zw0X2jmXPgp5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Ending Balance Outstanding"&gt;26.84&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zmucrn9Mnjrh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the six months ended June 30, 2024, the Company recorded stock-based compensation expense of $&lt;span id="xdx_902_eus-gaap--AllocatedShareBasedCompensationExpense_c20240101__20240630__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7jOsh1Znuj9" title="Stock-based compensation expense"&gt;208,178&lt;/span&gt; which is included in general and
administrative expense for the six months ended June 30, 2024. As of June 30, 2024, unrecognized compensation cost related to the grant
of RSUs was $&lt;span id="xdx_90C_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_iI_c20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zqlBvxiLpIj8" title="Unrecognized compensation cost"&gt;263,144&lt;/span&gt;. Unvested outstanding RSUs as of June 30, 2024 had a weighted average remaining vesting period of &lt;span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zV4L6MPc06Yg" title="Period for unrecognized compensation expense related to unvested options yet has not been recognized"&gt;1.3&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms
      contextRef="From2024-01-012024-06-30_custom_TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember"
      id="Fact002376">The aggregate number of shares of common stock that may be purchased pursuant to the Purchase Plan is equal to 2% of the
fully diluted common stock determined at the Close of the Merger Agreement, determined to be 11,443. In addition, the aggregate number
of shares of common stock that remain available to be awarded under the Purchase Plan, will automatically increase on January 1 of each
year for a period of 10 years commencing on January 1, 2024 and ending on January 1, 2033, in an amount equal to the lesser of one percent
(1%) of the total number of shares of the fully diluted common stock determined as of December 31 of the preceding year, or a number
of shares of common stock equal to two hundred percent (200%) of the initial share reserve of 11,443</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2024-06-30_custom_TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002378"
      unitRef="Shares">11443</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="From2024-01-012024-06-30_custom_TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember"
      id="Fact002380">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2024-01-012024-06-30_custom_TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember"
      id="Fact002382">2033-01-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <BNZI:InitialShareReserve
      contextRef="AsOf2024-06-30_custom_TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002384"
      unitRef="Shares">11443</BNZI:InitialShareReserve>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2024-06-30_custom_TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002386"
      unitRef="Shares">11443</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2023-12-31_custom_TwoThousandAndTwentyThreeEquityEmployeeStockPurchaseMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002388"
      unitRef="Shares">11443</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms
      contextRef="From2024-01-012024-06-30_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember"
      id="Fact002390">The aggregate number of shares of common stock that may be issued will not exceed approximately 12.5% of the fully diluted
common stock determined at the Close of the Merger, determined to be 71,522. In addition, the aggregate number of shares of common
stock that remain available to be awarded under the Plan, will automatically increase on January 1 of each year for a period of ten years
commencing on January 1, 2024 and ending on January 1, 2033, in an amount equal to 5% of the total number of shares of the fully diluted
common stock determined as of the day prior to such increase. The aggregate maximum number of shares of common stock that may be issued
pursuant to the exercise of incentive stock options is approximately three times the total number of shares of common stock initially
reserved for issuance, which were 71,522.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2024-06-30_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002392"
      unitRef="Shares">71522</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="From2024-01-012024-06-30_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember"
      id="Fact002394">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2024-01-012024-06-30_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember"
      id="Fact002396">2033-01-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <BNZI:InitialShareReserve
      contextRef="AsOf2024-06-30_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002398"
      unitRef="Shares">71522</BNZI:InitialShareReserve>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2024-06-30_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002400"
      unitRef="Shares">35276</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2023-12-31_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002402"
      unitRef="Shares">71522</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact002404">&lt;p id="xdx_898_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zcBZyKZItnZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes assumptions used to compute the fair value of options granted:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B6_z8eQEuIZYhre"&gt;Summary
of Assumptions Used to Compute Fair Value&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Stock price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90B_eus-gaap--SharePrice_iI_pid_c20240630__srt--RangeAxis__srt--MinimumMember_zKnVSsTJ3p3h" title="Stock price"&gt;0.29&lt;/span&gt;
                                            - &lt;span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20240630__srt--RangeAxis__srt--MaximumMember_zC1uihqzflk6" title="Stock price"&gt;0.61&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_901_eus-gaap--SharePrice_iI_pid_c20230630__srt--RangeAxis__srt--MinimumMember_zDPEvcLFqj38" title="Stock price"&gt;8.22&lt;/span&gt;
                                            - &lt;span id="xdx_908_eus-gaap--SharePrice_iI_pid_c20230630__srt--RangeAxis__srt--MaximumMember_z9hzqgL7ZZ43" title="Stock price"&gt;9.56&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%"&gt;Exercise price&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20240630__srt--RangeAxis__srt--MinimumMember_zDkSErL7se55" title="Exercise price"&gt;0.29&lt;/span&gt;
                                            - &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20240630__srt--RangeAxis__srt--MaximumMember_zWgqRPnwZjW3" title="Exercise price"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20230630_zAq6pJIPCpRc" title="Exercise price"&gt;11.98&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20240101__20240630_zmLwpcYhAyvi" title="Expected volatility"&gt;75.00&lt;/span&gt;
                                            - &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20240101__20240630_zBbOPcTrPb6e" title="Expected volatility"&gt;85.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_pid_dp_uPure_c20230101__20230630_ztU2OrJtNMkb" title="Expected volatility"&gt;80.00&lt;/span&gt;
                                            - &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_pid_dp_uPure_c20230101__20230630_zD26RurgFh45" title="Expected volatility"&gt;99.03&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pid_dtY_c20240101__20240630__srt--RangeAxis__srt--MinimumMember_zAyKCJ8htZgg" title="Expected term (in years)"&gt;5.75&lt;/span&gt;
                                            - &lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pid_dtY_c20240101__20240630__srt--RangeAxis__srt--MaximumMember_zzIhM7YJ3Bla" title="Expected term (in years)"&gt;10.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pid_dtY_c20230101__20230630__srt--RangeAxis__srt--MinimumMember_zGfbXH3RdF08" title="Expected term (in years)"&gt;5.25&lt;/span&gt;
                                            - &lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_pid_dtY_c20230101__20230630__srt--RangeAxis__srt--MaximumMember_zs49WzWRsND4" title="Expected term (in years)"&gt;6.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240101__20240630_z52UaMDeDmJg" title="Risk-free interest rate"&gt;4.20&lt;/span&gt;
                                            - &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240101__20240630_zCWv7c5xvbd8" title="Risk-free interest rate maximum"&gt;4.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230101__20230630_zkH1MeiO33E2" title="Risk-free interest rate"&gt;3.46&lt;/span&gt;
                                            - &lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230101__20230630_zzA9zXVHeeql" title="Risk-free interest rate maximum"&gt;4.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2024-06-30_srt_MinimumMember"
      decimals="INF"
      id="Fact002406"
      unitRef="USDPShares">0.29</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2024-06-30_srt_MaximumMember"
      decimals="INF"
      id="Fact002408"
      unitRef="USDPShares">0.61</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2023-06-30_srt_MinimumMember"
      decimals="INF"
      id="Fact002410"
      unitRef="USDPShares">8.22</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2023-06-30_srt_MaximumMember"
      decimals="INF"
      id="Fact002412"
      unitRef="USDPShares">9.56</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2024-06-30_srt_MinimumMember"
      decimals="INF"
      id="Fact002414"
      unitRef="USDPShares">0.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2024-06-30_srt_MaximumMember"
      decimals="INF"
      id="Fact002416"
      unitRef="USDPShares">5.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2023-06-30"
      decimals="INF"
      id="Fact002418"
      unitRef="USDPShares">11.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact002420"
      unitRef="Pure">0.7500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact002422"
      unitRef="Pure">0.8500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2023-01-012023-06-30"
      decimals="INF"
      id="Fact002424"
      unitRef="Pure">0.8000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2023-01-012023-06-30"
      decimals="INF"
      id="Fact002426"
      unitRef="Pure">0.9903</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-01-012024-06-30_srt_MinimumMember"
      id="Fact002428">P5Y9M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-01-012024-06-30_srt_MaximumMember"
      id="Fact002430">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-06-30_srt_MinimumMember"
      id="Fact002432">P5Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-06-30_srt_MaximumMember"
      id="Fact002434">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact002436"
      unitRef="Pure">0.0420</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact002438"
      unitRef="Pure">0.0450</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2023-01-012023-06-30"
      decimals="INF"
      id="Fact002440"
      unitRef="Pure">0.0346</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2023-01-012023-06-30"
      decimals="INF"
      id="Fact002442"
      unitRef="Pure">0.0431</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact002444">&lt;p id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zRi7V4xxubLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of stock option activity under the Plan is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_z2xXNhYxB3l9"&gt;Summary
of Stock Option Activity&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Shares&lt;br/&gt;
    Underlying&lt;br/&gt;
    Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt;
    Average&lt;br/&gt;
    Exercise &lt;br/&gt;
    Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt;
    Average&lt;br/&gt;
    Remaining&lt;br/&gt;
    Contractual&lt;br/&gt;
    Term&lt;br/&gt;
    (in years)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Intrinsic&lt;br/&gt;
    Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; padding-bottom: 1pt"&gt;Outstanding at December 31, 2023&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20240101__20240630_ztFvXyTUkkEh" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Shares Underlying Options, Beginning balanceShares Underlying Options, Beginning balance"&gt;14,962&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;p id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240101__20240630_zcZbv8jfXCC7" style="margin: 0" title="Weighted Average Exercise Price, Beginning BalanceWeighted Average Exercise Price, Beginning Balance"&gt;293.50&lt;/p&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zvNfdpNyqkY1" title="Weighted Average Remaining Contractual Term (in years), Outstanding"&gt;8.43&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20240101__20240630_zRQpN65h5urh" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Intrinsic Value, Outstanding, Beginning balanceIntrinsic Value, Outstanding, Ending balance"&gt;103,662&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20240101__20240630_zwkMAEfjeuP1" style="text-align: right" title="Shares Underlying Options, Granted"&gt;27,970&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240630_zPwx85o7rHpe" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;145.70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_dtY_c20240101__20240630_zQ7eoCRP4ai6" style="text-align: right" title="Weighted Average Remaining Contractual Term (in years), Granted"&gt;9.87&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20240101__20240630_z47M5JFpyxOi" style="text-align: right" title="Shares Underlying Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2460"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240101__20240630_zOQ0e3fT0EVg" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2462"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Expired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20240101__20240630_zM0FaLfxBEu8" style="text-align: right" title="Shares Underlying Options, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2464"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240101__20240630_zM4R3CUA0DE2" style="text-align: right" title="Weighted Average Exercise Price, Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2466"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20240101__20240630_zePYQvmI77Ej" style="border-bottom: Black 1pt solid; text-align: right" title="Shares Underlying Options, Forfeited"&gt;(9,283&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20240101__20240630_zvHUgT2WbE2j" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;239.11&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding at June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20240101__20240630_zsolsl68yANa" style="border-bottom: Black 1pt solid; text-align: right" title="Shares Underlying Options, Ending balance"&gt;33,649&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240101__20240630_zLFbwQaEisH8" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Ending Balance"&gt;185.69&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240101__20240630_zl6iSIxevtXf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Remaining Contractual Term (in years), Outstanding"&gt;9.17&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20240101__20240630_z2Qh7MYuIga2" style="border-bottom: Black 1pt solid; text-align: right" title="Intrinsic Value, Outstanding, Ending balance"&gt;1,807&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Exercisable at June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240630_zFhHoXXnZrMk" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares Underlying Options, Exercisable"&gt;8,675&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20240630_zwQkFeP31cM9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Exercisable"&gt;248.23&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20240630_zdGlF7RP2ovb" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Remaining Contractual Term (in years), Exercisable"&gt;8.34&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20240630_z643nuIkXzV1" style="border-bottom: Black 2.5pt double; text-align: right" title="Intrinsic Value, Exercisable"&gt;1,807&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002446"
      unitRef="Shares">14962</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002448"
      unitRef="USDPShares">293.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2023-01-012023-12-31" id="Fact002450">P8Y5M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002452"
      unitRef="USD">103662</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact002454"
      unitRef="Shares">27970</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact002456"
      unitRef="USDPShares">145.70</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <BNZI:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm contextRef="From2024-01-01to2024-06-30" id="Fact002458">P9Y10M13D</BNZI:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact002468"
      unitRef="Shares">9283</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact002470"
      unitRef="USDPShares">239.11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002472"
      unitRef="Shares">33649</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002474"
      unitRef="USDPShares">185.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2024-01-01to2024-06-30" id="Fact002476">P9Y2M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact002478"
      unitRef="USD">1807</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002480"
      unitRef="Shares">8675</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002482"
      unitRef="USDPShares">248.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2024-01-01to2024-06-30" id="Fact002484">P8Y4M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact002486"
      unitRef="USD">1807</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-06-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact002488"
      unitRef="USD">457231</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-06-30_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact002490"
      unitRef="USD">620987</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact002492"
      unitRef="USDPShares">8.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-01-012023-06-30"
      decimals="INF"
      id="Fact002494"
      unitRef="USDPShares">426.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact002496"
      unitRef="USD">1262655</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact002498"
      unitRef="USD">2575808</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2024-01-01to2024-06-30" id="Fact002500">P3Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2023-01-012023-06-30" id="Fact002502">P2Y11M19D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="From2024-01-012024-06-30_us-gaap_RestrictedStockUnitsRSUMember5495062"
      id="Fact002504">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact002506">&lt;p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_zcTlA4XasXGa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of the activity with respect to, and status of, RSUs during the six months ended June 30, 2024 is presented below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B8_z8pQSnAc30ee"&gt;Summary
of Activity with Respect Status of, RSUs&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Units&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted Average&lt;br/&gt;
    Grant Date &lt;br/&gt;
    Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Outstanding at December 31, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHEzkZvRXUcd" style="border-bottom: Black 1pt solid; text-align: right" title="Units, Outstanding Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2508"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zFcfbUvIBGfi" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Beginning balance Outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2510"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 60%"&gt;Granted&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7ccu5Rb8gb6" style="width: 16%; text-align: right" title="Granted"&gt;17,851&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ziDCLAG2AbW8" style="width: 16%; text-align: right" title="Weighted Average Grant Date Fair Value, Granted"&gt;26.64&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Vested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Forfeited&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_iN_di_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQiNv5EWSxk4" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited"&gt;(293&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z15EJTNWn0V4" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited"&gt;14.65&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding at June 30, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6bl6e9B6Imj" style="border-bottom: Black 2.5pt double; text-align: right" title="Units, Outstanding Ending Balance"&gt;17,558&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20240101__20240630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zw0X2jmXPgp5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Ending Balance Outstanding"&gt;26.84&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="From2024-01-012024-06-30_us-gaap_RestrictedStockUnitsRSUMember5495062"
      decimals="INF"
      id="Fact002512"
      unitRef="Shares">17851</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-01-012024-06-30_us-gaap_RestrictedStockUnitsRSUMember5495062"
      decimals="INF"
      id="Fact002514"
      unitRef="USDPShares">26.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="From2024-01-012024-06-30_us-gaap_RestrictedStockUnitsRSUMember5495062"
      decimals="INF"
      id="Fact002516"
      unitRef="Shares">293</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="From2024-01-012024-06-30_us-gaap_RestrictedStockUnitsRSUMember5495062"
      decimals="INF"
      id="Fact002518"
      unitRef="USDPShares">14.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2024-06-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact002520"
      unitRef="Shares">17558</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2024-06-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="INF"
      id="Fact002522"
      unitRef="USDPShares">26.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-01-012024-06-30_us-gaap_GeneralAndAdministrativeExpenseMember_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact002524"
      unitRef="USD">208178</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="AsOf2024-06-30_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact002526"
      unitRef="USD">263144</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="From2024-01-012024-06-30_us-gaap_RestrictedStockUnitsRSUMember5495062"
      id="Fact002528">P1Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact002530">&lt;p id="xdx_807_eus-gaap--IncomeTaxDisclosureTextBlock_zwfuPI5eekki" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;17.
&lt;span id="xdx_828_zdTUBxmmCtJ5"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company estimates an annual effective tax rate of &lt;span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_c20240401__20240630_zqWa5XjycSKj" title="Effective tax rate, percentage"&gt;&lt;span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_uPure_c20240101__20240630_zFpNvzNXFNU7" title="Effective tax rate, percentage"&gt;0&lt;/span&gt;&lt;/span&gt;% for the year ended December 31, 2024 as the Company incurred losses for the three
and six month period ended June 30, 2024 and is forecasting an estimated net loss for both financial statement and tax purposes for the
year ended December 31, 2024. Therefore, no federal or state income taxes are expected and none have been recorded at this time. Income
taxes have been accounted for using the liability method in accordance with FASB ASC 740.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zv317rHOKPo7" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zsWvzaqhoEId"&gt;Schedule of US Federal Income Tax Rate to the Company's Effective Tax Rate&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8AB_zSjT12iDXH03" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z8kLNSKICqFg" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zsb90aycqaO8"&gt;Schedule of Components of Income Tax Provision (Benefit)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8AB_zxyhYsbII48b" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zt7ANMg9HEg6" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zbWZ2xijiCHc"&gt;Schedule of Temporary Differences that Give Rise to Deferred Tax Assets and Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8AB_zBEDD4WrUTr9" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Due
to the Company&#x2019;s history of losses since inception, there is not enough evidence at this time to support that the Company will
generate future income of a sufficient amount and nature to utilize the benefits of its net deferred tax assets. Accordingly, the deferred
tax assets have been reduced by a full valuation allowance, since the Company cannot currently support that realization of its deferred
tax assets is more likely than not.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
June 30, 2024, the Company had no unrecognized tax benefits that would reduce the Company&#x2019;s effective tax rate if recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2024-04-012024-06-30"
      decimals="INF"
      id="Fact002532"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2024-01-01to2024-06-30"
      decimals="INF"
      id="Fact002534"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact002536">&lt;p id="xdx_891_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zv317rHOKPo7" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B3_zsWvzaqhoEId"&gt;Schedule of US Federal Income Tax Rate to the Company's Effective Tax Rate&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact002538">&lt;p id="xdx_89F_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z8kLNSKICqFg" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zsb90aycqaO8"&gt;Schedule of Components of Income Tax Provision (Benefit)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact002540">&lt;p id="xdx_890_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zt7ANMg9HEg6" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zbWZ2xijiCHc"&gt;Schedule of Temporary Differences that Give Rise to Deferred Tax Assets and Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2024-01-01to2024-06-30" id="Fact002542">&lt;p id="xdx_802_eus-gaap--SubsequentEventsTextBlock_zM9FDWNkxBc6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;18.
&lt;span id="xdx_825_zoS8D378eR8f"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 5, 2024, the Company issued &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20240705__20240705__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znDjh9tZOmK8"&gt;11,765&lt;/span&gt; shares of the Company&#x2019;s Class A common stock to GEM pursuant to the Unsecured Promissory
Note, dated February 5, 2024, between the Company and GEM.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 22, 2024, the Company entered into a subordinated business loan and security agreement (the &#x201c;Subordinated Business Loan and
Security Agreement&#x201d;) with Agile Lending, LLC and Agile Capital Funding, LLC as the collateral agent. On July 22, 2024 the Company
issued a subordinated secured promissory note for an aggregate principal amount of $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20240722__us-gaap--TypeOfArrangementAxis__custom--SubordinatedBusinessLoanAndSecurityAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zo6HkXACNRuk" title="Debt instrument face amount"&gt;787,500&lt;/span&gt; and received $&lt;span id="xdx_901_eus-gaap--ProceedsFromShortTermDebt_c20240722__20240722__us-gaap--TypeOfArrangementAxis__custom--SubordinatedBusinessLoanAndSecurityAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zIBg67Ymemw1" title="Proceeds from debt"&gt;750,000&lt;/span&gt; of proceeds, net of
administrative agent fees $&lt;span id="xdx_90C_ecustom--AgentFees_c20240722__20240722__us-gaap--TypeOfArrangementAxis__custom--SubordinatedBusinessLoanAndSecurityAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zjMWYV72lfp6" title="Agent fees"&gt;37,500&lt;/span&gt; to the collateral agent, with a maturity date of &lt;span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_dd_c20240722__20240722__us-gaap--TypeOfArrangementAxis__custom--SubordinatedBusinessLoanAndSecurityAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zwCKRBJp36Vl" title="Debt instrument, maturity date"&gt;February 5, 2025&lt;/span&gt; under the subordinated business loan
and security agreement. The loan under the agreement bears interest at a rate of &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20240722__us-gaap--TypeOfArrangementAxis__custom--SubordinatedBusinessLoanAndSecurityAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdpjNzUAf2Lk" title="Debt instrument, interest rate"&gt;42&lt;/span&gt;%, and will be calculated on a three hundred and sixty
(360) day year based on the actual number of days lapsed, and interest shall accrue on the loan commencing on and including the effective
date pursuant to the Agreement&#x2019;s weekly repayment and amortization schedule. The collateral under the subordinated business loan
and security agreement consists of all of the Company&#x2019;s goods, accounts, equipment, inventory, contract rights or rights to payment
of money, leases, license agreements, franchise agreements, general intangibles (including intellectual property), commercial tort claims,
documents, instruments (including any promissory notes), chattel paper (whether tangible or electronic), cash, deposit accounts and other
collateral accounts, all certificates of deposit, fixtures, letters of credit rights, securities, and all other investment property,
supporting obligations, and financial assets.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2024-07-052024-07-05_custom_GemAgreementMember_us-gaap_CommonClassAMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002543"
      unitRef="Shares">11765</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-07-22_custom_SubordinatedBusinessLoanAndSecurityAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002545"
      unitRef="USD">787500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="From2024-07-222024-07-22_custom_SubordinatedBusinessLoanAndSecurityAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002547"
      unitRef="USD">750000</us-gaap:ProceedsFromShortTermDebt>
    <BNZI:AgentFees
      contextRef="From2024-07-222024-07-22_custom_SubordinatedBusinessLoanAndSecurityAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002549"
      unitRef="USD">37500</BNZI:AgentFees>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-07-222024-07-22_custom_SubordinatedBusinessLoanAndSecurityAgreementMember_us-gaap_SubsequentEventMember"
      id="Fact002551">2025-02-05</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2024-07-22_custom_SubordinatedBusinessLoanAndSecurityAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002553"
      unitRef="Pure">0.42</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002561"
      unitRef="USD">2093718</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002562"
      unitRef="USD">1023499</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002564"
      unitRef="USD">110797</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002565"
      unitRef="USD">176276</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002567"
      unitRef="USD">5748</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002568"
      unitRef="USD">107860</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002570"
      unitRef="USD">105049</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002571"
      unitRef="USD">68416</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002573"
      unitRef="USD">741155</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002574"
      unitRef="USD">333507</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002576"
      unitRef="USD">2939922</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002577"
      unitRef="USD">1425422</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002579"
      unitRef="USD">4644</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002580"
      unitRef="USD">11803</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002582"
      unitRef="USD">2171526</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002583"
      unitRef="USD">2171526</us-gaap:Goodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002585"
      unitRef="USD">134013</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002586"
      unitRef="USD">307258</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DeferredCosts
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002589"
      unitRef="USD">1524934</us-gaap:DeferredCosts>
    <us-gaap:OtherAssets
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002591"
      unitRef="USD">38381</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002592"
      unitRef="USD">38381</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002594"
      unitRef="USD">5288486</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002595"
      unitRef="USD">5479324</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002603"
      unitRef="USD">6439863</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002604"
      unitRef="USD">1100249</us-gaap:AccountsPayableCurrent>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact002607"
      unitRef="USD">663804</BNZI:SimpleAgreementForFutureEquityCurrent>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002610"
      unitRef="USD">8802196</BNZI:SimpleAgreementForFutureEquityCurrent>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002613"
      unitRef="USD">8802196</BNZI:SimpleAgreementForFutureEquityCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-12-31_custom_YorkvilleMember"
      decimals="0"
      id="Fact002615"
      unitRef="USD">1766000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2022-12-31_custom_YorkvilleMember"
      decimals="0"
      id="Fact002616"
      unitRef="USD">1408826</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002618"
      unitRef="USD">2540091</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002619"
      unitRef="USD">3506508</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-12-31_custom_CPBFLendingLLCMember"
      decimals="0"
      id="Fact002621"
      unitRef="USD">2693841</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2022-12-31_custom_CPBFLendingLLCMember"
      decimals="0"
      id="Fact002622"
      unitRef="USD">2276534</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-12-31_custom_CPBFLendingLLCMember"
      decimals="0"
      id="Fact002624"
      unitRef="USD">2693841</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2022-12-31_custom_CPBFLendingLLCMember"
      decimals="0"
      id="Fact002625"
      unitRef="USD">2276534</us-gaap:ConvertibleDebtCurrent>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent
      contextRef="AsOf2022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact002628"
      unitRef="USD">845473</BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002631"
      unitRef="USD">1936827</BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002634"
      unitRef="USD">1936827</BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact002636"
      unitRef="USD">6659787</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact002637"
      unitRef="USD">6494051</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002639"
      unitRef="USD">2505137</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002642"
      unitRef="USD">2505137</us-gaap:NotesPayableCurrent>
    <BNZI:DeferredUnderwritingFeesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002645"
      unitRef="USD">4000000</BNZI:DeferredUnderwritingFeesCurrent>
    <BNZI:DeferredFeeCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002648"
      unitRef="USD">500000</BNZI:DeferredFeeCurrent>
    <BNZI:WarrantLiabilityCurrent
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact002651"
      unitRef="USD">641000</BNZI:WarrantLiabilityCurrent>
    <BNZI:WarrantLiabilityCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002654"
      unitRef="USD">575000</BNZI:WarrantLiabilityCurrent>
    <BNZI:WarrantLiabilityCurrent
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002657"
      unitRef="USD">575000</BNZI:WarrantLiabilityCurrent>
    <BNZI:EarnoutLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002660"
      unitRef="USD">59399</BNZI:EarnoutLiabilityCurrent>
    <BNZI:EarnoutLiabilityCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002661"
      unitRef="USD">289099</BNZI:EarnoutLiabilityCurrent>
    <BNZI:DueToRelatedPartyCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002663"
      unitRef="USD">67118</BNZI:DueToRelatedPartyCurrent>
    <BNZI:GemCommitmentFeeLiability
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002666"
      unitRef="USD">2000000</BNZI:GemCommitmentFeeLiability>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002669"
      unitRef="USD">1214096</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002670"
      unitRef="USD">930436</us-gaap:DeferredRevenueCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002672"
      unitRef="USD">234043</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002673"
      unitRef="USD">284963</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002675"
      unitRef="USD">5194240</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002676"
      unitRef="USD">745373</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002678"
      unitRef="USD">37089615</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002679"
      unitRef="USD">29284339</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002682"
      unitRef="USD">234043</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002684"
      unitRef="USD">75000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002685"
      unitRef="USD">75000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002687"
      unitRef="USD">37164615</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002688"
      unitRef="USD">29593382</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002699"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002701"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002703"
      unitRef="Shares">275000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002705"
      unitRef="Shares">275000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002707"
      unitRef="Shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002709"
      unitRef="Shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact002711"
      unitRef="Shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact002713"
      unitRef="Shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002715"
      unitRef="Shares">2585296</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002717"
      unitRef="Shares">2585296</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002719"
      unitRef="Shares">274162</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002721"
      unitRef="Shares">274162</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact002723"
      unitRef="Shares">2311134</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact002725"
      unitRef="Shares">2311134</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002727"
      unitRef="Shares">3935892</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002729"
      unitRef="Shares">3935892</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002731"
      unitRef="Shares">51219</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact002733"
      unitRef="Shares">51219</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact002735"
      unitRef="Shares">3884673</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact002737"
      unitRef="Shares">3884673</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002696"
      unitRef="USD">259</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002697"
      unitRef="USD">394</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002739"
      unitRef="USD">259</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002740"
      unitRef="USD">394</us-gaap:CommonStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002745"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002747"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002749"
      unitRef="Shares">75000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002751"
      unitRef="Shares">75000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002753"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact002755"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002757"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact002759"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002764"
      unitRef="USD">14889936</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002765"
      unitRef="USD">8245610</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002767"
      unitRef="USD">-46766324</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002768"
      unitRef="USD">-32360062</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002770"
      unitRef="USD">-31876129</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002771"
      unitRef="USD">-24114058</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact002773"
      unitRef="USD">5288486</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002774"
      unitRef="USD">5479324</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002779"
      unitRef="USD">4561300</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002780"
      unitRef="USD">5332979</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002782"
      unitRef="USD">1444618</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002783"
      unitRef="USD">1956964</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002785"
      unitRef="USD">3116682</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002786"
      unitRef="USD">3376015</us-gaap:GrossProfit>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002791"
      unitRef="USD">12905073</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002792"
      unitRef="USD">9275251</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:Depreciation
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002794"
      unitRef="USD">7160</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002795"
      unitRef="USD">9588</us-gaap:Depreciation>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002798"
      unitRef="USD">303327</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingExpenses
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002800"
      unitRef="USD">12912233</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002801"
      unitRef="USD">9588166</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002803"
      unitRef="USD">-9795551</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002804"
      unitRef="USD">-6212151</us-gaap:OperatingIncomeLoss>
    <BNZI:StandByEquityPurchaseAgreementCommitmentFeeAndDeferredFeeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002809"
      unitRef="USD">3826176</BNZI:StandByEquityPurchaseAgreementCommitmentFeeAndDeferredFeeExpense>
    <BNZI:GEMWarrantExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002812"
      unitRef="USD">2448000</BNZI:GEMWarrantExpense>
    <BNZI:GemCommitmentFeeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002815"
      unitRef="USD">2000000</BNZI:GemCommitmentFeeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002818"
      unitRef="USD">62985</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002819"
      unitRef="USD">150692</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002821"
      unitRef="USD">62985</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002822"
      unitRef="USD">150692</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002824"
      unitRef="USD">813</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact002827"
      unitRef="USD">2631060</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact002828"
      unitRef="USD">1651141</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002830"
      unitRef="USD">2923414</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002831"
      unitRef="USD">728949</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002833"
      unitRef="USD">2923414</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002834"
      unitRef="USD">728949</us-gaap:InterestExpenseNonoperating>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002837"
      unitRef="USD">-56653</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact002839"
      unitRef="USD">-1807000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002842"
      unitRef="USD">115000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002845"
      unitRef="USD">115000</us-gaap:FairValueAdjustmentOfWarrants>
    <BNZI:LossOnModificationOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact002849"
      unitRef="USD">120826</BNZI:LossOnModificationOfSimpleAgreementForFutureEquity>
    <BNZI:LossOnModificationOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002852"
      unitRef="USD">1602174</BNZI:LossOnModificationOfSimpleAgreementForFutureEquity>
    <BNZI:LossOnModificationOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002855"
      unitRef="USD">1602174</BNZI:LossOnModificationOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact002857"
      unitRef="USD">-207570</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact002858"
      unitRef="USD">307569</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002860"
      unitRef="USD">-2752430</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002861"
      unitRef="USD">4078431</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002863"
      unitRef="USD">-2752430</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002864"
      unitRef="USD">4078431</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact002866"
      unitRef="USD">1404863</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact002867"
      unitRef="USD">-254443</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002869"
      unitRef="USD">3063278</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002870"
      unitRef="USD">-606857</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002872"
      unitRef="USD">3063278</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002873"
      unitRef="USD">-606857</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002875"
      unitRef="USD">34000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002878"
      unitRef="USD">-4610711</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002879"
      unitRef="USD">-9256351</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002881"
      unitRef="USD">-14406262</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002882"
      unitRef="USD">-15468502</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002887"
      unitRef="USD">-14406262</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002888"
      unitRef="USD">-15468502</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact002890"
      unitRef="USDPShares">-105.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact002892"
      unitRef="USDPShares">-105.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact002894"
      unitRef="USDPShares">-111.83</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact002896"
      unitRef="USDPShares">-111.83</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact002898"
      unitRef="Shares">137074</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact002900"
      unitRef="Shares">137074</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact002902"
      unitRef="Shares">128822</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact002904"
      unitRef="Shares">128822</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact002912"
      unitRef="Shares">2328823</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact002906"
      unitRef="USD">6318491</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002914"
      unitRef="Shares">6359139</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002907"
      unitRef="USD">636</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002908"
      unitRef="USD">1151525</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002909"
      unitRef="USD">-16891560</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="Fact002910"
      unitRef="USD">-9420908</us-gaap:StockholdersEquity>
    <BNZI:RetroactiveApplicationOfRecapitalizationShares
      contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact002922"
      unitRef="Shares">-2328823</BNZI:RetroactiveApplicationOfRecapitalizationShares>
    <BNZI:RetroactiveApplicationOfRecapitalization
      contextRef="From2022-01-012022-12-31_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact002916"
      unitRef="USD">-6318491</BNZI:RetroactiveApplicationOfRecapitalization>
    <BNZI:RetroactiveApplicationOfRecapitalizationShares
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002924"
      unitRef="Shares">-2421780</BNZI:RetroactiveApplicationOfRecapitalizationShares>
    <BNZI:RetroactiveApplicationOfRecapitalization
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002917"
      unitRef="USD">-242</BNZI:RetroactiveApplicationOfRecapitalization>
    <BNZI:RetroactiveApplicationOfRecapitalization
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002918"
      unitRef="USD">6318737</BNZI:RetroactiveApplicationOfRecapitalization>
    <BNZI:StockholdersEquityAdjustedBalanceShares
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002932"
      unitRef="Shares">3937359</BNZI:StockholdersEquityAdjustedBalanceShares>
    <BNZI:StockholdersEquityAdjustedBalance
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002927"
      unitRef="USD">394</BNZI:StockholdersEquityAdjustedBalance>
    <BNZI:StockholdersEquityAdjustedBalance
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002928"
      unitRef="USD">7470258</BNZI:StockholdersEquityAdjustedBalance>
    <BNZI:StockholdersEquityAdjustedBalance
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002929"
      unitRef="USD">-16891560</BNZI:StockholdersEquityAdjustedBalance>
    <BNZI:StockholdersEquityAdjustedBalance
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002930"
      unitRef="USD">-9420908</BNZI:StockholdersEquityAdjustedBalance>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002940"
      unitRef="Shares">171</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002936"
      unitRef="USD">5016</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002938"
      unitRef="USD">5016</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2022-01-012022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002948"
      unitRef="Shares">-1638</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002952"
      unitRef="USD">770336</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002954"
      unitRef="USD">770336</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002959"
      unitRef="USD">-15468502</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact002960"
      unitRef="USD">-15468502</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002970"
      unitRef="Shares">3935892</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002963"
      unitRef="USD">394</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002964"
      unitRef="USD">8245610</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002965"
      unitRef="USD">-32360062</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002966"
      unitRef="USD">-24114058</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002980"
      unitRef="Shares">3935892</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002973"
      unitRef="USD">394</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002974"
      unitRef="USD">8245610</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact002975"
      unitRef="USD">-32360062</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact002976"
      unitRef="USD">-24114058</us-gaap:StockholdersEquity>
    <BNZI:ReverseRecapitalizationShares
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002988"
      unitRef="Shares">-1424624</BNZI:ReverseRecapitalizationShares>
    <BNZI:ReverseRecapitalization
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact002983"
      unitRef="USD">-142</BNZI:ReverseRecapitalization>
    <BNZI:ReverseRecapitalization
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact002984"
      unitRef="USD">-17858417</BNZI:ReverseRecapitalization>
    <BNZI:ReverseRecapitalization
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact002986"
      unitRef="USD">-17858559</BNZI:ReverseRecapitalization>
    <BNZI:ConversionOfSimpleAgreementForFutureEquityShares
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember_us-gaap_NonrelatedPartyMember"
      decimals="INF"
      id="Fact002996"
      unitRef="Shares">833</BNZI:ConversionOfSimpleAgreementForFutureEquityShares>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact002992"
      unitRef="USD">456234</BNZI:ConversionOfSimpleAgreementForFutureEquity>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact002994"
      unitRef="USD">456234</BNZI:ConversionOfSimpleAgreementForFutureEquity>
    <BNZI:ConversionOfSimpleAgreementForFutureEquityShares
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember_us-gaap_RelatedPartyMember"
      decimals="INF"
      id="Fact003004"
      unitRef="Shares">11039</BNZI:ConversionOfSimpleAgreementForFutureEquityShares>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002999"
      unitRef="USD">1</BNZI:ConversionOfSimpleAgreementForFutureEquity>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003000"
      unitRef="USD">6049765</BNZI:ConversionOfSimpleAgreementForFutureEquity>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003002"
      unitRef="USD">6049766</BNZI:ConversionOfSimpleAgreementForFutureEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember_us-gaap_NonrelatedPartyMember"
      decimals="INF"
      id="Fact003012"
      unitRef="Shares">10597</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003007"
      unitRef="USD">1</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003008"
      unitRef="USD">3346231</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003010"
      unitRef="USD">3346232</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember_us-gaap_RelatedPartyMember"
      decimals="INF"
      id="Fact003020"
      unitRef="Shares">22929</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003015"
      unitRef="USD">2</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003016"
      unitRef="USD">7271366</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003018"
      unitRef="USD">7271368</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <BNZI:ModificationOfConvertibleNotesPayable
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003024"
      unitRef="USD">9909</BNZI:ModificationOfConvertibleNotesPayable>
    <BNZI:ModificationOfConvertibleNotesPayable
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003026"
      unitRef="USD">9909</BNZI:ModificationOfConvertibleNotesPayable>
    <BNZI:SharesIssuedToYorkvilleForCommitmentFeeShares
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember_custom_YorkvilleMember"
      decimals="INF"
      id="Fact003034"
      unitRef="Shares">6000</BNZI:SharesIssuedToYorkvilleForCommitmentFeeShares>
    <BNZI:SharesIssuedToYorkvilleForCommitmentFee
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember_custom_YorkvilleMember"
      decimals="0"
      id="Fact003029"
      unitRef="USD">1</BNZI:SharesIssuedToYorkvilleForCommitmentFee>
    <BNZI:SharesIssuedToYorkvilleForCommitmentFee
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember_custom_YorkvilleMember"
      decimals="0"
      id="Fact003030"
      unitRef="USD">3287999</BNZI:SharesIssuedToYorkvilleForCommitmentFee>
    <BNZI:SharesIssuedToYorkvilleForCommitmentFee
      contextRef="From2023-01-012023-12-31_custom_YorkvilleMember"
      decimals="0"
      id="Fact003032"
      unitRef="USD">3288000</BNZI:SharesIssuedToYorkvilleForCommitmentFee>
    <BNZI:SharesIssuedUnderShareTransferAgreement
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003038"
      unitRef="USD">2498965</BNZI:SharesIssuedUnderShareTransferAgreement>
    <BNZI:SharesIssuedUnderShareTransferAgreement
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003040"
      unitRef="USD">2498965</BNZI:SharesIssuedUnderShareTransferAgreement>
    <BNZI:StockIssuedDuringPeriodIssuanceOfCantorFeeShares
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003048"
      unitRef="Shares">22279</BNZI:StockIssuedDuringPeriodIssuanceOfCantorFeeShares>
    <BNZI:StockIssuedDuringPeriodValueIssuanceOfCantorFeeShares
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003043"
      unitRef="USD">2</BNZI:StockIssuedDuringPeriodValueIssuanceOfCantorFeeShares>
    <BNZI:StockIssuedDuringPeriodValueIssuanceOfCantorFeeShares
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003044"
      unitRef="USD">-2</BNZI:StockIssuedDuringPeriodValueIssuanceOfCantorFeeShares>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-01-012023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003056"
      unitRef="Shares">353</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003052"
      unitRef="USD">30761</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003054"
      unitRef="USD">30761</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003060"
      unitRef="USD">1245796</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003062"
      unitRef="USD">1245796</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <BNZI:AdjustmentsToAdditionalPaidInCapitalExciseTax
      contextRef="From2023-01-012023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003066"
      unitRef="USD">305719</BNZI:AdjustmentsToAdditionalPaidInCapitalExciseTax>
    <BNZI:AdjustmentsToAdditionalPaidInCapitalExciseTax
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003068"
      unitRef="USD">305719</BNZI:AdjustmentsToAdditionalPaidInCapitalExciseTax>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003073"
      unitRef="USD">-14406262</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003074"
      unitRef="USD">-14406262</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003084"
      unitRef="Shares">2585296</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003077"
      unitRef="USD">259</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003078"
      unitRef="USD">14889936</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003079"
      unitRef="USD">-46766324</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact003080"
      unitRef="USD">-31876129</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003094"
      unitRef="Shares">2585296</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact003087"
      unitRef="USD">259</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact003088"
      unitRef="USD">14889936</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact003089"
      unitRef="USD">-46766324</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact003090"
      unitRef="USD">-31876129</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003099"
      unitRef="USD">-14406262</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003100"
      unitRef="USD">-15468502</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003105"
      unitRef="USD">7160</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003106"
      unitRef="USD">9588</us-gaap:Depreciation>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003108"
      unitRef="USD">-102112</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003109"
      unitRef="USD">92619</us-gaap:ProvisionForDoubtfulAccounts>
    <BNZI:NonCashSharesIssuedToYorkvilleForAggregateCommitmentFee
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003111"
      unitRef="USD">3288000</BNZI:NonCashSharesIssuedToYorkvilleForAggregateCommitmentFee>
    <BNZI:NonCashIssuanceOfWarrantsAccountedForAsLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003114"
      unitRef="USD">-2448000</BNZI:NonCashIssuanceOfWarrantsAccountedForAsLiabilities>
    <BNZI:NonCashSettlementOfGemCommitmentFee
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003117"
      unitRef="USD">2000000</BNZI:NonCashSettlementOfGemCommitmentFee>
    <BNZI:NonCashInterestExpense
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003120"
      unitRef="USD">686016</BNZI:NonCashInterestExpense>
    <BNZI:NonCashInterestExpense
      contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003121"
      unitRef="USD">854379</BNZI:NonCashInterestExpense>
    <BNZI:NonCashInterestExpense
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003123"
      unitRef="USD">513977</BNZI:NonCashInterestExpense>
    <BNZI:NonCashInterestExpense
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003124"
      unitRef="USD">55086</BNZI:NonCashInterestExpense>
    <BNZI:NonCashInterestExpense
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003126"
      unitRef="USD">513977</BNZI:NonCashInterestExpense>
    <BNZI:NonCashInterestExpense
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003127"
      unitRef="USD">55086</BNZI:NonCashInterestExpense>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003129"
      unitRef="USD">958822</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003130"
      unitRef="USD">235463</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003132"
      unitRef="USD">2410735</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003133"
      unitRef="USD">485717</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003135"
      unitRef="USD">2410735</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003136"
      unitRef="USD">485717</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003138"
      unitRef="USD">173245</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003139"
      unitRef="USD">152018</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003142"
      unitRef="USD">303327</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003144"
      unitRef="USD">1245796</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003145"
      unitRef="USD">770336</us-gaap:ShareBasedCompensation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003148"
      unitRef="USD">-56653</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <BNZI:ExciseTax
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003150"
      unitRef="USD">305719</BNZI:ExciseTax>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003153"
      unitRef="USD">-1807000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003156"
      unitRef="USD">115000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003159"
      unitRef="USD">115000</us-gaap:FairValueAdjustmentOfWarrants>
    <BNZI:LossOnModificationOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003163"
      unitRef="USD">120826</BNZI:LossOnModificationOfSimpleAgreementForFutureEquity>
    <BNZI:LossOnModificationOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003166"
      unitRef="USD">1602174</BNZI:LossOnModificationOfSimpleAgreementForFutureEquity>
    <BNZI:LossOnModificationOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003169"
      unitRef="USD">1602174</BNZI:LossOnModificationOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003171"
      unitRef="USD">-207570</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003172"
      unitRef="USD">307569</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003174"
      unitRef="USD">-2752430</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003175"
      unitRef="USD">4078431</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003177"
      unitRef="USD">-2752430</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003178"
      unitRef="USD">4078431</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfBifurcatedEmbeddedDerivativeLiabilities
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003180"
      unitRef="USD">-1404863</BNZI:ChangeInFairValueOfBifurcatedEmbeddedDerivativeLiabilities>
    <BNZI:ChangeInFairValueOfBifurcatedEmbeddedDerivativeLiabilities
      contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003181"
      unitRef="USD">254443</BNZI:ChangeInFairValueOfBifurcatedEmbeddedDerivativeLiabilities>
    <BNZI:ChangeInFairValueOfBifurcatedEmbeddedDerivativeLiabilities
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003183"
      unitRef="USD">-3063278</BNZI:ChangeInFairValueOfBifurcatedEmbeddedDerivativeLiabilities>
    <BNZI:ChangeInFairValueOfBifurcatedEmbeddedDerivativeLiabilities
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003184"
      unitRef="USD">606857</BNZI:ChangeInFairValueOfBifurcatedEmbeddedDerivativeLiabilities>
    <BNZI:ChangeInFairValueOfBifurcatedEmbeddedDerivativeLiabilities
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003186"
      unitRef="USD">-3063278</BNZI:ChangeInFairValueOfBifurcatedEmbeddedDerivativeLiabilities>
    <BNZI:ChangeInFairValueOfBifurcatedEmbeddedDerivativeLiabilities
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003187"
      unitRef="USD">606857</BNZI:ChangeInFairValueOfBifurcatedEmbeddedDerivativeLiabilities>
    <BNZI:ChangeInFairValueOfConvertiblePromissoryNotes
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003189"
      unitRef="USD">-34000</BNZI:ChangeInFairValueOfConvertiblePromissoryNotes>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003195"
      unitRef="USD">-65479</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003196"
      unitRef="USD">86308</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003198"
      unitRef="USD">407648</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003199"
      unitRef="USD">-425011</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <BNZI:DeferredOfferingCostsOperatingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003201"
      unitRef="USD">1708163</BNZI:DeferredOfferingCostsOperatingActivities>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003205"
      unitRef="USD">-52591</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003207"
      unitRef="USD">5339614</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003208"
      unitRef="USD">660844</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003210"
      unitRef="USD">67118</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003213"
      unitRef="USD">283660</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003214"
      unitRef="USD">-129604</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003216"
      unitRef="USD">4448867</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003217"
      unitRef="USD">384641</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003219"
      unitRef="USD">-284963</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003220"
      unitRef="USD">-243596</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <BNZI:IncreaseDecreaseInEarnoutLiability
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003222"
      unitRef="USD">-229700</BNZI:IncreaseDecreaseInEarnoutLiability>
    <BNZI:IncreaseDecreaseInEarnoutLiability
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003223"
      unitRef="USD">-710901</BNZI:IncreaseDecreaseInEarnoutLiability>
    <us-gaap:IncreaseDecreaseInDeferredLeasingFees
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003225"
      unitRef="USD">-500000</us-gaap:IncreaseDecreaseInDeferredLeasingFees>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003229"
      unitRef="USD">-37837</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003231"
      unitRef="USD">-1550781</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003232"
      unitRef="USD">-5168175</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003238"
      unitRef="USD">10806</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003241"
      unitRef="USD">-10806</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <BNZI:EffectOfMergerNetOfTransactionCosts
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003246"
      unitRef="USD">-7615462</BNZI:EffectOfMergerNetOfTransactionCosts>
    <BNZI:PaymentsOfDeferredOfferingCosts
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003250"
      unitRef="USD">1524934</BNZI:PaymentsOfDeferredOfferingCosts>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003252"
      unitRef="USD">4387701</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003255"
      unitRef="USD">3235000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003256"
      unitRef="USD">1753558</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003258"
      unitRef="USD">2583000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003259"
      unitRef="USD">4182290</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003261"
      unitRef="USD">2583000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003262"
      unitRef="USD">4182290</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003264"
      unitRef="USD">30761</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003265"
      unitRef="USD">5016</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003267"
      unitRef="USD">2621000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003268"
      unitRef="USD">4415930</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003270"
      unitRef="USD">1070219</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003271"
      unitRef="USD">-763051</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact003273"
      unitRef="USD">1023499</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="Fact003274"
      unitRef="USD">1786550</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact003276"
      unitRef="USD">2093718</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact003277"
      unitRef="USD">1023499</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003282"
      unitRef="USD">955848</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003283"
      unitRef="USD">630454</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003285"
      unitRef="USD">9862</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003286"
      unitRef="USD">-4875</us-gaap:IncomeTaxesPaidNet>
    <BNZI:IssuanceOfCantorFeeShares
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003291"
      unitRef="USD">111</BNZI:IssuanceOfCantorFeeShares>
    <BNZI:ModificationOfConvertibleNotesPayable
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003294"
      unitRef="USD">9909</BNZI:ModificationOfConvertibleNotesPayable>
    <BNZI:SharesIssuedToYorkvilleForAggregateCommitmentFee
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003297"
      unitRef="USD">3288000</BNZI:SharesIssuedToYorkvilleForAggregateCommitmentFee>
    <BNZI:SharesIssuedUnderShareTransferAgreement
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003300"
      unitRef="USD">2498965</BNZI:SharesIssuedUnderShareTransferAgreement>
    <BNZI:IssuanceOfWarrantsAccountedForAsALiability
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003303"
      unitRef="USD">2448000</BNZI:IssuanceOfWarrantsAccountedForAsALiability>
    <BNZI:GemCommitmentFee
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003306"
      unitRef="USD">2000000</BNZI:GemCommitmentFee>
    <BNZI:NoncashOrPartNoncashDeferredOfferingCosts
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003309"
      unitRef="USD">-3233097</BNZI:NoncashOrPartNoncashDeferredOfferingCosts>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003312"
      unitRef="USD">456234</BNZI:ConversionOfSimpleAgreementForFutureEquity>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003315"
      unitRef="USD">6049766</BNZI:ConversionOfSimpleAgreementForFutureEquity>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003318"
      unitRef="USD">6049766</BNZI:ConversionOfSimpleAgreementForFutureEquity>
    <BNZI:ConversionOfConvertibleNotes
      contextRef="From2023-01-012023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003321"
      unitRef="USD">3346232</BNZI:ConversionOfConvertibleNotes>
    <BNZI:ConversionOfConvertibleNotes
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003324"
      unitRef="USD">7271368</BNZI:ConversionOfConvertibleNotes>
    <BNZI:ConversionOfConvertibleNotes
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003327"
      unitRef="USD">7271368</BNZI:ConversionOfConvertibleNotes>
    <BNZI:ConvertibleNoteIssuedInSettlementOfAccruedInterest
      contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003331"
      unitRef="USD">321345</BNZI:ConvertibleNoteIssuedInSettlementOfAccruedInterest>
    <BNZI:ConvertibleNoteIssuedInSettlementOfAccruedInterest
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003334"
      unitRef="USD">100538</BNZI:ConvertibleNoteIssuedInSettlementOfAccruedInterest>
    <BNZI:ConvertibleNoteIssuedInSettlementOfAccruedInterest
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003337"
      unitRef="USD">100538</BNZI:ConvertibleNoteIssuedInSettlementOfAccruedInterest>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003340"
      unitRef="USD">25896</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesAtIssuance
      contextRef="From2022-01-012022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact003343"
      unitRef="USD">541223</BNZI:BifurcatedEmbeddedDerivativeLiabilitiesAtIssuance>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesAtIssuance
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003346"
      unitRef="USD">1292777</BNZI:BifurcatedEmbeddedDerivativeLiabilitiesAtIssuance>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesAtIssuance
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003349"
      unitRef="USD">1292777</BNZI:BifurcatedEmbeddedDerivativeLiabilitiesAtIssuance>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003352"
      unitRef="USD">762603</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact003354">&lt;p id="xdx_80D_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_z69teupHCD9i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;1.
&lt;span id="xdx_824_z6HmcAD23E42"&gt;Organization&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;The
Business &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Banzai
International, Inc. (the &#x201c;Company&#x201d; or &#x201c;Banzai&#x201d;) was incorporated in Delaware on &lt;span id="xdx_905_edei--EntityIncorporationDateOfIncorporation_c20230101__20231231_z4x2WRmAnfB9"&gt;September 30, 2015&lt;/span&gt;. Banzai is
a leading enterprise SaaS Video Engagement platform used by marketers to power webinars, trainings, virtual events, and on-demand video
content.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Close
of the Merger &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2023 (the &#x201c;Closing Date&#x201d;), 7GC &amp;amp; Co. Holdings Inc. (&#x201c;7GC&#x201d;), our predecessor company, consummated
the business combination pursuant to the Agreement and Plan of Merger and Reorganization, dated as of December 8, 2022 (the &#x201c;Original
Merger Agreement&#x201d;), by and among 7GC, Banzai International, Inc. (&#x201c;Legacy Banzai&#x201d;), 7GC Merger Sub I, Inc., an indirect
wholly owned subsidiary of 7GC (&#x201c;First Merger Sub&#x201d;), and 7GC Merger Sub II, LLC, a direct wholly owned subsidiary of 7GC
(&#x201c;Second Merger Sub&#x201d;), as amended by the Amendment to Agreement and Plan of Merger, dated as of August 4, 2023 (the &#x201c;Merger
Agreement Amendment&#x201d; and, together with the Original Merger Agreement, the &#x201c;Merger Agreement&#x201d;), by and between 7GC
and Legacy Banzai.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the terms of the Merger Agreement, a business combination between 7GC and Legacy Banzai was effected through (a) the merger of First
Merger Sub with and into Legacy Banzai, with Legacy Banzai surviving as a wholly-owned subsidiary of 7GC (Legacy Banzai, in its capacity
as the surviving corporation of the merger, the &#x201c;Surviving Corporation&#x201d;) (the &#x201c;First Merger&#x201d;) and (b) the subsequent
merger of the Surviving Corporation with and into Second Merger Sub, with Second Merger Sub being the surviving entity of the Second
Merger, which ultimately resulted in Legacy Banzai becoming a wholly-owned direct subsidiary of 7GC (the &#x201c;Second Merger&#x201d;
and, together with the First Merger, the &#x201c;Mergers&#x201d; and, collectively with the other transactions described in the Merger
Agreement, the &#x201c;Merger&#x201d;). On the Closing Date, and in connection with the closing of the Merger (the &#x201c;Closing&#x201d;),
7GC changed its name to Banzai International, Inc.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Although
7GC was the legal acquirer of Legacy Banzai in the merger, Legacy Banzai is deemed to be the accounting acquirer, and the historical
financial statements of Legacy Banzai became the basis for the historical financial statements of the Company upon the closing of the
merger.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furthermore,
the historical financial statements of Legacy Banzai became the historical financial statements of the Company upon the consummation
of the merger. As a result, the financial statements included in this Annual Report reflect (i) the historical operating results of Legacy
Banzai prior to the merger; (ii) the combined results of 7GC and Legacy Banzai following the close of the merger; (iii) the assets and
liabilities of Legacy Banzai at their historical cost and (iv) the Legacy Banzai&#x2019;s equity structure for all periods presented,
as affected by the recapitalization presentation after completion of the merger.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aggregate consideration payable to securityholders of Legacy Banzai at the Closing consisted of a number of shares of Class A Common
Stock or shares of Class B Common Stock, and cash in lieu of any fractional shares of Class A Common Stock or shares of Class B Common
Stock that would otherwise have been payable to any Legacy Banzai securityholders, equal to $&lt;span id="xdx_906_eus-gaap--AssetAcquisitionConsiderationTransferred_c20230101__20231231__dei--LegalEntityAxis__custom--BanzaiInternationalIncMember_zjI36nmjNoE7" title="Asset acquisition, consideration transferred"&gt;100,000,000&lt;/span&gt;. See &lt;i&gt;Note 4-Reverse Merger
Capitalization with 7GC &amp;amp; Co. Holdings Inc. &lt;/i&gt;for further details of the merger.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Termination
of Hyros Acquisition and Amended Merger Agreement with 7GC &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2022, the Company entered into an Agreement and Plan of Merger with Hyros, Inc., (&#x201c;Hyros&#x201d;) (the &#x201c;Hyros Purchase
Agreement&#x201d;) whereby Banzai would acquire &lt;span id="xdx_900_ecustom--PercentageOfVotingInterestsPlannedToAcquire_dp_uPure_c20221201__20221231__us-gaap--BusinessAcquisitionAxis__custom--HyrosIncMember_zmFJh1mNkCzd" title="Percentage of voting interests planned to acquire"&gt;100&lt;/span&gt;% of the issued share capital of Hyros for approximately $&lt;span id="xdx_904_eus-gaap--BusinessCombinationPriceOfAcquisitionExpected_pn6n6_c20221201__20221231__us-gaap--BusinessAcquisitionAxis__custom--HyrosIncMember_zXzzQ1Ulwz6e" title="Business combination price of acquisition expected"&gt;110&lt;/span&gt; million in a primarily
stock transaction. The acquisition was expected to enhance Banzai&#x2019;s role as a full-stack marketing technology platform, expand
its total addressable market, to significantly enhance the Banzai platform and accelerate its long-term revenue growth and operational
efficiency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Concurrently,
in December 2022, the Company entered into an Agreement and Plan of Merger and Reorganization (the &#x201c;Original Merger Agreement&#x201d;)
with 7GC &amp;amp; Co. Holdings Inc. (&#x201c;7GC&#x201d;), a blank check company formed for the purpose of effecting a merger, share exchange,
asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities, pending the
close of the Hyros Purchase Agreement. On July 31, 2023, Banzai sent a notice of termination to Hyros. On August 1, 2023, Banzai and
Hyros terminated the Hyros Purchase Agreement and the Hyros Side Letter (the &#x201c;Hyros Transaction Termination&#x201d;), with immediate
effect, in connection with the inability to procure the Hyros audited financial statements on the timeline contemplated by the Hyros
Purchase Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 4, 2023, the Company entered into an Amendment to the Agreement and Plan of Merger and Reorganization (the &#x201c;Amended Merger
Agreement&#x201d; and together with the Original Merger Agreement, the &#x201c;Merger Agreement&#x201d;) with 7GC (the &#x201c;Merger&#x201d;).
As a result of the Merger Agreement, all outstanding shares of capital stock of Banzai will be canceled and converted into the right
to receive newly issued shares of common stock, par value $&lt;span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230804__us-gaap--StatementClassOfStockAxis__custom--SevenGCCommonStockMember_zc4Py5aejqHa" title="Common stock, par value"&gt;0.0001&lt;/span&gt; per share, 7GC Common Stock determined based on a pre-money enterprise
valuation of Banzai of $&lt;span id="xdx_901_ecustom--BusinessCombinationProvisionalInformationInitialAccountingIncompleteReductionConsiderationTransferred_pn6n6_c20230804__20230804__us-gaap--StatementClassOfStockAxis__custom--SevenGCCommonStockMember_zYiryt84zU4b" title="Business combination provisional information initial accounting incomplete reduction consideration transferred"&gt;100&lt;/span&gt; million and a $&lt;span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20230804__us-gaap--StatementClassOfStockAxis__custom--SevenGCCommonStockMember_zr6PGqhMiOGa" title="Shares issued price per share"&gt;10.00&lt;/span&gt; price per share of 7GC Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Emerging
Growth Company &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
closure of the Merger, the Company became an &#x201c;emerging growth company,&#x201d; as defined in Section 2(a) of the Securities Act
of 1933, as amended, (the &#x201c;Securities Act&#x201d;), as modified by the Jumpstart our Business Startups Act of 2012, (the &#x201c;JOBS
Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public
companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic
reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and
stockholder approval of any golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section 102(b) (1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies are required to comply with the new or revised financial accounting standards. Private companies are
those companies that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the
requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not
to opt out of such extended transition period, which means that when a standard is issued or revised, it adopts the new or revised standard
at the time private companies adopt the new or revised standard. Therefore, the Company&#x2019;s financial statements may not be comparable
to certain public companies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <dei:EntityIncorporationDateOfIncorporation contextRef="From2023-01-012023-12-31" id="Fact003355">2015-09-30</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="From2023-01-012023-12-31_custom_BanzaiInternationalIncMember"
      decimals="0"
      id="Fact003357"
      unitRef="USD">100000000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <BNZI:PercentageOfVotingInterestsPlannedToAcquire
      contextRef="From2022-12-012022-12-31_custom_HyrosIncMember"
      decimals="INF"
      id="Fact003359"
      unitRef="Pure">1</BNZI:PercentageOfVotingInterestsPlannedToAcquire>
    <us-gaap:BusinessCombinationPriceOfAcquisitionExpected
      contextRef="From2022-12-012022-12-31_custom_HyrosIncMember"
      decimals="-6"
      id="Fact003361"
      unitRef="USD">110000000</us-gaap:BusinessCombinationPriceOfAcquisitionExpected>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-08-04_custom_SevenGCCommonStockMember"
      decimals="INF"
      id="Fact003363"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <BNZI:BusinessCombinationProvisionalInformationInitialAccountingIncompleteReductionConsiderationTransferred
      contextRef="From2023-08-042023-08-04_custom_SevenGCCommonStockMember"
      decimals="-6"
      id="Fact003365"
      unitRef="USD">100000000</BNZI:BusinessCombinationProvisionalInformationInitialAccountingIncompleteReductionConsiderationTransferred>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-08-04_custom_SevenGCCommonStockMember"
      decimals="INF"
      id="Fact003367"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2023-01-012023-12-31" id="Fact003369">&lt;p id="xdx_807_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_z6icBpvWQCLl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
&lt;span id="xdx_82E_zHEqevSf7oJ5"&gt;Going Concern&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023 the Company had cash of approximately $&lt;span id="xdx_90B_eus-gaap--Cash_iI_pn5n6_c20231231_zFCrUYiC7B19" title="Cash"&gt;2.1&lt;/span&gt; million. For the year ended December 31, 2023, the Company used approximately
$&lt;span id="xdx_901_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20230101__20231231_zsf0S57Z8NC1" title="Net cash used in operating activities"&gt;1.6&lt;/span&gt; million in cash for operating activities. The Company has incurred recurring net losses from operations and negative cash flows
from operating activities since inception. As of December 31, 2023, the Company had an accumulated deficit of approximately $&lt;span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20231231_zLOrCIRTOS58" title="Accumulated deficit"&gt;46.8&lt;/span&gt; million.
These factors raise substantial doubt regarding the Company&#x2019;s ability to continue as a going concern within one year of the date
these financial statements were issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
continuation of the Company as a going concern is dependent upon the continued financial support from its stockholders and debt holders.
Specifically, continuation is contingent on the Company&#x2019;s ability to obtain necessary equity or debt financing to continue operations,
and ultimately the Company&#x2019;s ability to generate profit from sales and positive operating cash flows, which is not assured.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s plans include obtaining future debt and equity financings associated with the close of the Merger described in &lt;i&gt;Note
4-Reverse Merger Capitalization with 7GC &amp;amp; Co. Holdings Inc..&lt;/i&gt; If the Company is unsuccessful in completing these planned transactions,
it may be required to reduce its spending rate to align with expected revenue levels and cash reserves, although there can be no guarantee
that it will be successful in doing so. Accordingly, the Company may be required to raise additional cash through debt or equity transactions.
It may not be able to secure financing in a timely manner or on favorable terms, if at all. As a result, management&#x2019;s plans cannot
be considered probable and thus do not alleviate substantial doubt about the Company&#x2019;s ability to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
accompanying audited consolidated financial statements have been prepared assuming that the Company will continue as a going concern
and do not include any adjustments that might result from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:Cash
      contextRef="AsOf2023-12-31"
      decimals="-5"
      id="Fact003371"
      unitRef="USD">2100000</us-gaap:Cash>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-01-012023-12-31"
      decimals="-5"
      id="Fact003373"
      unitRef="USD">-1600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-12-31"
      decimals="-5"
      id="Fact003375"
      unitRef="USD">-46800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2023-01-012023-12-31" id="Fact003377">&lt;p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zu8rW4Zxx4W5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3.
&lt;span id="xdx_820_z1M0mvXvfMv8"&gt;Summary of Significant Accounting Policies&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zfGhfNkLWX13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zlkKakw2weZ3"&gt;Basis
of Presentation&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s audited consolidated financial statements have been prepared in conformity with accounting principles generally accepted
in the United States of America (&#x201c;GAAP&#x201d;) as determined by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting
Standards Codification (&#x201c;ASC&#x201d;) and applicable regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) regarding
annual financial reporting.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;Effective September 19, 2024, the Company completed a &lt;span id="xdx_901_eus-gaap--StockholdersEquityReverseStockSplit_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zbEiRyMUfF9f" title="Reverse stock split"&gt;one-for-fifty (1-for-50) reverse stock split&lt;/span&gt; of our issued
and outstanding shares of Class A Common Stock without a corresponding reduction in the total number of authorized shares of our Class
A Common Stock (the &#x201c;Reverse Stock Split&#x201d;). All references to shares of the Company&#x2019;s Class A Common Stock in these
financial statements refer to the number of shares of Class A Common Stock after giving effect to the Reverse Stock Split and are presented
as if the Reverse Stock Split had occurred at the beginning of the earliest period presented.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ConsolidationPolicyTextBlock_zXT8URj9EB6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zkuEel5BPMli"&gt;Principles
of Consolidation&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying audited consolidated financial statements include the accounts of Banzai and its subsidiaries. The Company consolidates
all entities over which the Company has the power to govern the financial and operating policies and therefore exercises control, and
upon which the Company has a controlling financial interest. The existence and effect of both current voting rights and potential voting
rights that are currently exercisable or convertible are considered when assessing whether control of an entity is exercised. The subsidiary
is consolidated from the date at which the Company obtains control and is de-consolidated from the date at which control ceases. All
intercompany balances and transactions have been eliminated. The accounting policies of the subsidiary has been changed where necessary
to ensure consistency with the policies adopted by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the opinion of management, all necessary adjustments (consisting of normal recurring adjustments, intercompany adjustments, reclassifications
and non-recurring adjustments) have been recorded to present fairly our financial position as of December 31, 2023 and 2022, and the
results of operations and cash flows for the years ended December 31, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--UseOfEstimates_zuHXuPyQYhRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_zdFpqJxIRgOh"&gt;Use
of Estimates&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets, liabilities and disclosure of contingent assets and liabilities at the date of the audited consolidated
financial statements and the reported amounts of revenues and expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that estimates made as of the date
of the financial statements could change in the near term due to one or more future events. Actual results could differ significantly
from these estimates. Significant accounting estimates reflected in the Company&#x2019;s consolidated financial statements include estimates
of impairment of goodwill, recognition and measurement of convertible and Simple Agreement for Future Equity (SAFE) notes, including
the associated embedded derivatives, determination of the fair value of the warrant liabilities, and recognition and measurement of stock
compensation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_ecustom--CertainRisksAndUncertaintiesPolicyTextBlock_z8ay4HoCkSu8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zsDzZziuJ4vd"&gt;Certain
Risks and Uncertainties&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s business and operations are sensitive to general business and economic conditions. These conditions include short-term
and long-term interest rates, inflation, fluctuations in debt and equity capital markets and the general condition of the world economy.
A host of factors beyond the Company&#x2019;s control could cause fluctuations in these conditions. Adverse developments in these general
business and economic conditions could have a material adverse effect on the Company&#x2019;s financial condition and the results of its
operations. In addition, the Company will compete with many companies that currently have extensive and well-funded products, marketing
and sales operations. The Company may be unable to compete successfully against these companies. The Company&#x2019;s industry is characterized
by rapid changes in technology and market demands. As a result, the Company&#x2019;s products, services, or expertise may become obsolete
or unmarketable. The Company&#x2019;s future success will depend on its ability to adapt to technological advances, anticipate customer
and market demands, and enhance its current technology. The Company is also subject to risks which include, but are not limited to, dependence
on key personnel, reliance on third parties, successful integration of business acquisitions, protection of proprietary technology, and
compliance with regulatory requirements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z6Xf4Vp3eXUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_z7KrbnFFoL78"&gt;Cash&lt;/span&gt;
&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all highly liquid investments purchased with original maturities of 90 days or less to be cash equivalents. As of December
31, 2023 and 2022, the Company does &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zHZC1yuIkDSh" title="Cash equivalents"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_zbdZ5La5zXge" title="Cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt;t have any cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has no significant off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other
hedging arrangements. The Company holds cash in banks in excess of federally insured limits. However, the Company believes risk of loss
is minimal as the cash is held by large highly rated financial institutions. To reduce its risk associated with the failure of such financial
institutions, the Company evaluates at least annually the rating of the financial institutions in which it holds cash. Any material loss
that the Company may experience in the future could have an adverse effect on its ability to pay its operational expenses or make other
payments and may require the Company to move its cash to other high quality financial institutions. Currently, the Company is reviewing
its bank relationships in order to mitigate its risk to ensure that its exposure is limited or reduced to the FDIC protection limits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--CreditLossFinancialInstrumentPolicyTextBlock_z4CEO1MOeLi2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_869_zvk0lRYNYoBc"&gt;Accounts
Receivable and Allowance for Credit Losses&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable consist of balances due from customers as well as from payment service providers. Payment terms range from due upon receipt,
to net 30 days. Accounts receivable are stated net of an allowance for credit losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
allowance for expected credit losses is based on the probability of future collection under the current expected credited loss (&#x201c;CECL&#x201d;)
impairment model which was adopted by the Company on January 1, 2023, as discussed below within Recent Accounting Pronouncements. The
adoption of ASU No. 2016-13, Financial Instruments: Credit Losses (Topic 326) (&#x201c;ASU 2016-13&#x201d;) did not have a material impact
on these consolidated financial statements. Account balances are written off after all means of collection are exhausted and the balance
is deemed uncollectible. Subsequent recoveries are credited to the allowance. Changes in the allowance are recorded as adjustments to
credit losses in the period incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023 and 2022, the Company determined an allowance for credit losses of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_zgT9F1iYq8cl" title="Allowance for credit losses"&gt;5,748&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20221231_zVOV6K5QRpg3" title="Allowance for credit losses"&gt;107,860&lt;/span&gt; was required, respectively.
Further, for the years ended December 31, 2023 and 2022, the Company recognized bad debt expenses for accounts receivable balances of
$&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_905_ecustom--BadDebtExpensesForAccountsReceivable_c20230101__20231231_zDKkPUhsrPF4" title="Bad debt expenses for accounts receivable"&gt;65,013&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_906_ecustom--BadDebtExpensesForAccountsReceivable_c20220101__20221231_zoJJhJcKhFgc" title="Bad debt expenses for accounts receivable"&gt;142,162&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--AccountsReceivableAllowanceForCreditLossTableTextBlock_zbqJGbxKY76a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents changes in the allowance for credit losses for the year ended December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zVsFU8xPJC94" style="display: none"&gt;Summary of Changes in Allowance for Credit Losses&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_4B9_zusdgIkXYwgk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20230101__20231231_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iS_zzaB2moNMBK2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"&gt;Balance-January 1, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;107,860&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_zHYtpObRAUV9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Change in provision for credit losses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(102,112&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20230101__20231231_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iE_zUbNknEdjZYi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"&gt;Balance-December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,748&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zVBgIXWZNdx5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zaPcUMuaeQef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zAdor55zEb08"&gt;Property
and Equipment&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are recorded at cost and presented net of accumulated depreciation. Major additions and betterments are capitalized while
maintenance and repairs, which do not improve or extend the life of the respective assets, are expensed. Property and equipment are depreciated
on the straight-line basis over their estimated useful lives (&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zSSRZw2KtBH6" title="Property and equipment estimated useful lives"&gt;3 years&lt;/span&gt; for computer equipment).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zjX6nvAeHLwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zm3JzGt36lef"&gt;Goodwill&lt;/span&gt;
&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Goodwill
represents the excess of the purchase price over the fair value of the net identifiable assets acquired in a business combination. Goodwill
is reviewed for impairment at least annually, in December, or more frequently if a triggering event occurs between impairment testing
dates. As of December 31, 2023, the Company had &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_eus-gaap--NumberOfOperatingSegments_dc_uPure_c20230101__20231231_zrahYQTH7Ll1" title="Number of operating segments"&gt;one&lt;/span&gt; operating segment, which was deemed to be its reporting unit, for the purpose of
evaluating goodwill impairment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s impairment assessment begins with a qualitative assessment to determine whether it is more likely than not that the fair
value of the reporting unit is less than its carrying value. Qualitative factors may include, macroeconomic conditions, industry and
market considerations, cost factors, and other relevant entity and Company specific events. If, based on the qualitative test, the Company
determines that it is &#x201c;more likely than not&#x201d; that the fair value of a reporting unit is less than its carrying value, then
we evaluate goodwill for impairment by comparing the fair value of our reporting unit to its respective carrying value, including its
goodwill. If it is determined that it is not likely that the fair value of the reporting unit is less than its carrying value, then no
further testing is required.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
selection and assessment of qualitative factors used to determine whether it is more likely than not that the fair value of a reporting
unit exceeds the carrying value involves significant judgment and estimates. Fair values may be determined using a combination of both
income and market-based approaches. There were &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90F_eus-gaap--GoodwillImpairmentLoss_do_c20230101__20231231_zmjMI9vAKOzi" title="Goodwill, impairment loss"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90B_eus-gaap--GoodwillImpairmentLoss_do_c20220101__20221231_zqC9h3U6PFn2" title="Goodwill, impairment loss"&gt;no&lt;/span&gt;&lt;/span&gt; impairments of goodwill recorded for the years ended December 31, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--DeferredChargesPolicyTextBlock_zRKettLWH0A7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zavRtN8X5Hh4"&gt;Deferred
Offering Costs&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
2022 and 2023, the Company capitalized fees related to the Merger Agreement (see &lt;i&gt;Note 1-Organization&lt;/i&gt; and &lt;i&gt;Note 4-Merger&lt;/i&gt;)
as an asset. These fees were recognized as a reduction of equity, upon Closing of the Merger on December 14, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_ecustom--CapitalizedDeferredOfferingCostsTableTextBlock_zQHjvAAiKmnb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Capitalized
deferred offering costs consisted of the following, as of December 14, 2023 and December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zsBM5gxo7iQi" style="display: none"&gt;Summary of Capitalized Deferred Offering Costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231214_zeNpTt8Y44Q6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 14,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20221231_zTOzkOUDjl44" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredCosts_iI_hsrt--ProductOrServiceAxis__custom--SPACRelatedLegalFeesMember_zfmfkrt9uGj3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"&gt;SPAC-related legal fees&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;2,973,077&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;1,264,914&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredCosts_iI_hsrt--ProductOrServiceAxis__custom--InvestmentBankAdvisoryServicesMember_zvdEl3LVYaUc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Investment bank advisory services&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;135,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;135,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredCosts_iI_hsrt--ProductOrServiceAxis__custom--FederalTradeCommissionFilingFeesMember_zhvnd5H3iU1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;Federal Trade Commission filing fees&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;125,020&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;125,020&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredCosts_iI_z4voK7qnHL49" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Total deferred offering costs capitalized&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,233,097&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,524,934&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zTnVtrr7n3Ra" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
entire balance of Deferred Offering Costs capitalized as of December 14, 2023, was reclassified to Additional Paid-in- Capital, on December
14, 2023, in connection with the closing of the Merger. As a result, there was &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90D_eus-gaap--DeferredCosts_iI_dxL_c20231231_zyGmX2QG0mO5" title="Deferred offering costs::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3441"&gt;no&lt;/span&gt;&lt;/span&gt; Deferred Offering Costs balance as of December 31,
2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--WarrantLiabilitiesPolicyTextBlock_z28RseGibpjk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_z9wQV1OLWgc2"&gt;Warrant
Liabilities&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates
all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain
features that qualify as embedded derivatives. The classification of derivative instruments, including whether such instruments should
be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Warrant
Liability-related party &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Public Warrants are recognized as derivative liabilities in accordance with ASC 815 &lt;i&gt;Derivatives and Hedging&lt;/i&gt; (&#x201c;ASC 815&#x201d;).
Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at
each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair
value is recognized in the Company&#x2019;s consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Public Warrants were initially measured at fair value using a Monte Carlo simulation model and have subsequently been measured based
on the listed market price of such warrants. The determination of the fair value of the warrant liabilities may be subject to change
as more current information becomes available and accordingly the actual results could differ significantly. Warrant liabilities are
classified as current liabilities on the Company&#x2019;s consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Warrant
Liability &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
GEM Warrants were not considered indexed to the issuer&#x2019;s stock pursuant to ASC 815, as the holder&#x2019;s ability to receive one
percent of the total consideration received by the Company&#x2019;s stockholders in connection with a Change of Control in lieu of the
Warrant, where the surviving corporation is not publicly traded, adjusts the settlement value based on items outside the Company&#x2019;s
control in violation of the fixed-for-fixed option pricing model. As such, the Company recorded the Warrants as liabilities initially
measured at fair value with subsequent changes in fair value recognized in earnings each reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
measurement of fair value was determined utilizing a Monte Carlo simulation considering all relevant assumptions current at the date
of issuance (i.e., share price, exercise price, term, volatility, risk-free rate, probability of dilutive term of three years, and expected
time to conversion). The Company determined the Warrants were share issuance costs associated with an aborted offering to purchase equity.
Aborted offering costs may not be deferred and charged against proceeds of a subsequent offering. As such, the Company recorded an expense
for the corresponding fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_ecustom--SimpleAgreementsForFutureEquityPolicyTextBlock_zlAUqqjomGoc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zPq0YNlE7xpd"&gt;Simple
Agreements for Future Equity-SAFE&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for Simple Agreements for Future Equity (&#x201c;SAFE&#x201d;) at fair value in accordance with ASC 480 &lt;i&gt;Distinguishing
Liabilities from Equity&lt;/i&gt;. The SAFEs are subject to revaluation at the end of each reporting period, with changes in fair value recognized
in the accompanying Consolidated Statement of Operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zklLGTZVmuE1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_zJHotbxNCyk3"&gt;Concentration
of Business and Credit Risk&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents and
accounts receivable. The Company has no financial instruments with off-balance sheet risk of loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31, 2023, no customers accounted for 10% or more of accounts receivable. At December 31, 2022, three customers accounted for
10% or more of accounts receivable with concentrations of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zfeKCFKprEEj" title="Concentration risk, percentage"&gt;21&lt;/span&gt;%, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zDvqymcNSpik" title="Concentration risk, percentage"&gt;16&lt;/span&gt;%, and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zeStaXssLwy4" title="Concentration risk, percentage"&gt;10&lt;/span&gt;% and totaling approximately &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z81lifLRS1gc" title="Concentration risk, percentage"&gt;47&lt;/span&gt;% of the total accounts receivable
balance as of December 31, 2022. Total revenues from these customers amounted to $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231__srt--MajorCustomersAxis__custom--ThreeCustomersMember_zp5XKQtldbaa" title="Revenue"&gt;259,635&lt;/span&gt; for the year ended December 31, 2022. For the
years ended December 31, 2023 and 2022, no customers accounted for 10% or more of total revenues, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31, 2023 and 2022, one supplier accounted for 10% or more of accounts payable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zu4Ar8JqgHt7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zBW7nJMSOEIl"&gt;Loss
Per Share&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of
shares of common stock outstanding during the year. Diluted net loss per share excludes, when applicable, the potential impact of stock
options and convertible preferred stock because their effect would be anti-dilutive due to the net loss. Since the Company had a net
loss in each of the periods presented, basic and diluted net loss per common share are the same.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXwIRXui54D6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of basic and diluted net loss per share attributable to common stock was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_znRRvaeZYUj" style="display: none"&gt;Schedule of Basic and Diluted Net Loss Per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230101__20231231_zyljBRpoRnc" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220101__20221231_zMtTigL1f4rk" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;Numerator:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_zDotzyTRaJpi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Net loss attributable to common stock-basic and diluted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(14,406,262&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(15,468,502&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;Denominator:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted average shares-basic and diluted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231_zWHRKHsShk5j" title="Weighted average shares-basic"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231_zr2PW3EFJov3" title="Weighted average shares-diluted"&gt;137,074&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20220101__20221231_zhXpOvb1bcUe" title="Weighted average shares-basic"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20220101__20221231_zFyqvZPgwtV5" title="Weighted average shares-diluted"&gt;128,822&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Net loss per share attributable to common stock-basic and diluted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zBILTS3BFBK1" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_901_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_zQfQ7NrmJxn5" title="Net loss per share attributable to common stock-diluted"&gt;(105.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareBasic_pid_c20220101__20221231_zSbeAeQQ4J01" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pid_c20220101__20221231_zCH4fcc14tF5" title="Net loss per share attributable to common stock-diluted"&gt;(111.83&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;/p&gt;&lt;p id="xdx_8A9_zBcSb89tcJy7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zvZtEb6rjACc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Securities
that were excluded from loss per share as their effect would be anti-dilutive due to the net loss position that could potentially be
dilutive in future periods are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_zm0p93R1Rx62" style="display: none"&gt;Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230101__20231231_zD4sc1lVzEz5" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220101__20221231_za0SLNEum1m" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zjH8OzJsso7k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%"&gt;Options&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;14,962&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;7,420&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublicWarrantsMember_zXInKZOWwl8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Public warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;230,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3488"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--GemWarrantsMember_zTIHoj5QNScf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;GEM warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;16,571&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3491"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zNkxxWPIpY3g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;261,533&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,420&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zXKjJqiq7PQ1" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Antidilutive Securities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;261,533&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,420&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zMHynszJU8d1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--LesseeLeasesPolicyTextBlock_zpC8zMOMF35l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zdpRyXDVMLE"&gt;Leases&lt;/span&gt;
&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines if an arrangement is a lease at inception and classifies its leases at commencement. Operating leases are presented
as right-of-use (&#x201c;ROU&#x201d;) assets and the corresponding lease liabilities are included in operating lease liabilities, current
and operating lease liabilities, non-current on the Company&#x2019;s balance sheets. ROU assets represent the Company&#x2019;s right to
use an underlying asset, and lease liabilities represent the Company&#x2019;s obligation for lease payments in exchange for the ability
to use the asset for the duration of the lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ROU
assets and lease liabilities are recognized at commencement date and determined using the present value of the future minimum lease payments
over the lease term. The Company uses an incremental borrowing rate based on estimated rate of interest for collateralized borrowing
since the Company&#x2019;s leases do not include an implicit interest rate. The estimated incremental borrowing rate considers market
data, actual lease economic environment, and actual lease term at commencement date. The lease term may include options to extend when
it is reasonably certain that the Company will exercise that option. In addition, the Company does not recognize short-term leases that
have a term of twelve months or less as ROU assets or lease liabilities. The Company recognizes operating lease expense on a straight-line
basis over the lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has lease agreements which contain both lease and non-lease components, which it has elected to account for as a single lease
component when the payments are fixed. As such, variable lease payments, including those not dependent on an index or rate, such as real
estate taxes, common area maintenance, and other costs that are subject to fluctuation from period to period are not included in lease
measurement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates long-lived assets for recoverability if there are indicators of potential impairment. Indicators of potential impairment
may include subleasing a location for less than the head lease cost. If there are indicators of potential impairment, the Company will
test the assets for recoverability. If the undiscounted cash flows estimated to be generated are less than the carrying value of the
underlying assets, the assets are deemed impaired. If it is determined that assets are impaired, an impairment loss is calculated based
on the amount that the asset&#x2019;s book value exceeds its fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zZXKp406CUbd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zCNL1DgggVef"&gt;Revenue
Recognition&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
is generated through Banzai providing marketing and webinar platform subscription software service for a set period of time. The Statement
of Work (&#x201c;SOW&#x201d;) or Invoice, and the accompanying documents are negotiated and signed by both parties (if applicable). Alternatively,
customer contracting is achieved via self service and invoicing is initiated automatically once the customer accepts the terms and conditions
on the platform, based on their selection of the desired subscription product. When execution or completion of the contract occurs, the
contract is valid and revenue is earned when the service is provided for each period of performance, daily. The amount is paid by the
customer based on the contract terms monthly, quarterly, or annually, with the majority paid via credit card processing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue in an amount that reflects the consideration to which it expects to be entitled in exchange for the transfer
of promised services to its customers. To determine revenue recognition for contracts with customers, the Company performs the following
steps described in ASC 606: (1) identifies the contract with the customer, or Step 1, (2) identifies the performance obligations in the
contract, or Step 2, (3) determines the transaction price, or Step 3, (4) allocates the transaction price to the performance obligations
in the contract, or Step 4, and (5) recognizes revenue when (or as) the entity satisfies a performance obligation, or Step 5.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
from contracts with customers are not recorded until the Company has the approval and commitment from the parties, the rights of the
parties are identified, payment terms are established, the contract has commercial substance and collectability of the consideration
is probable. The Company also evaluates the following indicators, amongst others, when determining whether it is acting as a principal
in the transaction (and therefore whether to record revenue on a gross basis): (i) whether the Company is primarily responsible for fulfilling
the promise to provide the specified good or service, (ii) whether the Company has the inventory risk before the specified good or service
has been transferred to a customer or after transfer of control to the customerCan and (iii) whether the Company has the discretion to
establish the price for the specified good or service. If the terms of a transaction do not indicate that the Company is acting as a
principal in the transaction, then the Company is acting as an agent in the transaction and therefore, the associated revenue is recognized
on a net basis (that is revenue net of costs).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
is recognized once control passes to the customer. The following indicators are evaluated in determining when control has passed to the
customer: (i) whether the Company has a right to payment for the product or service, (ii) whether the customer has legal title to the
product or service, (iii) whether the Company has transferred physical possession of the product or service to the customer, (iv) whether
the customer has the significant risk and rewards of ownership of the product or service and (v) whether the customer has accepted the
product or service. When an arrangement contains more than one performance obligation, the Company will allocate the transaction price
to each performance obligation on a relative standalone selling price basis. The Company utilizes the observable price of products and
services when they are sold separately to similar customers in order to estimate standalone selling price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--CostOfSalesPolicyTextBlock_zfksxNI7mG0c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zJclXt0KNfFg"&gt;Costs
of Revenue&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Costs
of revenue consist primarily of infrastructure, streaming service, data license and contracted services costs, as well as merchant fees
and payroll costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--AdvertisingCostsPolicyTextBlock_zeBFUbSbekr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zSNjRAolxZl2"&gt;Advertising
Costs&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Advertising
costs are expensed as incurred. Advertising costs were $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_906_eus-gaap--AdvertisingExpense_c20230101__20231231_zdPo9d2xTJr4" title="Advertising costs"&gt;941,737&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_901_eus-gaap--AdvertisingExpense_c20220101__20221231_zSOcuVwqs666" title="Advertising costs"&gt;783,764&lt;/span&gt; for the years ended December 31, 2023 and 2022, respectively,
which are included in general and administrative expenses on the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zLD9TM4Vqtma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zsvn8rSw1lJ9"&gt;Stock-Based
Compensation&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company expenses stock-based compensation to employees and non-employees over the requisite service period based on the estimated grant-date
fair value of the awards in accordance with ASC 718, &lt;i&gt;Stock Compensation&lt;/i&gt;. The Company accounts for forfeitures as they occur. The
Company estimates the fair value of stock option grants using the Black-Scholes option pricing model, and the assumptions used in calculating
the fair value of stock-based awards represent management&#x2019;s best estimates and involve inherent uncertainties and the application
of management&#x2019;s judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zb8dGSby8Qj7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zFA5mQqvNgQd"&gt;Income
Taxes&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are recorded in accordance with ASC 740, &lt;i&gt;Income Taxes&lt;/i&gt; (&#x201c;ASC 740&#x201d;), which provides for deferred taxes using an
asset and liability approach. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of
events that have been included in the financial statements or tax returns. Deferred tax assets and liabilities are determined based on
the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year
in which the differences are expected to reverse. Valuation allowances are provided, if based upon the weight of available evidence,
it is more likely than not that some or all of the deferred tax assets will not be realized. The Company accounts for uncertain tax positions
in accordance with the provisions of ASC 740. When uncertain tax positions exist, the Company recognizes the tax benefit of tax positions
to the extent that the benefit would more likely than not be realized assuming examination by the taxing authority. The determination
as to whether the tax benefit will more likely than not be realized is based upon the technical merits of the tax position as well as
consideration of the available facts and circumstances. The Company recognizes any interest and penalties accrued related to unrecognized
tax benefits as income tax expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--DerivativesPolicyTextBlock_zUSVWbE1aQA" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zgqhFh80Eifd"&gt;Derivative
Financial Instruments&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates all its financial instruments to determine if such instruments contain features that qualify as embedded derivatives.
Embedded derivatives must be separately measured from the host contract if all the requirements for bifurcation are met. The assessment
of the conditions surrounding the bifurcation of embedded derivatives depends on the nature of the host contract. Bifurcated embedded
derivatives are recognized at fair value, with changes in fair value recognized in the statement of operations each period. Bifurcated
embedded derivatives are classified with the related host contract in the Company&#x2019;s balance sheet. Refer to &lt;i&gt;Note 8-Fair Value
Measurements&lt;/i&gt; and &lt;i&gt;Note 14-Debt&lt;/i&gt; for further detail.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zCPP2ukOwZ8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zlyPlzS2VVSk"&gt;Fair
Value of Financial Instruments&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with FASB ASC 820 &lt;i&gt;Fair Value Measurements and Disclosures&lt;/i&gt;, the Company uses a three-level hierarchy for fair value
measurements of certain assets and liabilities for financial reporting purposes that distinguishes between market participant assumptions
developed from market data obtained from outside sources (observable inputs) and the Company&#x2019;s own assumptions about market participant
assumptions developed from the best information available to us in the circumstances (unobservable inputs). The fair value hierarchy
is divided into three levels based on the source of inputs as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1: Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2: Inputs other than Level 1 prices for similar assets or liabilities that are directly or indirectly observable in the marketplace.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3: Unobservable inputs which are supported by little or no market activity and values determined using pricing models, discounted cash
flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment
or estimation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management
during the years ended December 31, 2023 and 2022. The carrying amount of cash, accounts receivable, prepaid expenses and other current
assets, accounts payable, accrued expenses, deferred revenue, and other current liabilities approximated their fair values as of December
31, 2023 and 2022. During 2022, the Company carried convertible notes bifurcated embedded derivatives and Simple Agreements for Future
Equity (&#x201c;SAFE&#x201d;) investments at their fair value (see &lt;i&gt;Note 8-Fair Value Measurements&lt;/i&gt; for fair value information).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--BusinessCombinationsPolicy_zYdZ3SJwjpm3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zzx8NwE9bq2g"&gt;Business
Combinations&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for business combinations in accordance with FASB ASC 805 (&#x201c;ASC 805&#x201d;), &lt;i&gt;Business Combinations&lt;/i&gt;. Accordingly,
identifiable tangible and intangible assets acquired and liabilities assumed are recorded at their estimated fair values, the excess
of the purchase consideration over the fair values of net assets acquired is recorded as goodwill, and transaction costs are expensed
as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zx2z8PsK1Jbj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zF2dah4L1ZBi"&gt;Recent
Accounting Pronouncements&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Recent
accounting pronouncements not yet effective &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09 (Topic 740), Improvements to income tax disclosures, which enhances the disclosure requirements
for the income tax rate reconciliation, domestic and foreign income taxes paid, requiring disclosure of disaggregated income taxes paid
by jurisdiction, unrecognized tax benefits, and modifies other income tax-related disclosures. The amendments are effective for annual
periods beginning after December 15, 2024. Early adoption is permitted and should be applied prospectively. The Company is currently
evaluating the effect of adopting this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85C_zMJAmTwyhpBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="From2023-01-012023-12-31" id="Fact003379">&lt;p id="xdx_84B_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zfGhfNkLWX13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zlkKakw2weZ3"&gt;Basis
of Presentation&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s audited consolidated financial statements have been prepared in conformity with accounting principles generally accepted
in the United States of America (&#x201c;GAAP&#x201d;) as determined by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting
Standards Codification (&#x201c;ASC&#x201d;) and applicable regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) regarding
annual financial reporting.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;Effective September 19, 2024, the Company completed a &lt;span id="xdx_901_eus-gaap--StockholdersEquityReverseStockSplit_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zbEiRyMUfF9f" title="Reverse stock split"&gt;one-for-fifty (1-for-50) reverse stock split&lt;/span&gt; of our issued
and outstanding shares of Class A Common Stock without a corresponding reduction in the total number of authorized shares of our Class
A Common Stock (the &#x201c;Reverse Stock Split&#x201d;). All references to shares of the Company&#x2019;s Class A Common Stock in these
financial statements refer to the number of shares of Class A Common Stock after giving effect to the Reverse Stock Split and are presented
as if the Reverse Stock Split had occurred at the beginning of the earliest period presented.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:StockholdersEquityReverseStockSplit
      contextRef="From2024-09-192024-09-19_us-gaap_SubsequentEventMember"
      id="Fact003381">one-for-fifty (1-for-50) reverse stock split</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact003383">&lt;p id="xdx_84F_eus-gaap--ConsolidationPolicyTextBlock_zXT8URj9EB6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zkuEel5BPMli"&gt;Principles
of Consolidation&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying audited consolidated financial statements include the accounts of Banzai and its subsidiaries. The Company consolidates
all entities over which the Company has the power to govern the financial and operating policies and therefore exercises control, and
upon which the Company has a controlling financial interest. The existence and effect of both current voting rights and potential voting
rights that are currently exercisable or convertible are considered when assessing whether control of an entity is exercised. The subsidiary
is consolidated from the date at which the Company obtains control and is de-consolidated from the date at which control ceases. All
intercompany balances and transactions have been eliminated. The accounting policies of the subsidiary has been changed where necessary
to ensure consistency with the policies adopted by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the opinion of management, all necessary adjustments (consisting of normal recurring adjustments, intercompany adjustments, reclassifications
and non-recurring adjustments) have been recorded to present fairly our financial position as of December 31, 2023 and 2022, and the
results of operations and cash flows for the years ended December 31, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2023-01-012023-12-31" id="Fact003385">&lt;p id="xdx_842_eus-gaap--UseOfEstimates_zuHXuPyQYhRc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_zdFpqJxIRgOh"&gt;Use
of Estimates&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets, liabilities and disclosure of contingent assets and liabilities at the date of the audited consolidated
financial statements and the reported amounts of revenues and expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that estimates made as of the date
of the financial statements could change in the near term due to one or more future events. Actual results could differ significantly
from these estimates. Significant accounting estimates reflected in the Company&#x2019;s consolidated financial statements include estimates
of impairment of goodwill, recognition and measurement of convertible and Simple Agreement for Future Equity (SAFE) notes, including
the associated embedded derivatives, determination of the fair value of the warrant liabilities, and recognition and measurement of stock
compensation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <BNZI:CertainRisksAndUncertaintiesPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact003387">&lt;p id="xdx_841_ecustom--CertainRisksAndUncertaintiesPolicyTextBlock_z8ay4HoCkSu8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zsDzZziuJ4vd"&gt;Certain
Risks and Uncertainties&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s business and operations are sensitive to general business and economic conditions. These conditions include short-term
and long-term interest rates, inflation, fluctuations in debt and equity capital markets and the general condition of the world economy.
A host of factors beyond the Company&#x2019;s control could cause fluctuations in these conditions. Adverse developments in these general
business and economic conditions could have a material adverse effect on the Company&#x2019;s financial condition and the results of its
operations. In addition, the Company will compete with many companies that currently have extensive and well-funded products, marketing
and sales operations. The Company may be unable to compete successfully against these companies. The Company&#x2019;s industry is characterized
by rapid changes in technology and market demands. As a result, the Company&#x2019;s products, services, or expertise may become obsolete
or unmarketable. The Company&#x2019;s future success will depend on its ability to adapt to technological advances, anticipate customer
and market demands, and enhance its current technology. The Company is also subject to risks which include, but are not limited to, dependence
on key personnel, reliance on third parties, successful integration of business acquisitions, protection of proprietary technology, and
compliance with regulatory requirements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BNZI:CertainRisksAndUncertaintiesPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact003389">&lt;p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z6Xf4Vp3eXUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_z7KrbnFFoL78"&gt;Cash&lt;/span&gt;
&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all highly liquid investments purchased with original maturities of 90 days or less to be cash equivalents. As of December
31, 2023 and 2022, the Company does &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_908_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20231231_zHZC1yuIkDSh" title="Cash equivalents"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_zbdZ5La5zXge" title="Cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt;t have any cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has no significant off-balance-sheet concentration of credit risk such as foreign exchange contracts, option contracts or other
hedging arrangements. The Company holds cash in banks in excess of federally insured limits. However, the Company believes risk of loss
is minimal as the cash is held by large highly rated financial institutions. To reduce its risk associated with the failure of such financial
institutions, the Company evaluates at least annually the rating of the financial institutions in which it holds cash. Any material loss
that the Company may experience in the future could have an adverse effect on its ability to pay its operational expenses or make other
payments and may require the Company to move its cash to other high quality financial institutions. Currently, the Company is reviewing
its bank relationships in order to mitigate its risk to ensure that its exposure is limited or reduced to the FDIC protection limits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact003391"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact003393"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CreditLossFinancialInstrumentPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact003395">&lt;p id="xdx_84F_eus-gaap--CreditLossFinancialInstrumentPolicyTextBlock_z4CEO1MOeLi2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_869_zvk0lRYNYoBc"&gt;Accounts
Receivable and Allowance for Credit Losses&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable consist of balances due from customers as well as from payment service providers. Payment terms range from due upon receipt,
to net 30 days. Accounts receivable are stated net of an allowance for credit losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
allowance for expected credit losses is based on the probability of future collection under the current expected credited loss (&#x201c;CECL&#x201d;)
impairment model which was adopted by the Company on January 1, 2023, as discussed below within Recent Accounting Pronouncements. The
adoption of ASU No. 2016-13, Financial Instruments: Credit Losses (Topic 326) (&#x201c;ASU 2016-13&#x201d;) did not have a material impact
on these consolidated financial statements. Account balances are written off after all means of collection are exhausted and the balance
is deemed uncollectible. Subsequent recoveries are credited to the allowance. Changes in the allowance are recorded as adjustments to
credit losses in the period incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023 and 2022, the Company determined an allowance for credit losses of $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20231231_zgT9F1iYq8cl" title="Allowance for credit losses"&gt;5,748&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20221231_zVOV6K5QRpg3" title="Allowance for credit losses"&gt;107,860&lt;/span&gt; was required, respectively.
Further, for the years ended December 31, 2023 and 2022, the Company recognized bad debt expenses for accounts receivable balances of
$&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_905_ecustom--BadDebtExpensesForAccountsReceivable_c20230101__20231231_zDKkPUhsrPF4" title="Bad debt expenses for accounts receivable"&gt;65,013&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_906_ecustom--BadDebtExpensesForAccountsReceivable_c20220101__20221231_zoJJhJcKhFgc" title="Bad debt expenses for accounts receivable"&gt;142,162&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--AccountsReceivableAllowanceForCreditLossTableTextBlock_zbqJGbxKY76a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents changes in the allowance for credit losses for the year ended December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zVsFU8xPJC94" style="display: none"&gt;Summary of Changes in Allowance for Credit Losses&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_4B9_zusdgIkXYwgk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20230101__20231231_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iS_zzaB2moNMBK2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"&gt;Balance-January 1, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;107,860&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_zHYtpObRAUV9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Change in provision for credit losses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(102,112&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20230101__20231231_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iE_zUbNknEdjZYi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"&gt;Balance-December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,748&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zVBgIXWZNdx5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CreditLossFinancialInstrumentPolicyTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact003397"
      unitRef="USD">5748</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact003399"
      unitRef="USD">107860</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <BNZI:BadDebtExpensesForAccountsReceivable
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003401"
      unitRef="USD">65013</BNZI:BadDebtExpensesForAccountsReceivable>
    <BNZI:BadDebtExpensesForAccountsReceivable
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003403"
      unitRef="USD">142162</BNZI:BadDebtExpensesForAccountsReceivable>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact003405">&lt;p id="xdx_89D_eus-gaap--AccountsReceivableAllowanceForCreditLossTableTextBlock_zbqJGbxKY76a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents changes in the allowance for credit losses for the year ended December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zVsFU8xPJC94" style="display: none"&gt;Summary of Changes in Allowance for Credit Losses&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_4B9_zusdgIkXYwgk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20230101__20231231_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iS_zzaB2moNMBK2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"&gt;Balance-January 1, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;107,860&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_zHYtpObRAUV9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Change in provision for credit losses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(102,112&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20230101__20231231_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iE_zUbNknEdjZYi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"&gt;Balance-December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,748&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact003407"
      unitRef="USD">107860</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003409"
      unitRef="USD">-102112</us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact003411"
      unitRef="USD">5748</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact003413">&lt;p id="xdx_843_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zaPcUMuaeQef" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zAdor55zEb08"&gt;Property
and Equipment&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are recorded at cost and presented net of accumulated depreciation. Major additions and betterments are capitalized while
maintenance and repairs, which do not improve or extend the life of the respective assets, are expensed. Property and equipment are depreciated
on the straight-line basis over their estimated useful lives (&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dc_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zSSRZw2KtBH6" title="Property and equipment estimated useful lives"&gt;3 years&lt;/span&gt; for computer equipment).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2023-12-31_us-gaap_ComputerEquipmentMember"
      id="Fact003415">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="From2023-01-012023-12-31" id="Fact003417">&lt;p id="xdx_849_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zjX6nvAeHLwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zm3JzGt36lef"&gt;Goodwill&lt;/span&gt;
&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Goodwill
represents the excess of the purchase price over the fair value of the net identifiable assets acquired in a business combination. Goodwill
is reviewed for impairment at least annually, in December, or more frequently if a triggering event occurs between impairment testing
dates. As of December 31, 2023, the Company had &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_907_eus-gaap--NumberOfOperatingSegments_dc_uPure_c20230101__20231231_zrahYQTH7Ll1" title="Number of operating segments"&gt;one&lt;/span&gt; operating segment, which was deemed to be its reporting unit, for the purpose of
evaluating goodwill impairment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s impairment assessment begins with a qualitative assessment to determine whether it is more likely than not that the fair
value of the reporting unit is less than its carrying value. Qualitative factors may include, macroeconomic conditions, industry and
market considerations, cost factors, and other relevant entity and Company specific events. If, based on the qualitative test, the Company
determines that it is &#x201c;more likely than not&#x201d; that the fair value of a reporting unit is less than its carrying value, then
we evaluate goodwill for impairment by comparing the fair value of our reporting unit to its respective carrying value, including its
goodwill. If it is determined that it is not likely that the fair value of the reporting unit is less than its carrying value, then no
further testing is required.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
selection and assessment of qualitative factors used to determine whether it is more likely than not that the fair value of a reporting
unit exceeds the carrying value involves significant judgment and estimates. Fair values may be determined using a combination of both
income and market-based approaches. There were &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90F_eus-gaap--GoodwillImpairmentLoss_do_c20230101__20231231_zmjMI9vAKOzi" title="Goodwill, impairment loss"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90B_eus-gaap--GoodwillImpairmentLoss_do_c20220101__20221231_zqC9h3U6PFn2" title="Goodwill, impairment loss"&gt;no&lt;/span&gt;&lt;/span&gt; impairments of goodwill recorded for the years ended December 31, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:NumberOfOperatingSegments
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact003419"
      unitRef="Pure">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003421"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003423"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact003425">&lt;p id="xdx_843_eus-gaap--DeferredChargesPolicyTextBlock_zRKettLWH0A7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86B_zavRtN8X5Hh4"&gt;Deferred
Offering Costs&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
2022 and 2023, the Company capitalized fees related to the Merger Agreement (see &lt;i&gt;Note 1-Organization&lt;/i&gt; and &lt;i&gt;Note 4-Merger&lt;/i&gt;)
as an asset. These fees were recognized as a reduction of equity, upon Closing of the Merger on December 14, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_ecustom--CapitalizedDeferredOfferingCostsTableTextBlock_zQHjvAAiKmnb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Capitalized
deferred offering costs consisted of the following, as of December 14, 2023 and December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zsBM5gxo7iQi" style="display: none"&gt;Summary of Capitalized Deferred Offering Costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231214_zeNpTt8Y44Q6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 14,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20221231_zTOzkOUDjl44" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredCosts_iI_hsrt--ProductOrServiceAxis__custom--SPACRelatedLegalFeesMember_zfmfkrt9uGj3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"&gt;SPAC-related legal fees&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;2,973,077&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;1,264,914&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredCosts_iI_hsrt--ProductOrServiceAxis__custom--InvestmentBankAdvisoryServicesMember_zvdEl3LVYaUc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Investment bank advisory services&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;135,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;135,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredCosts_iI_hsrt--ProductOrServiceAxis__custom--FederalTradeCommissionFilingFeesMember_zhvnd5H3iU1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;Federal Trade Commission filing fees&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;125,020&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;125,020&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredCosts_iI_z4voK7qnHL49" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Total deferred offering costs capitalized&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,233,097&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,524,934&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zTnVtrr7n3Ra" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
entire balance of Deferred Offering Costs capitalized as of December 14, 2023, was reclassified to Additional Paid-in- Capital, on December
14, 2023, in connection with the closing of the Merger. As a result, there was &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90D_eus-gaap--DeferredCosts_iI_dxL_c20231231_zyGmX2QG0mO5" title="Deferred offering costs::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3441"&gt;no&lt;/span&gt;&lt;/span&gt; Deferred Offering Costs balance as of December 31,
2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DeferredChargesPolicyTextBlock>
    <BNZI:CapitalizedDeferredOfferingCostsTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact003427">&lt;p id="xdx_896_ecustom--CapitalizedDeferredOfferingCostsTableTextBlock_zQHjvAAiKmnb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Capitalized
deferred offering costs consisted of the following, as of December 14, 2023 and December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zsBM5gxo7iQi" style="display: none"&gt;Summary of Capitalized Deferred Offering Costs&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231214_zeNpTt8Y44Q6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 14,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20221231_zTOzkOUDjl44" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredCosts_iI_hsrt--ProductOrServiceAxis__custom--SPACRelatedLegalFeesMember_zfmfkrt9uGj3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"&gt;SPAC-related legal fees&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;2,973,077&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;1,264,914&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredCosts_iI_hsrt--ProductOrServiceAxis__custom--InvestmentBankAdvisoryServicesMember_zvdEl3LVYaUc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Investment bank advisory services&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;135,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;135,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredCosts_iI_hsrt--ProductOrServiceAxis__custom--FederalTradeCommissionFilingFeesMember_zhvnd5H3iU1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;Federal Trade Commission filing fees&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;125,020&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;125,020&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredCosts_iI_z4voK7qnHL49" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Total deferred offering costs capitalized&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,233,097&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,524,934&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BNZI:CapitalizedDeferredOfferingCostsTableTextBlock>
    <us-gaap:DeferredCosts
      contextRef="AsOf2023-12-14_custom_SPACRelatedLegalFeesMember"
      decimals="0"
      id="Fact003429"
      unitRef="USD">2973077</us-gaap:DeferredCosts>
    <us-gaap:DeferredCosts
      contextRef="AsOf2022-12-31_custom_SPACRelatedLegalFeesMember"
      decimals="0"
      id="Fact003430"
      unitRef="USD">1264914</us-gaap:DeferredCosts>
    <us-gaap:DeferredCosts
      contextRef="AsOf2023-12-14_custom_InvestmentBankAdvisoryServicesMember"
      decimals="0"
      id="Fact003432"
      unitRef="USD">135000</us-gaap:DeferredCosts>
    <us-gaap:DeferredCosts
      contextRef="AsOf2022-12-31_custom_InvestmentBankAdvisoryServicesMember"
      decimals="0"
      id="Fact003433"
      unitRef="USD">135000</us-gaap:DeferredCosts>
    <us-gaap:DeferredCosts
      contextRef="AsOf2023-12-14_custom_FederalTradeCommissionFilingFeesMember"
      decimals="0"
      id="Fact003435"
      unitRef="USD">125020</us-gaap:DeferredCosts>
    <us-gaap:DeferredCosts
      contextRef="AsOf2022-12-31_custom_FederalTradeCommissionFilingFeesMember"
      decimals="0"
      id="Fact003436"
      unitRef="USD">125020</us-gaap:DeferredCosts>
    <us-gaap:DeferredCosts
      contextRef="AsOf2023-12-14"
      decimals="0"
      id="Fact003438"
      unitRef="USD">3233097</us-gaap:DeferredCosts>
    <us-gaap:DeferredCosts
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact003439"
      unitRef="USD">1524934</us-gaap:DeferredCosts>
    <BNZI:WarrantLiabilitiesPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact003443">&lt;p id="xdx_84B_ecustom--WarrantLiabilitiesPolicyTextBlock_z28RseGibpjk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_866_z9wQV1OLWgc2"&gt;Warrant
Liabilities&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates
all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain
features that qualify as embedded derivatives. The classification of derivative instruments, including whether such instruments should
be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Warrant
Liability-related party &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Public Warrants are recognized as derivative liabilities in accordance with ASC 815 &lt;i&gt;Derivatives and Hedging&lt;/i&gt; (&#x201c;ASC 815&#x201d;).
Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at
each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair
value is recognized in the Company&#x2019;s consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Public Warrants were initially measured at fair value using a Monte Carlo simulation model and have subsequently been measured based
on the listed market price of such warrants. The determination of the fair value of the warrant liabilities may be subject to change
as more current information becomes available and accordingly the actual results could differ significantly. Warrant liabilities are
classified as current liabilities on the Company&#x2019;s consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Warrant
Liability &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
GEM Warrants were not considered indexed to the issuer&#x2019;s stock pursuant to ASC 815, as the holder&#x2019;s ability to receive one
percent of the total consideration received by the Company&#x2019;s stockholders in connection with a Change of Control in lieu of the
Warrant, where the surviving corporation is not publicly traded, adjusts the settlement value based on items outside the Company&#x2019;s
control in violation of the fixed-for-fixed option pricing model. As such, the Company recorded the Warrants as liabilities initially
measured at fair value with subsequent changes in fair value recognized in earnings each reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
measurement of fair value was determined utilizing a Monte Carlo simulation considering all relevant assumptions current at the date
of issuance (i.e., share price, exercise price, term, volatility, risk-free rate, probability of dilutive term of three years, and expected
time to conversion). The Company determined the Warrants were share issuance costs associated with an aborted offering to purchase equity.
Aborted offering costs may not be deferred and charged against proceeds of a subsequent offering. As such, the Company recorded an expense
for the corresponding fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BNZI:WarrantLiabilitiesPolicyTextBlock>
    <BNZI:SimpleAgreementsForFutureEquityPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact003445">&lt;p id="xdx_845_ecustom--SimpleAgreementsForFutureEquityPolicyTextBlock_zlAUqqjomGoc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_867_zPq0YNlE7xpd"&gt;Simple
Agreements for Future Equity-SAFE&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for Simple Agreements for Future Equity (&#x201c;SAFE&#x201d;) at fair value in accordance with ASC 480 &lt;i&gt;Distinguishing
Liabilities from Equity&lt;/i&gt;. The SAFEs are subject to revaluation at the end of each reporting period, with changes in fair value recognized
in the accompanying Consolidated Statement of Operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BNZI:SimpleAgreementsForFutureEquityPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2023-01-012023-12-31" id="Fact003447">&lt;p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zklLGTZVmuE1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86E_zJHotbxNCyk3"&gt;Concentration
of Business and Credit Risk&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents and
accounts receivable. The Company has no financial instruments with off-balance sheet risk of loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31, 2023, no customers accounted for 10% or more of accounts receivable. At December 31, 2022, three customers accounted for
10% or more of accounts receivable with concentrations of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zfeKCFKprEEj" title="Concentration risk, percentage"&gt;21&lt;/span&gt;%, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zDvqymcNSpik" title="Concentration risk, percentage"&gt;16&lt;/span&gt;%, and &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zeStaXssLwy4" title="Concentration risk, percentage"&gt;10&lt;/span&gt;% and totaling approximately &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThreeCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z81lifLRS1gc" title="Concentration risk, percentage"&gt;47&lt;/span&gt;% of the total accounts receivable
balance as of December 31, 2022. Total revenues from these customers amounted to $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231__srt--MajorCustomersAxis__custom--ThreeCustomersMember_zp5XKQtldbaa" title="Revenue"&gt;259,635&lt;/span&gt; for the year ended December 31, 2022. For the
years ended December 31, 2023 and 2022, no customers accounted for 10% or more of total revenues, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
December 31, 2023 and 2022, one supplier accounted for 10% or more of accounts payable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember_us-gaap_AccountsReceivableMember"
      decimals="INF"
      id="Fact003449"
      unitRef="Pure">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_CustomerConcentrationRiskMember_custom_CustomerTwoMember_us-gaap_AccountsReceivableMember"
      decimals="INF"
      id="Fact003451"
      unitRef="Pure">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_CustomerConcentrationRiskMember_custom_CustomerThreeMember_us-gaap_AccountsReceivableMember"
      decimals="INF"
      id="Fact003453"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_CustomerConcentrationRiskMember_custom_ThreeCustomersMember_us-gaap_AccountsReceivableMember"
      decimals="INF"
      id="Fact003455"
      unitRef="Pure">0.47</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_custom_ThreeCustomersMember"
      decimals="0"
      id="Fact003457"
      unitRef="USD">259635</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact003459">&lt;p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zu4Ar8JqgHt7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_861_zBW7nJMSOEIl"&gt;Loss
Per Share&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of
shares of common stock outstanding during the year. Diluted net loss per share excludes, when applicable, the potential impact of stock
options and convertible preferred stock because their effect would be anti-dilutive due to the net loss. Since the Company had a net
loss in each of the periods presented, basic and diluted net loss per common share are the same.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXwIRXui54D6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of basic and diluted net loss per share attributable to common stock was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_znRRvaeZYUj" style="display: none"&gt;Schedule of Basic and Diluted Net Loss Per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230101__20231231_zyljBRpoRnc" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220101__20221231_zMtTigL1f4rk" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;Numerator:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_zDotzyTRaJpi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Net loss attributable to common stock-basic and diluted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(14,406,262&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(15,468,502&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;Denominator:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted average shares-basic and diluted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231_zWHRKHsShk5j" title="Weighted average shares-basic"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231_zr2PW3EFJov3" title="Weighted average shares-diluted"&gt;137,074&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20220101__20221231_zhXpOvb1bcUe" title="Weighted average shares-basic"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20220101__20221231_zFyqvZPgwtV5" title="Weighted average shares-diluted"&gt;128,822&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Net loss per share attributable to common stock-basic and diluted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zBILTS3BFBK1" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_901_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_zQfQ7NrmJxn5" title="Net loss per share attributable to common stock-diluted"&gt;(105.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareBasic_pid_c20220101__20221231_zSbeAeQQ4J01" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pid_c20220101__20221231_zCH4fcc14tF5" title="Net loss per share attributable to common stock-diluted"&gt;(111.83&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;/p&gt;&lt;p id="xdx_8A9_zBcSb89tcJy7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zvZtEb6rjACc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Securities
that were excluded from loss per share as their effect would be anti-dilutive due to the net loss position that could potentially be
dilutive in future periods are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_zm0p93R1Rx62" style="display: none"&gt;Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230101__20231231_zD4sc1lVzEz5" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220101__20221231_za0SLNEum1m" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zjH8OzJsso7k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%"&gt;Options&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;14,962&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;7,420&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublicWarrantsMember_zXInKZOWwl8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Public warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;230,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3488"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--GemWarrantsMember_zTIHoj5QNScf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;GEM warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;16,571&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3491"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zNkxxWPIpY3g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;261,533&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,420&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zXKjJqiq7PQ1" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Antidilutive Securities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;261,533&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,420&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zMHynszJU8d1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact003461">&lt;p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zXwIRXui54D6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of basic and diluted net loss per share attributable to common stock was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_znRRvaeZYUj" style="display: none"&gt;Schedule of Basic and Diluted Net Loss Per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230101__20231231_zyljBRpoRnc" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220101__20221231_zMtTigL1f4rk" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;Numerator:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NetIncomeLossAvailableToCommonStockholdersDiluted_zDotzyTRaJpi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Net loss attributable to common stock-basic and diluted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(14,406,262&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(15,468,502&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;Denominator:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted average shares-basic and diluted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230101__20231231_zWHRKHsShk5j" title="Weighted average shares-basic"&gt;&lt;span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230101__20231231_zr2PW3EFJov3" title="Weighted average shares-diluted"&gt;137,074&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20220101__20221231_zhXpOvb1bcUe" title="Weighted average shares-basic"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20220101__20221231_zFyqvZPgwtV5" title="Weighted average shares-diluted"&gt;128,822&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Net loss per share attributable to common stock-basic and diluted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--EarningsPerShareBasic_pid_c20230101__20231231_zBILTS3BFBK1" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_901_eus-gaap--EarningsPerShareDiluted_pid_c20230101__20231231_zQfQ7NrmJxn5" title="Net loss per share attributable to common stock-diluted"&gt;(105.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--EarningsPerShareBasic_pid_c20220101__20221231_zSbeAeQQ4J01" title="Net loss per share attributable to common stock-basic"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pid_c20220101__20221231_zCH4fcc14tF5" title="Net loss per share attributable to common stock-diluted"&gt;(111.83&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;/p&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003463"
      unitRef="USD">-14406262</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003464"
      unitRef="USD">-15468502</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact003466"
      unitRef="Shares">137074</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact003468"
      unitRef="Shares">137074</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact003470"
      unitRef="Shares">128822</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact003472"
      unitRef="Shares">128822</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact003474"
      unitRef="USDPShares">-105.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact003476"
      unitRef="USDPShares">-105.10</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact003478"
      unitRef="USDPShares">-111.83</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact003480"
      unitRef="USDPShares">-111.83</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2023-01-012023-12-31" id="Fact003482">&lt;p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zvZtEb6rjACc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Securities
that were excluded from loss per share as their effect would be anti-dilutive due to the net loss position that could potentially be
dilutive in future periods are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_zm0p93R1Rx62" style="display: none"&gt;Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230101__20231231_zD4sc1lVzEz5" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20220101__20221231_za0SLNEum1m" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;As of December 31,&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zjH8OzJsso7k" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%"&gt;Options&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;14,962&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;7,420&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--PublicWarrantsMember_zXInKZOWwl8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Public warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;230,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3488"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--GemWarrantsMember_zTIHoj5QNScf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;GEM warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;16,571&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3491"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zNkxxWPIpY3g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;261,533&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,420&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zXKjJqiq7PQ1" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Antidilutive Securities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;261,533&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,420&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact003484"
      unitRef="Shares">14962</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact003485"
      unitRef="Shares">7420</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact003487"
      unitRef="Shares">230000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31_custom_GemWarrantsMember"
      decimals="INF"
      id="Fact003490"
      unitRef="Shares">16571</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact003493"
      unitRef="Shares">261533</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact003494"
      unitRef="Shares">7420</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact003496"
      unitRef="Shares">261533</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact003497"
      unitRef="Shares">7420</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact003499">&lt;p id="xdx_84A_eus-gaap--LesseeLeasesPolicyTextBlock_zpC8zMOMF35l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86F_zdpRyXDVMLE"&gt;Leases&lt;/span&gt;
&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines if an arrangement is a lease at inception and classifies its leases at commencement. Operating leases are presented
as right-of-use (&#x201c;ROU&#x201d;) assets and the corresponding lease liabilities are included in operating lease liabilities, current
and operating lease liabilities, non-current on the Company&#x2019;s balance sheets. ROU assets represent the Company&#x2019;s right to
use an underlying asset, and lease liabilities represent the Company&#x2019;s obligation for lease payments in exchange for the ability
to use the asset for the duration of the lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ROU
assets and lease liabilities are recognized at commencement date and determined using the present value of the future minimum lease payments
over the lease term. The Company uses an incremental borrowing rate based on estimated rate of interest for collateralized borrowing
since the Company&#x2019;s leases do not include an implicit interest rate. The estimated incremental borrowing rate considers market
data, actual lease economic environment, and actual lease term at commencement date. The lease term may include options to extend when
it is reasonably certain that the Company will exercise that option. In addition, the Company does not recognize short-term leases that
have a term of twelve months or less as ROU assets or lease liabilities. The Company recognizes operating lease expense on a straight-line
basis over the lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has lease agreements which contain both lease and non-lease components, which it has elected to account for as a single lease
component when the payments are fixed. As such, variable lease payments, including those not dependent on an index or rate, such as real
estate taxes, common area maintenance, and other costs that are subject to fluctuation from period to period are not included in lease
measurement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates long-lived assets for recoverability if there are indicators of potential impairment. Indicators of potential impairment
may include subleasing a location for less than the head lease cost. If there are indicators of potential impairment, the Company will
test the assets for recoverability. If the undiscounted cash flows estimated to be generated are less than the carrying value of the
underlying assets, the assets are deemed impaired. If it is determined that assets are impaired, an impairment loss is calculated based
on the amount that the asset&#x2019;s book value exceeds its fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact003501">&lt;p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zZXKp406CUbd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zCNL1DgggVef"&gt;Revenue
Recognition&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
is generated through Banzai providing marketing and webinar platform subscription software service for a set period of time. The Statement
of Work (&#x201c;SOW&#x201d;) or Invoice, and the accompanying documents are negotiated and signed by both parties (if applicable). Alternatively,
customer contracting is achieved via self service and invoicing is initiated automatically once the customer accepts the terms and conditions
on the platform, based on their selection of the desired subscription product. When execution or completion of the contract occurs, the
contract is valid and revenue is earned when the service is provided for each period of performance, daily. The amount is paid by the
customer based on the contract terms monthly, quarterly, or annually, with the majority paid via credit card processing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue in an amount that reflects the consideration to which it expects to be entitled in exchange for the transfer
of promised services to its customers. To determine revenue recognition for contracts with customers, the Company performs the following
steps described in ASC 606: (1) identifies the contract with the customer, or Step 1, (2) identifies the performance obligations in the
contract, or Step 2, (3) determines the transaction price, or Step 3, (4) allocates the transaction price to the performance obligations
in the contract, or Step 4, and (5) recognizes revenue when (or as) the entity satisfies a performance obligation, or Step 5.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
from contracts with customers are not recorded until the Company has the approval and commitment from the parties, the rights of the
parties are identified, payment terms are established, the contract has commercial substance and collectability of the consideration
is probable. The Company also evaluates the following indicators, amongst others, when determining whether it is acting as a principal
in the transaction (and therefore whether to record revenue on a gross basis): (i) whether the Company is primarily responsible for fulfilling
the promise to provide the specified good or service, (ii) whether the Company has the inventory risk before the specified good or service
has been transferred to a customer or after transfer of control to the customerCan and (iii) whether the Company has the discretion to
establish the price for the specified good or service. If the terms of a transaction do not indicate that the Company is acting as a
principal in the transaction, then the Company is acting as an agent in the transaction and therefore, the associated revenue is recognized
on a net basis (that is revenue net of costs).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue
is recognized once control passes to the customer. The following indicators are evaluated in determining when control has passed to the
customer: (i) whether the Company has a right to payment for the product or service, (ii) whether the customer has legal title to the
product or service, (iii) whether the Company has transferred physical possession of the product or service to the customer, (iv) whether
the customer has the significant risk and rewards of ownership of the product or service and (v) whether the customer has accepted the
product or service. When an arrangement contains more than one performance obligation, the Company will allocate the transaction price
to each performance obligation on a relative standalone selling price basis. The Company utilizes the observable price of products and
services when they are sold separately to similar customers in order to estimate standalone selling price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact003503">&lt;p id="xdx_848_eus-gaap--CostOfSalesPolicyTextBlock_zfksxNI7mG0c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zJclXt0KNfFg"&gt;Costs
of Revenue&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Costs
of revenue consist primarily of infrastructure, streaming service, data license and contracted services costs, as well as merchant fees
and payroll costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact003505">&lt;p id="xdx_845_eus-gaap--AdvertisingCostsPolicyTextBlock_zeBFUbSbekr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zSNjRAolxZl2"&gt;Advertising
Costs&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Advertising
costs are expensed as incurred. Advertising costs were $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_906_eus-gaap--AdvertisingExpense_c20230101__20231231_zdPo9d2xTJr4" title="Advertising costs"&gt;941,737&lt;/span&gt; and $&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN1bW1hcnkgb2YgU2lnbmlmaWNhbnQgQWNjb3VudGluZyBQb2xpY2llcyAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_901_eus-gaap--AdvertisingExpense_c20220101__20221231_zSOcuVwqs666" title="Advertising costs"&gt;783,764&lt;/span&gt; for the years ended December 31, 2023 and 2022, respectively,
which are included in general and administrative expenses on the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003507"
      unitRef="USD">941737</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003509"
      unitRef="USD">783764</us-gaap:AdvertisingExpense>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2023-01-012023-12-31" id="Fact003511">&lt;p id="xdx_840_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zLD9TM4Vqtma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_862_zsvn8rSw1lJ9"&gt;Stock-Based
Compensation&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company expenses stock-based compensation to employees and non-employees over the requisite service period based on the estimated grant-date
fair value of the awards in accordance with ASC 718, &lt;i&gt;Stock Compensation&lt;/i&gt;. The Company accounts for forfeitures as they occur. The
Company estimates the fair value of stock option grants using the Black-Scholes option pricing model, and the assumptions used in calculating
the fair value of stock-based awards represent management&#x2019;s best estimates and involve inherent uncertainties and the application
of management&#x2019;s judgment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact003513">&lt;p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_zb8dGSby8Qj7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_860_zFA5mQqvNgQd"&gt;Income
Taxes&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are recorded in accordance with ASC 740, &lt;i&gt;Income Taxes&lt;/i&gt; (&#x201c;ASC 740&#x201d;), which provides for deferred taxes using an
asset and liability approach. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of
events that have been included in the financial statements or tax returns. Deferred tax assets and liabilities are determined based on
the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year
in which the differences are expected to reverse. Valuation allowances are provided, if based upon the weight of available evidence,
it is more likely than not that some or all of the deferred tax assets will not be realized. The Company accounts for uncertain tax positions
in accordance with the provisions of ASC 740. When uncertain tax positions exist, the Company recognizes the tax benefit of tax positions
to the extent that the benefit would more likely than not be realized assuming examination by the taxing authority. The determination
as to whether the tax benefit will more likely than not be realized is based upon the technical merits of the tax position as well as
consideration of the available facts and circumstances. The Company recognizes any interest and penalties accrued related to unrecognized
tax benefits as income tax expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact003515">&lt;p id="xdx_843_eus-gaap--DerivativesPolicyTextBlock_zUSVWbE1aQA" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_865_zgqhFh80Eifd"&gt;Derivative
Financial Instruments&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluates all its financial instruments to determine if such instruments contain features that qualify as embedded derivatives.
Embedded derivatives must be separately measured from the host contract if all the requirements for bifurcation are met. The assessment
of the conditions surrounding the bifurcation of embedded derivatives depends on the nature of the host contract. Bifurcated embedded
derivatives are recognized at fair value, with changes in fair value recognized in the statement of operations each period. Bifurcated
embedded derivatives are classified with the related host contract in the Company&#x2019;s balance sheet. Refer to &lt;i&gt;Note 8-Fair Value
Measurements&lt;/i&gt; and &lt;i&gt;Note 14-Debt&lt;/i&gt; for further detail.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2023-01-012023-12-31" id="Fact003517">&lt;p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zCPP2ukOwZ8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_86D_zlyPlzS2VVSk"&gt;Fair
Value of Financial Instruments&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with FASB ASC 820 &lt;i&gt;Fair Value Measurements and Disclosures&lt;/i&gt;, the Company uses a three-level hierarchy for fair value
measurements of certain assets and liabilities for financial reporting purposes that distinguishes between market participant assumptions
developed from market data obtained from outside sources (observable inputs) and the Company&#x2019;s own assumptions about market participant
assumptions developed from the best information available to us in the circumstances (unobservable inputs). The fair value hierarchy
is divided into three levels based on the source of inputs as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1: Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2: Inputs other than Level 1 prices for similar assets or liabilities that are directly or indirectly observable in the marketplace.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3: Unobservable inputs which are supported by little or no market activity and values determined using pricing models, discounted cash
flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment
or estimation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management
during the years ended December 31, 2023 and 2022. The carrying amount of cash, accounts receivable, prepaid expenses and other current
assets, accounts payable, accrued expenses, deferred revenue, and other current liabilities approximated their fair values as of December
31, 2023 and 2022. During 2022, the Company carried convertible notes bifurcated embedded derivatives and Simple Agreements for Future
Equity (&#x201c;SAFE&#x201d;) investments at their fair value (see &lt;i&gt;Note 8-Fair Value Measurements&lt;/i&gt; for fair value information).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:BusinessCombinationsPolicy contextRef="From2023-01-012023-12-31" id="Fact003519">&lt;p id="xdx_843_eus-gaap--BusinessCombinationsPolicy_zYdZ3SJwjpm3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_863_zzx8NwE9bq2g"&gt;Business
Combinations&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for business combinations in accordance with FASB ASC 805 (&#x201c;ASC 805&#x201d;), &lt;i&gt;Business Combinations&lt;/i&gt;. Accordingly,
identifiable tangible and intangible assets acquired and liabilities assumed are recorded at their estimated fair values, the excess
of the purchase consideration over the fair values of net assets acquired is recorded as goodwill, and transaction costs are expensed
as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-01-012023-12-31" id="Fact003521">&lt;p id="xdx_840_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zx2z8PsK1Jbj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="xdx_868_zF2dah4L1ZBi"&gt;Recent
Accounting Pronouncements&lt;/span&gt; &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Recent
accounting pronouncements not yet effective &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09 (Topic 740), Improvements to income tax disclosures, which enhances the disclosure requirements
for the income tax rate reconciliation, domestic and foreign income taxes paid, requiring disclosure of disaggregated income taxes paid
by jurisdiction, unrecognized tax benefits, and modifies other income tax-related disclosures. The amendments are effective for annual
periods beginning after December 15, 2024. Early adoption is permitted and should be applied prospectively. The Company is currently
evaluating the effect of adopting this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock contextRef="From2023-01-012023-12-31" id="Fact003523">&lt;p id="xdx_802_eus-gaap--MergersAcquisitionsAndDispositionsDisclosuresTextBlock_zCXRbL349Zq8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;4.
&lt;span id="xdx_825_zkYJIT0ouZS3"&gt;Reverse Merger Capitalization with 7GC &amp;amp; Co. Holdings Inc.&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2023 (the &#x201c;Closing Date&#x201d;), Banzai consummated the previously announced Merger with 7GC, as a result of which
Banzai became a wholly-owned subsidiary of 7GC. While 7GC was the legal acquirer of Banzai in the merger, for accounting purposes, Legacy
Banzai was deemed to be the accounting acquirer in the merger. The determination was primarily based on Legacy Banzai&#x2019;s stockholders
having a majority of the voting power in the combined Company, Legacy Banzai having the ability to appoint a majority of the Board of
Directors of the Company, Legacy Banzai&#x2019;s existing management team comprising the senior management of the combined Company, Legacy
Banzai comprising the ongoing operations of the combined Company and the combined Company assumed the name &#x201c;Banzai International,
Inc.&#x201d;. Accordingly, for accounting purposes, the merger was treated as the equivalent of Legacy Banzai issuing stock for the net
assets of 7GC, accompanied by a recapitalization. The net assets of 7GC are stated at historical cost, with no goodwill or other intangible
assets recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Preferred
Stock Conversion &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Immediately
prior to the First Merger (the &#x201c;First Effective Time&#x201d;), each share of Legacy Banzai Series A preferred stock, par value $&lt;span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20231214__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zUWOyacQ1MLd" title="Preferred stock par value"&gt;0.0001&lt;/span&gt;
(the &#x201c;Legacy Banzai Preferred Stock&#x201d;), that was issued and outstanding was automatically converted into &lt;span id="xdx_901_eus-gaap--PreferredStockConvertibleConversionRatio_iI_dc_c20231214__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zne1MVbZfXK4" title="Preferred stock, convertible, conversion ratio"&gt;one&lt;/span&gt; share of Legacy
Banzai Class A Common Stock, par value $&lt;span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231214__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zOA2og9cFEG4" title="Common stock par value"&gt;0.0001&lt;/span&gt; (the &#x201c;Legacy Banzai Class A Common Stock&#x201d;) in accordance with the Amended
and Restated Certificate of Incorporation of Legacy Banzai, such that each converted share of Legacy Banzai Preferred Stock was no longer
outstanding and ceased to exist, and each holder of shares of Legacy Banzai Preferred Stock thereafter ceased to have any rights with
respect to such securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
the First Effective Time, by virtue of the First Merger and without any action on the part of 7GC, First Merger Sub, Legacy Banzai or
the holders of any of the following securities:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;each
    outstanding share of Legacy Banzai Class A Common Stock, including the shares of Legacy Banzai Class A Common Stock from the conversion
    of the Legacy Banzai Preferred Stock described above, and each outstanding share of Class B common stock of Legacy Banzai, par value
    $&lt;span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231214__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zujlQ1HiTFAf" title="Common stock par value"&gt;0.0001&lt;/span&gt; per share (the &#x201c;Legacy Banzai Class B Common Stock&#x201d; and together with Legacy Banzai Class A Common Stock, &#x201c;Legacy
    Banzai Common Stock&#x201d;) (in each case, other than dissenting shares and any shares held in the treasury of Legacy Banzai), was
    cancelled and converted into the right to receive a number of shares of Class A Common Stock or a number of shares of Class B common
    stock of the Company, par value $&lt;span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231214__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zrovnzXztCpc" title="Common stock par value"&gt;0.0001&lt;/span&gt; (&#x201c;Class B Common Stock&#x201d; and, collectively with Class A Common Stock, the
    &#x201c;Common Stock&#x201d;), respectively, equal to (x) the Per Share Value (as defined below) divided by (y) $&lt;span id="xdx_905_ecustom--ExchangeRatio_iI_c20231214__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdUaPK5x9SMd" title="Common stock par value"&gt;10.00&lt;/span&gt; (the &#x201c;Exchange
    Ratio&#x201d;); &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)
    each option to purchase Legacy Banzai Class A Common Stock (&#x201c;Legacy Banzai Option&#x201d;), whether vested or unvested, that
    was outstanding immediately prior to the First Effective Time and held by any securityholders of Legacy Banzai immediately prior
    to the First Effective Time (each, a &#x201c;Pre-Closing Holder&#x201d;) who was providing services to Legacy Banzai immediately prior
    to the First Effective Time (a &#x201c;Pre-Closing Holder Service Provider&#x201d;), was assumed and converted into an option (a &#x201c;Company
    Option&#x201d;) to purchase shares of Class A Common Stock, calculated in the manner set forth in the Merger Agreement; and (2) the
    vested portion of each Legacy Banzai Option that was outstanding at such time and held by a Pre-Closing Holder who was not then providing
    services to Legacy Banzai (a &#x201c;Pre-Closing Holder Non-Service Provider&#x201d;) was assumed and converted into a Company Option
    to purchase shares of Class A Common Stock, calculated in the manner set forth in the Merger Agreement; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;each
                                            right of each SAFE investor to receive a portion of the Total Consideration (as defined below)
                                            pursuant to certain Simple Agreements for Future Equity (&#x201c;each, a &#x201c;SAFE Agreement&#x201d;)
                                            that was outstanding immediately prior to the First Effective Time was cancelled and converted
                                            into the right (each, a &#x201c;SAFE Right&#x201d;) to receive a number of shares of Class
                                            A Common Stock equal to (i) the Purchase Amount as defined in the applicable SAFE Agreement
                                            that governed such SAFE Right (the &#x201c;SAFE Purchase Amount&#x201d;) in respect of such
                                            SAFE Right divided by the Valuation Cap Price as defined in each SAFE Agreement in respect
                                            of such SAFE Right multiplied by (ii) the Exchange Ratio; and&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;each
    Subordinated Convertible Note set forth in Section 1.1(a) of the Legacy Banzai disclosure schedules to the Merger Agreement (the
    &#x201c;Subordinated Convertible Notes&#x201d;) that was outstanding immediately prior to the First Effective Time was cancelled and
    converted into the right to receive a number of shares of Class A Common Stock equal to (i) all of the outstanding principal and
    interest in respect of such Subordinated Convertible Note, divided by the quotient obtained by dividing the Valuation Cap by the
    Fully Diluted Capitalization (each as defined in and determined pursuant to the terms of such Subordinated Convertible Note) in respect
    of such Subordinated Convertible Note, multiplied by (ii) the Exchange Ratio.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(e)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x201c;Per
    Share Value&#x201d; equals (i) an amount equal to $&lt;span id="xdx_908_eus-gaap--AssetAcquisitionConsiderationTransferred_c20231214__20231214__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember_zPccf1z2sNxb" title="Asset acquisition, consideration transferred"&gt;100,000,000&lt;/span&gt;, payable in shares of Class A Common Stock or shares of Class B Common
    Stock, as applicable (the &#x201c;Total Consideration&#x201d;), divided by (ii) (A) the total number of shares of Legacy Banzai Class
    A Common Stock and Legacy Banzai Class B Common Stock issued and outstanding as of immediately prior to the First Effective Time,
    (B) the maximum aggregate number of shares of Legacy Banzai Class A Common Stock issuable upon full exercise of Legacy Banzai Options
    issued, outstanding, and vested immediately prior to the First Effective Time, (C) the maximum aggregate number of shares of Legacy
    Banzai Class A Common Stock issuable upon conversion of certain senior convertible notes outstanding as of immediately prior to the
    First Effective Time at the applicable conversion price, (D) the maximum aggregate number of shares of Legacy Banzai Class A Common
    Stock issuable upon conversion of all of the outstanding principal and interest under the Subordinated Convertible Notes as of immediately
    prior to the First Effective Time at the applicable conversion price, and (E) the maximum aggregate number of shares of Legacy Banzai
    Class A Common Stock issuable upon conversion of the SAFE Purchase Amount under each SAFE Right as of immediately prior to the First
    Effective Time at the applicable SAFE Conversion Price. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
the effective time of the Second Merger (the &#x201c;Second Effective Time&#x201d;), by virtue of the Second Merger and without any action
on the part of 7GC, Surviving Corporation, Second Merger Sub or the holders of any securities of 7GC or the Surviving Corporation or
the Second Merger Sub, each share of common stock of the Surviving Corporation issued and outstanding immediately prior to the Second
Effective Time was cancelled and extinguished, and no consideration was delivered therefor.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Retroactive
Restatement for Conversion of Common Stock and Series A Preferred Stock by Applying Exchange Ratio &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
the closing of the merger, holders of Legacy Banzai common stock and Series A preferred stock received shares of common stock in an amount
determined by application of the Exchange Ratio. In accordance with guidance applicable to these circumstances, the equity structure
has been restated in all comparable periods, prior to the merger, up to December 14, 2023, to reflect the number of shares of the Company&#x2019;s
common stock, $&lt;span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231214__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zHUdll0a6U9k" title="Common stock par value"&gt;0.0001&lt;/span&gt; par value per share, issued to Legacy Banzai&#x2019;s stockholders in connection with the merger. As such, the shares
and corresponding capital amounts and earnings per share related to Legacy Banzai&#x2019;s outstanding Series A preferred stock and Legacy
Banzai&#x2019;s common stock prior to the merger have been retroactively restated as shares reflecting the exchange ratio of approximately
&lt;span id="xdx_90E_ecustom--ExchangeRatio_iI_c20231214__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember_z9jVdOmoQaf" title="Exchange ratio"&gt;0.6147&lt;/span&gt; established in the merger. Legacy Banzai&#x2019;s Series A preferred stock previously classified as temporary equity was retroactively
adjusted, converted into common stock and reclassified to permanent equity as a result of the reverse recapitalization. The consolidated
assets, liabilities, and results of operations prior to the merger are those of Legacy Banzai.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aggregate consideration payable to securityholders of Banzai at the Closing Date was equal to $&lt;span id="xdx_90C_ecustom--BusinessCombinationProvisionalInformationInitialAccountingIncompleteReductionConsiderationTransferred_c20231214__20231214__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember_zJ7ZAVcuVI3g" title="Enterprise valuation amount"&gt;100,000,000&lt;/span&gt;. Holders of &lt;span id="xdx_904_ecustom--NumberOfSharesHeldBySecurityHolders_iI_c20231214__us-gaap--StatementClassOfStockAxis__custom--SevenGCClassACommonStockMember_zWf1da6bOeXi" title="Number of shares held by security holders"&gt;3,207,428&lt;/span&gt; shares
of 7GC&#x2019;s Class A common stock, par value $&lt;span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231214__us-gaap--StatementClassOfStockAxis__custom--SevenGCClassACommonStockMember_zpUrDCGlVjB5" title="Common stock par value"&gt;0.0001&lt;/span&gt; per share (&#x201c;7GC Class A Common Stock&#x201d;), exercised their right to redeem
their shares for cash at a redemption price of approximately $&lt;span id="xdx_907_ecustom--RedemptionPricePerShare_iI_c20231214__us-gaap--StatementClassOfStockAxis__custom--SevenGCClassACommonStockMember_zS1ne1AA1AJi" title="Redemption price per share"&gt;10.76&lt;/span&gt; per share, for an aggregate redemption amount of $&lt;span id="xdx_905_ecustom--AggregateRedemptionAmount_iI_c20231214__us-gaap--StatementClassOfStockAxis__custom--SevenGCClassACommonStockMember_zOWsuIThXChk" title="Aggregate redemption amount"&gt;34,524,065&lt;/span&gt;. Immediately
prior to the Closing Date, each share of Banzai&#x2019;s Preferred Stock that was issued and outstanding was automatically converted into
&lt;span id="xdx_905_eus-gaap--PreferredStockConvertibleConversionRatio_iI_dc_c20231214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember_zDe7tDmwqbr4" title="Preferred stock, convertible, conversion ratio"&gt;one&lt;/span&gt; share of Banzai&#x2019;s Class A Common Stock, par value $&lt;span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember_zUh5DEdb7oXd" title="Common stock par value"&gt;0.0001&lt;/span&gt; per share. Each share of Banzai&#x2019;s Class B Common Stock that
was not held by the Chief Executive Officer of the Company converted to &lt;span id="xdx_900_ecustom--CommonStockConvertibleConversionRatio_iI_dc_c20231214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember_zNj34eoDTs44" title="Common stock, convertible, conversion ratio"&gt;one&lt;/span&gt; share of Banzai&#x2019;s Class A Common Stock, while the Chief
Executive Officer received Class B Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
the terms and subject to the conditions set forth in the Merger Agreement, at the Second Effective Time, each share of common stock of
the Surviving Corporation issued and outstanding immediately prior to the Second Effective Time was cancelled and no consideration was
delivered therefore.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Treatment
of Outstanding Equity Awards &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, as of the First Effective Time: (i) each Legacy Banzai Option, whether vested or unvested, that was outstanding immediately
prior to the First Effective Time and held by a Pre-Closing Holder Service Provider, was assumed and converted into a Company Option
with respect to a number of shares of Class A Common Stock calculated in the manner set forth in the Merger Agreement; and (ii) the vested
portion of each Legacy Banzai Option that was outstanding at such time and held by a Pre-Closing Holder Non-Service Provider was assumed
and converted into a Company Option with respect to a number of shares of Class A Common Stock calculated in the manner set forth in
the Merger Agreement. See &lt;i&gt;Note 19-Stock-Based Compensation&lt;/i&gt; for further details related to the outstanding equity awards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Treatment
of SAFE Rights &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of the First Effective Time, each SAFE Right that was outstanding immediately prior to the First Effective Time was cancelled and converted
into and became the right to receive a number of shares of Class A Common Stock equal to the SAFE Purchase Amount in respect of such
SAFE Right divided by the SAFE Conversion Price in respect of such SAFE Right multiplied by (ii) the Exchange Ratio. See &lt;i&gt;Note 16-Simple
Agreements for Future Equity&lt;/i&gt; for further details related to the SAFEs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Treatment
of Convertible Notes &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of the First Effective Time, each Subordinated Convertible Note that was outstanding immediately prior to the First Effective Time was
cancelled and converted into the right to receive a number of shares of Class A Common Stock equal to (i) all of the outstanding principal
and interest in respect of such Subordinated Convertible Note divided by the Subordinated Convertible Note Conversion Price in respect
of such Subordinated Convertible Note, multiplied by (ii) the Exchange Ratio. In connection with the Forbearance Agreement and amended
and restated Senior Convertible Notes, each Senior Convertible Note remained outstanding following the Closing (to be convertible at
CP BF&#x2019;s option into shares of Class A Common Stock after the Merger).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2023, Legacy Banzai entered into the Forbearance Amendment, pursuant to which CP BF agreed not to exercise any right or
remedy under the Loan Agreement with CP BF entered into on February 19, 2021 (the &#x201c;CP BF Loan Agreement&#x201d;), including its
right to accelerate the aggregate amount outstanding under the CP BF Loan Agreement, until (a) the date that is the earlier of the date
that all Yorkville Promissory Notes to be issued under the SEPA (See below for further detail) have been repaid (and/or converted) in
full, or (b) six months after the Closing of the Merger. See below and &lt;i&gt;Note 14-Debt&lt;/i&gt; for further details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Material
Agreements Related to the Close of the Merger &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the close of the merger, the following material agreements and transactions were entered into by 7GC and Legacy Banzai:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Sponsor
    Forfeiture Agreement&lt;/b&gt;-On August 4, 2023, 7GC, 7GC &amp;amp; Co. Holdings LLC, a Delaware limited liability company (the &#x201c;Sponsor&#x201d;),
    and Legacy Banzai entered into a Sponsor Forfeiture Agreement (the &#x201c;Sponsor Forfeiture Agreement&#x201d;), pursuant to which,
    contingent upon Closing, the Sponsor agreed to forfeit all &lt;span id="xdx_900_ecustom--WarrantsIssued_c20230804__20230804__us-gaap--ClassOfWarrantOrRightAxis__custom--ForfeitedPrivatePlacementWarrantsMember__us-gaap--TypeOfArrangementAxis__custom--SponsorForfeitureAgreementMember_zinc073gqLW3" title="Warrants issued"&gt;7,350,000&lt;/span&gt; of its private placement warrants to purchase shares of 7GC
    Class A Common Stock, exercisable at $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230804__us-gaap--ClassOfWarrantOrRightAxis__custom--ForfeitedPrivatePlacementWarrantsMember__us-gaap--TypeOfArrangementAxis__custom--SponsorForfeitureAgreementMember_zKTbIMaw4OVk" title="Warrants price per share"&gt;11.50&lt;/span&gt; per share (the &#x201c;Forfeited Private Placement Warrants&#x201d;), acquired by the Sponsor
    in December 2020 in connection with the IPO. At the Closing, the Forfeited Private Placement Warrants were transferred from the Sponsor
    to 7GC for cancellation in exchange for no consideration, and 7GC retired and cancelled all of the Forfeited Private Placement Warrants.
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Yorkville
    Standby Equity Purchase Agreement (&#x201c;SEPA&#x201d;)&lt;/b&gt;-On December 14, 2023, the Company entered into the Original SEPA with
    Legacy Banzai and Yorkville. Additionally, Yorkville agreed to advance to the Company the principal amount of $&lt;span id="xdx_905_ecustom--PrincipalAmountAgreedToAdvance_iI_pn5n6_c20231214__us-gaap--TypeOfArrangementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_znAOofvGgZmc" title="Principal amount agreed to advance"&gt;3.5&lt;/span&gt; million, which
    was subsequently increased pursuant to the SEPA Supplemental Agreement by $&lt;span id="xdx_905_ecustom--IncreasedPrincipalAmountAgreedToAdvance_iI_pn5n6_c20231214__us-gaap--TypeOfArrangementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zIscL9gX8C7d" title="Increased principal amount agreed to advance"&gt;1.0&lt;/span&gt; million to an aggregate principal amount of $&lt;span id="xdx_90F_ecustom--AggregatePrincipalAmount_iI_pn5n6_c20231214__us-gaap--TypeOfArrangementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zl7Xqr06OYnl" title="Aggregate principal amount"&gt;4.5&lt;/span&gt; million
    (the &#x201c;Pre-Paid Advance&#x201d;). The Pre-Paid Advance is evidenced by promissory notes convertible into shares of Class A Common
    Stock (each, a &#x201c;Yorkville Promissory Note&#x201d;). See &lt;i&gt;Note 14-Debt &lt;/i&gt;and &lt;i&gt;Note 18-Equity &lt;/i&gt;for further details of
    these transactions. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share
    Transfer Agreements and Alco Promissory Notes&lt;/b&gt;-In connection with the Merger, Legacy Banzai issued the Alco September 2023 Promissory
    Note and the Alco November 2023 Promissory Note and entered into certain share transfer agreements (the &#x201c;Prior Transfer Agreements&#x201d;),
    dated October 3, 2023 and November 16, 2023, with Alco, 7GC and Sponsor, pursuant to which the parties agreed, concurrently with
    and contingent upon the Closing, that the Sponsor would forfeit &lt;span id="xdx_90C_ecustom--ForfeitureOfCommonStockShares_iI_c20231003__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementsAndAlcoPromissoryNotesMember__us-gaap--StatementClassOfStockAxis__custom--SevenGCClassBCommonStockMember_z4FKlfOheGzf" title="Forfeiture of common stock shares"&gt;3,000&lt;/span&gt; and &lt;span id="xdx_908_ecustom--ForfeitureOfCommonStockShares_iI_c20231116__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementsAndAlcoPromissoryNotesMember__us-gaap--StatementClassOfStockAxis__custom--SevenGCClassBCommonStockMember_zRQiCUuOIsi3" title="Forfeiture of common stock shares"&gt;1,500&lt;/span&gt; shares of 7GC Class B Common Stock and the Company
    would issue to Alco &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231003__20231003__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementsAndAlcoPromissoryNotesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zLa1lODQZxJ9" title="Common stock shares issued"&gt;150,000&lt;/span&gt; and &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231116__20231116__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementsAndAlcoPromissoryNotesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zvBRKEwgdfR3" title="Common stock shares issued"&gt;1,500&lt;/span&gt; shares of Class A Common Stock. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 13, 2023, in connection with the Merger, 7GC and the Sponsor entered into a share transfer agreement (the &#x201c;December
Share Transfer Agreement&#x201d;) with Alco, pursuant to which &lt;span id="xdx_902_ecustom--ShareTransferAgreementDescription_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementsAndAlcoPromissoryNotesMember_ztEeo8h8L1h1" title="Share transfer agreement description"&gt;for
each $&lt;span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20231213__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementsAndAlcoPromissoryNotesMember_zXLvalnUYcYf" title="Debt instrument conversion price per share"&gt;10.00&lt;/span&gt;
in principal borrowed under the New Alco Note, the Sponsor agreed to forfeit three shares of 7GC Class B Common Stock held by the
Sponsor, in exchange for the right of Alco to receive three shares of Class A Common Stock, in each case, at (and contingent upon)
the Closing, with such forfeited and issued shares capped at an amount equal to &lt;span id="xdx_905_ecustom--ForfeitedAndIssuedSharesCapped_iI_c20231213__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementsAndAlcoPromissoryNotesMember_zfF9AqZxiTTi" title="Forfeited and issued shares capped"&gt;12,000&lt;/span&gt;.&lt;/span&gt;
Additionally, in connection with the December Share Transfer Agreement, (a) Legacy Banzai issued the New Alco Note to Alco in the
aggregate principal amount of $&lt;span id="xdx_903_ecustom--AggregatePrincipalAmount_iI_pn5n6_c20231213__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementsAndAlcoPromissoryNotesMember_zCeMFHwwvIKh" title="Aggregate principal amount"&gt;2.0&lt;/span&gt;
million, which bears interest at a rate of &lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231213__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementsAndAlcoPromissoryNotesMember_zed2KHliT3tc" title="Debt instrument, interest rate"&gt;8&lt;/span&gt;%
per annum and will be due and payable on December 31, 2024, and (b) Legacy Banzai, Alco, and CP BF Lending, LLC agreed to amend that
certain Subordinated Promissory Note issued by Legacy Banzai to Alco on September 13, 2023 in the aggregate principal amount of
$&lt;span id="xdx_90C_ecustom--AggregatePrincipalAmount_iI_pn5n6_c20230913__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementsAndAlcoPromissoryNotesMember_zLFpiJHCPSE9" title="Aggregate principal amount"&gt;1.5&lt;/span&gt;
million to extend the maturity date from &lt;span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDateRangeStart1_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementsAndAlcoPromissoryNotesMember_zmSgIyKVwrck" title="Debt instrument, maturity date range, start"&gt;January
10, 2024&lt;/span&gt; to &lt;span id="xdx_90D_eus-gaap--DebtInstrumentMaturityDateRangeEnd1_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementsAndAlcoPromissoryNotesMember_z0VGmBWg7Nch" title="Debt instrument, maturity date range, end"&gt;September
30, 2024&lt;/span&gt; (the &#x201c;Alco Note Amendment&#x201d;). Immediately prior to, and substantially concurrently with, the Closing, (i)
the Sponsor surrendered and forfeited to 7GC for no consideration an aggregate of &lt;span id="xdx_90D_ecustom--ForfeitureOfCommonStockShares_iI_c20231213__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementsAndAlcoPromissoryNotesMember__us-gaap--StatementClassOfStockAxis__custom--SevenGCClassBCommonStockMember_zajyDeN83Tt3" title="Forfeiture of common stock shares"&gt;16,500&lt;/span&gt; shares of 7GC Class B Common Stock and (ii) the Company issued to Alco &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231213__20231213__us-gaap--TypeOfArrangementAxis__custom--ShareTransferAgreementsAndAlcoPromissoryNotesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zlqmyw92fVDe" title="Common stock shares issued"&gt;16,500&lt;/span&gt; shares of Class A Common Stock pursuant to the Share Transfer Agreements. See &lt;i&gt;Note 14-Debt &lt;/i&gt;for further details of
these transactions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;GEM
    Agreements&lt;/b&gt;-On May 27, 2022, Legacy Banzai entered into a certain share purchase agreement with GEM (the &#x201c;GEM Agreement&#x201d;),
    pursuant to which, among other things, upon the terms and subject to the conditions of the GEM Agreement, GEM was to purchase from
    Legacy Banzai (or its successor per the GEM Agreement) up to the number of duly authorized, validly issued, fully paid and non-assessable
    shares of common stock having an aggregate value of $&lt;span id="xdx_900_ecustom--EquityCommitmentByInvestor_iI_c20220527__us-gaap--TypeOfArrangementAxis__custom--GemAgreementsMember_zRgO6WWx5Et4" title="Equity commitment by investor"&gt;100,000,000&lt;/span&gt;. Further, in terms of the GEM Agreement, on the date of public listing
    of Legacy Banzai, Legacy Banzai was required to make and execute a warrant granting GEM the right to purchase up to the number of
    common shares of Legacy Banzai that would be equal to &lt;span id="xdx_90F_ecustom--PercentageOfRightToPurchaseOfTotalEquityInterests_pid_dp_uPure_c20220527__20220527__us-gaap--TypeOfArrangementAxis__custom--GemAgreementsMember__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z0D27J83PX8d" title="Percentage of right to purchase of total equity interests"&gt;3&lt;/span&gt;% of the total equity interests, calculated on a fully diluted basis, and
    at an exercise price per share equal to the lesser of (i) the public offering price or closing bid price on the date of public listing
    or (ii) the quotient obtained by dividing $&lt;span id="xdx_90F_ecustom--AmountDividedOnNumberOfEquityInterestsToObtainQuotient_pn6n6_c20220527__20220527__us-gaap--TypeOfArrangementAxis__custom--GemAgreementsMember_zkcNyGLrOZQl" title="Amount divided on number of equity interests to obtain quotient"&gt;650&lt;/span&gt; million by the total number of equity interests. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 13, 2023, Legacy Banzai and GEM entered into that certain binding term sheet (the &#x201c;GEM Term Sheet&#x201d;) and, on December
14, 2023, a letter agreement (the &#x201c;GEM Letter&#x201d;), agreeing to terminate in its entirety the GEM Agreement by and between Legacy
Banzai and GEM, other than with respect to the Company&#x2019;s obligation (as the post-combination company in the Merger) to issue to
GEM a warrant (the &#x201c;GEM Warrant&#x201d;) granting the right to purchase Class A Common Stock in an amount equal to &lt;span id="xdx_906_ecustom--PercentageOfRightToPurchaseOfTotalEquityInterests_pid_dp_uPure_c20231213__20231213__us-gaap--TypeOfArrangementAxis__custom--GemAgreementsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zxkXdBsGBhb4" title="Percentage of right to purchase of total equity interests"&gt;3&lt;/span&gt;% of the total
number of equity interests outstanding as of the Closing, calculated on a fully diluted basis, at an exercise price on the terms and
conditions set forth therein, in exchange for issuance of a $&lt;span id="xdx_90F_eus-gaap--ConvertibleDebt_iI_pn5n6_c20231213__us-gaap--TypeOfArrangementAxis__custom--GemAgreementsMember_zc36TF9fyWDh" title="Convertible debenture"&gt;2.0&lt;/span&gt; million convertible debenture with a &lt;span id="xdx_90A_eus-gaap--DebtInstrumentTerm_dxL_c20231213__20231213__us-gaap--TypeOfArrangementAxis__custom--GemAgreementsMember_zJEilTEX8Kjk" title="Convertible debenture maturity period::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3607"&gt;five-year&lt;/span&gt;&lt;/span&gt; maturity and &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231213__us-gaap--TypeOfArrangementAxis__custom--GemAgreementsMember_zMSdVZHC1sCe" title="Debt instrument, interest rate"&gt;0&lt;/span&gt;% coupon,
with the documentation of such debenture to be agreed upon and finalized promptly following the Closing. See &lt;i&gt;Note 15-Warrant Liabilities
&lt;/i&gt;for further details of these transactions, and &lt;i&gt;Note 21-Subsequent Events&lt;/i&gt; for details related to the subsequent settlement
agreement entered into with GEM, in 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;7GC
    Promissory Notes&lt;/b&gt;-On December 12, 2023, in connection with the Merger, the Sponsor came to a non-binding agreement with 7GC to
    amend the optional conversion provision of the 7GC Promissory Notes, consisting of (i) the 7GC 2022 Promissory Note, issued by 7GC
    to the Sponsor, pursuant to which 7GC may borrow up to $&lt;span id="xdx_907_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20231212__us-gaap--TypeOfArrangementAxis__custom--SevenGCPromissoryNotesMemberMember_zYRBQDBRWGdk" title="Maximum borrowing capacity"&gt;2,300,000&lt;/span&gt; from the Sponsor, and (ii) the 2023 Promissory Note, to provide
    that the Sponsor has the right to elect to convert up to the full amount of the principal balance of the 7GC Promissory Notes, in
    whole or in part, &lt;span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_uTradingday_c20231212__20231212__us-gaap--TypeOfArrangementAxis__custom--SevenGCPromissoryNotesMemberMember_zQmtWiPsImVe" title="Debt instrument, convertible, threshold trading days"&gt;30&lt;/span&gt; days after the Closing at a conversion price equal to the average daily VWAP of Class A Common Stock for
    the &lt;span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_uTradingday_c20231212__20231212__us-gaap--TypeOfArrangementAxis__custom--SevenGCPromissoryNotesMemberMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zJs0B4S93fr1" title="Debt instrument, convertible, threshold trading days"&gt;30&lt;/span&gt; trading days following the Closing (equal to approximately $&lt;span id="xdx_901_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20231212__us-gaap--TypeOfArrangementAxis__custom--SevenGCPromissoryNotesMemberMember_zxWH8EX7A026" title="Debt instrument conversion price per share"&gt;2.86&lt;/span&gt; per share). See &lt;i&gt;Note 14-Debt and Note 6-Related Party
    Transactions &lt;/i&gt;for further details of this transaction, and &lt;i&gt;Note 21-Subsequent Events&lt;/i&gt; for details related to the subsequent
    conversion of the 7GC Promissory Notes, in 2024. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;CP
    BF Senior Convertible Notes&lt;/b&gt;-On February 19, 2021, Legacy Banzai issued the First Senior Convertible Note in an aggregate principal
    amount of $&lt;span id="xdx_903_ecustom--AggregatePrincipalAmount_iI_c20210219__us-gaap--TypeOfArrangementAxis__custom--CpBfSeniorConvertibleNotesMember__us-gaap--DebtInstrumentAxis__custom--FirstSeniorConvertibleNoteMember_z5VouLgaMMUk" title="Aggregate principal amount"&gt;1,500,000&lt;/span&gt; to CP BF in connection with the Loan Agreement. On October 10, 2022, the Loan Agreement was amended, whereby
    CP BF waived payment by Banzai of four months of cash interest with respect to the term loan under the Loan Agreement in replacement
    for the Second Senior Convertible Note in an aggregate principal amount of $&lt;span id="xdx_904_ecustom--AggregatePrincipalAmount_iI_c20221010__us-gaap--TypeOfArrangementAxis__custom--CpBfSeniorConvertibleNotesMember__us-gaap--DebtInstrumentAxis__custom--FirstSeniorConvertibleNoteMember_ztcd9vQ7lUx8" title="Aggregate principal amount"&gt;321,345&lt;/span&gt;. On August 24, 2023, Legacy Banzai and CP BF
    entered into the Forbearance Agreement, in connection with which they agreed to amend and restate the Senior Convertible Notes so
    that they would not convert at the Closing of the Merger as a &#x201c;Change of Control.&#x201d; After Closing, the Senior Convertible
    Notes became convertible, at CP BF&#x2019;s option on &lt;span id="xdx_90F_ecustom--ConvertibleWrittenNoticePeriod_dtD_c20230824__20230824__us-gaap--TypeOfArrangementAxis__custom--CpBfSeniorConvertibleNotesMember_zLzMArckarte" title="Convertible written notice period"&gt;5&lt;/span&gt; days&#x2019; written notice to the Company, into shares of Class A Common Stock.
    The Senior Convertible Notes provide that, at all times after a SPAC Transaction (as defined in the Senior Convertible Notes), the
    conversion price for any such conversion is approximately $&lt;span id="xdx_903_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230824__us-gaap--TypeOfArrangementAxis__custom--CpBfSeniorConvertibleNotesMember_zIPgEzHCIoKb" title="Debt instrument conversion price per share"&gt;217.43&lt;/span&gt; per share (subject to adjustment as set forth therein). See &lt;i&gt;Note
    14-Debt &lt;/i&gt;for further details of this transaction. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Cantor
    Fee Agreement&lt;/b&gt;-On November 8, 2023, Cantor Fitzgerald &amp;amp; Co. (&#x201c;Cantor&#x201d;) and 7GC entered into the Fee Reduction
    Agreement, pursuant to which Cantor agreed to forfeit $&lt;span id="xdx_900_ecustom--DeferredUnderwritingFeesForfeit_iI_c20231108__us-gaap--TypeOfArrangementAxis__custom--CantorFeeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember_zap8sZUBzjme" title="Deferred underwriting fees forfeit"&gt;4,050,000&lt;/span&gt; of the aggregate of $&lt;span id="xdx_907_ecustom--DeferredUnderwritingFeesPayable_iI_c20231108__us-gaap--TypeOfArrangementAxis__custom--CantorFeeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember_zROqVENT0Dv2" title="Deferred underwriting fees payable"&gt;8,050,000&lt;/span&gt; of deferred underwriting fees payable
    (&#x201c;Original Deferred Fee&#x201d;), with the remaining $&lt;span id="xdx_90A_ecustom--IncreaseDecreaseInDeferredUnderwritingFees_iI_c20231108__us-gaap--TypeOfArrangementAxis__custom--CantorFeeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember_zoTBfnd2s3G7" title="Increase decrease in deferred underwriting fees"&gt;4,000,000&lt;/span&gt; payable by 7GC to Cantor (the &#x201c;Reduced Deferred Fee&#x201d;)
    following the Closing of the Merger. Pursuant to the Fee Reduction Agreement, the Reduced Deferred Fee was payable in the form of
    the Cantor Fee Shares, calculated as a number of shares of Class A Common Stock equal to the greater of (a) &lt;span id="xdx_906_ecustom--DeferredUnderwritingFeesPayableInShares_iI_c20231108__us-gaap--TypeOfArrangementAxis__custom--CantorFeeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--GcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember_z097Vsczgnfk" title="Deferred underwriting fees payable in shares"&gt;400,000&lt;/span&gt; or (b) the quotient
    obtained by dividing (x) the Reduced Deferred Fee by (y) the dollar volume-weighted average price for the shares of Class A Common
    Stock on Nasdaq, over the five trading days immediately preceding the date of filing of this resale registration statement on Form
    S-1, as reported by Bloomberg through its &#x201c;AQR&#x201d; function (as adjusted for any stock dividend, split, combination, recapitalization
    or other similar transaction). 7GC and Cantor amended the Fee Reduction Agreement on December 28, 2023 to provide that the Reduced
    Deferred Fee was payable in the form of &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231228__20231228__us-gaap--TypeOfArrangementAxis__custom--CantorFeeAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zh9NBaOJDpr3" title="Common stock shares issued"&gt;22,279&lt;/span&gt; shares of Class A Common Stock and to provide that Cantor is subject to a 12-month
    lock-up with respect to the Cantor Fee Shares. On December 28, 2023, the Company issued the Cantor Fee Shares to Cantor, covering
    the Reduced Deferred Fee in accordance with the Fee Reduction Agreement. Pursuant to the Fee Reduction Agreement, the Company also
    agreed to use its reasonable best efforts to have the registration statement declared effective by the SEC by the 120th calendar
    day after December 29, 2023, the date of the initial filing thereof, and to maintain the effectiveness of such registration statement
    until the earliest to occur of (i) the second anniversary of the date of the effectiveness thereof, (ii) the Cantor Fee Shares shall
    have been sold, transferred, disposed of or exchanged by Cantor, and (iii) the Cantor Fee Shares issued to Cantor may be sold without
    registration pursuant to Rule 144 under the Securities Act (such obligations, the &#x201c;Cantor Registration Rights Obligations&#x201d;).
    See &lt;i&gt;Note 17-Commitments and Contingencies &lt;/i&gt;for further details of this transaction. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
the closing of the merger, the Company&#x2019;s certificate of incorporation was amended and restated to, among other things, increase
the total number of authorized shares of all classes of capital stock to &lt;span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20231214__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgyvvxPMfBQd" title="Common stock, shares authorized"&gt;105,000,000&lt;/span&gt; shares, consisting of &lt;span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20231214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zOGMLRaRG57k" title="Common stock, shares authorized"&gt;5,000,000&lt;/span&gt; shares of Class
A Common Stock, &lt;span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_c20231214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z5fZ2beku4P7" title="Common stock, shares authorized"&gt;25,000,000&lt;/span&gt; shares of Class B Common Stock, and &lt;span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_c20231214_z5LYWm84sVH2" title="Preferred stock, shares authorized"&gt;75,000,000&lt;/span&gt; shares of Preferred Stock, all having a par value of $&lt;span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231214_zV61XpmCrO6a" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt;
per share. As of December 31, 2023, there were &lt;span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_c20231231_zHIuc040Wxek" title="Common stock, shares outstanding"&gt;2,585,296&lt;/span&gt; shares of Common Stock and &lt;span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_zCaTLEB2kdv4" title="Preferred stock, shares outstanding"&gt;no&lt;/span&gt; shares of Preferred Stock outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Reconciliation
of the Merger to the Company&#x2019;s Consolidated Financial Statements &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_ecustom--ScheduleOfReconciliationOfTheMergerToTheCompanysConsolidatedCashFlowsTableTextBlock_zm0lv5GLygGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reconciles the elements of the Merger to the consolidated statements of cash flows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zSP9acBWFvJb" style="display: none"&gt;Schedule of Reconciliation of the Merger to the Company's Consolidated Cash Flows&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231214__20231214__us-gaap--ReclassificationTypeAxis__custom--RecapitalizationMember_zwD3SEXj1C9l" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Recapitalization&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DeferredUnderwritingFeesAssumed_zUIhn4EEqwu5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"&gt;Deferred underwriting fees assumed&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;4,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ConvertibleNotesPayableAssumed_zf1HGYqwMUj3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Convertible notes payable assumed&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,550,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--WarrantLiabilitiesAssumed_zZ0f7TJXlha8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Warrant liabilities assumed&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;460,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--EffectOnEquity_zZvP2m7iYjsb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;Less: effect on equity&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(14,625,462&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--EffectOfReverseRecapitalizationNetOfTransactionCosts_zcrKfXsx33b6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Effect of reverse recapitalization, net of transaction costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(7,615,462&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_z2LodATCh5J8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_ecustom--ScheduleOfReconciliationOfTheMergerToTheCompanysConsolidatedStatementsOfChangesInStockholdersDeficitTableTextBlock_z04qO4LVhUi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reconciles the elements of the Merger to the consolidated statements of changes in stockholders&#x2019; deficit:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;span id="xdx_8B6_zHUh6XTeFKG5" style="display: none"&gt;Schedule of Reconciliation of the Merger to the Company&#x2019;s Statements of Changes in Stockholders&#x2019; Deficit&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231214__20231214__us-gaap--ReclassificationTypeAxis__custom--RecapitalizationMember_zxyWyQxwuVo4" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Recapitalization&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--CashAcquired_ztphF0MV1KWi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"&gt;Cash&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;197,166&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--NonCashNetWorkingCapitalAssumed_z9cp9MdN6vni" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Non-cash net working capital assumed&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(7,812,628&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DeferredUnderwritingFeesAssumed_iN_di_zz4uoOuOz0M4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Deferred underwriting fees assumed&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(4,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ConvertibleNotesPayableAssumed_iN_di_zLVPSBYxAGvd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Convertible notes payable assumed&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(2,550,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FairValueOfAssumedWarrantLiabilities_zwmL3VKoay8e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Fair value of assumed warrant liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(460,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--TransactionCosts_z0hEa5K36TH8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Transaction costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(3,233,097&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--EffectOfReverseRecapitalizationEffectOnEquity_zeqjU0y1EuH5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Effect of reverse recapitalization&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(17,858,559&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zgsRIT3Ndgwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
effect of the reverse recapitalization above differs from the effect of equity on the consolidated statements of cash flows, due to the
transaction costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Effect
of Merger on Class A and Class B Common Stock &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
the Close of the Merger, holders of Legacy Banzai common stock and Series A preferred stock were converted into shares of common stock
in an amount determined by application of the Exchange Ratio. As noted above, the equity structure has been restated in all comparable
periods, prior to the Merger, up to December 14, 2023, to reflect the number of shares of the Company&#x2019;s common stock, $&lt;span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember_z10uyoaWMlRj" title="Common stock par value"&gt;0.0001&lt;/span&gt; par
value per share, issued to Legacy Banzai&#x2019;s stockholders in connection with the Merger. At January 1, 2022, the Company had &lt;span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20220101__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember_zKJCJdZEZPE4" title="Common stock, shares outstanding"&gt;&lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220101__20220101__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember_zDYRu6TuATW" title="Common stock shares issued"&gt;6,359,139&lt;/span&gt;&lt;/span&gt;
shares of common stock issued and outstanding, consisting of &lt;span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20220101__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zfkp6w2nKKUj" title="Common stock, shares outstanding"&gt;&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220101__20220101__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zbPYpmL1Bu17" title="Common stock shares issued"&gt;39,139&lt;/span&gt;&lt;/span&gt; shares of Class A common stock and &lt;span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_c20220101__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zh7uI5J1LaFk" title="Common stock, shares outstanding"&gt;&lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220101__20220101__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zmYE10p0FAke" title="Common stock shares issued"&gt;6,320,000&lt;/span&gt;&lt;/span&gt; shares of Class B
common stock. Additionally, the company had &lt;span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_c20220101__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zNicrmbce8h4" title="Preferred stock, shares outstanding"&gt;2,328,823&lt;/span&gt; shares of Series A preferred stock outstanding. The retrospective impact of the
recapitalization to Class A common stock and Class B common stock was a decrease of &lt;span id="xdx_90A_ecustom--IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization_c20220101__20220101__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zhDeRejJRut6" title="Decrease in stock due to retrospective impact of recapitalization"&gt;15,082&lt;/span&gt; and &lt;span id="xdx_902_ecustom--IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization_c20220101__20220101__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zKLjCNtNrHl5" title="Decrease in stock due to retrospective impact of recapitalization"&gt;2,435,327&lt;/span&gt;, respectively. The retrospective
impact of the Series A preferred stock outstanding was a decrease of &lt;span id="xdx_901_ecustom--IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization_c20220101__20220101__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zcXSOf7kPNC7" title="Decrease in stock due to retrospective impact of recapitalization"&gt;897,380&lt;/span&gt; shares. The total impact to common stock was &lt;span id="xdx_908_ecustom--IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization_c20220101__20220101__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zVXMOVAnirzg" title="Decrease in stock due to retrospective impact of recapitalization"&gt;1,758,003&lt;/span&gt; which
was determined by the decrease in the Class A and Class B common stock of &lt;span id="xdx_907_ecustom--IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization_c20220101__20220101__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zGI7XGBbCyAj" title="Decrease in stock due to retrospective impact of recapitalization"&gt;15,082&lt;/span&gt; and &lt;span id="xdx_90C_ecustom--IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization_c20220101__20220101__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zdgAyWMloFif" title="Decrease in stock due to retrospective impact of recapitalization"&gt;2,435,327&lt;/span&gt;, respectively, offset by the increase
of reclassification of the Series A preferred stock into common stock of &lt;span id="xdx_900_ecustom--IncreaseOfReclassificationOfSeriesAPreferredStockIntoCommonStock_c20220101__20220101__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember_zGQJ3o8aKeIi" title="Increase of reclassification of series a preferred stock into common stock"&gt;28,629&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
total shares of common stock issued and outstanding at December 31, 2022, after giving effect to the recapitalization and activity during
the year, was &lt;span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z47xncQWTaHc" title="Common stock, shares outstanding"&gt;&lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zWdX1Ejygsg5" title="Common stock shares issued"&gt;3,935,892&lt;/span&gt;&lt;/span&gt;, consisting of &lt;span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zPPQ8H3ISV5l" title="Common stock, shares outstanding"&gt;&lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zTHx3wMtdQO3" title="Common stock shares issued"&gt;51,219&lt;/span&gt;&lt;/span&gt; shares of Class A common stock and &lt;span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_c20221231__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zzbaFWqKWx51" title="Common stock, shares outstanding"&gt;&lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20220101__20221231__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zRlZcu4lT9Pl" title="Common stock shares issued"&gt;3,884,673&lt;/span&gt;&lt;/span&gt; shares of Class B common stock. At December
31, 2023, the Company had &lt;span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20231231__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zh6VbIG0TmE6" title="Common stock, shares outstanding"&gt;&lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zrxvt2iVykH5" title="Common stock shares issued"&gt;2,585,297&lt;/span&gt;&lt;/span&gt; shares of common stock issued and outstanding, consisting of &lt;span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_c20231231__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zxqDcRWZNJzh" title="Common stock, shares outstanding"&gt;&lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zaMEPCfjtWbh" title="Common stock shares issued"&gt;274,162&lt;/span&gt;&lt;/span&gt; shares of Class A common
stock and &lt;span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_c20231231__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z133dSb2GlF4" title="Common stock, shares outstanding"&gt;&lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--BanzaiInternationalIncMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zlt9868hTC88" title="Common stock shares issued"&gt;2,311,134&lt;/span&gt;&lt;/span&gt; shares of Class B common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact003525"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact003527"
      unitRef="Pure">1</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003529"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact003531"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember5435062"
      decimals="INF"
      id="Fact003533"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <BNZI:ExchangeRatio
      contextRef="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember5435062"
      decimals="INF"
      id="Fact003535"
      unitRef="Pure">10.00</BNZI:ExchangeRatio>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="From2023-12-142023-12-14_custom_BanzaiInternationalIncMember5435078"
      decimals="0"
      id="Fact003537"
      unitRef="USD">100000000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember5435062"
      decimals="INF"
      id="Fact003539"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <BNZI:ExchangeRatio
      contextRef="AsOf2023-12-14_custom_BanzaiInternationalIncMember5435093"
      decimals="INF"
      id="Fact003541"
      unitRef="Pure">0.6147</BNZI:ExchangeRatio>
    <BNZI:BusinessCombinationProvisionalInformationInitialAccountingIncompleteReductionConsiderationTransferred
      contextRef="From2023-12-142023-12-14_custom_BanzaiInternationalIncMember5435078"
      decimals="0"
      id="Fact003543"
      unitRef="USD">100000000</BNZI:BusinessCombinationProvisionalInformationInitialAccountingIncompleteReductionConsiderationTransferred>
    <BNZI:NumberOfSharesHeldBySecurityHolders
      contextRef="AsOf2023-12-14_custom_SevenGCClassACommonStockMember"
      decimals="INF"
      id="Fact003545"
      unitRef="Shares">3207428</BNZI:NumberOfSharesHeldBySecurityHolders>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14_custom_SevenGCClassACommonStockMember"
      decimals="INF"
      id="Fact003547"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <BNZI:RedemptionPricePerShare
      contextRef="AsOf2023-12-14_custom_SevenGCClassACommonStockMember"
      decimals="INF"
      id="Fact003549"
      unitRef="USDPShares">10.76</BNZI:RedemptionPricePerShare>
    <BNZI:AggregateRedemptionAmount
      contextRef="AsOf2023-12-14_custom_SevenGCClassACommonStockMember"
      decimals="0"
      id="Fact003551"
      unitRef="USD">34524065</BNZI:AggregateRedemptionAmount>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003553"
      unitRef="Pure">1</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003555"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <BNZI:CommonStockConvertibleConversionRatio
      contextRef="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact003557"
      unitRef="Pure">1</BNZI:CommonStockConvertibleConversionRatio>
    <BNZI:WarrantsIssued
      contextRef="From2023-08-042023-08-04_custom_ForfeitedPrivatePlacementWarrantsMember_custom_SponsorForfeitureAgreementMember"
      decimals="INF"
      id="Fact003559"
      unitRef="Shares">7350000</BNZI:WarrantsIssued>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-08-04_custom_ForfeitedPrivatePlacementWarrantsMember_custom_SponsorForfeitureAgreementMember"
      decimals="INF"
      id="Fact003561"
      unitRef="USDPShares">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <BNZI:PrincipalAmountAgreedToAdvance
      contextRef="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="-5"
      id="Fact003563"
      unitRef="USD">3500000</BNZI:PrincipalAmountAgreedToAdvance>
    <BNZI:IncreasedPrincipalAmountAgreedToAdvance
      contextRef="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="-5"
      id="Fact003565"
      unitRef="USD">1000000.0</BNZI:IncreasedPrincipalAmountAgreedToAdvance>
    <BNZI:AggregatePrincipalAmount
      contextRef="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="-5"
      id="Fact003567"
      unitRef="USD">4500000</BNZI:AggregatePrincipalAmount>
    <BNZI:ForfeitureOfCommonStockShares
      contextRef="AsOf2023-10-03_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember_custom_SevenGCClassBCommonStockMember"
      decimals="INF"
      id="Fact003569"
      unitRef="Shares">3000</BNZI:ForfeitureOfCommonStockShares>
    <BNZI:ForfeitureOfCommonStockShares
      contextRef="AsOf2023-11-16_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember_custom_SevenGCClassBCommonStockMember"
      decimals="INF"
      id="Fact003571"
      unitRef="Shares">1500</BNZI:ForfeitureOfCommonStockShares>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-10-032023-10-03_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003573"
      unitRef="Shares">150000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-11-162023-11-16_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003575"
      unitRef="Shares">1500</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <BNZI:ShareTransferAgreementDescription
      contextRef="From2023-01-012023-12-31_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember"
      id="Fact003577">for
each $10.00
in principal borrowed under the New Alco Note, the Sponsor agreed to forfeit three shares of 7GC Class B Common Stock held by the
Sponsor, in exchange for the right of Alco to receive three shares of Class A Common Stock, in each case, at (and contingent upon)
the Closing, with such forfeited and issued shares capped at an amount equal to 12,000.</BNZI:ShareTransferAgreementDescription>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2023-12-13_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember"
      decimals="INF"
      id="Fact003579"
      unitRef="USDPShares">10.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <BNZI:ForfeitedAndIssuedSharesCapped
      contextRef="AsOf2023-12-13_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember"
      decimals="INF"
      id="Fact003581"
      unitRef="Shares">12000</BNZI:ForfeitedAndIssuedSharesCapped>
    <BNZI:AggregatePrincipalAmount
      contextRef="AsOf2023-12-13_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember"
      decimals="-5"
      id="Fact003583"
      unitRef="USD">2000000.0</BNZI:AggregatePrincipalAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-12-13_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember"
      decimals="INF"
      id="Fact003585"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <BNZI:AggregatePrincipalAmount
      contextRef="AsOf2023-09-13_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember"
      decimals="-5"
      id="Fact003587"
      unitRef="USD">1500000</BNZI:AggregatePrincipalAmount>
    <us-gaap:DebtInstrumentMaturityDateRangeStart1
      contextRef="From2023-01-012023-12-31_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember"
      id="Fact003589">2024-01-10</us-gaap:DebtInstrumentMaturityDateRangeStart1>
    <us-gaap:DebtInstrumentMaturityDateRangeEnd1
      contextRef="From2023-01-012023-12-31_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember"
      id="Fact003591">2024-09-30</us-gaap:DebtInstrumentMaturityDateRangeEnd1>
    <BNZI:ForfeitureOfCommonStockShares
      contextRef="AsOf2023-12-13_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember_custom_SevenGCClassBCommonStockMember"
      decimals="INF"
      id="Fact003593"
      unitRef="Shares">16500</BNZI:ForfeitureOfCommonStockShares>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-12-132023-12-13_custom_ShareTransferAgreementsAndAlcoPromissoryNotesMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003595"
      unitRef="Shares">16500</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <BNZI:EquityCommitmentByInvestor
      contextRef="AsOf2022-05-27_custom_GemAgreementsMember"
      decimals="0"
      id="Fact003597"
      unitRef="USD">100000000</BNZI:EquityCommitmentByInvestor>
    <BNZI:PercentageOfRightToPurchaseOfTotalEquityInterests
      contextRef="From2022-05-272022-05-27_custom_GemAgreementsMember_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003599"
      unitRef="Pure">0.03</BNZI:PercentageOfRightToPurchaseOfTotalEquityInterests>
    <BNZI:AmountDividedOnNumberOfEquityInterestsToObtainQuotient
      contextRef="From2022-05-272022-05-27_custom_GemAgreementsMember"
      decimals="-6"
      id="Fact003601"
      unitRef="USD">650000000</BNZI:AmountDividedOnNumberOfEquityInterestsToObtainQuotient>
    <BNZI:PercentageOfRightToPurchaseOfTotalEquityInterests
      contextRef="From2023-12-132023-12-13_custom_GemAgreementsMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003603"
      unitRef="Pure">0.03</BNZI:PercentageOfRightToPurchaseOfTotalEquityInterests>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2023-12-13_custom_GemAgreementsMember"
      decimals="-5"
      id="Fact003605"
      unitRef="USD">2000000.0</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-12-13_custom_GemAgreementsMember"
      decimals="INF"
      id="Fact003609"
      unitRef="Pure">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2023-12-12_custom_SevenGCPromissoryNotesMemberMember"
      decimals="0"
      id="Fact003611"
      unitRef="USD">2300000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="From2023-12-122023-12-12_custom_SevenGCPromissoryNotesMemberMember"
      decimals="INF"
      id="Fact003613"
      unitRef="Tradingday">30</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="From2023-12-122023-12-12_custom_SevenGCPromissoryNotesMemberMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003615"
      unitRef="Tradingday">30</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2023-12-12_custom_SevenGCPromissoryNotesMemberMember"
      decimals="INF"
      id="Fact003617"
      unitRef="USDPShares">2.86</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <BNZI:AggregatePrincipalAmount
      contextRef="AsOf2021-02-19_custom_CpBfSeniorConvertibleNotesMember_custom_FirstSeniorConvertibleNoteMember"
      decimals="0"
      id="Fact003619"
      unitRef="USD">1500000</BNZI:AggregatePrincipalAmount>
    <BNZI:AggregatePrincipalAmount
      contextRef="AsOf2022-10-10_custom_CpBfSeniorConvertibleNotesMember_custom_FirstSeniorConvertibleNoteMember"
      decimals="0"
      id="Fact003621"
      unitRef="USD">321345</BNZI:AggregatePrincipalAmount>
    <BNZI:ConvertibleWrittenNoticePeriod
      contextRef="From2023-08-242023-08-24_custom_CpBfSeniorConvertibleNotesMember"
      id="Fact003623">P5D</BNZI:ConvertibleWrittenNoticePeriod>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2023-08-24_custom_CpBfSeniorConvertibleNotesMember"
      decimals="INF"
      id="Fact003625"
      unitRef="USDPShares">217.43</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <BNZI:DeferredUnderwritingFeesForfeit
      contextRef="AsOf2023-11-08_custom_CantorFeeAgreementMember_custom_GcCoHoldingsIncMember_custom_CantorFitzgeraldMember"
      decimals="0"
      id="Fact003627"
      unitRef="USD">4050000</BNZI:DeferredUnderwritingFeesForfeit>
    <BNZI:DeferredUnderwritingFeesPayable
      contextRef="AsOf2023-11-08_custom_CantorFeeAgreementMember_custom_GcCoHoldingsIncMember_custom_CantorFitzgeraldMember"
      decimals="0"
      id="Fact003629"
      unitRef="USD">8050000</BNZI:DeferredUnderwritingFeesPayable>
    <BNZI:IncreaseDecreaseInDeferredUnderwritingFees
      contextRef="AsOf2023-11-08_custom_CantorFeeAgreementMember_custom_GcCoHoldingsIncMember_custom_CantorFitzgeraldMember"
      decimals="0"
      id="Fact003631"
      unitRef="USD">4000000</BNZI:IncreaseDecreaseInDeferredUnderwritingFees>
    <BNZI:DeferredUnderwritingFeesPayableInShares
      contextRef="AsOf2023-11-08_custom_CantorFeeAgreementMember_custom_GcCoHoldingsIncMember_custom_CantorFitzgeraldMember"
      decimals="INF"
      id="Fact003633"
      unitRef="Shares">400000</BNZI:DeferredUnderwritingFeesPayableInShares>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-12-282023-12-28_custom_CantorFeeAgreementMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003635"
      unitRef="Shares">22279</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-14_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003637"
      unitRef="Shares">105000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-14_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003639"
      unitRef="Shares">5000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-14_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact003641"
      unitRef="Shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-14"
      decimals="INF"
      id="Fact003643"
      unitRef="Shares">75000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14"
      decimals="INF"
      id="Fact003645"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact003647"
      unitRef="Shares">2585296</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact003649"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <BNZI:ScheduleOfReconciliationOfTheMergerToTheCompanysConsolidatedCashFlowsTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact003651">&lt;p id="xdx_89E_ecustom--ScheduleOfReconciliationOfTheMergerToTheCompanysConsolidatedCashFlowsTableTextBlock_zm0lv5GLygGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reconciles the elements of the Merger to the consolidated statements of cash flows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zSP9acBWFvJb" style="display: none"&gt;Schedule of Reconciliation of the Merger to the Company's Consolidated Cash Flows&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231214__20231214__us-gaap--ReclassificationTypeAxis__custom--RecapitalizationMember_zwD3SEXj1C9l" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Recapitalization&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DeferredUnderwritingFeesAssumed_zUIhn4EEqwu5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"&gt;Deferred underwriting fees assumed&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;4,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ConvertibleNotesPayableAssumed_zf1HGYqwMUj3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Convertible notes payable assumed&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,550,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--WarrantLiabilitiesAssumed_zZ0f7TJXlha8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Warrant liabilities assumed&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;460,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--EffectOnEquity_zZvP2m7iYjsb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;Less: effect on equity&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(14,625,462&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--EffectOfReverseRecapitalizationNetOfTransactionCosts_zcrKfXsx33b6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Effect of reverse recapitalization, net of transaction costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(7,615,462&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BNZI:ScheduleOfReconciliationOfTheMergerToTheCompanysConsolidatedCashFlowsTableTextBlock>
    <BNZI:DeferredUnderwritingFeesAssumed
      contextRef="From2023-12-142023-12-14_custom_RecapitalizationMember"
      decimals="0"
      id="Fact003653"
      unitRef="USD">4000000</BNZI:DeferredUnderwritingFeesAssumed>
    <BNZI:ConvertibleNotesPayableAssumed
      contextRef="From2023-12-142023-12-14_custom_RecapitalizationMember"
      decimals="0"
      id="Fact003655"
      unitRef="USD">2550000</BNZI:ConvertibleNotesPayableAssumed>
    <BNZI:WarrantLiabilitiesAssumed
      contextRef="From2023-12-142023-12-14_custom_RecapitalizationMember"
      decimals="0"
      id="Fact003657"
      unitRef="USD">460000</BNZI:WarrantLiabilitiesAssumed>
    <BNZI:EffectOnEquity
      contextRef="From2023-12-142023-12-14_custom_RecapitalizationMember"
      decimals="0"
      id="Fact003659"
      unitRef="USD">-14625462</BNZI:EffectOnEquity>
    <BNZI:EffectOfReverseRecapitalizationNetOfTransactionCosts
      contextRef="From2023-12-142023-12-14_custom_RecapitalizationMember"
      decimals="0"
      id="Fact003661"
      unitRef="USD">-7615462</BNZI:EffectOfReverseRecapitalizationNetOfTransactionCosts>
    <BNZI:ScheduleOfReconciliationOfTheMergerToTheCompanysConsolidatedStatementsOfChangesInStockholdersDeficitTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact003663">&lt;p id="xdx_896_ecustom--ScheduleOfReconciliationOfTheMergerToTheCompanysConsolidatedStatementsOfChangesInStockholdersDeficitTableTextBlock_z04qO4LVhUi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table reconciles the elements of the Merger to the consolidated statements of changes in stockholders&#x2019; deficit:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;span id="xdx_8B6_zHUh6XTeFKG5" style="display: none"&gt;Schedule of Reconciliation of the Merger to the Company&#x2019;s Statements of Changes in Stockholders&#x2019; Deficit&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231214__20231214__us-gaap--ReclassificationTypeAxis__custom--RecapitalizationMember_zxyWyQxwuVo4" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Recapitalization&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--CashAcquired_ztphF0MV1KWi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"&gt;Cash&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;197,166&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--NonCashNetWorkingCapitalAssumed_z9cp9MdN6vni" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Non-cash net working capital assumed&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(7,812,628&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DeferredUnderwritingFeesAssumed_iN_di_zz4uoOuOz0M4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Deferred underwriting fees assumed&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(4,000,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ConvertibleNotesPayableAssumed_iN_di_zLVPSBYxAGvd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Convertible notes payable assumed&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(2,550,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FairValueOfAssumedWarrantLiabilities_zwmL3VKoay8e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Fair value of assumed warrant liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(460,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--TransactionCosts_z0hEa5K36TH8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Transaction costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(3,233,097&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--EffectOfReverseRecapitalizationEffectOnEquity_zeqjU0y1EuH5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Effect of reverse recapitalization&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(17,858,559&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BNZI:ScheduleOfReconciliationOfTheMergerToTheCompanysConsolidatedStatementsOfChangesInStockholdersDeficitTableTextBlock>
    <BNZI:CashAcquired
      contextRef="From2023-12-142023-12-14_custom_RecapitalizationMember"
      decimals="0"
      id="Fact003665"
      unitRef="USD">197166</BNZI:CashAcquired>
    <BNZI:NonCashNetWorkingCapitalAssumed
      contextRef="From2023-12-142023-12-14_custom_RecapitalizationMember"
      decimals="0"
      id="Fact003667"
      unitRef="USD">-7812628</BNZI:NonCashNetWorkingCapitalAssumed>
    <BNZI:DeferredUnderwritingFeesAssumed
      contextRef="From2023-12-142023-12-14_custom_RecapitalizationMember"
      decimals="0"
      id="Fact003669"
      unitRef="USD">4000000</BNZI:DeferredUnderwritingFeesAssumed>
    <BNZI:ConvertibleNotesPayableAssumed
      contextRef="From2023-12-142023-12-14_custom_RecapitalizationMember"
      decimals="0"
      id="Fact003671"
      unitRef="USD">2550000</BNZI:ConvertibleNotesPayableAssumed>
    <BNZI:FairValueOfAssumedWarrantLiabilities
      contextRef="From2023-12-142023-12-14_custom_RecapitalizationMember"
      decimals="0"
      id="Fact003673"
      unitRef="USD">-460000</BNZI:FairValueOfAssumedWarrantLiabilities>
    <BNZI:TransactionCosts
      contextRef="From2023-12-142023-12-14_custom_RecapitalizationMember"
      decimals="0"
      id="Fact003675"
      unitRef="USD">-3233097</BNZI:TransactionCosts>
    <BNZI:EffectOfReverseRecapitalizationEffectOnEquity
      contextRef="From2023-12-142023-12-14_custom_RecapitalizationMember"
      decimals="0"
      id="Fact003677"
      unitRef="USD">-17858559</BNZI:EffectOfReverseRecapitalizationEffectOnEquity>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember5435062"
      decimals="INF"
      id="Fact003679"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-01-01_custom_BanzaiInternationalIncMember"
      decimals="INF"
      id="Fact003681"
      unitRef="Shares">6359139</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-01-012022-01-01_custom_BanzaiInternationalIncMember"
      decimals="INF"
      id="Fact003683"
      unitRef="Shares">6359139</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-01-01_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003685"
      unitRef="Shares">39139</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-01-012022-01-01_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003687"
      unitRef="Shares">39139</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-01-01_custom_BanzaiInternationalIncMember_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact003689"
      unitRef="Shares">6320000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-01-012022-01-01_custom_BanzaiInternationalIncMember_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact003691"
      unitRef="Shares">6320000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-01-01_custom_BanzaiInternationalIncMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact003693"
      unitRef="Shares">2328823</us-gaap:PreferredStockSharesOutstanding>
    <BNZI:IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization
      contextRef="From2022-01-012022-01-01_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003695"
      unitRef="Shares">15082</BNZI:IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization>
    <BNZI:IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization
      contextRef="From2022-01-012022-01-01_custom_BanzaiInternationalIncMember_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact003697"
      unitRef="Shares">2435327</BNZI:IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization>
    <BNZI:IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization
      contextRef="From2022-01-012022-01-01_custom_BanzaiInternationalIncMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact003699"
      unitRef="Shares">897380</BNZI:IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization>
    <BNZI:IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization
      contextRef="From2022-01-012022-01-01_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003701"
      unitRef="Shares">1758003</BNZI:IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization>
    <BNZI:IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization
      contextRef="From2022-01-012022-01-01_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003703"
      unitRef="Shares">15082</BNZI:IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization>
    <BNZI:IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization
      contextRef="From2022-01-012022-01-01_custom_BanzaiInternationalIncMember_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact003705"
      unitRef="Shares">2435327</BNZI:IncreaseDecreaseInStockDueToRetrospectiveImpactOfRecapitalization>
    <BNZI:IncreaseOfReclassificationOfSeriesAPreferredStockIntoCommonStock
      contextRef="From2022-01-012022-01-01_custom_BanzaiInternationalIncMember"
      decimals="INF"
      id="Fact003707"
      unitRef="Shares">28629</BNZI:IncreaseOfReclassificationOfSeriesAPreferredStockIntoCommonStock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003709"
      unitRef="Shares">3935892</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-01-012022-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003711"
      unitRef="Shares">3935892</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003713"
      unitRef="Shares">51219</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-01-012022-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003715"
      unitRef="Shares">51219</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact003717"
      unitRef="Shares">3884673</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2022-01-012022-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact003719"
      unitRef="Shares">3884673</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003721"
      unitRef="Shares">2585297</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-01-012023-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact003723"
      unitRef="Shares">2585297</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003725"
      unitRef="Shares">274162</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-01-012023-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact003727"
      unitRef="Shares">274162</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact003729"
      unitRef="Shares">2311134</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-01-012023-12-31_custom_BanzaiInternationalIncMember_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact003731"
      unitRef="Shares">2311134</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact003733">&lt;p id="xdx_801_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_zkhm9aUju9R7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;5.
&lt;span id="xdx_821_zgjpNkO59AF7"&gt;Asset Disposal&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Disposal
of High Attendance Assets &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 1, 2022, the Company sold the assets and liabilities of High Attendance, a subsidiary of the Company, back to its former owner (the
&#x201c;Buyer&#x201d;), from whom the assets were originally purchased during the year ended December 31, 2020 pursuant to an Asset Purchase
Agreement. At the time of the sale, the Buyer was employed by and a securityholder of the Company. The sale was accounted for as a nonmonetary
transaction as the Company determined the sale of the High Attendance asset group represents the rescission of the prior acquisition
of these assets in the asset acquisition which occurred during the year ended December 31, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
assets and liabilities of High Attendance were exchanged for the cancellation of &lt;span id="xdx_903_eus-gaap--StockRepurchasedDuringPeriodShares_c20220701__20220701__us-gaap--BusinessAcquisitionAxis__custom--HighAttendanceMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zGdi9mEG8ZK5" title="Cancellation of shares"&gt;1,638&lt;/span&gt; shares of restricted Class A Common Stock of
the Company, par value $&lt;span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220701__us-gaap--BusinessAcquisitionAxis__custom--HighAttendanceMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zX7p62jCMis6" title="Common stock par value"&gt;0.0001&lt;/span&gt; per share, held by the former owner of High Attendance, and which were previously granted to the Buyer
as consideration for the acquisition of High Attendance during the year ended December 31, 2020. As additional consideration for the
Buyer&#x2019;s assumption of liabilities relating to the purchased assets of High Attendance, the Company paid $&lt;span id="xdx_908_eus-gaap--BusinessCombinationConsiderationTransferred1_c20220701__20220701__us-gaap--BusinessAcquisitionAxis__custom--HighAttendanceMember_zqwQBu7RDX8e" title="Liabilities relating to purchased assets"&gt;17,500&lt;/span&gt; to the Buyer at
closing. The shares of restricted Class A Common Stock had vesting terms over &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dtM_c20220701__20220701__us-gaap--BusinessAcquisitionAxis__custom--HighAttendanceMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zhaB9COp1yPf" title="Common stock vesting term"&gt;24&lt;/span&gt; months of continuous service from the date of the initial
purchase during the year ended December 31, 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with the provisions of ASC 845 &lt;i&gt;Nonmonetary Transactions&lt;/i&gt;, the Company recorded the cancellation of &lt;span id="xdx_901_eus-gaap--StockRepurchasedDuringPeriodShares_c20220701__20220701__us-gaap--BusinessAcquisitionAxis__custom--HighAttendanceMember_zHSELiy566P8" title="Cancellation of shares"&gt;81,908&lt;/span&gt; shares of
restricted Class A Common Stock as a reduction of additional paid in capital, and &lt;span id="xdx_90E_eus-gaap--GainLossOnInvestments_do_c20220701__20220701__us-gaap--BusinessAcquisitionAxis__custom--HighAttendanceMember_zt6hXXXfjtVj" title="Gain (loss) from cancellation of shares"&gt;no&lt;/span&gt; gain or loss was recorded in this transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2022-07-012022-07-01_custom_HighAttendanceMember_us-gaap_CommonClassAMember_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="Fact003735"
      unitRef="Shares">1638</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-07-01_custom_HighAttendanceMember_us-gaap_CommonClassAMember_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="Fact003737"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2022-07-012022-07-01_custom_HighAttendanceMember"
      decimals="0"
      id="Fact003739"
      unitRef="USD">17500</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="From2022-07-012022-07-01_custom_HighAttendanceMember_us-gaap_CommonClassAMember_us-gaap_RestrictedStockMember"
      id="Fact003741">P24M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2022-07-012022-07-01_custom_HighAttendanceMember"
      decimals="INF"
      id="Fact003743"
      unitRef="Shares">81908</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:GainLossOnInvestments
      contextRef="From2022-07-012022-07-01_custom_HighAttendanceMember"
      decimals="0"
      id="Fact003745"
      unitRef="USD">0</us-gaap:GainLossOnInvestments>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact003747">&lt;p id="xdx_80F_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zy82CYXoC4o7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;6.
&lt;span id="xdx_827_zP7t9xYo7YOl"&gt;Related Party Transactions&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;7GC
Related Party Promissory Notes &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 21, 2022, 7GC issued an unsecured promissory note (the &#x201c;December 2022 7GC Note&#x201d;) to the Sponsor, 7GC &amp;amp; Co. Holdings
LLC, which provides for borrowings from time to time of up to an aggregate of $&lt;span id="xdx_909_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20221221__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalDrawdownsAndExtensionDrawdownsMember_z6Q7qZlQDJag" title="Maximum borrowing capacity"&gt;2,300,000&lt;/span&gt;. Up to $&lt;span id="xdx_909_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20221221__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalDrawdownsMember_zZo7wjvRg2Gh" title="Maximum borrowing capacity"&gt;500,000&lt;/span&gt; of the December 2022 7GC Note
may be drawn and used for Working Capital Drawdowns and up to $&lt;span id="xdx_90D_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20221221__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--ExtensionDrawdownsMember_zHCvPxVRuT51" title="Maximum borrowing capacity"&gt;1,800,000&lt;/span&gt; of the December 2022 7GC Note may be drawn and used for Extension
Drawdowns. 7GC borrowed $&lt;span id="xdx_900_eus-gaap--ProceedsFromRelatedPartyDebt_c20221221__20221221__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalDrawdownsAndExtensionDrawdownsMember_zgPuMjH12Qkj" title="Proceeds from related party debt"&gt;1,100,000&lt;/span&gt; under the December 2022 7GC Note on December 21, 2022, $&lt;span id="xdx_905_eus-gaap--ProceedsFromRelatedPartyDebt_c20221221__20221221__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalDrawdownsMember_z7ZjhUtB1Vca" title="Proceeds from related party debt"&gt;900,000&lt;/span&gt; of which was an Extension Drawdown
and $&lt;span id="xdx_900_eus-gaap--ProceedsFromRelatedPartyDebt_c20221221__20221221__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--ExtensionDrawdownsMember_zXk7bm3EHqO1" title="Proceeds from related party debt"&gt;200,000&lt;/span&gt; of which was a Working Capital Drawdown. The December 2022 7GC Note does not bear interest and is repayable in full upon
the earlier of the consummation of a Business Combination or the date 7GC liquidates the Trust Account upon the failure to consummate
a Business Combination within the requisite time period. Upon the consummation of a Business Combination, the Sponsor shall have the
option, but not the obligation, to convert the principal balance of the December 2022 7GC Note, in whole or in part, into that number
of shares of Class A common stock, $&lt;span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221221__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalDrawdownsAndExtensionDrawdownsMember_zeMPjINlIpC" title="Common stock par value"&gt;0.0001&lt;/span&gt; par value per share, of 7GC (the &#x201c;Converted Shares&#x201d;) equal to the principal amount
of the December 2022 7GC Note so converted divided by $&lt;span id="xdx_901_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20221221__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember_z2TgIo0lqyij" title="Debt instrument conversion price per share"&gt;10.00&lt;/span&gt;. The terms of the Converted Shares, if issued, will be identical to the
terms of 7GC&#x2019;s Public Shares, except that the Converted Shares (x) will not be registered under the Securities Act, and (y) will
be subject to the terms of that certain letter agreement, dated as of December 22, 2020, among 7GC, the Sponsor, and certain other parties
thereto. The December 2022 7GC Note is subject to customary events of default, the occurrence of which automatically trigger the unpaid
principal balance of the December 2022 7GC Note and all other sums payable with regard to the December 2022 7GC Note becoming immediately
due and payable. On February 9, 2023, 7GC borrowed an additional $&lt;span id="xdx_907_eus-gaap--ProceedsFromRelatedPartyDebt_c20230209__20230209__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalDrawdownsMember_zjroCbJOArF" title="Proceeds from related party debt"&gt;177,500&lt;/span&gt; under the December 2022 7GC Note which was a Working Capital
Drawdown. During the three months ended June 30, 2023 an additional $&lt;span id="xdx_902_eus-gaap--ProceedsFromRelatedPartyDebt_c20230401__20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalDrawdownsMember_zlOqfuBMaRBc" title="Proceeds from related party debt"&gt;122,500&lt;/span&gt; was borrowed under the Working Capital Drawdown, for a total
outstanding of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentCarryingAmount_iI_c20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalDrawdownsMember_zK324PQzqPPd" title="Outstanding principal amount"&gt;500,000&lt;/span&gt;. During the three months ended June 30, 2023 an additional $&lt;span id="xdx_905_eus-gaap--ProceedsFromRelatedPartyDebt_c20230401__20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--ExtensionDrawdownsMember_zPvIAyxyXLVa" title="Proceeds from related party debt"&gt;900,000&lt;/span&gt; was borrowed as an Extensions drawdown, for
a total outstanding of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentCarryingAmount_iI_c20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--ExtensionDrawdownsMember_zzHGzHN22py5" title="Outstanding principal amount"&gt;1,800,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 3, 2023, 7GC issued an additional unsecured promissory note (the &#x201c;October 2023 7GC Note&#x201d;, together with the December
2022 7GC Note, the &#x201c; 7GC Promissory Notes&#x201d;) to the Sponsor, which provides for borrowings from time to time of up to an aggregate
of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20231003__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--DebtInstrumentAxis__custom--WorkingCapitalLoansMember_zFR8VypMmVxj" title="Aggregate principal amount"&gt;500,000&lt;/span&gt; for working capital purposes. The October 2023 7GC Note does &lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dpo_uPure_c20231003__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--DebtInstrumentAxis__custom--WorkingCapitalLoansMember_zpQRXJ2fxSrg" title="Debt instrument, interest rate"&gt;no&lt;/span&gt;t bear interest and is repayable in full upon the earlier
of the consummation of a Business Combination or the date 7GC liquidates the Trust Account established in connection with 7GC&#x2019;s
Initial Public Offering upon the failure of 7GC to consummate a Business Combination within the requisite time period. Upon the consummation
of a Business Combination, the Sponsor shall have the option, but not the obligation, to convert the principal balance of the October
2023 7GC Note, in whole or in part, into that number of the Converted Shares, equal to the principal amount of the October 2023 7GC Note
so converted divided by $&lt;span id="xdx_903_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20231003__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--DebtInstrumentAxis__custom--WorkingCapitalLoansMember_zHdi6Wnz9AGf" title="Debt instrument conversion price per share"&gt;10.00&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
Closing of the Merger, Banzai assumed the 7GC Promissory Notes which remained outstanding as of December 31, 2023. As of December 31,
2023, $&lt;span id="xdx_905_eus-gaap--LoansPayableCurrent_iI_c20231231__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember_zNS8g9H8tJ27" title="Loans payable current"&gt;2,540,091&lt;/span&gt; was outstanding on the loans. See &lt;i&gt;Note 14-Debt &lt;/i&gt;for further details of these transactions and associated balances
and &lt;i&gt;Note 21-Subsequent Events&lt;/i&gt; for details related to the subsequent conversion of the 7GC Promissory Notes, in 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Due
to Related Party of 7GC &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2023, the Sponsor paid certain expenses on behalf of 7GC. Upon Closing of the Merger, Banzai assumed the
$&lt;span id="xdx_903_eus-gaap--OtherLiabilitiesCurrent_iI_c20231231__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zAeQzLziIJwa" title="Due to related party"&gt;67,118&lt;/span&gt; liability. As of December 31, 2023, the entire balance remained outstanding and is included within due to related party under
current liabilities on the accompanying consolidated balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Legacy
Banzai Related Party Transactions &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2022 and 2023, Legacy Banzai issued Promissory Notes and Convertible Notes to related parties. See &lt;i&gt;Note 14-Debt &lt;/i&gt;for further details
related to these transactions and associated balances. Legacy Banzai also entered into Simple Agreements for Future Equity (SAFE) arrangements
with related parties during 2021. See &lt;i&gt;Note 16-Simple Agreements for Future Equity &lt;/i&gt;for further details of these transactions and
associated balances.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2022-12-21_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalDrawdownsAndExtensionDrawdownsMember"
      decimals="0"
      id="Fact003749"
      unitRef="USD">2300000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2022-12-21_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalDrawdownsMember"
      decimals="0"
      id="Fact003751"
      unitRef="USD">500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2022-12-21_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_ExtensionDrawdownsMember"
      decimals="0"
      id="Fact003753"
      unitRef="USD">1800000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2022-12-212022-12-21_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalDrawdownsAndExtensionDrawdownsMember"
      decimals="0"
      id="Fact003755"
      unitRef="USD">1100000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2022-12-212022-12-21_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalDrawdownsMember"
      decimals="0"
      id="Fact003757"
      unitRef="USD">900000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2022-12-212022-12-21_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_ExtensionDrawdownsMember"
      decimals="0"
      id="Fact003759"
      unitRef="USD">200000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-12-21_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalDrawdownsAndExtensionDrawdownsMember"
      decimals="INF"
      id="Fact003761"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2022-12-21_custom_SevenGcCoHoldingsIncMember"
      decimals="INF"
      id="Fact003763"
      unitRef="USDPShares">10.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2023-02-092023-02-09_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalDrawdownsMember"
      decimals="0"
      id="Fact003765"
      unitRef="USD">177500</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2023-04-012023-06-30_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalDrawdownsMember"
      decimals="0"
      id="Fact003767"
      unitRef="USD">122500</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-06-30_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalDrawdownsMember"
      decimals="0"
      id="Fact003769"
      unitRef="USD">500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2023-04-012023-06-30_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_ExtensionDrawdownsMember"
      decimals="0"
      id="Fact003771"
      unitRef="USD">900000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-06-30_custom_SponsorMember_custom_SevenGcCoHoldingsIncMember_custom_ExtensionDrawdownsMember"
      decimals="0"
      id="Fact003773"
      unitRef="USD">1800000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-10-03_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalLoansMember"
      decimals="0"
      id="Fact003775"
      unitRef="USD">500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-10-03_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalLoansMember"
      decimals="INF"
      id="Fact003777"
      unitRef="Pure">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2023-10-03_custom_SevenGcCoHoldingsIncMember_custom_WorkingCapitalLoansMember"
      decimals="INF"
      id="Fact003779"
      unitRef="USDPShares">10.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2023-12-31_custom_SevenGcCoHoldingsIncMember"
      decimals="0"
      id="Fact003781"
      unitRef="USD">2540091</us-gaap:LoansPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-12-31_custom_SevenGcCoHoldingsIncMember_custom_SponsorMember"
      decimals="0"
      id="Fact003783"
      unitRef="USD">67118</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="From2023-01-012023-12-31" id="Fact003785">&lt;p id="xdx_801_eus-gaap--RevenueFromContractWithCustomerTextBlock_zkychWb5Hsfa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;7.
&lt;span id="xdx_82A_zdy3IYQ2RJz4"&gt;Revenue&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
ASC 606, revenue is recognized throughout the life of the executed agreement. The Company measures revenue based on considerations specified
in terms and conditions agreed to by a customer. Furthermore, the Company recognizes revenue when a performance obligation is satisfied
by transferring control of the service to the customer, which occurs over time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s services include providing end-to-end video engagement solutions that provide a fast, intuitive and powerful platform
of marketing tools that create more intent-driven videos, webinars, virtual events and other digital and in-person marketing campaigns.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
noted within the SOW&#x2019;s and invoices, agreements range from monthly to annual and Banzai generally provides for net &lt;span id="xdx_90A_ecustom--PaymentTerm_dtY_c20230101__20231231_zFEcyO6Mgzvi" title="Payment Term"&gt;30&lt;/span&gt;-day payment
terms with the payment made directly through check or electronic means.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Banzai&#x2019;s
Management believes its exposure to credit risk is sufficiently mitigated by collection through credit card sales or direct payment from
established clients.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the provisions of ASC 606, under which the Company recognizes revenue when the customer obtains control of promised goods
or services, in an amount that reflects the consideration which is expected to be received in exchange for those goods or services. The
Company recognize revenues following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify
the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance
obligation(s) in the contract; and (v) recognize revenues when (or as) the Company satisfies a performance obligation. The Company only
applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange
for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope
of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations
and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction
price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. Sales, value add,
and other taxes collected on behalf of third parties are excluded from revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Nature
of Products and Services &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following is a description of the Company&#x2019;s products and services from which the Company generates revenue, as well as the nature,
timing of satisfaction of performance obligations, and significant payment terms for each, as applicable:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Demio
&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Demio product is a full-stack technology that marketers can leverage live and automated for video marketing content such as webinars
and virtual events. Software products are provided to Demio customers for a range of attendees and hosts within a specified time frame
at a specified established price. &lt;span id="xdx_906_eus-gaap--RevenuePerformanceObligationDescriptionOfTiming_c20230101__20231231__srt--ProductOrServiceAxis__custom--DemioMember_z1Vgck637234" title="Performance obligations, timing"&gt;The performance obligations identified include access to the suite and platform, within the parameters
established, and within the standards established in the agreement. Contracts include a standalone selling price for the number of webinars
and hosts as a performance obligation. There are no financing components and payments are typically net 30 of date or receipt of invoice.
It is nearly 100% certain that a significant revenue reversal will not occur. The Company recognizes revenue for its sale of Demio services
over time which corresponds with the period of time that access to the service is provided.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Reach
&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;While
the Reach product is in the process of being phased out, the Company continues to generate revenues from the product. The Reach product
provides a multi-channel targeted audience acquisition (via Reach) to bolster engagement and Return on Investment (ROI). Banzai enables
marketing teams to create winning webinars and virtual and in-person events that increase marketing efficiency and drive additional revenue.
Software products are provided to Reach customers for a range of simultaneous events and registrations within a specified time frame
at a specified established price. &lt;span id="xdx_909_eus-gaap--RevenuePerformanceObligationDescriptionOfTiming_c20230101__20231231__srt--ProductOrServiceAxis__custom--ReachMember_zYkrjitAP3e7" title="Performance obligations, timing"&gt;The performance obligations identified include access to the suite and platform, within the parameters
established, and within the standards established in the agreement. Contracts include a standalone selling price for the number of simultaneous
published events as a performance obligation. There are no financing components and payments are typically net 30 of date or receipt
of invoice. It is nearly 100% certain that a significant revenue reversal will not occur. The Company recognizes revenue for its sale
of Reach services over time which corresponds with the timing the service is rendered.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Service
Trade Revenue &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has &lt;span id="xdx_909_ecustom--NumberOfCustomersWhichIsAlsoVendor_dc_c20230101__20231231_zNzOXnntT1d3" title="Customer vendor"&gt;one&lt;/span&gt; customer for which the customer is also a vendor. For this one customer, the Company exchanged services for approximately
$&lt;span id="xdx_902_ecustom--ServicesRevenueFromVendorCustomer_c20230101__20231231_z9iIaUoit4m" title="Exchanged services"&gt;375,000&lt;/span&gt; and $&lt;span id="xdx_903_ecustom--ServicesRevenueFromVendorCustomer_c20220101__20221231_z1kKZEbohJc4" title="Exchanged services"&gt;293,500&lt;/span&gt;, during the years ended December 31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Disaggregation
of Revenue &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_zphrYZbGlPS9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes revenue by region based on the billing address of customers:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B9_zETUY4e6QPE4" style="display: none"&gt;Summary
of Revenue by Region&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Percentage&lt;br/&gt; of Revenue&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Percentage&lt;br/&gt; of Revenue&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"&gt;Americas&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20231231__srt--StatementGeographicalAxis__srt--AmericasMember_zdYbNkh69Y6k" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Revenue"&gt;2,677,050&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__srt--StatementGeographicalAxis__srt--AmericasMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zp8tKoE1K461" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Percentage of Revenue"&gt;59&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__srt--AmericasMember_zkMpyWJALV6e" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Revenue"&gt;3,307,129&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--StatementGeographicalAxis__srt--AmericasMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zyvXT9LA0wx6" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Percentage of Revenue"&gt;62&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Europe, Middle East and Africa (EMEA)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20231231__srt--StatementGeographicalAxis__us-gaap--EMEAMember_zaH7PSTivGA4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue"&gt;1,511,886&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__srt--StatementGeographicalAxis__us-gaap--EMEAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zI7N1zjv6kM7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Percentage of Revenue"&gt;33&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__us-gaap--EMEAMember_zELcQ9Hat4tc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue"&gt;1,588,539&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--StatementGeographicalAxis__us-gaap--EMEAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zMqC1q5KeQX6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Percentage of Revenue"&gt;30&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;Asia Pacific&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20231231__srt--StatementGeographicalAxis__srt--AsiaPacificMember_zP5Ciu5bXXGc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue"&gt;372,364&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__srt--StatementGeographicalAxis__srt--AsiaPacificMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zh535qw26aMb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Percentage of Revenue"&gt;8&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__srt--AsiaPacificMember_zPv4dUnP2yka" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue"&gt;437,311&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--StatementGeographicalAxis__srt--AsiaPacificMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zGq5jJrr11l8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Percentage of Revenue"&gt;8&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20231231_zkplfrs7oR34" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount"&gt;4,561,300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_znLrThnR2Ou2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Percentage of Revenue"&gt;100&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231_zi8SZwfNQZIh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount"&gt;5,332,979&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zXxgXZ36YG2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Percentage of Revenue"&gt;100&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zfaBGcSJY1sa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Contract
Balances &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Accounts
Receivable, Net &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
receivable is recorded when an unconditional right to invoice and receive payment exists, such that only the passage of time is required
before payment of consideration is due. &lt;span id="xdx_908_ecustom--AccountsReceivableContractualTerm_c20230101__20231231_zn2CoyStp2sa" title="Accounts receivable contractual term"&gt;The Company receives payments from customers based upon agreed-upon contractual terms, typically
within 30 days of invoicing the customer.&lt;/span&gt; The timing of revenue recognition may differ from the timing of invoicing to customers.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zZMj08AdZKml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B6_zkKZm4HpqTva" style="display: none"&gt;Summary
of Accounts Receivable, Net&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;For The Years Ended December 31,&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Opening&lt;br/&gt; Balance&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Closing&lt;br/&gt; Balance&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Opening&lt;br/&gt; Balance&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Closing&lt;br/&gt; Balance&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"&gt;Accounts receivable, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AccountsReceivableNetCurrent_iS_c20230101__20231231_zjxoQ5YelkR1" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Opening Balance"&gt;68,416&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AccountsReceivableNetCurrent_iE_c20230101__20231231_zHFyNlySmuIl" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Closing Balance"&gt;105,049&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccountsReceivableNetCurrent_iS_c20220101__20221231_z3CbNCUlFxU1" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Opening Balance"&gt;74,727&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccountsReceivableNetCurrent_iE_c20220101__20221231_zJr0nPh8EWDa" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Closing Balance"&gt;68,416&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zs6BRtjJ5oF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Costs
to Obtain a Contract &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sales
commissions, the principal costs incurred to obtain a contract, are earned when the contract is executed. Management has capitalized
these costs and amortized the commission expense over time in accordance with the related contract&#x2019;s term. For the years ended
December 31, 2023 and 2022, commission expenses were $&lt;span id="xdx_90E_eus-gaap--SalesCommissionsAndFees_c20230101__20231231_zRUYaB7vtbxb" title="Commission expenses"&gt;299,450&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--SalesCommissionsAndFees_c20220101__20221231_zFclMHzjxbmi" title="Commission expenses"&gt;434,446&lt;/span&gt;, respectively. Capitalized commissions at the years ended
December 31, 2023 and 2022 were $&lt;span id="xdx_904_eus-gaap--CapitalizedContractCostNetCurrent_iI_c20231231_zx9L3674v2Y3" title="Capitalized commissions"&gt;51,472&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--CapitalizedContractCostNetCurrent_iI_c20221231_zxhcaq5GnF2h" title="Capitalized commissions"&gt;69,737&lt;/span&gt;, respectively, and are included within Prepaid expenses and other current assets
on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--CapitalizedContractCostTableTextBlock_zOO5qZWaNoxj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following summarizes the Costs to obtain a contract activity during the years ended December 31, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B3_zr7mcoDc01N8" style="display: none"&gt;Summary
of Costs to Obtain Contract Activity&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"&gt;Balance-December 31, 2021&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--CapitalizedContractCostNetCurrent_iS_c20220101__20221231_z7tvXOeLfAJb" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Capitalized contract cost, beginning balance"&gt;90,662&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"&gt;Commissions Incurred&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--CommissionsIncurred_c20220101__20221231_zbrVg1HianA3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Commissions Incurred"&gt;343,003&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; text-align: justify"&gt;Deferred Commissions Recognized&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--DeferredCommissionsRecognized_iN_di_c20220101__20221231_zbo9PRNB5shf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deferred Commissions Recognized"&gt;(363,928&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Balance-December 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CapitalizedContractCostNetCurrent_iS_c20230101__20231231_zm30J0zMzm67" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Capitalized contract cost, beginning balance"&gt;69,737&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"&gt;Commissions Incurred&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--CommissionsIncurred_c20230101__20231231_zhq0QxERnDHf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Commissions Incurred"&gt;242,810&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; text-align: justify"&gt;Deferred Commissions Recognized&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--DeferredCommissionsRecognized_iN_di_c20230101__20231231_zzsN0H3syVnd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deferred Commissions Recognized"&gt;(261,075&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"&gt;Balance-December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CapitalizedContractCostNetCurrent_iE_c20230101__20231231_zD6GO0SMST68" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Capitalized contract cost, ending balance"&gt;51,472&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_z23xwdWSsigf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <BNZI:PaymentTerm contextRef="From2023-01-012023-12-31" id="Fact003787">P30Y</BNZI:PaymentTerm>
    <us-gaap:RevenuePerformanceObligationDescriptionOfTiming
      contextRef="From2023-01-012023-12-31_custom_DemioMember"
      id="Fact003789">The performance obligations identified include access to the suite and platform, within the parameters
established, and within the standards established in the agreement. Contracts include a standalone selling price for the number of webinars
and hosts as a performance obligation. There are no financing components and payments are typically net 30 of date or receipt of invoice.
It is nearly 100% certain that a significant revenue reversal will not occur. The Company recognizes revenue for its sale of Demio services
over time which corresponds with the period of time that access to the service is provided.</us-gaap:RevenuePerformanceObligationDescriptionOfTiming>
    <us-gaap:RevenuePerformanceObligationDescriptionOfTiming
      contextRef="From2023-01-012023-12-31_custom_ReachMember"
      id="Fact003791">The performance obligations identified include access to the suite and platform, within the parameters
established, and within the standards established in the agreement. Contracts include a standalone selling price for the number of simultaneous
published events as a performance obligation. There are no financing components and payments are typically net 30 of date or receipt
of invoice. It is nearly 100% certain that a significant revenue reversal will not occur. The Company recognizes revenue for its sale
of Reach services over time which corresponds with the timing the service is rendered.</us-gaap:RevenuePerformanceObligationDescriptionOfTiming>
    <BNZI:NumberOfCustomersWhichIsAlsoVendor
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact003793"
      unitRef="Integer">1</BNZI:NumberOfCustomersWhichIsAlsoVendor>
    <BNZI:ServicesRevenueFromVendorCustomer
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003795"
      unitRef="USD">375000</BNZI:ServicesRevenueFromVendorCustomer>
    <BNZI:ServicesRevenueFromVendorCustomer
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003797"
      unitRef="USD">293500</BNZI:ServicesRevenueFromVendorCustomer>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact003799">&lt;p id="xdx_898_eus-gaap--DisaggregationOfRevenueTableTextBlock_zphrYZbGlPS9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes revenue by region based on the billing address of customers:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B9_zETUY4e6QPE4" style="display: none"&gt;Summary
of Revenue by Region&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year Ended December 31,&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Percentage&lt;br/&gt; of Revenue&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Percentage&lt;br/&gt; of Revenue&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"&gt;Americas&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20231231__srt--StatementGeographicalAxis__srt--AmericasMember_zdYbNkh69Y6k" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Revenue"&gt;2,677,050&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__srt--StatementGeographicalAxis__srt--AmericasMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zp8tKoE1K461" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Percentage of Revenue"&gt;59&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__srt--AmericasMember_zkMpyWJALV6e" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Revenue"&gt;3,307,129&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--StatementGeographicalAxis__srt--AmericasMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zyvXT9LA0wx6" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Percentage of Revenue"&gt;62&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Europe, Middle East and Africa (EMEA)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20231231__srt--StatementGeographicalAxis__us-gaap--EMEAMember_zaH7PSTivGA4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue"&gt;1,511,886&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__srt--StatementGeographicalAxis__us-gaap--EMEAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zI7N1zjv6kM7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Percentage of Revenue"&gt;33&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__us-gaap--EMEAMember_zELcQ9Hat4tc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue"&gt;1,588,539&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--StatementGeographicalAxis__us-gaap--EMEAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zMqC1q5KeQX6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Percentage of Revenue"&gt;30&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;Asia Pacific&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20231231__srt--StatementGeographicalAxis__srt--AsiaPacificMember_zP5Ciu5bXXGc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue"&gt;372,364&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__srt--StatementGeographicalAxis__srt--AsiaPacificMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zh535qw26aMb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Percentage of Revenue"&gt;8&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231__srt--StatementGeographicalAxis__srt--AsiaPacificMember_zPv4dUnP2yka" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue"&gt;437,311&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--StatementGeographicalAxis__srt--AsiaPacificMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zGq5jJrr11l8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Percentage of Revenue"&gt;8&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20231231_zkplfrs7oR34" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount"&gt;4,561,300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_znLrThnR2Ou2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Percentage of Revenue"&gt;100&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20220101__20221231_zi8SZwfNQZIh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Amount"&gt;5,332,979&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--GeographicConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zXxgXZ36YG2" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Percentage of Revenue"&gt;100&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_srt_AmericasMember"
      decimals="0"
      id="Fact003801"
      unitRef="USD">2677050</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_srt_AmericasMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact003803"
      unitRef="Pure">0.59</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_srt_AmericasMember"
      decimals="0"
      id="Fact003805"
      unitRef="USD">3307129</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_srt_AmericasMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact003807"
      unitRef="Pure">0.62</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_us-gaap_EMEAMember"
      decimals="0"
      id="Fact003809"
      unitRef="USD">1511886</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_EMEAMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact003811"
      unitRef="Pure">0.33</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_us-gaap_EMEAMember"
      decimals="0"
      id="Fact003813"
      unitRef="USD">1588539</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_EMEAMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact003815"
      unitRef="Pure">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31_srt_AsiaPacificMember"
      decimals="0"
      id="Fact003817"
      unitRef="USD">372364</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_srt_AsiaPacificMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact003819"
      unitRef="Pure">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31_srt_AsiaPacificMember"
      decimals="0"
      id="Fact003821"
      unitRef="USD">437311</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_srt_AsiaPacificMember_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact003823"
      unitRef="Pure">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003825"
      unitRef="USD">4561300</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-01-012023-12-31_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact003827"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003829"
      unitRef="USD">5332979</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-01-012022-12-31_us-gaap_GeographicConcentrationRiskMember_us-gaap_RevenueFromContractWithCustomerMember"
      decimals="INF"
      id="Fact003831"
      unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1>
    <BNZI:AccountsReceivableContractualTerm contextRef="From2023-01-012023-12-31" id="Fact003833">The Company receives payments from customers based upon agreed-upon contractual terms, typically
within 30 days of invoicing the customer.</BNZI:AccountsReceivableContractualTerm>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="From2023-01-012023-12-31" id="Fact003835">&lt;p id="xdx_89F_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zZMj08AdZKml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B6_zkKZm4HpqTva" style="display: none"&gt;Summary
of Accounts Receivable, Net&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;For The Years Ended December 31,&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Opening&lt;br/&gt; Balance&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Closing&lt;br/&gt; Balance&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Opening&lt;br/&gt; Balance&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Closing&lt;br/&gt; Balance&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: justify"&gt;Accounts receivable, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AccountsReceivableNetCurrent_iS_c20230101__20231231_zjxoQ5YelkR1" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Opening Balance"&gt;68,416&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--AccountsReceivableNetCurrent_iE_c20230101__20231231_zHFyNlySmuIl" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Closing Balance"&gt;105,049&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccountsReceivableNetCurrent_iS_c20220101__20221231_z3CbNCUlFxU1" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Opening Balance"&gt;74,727&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccountsReceivableNetCurrent_iE_c20220101__20221231_zJr0nPh8EWDa" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Closing Balance"&gt;68,416&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact003837"
      unitRef="USD">68416</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact003839"
      unitRef="USD">105049</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="Fact003841"
      unitRef="USD">74727</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact003843"
      unitRef="USD">68416</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:SalesCommissionsAndFees
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003845"
      unitRef="USD">299450</us-gaap:SalesCommissionsAndFees>
    <us-gaap:SalesCommissionsAndFees
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003847"
      unitRef="USD">434446</us-gaap:SalesCommissionsAndFees>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact003849"
      unitRef="USD">51472</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact003851"
      unitRef="USD">69737</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:CapitalizedContractCostTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact003853">&lt;p id="xdx_890_eus-gaap--CapitalizedContractCostTableTextBlock_zOO5qZWaNoxj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following summarizes the Costs to obtain a contract activity during the years ended December 31, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B3_zr7mcoDc01N8" style="display: none"&gt;Summary
of Costs to Obtain Contract Activity&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"&gt;Balance-December 31, 2021&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--CapitalizedContractCostNetCurrent_iS_c20220101__20221231_z7tvXOeLfAJb" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Capitalized contract cost, beginning balance"&gt;90,662&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"&gt;Commissions Incurred&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--CommissionsIncurred_c20220101__20221231_zbrVg1HianA3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Commissions Incurred"&gt;343,003&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; text-align: justify"&gt;Deferred Commissions Recognized&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--DeferredCommissionsRecognized_iN_di_c20220101__20221231_zbo9PRNB5shf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deferred Commissions Recognized"&gt;(363,928&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Balance-December 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CapitalizedContractCostNetCurrent_iS_c20230101__20231231_zm30J0zMzm67" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Capitalized contract cost, beginning balance"&gt;69,737&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"&gt;Commissions Incurred&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--CommissionsIncurred_c20230101__20231231_zhq0QxERnDHf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Commissions Incurred"&gt;242,810&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; text-align: justify"&gt;Deferred Commissions Recognized&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--DeferredCommissionsRecognized_iN_di_c20230101__20231231_zzsN0H3syVnd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deferred Commissions Recognized"&gt;(261,075&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"&gt;Balance-December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CapitalizedContractCostNetCurrent_iE_c20230101__20231231_zD6GO0SMST68" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Capitalized contract cost, ending balance"&gt;51,472&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:CapitalizedContractCostTableTextBlock>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="Fact003855"
      unitRef="USD">90662</us-gaap:CapitalizedContractCostNetCurrent>
    <BNZI:CommissionsIncurred
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003857"
      unitRef="USD">343003</BNZI:CommissionsIncurred>
    <BNZI:DeferredCommissionsRecognized
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact003859"
      unitRef="USD">363928</BNZI:DeferredCommissionsRecognized>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact003861"
      unitRef="USD">69737</us-gaap:CapitalizedContractCostNetCurrent>
    <BNZI:CommissionsIncurred
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003863"
      unitRef="USD">242810</BNZI:CommissionsIncurred>
    <BNZI:DeferredCommissionsRecognized
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact003865"
      unitRef="USD">261075</BNZI:DeferredCommissionsRecognized>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact003867"
      unitRef="USD">51472</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2023-01-012023-12-31" id="Fact003869">&lt;p id="xdx_80B_eus-gaap--FairValueDisclosuresTextBlock_z1nT8YtR4g66" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;8.
&lt;span id="xdx_822_zeW0k2yJich3"&gt;Fair Value Measurements&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value measurements discussed herein are based upon certain market assumptions and pertinent information available to management
as of and during the years ended December 31, 2023 and 2022. The carrying amount of accounts payable approximated fair value as they
are short term in nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
Value on a Non-recurring Basis &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of non-financial assets measured at fair value on a non-recurring basis, classified as Level 3 in the fair value hierarchy,
is determined based on using market-based approaches, or estimates of discounted expected future cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Fair
Value on a Recurring Basis &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows the guidance in ASC 820 &lt;i&gt;Fair Value Measurements and Disclosures&lt;/i&gt; for its financial assets and liabilities that
are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and
reported at fair value at least annually. The estimated fair value of the Public Warrants liabilities represent Level 2 measurements.
The estimated fair value of the convertible notes bifurcated embedded derivative liabilities, GEM warrant liabilities, Yorkville convertible
note, and SAFE represent Level 3 measurements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zPz8glwhT6yb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents information about the Company&#x2019;s financial instruments that are measured at fair value on a recurring basis
at December 31, 2023 and 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such
fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span id="xdx_8B2_zkYcNsE50Ps" style="display: none"&gt;Schedule
of Fair Value on Recurring Basis&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;Description&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Level&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20231231_zp6krukJdcx" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20221231_ztDp3DWl4uKd" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LiabilitiesAbstract_iB_zCWsR4jEpkk5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;Liabilities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--WarrantLiabilitiesPublic_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zJTGh0lYgJZk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 46%; text-align: left"&gt;Warrant liabilities-public&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;2&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;575,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3877"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--GEMWarrantLiabilities_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBZa8mHdStXi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;GEM warrant liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;641,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3880"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ConvertibleDebt_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWLMAIaQeR86" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Yorkville convertible note&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,766,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3883"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BifurcatedEmbeddedDerivativeLiabilitiesCurrent_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zVfVeWBnWhE5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Bifurcated embedded derivative liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3885"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;845,473&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--BifurcatedEmbeddedDerivativeLiabilitiesCurrent_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zpccjlslJlNg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Bifurcated embedded derivative liabilities-related party&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3888"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,936,827&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--SimpleAgreementForFutureEquity_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3aMnS34Nhu" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;SAFE&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3891"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;663,804&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--SimpleAgreementForFutureEquity_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zVckMCkyVps3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;SAFE-related party&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3894"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,802,196&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zY4arxVzbSrg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrant
Liability-Public Warrants &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company assumed &lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zjeS70EjUc4i" title="Warrants outstanding"&gt;230,000&lt;/span&gt; Public Warrants in the Merger which remained outstanding as of December 31, 2023. The fair values of the Public
Warrants are measured based on the listed market price of such warrants through December 31, 2023. See &lt;i&gt;Note 15-Warrant Liabilities
&lt;/i&gt;for further details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the period from December 14, 2023 through December 31, 2023, the Company recognized a benefit of approximately $&lt;span id="xdx_90F_eus-gaap--FairValueAdjustmentOfWarrants_c20231214__20231214__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zI95olaebs89"&gt;115,000&lt;/span&gt; resulting from
changes in the fair value of the derivative warrant liabilities, presented as change in fair value of warrant liabilities in the accompanying
condensed consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated fair values of the Public Warrants prior to being separately listed and traded, were initially determined using Level 3 inputs.
Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate
and dividend yield. The Company estimates the volatility of its common stock warrants based on implied volatility from the Company&#x2019;s
traded warrants and from historical volatility of select peer company&#x2019;s common stock that matches the expected remaining life of
the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar
to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual
term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_ecustom--SummaryOfChangesInTheFairValueOfTheWarrantsLiabilityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsLiabilityMember_zgqWMosX77Pk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the changes in the fair value of the Public Warrants liability which are Level 2 financial liabilities
that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8BD_zqYQhIkqhrJ2" style="display: none"&gt;Summary
of Changes in the Fair Value of the Warrants Liability&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsLiabilityMember_z54QuRuAEmie" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--PublicWarrantsLiability_iS_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zC8NTXskAOj6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Balance at December 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3902"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--MergerDateAssumptionOfPublicWarrants_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zeLHnidV2Bti" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Merger date assumption of public warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;460,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--ChangeInFairValueOfPublicWarrantsLiability_di_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zNcIyFWldgpd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;115,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--PublicWarrantsLiability_iE_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zOGzruKzmtZg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;575,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zxplKmUG8Sxl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrant
Liability-GEM Warrants &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
measurement of fair value of the GEM Warrants were determined utilizing a Monte Carlo simulation considering all relevant assumptions
current at the date of issuance (i.e., share price, exercise price, term, volatility, risk-free rate, probability of dilutive term of
three years, and expected time to conversion). Refer to &lt;i&gt;Note 15-Warrant Liabilities&lt;/i&gt; for further details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, the Company recognized a benefit (loss) of approximately $&lt;span id="xdx_902_eus-gaap--FairValueAdjustmentOfWarrants_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zhgw2oWQeQok"&gt;1,807,000&lt;/span&gt;, resulting from changes in the fair value of
the derivative warrant liabilities, presented as change in fair value of warrant liabilities in the accompanying condensed consolidated
statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_ecustom--SummaryOfChangesInTheFairValueOfTheWarrantsLiabilityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--GemWarrantsLiabilityMember_zH6dl1F9M9rb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the changes in the fair value of the GEM Warrants liability which are Level 3 financial liabilities
that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8BB_zvUASmJ95q37" style="display: none"&gt;Summary
of Changes in the Fair Value of the Warrants Liability&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsLiabilityMember_zVlWPIOOtAN6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--PublicWarrantsLiability_iS_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBx5y94IzCOd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Balance at December 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3913"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--IssuanceOfGemWarrants_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp86JZmi7EYd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Issuance of GEM warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;2,448,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ChangeInFairValueOfPublicWarrantsLiability_iN_di_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z7ZMrD4RK574" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,807,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--PublicWarrantsLiability_iE_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_ziLokCbO1Sd7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;641,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zKB5xJ1ZZZPc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Yorkville
Convertible Note &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
measurement of fair value of the Yorkville convertible note were determined utilizing a Monte Carlo simulation considering all relevant
assumptions current at the date of issuance (i.e., share price, term, volatility, risk-free rate, and probability of optional redemption).
Refer to &lt;i&gt;Note 14-Debt&lt;/i&gt; for further details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issuance
of yorkville convertible note&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, the Company recognized a benefit (loss) of approximately $(&lt;span id="xdx_909_ecustom--FairValueAdjustmentOfConvertibleNote_iN_di_c20230101__20231231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_ze7jKnOVT5X2" title="Benefit (loss) of changes in the fair value"&gt;34,000&lt;/span&gt;) resulting from changes in the fair value of
the Yorkville convertible note, presented as change in fair value of convertible promissory notes in the accompanying condensed consolidated
statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_ecustom--SummaryOfChangesInFairValueOfConvertibleNoteTableTextBlock_zqdy3vxL3qFa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the changes in the fair value of the Yorkville convertible note which is a Level 3 financial
liability measured at fair value on a recurring basis:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B5_zcUo3zhzh91i" style="display: none"&gt;Summary
of Changes in Fair Value of Yorkville Convertible Note&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230101__20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zayvrdJ643t6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConvertibleDebt_iS_zeyybmAQL5tc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Balance at December 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3925"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--IssuanceOfYorkvilleConvertibleNote_zOnPT7tGhaGb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Issuance of yorkville convertible note&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;1,800,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ChangeInFairValueOfYorkvilleConvertibleNote_zYZwfeBsXzn3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(34,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ConvertibleDebt_iE_z5Z8pTCWx6gf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,766,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zUQzFOasTMXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Bifurcated
Embedded Derivative Liability &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the embedded put option was determined using a Black Scholes option pricing model. Estimating fair values of embedded conversion
features requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the
instrument with related changes in internal and external market factors. Because the embedded conversion features are initially and subsequently
carried at fair values, the Company&#x2019;s consolidated statements of operations will reflect the volatility in these estimate and assumption
changes. On December 14, 2023, all outstanding principal and accrued interest, including the carrying value of any related embedded derivative,
related to the Related Party Convertible Notes and Third Party Convertible Notes converted into the Company&#x2019;s Class A Common Stock
pursuant to the close of the Merger Agreement. Refer to &lt;i&gt;Note 14-Debt&lt;/i&gt; for further details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_z10w2dGVkhqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the changes in the fair value of the bifurcated embedded derivative liability, related to the
Related Party and Third Party Convertible Debt, respectively, which are Level 3 financial liabilities that are measured at fair value
on a recurring basis:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span id="xdx_8B4_zkb5yGzQMsL9" style="display: none"&gt;Schedule
of Derivative Liabilities&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%"&gt;Balance at December 31, 2021&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iS_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zrbBxLWv6cz" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3935"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iS_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zhJHK2xVC09l" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Balance"&gt;4,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Issuance of convertible notes with bifurcated embedded derivatives&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IssuanceOfConvertibleNotes_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zaFzfM9KnpWk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of convertible notes with bifurcated embedded derivatives"&gt;1,398,595&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IssuanceOfConvertibleNotes_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zKRl4PfHgLIh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of convertible notes with bifurcated embedded derivatives"&gt;586,405&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Issuance of CP BF convertible notes with bifurcated embedded derivative&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IssuanceOfCpBfConvertibleNotes_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zyfpFzvEAAx2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of CP BF convertible notes with bifurcated embedded derivative"&gt;1,375&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--IssuanceOfCpBfConvertibleNotes_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zaRUYFCspo77" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of CP BF convertible notes with bifurcated embedded derivative"&gt;625&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Extinguishment of Old Alco Note derivative&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ExtinguishmentOfDebtAmount_iN_di_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zc7CfhkDi8r6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Extinguishment of Old Alco Note derivative"&gt;(70,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ExtinguishmentOfDebtAmount_iN_di_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_z1yFbY0vEokb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Extinguishment of Old Alco Note derivative"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3949"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_iN_di_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z456oiCNR8i5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;606,857&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_iN_di_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zwnzKFtiOIC4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;254,443&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Balance at December 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iS_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zg1jVvBh5WPl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance"&gt;1,936,827&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iS_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_znocQkQebY79" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance"&gt;845,473&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Issuance of convertible notes with bifurcated embedded derivative&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IssuanceOfConvertibleNotes_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zO2mGwqt5Ti5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of convertible notes with bifurcated embedded derivative"&gt;1,126,451&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IssuanceOfConvertibleNotes_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zGEhxHyVwql8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of convertible notes with bifurcated embedded derivative"&gt;559,390&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_iN_di_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z8TX0qPKMMbd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;(3,063,278&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_iN_di_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zamuhU3C4Til" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;(1,404,863&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iE_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zRWBw4aXkQg1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3967"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iE_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zpAaehiN8eJb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3969"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_z9yZkZQyUDcf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Simple
Agreements for Future Equity (SAFE) &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2021, the Company entered into Simple Agreements for Future Equity (SAFE) arrangements (the &#x201c;SAFEs&#x201d;). In the event of an
Equity Financing (as defined in the SAFEs agreements), the SAFEs will automatically convert into shares of the Company&#x2019;s common
or preferred stock at a discount of &lt;span id="xdx_90D_ecustom--PercentageOfDiscountPricePerShare_dp_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SimpleAgreementsForFutureEquityMember_zSGs7ktYNAui" title="Discount price"&gt;15&lt;/span&gt;% of the per share price of the shares offered in the Equity Financing (the &#x201c;Discount Price&#x201d;).
In the event of a Liquidity Event, SPAC Transaction or Dissolution Event (all terms as defined in the SAFEs agreements), the holders
of the SAFEs will be entitled to receive cash or shares of the Company&#x2019;s common or preferred stock. The number of shares required
to be issued to settle the SAFEs at the equity financing is variable, because that number will be determined by the discounted fair value
of the Company&#x2019;s equity shares on the date of settlement (i.e., Discount Price). Regardless of the fair value of the shares on
the date of settlement, the holder will receive a fixed monetary value based on the Purchase Amount of the SAFE. If there is a Liquidity
Event or SPAC Transaction before the settlement or termination of the SAFEs, the SAFEs will automatically be entitled to receive a portion
of Proceeds, due and payable immediately prior to, or concurrent with, the consummation of such Liquidity Event or SPAC Transaction,
equal to the greater of (i) two times (2x) the Purchase Amount (the &#x201c;Cash-Out Amount&#x201d;) or (ii) the amount payable on the
number of shares of Common Stock equal to the Purchase Amount divided by the Liquidity Price (as defined in the SAFEs agreements). Refer
to &lt;i&gt;Note 16-Simple Agreements for Future Equity&lt;/i&gt; for additional information related to the Company&#x2019;s SAFEs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the SAFEs was determined using a scenario-based method for the pre-modification SAFE&#x2019;s and a Monte Carlo simulation
method for the post-modification SAFEs. The value of the SAFE liability as of December 31, 2023 and 2022 is based on significant inputs
not observable in the market, which represents a Level 3 measurement within the fair value hierarchy. The fair value of the SAFEs on
the date of issuance was determined to be $&lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SimpleAgreementsForFutureEquityMember_zlcSAKuboRY8" title="Face value of the convertible notes"&gt;3,836,000&lt;/span&gt;. On December 14, 2023, all outstanding principal related to the Third Party SAFEs
and Related Party SAFEs converted into the Company&#x2019;s Class A Common Stock pursuant to the close of the Merger Agreement. Refer
to &lt;i&gt;Note 16-Simple Agreements for Future Equity&lt;/i&gt; for further details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--FairValueConcentrationOfRiskTextBlock_zj4OnkSSMCbe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the activity of the Related Party and Third Party SAFE liabilities, respectively (See &lt;i&gt;Note
16-Simple Agreements for Future Equity&lt;/i&gt; for further detail), which represents a recurring fair value measurement at the end of each
reporting period:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B4_zYr62P3sqv78" style="display: none"&gt;Schedule
of Fair Value Measurements&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%"&gt;Balance at December 31, 2021&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--SimpleAgreementForFutureEquityCurrent_iS_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zFCzw3GxCgeh" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Balance"&gt;3,121,591&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--SimpleAgreementForFutureEquityCurrent_iS_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zzovQLGfemFj" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Balance"&gt;235,409&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ChangeInFairValueOfSimpleAgreementForFutureEquity_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zcukEDSStUxe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;4,078,431&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ChangeInFairValueOfSimpleAgreementForFutureEquity_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zW7yJYB6zpih" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;307,569&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Loss on modification&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--LossOnModificationOfSimpleAgreementForFutureEquity_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_ztRznXVZbst4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss on modification"&gt;1,602,174&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--LossOnModificationOfSimpleAgreementForFutureEquity_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zGzYUNXHVElj" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss on modification"&gt;120,826&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Balance at December 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--SimpleAgreementForFutureEquityCurrent_iS_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z4RZlpeQvEUb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance"&gt;8,802,196&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--SimpleAgreementForFutureEquityCurrent_iS_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zJcTqRX4F7mg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance"&gt;663,804&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ChangeInFairValueOfSimpleAgreementForFutureEquity_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zZWIgzHYU7W7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;(2,752,430&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ChangeInFairValueOfSimpleAgreementForFutureEquity_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zT8cpXEwsBH1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;(207,570&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Conversion of SAFEs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ConversionOfSimpleAgreementForFutureEquity_iN_di_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zQKG6gdGR5m3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Conversion of SAFEs"&gt;(6,049,766&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ConversionOfSimpleAgreementForFutureEquity_iN_di_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zTR02e4L8Naj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Conversion of SAFEs"&gt;(456,234&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--SimpleAgreementForFutureEquityCurrent_iE_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zLLk9YE91Xna" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4001"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--SimpleAgreementForFutureEquityCurrent_iE_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zUiOwFTr0yz5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4003"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zUN6WlPZSHTj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact003871">&lt;p id="xdx_892_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zPz8glwhT6yb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents information about the Company&#x2019;s financial instruments that are measured at fair value on a recurring basis
at December 31, 2023 and 2022, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such
fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span id="xdx_8B2_zkYcNsE50Ps" style="display: none"&gt;Schedule
of Fair Value on Recurring Basis&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;Description&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Level&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20231231_zp6krukJdcx" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20221231_ztDp3DWl4uKd" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LiabilitiesAbstract_iB_zCWsR4jEpkk5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;Liabilities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--WarrantLiabilitiesPublic_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zJTGh0lYgJZk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 46%; text-align: left"&gt;Warrant liabilities-public&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;2&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;575,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3877"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--GEMWarrantLiabilities_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBZa8mHdStXi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;GEM warrant liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;641,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3880"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ConvertibleDebt_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWLMAIaQeR86" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Yorkville convertible note&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,766,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3883"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BifurcatedEmbeddedDerivativeLiabilitiesCurrent_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zVfVeWBnWhE5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Bifurcated embedded derivative liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3885"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;845,473&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--BifurcatedEmbeddedDerivativeLiabilitiesCurrent_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zpccjlslJlNg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Bifurcated embedded derivative liabilities-related party&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3888"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,936,827&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--SimpleAgreementForFutureEquity_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z3aMnS34Nhu" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;SAFE&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3891"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;663,804&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--SimpleAgreementForFutureEquity_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zVckMCkyVps3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;SAFE-related party&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3894"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,802,196&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <BNZI:WarrantLiabilitiesPublic
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel2Member"
      decimals="0"
      id="Fact003876"
      unitRef="USD">575000</BNZI:WarrantLiabilitiesPublic>
    <BNZI:GEMWarrantLiabilities
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact003879"
      unitRef="USD">641000</BNZI:GEMWarrantLiabilities>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact003882"
      unitRef="USD">1766000</us-gaap:ConvertibleDebt>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact003886"
      unitRef="USD">845473</BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent>
    <BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003889"
      unitRef="USD">1936827</BNZI:BifurcatedEmbeddedDerivativeLiabilitiesCurrent>
    <BNZI:SimpleAgreementForFutureEquity
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact003892"
      unitRef="USD">663804</BNZI:SimpleAgreementForFutureEquity>
    <BNZI:SimpleAgreementForFutureEquity
      contextRef="AsOf2022-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003895"
      unitRef="USD">8802196</BNZI:SimpleAgreementForFutureEquity>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact003897"
      unitRef="Shares">230000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-12-142023-12-14_custom_PublicWarrantsMember"
      decimals="0"
      id="Fact003898"
      unitRef="USD">115000</us-gaap:FairValueAdjustmentOfWarrants>
    <BNZI:SummaryOfChangesInTheFairValueOfTheWarrantsLiabilityTableTextBlock
      contextRef="From2023-01-012023-12-31_custom_PublicWarrantsLiabilityMember"
      id="Fact003900">&lt;p id="xdx_897_ecustom--SummaryOfChangesInTheFairValueOfTheWarrantsLiabilityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsLiabilityMember_zgqWMosX77Pk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the changes in the fair value of the Public Warrants liability which are Level 2 financial liabilities
that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8BD_zqYQhIkqhrJ2" style="display: none"&gt;Summary
of Changes in the Fair Value of the Warrants Liability&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsLiabilityMember_z54QuRuAEmie" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--PublicWarrantsLiability_iS_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zC8NTXskAOj6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Balance at December 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3902"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--MergerDateAssumptionOfPublicWarrants_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zeLHnidV2Bti" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Merger date assumption of public warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;460,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--ChangeInFairValueOfPublicWarrantsLiability_di_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zNcIyFWldgpd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;115,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--PublicWarrantsLiability_iE_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zOGzruKzmtZg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;575,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BNZI:SummaryOfChangesInTheFairValueOfTheWarrantsLiabilityTableTextBlock>
    <BNZI:MergerDateAssumptionOfPublicWarrants
      contextRef="From2023-01-012023-12-31_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel2Member"
      decimals="0"
      id="Fact003904"
      unitRef="USD">460000</BNZI:MergerDateAssumptionOfPublicWarrants>
    <BNZI:ChangeInFairValueOfPublicWarrantsLiability
      contextRef="From2023-01-012023-12-31_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel2Member"
      decimals="0"
      id="Fact003906"
      unitRef="USD">-115000</BNZI:ChangeInFairValueOfPublicWarrantsLiability>
    <BNZI:PublicWarrantsLiability
      contextRef="AsOf2023-12-31_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel2Member"
      decimals="0"
      id="Fact003908"
      unitRef="USD">575000</BNZI:PublicWarrantsLiability>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2023-01-012023-12-31_custom_PublicWarrantsMember5441437"
      decimals="0"
      id="Fact003909"
      unitRef="USD">1807000</us-gaap:FairValueAdjustmentOfWarrants>
    <BNZI:SummaryOfChangesInTheFairValueOfTheWarrantsLiabilityTableTextBlock
      contextRef="From2023-01-012023-12-31_custom_GemWarrantsLiabilityMember"
      id="Fact003911">&lt;p id="xdx_898_ecustom--SummaryOfChangesInTheFairValueOfTheWarrantsLiabilityTableTextBlock_hus-gaap--ClassOfWarrantOrRightAxis__custom--GemWarrantsLiabilityMember_zH6dl1F9M9rb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the changes in the fair value of the GEM Warrants liability which are Level 3 financial liabilities
that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8BB_zvUASmJ95q37" style="display: none"&gt;Summary
of Changes in the Fair Value of the Warrants Liability&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsLiabilityMember_zVlWPIOOtAN6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--PublicWarrantsLiability_iS_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBx5y94IzCOd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Balance at December 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3913"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--IssuanceOfGemWarrants_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zp86JZmi7EYd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Issuance of GEM warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;2,448,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ChangeInFairValueOfPublicWarrantsLiability_iN_di_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z7ZMrD4RK574" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,807,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--PublicWarrantsLiability_iE_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_ziLokCbO1Sd7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;641,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BNZI:SummaryOfChangesInTheFairValueOfTheWarrantsLiabilityTableTextBlock>
    <BNZI:IssuanceOfGemWarrants
      contextRef="From2023-01-012023-12-31_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact003915"
      unitRef="USD">2448000</BNZI:IssuanceOfGemWarrants>
    <BNZI:ChangeInFairValueOfPublicWarrantsLiability
      contextRef="From2023-01-012023-12-31_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact003917"
      unitRef="USD">1807000</BNZI:ChangeInFairValueOfPublicWarrantsLiability>
    <BNZI:PublicWarrantsLiability
      contextRef="AsOf2023-12-31_custom_PublicWarrantsLiabilityMember_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact003919"
      unitRef="USD">641000</BNZI:PublicWarrantsLiability>
    <BNZI:FairValueAdjustmentOfConvertibleNote
      contextRef="From2023-01-012023-12-31_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact003921"
      unitRef="USD">-34000</BNZI:FairValueAdjustmentOfConvertibleNote>
    <BNZI:SummaryOfChangesInFairValueOfConvertibleNoteTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact003923">&lt;p id="xdx_898_ecustom--SummaryOfChangesInFairValueOfConvertibleNoteTableTextBlock_zqdy3vxL3qFa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the changes in the fair value of the Yorkville convertible note which is a Level 3 financial
liability measured at fair value on a recurring basis:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B5_zcUo3zhzh91i" style="display: none"&gt;Summary
of Changes in Fair Value of Yorkville Convertible Note&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230101__20231231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zayvrdJ643t6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--ConvertibleDebt_iS_zeyybmAQL5tc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Balance at December 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3925"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--IssuanceOfYorkvilleConvertibleNote_zOnPT7tGhaGb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Issuance of yorkville convertible note&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;1,800,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ChangeInFairValueOfYorkvilleConvertibleNote_zYZwfeBsXzn3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(34,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--ConvertibleDebt_iE_z5Z8pTCWx6gf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,766,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BNZI:SummaryOfChangesInFairValueOfConvertibleNoteTableTextBlock>
    <BNZI:IssuanceOfYorkvilleConvertibleNote
      contextRef="From2023-01-012023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact003927"
      unitRef="USD">1800000</BNZI:IssuanceOfYorkvilleConvertibleNote>
    <BNZI:ChangeInFairValueOfYorkvilleConvertibleNote
      contextRef="From2023-01-012023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact003929"
      unitRef="USD">-34000</BNZI:ChangeInFairValueOfYorkvilleConvertibleNote>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact003931"
      unitRef="USD">1766000</us-gaap:ConvertibleDebt>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact003933">&lt;p id="xdx_895_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_z10w2dGVkhqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the changes in the fair value of the bifurcated embedded derivative liability, related to the
Related Party and Third Party Convertible Debt, respectively, which are Level 3 financial liabilities that are measured at fair value
on a recurring basis:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span id="xdx_8B4_zkb5yGzQMsL9" style="display: none"&gt;Schedule
of Derivative Liabilities&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%"&gt;Balance at December 31, 2021&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iS_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zrbBxLWv6cz" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3935"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iS_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zhJHK2xVC09l" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Balance"&gt;4,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Issuance of convertible notes with bifurcated embedded derivatives&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IssuanceOfConvertibleNotes_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zaFzfM9KnpWk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of convertible notes with bifurcated embedded derivatives"&gt;1,398,595&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IssuanceOfConvertibleNotes_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zKRl4PfHgLIh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of convertible notes with bifurcated embedded derivatives"&gt;586,405&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Issuance of CP BF convertible notes with bifurcated embedded derivative&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IssuanceOfCpBfConvertibleNotes_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zyfpFzvEAAx2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of CP BF convertible notes with bifurcated embedded derivative"&gt;1,375&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--IssuanceOfCpBfConvertibleNotes_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zaRUYFCspo77" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of CP BF convertible notes with bifurcated embedded derivative"&gt;625&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Extinguishment of Old Alco Note derivative&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ExtinguishmentOfDebtAmount_iN_di_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zc7CfhkDi8r6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Extinguishment of Old Alco Note derivative"&gt;(70,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ExtinguishmentOfDebtAmount_iN_di_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_z1yFbY0vEokb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Extinguishment of Old Alco Note derivative"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3949"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_iN_di_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z456oiCNR8i5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;606,857&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_iN_di_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zwnzKFtiOIC4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;254,443&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Balance at December 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iS_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zg1jVvBh5WPl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance"&gt;1,936,827&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iS_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_znocQkQebY79" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance"&gt;845,473&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Issuance of convertible notes with bifurcated embedded derivative&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IssuanceOfConvertibleNotes_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zO2mGwqt5Ti5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of convertible notes with bifurcated embedded derivative"&gt;1,126,451&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IssuanceOfConvertibleNotes_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zGEhxHyVwql8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Issuance of convertible notes with bifurcated embedded derivative"&gt;559,390&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Change in fair value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_iN_di_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z8TX0qPKMMbd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;(3,063,278&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_iN_di_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zamuhU3C4Til" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;(1,404,863&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iE_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zRWBw4aXkQg1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3967"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DerivativeAssetsLiabilitiesAtFairValueNet_iE_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zpAaehiN8eJb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3969"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="AsOf2021-12-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact003937"
      unitRef="USD">4000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <BNZI:IssuanceOfConvertibleNotes
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003939"
      unitRef="USD">1398595</BNZI:IssuanceOfConvertibleNotes>
    <BNZI:IssuanceOfConvertibleNotes
      contextRef="From2022-01-012022-12-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact003941"
      unitRef="USD">586405</BNZI:IssuanceOfConvertibleNotes>
    <BNZI:IssuanceOfCpBfConvertibleNotes
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003943"
      unitRef="USD">1375</BNZI:IssuanceOfCpBfConvertibleNotes>
    <BNZI:IssuanceOfCpBfConvertibleNotes
      contextRef="From2022-01-012022-12-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact003945"
      unitRef="USD">625</BNZI:IssuanceOfCpBfConvertibleNotes>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003947"
      unitRef="USD">70000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003951"
      unitRef="USD">-606857</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2022-01-012022-12-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact003953"
      unitRef="USD">-254443</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003955"
      unitRef="USD">1936827</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet
      contextRef="AsOf2022-12-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact003957"
      unitRef="USD">845473</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
    <BNZI:IssuanceOfConvertibleNotes
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003959"
      unitRef="USD">1126451</BNZI:IssuanceOfConvertibleNotes>
    <BNZI:IssuanceOfConvertibleNotes
      contextRef="From2023-01-012023-12-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact003961"
      unitRef="USD">559390</BNZI:IssuanceOfConvertibleNotes>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003963"
      unitRef="USD">3063278</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="From2023-01-012023-12-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact003965"
      unitRef="USD">1404863</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <BNZI:PercentageOfDiscountPricePerShare
      contextRef="From2021-01-012021-12-31_custom_SimpleAgreementsForFutureEquityMember"
      decimals="INF"
      id="Fact003971"
      unitRef="Pure">0.15</BNZI:PercentageOfDiscountPricePerShare>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-12-31_custom_SimpleAgreementsForFutureEquityMember"
      decimals="0"
      id="Fact003973"
      unitRef="USD">3836000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:FairValueConcentrationOfRiskTextBlock contextRef="From2023-01-012023-12-31" id="Fact003975">&lt;p id="xdx_896_eus-gaap--FairValueConcentrationOfRiskTextBlock_zj4OnkSSMCbe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following tables set forth a summary of the activity of the Related Party and Third Party SAFE liabilities, respectively (See &lt;i&gt;Note
16-Simple Agreements for Future Equity&lt;/i&gt; for further detail), which represents a recurring fair value measurement at the end of each
reporting period:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B4_zYr62P3sqv78" style="display: none"&gt;Schedule
of Fair Value Measurements&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%"&gt;Balance at December 31, 2021&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--SimpleAgreementForFutureEquityCurrent_iS_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zFCzw3GxCgeh" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Balance"&gt;3,121,591&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_ecustom--SimpleAgreementForFutureEquityCurrent_iS_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zzovQLGfemFj" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Balance"&gt;235,409&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ChangeInFairValueOfSimpleAgreementForFutureEquity_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zcukEDSStUxe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;4,078,431&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ChangeInFairValueOfSimpleAgreementForFutureEquity_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zW7yJYB6zpih" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;307,569&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Loss on modification&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--LossOnModificationOfSimpleAgreementForFutureEquity_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_ztRznXVZbst4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss on modification"&gt;1,602,174&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--LossOnModificationOfSimpleAgreementForFutureEquity_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zGzYUNXHVElj" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Loss on modification"&gt;120,826&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Balance at December 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--SimpleAgreementForFutureEquityCurrent_iS_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z4RZlpeQvEUb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance"&gt;8,802,196&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--SimpleAgreementForFutureEquityCurrent_iS_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zJcTqRX4F7mg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance"&gt;663,804&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ChangeInFairValueOfSimpleAgreementForFutureEquity_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zZWIgzHYU7W7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;(2,752,430&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ChangeInFairValueOfSimpleAgreementForFutureEquity_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zT8cpXEwsBH1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value"&gt;(207,570&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Conversion of SAFEs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ConversionOfSimpleAgreementForFutureEquity_iN_di_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zQKG6gdGR5m3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Conversion of SAFEs"&gt;(6,049,766&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ConversionOfSimpleAgreementForFutureEquity_iN_di_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zTR02e4L8Naj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Conversion of SAFEs"&gt;(456,234&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Balance at December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--SimpleAgreementForFutureEquityCurrent_iE_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zLLk9YE91Xna" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4001"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--SimpleAgreementForFutureEquityCurrent_iE_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyConvertibleDebtMember_zUiOwFTr0yz5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4003"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:FairValueConcentrationOfRiskTextBlock>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2021-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003977"
      unitRef="USD">3121591</BNZI:SimpleAgreementForFutureEquityCurrent>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2021-12-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact003979"
      unitRef="USD">235409</BNZI:SimpleAgreementForFutureEquityCurrent>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003981"
      unitRef="USD">4078431</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact003983"
      unitRef="USD">307569</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:LossOnModificationOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003985"
      unitRef="USD">1602174</BNZI:LossOnModificationOfSimpleAgreementForFutureEquity>
    <BNZI:LossOnModificationOfSimpleAgreementForFutureEquity
      contextRef="From2022-01-012022-12-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact003987"
      unitRef="USD">120826</BNZI:LossOnModificationOfSimpleAgreementForFutureEquity>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003989"
      unitRef="USD">8802196</BNZI:SimpleAgreementForFutureEquityCurrent>
    <BNZI:SimpleAgreementForFutureEquityCurrent
      contextRef="AsOf2022-12-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact003991"
      unitRef="USD">663804</BNZI:SimpleAgreementForFutureEquityCurrent>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003993"
      unitRef="USD">-2752430</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact003995"
      unitRef="USD">-207570</BNZI:ChangeInFairValueOfSimpleAgreementForFutureEquity>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact003997"
      unitRef="USD">6049766</BNZI:ConversionOfSimpleAgreementForFutureEquity>
    <BNZI:ConversionOfSimpleAgreementForFutureEquity
      contextRef="From2023-01-012023-12-31_custom_ThirdPartyConvertibleDebtMember"
      decimals="0"
      id="Fact003999"
      unitRef="USD">456234</BNZI:ConversionOfSimpleAgreementForFutureEquity>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact004005">&lt;p id="xdx_805_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zbvFGetxbnJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;9.
&lt;span id="xdx_82B_zFjEgodOJ2sg"&gt;Property and Equipment &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--PropertyPlantAndEquipmentTextBlock_zntX4P18Ierk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment, net consisted of the following at the dates indicated:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B6_zuuMEyNMiXua" style="display: none"&gt;Schedule of Property and Equipment, Net&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20231231_zV6HVGiTGvVh" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20221231_z7f7w6rAKvs9" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zeusd3roOfY8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Computers and equipment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;30,867&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;30,866&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_zF6x78U4dMW4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Less: accumulated depreciation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(26,223&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(19,063&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentNet_iI_z0a8kt0Ilp09" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,644&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;11,803&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zwBtIA3Lpg8d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
expense for the years ended December 31, 2023 and 2022 was $&lt;span id="xdx_90A_eus-gaap--Depreciation_c20230101__20231231_zLF6K1qGWLWl" title="Depreciation expense"&gt;7,160&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--Depreciation_c20220101__20221231_zaMFAMY530r4" title="Depreciation expense"&gt;9,588&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2023-01-012023-12-31" id="Fact004007">&lt;p id="xdx_89A_eus-gaap--PropertyPlantAndEquipmentTextBlock_zntX4P18Ierk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment, net consisted of the following at the dates indicated:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B6_zuuMEyNMiXua" style="display: none"&gt;Schedule of Property and Equipment, Net&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20231231_zV6HVGiTGvVh" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20221231_z7f7w6rAKvs9" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zeusd3roOfY8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Computers and equipment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;30,867&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;30,866&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_zF6x78U4dMW4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Less: accumulated depreciation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(26,223&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(19,063&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentNet_iI_z0a8kt0Ilp09" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Property and equipment, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,644&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;11,803&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-12-31_us-gaap_ComputerEquipmentMember"
      decimals="0"
      id="Fact004009"
      unitRef="USD">30867</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2022-12-31_us-gaap_ComputerEquipmentMember"
      decimals="0"
      id="Fact004010"
      unitRef="USD">30866</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004012"
      unitRef="USD">26223</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004013"
      unitRef="USD">19063</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004015"
      unitRef="USD">4644</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004016"
      unitRef="USD">11803</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact004018"
      unitRef="USD">7160</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004020"
      unitRef="USD">9588</us-gaap:Depreciation>
    <BNZI:PrepaidExpensesAndOtherCurrentAssetsTextBlock contextRef="From2023-01-012023-12-31" id="Fact004022">&lt;p id="xdx_803_ecustom--PrepaidExpensesAndOtherCurrentAssetsTextBlock_zgynxbZHDeej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;10.
&lt;span id="xdx_825_zqQEdQHxtGt8"&gt;Prepaid Expenses and Other Current Assets &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zYe9j865Aoha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
expenses and other current assets consisted of the following at the dates indicated:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span id="xdx_8BE_zh4SWLI7Lso3" style="display: none"&gt;Summary
of Prepaid Expenses and Other Current Assets&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20231231_z0fJaoNEHs39" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20221231_zXY8a9FH56Ua" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Prepaid expenses and other current assets:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ServiceTrade_iI_maPEAOAzwvC_z2MznlXtKs5a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left; padding-left: 10pt"&gt;Service Trade&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;364,384&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;97,875&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--PrepaidConsultingCosts_iI_maPEAOAzwvC_zHukKJgxrbIl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Prepaid consulting costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;120,332&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,124&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--PrepaidDataLicenseAndSubscriptionCosts_iI_maPEAOAzwvC_zzqazZCdeSYj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Prepaid data license and subscription costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;53,124&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;40,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--PrepaidCommissions_iI_maPEAOAzwvC_zT1wYq0FLLO9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Prepaid commissions&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;51,472&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;69,737&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--PrepaidSoftwareCosts_iI_maPEAOAzwvC_zN7QMlVD7Wq2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Prepaid software costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;29,887&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;10,255&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--PrepaidMerchantFees_iI_maPEAOAzwvC_zKPd8kB9hci7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Prepaid merchant fees&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;26,224&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;26,401&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--PrepaidInsurance_iI_maPEAOAzwvC_zoJYlVatwuNl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Prepaid insurance costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;17,661&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;15,430&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--PrepaidAdvertising_iI_maPEAOAzwvC_zpVoFy8bexQ2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Prepaid advertising and marketing costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;11,074&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;32,178&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OtherAssetsCurrent_iI_maPEAOAzwvC_zovXU9mE8NI5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; padding-left: 10pt"&gt;Other current assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;66,997&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;38,507&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzwvC_z8y3HnkxRFZe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total prepaid expenses and other current assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;741,155&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;333,507&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zrq8nZutbSh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</BNZI:PrepaidExpensesAndOtherCurrentAssetsTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact004024">&lt;p id="xdx_896_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zYe9j865Aoha" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
expenses and other current assets consisted of the following at the dates indicated:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span id="xdx_8BE_zh4SWLI7Lso3" style="display: none"&gt;Summary
of Prepaid Expenses and Other Current Assets&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20231231_z0fJaoNEHs39" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20221231_zXY8a9FH56Ua" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Prepaid expenses and other current assets:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ServiceTrade_iI_maPEAOAzwvC_z2MznlXtKs5a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left; padding-left: 10pt"&gt;Service Trade&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;364,384&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;97,875&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--PrepaidConsultingCosts_iI_maPEAOAzwvC_zHukKJgxrbIl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Prepaid consulting costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;120,332&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,124&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--PrepaidDataLicenseAndSubscriptionCosts_iI_maPEAOAzwvC_zzqazZCdeSYj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Prepaid data license and subscription costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;53,124&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;40,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--PrepaidCommissions_iI_maPEAOAzwvC_zT1wYq0FLLO9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Prepaid commissions&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;51,472&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;69,737&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--PrepaidSoftwareCosts_iI_maPEAOAzwvC_zN7QMlVD7Wq2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Prepaid software costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;29,887&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;10,255&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--PrepaidMerchantFees_iI_maPEAOAzwvC_zKPd8kB9hci7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Prepaid merchant fees&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;26,224&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;26,401&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--PrepaidInsurance_iI_maPEAOAzwvC_zoJYlVatwuNl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Prepaid insurance costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;17,661&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;15,430&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--PrepaidAdvertising_iI_maPEAOAzwvC_zpVoFy8bexQ2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Prepaid advertising and marketing costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;11,074&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;32,178&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OtherAssetsCurrent_iI_maPEAOAzwvC_zovXU9mE8NI5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; padding-left: 10pt"&gt;Other current assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;66,997&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;38,507&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzwvC_z8y3HnkxRFZe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total prepaid expenses and other current assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;741,155&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;333,507&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <BNZI:ServiceTrade
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004026"
      unitRef="USD">364384</BNZI:ServiceTrade>
    <BNZI:ServiceTrade
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004027"
      unitRef="USD">97875</BNZI:ServiceTrade>
    <BNZI:PrepaidConsultingCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004029"
      unitRef="USD">120332</BNZI:PrepaidConsultingCosts>
    <BNZI:PrepaidConsultingCosts
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004030"
      unitRef="USD">3124</BNZI:PrepaidConsultingCosts>
    <BNZI:PrepaidDataLicenseAndSubscriptionCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004032"
      unitRef="USD">53124</BNZI:PrepaidDataLicenseAndSubscriptionCosts>
    <BNZI:PrepaidDataLicenseAndSubscriptionCosts
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004033"
      unitRef="USD">40000</BNZI:PrepaidDataLicenseAndSubscriptionCosts>
    <BNZI:PrepaidCommissions
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004035"
      unitRef="USD">51472</BNZI:PrepaidCommissions>
    <BNZI:PrepaidCommissions
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004036"
      unitRef="USD">69737</BNZI:PrepaidCommissions>
    <BNZI:PrepaidSoftwareCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004038"
      unitRef="USD">29887</BNZI:PrepaidSoftwareCosts>
    <BNZI:PrepaidSoftwareCosts
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004039"
      unitRef="USD">10255</BNZI:PrepaidSoftwareCosts>
    <BNZI:PrepaidMerchantFees
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004041"
      unitRef="USD">26224</BNZI:PrepaidMerchantFees>
    <BNZI:PrepaidMerchantFees
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004042"
      unitRef="USD">26401</BNZI:PrepaidMerchantFees>
    <us-gaap:PrepaidInsurance
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004044"
      unitRef="USD">17661</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004045"
      unitRef="USD">15430</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidAdvertising
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004047"
      unitRef="USD">11074</us-gaap:PrepaidAdvertising>
    <us-gaap:PrepaidAdvertising
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004048"
      unitRef="USD">32178</us-gaap:PrepaidAdvertising>
    <us-gaap:OtherAssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004050"
      unitRef="USD">66997</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004051"
      unitRef="USD">38507</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004053"
      unitRef="USD">741155</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004054"
      unitRef="USD">333507</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:GoodwillDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact004056">&lt;p id="xdx_80C_eus-gaap--GoodwillDisclosureTextBlock_z27cFMfuQBBg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;11.
&lt;span id="xdx_826_z14nw5rt16nb"&gt;Goodwill&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfGoodwillTextBlock_zNb0OO0YThA9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following summarizes our goodwill activity during the years ended December 31, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B9_zr71KkByZ7eg" style="display: none"&gt;Summary of Goodwill&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%"&gt;Goodwill-December 31, 2021&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iS_c20220101__20221231_zo8EXG5Sks41" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Goodwill, balance"&gt;2,171,526&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Impairment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--GoodwillImpairmentLoss_d0_c20220101__20221231_zoicVzZ3wd53" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Impairment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Goodwill-December 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Goodwill_iS_c20230101__20231231_zB3As7p02gT6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Goodwill, balance"&gt;2,171,526&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;Impairment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--GoodwillImpairmentLoss_d0_c20230101__20231231_zMKAZil46Qn7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Impairment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Goodwill-December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Goodwill_iE_c20230101__20231231_zcOHjMTKSmPe" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Goodwill, balance"&gt;2,171,526&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zfZ3eer8scu1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
the Company has &lt;span id="xdx_90C_eus-gaap--NumberOfOperatingSegments_dc_c20230101__20231231_z1l8uiolwBpd" title="Number of operating segments"&gt;one&lt;/span&gt; operating segment which was deemed to be its only reporting unit, goodwill is allocated to that &lt;span id="xdx_900_eus-gaap--NumberOfReportableSegments_dc_c20230101__20231231_z7OHLoMmcFVi" title="Number of reporting segments"&gt;one&lt;/span&gt; reporting unit
and the carrying value is determined based on the equity of the entire company for purposes of evaluating goodwill impairment. The last
quantitative goodwill impairment analysis was performed on December 31, 2022 where the Company determined that the carrying value of
the Company&#x2019;s reporting unit was negative. As of December 31, 2023, the date of the last goodwill impairment analysis, the reporting
unit had a negative carrying value. &lt;span id="xdx_904_eus-gaap--GoodwillImpairmentLoss_do_c20230101__20231231_zQM4ERgmo9I" title="Impairment of goodwill"&gt;&lt;span id="xdx_909_eus-gaap--GoodwillImpairmentLoss_do_c20220101__20221231_zGctmtQcm2H5" title="Impairment of goodwill"&gt;No&lt;/span&gt;&lt;/span&gt; impairment of goodwill was identified as of December 31, 2023 or 2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="From2023-01-012023-12-31" id="Fact004058">&lt;p id="xdx_890_eus-gaap--ScheduleOfGoodwillTextBlock_zNb0OO0YThA9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following summarizes our goodwill activity during the years ended December 31, 2023 and 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B9_zr71KkByZ7eg" style="display: none"&gt;Summary of Goodwill&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%"&gt;Goodwill-December 31, 2021&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iS_c20220101__20221231_zo8EXG5Sks41" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Goodwill, balance"&gt;2,171,526&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Impairment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--GoodwillImpairmentLoss_d0_c20220101__20221231_zoicVzZ3wd53" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Impairment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Goodwill-December 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Goodwill_iS_c20230101__20231231_zB3As7p02gT6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Goodwill, balance"&gt;2,171,526&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;Impairment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--GoodwillImpairmentLoss_d0_c20230101__20231231_zMKAZil46Qn7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Impairment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Goodwill-December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Goodwill_iE_c20230101__20231231_zcOHjMTKSmPe" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Goodwill, balance"&gt;2,171,526&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="Fact004060"
      unitRef="USD">2171526</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004062"
      unitRef="USD">-0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004064"
      unitRef="USD">2171526</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact004066"
      unitRef="USD">-0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004068"
      unitRef="USD">2171526</us-gaap:Goodwill>
    <us-gaap:NumberOfOperatingSegments
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004070"
      unitRef="Integer">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004072"
      unitRef="Integer">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact004074"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004076"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2023-01-012023-12-31" id="Fact004078">&lt;p id="xdx_807_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_ztZsmO2si7oh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12.
&lt;span&gt;Accrued and Other Current Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span&gt;&#160;&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_82E_zHKduJ4kTWJ9" style="display: none"&gt;Accrued
Expenses and Other Current Liabilities&lt;/span&gt;&lt;/b&gt; &lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zAVebgKBqpD7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
and other current liabilities consisted of the following at the dates indicated:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B8_ztne6nUiwZrb" style="display: none"&gt;Summary
of Accrued Expenses and Other Current Liabilities&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20231231_zzYErSD31NL1" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20221231_zgf7FCiY2Ru8" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accrued and other current liabilities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--AccruedLegalCosts_iI_maALAOLzQvM_zH4mBB3lvgR7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left; padding-left: 10pt"&gt;Accrued legal costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;2,694,439&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;31,355&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--AccruedAccountingAndProfessionalServicesCosts_iI_maALAOLzQvM_z7LS1NxRThXa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Accrued accounting and professional services costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,511,889&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;94,573&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--SalesTaxPayableCurrent_iI_maALAOLzQvM_zLfY03eLX3K7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Sales tax payable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;314,873&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;230,617&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--ExciseTaxPayableCurrent_iI_maALAOLzQvM_zJMMpt7yTvS3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Excise tax payable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;223,717&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4092"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AccruedPayrollAndBenefitCosts_iI_maALAOLzQvM_zztnz0JxUHP3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Accrued payroll and benefit costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;185,504&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;95,947&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DepositLiabilityCurrent_iI_maALAOLzQvM_zkwAysgLXCm9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;Deposits&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;54,102&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4098"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--AccruedStreamingServiceCosts_iI_maALAOLzQvM_zmsyZDzXIZt6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Accrued streaming service costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;37,765&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4101"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--AccruedSubscriptionCosts_iI_maALAOLzQvM_z7Q047BorHy6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Accrued subscription costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;22,110&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;28,774&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AccruedOfferingCosts_iI_maALAOLzQvM_z4FFo8ba4C7b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Accrued offering costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4106"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;261,090&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OtherLiabilitiesCurrent_iI_maALAOLzQvM_zErfGud4ezBe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; padding-left: 10pt"&gt;Other current liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;149,841&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,017&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iTI_mtALAOLzQvM_zjGqGNdYdmo5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Total accrued and other current liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,194,240&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;745,373&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zW2fspc8j1b5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004080">&lt;p id="xdx_89A_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zAVebgKBqpD7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accrued
and other current liabilities consisted of the following at the dates indicated:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8B8_ztne6nUiwZrb" style="display: none"&gt;Summary
of Accrued Expenses and Other Current Liabilities&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20231231_zzYErSD31NL1" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;br/&gt; 2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20221231_zgf7FCiY2Ru8" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;December 31,&lt;br/&gt; 2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accrued and other current liabilities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--AccruedLegalCosts_iI_maALAOLzQvM_zH4mBB3lvgR7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left; padding-left: 10pt"&gt;Accrued legal costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;2,694,439&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;31,355&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--AccruedAccountingAndProfessionalServicesCosts_iI_maALAOLzQvM_z7LS1NxRThXa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Accrued accounting and professional services costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,511,889&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;94,573&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--SalesTaxPayableCurrent_iI_maALAOLzQvM_zLfY03eLX3K7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Sales tax payable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;314,873&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;230,617&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--ExciseTaxPayableCurrent_iI_maALAOLzQvM_zJMMpt7yTvS3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Excise tax payable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;223,717&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4092"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--AccruedPayrollAndBenefitCosts_iI_maALAOLzQvM_zztnz0JxUHP3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Accrued payroll and benefit costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;185,504&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;95,947&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DepositLiabilityCurrent_iI_maALAOLzQvM_zkwAysgLXCm9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;Deposits&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;54,102&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4098"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--AccruedStreamingServiceCosts_iI_maALAOLzQvM_zmsyZDzXIZt6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Accrued streaming service costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;37,765&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4101"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--AccruedSubscriptionCosts_iI_maALAOLzQvM_z7Q047BorHy6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Accrued subscription costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;22,110&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;28,774&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--AccruedOfferingCosts_iI_maALAOLzQvM_z4FFo8ba4C7b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 10pt"&gt;Accrued offering costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4106"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;261,090&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OtherLiabilitiesCurrent_iI_maALAOLzQvM_zErfGud4ezBe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; padding-left: 10pt"&gt;Other current liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;149,841&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,017&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iTI_mtALAOLzQvM_zjGqGNdYdmo5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Total accrued and other current liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,194,240&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;745,373&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <BNZI:AccruedLegalCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004082"
      unitRef="USD">2694439</BNZI:AccruedLegalCosts>
    <BNZI:AccruedLegalCosts
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004083"
      unitRef="USD">31355</BNZI:AccruedLegalCosts>
    <BNZI:AccruedAccountingAndProfessionalServicesCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004085"
      unitRef="USD">1511889</BNZI:AccruedAccountingAndProfessionalServicesCosts>
    <BNZI:AccruedAccountingAndProfessionalServicesCosts
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004086"
      unitRef="USD">94573</BNZI:AccruedAccountingAndProfessionalServicesCosts>
    <BNZI:SalesTaxPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004088"
      unitRef="USD">314873</BNZI:SalesTaxPayableCurrent>
    <BNZI:SalesTaxPayableCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004089"
      unitRef="USD">230617</BNZI:SalesTaxPayableCurrent>
    <BNZI:ExciseTaxPayableCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004091"
      unitRef="USD">223717</BNZI:ExciseTaxPayableCurrent>
    <BNZI:AccruedPayrollAndBenefitCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004094"
      unitRef="USD">185504</BNZI:AccruedPayrollAndBenefitCosts>
    <BNZI:AccruedPayrollAndBenefitCosts
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004095"
      unitRef="USD">95947</BNZI:AccruedPayrollAndBenefitCosts>
    <us-gaap:DepositLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004097"
      unitRef="USD">54102</us-gaap:DepositLiabilityCurrent>
    <BNZI:AccruedStreamingServiceCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004100"
      unitRef="USD">37765</BNZI:AccruedStreamingServiceCosts>
    <BNZI:AccruedSubscriptionCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004103"
      unitRef="USD">22110</BNZI:AccruedSubscriptionCosts>
    <BNZI:AccruedSubscriptionCosts
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004104"
      unitRef="USD">28774</BNZI:AccruedSubscriptionCosts>
    <BNZI:AccruedOfferingCosts
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004107"
      unitRef="USD">261090</BNZI:AccruedOfferingCosts>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004109"
      unitRef="USD">149841</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004110"
      unitRef="USD">3017</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004112"
      unitRef="USD">5194240</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004113"
      unitRef="USD">745373</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <BNZI:DeferredRevenueTextBlock contextRef="From2023-01-012023-12-31" id="Fact004115">&lt;p id="xdx_80F_ecustom--DeferredRevenueTextBlock_zl5oqeOPaL26" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;13.
&lt;span id="xdx_829_zSjzk6felt9g"&gt;Deferred Revenue &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
revenue represents amounts that have been collected in advance of revenue recognition and is recognized as revenue when transfer of control
to customers has occurred or services have been provided. The deferred revenue balance does not represent the total contract value of
annual or multi-year, non-cancelable revenue agreements. Differences between the revenue recognized per the below schedule, and the revenue
recognized per the consolidated statement of operations, reflect amounts not recognized through the deferred revenue process, and which
have been determined to be insignificant. For the year ended December 31, 2023, the Company recognized $&lt;span id="xdx_906_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20230101__20231231_z91vws0KxUtb" title="Recognition of deferred revenue"&gt;930,436&lt;/span&gt; in revenue that was included
in the prior year deferred revenue balance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_zXtZ4lw1pY27" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
change in deferred revenue was as follows for the periods indicated:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span id="xdx_8B2_ziJj8nzuz3Nk" style="display: none"&gt;Summary of Changes in Deferred Revenue&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230101__20231231_zKsJ2osIUXji" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20220101__20221231_zmTAXdDycZm2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ContractWithCustomerLiability_iS_zRE8pSmtYLM8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 64%"&gt;Deferred revenue, beginning of period&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;930,436&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;1,060,040&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ContractWithCustomerLiabilityBillings_zKYdcS0bcCH9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Billings&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,781,924&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,040,665&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenuePriorYear_iN_di_zrRiVij51Vo7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Revenue recognized (prior year deferred revenue)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(930,436&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,004,697&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenueCurrentYear_iN_di_z50CXmq8Zpy2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Revenue recognized (current year deferred revenue)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(3,567,828&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(4,165,572&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ContractWithCustomerLiability_iE_z7qNbs36WF46" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deferred revenue, end of period&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,214,096&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;930,436&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AC_zX5lHE4gUUQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BNZI:DeferredRevenueTextBlock>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact004117"
      unitRef="USD">930436</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004119">&lt;p id="xdx_89B_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_zXtZ4lw1pY27" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
change in deferred revenue was as follows for the periods indicated:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span id="xdx_8B2_ziJj8nzuz3Nk" style="display: none"&gt;Summary of Changes in Deferred Revenue&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20230101__20231231_zKsJ2osIUXji" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20220101__20221231_zmTAXdDycZm2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--ContractWithCustomerLiability_iS_zRE8pSmtYLM8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 64%"&gt;Deferred revenue, beginning of period&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;930,436&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;1,060,040&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--ContractWithCustomerLiabilityBillings_zKYdcS0bcCH9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Billings&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,781,924&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;5,040,665&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenuePriorYear_iN_di_zrRiVij51Vo7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Revenue recognized (prior year deferred revenue)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(930,436&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,004,697&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenueCurrentYear_iN_di_z50CXmq8Zpy2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Revenue recognized (current year deferred revenue)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(3,567,828&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(4,165,572&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ContractWithCustomerLiability_iE_z7qNbs36WF46" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deferred revenue, end of period&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,214,096&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;930,436&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004121"
      unitRef="USD">930436</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="Fact004122"
      unitRef="USD">1060040</us-gaap:ContractWithCustomerLiability>
    <BNZI:ContractWithCustomerLiabilityBillings
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact004124"
      unitRef="USD">4781924</BNZI:ContractWithCustomerLiabilityBillings>
    <BNZI:ContractWithCustomerLiabilityBillings
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004125"
      unitRef="USD">5040665</BNZI:ContractWithCustomerLiabilityBillings>
    <BNZI:ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenuePriorYear
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact004127"
      unitRef="USD">930436</BNZI:ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenuePriorYear>
    <BNZI:ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenuePriorYear
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004128"
      unitRef="USD">1004697</BNZI:ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenuePriorYear>
    <BNZI:ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenueCurrentYear
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact004130"
      unitRef="USD">3567828</BNZI:ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenueCurrentYear>
    <BNZI:ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenueCurrentYear
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004131"
      unitRef="USD">4165572</BNZI:ContractWithCustomerLiabilityRevenueRecognitionOfDeferredRevenueCurrentYear>
    <us-gaap:ContractWithCustomerLiability
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004133"
      unitRef="USD">1214096</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004134"
      unitRef="USD">930436</us-gaap:ContractWithCustomerLiability>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact004136">&lt;p id="xdx_801_eus-gaap--DebtDisclosureTextBlock_zhLs3PB96jMb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;14.
&lt;span id="xdx_820_zy6hc2q9FWL5"&gt;Debt&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Convertible
Notes &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Convertible
Notes-Related Party &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 21, 2022, the Company issued a subordinated convertible promissory note (&#x201c;Old Alco Note&#x201d;) for a principal sum of $&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20220321__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zUqzz3sjImk9" title="Principal amount"&gt;2,000,000&lt;/span&gt;
to Alco Investment Company (&#x201c;Alco&#x201d;), a related party. Alco held approximately &lt;span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220321__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zUokp6cXvwBf" title="Ownership percentage"&gt;5&lt;/span&gt;% of the issued equity of the Company, through
its ownership of Series A preferred stock. The Old Alco Note bore interest at a rate of &lt;span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20220321__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zlohpJK8HNb5" title="Ownership percentage"&gt;15&lt;/span&gt;% per annum until exchanged. The outstanding
principal and accrued interest were due and payable on December 31, 2023 (&#x201c;Original Maturity Date&#x201d;), provided that, Alco
could elect to extend the Original Maturity Date up to two times by additional 12-month increments by delivering written notice to the
Company prior to the Original Maturity Date of such election. &lt;span id="xdx_908_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20220321__20220321__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_z3zruRGisOT4" title="Debt instrument conversion feature"&gt;The outstanding principal and interest under the Old Alco Note was, at
the Holder&#x2019;s election, either (i) effective upon the closing of an Equity Financing (as defined in the agreement), to be converted
into shares of the same series of preferred stock of the Company issued to other investors in the Equity Financing (the &#x201c;Equity
Financing Securities&#x201d;) at a conversion price equal to &lt;span id="xdx_906_ecustom--DebtInstrumentConversionPercentage_dp_c20220321__20220321__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_z2LGjqyj3Vml" title="Ownership percentage"&gt;85&lt;/span&gt;% of the price per share of Equity Financing Securities paid by the other
investors in the Equity Financing, with any resulting fraction of a share rounded to the nearest whole share (with 0.5 being rounded
up) (the &#x201c;Conversion Option&#x201d;) or (ii) immediately prior to the closing of an Equity Financing, become due and payable in
cash.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
embedded redemption put feature upon an Equity Financing is not clearly and closely related to the debt host instrument, was separated
from the debt host and initially measured at fair value. Subsequent changes in fair value of the feature are recognized in the Consolidated
Statement of Operations. The fair value (see &lt;i&gt;Note 8-Fair Value Measurements&lt;/i&gt;) of the bifurcated derivative liability was estimated
utilizing the with and without method which uses the probability weighted difference between the scenarios with the derivative and the
plain vanilla maturity scenario without a derivative.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Discounts
to the principal amounts were included in the carrying value of the Old Alco Note and amortized to interest expense over the remaining
term of the underlying debt. During 2022, the Company recorded a $&lt;span id="xdx_90F_eus-gaap--AmortizationOfDebtDiscountPremium_c20220101__20221231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zAmG2IdtBLI1" title="Debt discount"&gt;151,000&lt;/span&gt; debt discount upon issuance of the Old Alco Note. For the year
ended December 31, 2022, interest expense on the Old Alco Note totaled $&lt;span id="xdx_901_eus-gaap--InterestExpenseDebt_c20220101__20221231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zdZYdVG0ZFy7" title="Interest expense"&gt;124,621&lt;/span&gt;, comprised of $&lt;span id="xdx_90B_eus-gaap--InterestExpenseDebtExcludingAmortization_c20220101__20221231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zaA1gsbtQtN3" title="Contractual interest"&gt;100,274&lt;/span&gt; of contractual interest and $&lt;span id="xdx_900_eus-gaap--AmortizationOfFinancingCosts_c20220101__20221231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zlhDTT1TQKa7" title="Amortization of the discount"&gt;24,347&lt;/span&gt;
for the amortization of the discount. The effective interest rate was &lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20221231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_z5J7G6KtVZyb" title="Interest rate"&gt;20&lt;/span&gt;% prior to the exchange of the Old Alco Note as noted below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 19, 2022, the Company and Alco entered into an exchange agreement whereby Alco and the Company agreed to the cancellation of the
Old Alco Note in exchange for the issuance of a new subordinated convertible promissory note in the principal amount of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20220719__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zq107goU8P6i" title="Principal amount"&gt;2,101,744&lt;/span&gt; (representing
the principal amount plus accrued interest under the Old Alco Note) (the &#x201c;New Alco Note&#x201d;). In accordance with ASC 470 &lt;i&gt;Debt&lt;/i&gt;,
the Company treated the Old Alco Note as extinguished and recognized a loss on debt extinguishment of $&lt;span id="xdx_907_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20220719__20220719__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zcX0iZw8P8s3" title="Loss on debt extinguishment"&gt;56,653&lt;/span&gt;, determined by the sum
of the fair value of the New Alco Note in excess of the carrying value of the Old Alco Note less the bifurcated embedded derivative liability
at the time of the modification.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Between
July and September 2022, the Company issued additional subordinated convertible notes (together with the New Alco Note, the &#x201c;2022
Related Party Convertible Notes&#x201d;) for an aggregate amount of $&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20220731__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMansonWardAndDNXMember_zE6KF3BEi4dc" title="Principal amount"&gt;&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20220930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMansonWardAndDNXMember_z3V7z1Io8QIk" title="Principal amount"&gt;4,200,538&lt;/span&gt;&lt;/span&gt; to related parties Alco, Mason Ward and DNX. Between March
and September 2023, the Company issued additional subordinate convertible notes (together with the 2022 Related Party Convertible Notes,
the &#x201c;Related Party Convertible Notes&#x201d;) for an aggregate amount of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20230331__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMansonWardDNXAndWilliamBryantMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zPQzPB8TmHB8" title="Principal amount"&gt;&lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMansonWardDNXAndWilliamBryantMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zShHSSm7GuJ" title="Principal amount"&gt;2,583,000&lt;/span&gt;&lt;/span&gt; to related parties Alco, Mason Ward, DNX and
William Bryant. DNX held in excess of &lt;span id="xdx_90D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230930__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DNXMember__srt--RangeAxis__srt--MinimumMember_zJcgASWyWSBb" title="Issued equity percentage"&gt;5&lt;/span&gt;% of the issued equity of the Company, through its ownership of Series A preferred stock. William
Bryant will become a member of the Board of Directors upon completion of the Merger. &lt;span id="xdx_906_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20230401__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zKDXXuPgq362" title="Debt instrument conversion feature"&gt;The Related Party Convertible Notes bear interest
at a rate of &lt;span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zZ74X056fnFe" title="Issued equity percentage"&gt;8&lt;/span&gt;% per annum, and are convertible into the same series of capital stock of the Company to be issued to other investors upon
a Qualified Financing (as defined in the agreement) at a conversion price equal to the lesser of (i) &lt;span id="xdx_903_ecustom--DebtInstrumentConversionPercentage_dp_c20230401__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zIVtfNkXU05i" title="Debt instrument conversion percentage"&gt;80&lt;/span&gt;% of the per share price paid
by the cash purchasers of such Qualified Financing Securities (as defined in the agreement) in the Qualified Financing, or (ii) the conversion
price obtained by dividing $&lt;span id="xdx_908_ecustom--NumeratorUsedForObtainingConversionPrice_c20230401__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zX9mjEVCLzL1" title="Conversion price"&gt;50,000,000&lt;/span&gt; by the Fully Diluted Capitalization (as defined in the agreement). If not sooner converted or
prepaid, the Convertible Notes are payable no later than the earlier of (a) the written demand by the holders of a majority-in-interest
of the Notes then outstanding on or after September 1, 2023, (b) consummation of a Liquidity Event (as defined in the agreement), or
(c) the written demand by the Majority Holders (as defined in the agreement) after an Event of Default (as defined in the agreement)
has occurred. In the event of a Liquidity Event (as defined below) while this Note is outstanding, immediately prior to the closing of
such Liquidity Event and in full satisfaction of this Note, an amount equal to the greater of (a) the Outstanding Amount, or (b) two
times (2x) the principal amount of this Note then outstanding shall become immediately due and payable in cash.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
embedded redemption put feature upon an Equity Financing and the optional redemption upon a Liquidity Event at a substantial premium
are not clearly and closely related to the debt host instrument, were separated and bundled together, assigned probabilities of being
affected and initially measured at fair value. Subsequent changes in fair value of the feature will be recognized in the Consolidated
Statement of Operations. The fair value of the bifurcated derivative liability was estimated utilizing the with and without method which
uses the probability weighted difference between the scenarios with the derivative and the plain vanilla maturity scenario without a
derivative (see &lt;i&gt;Note 8-Fair Value Measurements&lt;/i&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Discounts
to the principal amounts are included in the carrying value of the Related Party Convertible Notes and amortized to interest expense
over the contractual term of the underlying debt. During 2022, the Company recorded a $&lt;span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zAIy7GYWIFYf" title="Amortization of debt discount"&gt;1,311,025&lt;/span&gt; debt discount upon issuance of the above
described Related Party Convertible Notes, which is comprised of $&lt;span id="xdx_903_ecustom--BifurcatedDerivative_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zQ4tUmX2e2v1" title="Bifurcated derivative"&gt;1,292,777&lt;/span&gt; related to the bifurcated derivative and $&lt;span id="xdx_901_eus-gaap--DeferredFinanceCostsNet_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zhcBvxdaK0Mc" title="Debt issuance costs"&gt;18,248&lt;/span&gt; of debt
issuance costs. During the year ended December 31, 2023, the Company recorded a $&lt;span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zrGdt1Fd1QRj" title="Amortization of debt discount"&gt;1,126,451&lt;/span&gt; debt discount upon issuance of additional
Related Party Convertible Notes. For the year ended December 31, 2023, interest expense on the Related Party Convertible Notes totaled
$&lt;span id="xdx_903_eus-gaap--InterestExpense_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zc70sMxyqa4d" title="Interest expense"&gt;2,307,013&lt;/span&gt;, comprised of $&lt;span id="xdx_90A_eus-gaap--InterestExpenseDebt_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_z57Aw52ym54a" title="Interest expense debt"&gt;464,071&lt;/span&gt; of contractual interest and $&lt;span id="xdx_90A_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zeP2NlJsF4lg" title="Amortization of the discount"&gt;1,842,942&lt;/span&gt; for the amortization of the discount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;March
2023 Amendment&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2023, the 2022 Related Party Convertible Notes were amended to extend the maturity to December 31, 2023. The Company evaluated
the terms of the First Amendment in accordance with ASC 470-60, Troubled Debt Restructurings, and ASC 470-50, Debt Modifications and
Extinguishments. The Company determined that the Company was granted a concession by the lender based on the decrease of the effective
borrowing rate on the First Amendment. Accordingly, the Company accounted for the First Amendment as a troubled debt restructuring. As
a result, the Company accounted for the troubled debt restructuring by calculating a new effective interest rate for the First Amendment
based on the carrying amount of the debt and the present value of the revised future cash flow payment stream. The troubled debt restructuring
did not result in recognition of a gain or loss in the consolidated statement of operations but does impact interest expense recognized
in the future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion
of Related Party Convertible Notes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2023, all outstanding principal and accrued interest, net of the remaining debt discount, related to the Related Party Convertible
Notes, totaling $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20231214__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_z35BaLx2fCgj" title="Principal amount"&gt;7,271,368&lt;/span&gt; converted into &lt;span id="xdx_902_eus-gaap--ConversionOfStockSharesConverted1_c20231214__20231214__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RelatedPartyConvertibleNotesMember_zTHULUT2CiZ4" title="Conversion of stock"&gt;22,929&lt;/span&gt; shares the Company&#x2019;s Class A Common Stock pursuant to the close of the Merger
Agreement and application of the exchange ratio.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Convertible
Notes-Third Party&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Between
July and September 2022, the Company issued additional subordinated convertible notes (the &#x201c;2022 Third Party Convertible Notes&#x201d;)
for an aggregate amount of $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyCreditorsMember__us-gaap--LongtermDebtTypeAxis__custom--TwoThousandTwentyTwoThirdPartyConvertibleNotesMember_zdpnAEPWmVMk" title="Principal amount"&gt;1,761,206&lt;/span&gt; to third-party creditors. Between March and September 2023, the Company issued additional subordinate
convertible notes (together with the 2022 Third Party Convertible Notes, the &#x201c;Third Party Convertible Notes&#x201d;) for an aggregate
amount of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20220930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyCreditorsMember__us-gaap--LongtermDebtTypeAxis__custom--ThirdPartyConvertibleNotesMember_zXs7FHucmKMl" title="Principal amount"&gt;1,435,000&lt;/span&gt; to third-party creditors. &lt;span id="xdx_900_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20230401__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zxS9ar6d0h1k"&gt;The Third Party Convertible Notes bear interest at a rate of &lt;span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zJ7ALnz4Lw8j"&gt;8&lt;/span&gt;% per annum, and are convertible
into the same series of capital stock of the Company to be issued to other investors upon a Qualified Financing (as defined in the agreement)
at a conversion price equal to the lesser of (i) &lt;span id="xdx_909_ecustom--DebtInstrumentConversionPercentage_dp_c20230401__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zS3Dj8RiVDhb"&gt;80&lt;/span&gt;% of the per share price paid by the cash purchasers of such Qualified Financing Securities
(as defined in the agreement) in the Qualified Financing, or (ii) the conversion price obtained by dividing $&lt;span id="xdx_90E_ecustom--NumeratorUsedForObtainingConversionPrice_dp_c20230401__20230930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zCP5wSySbco2"&gt;50,000,000&lt;/span&gt; by the Fully
Diluted Capitalization (as defined in the agreement). If not sooner converted or prepaid, the Convertible Notes are payable no later
than the earlier of (a) the written demand by the holders of a majority-in-interest of the Notes then outstanding on or after September
1, 2023, (b) consummation of a Liquidity Event (as defined in the agreement), or (c) the written demand by the Majority Holders (as defined
in the agreement) after an Event of Default (as defined in the agreement) has occurred. In the event of a Liquidity Event (as defined
below) while this Note is outstanding, immediately prior to the closing of such Liquidity Event and in full satisfaction of this Note,
an amount equal to the greater of (a) the Outstanding Amount, or (b) two times (2x) the principal amount of this Note then outstanding
shall become immediately due and payable in cash.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
embedded redemption put feature upon an Equity Financing and the optional redemption upon a Liquidity Event at a substantial premium
are not clearly and closely related to the debt host instrument, were separated and bundled together, assigned probabilities of being
affected and initially measured at fair value. Subsequent changes in fair value of the feature will be recognized in the Consolidated
Statement of Operations. The fair value of the bifurcated derivative liability was estimated utilizing the with and without method which
uses the probability weighted difference between the scenarios with the derivative and the plain vanilla maturity scenario without a
derivative (see &lt;i&gt;Note 8-Fair Value Measurements&lt;/i&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Discounts
to the principal amounts are included in the carrying value of the Third Party Convertible Notes and amortized to interest expense over
the contractual term of the underlying debt. During 2022, the Company recorded a $&lt;span id="xdx_90A_ecustom--DebtInstrumentUnamortizedDebtIssuanceCostsIncurredDuringThePeriod_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--AdditionalSubordinatedConvertibleNotesTwoThousandAndTwentyTwoMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zJFObZJrRih7" title="Debt discount"&gt;548,871&lt;/span&gt; debt discount upon issuance of the Third Party
Convertible Notes, which is comprised of $&lt;span id="xdx_905_ecustom--DebtInstrumentUnamortizedDebtIssuanceCostsIncurredDuringThePeriod_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--AdditionalSubordinatedConvertibleNotesTwoThousandAndTwentyTwoMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember__custom--ComponentsAxis__custom--BifurcatedDerivativePortionMember_zh2tr6stXog8" title="Debt discount"&gt;541,223&lt;/span&gt; related to the bifurcated derivative and $&lt;span id="xdx_903_ecustom--DebtInstrumentUnamortizedDebtIssuanceCostsIncurredDuringThePeriod_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--AdditionalSubordinatedConvertibleNotesTwoThousandAndTwentyTwoMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember__custom--ComponentsAxis__custom--DebtPortionMember_zhUn6vlGjdtb" title="Debt discount"&gt;7,648&lt;/span&gt; of debt issuance costs. During the
year ended December 31, 2023, the Company recorded a $&lt;span id="xdx_902_ecustom--DebtInstrumentUnamortizedDebtIssuanceCostsIncurredDuringThePeriod_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--AdditionalSubordinatedConvertibleNotesTwoThousandAndTwentyTwoMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zPFyI7wblnMk"&gt;559,390&lt;/span&gt; debt discount upon issuance of additional Third Party Convertible Notes.
For the year ended December 31, 2023, interest expense on the Third Party Convertible Notes totaled $&lt;span id="xdx_907_eus-gaap--InterestExpense_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandAndTwentyTwoConvertibleNotesMember_zqCIqXdTWTsi"&gt;1,063,093&lt;/span&gt;, comprised of $&lt;span id="xdx_90F_eus-gaap--InterestExpenseDebt_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandAndTwentyTwoConvertibleNotesMember_z4u407lmG2vb"&gt;188,059&lt;/span&gt;
of contractual interest and $&lt;span id="xdx_901_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--TwoThousandAndTwentyTwoConvertibleNotesMember_zDRUhJx0awE8"&gt;875,034&lt;/span&gt; for the amortization of the discount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;March
2023 Amendment &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2023, the 2022 Related Party Convertible Notes were amended to extend the maturity to December 31, 2023. The Company evaluated
the terms of the First Amendment in accordance with ASC 470-60, Troubled Debt Restructurings, and ASC 470-50, Debt Modifications and
Extinguishments. The Company determined that the Company was granted a concession by the lender based on the decrease of the effective
borrowing rate on the First Amendment. Accordingly, the Company accounted for the First Amendment as a troubled debt restructuring. As
a result, the Company accounted for the troubled debt restructuring by calculating a new effective interest rate for the First Amendment
based on the carrying amount of the debt and the present value of the revised future cash flow payment stream. The troubled debt restructuring
did not result in recognition of a gain or loss in the consolidated statement of operations but does impact interest expense recognized
in the future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion
of Third Party Convertible Notes &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2023, all outstanding principal and accrued interest, net of the remaining debt discount, related to the Third Party Convertible
Notes, totaling $&lt;span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_iI_c20231214__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zC2xCYLh4mFl" title="Principal amount"&gt;3,346,232&lt;/span&gt; converted into &lt;span id="xdx_90A_eus-gaap--ConversionOfStockSharesConverted1_c20231214__20231214__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_z7zYwn2Mx52h" title="Conversion of stock"&gt;10,597&lt;/span&gt; shares the Company&#x2019;s Class A Common Stock pursuant to the close of the Merger
Agreement and application of the exchange ratio.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ConvertibleDebtTableTextBlock_zEtCTGwl8ruc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the Related Party and Third Party Convertible Notes, respectively, as of December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8BE_z6oOcNJaH4s4" style="display: none"&gt;Schedule of Related Party and Third Related
Party Convertible Notes&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zuUkOIsuHJSf" style="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zZttpaKCDqTg" style="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_zt0g4rAGdJ78" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;Face value of the convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;6,783,538&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;3,196,206&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--UnamortizedDebtDiscountOnConvertibleNotesPayable_iI_zRLlD9TOqE17" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Debt discount, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(131,867&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(83,688&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iI_z67p2JcEwDZ" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Carrying value of the convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,651,671&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,112,518&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--InterestPayableOnConvertibleDebt_iI_z9Wqoy7kbsZi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;619,697&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;233,714&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ConversionOfConvertibleNote_iI_zJwvejqx5cQi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Conversion of convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(7,271,368&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(3,346,232&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ConvertibleDebtIncludingAccruedInterest_iI_zqCyps83IAmc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Total convertible notes and accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4237"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4238"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the Related Party and Third Party Convertible Notes, respectively, as of December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zQ1q31r3dVzb" style="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_z0b2IJumKsza" style="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_zil7JYt68Ne1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;Face value of the convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;4,200,538&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;1,761,206&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--UnamortizedDebtDiscountOnConvertibleNotesPayable_iI_z9wf7kNbbLM" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Debt discount, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(849,656&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(398,034&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iI_z1gAZGDjYU79" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Carrying value of the convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,350,882&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,363,172&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--InterestPayableOnConvertibleDebt_iI_z5UwPhIgEQK6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;155,626&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;45,654&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ConvertibleDebtIncludingAccruedInterest_iI_zIXer5M2ZQtg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Total convertible notes and accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,506,508&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,408,826&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zACyJWdx3vgf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Promissory
Notes &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Promissory
Notes-Related Party &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 30, 2023, the Company issued a subordinate promissory note (&#x201c;Alco August Promissory Note&#x201d;) in the aggregate principal
amount of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20230830__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_z9WUq2llGvwe"&gt;150,000&lt;/span&gt; to Alco Investment Company, a related party. Alco held its ownership of over &lt;span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20230830__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zG4hNNgsCf3f"&gt;10&lt;/span&gt;% of the issued equity of the Company,
through its ownership of Series A preferred stock. The Alco August Promissory Note bears interest at a rate of &lt;span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20230830__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zF0yZSUZVWMa"&gt;8&lt;/span&gt;% per annum. The outstanding
principal and accrued interest are due and payable on &lt;span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20230830__20230830__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zqNiXOFqGm0l"&gt;April 29, 2024&lt;/span&gt;. The Company recorded a $&lt;span id="xdx_906_eus-gaap--DeferredFinanceCostsGross_iI_c20230830__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zKr2RpqIV563"&gt;3,711&lt;/span&gt; debt discount upon issuance of the
Alco August Promissory Note. For the year ended December 31, 2023, interest expense on the Alco August Promissory Note totaled $&lt;span id="xdx_90E_eus-gaap--InterestExpense_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zuWQCIgNzFxg"&gt;4,494&lt;/span&gt;,
comprised of $&lt;span id="xdx_903_eus-gaap--InterestExpenseDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_z20OXOX56J3h"&gt;4,044&lt;/span&gt; of contractual accrued interest and $&lt;span id="xdx_907_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zq884pAYOZTl"&gt;450&lt;/span&gt; for the amortization of the discount. As of December 31, 2023, $&lt;span id="xdx_90F_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zJjb56qsVqG9"&gt;150,000&lt;/span&gt;
of principal and $&lt;span id="xdx_905_ecustom--InterestPayableOnOtherNotesPayableCurrent_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_z6Rsj1xkNf8c"&gt;4,044&lt;/span&gt; of accrued interest is outstanding under the Alco August Promissory Note recorded in note payable-related party
on the balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 13, 2023, the Company issued a subordinate promissory note (&#x201c;Alco September Promissory Note&#x201d;) in the aggregate
principal amount of up to $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zWaY28rVcAH1"&gt;1,500,000&lt;/span&gt; to Alco Investment Company, a related party. The Alco September Promissory Note bears interest at
a rate of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zU8MIJaMh1Wc"&gt;8&lt;/span&gt;% per annum. The outstanding principal and accrued interest are due and payable on &lt;span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20230913__20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zC1XU5wwYbmi"&gt;January 10, 2024&lt;/span&gt;. The Company recorded
$&lt;span id="xdx_909_eus-gaap--DeferredFinanceCostsNet_iI_c20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_z2v9ifC0r4xf"&gt;8,588&lt;/span&gt; of debt issuance costs and a $&lt;span id="xdx_909_eus-gaap--AmortizationOfDebtDiscountPremium_c20230913__20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_z26rfDdSeSb9"&gt;638,808&lt;/span&gt; debt discount upon issuance of the Alco September Promissory Note, relating to the share
transfer agreements, see below. For the year ended December 31, 2023, interest expense on the Alco September Promissory Note totaled
$&lt;span id="xdx_901_eus-gaap--InterestExpense_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zbnDof4mJRxl"&gt;478,815&lt;/span&gt;, comprised of $&lt;span id="xdx_90F_eus-gaap--InterestExpenseDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zpz8GOihjch8"&gt;30,575&lt;/span&gt; of contractual accrued interest and $&lt;span id="xdx_908_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zq3W23HpOw1f"&gt;448,240&lt;/span&gt; for the amortization of the discount. As of December 31,
2023, $&lt;span id="xdx_902_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zeEojYAW8Bui"&gt;1,500,000&lt;/span&gt; of principal and $&lt;span id="xdx_90A_ecustom--InterestPayableOnOtherNotesPayableCurrent_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zGGQ84vq05pb"&gt;30,575&lt;/span&gt; of accrued interest is outstanding under the Alco September Promissory Note recorded in note
payable-related party on the balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the issuance of the Alco September Promissory Note, the Company, 7GC and the Sponsor entered into a share transfer agreement
(the &#x201c;Alco October Share Transfer Agreement&#x201d;) with Alco Investment Company, pursuant to which &lt;span id="xdx_903_eus-gaap--DebtConversionDescription_c20230101__20231231__custom--ComponentsAxis__custom--AlcoOctoberShareTransferAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember_zjGl5CTtRzk8"&gt;for each $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230913__custom--ComponentsAxis__custom--AlcoOctoberShareTransferAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember_zVuSI8hZIRVe"&gt;500.00&lt;/span&gt; in principal
borrowed under the Alco September Promissory Note, the Sponsor agreed to forfeit one share of 7GC Class B Common Stock held by the Sponsor,
in exchange for the right of Alco to receive one New Banzai Class A Share&lt;/span&gt;, in each case, at (and contingent upon) the Closing, with such
forfeited and issued shares capped at an amount equal to &lt;span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20230913__20230913__custom--ComponentsAxis__custom--AlcoOctoberShareTransferAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember_zXTTvJLHDsId"&gt;3,000&lt;/span&gt;. Pursuant to the Alco October Share Transfer Agreement, the shares are
subject to an &lt;span id="xdx_906_ecustom--LockUpPeriod_dtD_c20230913__20230913__custom--ComponentsAxis__custom--AlcoOctoberShareTransferAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember_zDLsN2d5x0Ii"&gt;180&lt;/span&gt;-day lock-up period upon issuance of the shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 16, 2023, the Company issued a subordinate promissory note (&#x201c;Alco November Promissory Note&#x201d;) in the aggregate principal
amount of up to $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20231116__us-gaap--LongtermDebtTypeAxis__custom--AlcoAugustPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zhbkJMasnUGg"&gt;750,000&lt;/span&gt; to Alco Investment Company, a related party. The Alco November Promissory Note bears interest at a rate of &lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20231116__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zkpNMI0WTOB4"&gt;8&lt;/span&gt;%
per annum. The outstanding principal and accrued interest are due and payable on &lt;span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20231116__20231116__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_z41TkxJDC5ij"&gt;April 13, 2024&lt;/span&gt;. The Company recorded a $&lt;span id="xdx_90A_eus-gaap--DeferredFinanceCostsNet_iI_c20231116__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zkdJtgpX43z"&gt;363,905&lt;/span&gt; debt
discount upon issuance of the Alco November Promissory Note relating to the share transfer agreements, see below. For the year ended
December 31, 2023, interest expense on the Alco November Promissory Note totaled $&lt;span id="xdx_905_eus-gaap--InterestExpense_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_z4c6N60KqmTc"&gt;94,005&lt;/span&gt;, comprised of $&lt;span id="xdx_90D_eus-gaap--InterestExpenseDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_z2MBhWwc3f5a"&gt;7,397&lt;/span&gt; of contractual accrued
interest and $&lt;span id="xdx_905_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zNMvb4VDeFu4"&gt;86,608&lt;/span&gt; for the amortization of the discount. As of December 31, 2023, $&lt;span id="xdx_903_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_z72kyu8XQmwi"&gt;750,000&lt;/span&gt; of principal and $&lt;span id="xdx_90F_ecustom--InterestPayableOnOtherNotesPayableCurrent_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zMCzE8jx736l"&gt;7,397&lt;/span&gt; of accrued interest
is outstanding under the Alco November Promissory Note recorded in note payable-related party on the consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the issuance of the Alco November Promissory Note, the Company, 7GC and the Sponsor entered into a share transfer
agreement (the &#x201c;November 2023 Share Transfer Agreement&#x201d;) with Alco Investment Company, pursuant to which &lt;span id="xdx_90B_eus-gaap--DebtConversionDescription_c20230101__20231231__custom--ComponentsAxis__custom--AlcoNovemberShareTransferAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember_zOGbmbFqo7C4"&gt;for
each $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230913__custom--ComponentsAxis__custom--AlcoNovemberShareTransferAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember_zn7Kza5MBayh"&gt;500.00&lt;/span&gt;
in principal borrowed under the Alco November Promissory Note, the Sponsor agreed to forfeit one share of 7GC Class B Common Stock
held by the Sponsor, in exchange for the right of Alco to receive one New Banzai Class A Share&lt;/span&gt;, in each case, at (and
contingent upon) the Closing, with such forfeited and issued shares capped at an amount equal to &lt;span id="xdx_901_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20230913__20230913__custom--ComponentsAxis__custom--AlcoNovemberShareTransferAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember_zZP60XZX2IKh"&gt;1,500&lt;/span&gt;. Pursuant to the November 2023 Transfer Agreement, the shares are subject to an &lt;span id="xdx_90B_ecustom--LockUpPeriod_dtD_c20230913__20230913__custom--ComponentsAxis__custom--AlcoNovemberShareTransferAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember_zUPzgrDplMPa"&gt;180&lt;/span&gt;-day
lock-up period upon issuance of the shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 13, 2023, the Company issued a subordinate promissory note (&#x201c;Alco December Promissory Note&#x201d;) in the aggregate principal
amount of up to $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20231213__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_ze153ntR3N2a"&gt;2,000,000&lt;/span&gt; to Alco Investment Company, a related party. The Alco December Promissory Note bears interest at a rate of
&lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20231213__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_ztLRIG2pLHJk"&gt;8&lt;/span&gt;% per annum. The outstanding principal and accrued interest are due and payable on &lt;span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_dd_c20231213__20231213__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zSp6Z0KqiT4d"&gt;December 31, 2024&lt;/span&gt;. The Company recorded a $&lt;span id="xdx_90B_eus-gaap--DeferredFinanceCostsNet_iI_c20231213__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zo4kbbQYKT7d"&gt;1,496,252&lt;/span&gt;
debt discount upon issuance of the Alco December Promissory Note, relating to the share transfer agreements, see below. For the year
ended December 31, 2023, interest expense on the Alco December Promissory Note totaled $&lt;span id="xdx_903_eus-gaap--InterestExpense_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_z97sLSzhgDw"&gt;39,087&lt;/span&gt;, comprised of $&lt;span id="xdx_90B_eus-gaap--InterestExpenseDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zL1zEU2086qd"&gt;7,890&lt;/span&gt; of contractual accrued
interest and $&lt;span id="xdx_905_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zf4NNKRWFqjb"&gt;31,197&lt;/span&gt; for the amortization of the discount. As of December 31, 2023, $&lt;span id="xdx_903_eus-gaap--OtherNotesPayableCurrent_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zyGr4YaslkG"&gt;2,000,000&lt;/span&gt; of principal and $&lt;span id="xdx_902_ecustom--InterestPayableOnOtherNotesPayableCurrent_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoDecemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_z7lmf5xXIfQh"&gt;7,890&lt;/span&gt; of accrued interest
is outstanding under the Alco December Promissory Note recorded in note payable - related party on the consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the issuance of the Alco December Promissory Note, the Company, 7GC and the Sponsor entered into a share transfer agreement
(the &#x201c;December 2023 Share Transfer Agreement&#x201d;, together with the November 2023 Share Transfer Agreement and Alco October
Share Transfer Agreement, the &#x201c;Alco Share Transfer Agreements&#x201d;) with Alco Investment Company, pursuant to which &lt;span id="xdx_904_eus-gaap--DebtConversionDescription_c20230101__20231231__custom--ComponentsAxis__custom--December2023ShareTransferAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember_z3CQ8krfWj85"&gt;for each
$&lt;span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230913__custom--ComponentsAxis__custom--December2023ShareTransferAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember_zHeaO70gZw7l"&gt;500.00&lt;/span&gt; in principal borrowed under the December 2023 Note, the Sponsor agreed to forfeit three shares of 7GC Class B Common Stock held
by the Sponsor, in exchange for the right of Alco to receive three New Banzai Class A Shares&lt;/span&gt;, in each case, at (and contingent upon)
the Closing, with such forfeited and issued shares capped at an amount equal to &lt;span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20230913__20230913__custom--ComponentsAxis__custom--December2023ShareTransferAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember_zsarM9qL1ame"&gt;12,000&lt;/span&gt;. Pursuant to the December Share 2023 Transfer
Agreement, the shares are subject to an &lt;span id="xdx_905_ecustom--LockUpPeriod_dtD_c20230913__20230913__custom--ComponentsAxis__custom--December2023ShareTransferAgreementMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoNovemberPromissoryNoteMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember_zyosFhWQpGha"&gt;180&lt;/span&gt;-day lock-up period upon issuance of the shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the Alco Share Transfer Agreements, the Company considered the guidance under ASC 815, Derivatives and Hedging, and determined that the
Investor Shares underlying each of the Share Transfer Agreements described above, met the definition of a freestanding financial instrument
and are not precluded from being considered indexed to the Company&#x2019;s common stock. The Company determined that these shares represent
a freestanding equity contract issued to the lender, resulting in a discount recorded on the notes when they are issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity-classified
contracts are initially measured at fair value (or allocated value). Subsequent changes in fair value are not recognized if the contracts
continue to be classified in equity. The measurement of fair value was determined utilizing various put option models in estimating the
discount lack of marketability (the &#x201c;DLOM&#x201d;) applied to the public share price as the shares underlying each of the Share
Transfer Agreements are subject to a lock-up period pursuant to each agreement, to estimate the fair value of the shares transferred.
Option pricing models assume that the cost to purchase a stock option relates directly to the measurement of the DLOM. The logic behind
these models is that investors may be able to quantify this price risk, due to lack of marketability, over a particular holding period
where price volatility is usually estimated as a proxy for risk. The inputs and assumptions utilized in the fair value estimation included
the Company&#x2019;s stock price on the measurement date, a DLOM as described above, the number of shares pursuant to each Share Transfer
Agreement, and a probability weighted factor for the Company&#x2019;s expected percentage of completing its Business Combination, at each
Share Transfer Agreement date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the Alco September Promissory Note, of which $&lt;span id="xdx_90C_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20230913__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zNkTr4dW5kOg"&gt;1,000,000&lt;/span&gt; was drawn on September 13, 2023, the DLOM was estimated using the put option
models described above and the following assumptions: a holding period for the shares of 272 days (approximately &lt;span id="xdx_90F_ecustom--HoldingPeriodForShares_dtY_c20230913__20230913__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_z0eyA6q1ShG5"&gt;0.77&lt;/span&gt; years) measured
from the date of issuance of the $&lt;span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfDebt_c20230913__20230913__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zvKq4Z5vNiwb"&gt;1,000,000&lt;/span&gt; of proceeds under the September Note through the issuance of the shares under the Alco October
Share Transfer Agreement on December 14, 2023 at which time the &lt;span id="xdx_904_ecustom--LockUpPeriod_dtD_c20230913__20230913__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zmST724DLJa1"&gt;180&lt;/span&gt;-day lock-up period commenced; a re-levered equity volatility estimated
using guideline public companies of &lt;span id="xdx_906_ecustom--EstimatedReLeveredEquityVolatilityRate_pid_dp_uPure_c20230913__20230913__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zhlRU05ZlDx4" title="Estimated re-levered equity volatility rate"&gt;54.0&lt;/span&gt;%; and a risk-free rate commensurate with the term of &lt;span id="xdx_90C_ecustom--CommensurateRiskFreeRate_dp_uPure_c20230913__20230913__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_z5ieaHdi5skb" title="Commensurate risk-free rate"&gt;5.3&lt;/span&gt;%. The put option models provided a
DLOM range of &lt;span id="xdx_903_ecustom--EstimatedReLeveredEquityVolatilityRate_dp_c20230913__20230913__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__srt--RangeAxis__srt--MinimumMember_zFYr84OOnMW2" title="Estimated re-levered equity volatility rate"&gt;10.7&lt;/span&gt;% to &lt;span id="xdx_90D_ecustom--EstimatedReLeveredEquityVolatilityRate_dp_c20230913__20230913__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__srt--RangeAxis__srt--MaximumMember_z2Id4rbLeai1" title="Estimated re-levered equity volatility rate"&gt;16.0&lt;/span&gt;% and the concluded DLOM was estimated to be &lt;span id="xdx_908_ecustom--PercentageOfDiscountLackOfMarketability_dp_c20230913__20230913__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__srt--RangeAxis__srt--WeightedAverageMember_zHQ5Mpr94qMb" title="Estimated re-levered equity volatility rate"&gt;12.5&lt;/span&gt;%. The Company&#x2019;s expected percentage of completing
the Merger on this date was &lt;span id="xdx_90B_ecustom--ExpectedPercentageOfCompletingTheMerger_dp_c20230913__20230913__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zVbfSBJD0irc" title="Expected percentage of completing the merger"&gt;80&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the remaining $&lt;span id="xdx_90B_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20231003__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_z6fH68vYFMcb"&gt;500,000&lt;/span&gt; drawn on the Alco September Promissory Note on October 3, 2023, the DLOM was estimated using the put option models
described above and the following assumptions: a holding period for the shares of 252 days (approximately &lt;span id="xdx_900_ecustom--HoldingPeriodForShares_dtY_c20231003__20231003__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zonLwQGNZbg8"&gt;0.72&lt;/span&gt; years) measured from the
date of issuance of the remaining $&lt;span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfDebt_c20231003__20231003__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zX812khQTj42"&gt;500,000&lt;/span&gt; of proceeds under the September Note through the issuance of the shares under the Alco October
Share Transfer Agreement on December 14, 2023 at which time the &lt;span id="xdx_90F_ecustom--LockUpPeriod_dtD_c20231003__20231003__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zZ9bWnFWdQ17"&gt;180&lt;/span&gt;-day lock-up period commenced; a re-levered equity volatility estimated
using guideline public companies of &lt;span id="xdx_90D_ecustom--EstimatedReLeveredEquityVolatilityRate_dp_c20231003__20231003__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_z7CORfKJqNj1" title="Estimated re-levered equity volatility rate"&gt;52.0&lt;/span&gt;%; and a risk-free rate commensurate with the term of &lt;span id="xdx_903_ecustom--CommensurateRiskFreeRate_dp_c20231003__20231003__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zHZHEGRZ31Zi" title="Commensurate risk-free rate"&gt;5.4&lt;/span&gt;%. The put option models provided a
DLOM range of &lt;span id="xdx_901_ecustom--EstimatedReLeveredEquityVolatilityRate_dp_c20231003__20231003__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__srt--RangeAxis__srt--MinimumMember_zMlaMWXWq4Ic" title="Estimated re-levered equity volatility rate"&gt;10.0&lt;/span&gt;% to &lt;span id="xdx_90F_ecustom--EstimatedReLeveredEquityVolatilityRate_dp_c20231003__20231003__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__srt--RangeAxis__srt--MaximumMember_zyZRYMKFRm42" title="Estimated re-levered equity volatility rate"&gt;15.0&lt;/span&gt;% and the concluded DLOM was estimated to be &lt;span id="xdx_905_ecustom--PercentageOfDiscountLackOfMarketability_dp_c20231003__20231003__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__srt--RangeAxis__srt--WeightedAverageMember_zCbBTaPJZR79" title="Estimated re-levered equity volatility rate"&gt;11.5&lt;/span&gt;%. The Company&#x2019;s expected percentage of completing
the Merger on this date was &lt;span id="xdx_907_ecustom--ExpectedPercentageOfCompletingTheMerger_dp_c20231003__20231003__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zzJVr5xYNuZa" title="Expected percentage of completing the merger"&gt;80&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the Alco November Promissory Note, the DLOM was estimated using the put option models described above and the following assumptions:
a holding period for the shares of 208 days (approximately &lt;span id="xdx_90F_ecustom--HoldingPeriodForShares_dtY_c20231116__20231116__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zTEMpMAzk8cj"&gt;0.60&lt;/span&gt; years) measured from the issuance date of the November Note through the
issuance of the shares under the November 2023 Share Transfer Agreement on December 14, 2023 at which time the &lt;span id="xdx_90F_ecustom--LockUpPeriod_dtD_c20231116__20231116__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zFf3AqmNCEDl"&gt;180&lt;/span&gt;-day lock-up period
commenced; a re-levered equity volatility estimated using guideline public companies of &lt;span id="xdx_903_ecustom--EstimatedReLeveredEquityVolatilityRate_dp_c20231116__20231116__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zY8oMZh9A9pg" title="Estimated re-levered equity volatility rate"&gt;54.0&lt;/span&gt;%; and a risk-free rate commensurate with
the term of &lt;span id="xdx_906_ecustom--CommensurateRiskFreeRate_dp_c20231116__20231116__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zKYeEElcbSV6" title="Commensurate risk-free rate"&gt;5.2&lt;/span&gt;%. The put option models provided a DLOM range of &lt;span id="xdx_90A_ecustom--EstimatedReLeveredEquityVolatilityRate_dp_c20231116__20231116__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__srt--RangeAxis__srt--MinimumMember_zZDDMSW8VwF" title="Estimated re-levered equity volatility rate"&gt;9.5&lt;/span&gt;% to &lt;span id="xdx_902_ecustom--EstimatedReLeveredEquityVolatilityRate_dp_c20231116__20231116__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__srt--RangeAxis__srt--MaximumMember_z2PKNJS29p2b" title="Estimated re-levered equity volatility rate"&gt;15.0&lt;/span&gt;% and the concluded DLOM was estimated to be &lt;span id="xdx_903_ecustom--PercentageOfDiscountLackOfMarketability_dp_c20231116__20231116__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__srt--RangeAxis__srt--WeightedAverageMember_zPYXqWfzglok" title="Estimated re-levered equity volatility rate"&gt;11.5&lt;/span&gt;%. The
Company&#x2019;s expected percentage of completing the Merger on this date was &lt;span id="xdx_903_ecustom--ExpectedPercentageOfCompletingTheMerger_dp_c20231116__20231116__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zWyB50UegyP1" title="Expected percentage of completing the merger"&gt;100&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the Alco December Promissory Note, the DLOM was estimated using the put option models described above and the following assumptions:
a holding period for the shares of 180 days (approximately &lt;span id="xdx_900_ecustom--HoldingPeriodForShares_dtY_c20231213__20231213__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_z4q4iObpgl2f"&gt;0.49&lt;/span&gt; years) measured from the issuance date of the December Note through the
issuance of the shares under the December 2023 Share Transfer Agreement on December 14, 2023 at which time the &lt;span id="xdx_906_ecustom--LockUpPeriod_dtD_c20231213__20231213__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_z3I4yYYUltdi"&gt;180&lt;/span&gt;-day lock-up period
commenced; a re-levered equity volatility estimated using guideline public companies of &lt;span id="xdx_905_ecustom--EstimatedReLeveredEquityVolatilityRate_dp_c20231213__20231213__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zEdtqpd8P1je" title="Estimated re-levered equity volatility rate"&gt;47.0&lt;/span&gt;%; and a risk-free rate commensurate with
the term of &lt;span id="xdx_903_ecustom--CommensurateRiskFreeRate_dp_c20231213__20231213__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zOqJzZN9aXNb" title="Commensurate risk-free rate"&gt;5.2&lt;/span&gt;%. The put option models provided a DLOM range of &lt;span id="xdx_90D_ecustom--EstimatedReLeveredEquityVolatilityRate_dp_c20231213__20231213__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__srt--RangeAxis__srt--MinimumMember_zJtN8lbhrxLi" title="Estimated re-levered equity volatility rate"&gt;7.5&lt;/span&gt;% to &lt;span id="xdx_90A_ecustom--EstimatedReLeveredEquityVolatilityRate_dp_c20231213__20231213__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__srt--RangeAxis__srt--MaximumMember_zFSFQRbQ8Wr9" title="Estimated re-levered equity volatility rate"&gt;12.0&lt;/span&gt;% and the concluded DLOM was estimated to be &lt;span id="xdx_90E_ecustom--PercentageOfDiscountLackOfMarketability_dp_c20231213__20231213__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__srt--RangeAxis__srt--WeightedAverageMember_zO67TmRHQWQ1" title="Estimated re-levered equity volatility rate"&gt;9.0&lt;/span&gt;%. The Company&#x2019;s
expected percentage of completing its Business Combination on this date was &lt;span id="xdx_907_ecustom--ExpectedPercentageOfCompletingTheMerger_dp_c20231213__20231213__us-gaap--OptionIndexedToIssuersEquityTypeAxis__us-gaap--PutOptionMember__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember_zm1NYqwXRPUa" title="Expected percentage of completing the merger"&gt;100&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Modification
of Alco September Promissory Note &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the September 2023 Alco Promissory Note was amended to extend the maturity date to &lt;span id="xdx_900_eus-gaap--DebtInstrumentMaturityDateRangeEnd1_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember_zJXuudYxCYg9" title="Debt instrument, maturity date range, end"&gt;September 30, 2024&lt;/span&gt;. Alco is a related
party to the Company due to its ownership of over &lt;span id="xdx_90D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20231231__us-gaap--LongtermDebtTypeAxis__custom--AlcoSeptemberPromissoryNoteMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--AlcoMember_zft8QcOP3dwh" title="Equity percentage owned percentage"&gt;10&lt;/span&gt;% of the issued equity of the Company. The Company evaluated the terms of the Amendment
in accordance with ASC 470-60, Troubled Debt Restructurings, and ASC 470-50, Debt Modifications and Extinguishments. The Company determined
that the Company was granted a concession by the lender based on the decrease of the effective borrowing rate resulting from the First
Amendment. Accordingly, the Company accounted for the Amendment as a troubled debt restructuring. As a result, the Company accounted
for the troubled debt restructuring by calculating a new effective interest rate for the Amendment based on the carrying amount of the
debt and the present value of the revised future cash flow payment stream. The troubled debt restructuring did not result in recognition
of a gain or loss in the consolidated statement of operations but does impact interest expense to be recognized in future periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Promissory
Notes-7GC &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company assumed &lt;span id="xdx_900_ecustom--NumberOfPromissoryNotesInConnectionWithMerger_iI_dc_uInteger_c20231231_zxt1dQb3zPc6" title="Number of promissory notes In connection with merger"&gt;two&lt;/span&gt; promissory notes in connection with the Merger which remained outstanding as of December 31, 2023. The promissory
notes were issued on December 21, 2022 for a principal amount of $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pid_c20221221__us-gaap--LongtermDebtTypeAxis__custom--DecemberTwoThousandTwentyTwoSevenGCNoteMember_z4O1FQn7oXRe" title="Aggregate principal amount"&gt;2,300,000&lt;/span&gt; (&#x201c;December 2022 7GC Note&#x201d;) and on October 3,
2023 for a principal amount of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pid_c20231003__us-gaap--LongtermDebtTypeAxis__custom--DecemberTwoThousandTwentyTwoSevenGCNoteMember_zmUqi4ITYzv2" title="Aggregate principal amount"&gt;250,000&lt;/span&gt; (&#x201c;October 2023 7G Note, together with the December 2022 7GC Note, the &#x201c;7GC Promissory
Notes&#x201d;). The 7GC Promissory Notes were issued to the Sponsor, 7GC &amp;amp; Co. Holdings LLC. The 7GC Promissory Notes do not bear
interest and were repayable in full upon the earlier of the consummation of a business combination or the date the Company liquidates
the trust account (the &#x201c;Trust Account&#x201d;) established in connection with the Company&#x2019;s initial public offering (the &#x201c;IPO&#x201d;)
upon the failure of the Company to consummate a business combination within the requisite time period. Under the original terms of the
7GC Promissory Notes, the Sponsor has the option, but not the obligation, to convert the principal balance of the Note, in whole or in
part, into that number of shares of Class A common stock, $&lt;span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231003__us-gaap--LongtermDebtTypeAxis__custom--SevenGCPromissoryNotesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zi7trq7gTIF4" title="Common stock par value"&gt;0.0001&lt;/span&gt; par value per share, of the Company equal to the principal amount of
the Note so converted divided by $&lt;span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--SevenGCPromissoryNotesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zTIPQgOi9MT9" title="Debt instrument conversion price per share"&gt;10.00&lt;/span&gt;. As of December 31, 2023 and the Merger date, $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentCarryingAmount_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--SevenGCPromissoryNotesMember_zUgj08JfLpG3" title="Outstanding principal amount"&gt;2,550,000&lt;/span&gt; was outstanding under the 7GC Promissory
Notes. The combined balance of the outstanding amount of $&lt;span id="xdx_906_eus-gaap--DebtInstrumentCarryingAmount_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--SevenGCPromissoryNotesMember_zXTqxHpsfVH2" title="Outstanding principal amount"&gt;2,550,000&lt;/span&gt; offset by the effect of the modification as discussed below of $&lt;span id="xdx_903_ecustom--ModificationOfConvertibleNotesPayable_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--SevenGCPromissoryNotesMember_zRDi0Xkp1e6k" title="Modification of convertible notes payable"&gt;9,909&lt;/span&gt;
results in the $&lt;span id="xdx_907_eus-gaap--LoansPayableCurrent_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--SevenGCPromissoryNotesMember_zpK03jkwwgja" title="Loans payable current"&gt;2,540,091&lt;/span&gt; balance recorded on Consolidated Balance Sheets in Convertible notes-related party. See &lt;i&gt;Note 6-Related Party
Transactions &lt;/i&gt;for further details of these transactions and associated balances and &lt;i&gt;Note 21-Subsequent Events&lt;/i&gt; for details related
to the subsequent conversion of the 7GC Promissory Notes, in 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Modification
of Promissory Notes-7GC &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 12, 2023, in connection with the Merger, the Sponsor came to a non-binding agreement (&#x201c;First Amendment&#x201d;) with the
Company to amend the optional conversion provision of the 7GC Promissory Notes. The First Amendment provided that the holder has the
right to elect to convert up to the full amount of the principal balance of the 7GC Promissory Notes, in whole or in part, &lt;span id="xdx_900_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_c20231212__20231212__us-gaap--LongtermDebtTypeAxis__custom--SevenGCPromissoryNotesMember_zPFQoPc0CVGd" title="Debt instrument, convertible, threshold trading days"&gt;30&lt;/span&gt; days after
the closing of the Merger (the &#x201c;Closing&#x201d;) at a conversion price equal to the average daily VWAP of Class A Common Stock
for the &lt;span id="xdx_907_eus-gaap--DebtInstrumentConvertibleThresholdTradingDays_c20231212__20231212__us-gaap--LongtermDebtTypeAxis__custom--SevenGCPromissoryNotesMember_za3Ruje8X9F2" title="Debt instrument, convertible, threshold trading days"&gt;30&lt;/span&gt; trading days following the Closing. This amendment was deemed to be a debt modification in accordance with ASC 470, Debt,
which will be accounted for prospectively. Modification does not result in recognition of a gain or loss in the consolidated statement
of operations but does impact interest expense recognized in the future. Pursuant to ASC 470, if the modification or exchange of a convertible
debt instrument is not accounted for as an extinguishment, the accounting for the change in the fair value of the embedded conversion
option which increases the value of the embedded conversion option (calculated as the difference between the fair value of the embedded
conversion option immediately before and after the modification or exchange) is recorded as a reduction to the carrying amount of the
7GC Promissory Notes with a corresponding increase to additional paid in capital. At the time of modification, it was determined the
embedded conversion option value increased by $&lt;span id="xdx_907_ecustom--ModificationOfConvertibleNotesPayable_c20231212__20231212__us-gaap--LongtermDebtTypeAxis__custom--SevenGCPromissoryNotesMember_zP9KAvNqNo5" title="Modification of convertible notes payable"&gt;9,909&lt;/span&gt; and was recorded as a reduction to the carrying amount of the 7GC Promissory Notes
which are recorded on the Consolidated Balance Sheets in Convertible notes-related party.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Convertible
Promissory Notes (Yorkville) &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2023, in connection with and pursuant to the terms of its Standby Equity Purchase Agreement (&#x201c;SEPA&#x201d;) with YA
II PN, LTD, a Cayman Islands exempt limited partnership managed by Yorkville Advisors Global, LP (&#x201c;Yorkville&#x201d;), (refer to
&lt;i&gt;Note 18-Equity&lt;/i&gt; for further details), Yorkville agreed to advance to the Company, in exchange for convertible promissory notes,
an aggregate principal amount of up to $&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20231214__srt--RangeAxis__srt--MaximumMember__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zOYLTiN6oM46" title="Aggregate principal amount"&gt;3,500,000&lt;/span&gt;, $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20231214__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zgzdwdRpjfMk" title="Aggregate principal amount"&gt;2,000,000&lt;/span&gt; of which was funded at the Closing in exchange for the issuance by the
Company of a Convertible Promissory Note (the &#x201c;Yorkville Convertible Note&#x201d;) and $&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20231214__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zeCKp4uO2x86" title="Aggregate principal amount"&gt;1,500,000&lt;/span&gt; of which (the &#x201c;Second Tranche&#x201d;)
will be funded upon the effectiveness of a registration statement for the resale under the Securities Act by Yorkville of the shares
of Class A common stock issued under the SEPA pursuant to an Advance requested to be included in such registration statement; provided
that if at the time of the initial filing of the registration statement, shares issuable under the Exchange Cap multiplied by the closing
price on the day prior to such filing is less than $&lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20231214__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zzIeGeVUu8G8" title="Aggregate principal amount"&gt;7,000,000&lt;/span&gt;, the Second Tranche will be further conditioned upon the Company obtaining
stockholder approval to exceed the Exchange Cap. The registration statement was declared effective on February 14, 2024, and the value
of shares issuable upon the initial filing of the registration statement was less than $&lt;span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_c20240214__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXLYclF7fL6e" title="Aggregate principal amount"&gt;7,000,000&lt;/span&gt;. On March 25, 2024 the Company obtained
stockholder approval to exceed the Exchange Cap and the Second Tranche was funded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company received net proceeds of $&lt;span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfDebt_c20231214__20231214__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zpAQtNB5a4X" title="Net proceeds from issuance of convertible promissory notes"&gt;1,800,000&lt;/span&gt; million after a non-cash original issue discount of $&lt;span id="xdx_90E_eus-gaap--AmortizationOfDebtDiscountPremium_pn5n6_c20231214__20231214__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_zqhp3sLoNgQ4" title="Debt discount upon issuance"&gt;.2&lt;/span&gt; million.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Yorkville Convertible Note has a maturity date of &lt;span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20231214__20231214__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zAINMo7R2rp6" title="Debt instrument, maturity date"&gt;June 14, 2024&lt;/span&gt;, and accrues interest at &lt;span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231214__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zzMGrmAEFkI2" title="Debt instrument, interest rate"&gt;0&lt;/span&gt;% per annum, subject to an increase to &lt;span id="xdx_904_eus-gaap--DebtInstrumentInterestRateIncreaseDecrease_pid_dp_uPure_c20231214__20231214__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zvVJxHDMKEf3" title="Debt instrument, increase in interest rate"&gt;18&lt;/span&gt;%
per annum upon events of default as defined in the agreement. As of December 31, 2023, no events of default have occurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additionally,
Yorkville has the right to convert any portion of the outstanding principal into shares of Class A common stock at any time. The number
of shares issuable upon conversion is equal to the amount of principal to be converted (as specified by Yorkville) divided by the Conversion
Price (as defined in the Standby Equity Purchase Agreement disclosure below). Yorkville will not have the right to convert any portion
of the principal to the extent that after giving effect to such conversion, Yorkville would beneficially own in excess of &lt;span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentRate_pid_dp_uPure_c20231214__20231214__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zWhLrXAH9x98" title="Conversion rate percentage of common stock outstanding"&gt;9.99&lt;/span&gt;% of the
total number of shares of Class A common stock outstanding after giving effect to such conversion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additionally,
the Company, at its option, shall have the right, but not the obligation, to redeem early a portion or all amounts outstanding under
the Promissory Notes at a redemption amount equal to the outstanding principal balance being repaid or redeemed, plus a &lt;span id="xdx_903_ecustom--PercentageOfPrepaymentPremium_iI_pid_dp_uPure_c20231214__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember_z9GNRtJ64QG" title="Prepayment premium"&gt;10&lt;/span&gt;% prepayment
premium, plus all accrued and unpaid interest; provided that (i) the Company provides Yorkville with no less than ten trading days&#x2019;
prior written notice thereof and (ii) on the date such notice is issued, the VWAP of Class A common stock is less than the Fixed
Price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
the occurrence of certain triggering events, as defined in the Yorkville Convertible Note agreement (each an &#x201c;Amortization Event&#x201d;),
the Company may be required to make monthly repayments of amounts outstanding under the Yorkville Convertible Note, with each monthly
repayment to be in an amount equal to the sum of (x) $&lt;span id="xdx_907_eus-gaap--RepaymentsOfConvertibleDebt_c20231214__20231214__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_znofxkMvj1n2" title="Repayment of convertible debt"&gt;1,000,000&lt;/span&gt;, plus (y) &lt;span id="xdx_90B_ecustom--PercentageOfRepaymentOfConvertibleDebtAmount_iI_pid_dp_uPure_c20231214__dei--LegalEntityAxis__custom--YorkvilleAdvisorsGlobalLPMember__us-gaap--TypeOfArrangementAxis__custom--StandbyEquityPurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zWaqx26msjVa" title="Percentage of repayment of convertible debt, amount"&gt;10&lt;/span&gt;% in respect of such amount, and (z) all outstanding accrued
and unpaid interest as of each payment date. See &lt;i&gt;Note 21-Subsequent Events &lt;/i&gt;for details related to the receipt by the Company of
a an amortization event waiver, from Yorkville, in January, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, the principal amount outstanding under the Yorkville Convertible Note is $&lt;span id="xdx_905_eus-gaap--DebtInstrumentCarryingAmount_iI_pn6n6_c20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zkpvQHOukVF6" title="Outstanding principal amount"&gt;2&lt;/span&gt; million. During the year ended December
31, 2023, the Company recorded interest expense of $&lt;span id="xdx_90F_eus-gaap--InterestExpense_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zKGgobQ5ezog" title="Interest expense"&gt;0&lt;/span&gt; in connection with the Yorkville Convertible Note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Yorkville Convertible Note is required to be measured at fair value pursuant to ASC 480 &lt;i&gt;Distinguishing Liabilities from Equity&lt;/i&gt;
(&#x201c;ASC 480&#x201d;) at the date of issuance, December 14, 2023, and in subsequent reporting periods, due to the variable share-settled
feature described above in which, if converted, the value to be received by Yorkville fluctuates based on something other than the fair
value of the Company&#x2019;s common stock. The fair value of the Yorkville Convertible Note as of December 14, 2023 and December 31,
2023 was $&lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20231214__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zmqKlt0NDnVg" title="Aggregate principal amount"&gt;1,800,000&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zcv9RBmH7al8" title="Aggregate principal amount"&gt;1,766,000&lt;/span&gt;, respectively. The Company used a Monte Carlo simulation model in order to determine the Yorkville
Convertible Note&#x2019;s fair value at December 14, 2023, with the following inputs: the fair value of the Company&#x2019;s common stock
of $&lt;span id="xdx_902_eus-gaap--SharePrice_iI_c20231214__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zityJGaaMbog" title="Original issuance price"&gt;10.96&lt;/span&gt; on the issuance date, estimated equity volatility of &lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20231214__20231214__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zNp0PEFbTcz" title="Estimated equity volatility"&gt;43&lt;/span&gt;%, the time to maturity of &lt;span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20231214__20231214__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zJMWVqQWZ3rk" title="Time to maturit"&gt;0.5&lt;/span&gt; years, a discounted market interest rate
of &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_pid_dp_uPure_c20231214__20231214__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zCs9wbuDvgD4" title="Discounted market interest rate"&gt;14.9&lt;/span&gt;%, a risk free rate of &lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20231214__20231214__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zGLdikRk6vP" title="Risk free rate"&gt;5.30&lt;/span&gt;%, and probability of optional redemption &lt;span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsProbabilityOptionalRedemptionRate_pid_dp_uPure_c20231214__20231214__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zRiM2f0m6R51" title="Probability of optional redemption rate"&gt;10.0&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended December 31, 2023, the Company recorded a gain of $&lt;span id="xdx_901_ecustom--ChangeInFairValueOfConvertiblePromissoryNotes_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_z0QOUKDG69Ub" title="Change in fair value of convertible promissory notes"&gt;34,000&lt;/span&gt; related to the change in fair value of the Yorkville Convertible
Note liability. The Company used a Monte Carlo simulation model in order to determine the Yorkville Convertible Note&#x2019;s fair value
at December 31, 2023, with the following inputs: the fair value of the Company&#x2019;s common stock of $&lt;span id="xdx_90B_eus-gaap--SharePrice_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zRwkzGZezQEa" title="Original issuance price"&gt;1.88&lt;/span&gt; on December 31, 2023, estimated
equity volatility of &lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zMtMgNivPWg" title="Estimated equity volatility"&gt;71&lt;/span&gt;%, the time to maturity of &lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zoQ7ZEbmYnq9" title="Time to maturity"&gt;0.46&lt;/span&gt; years, a discounted market interest rate of &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions_pid_dp_uPure_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zS6kszt4gNki" title="Discounted market interest rate"&gt;14&lt;/span&gt;%, a risk free rate of &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_znTOQnm27KDb" title="Risk free rate"&gt;5.28&lt;/span&gt;%, and
probability of optional redemption &lt;span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsProbabilityOptionalRedemptionRate_pid_dp_uPure_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--YorkvilleConvertibleNoteMember_zt3RToISRdje" title="Probability of optional redemption rate"&gt;10.0&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Term
and Convertible Notes (CP BF) &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 19, 2021, the Company entered into a loan agreement with CP BF Lending, LLC (&#x201c;CP BF&#x201d;) for $&lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20210219__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember_zHiPlJsytj5c" title="Aggregate principal amount"&gt;8,000,000&lt;/span&gt; (the &#x201c;Loan
Agreement&#x201d;). The Loan Agreement was comprised of a Term Note for $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20210219__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember_zZu3L1sKVUx6" title="Aggregate principal amount"&gt;6,500,000&lt;/span&gt; and a Convertible Note for $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20210219__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zayzBdGCRPpj" title="Aggregate principal amount"&gt;1,500,000&lt;/span&gt;, with the option
upon the request of the Company for Additional Loan (&#x201c;Additional Loan&#x201d;) principal amount of up to $&lt;span id="xdx_903_ecustom--DebtInstrumentAdditionalBorrowingCapacity_iI_c20210219__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember_zDauf8QUdgi7" title="Additional loan principal amount"&gt;7,000,000&lt;/span&gt;, evidenced by
additional notes with &lt;span id="xdx_90F_ecustom--PercentageOfAdditionalBorrowingPrincipalAmount_iI_pid_dp_uPure_c20210219__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember_zX9UVTHEiPck" title="Percentage of additional borrowing principal amount"&gt;81.25&lt;/span&gt;% of the principal amount of such Additional Loan being evidenced by a Term Note, and &lt;span id="xdx_90F_ecustom--PercentageOfAdditionalBorrowingPrincipalAmount_iI_pid_dp_uPure_c20210219__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z7bvzPYcTVsj" title="Percentage of additional borrowing principal amount"&gt;18.75&lt;/span&gt;% of the principal
amount of such an Additional Loan being evidenced by a Convertible Note. The Term Note bears cash interest at a rate of &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210219__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember_zIbJFuvt9vE5" title="Debt instrument, interest rate"&gt;14&lt;/span&gt;% per annum
paid &lt;span id="xdx_900_eus-gaap--DebtInstrumentFrequencyOfPeriodicPayment_c20210219__20210219__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember_zmGcLbnpzmc7" title="Frequency of periodic interest payment"&gt;monthly&lt;/span&gt; and accrued interest payable-in-kind (&#x201c;PIK&#x201d;) cumulatively at 1.5% per annum. The outstanding principal balance
of the Term Note together with accrued and unpaid interest thereon, unpaid fees and expenses and any other Obligations then due, shall
be paid on February 19, 2025 (&#x201c;Loan Maturity Date&#x201d;). The Convertible Note accrues PIK interest cumulatively at a rate of
&lt;span id="xdx_909_ecustom--PaidInKindInterestRate_pid_dp_uPure_c20210219__20210219__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_ztAl1ZiXStq5" title="Accrued interest payable-in-kind"&gt;15.5&lt;/span&gt;% per annum, and is convertible into Class A Common Stock upon Qualified Financing (as defined in the agreement), upon a Change of
Control (as defined in the agreement), upon Prepayment, or at Maturity at a fixed conversion price. If not sooner converted or prepaid,
the Convertible Note principal together with accrued and unpaid interest thereon, unpaid fees and expenses and any other Obligations
then due, shall be paid on the Loan Maturity Date. Upon the occurrence, and during the continuance, of an Event of Default (as defined
in the agreement), interest on the Term Note will bear cash interest at a per annum rate of &lt;span id="xdx_908_ecustom--CashInterestDefaultPercentage_iI_pid_dp_uPure_c20210219__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember_zYOV1FAHvaEk" title="Cash interest default percentage"&gt;20&lt;/span&gt;% (&#x201c;Default Rate&#x201d;) and &lt;span id="xdx_90E_ecustom--InterestPayableInKindDefaultPercentage_iI_pid_dcp_uPure_c20210219__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember_znQGcHJF5Ab4" title="Interest payable-in-kind default percentage"&gt;no&lt;/span&gt; PIK
interest shall accrue at any time during an Event of Default and the Convertible Note will bear PIK Interest at a per annum at the Default
Rate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additionally,
the Company may voluntarily prepay the Principal of the Loans, in accordance with their terms, in whole or in part at any time. On the
date of any such prepayment, the Company will owe to Lender: (i) all accrued and unpaid Cash Interest with respect to the principal amount
so prepaid through the date the prepayment is made; (ii) if such prepayment is prior to the twelve-month anniversary of the Closing Date,
all unpaid interest (including for the avoidance of doubt, PIK Interest and Cash Interest) with respect to the principal amount so prepaid
that would have been due and payable on or prior to the twelve-month anniversary of the Closing Date had the Loans remained outstanding
until such twelve-month anniversary date (the &#x201c;Yield Maintenance Premium&#x201d;); (iii) the Exit Fee with respect to the principal
amount so prepaid, calculated as &lt;span id="xdx_907_ecustom--ExitFeePercentage_pid_dp_uPure_c20210219__20210219__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember_zRJWzPtdHkzj" title="Exit fee percentage"&gt;1.0&lt;/span&gt;% of the outstanding principal balance of the Loans, with only the portion of the principal balance
so converted counted for purposes of determining the applicable Exit Fee; and provided further, that, in the event of a partial prepayment
of the Loans, the Exit Fee shall be calculated on the principal amount so repaid and not on the entire outstanding principal balance
thereof, and (iv) all other Obligations, if any, that shall have become due and payable hereunder with respect to the principal amount
so prepaid.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--DebtInstrumentCovenantDescription_c20230101__20231231__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember_zg4DzRPGGgM8" title="Debt covenant description"&gt;The
Loan Agreement contains customary covenants, including restrictions on the Company&#x2019;s ability to incur indebtedness, grant liens
or security interest on assets, make acquisitions, loans, advances or investments, or sell or otherwise transfer assets, among others.
The Loan Agreement also contains other financial covenants related to minimum gross profit margin, minimum ARR (Annual Recurring Revenue)
growth rate, and fixed charge ratio, among other financial covenants per the terms of the Loan Agreement.&lt;/span&gt; The Loan Agreement is secured
by a first-priority Lien (subject to Permitted Liens) on and security interest in the Collateral pursuant to the terms of the Collateral
Documents. The Loan Agreement named Joseph Davy, CEO, as Guarantor, and per the term of the Loan Agreement, he is willing to guarantee
the full payment, performance and collection of all of the Credit Parties&#x2019; obligations thereunder and under the Loan Agreement,
all as further set forth therein.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--DebtInstrumentCovenantCompliance_c20230101__20231231__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember_zarhNtEKlmJf" title="Debt Instrument, covenant compliance description"&gt;For
all respective periods presented, the Company was not in compliance with the Minimum Gross Profit Margin covenant in section 7.14.1 of
the Loan Agreement, the Minimum ARR Growth covenant in section 7.14.2 of the Loan Agreement, and the Fixed Charge Coverage Ratio covenant
in section 7.14.3 of the Loan Agreement. As a result of the Company&#x2019;s noncompliance with the financial covenants, the entire principal
amount and all unpaid and accrued interest will be classified as current on the Company&#x2019;s consolidated balance sheets.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
the occurrence of an Event of Default, and at any time thereafter unless and until such Event of Default has been waived by CP BF or
cured to the satisfaction of Lender, subject to the exercise of customary commercial underwriting standards in determining such satisfaction,
Lender may, without notice or demand to the Credit Parties declare the unpaid principal of and any accrued interest shall be immediately
due and payable. While the Company and the Lender are engaged in good faith discussions to resolve these matters, no agreement to resolve
such matters has been reached and all of the Loans remain in default for the reasons stated above, and the Lender is not presently exercising
remedies, which the Lender reserves the right to so do at any time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 19, 2021, the Company capitalized $&lt;span id="xdx_904_ecustom--DebtIssuanceCostsCapitalized_c20210219__20210219__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember_zEmKr6v3kwC7" title="Capitalized debt issuance costs"&gt;310,589&lt;/span&gt; and $&lt;span id="xdx_90B_ecustom--DebtIssuanceCostsCapitalized_c20210219__20210219__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zY4yLooQt9f3" title="Capitalized debt issuance costs"&gt;71,674&lt;/span&gt; of costs associated with the issuance of the Term Note and Convertible
Notes, respectively, and amortizes these costs to interest expense over the term of the debt, using the effective interest method. The
capitalized debt issuance costs are presented as a reduction of the carrying value of the Term Note and Convertible Notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
embedded redemption put feature upon a Prepayment and Default Interest triggering events that are unrelated to the creditworthiness of
the Company are not clearly and closely related to the debt host instrument, were separated and bundled together, as a derivative and
assigned probabilities of being affected and initially measured at fair value in the amount of $&lt;span id="xdx_903_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_c20210219__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember_zc3l5vuBbJIh" title="Derivatives measured at fair value"&gt;3,000&lt;/span&gt;. Subsequent changes in fair value
of the feature will be recognized as a gain or loss in the Consolidated Statement of Operations. The fair value of the bifurcated derivative
liability was estimated utilizing the with and without method which uses the probability weighted difference between the scenarios with
the derivative and the plain vanilla maturity scenario without a derivative (See &lt;i&gt;Note 8-Fair Value Measurements&lt;/i&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 10, 2022 the Loan Agreement was amended, where CP BF waived payment by the Company of four months of cash interest with respect
to the Term Note in replacement for a Convertible Note (&#x201c;First Amendment Convertible Note&#x201d;) in the principal amount of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20221010__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__custom--FirstAmendmentConvertibleNoteMember_z6m2aNmHQ7p6" title="Aggregate principal amount"&gt;321,345&lt;/span&gt;,
which is not considered an Additional Loan as defined above. The First Amendment Convertible Note has the same features as the Convertible
Note described above.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Discounts
to the principal amounts, relating to the debt issuance costs and embedded features, are included in the carrying value of the Convertible
Notes and amortized to interest expense over the remaining term of the underlying debt. During 2022, the Company recorded a $&lt;span id="xdx_90E_ecustom--DebtIssuanceCostsIncurredDuringThePeriodGross_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zNOseRlE1cri" title="Debt issuance costs incurred during the period gross"&gt;2,000&lt;/span&gt; debt
discount upon issuance of the Convertible Notes. For the year ended December 31, 2023, interest expense on the Term Note totaled $&lt;span id="xdx_902_eus-gaap--InterestExpense_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zJm8PbTgdM4l" title="Interest expense"&gt;1,140,106&lt;/span&gt;,
comprised of $&lt;span id="xdx_90D_eus-gaap--InterestExpenseDebt_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember_zhi18iFM7b6f" title="Interest expense debt"&gt;1,058,230&lt;/span&gt; of contractual interest and $&lt;span id="xdx_907_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember_zS1OOW1YwIKa" title="Debt related commitement fees and debt issuance costs"&gt;81,876&lt;/span&gt; for the amortization of the discount. The effective interest rate for the
Term Note was &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20231231__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember_zVwRiVo9SFU8" title="Effective interest rate percentage"&gt;&lt;span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20221231__us-gaap--LineOfCreditFacilityAxis__custom--CPBFLendingLLCMember__us-gaap--LongtermDebtTypeAxis__custom--TermNoteMember_z3ZJLj2Wm6d4" title="Effective interest rate percentage"&gt;16&lt;/span&gt;&lt;/span&gt;% for years ended December 31, 2023 and 2022. For the year ended December 31, 2023, interest expense on the Convertible
Notes totaled $&lt;span id="xdx_904_eus-gaap--InterestExpense_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zLychaJB9OM" title="Interest expense"&gt;422,507&lt;/span&gt;, comprised of $&lt;span id="xdx_90F_eus-gaap--InterestExpenseDebt_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zE88MRM8K58k" title="Interest expense debt"&gt;395,575&lt;/span&gt; of contractual interest and $&lt;span id="xdx_904_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zTiTim0ifdJj" title="Debt related commitement fees and debt issuance costs"&gt;26,932&lt;/span&gt; for the amortization of the discount. The effective
interest rate for the CP BF Convertible Note and First Amendment Convertible Note was &lt;span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20231231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zmubUR5UVTK4" title="Effective interest rate percentage"&gt;&lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_pid_dp_uPure_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zqVIoa8oZNf9" title="Effective interest rate percentage"&gt;16&lt;/span&gt;&lt;/span&gt;% for the years ended December 31, 2023 and 2022.
For the year ended December 31, 2022, interest expense on the Term Note totaled $&lt;span id="xdx_901_eus-gaap--InterestExpense_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_znKAfKgn5ci1" title="Interest expense"&gt;1,110,296&lt;/span&gt;, comprised of $&lt;span id="xdx_907_eus-gaap--InterestExpenseDebt_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zJPScOL3qTah" title="Interest expense debt"&gt;1,042,291&lt;/span&gt; of contractual interest
and $&lt;span id="xdx_906_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--MediumTermNotesMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_z5rv3eKeQAfb" title="Debt related commitement fees and debt issuance costs"&gt;68,006&lt;/span&gt; for the amortization of the discount. For the year ended December 31, 2022, interest expense on the Convertible Notes totaled
$&lt;span id="xdx_902_eus-gaap--InterestExpense_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zV9CNVhFpgy8" title="Interest expense"&gt;319,743&lt;/span&gt;, comprised of $&lt;span id="xdx_909_eus-gaap--InterestExpenseDebt_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zcwUC0o9hqgb" title="Interest expense debt"&gt;303,121&lt;/span&gt; of contractual interest and $&lt;span id="xdx_906_eus-gaap--DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_znl9b73t4Svb" title="Debt related commitement fees and debt issuance costs"&gt;16,622&lt;/span&gt; for the amortization of the discount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes a combination of scenario-based methods and Black-Scholes option pricing models to determine the average share count
outstanding at conversion and the simulated price per share for the Company as of the valuation date. Key inputs into these models included
the timing and probability of the identified scenarios, and for Black-Scholes option pricing models used for notes that included a valuation
cap, equity values, risk-free rate and volatility.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Modification
of Term and Convertible Notes (CP BF) &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 24, 2023, the Company entered into a forbearance agreement (the &#x201c;Forbearance Agreement&#x201d;) with CP BF Lending. Under
the terms of this Forbearance Agreement, and as a result of the Company&#x2019;s non-compliance with certain covenants of its Loan Agreement
with CP BF, CP BF agreed to (i) amend certain provisions of the Loan Agreement to clarify the treatment of the Merger with 7GC under
the Loan Agreement, (ii) consent to the consummation of the Merger Agreement with 7GC and (iii) forbear from exercising any of its rights
and remedies under the Loan Agreement with the Company from the effective date of the Forbearance Agreement until the earlier of (a)
the four-month anniversary of the closing of the Merger if the Merger is closed on or prior to December 29, 2023, (b) December 29, 2023
if the Merger is not consummated on or prior to December 29, 2023 or (c) the date on which any Termination Event (as defined within the
Forbearance Agreement) shall have occurred. In connection with the Forbearance Agreement, CP BF and the Company also agreed to amend
and restate CP BF&#x2019;s existing convertible promissory notes (the &#x201c;A&amp;amp;R CP BF Notes&#x201d;) so that they may remain outstanding
following the closing of the Merger and, at CP BF&#x2019;s option, be convertible into Class A shares of the combined company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2023, the Company entered into the First Amendment to the Forbearance Agreement with the Lender. In particular, the Company
agreed to pay the Lender an amount in cash equal to $&lt;span id="xdx_90D_ecustom--AmendmentFee_c20231214__20231214__us-gaap--LongtermDebtTypeAxis__custom--FirstAmendmentConvertibleNoteMember_zB9l0uhoOS59" title="Amendment fee"&gt;23,748&lt;/span&gt; (the &#x201c;Amendment Fee&#x201d;) on the execution date to extend the forbearance
period from the four-month anniversary of the closing of the Merger to the six-month anniversary of the closing of the Merger. This amendment
was deemed to be a debt modification in accordance with ASC 470, Debt, which will be accounted for prospectively. Modification does not
result in recognition of a gain or loss in the consolidated statement of operations but does impact interest expense recognized in the
future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfDebtTableTextBlock_zsLaeqFTG5G6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the CP BF convertible notes as of December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zTSESSXAzAVk" style="display: none"&gt;Summary of Convertible Notes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20231231__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zeBcmMrC9RP5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_zJIwvJ7OBzEe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Face value of the CB BF convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;1,821,345&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--UnamortizedDebtDiscountOnConvertibleNotesPayable_iI_zukSd0ApjL5a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Debt discount, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(41,983&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ConvertibleNotesPayable_iI_zPg5M0IXIll9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Carrying value of the CB BF convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,779,362&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--InterestPayableOnConvertibleDebt_iI_zlIWGunbEzN6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;914,479&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ConvertibleDebtIncludingAccruedInterest_iI_z7NBofTirKO3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Total CB BF convertible notes and accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,693,841&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the CP BF convertible notes as of December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20221231__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zpka8r0iRLX3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_zq5g0iGSQflj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Face value of the CB BF convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;1,821,345&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--UnamortizedDebtDiscountOnConvertibleNotesPayable_iI_zzE6tLeb4Mz5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Debt discount, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(63,715&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ConvertibleNotesPayable_iI_za9YaJwY6tih" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Carrying value of the CB BF convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,757,630&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--InterestPayableOnConvertibleDebt_iI_zWlgbMvl8Gl5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;518,904&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ConvertibleDebtIncludingAccruedInterest_iI_z5nI3pWkTxG4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Total CB BF convertible notes and accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,276,534&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8AB_zz26UsbxWWAc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_ecustom--TermNotesDebtTableTextBlock_zMR9Y6QKEFU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the CP BF term note as of December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;span id="xdx_8B9_z7ttMYXd4Ku3" style="display: none"&gt;Summary of Term Notes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20231231__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zh7m1TllqQ62" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OtherNotesPayableCurrent_iI_zvog5C9pH6yc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Face value of the CB BF term note&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;6,500,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--UnamortizedDebtDiscountOnOtherNotesPayable_iNI_di_zp7snBpq9Ie7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Debt discount, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(129,586&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NotesPayableFairValueDisclosure_iI_zwzUyTxIo8ib" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Carrying value of the CB BF term note&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,370,414&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccruedInterestOnNotesPayableCurrent_iI_z9dmDXaEDfY" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;289,373&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--NotesPayableIncludingAccruedInterest_iI_zvD1v3DN2Lz8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Total CB BF term note and accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,659,787&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the CP BF term note as of December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20221231__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zu8Qtu4f1Hf5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OtherNotesPayableCurrent_iI_zHTWr6m5a5ta" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Face value of the CB BF term note&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;6,500,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--UnamortizedDebtDiscountOnOtherNotesPayable_iNI_di_zji1Q5d7tric" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Debt discount, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(192,911&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NotesPayableFairValueDisclosure_iI_zahlZYOFUieb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Carrying value of the CB BF term note&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,307,089&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccruedInterestOnNotesPayableCurrent_iI_zZpb93u8QAJ5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;186,962&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--NotesPayableIncludingAccruedInterest_iI_zgD5SjQprCCh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Total CB BF term note and accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,494,051&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A7_zHuNGdCl7t74" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-03-21_custom_AlcoMember"
      decimals="0"
      id="Fact004138"
      unitRef="USD">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2022-03-21_custom_AlcoMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact004140"
      unitRef="Pure">0.05</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2022-03-21_custom_AlcoMember"
      decimals="INF"
      id="Fact004142"
      unitRef="Pure">0.15</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature
      contextRef="From2022-03-212022-03-21_custom_AlcoMember"
      id="Fact004144">The outstanding principal and interest under the Old Alco Note was, at
the Holder&#x2019;s election, either (i) effective upon the closing of an Equity Financing (as defined in the agreement), to be converted
into shares of the same series of preferred stock of the Company issued to other investors in the Equity Financing (the &#x201c;Equity
Financing Securities&#x201d;) at a conversion price equal to 85% of the price per share of Equity Financing Securities paid by the other
investors in the Equity Financing, with any resulting fraction of a share rounded to the nearest whole share (with 0.5 being rounded
up) (the &#x201c;Conversion Option&#x201d;) or (ii) immediately prior to the closing of an Equity Financing, become due and payable in
cash.</us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature>
    <BNZI:DebtInstrumentConversionPercentage
      contextRef="From2022-03-212022-03-21_custom_AlcoMember"
      decimals="INF"
      id="Fact004146"
      unitRef="Pure">0.85</BNZI:DebtInstrumentConversionPercentage>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2022-01-012022-12-31_custom_AlcoMember"
      decimals="0"
      id="Fact004148"
      unitRef="USD">151000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestExpenseDebt
      contextRef="From2022-01-012022-12-31_custom_AlcoMember"
      decimals="0"
      id="Fact004150"
      unitRef="USD">124621</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="From2022-01-012022-12-31_custom_AlcoMember"
      decimals="0"
      id="Fact004152"
      unitRef="USD">100274</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="From2022-01-012022-12-31_custom_AlcoMember"
      decimals="0"
      id="Fact004154"
      unitRef="USD">24347</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2022-12-31_custom_AlcoMember"
      decimals="INF"
      id="Fact004156"
      unitRef="Pure">0.20</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-07-19_custom_AlcoMember"
      decimals="0"
      id="Fact004158"
      unitRef="USD">2101744</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2022-07-192022-07-19_custom_AlcoMember"
      decimals="0"
      id="Fact004160"
      unitRef="USD">56653</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-07-31_custom_AlcoMansonWardAndDNXMember"
      decimals="0"
      id="Fact004162"
      unitRef="USD">4200538</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-09-30_custom_AlcoMansonWardAndDNXMember"
      decimals="0"
      id="Fact004164"
      unitRef="USD">4200538</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-03-31_custom_AlcoMansonWardDNXAndWilliamBryantMember_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact004166"
      unitRef="USD">2583000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-09-30_custom_AlcoMansonWardDNXAndWilliamBryantMember_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact004168"
      unitRef="USD">2583000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2023-09-30_custom_DNXMember_custom_RelatedPartyConvertibleNotesMember_us-gaap_SeriesAPreferredStockMember_srt_MinimumMember"
      decimals="INF"
      id="Fact004170"
      unitRef="Pure">0.05</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature
      contextRef="From2023-04-012023-09-30_custom_RelatedPartyConvertibleNotesMember"
      id="Fact004172">The Related Party Convertible Notes bear interest
at a rate of 8% per annum, and are convertible into the same series of capital stock of the Company to be issued to other investors upon
a Qualified Financing (as defined in the agreement) at a conversion price equal to the lesser of (i) 80% of the per share price paid
by the cash purchasers of such Qualified Financing Securities (as defined in the agreement) in the Qualified Financing, or (ii) the conversion
price obtained by dividing $50,000,000 by the Fully Diluted Capitalization (as defined in the agreement). If not sooner converted or
prepaid, the Convertible Notes are payable no later than the earlier of (a) the written demand by the holders of a majority-in-interest
of the Notes then outstanding on or after September 1, 2023, (b) consummation of a Liquidity Event (as defined in the agreement), or
(c) the written demand by the Majority Holders (as defined in the agreement) after an Event of Default (as defined in the agreement)
has occurred. In the event of a Liquidity Event (as defined below) while this Note is outstanding, immediately prior to the closing of
such Liquidity Event and in full satisfaction of this Note, an amount equal to the greater of (a) the Outstanding Amount, or (b) two
times (2x) the principal amount of this Note then outstanding shall become immediately due and payable in cash.</us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-09-30_custom_RelatedPartyConvertibleNotesMember"
      decimals="INF"
      id="Fact004174"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <BNZI:DebtInstrumentConversionPercentage
      contextRef="From2023-04-012023-09-30_custom_RelatedPartyConvertibleNotesMember"
      decimals="INF"
      id="Fact004176"
      unitRef="Pure">0.80</BNZI:DebtInstrumentConversionPercentage>
    <BNZI:NumeratorUsedForObtainingConversionPrice
      contextRef="From2023-04-012023-09-30_custom_RelatedPartyConvertibleNotesMember"
      decimals="INF"
      id="Fact004178"
      unitRef="USDPShares">50000000</BNZI:NumeratorUsedForObtainingConversionPrice>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2022-01-012022-12-31_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact004180"
      unitRef="USD">1311025</us-gaap:AmortizationOfDebtDiscountPremium>
    <BNZI:BifurcatedDerivative
      contextRef="AsOf2022-12-31_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact004182"
      unitRef="USD">1292777</BNZI:BifurcatedDerivative>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="AsOf2022-12-31_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact004184"
      unitRef="USD">18248</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-01-012023-12-31_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact004186"
      unitRef="USD">1126451</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestExpense
      contextRef="From2023-01-012023-12-31_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact004188"
      unitRef="USD">2307013</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-01-012023-12-31_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact004190"
      unitRef="USD">464071</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2023-01-012023-12-31_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact004192"
      unitRef="USD">1842942</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-14_custom_RelatedPartyConvertibleNotesMember"
      decimals="0"
      id="Fact004194"
      unitRef="USD">7271368</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2023-12-142023-12-14_custom_RelatedPartyConvertibleNotesMember"
      decimals="INF"
      id="Fact004196"
      unitRef="Shares">22929</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-09-30_custom_ThirdPartyCreditorsMember_custom_TwoThousandTwentyTwoThirdPartyConvertibleNotesMember"
      decimals="0"
      id="Fact004198"
      unitRef="USD">1761206</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-09-30_custom_ThirdPartyCreditorsMember_custom_ThirdPartyConvertibleNotesMember"
      decimals="0"
      id="Fact004200"
      unitRef="USD">1435000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature
      contextRef="From2023-04-012023-09-30_us-gaap_NonrelatedPartyMember"
      id="Fact004201">The Third Party Convertible Notes bear interest at a rate of 8% per annum, and are convertible
into the same series of capital stock of the Company to be issued to other investors upon a Qualified Financing (as defined in the agreement)
at a conversion price equal to the lesser of (i) 80% of the per share price paid by the cash purchasers of such Qualified Financing Securities
(as defined in the agreement) in the Qualified Financing, or (ii) the conversion price obtained by dividing $50,000,000 by the Fully
Diluted Capitalization (as defined in the agreement). If not sooner converted or prepaid, the Convertible Notes are payable no later
than the earlier of (a) the written demand by the holders of a majority-in-interest of the Notes then outstanding on or after September
1, 2023, (b) consummation of a Liquidity Event (as defined in the agreement), or (c) the written demand by the Majority Holders (as defined
in the agreement) after an Event of Default (as defined in the agreement) has occurred. In the event of a Liquidity Event (as defined
below) while this Note is outstanding, immediately prior to the closing of such Liquidity Event and in full satisfaction of this Note,
an amount equal to the greater of (a) the Outstanding Amount, or (b) two times (2x) the principal amount of this Note then outstanding
shall become immediately due and payable in cash.</us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-09-30_us-gaap_NonrelatedPartyMember"
      decimals="INF"
      id="Fact004202"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <BNZI:DebtInstrumentConversionPercentage
      contextRef="From2023-04-012023-09-30_us-gaap_NonrelatedPartyMember"
      decimals="INF"
      id="Fact004203"
      unitRef="Pure">0.80</BNZI:DebtInstrumentConversionPercentage>
    <BNZI:NumeratorUsedForObtainingConversionPrice
      contextRef="From2023-04-012023-09-30_us-gaap_NonrelatedPartyMember"
      decimals="INF"
      id="Fact004204"
      unitRef="USDPShares">500000</BNZI:NumeratorUsedForObtainingConversionPrice>
    <BNZI:DebtInstrumentUnamortizedDebtIssuanceCostsIncurredDuringThePeriod
      contextRef="From2022-01-012022-12-31_custom_AdditionalSubordinatedConvertibleNotesTwoThousandAndTwentyTwoMember_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact004206"
      unitRef="USD">548871</BNZI:DebtInstrumentUnamortizedDebtIssuanceCostsIncurredDuringThePeriod>
    <BNZI:DebtInstrumentUnamortizedDebtIssuanceCostsIncurredDuringThePeriod
      contextRef="From2022-01-012022-12-31_custom_AdditionalSubordinatedConvertibleNotesTwoThousandAndTwentyTwoMember_us-gaap_NonrelatedPartyMember_custom_BifurcatedDerivativePortionMember"
      decimals="0"
      id="Fact004208"
      unitRef="USD">541223</BNZI:DebtInstrumentUnamortizedDebtIssuanceCostsIncurredDuringThePeriod>
    <BNZI:DebtInstrumentUnamortizedDebtIssuanceCostsIncurredDuringThePeriod
      contextRef="From2022-01-012022-12-31_custom_AdditionalSubordinatedConvertibleNotesTwoThousandAndTwentyTwoMember_us-gaap_NonrelatedPartyMember_custom_DebtPortionMember"
      decimals="0"
      id="Fact004210"
      unitRef="USD">7648</BNZI:DebtInstrumentUnamortizedDebtIssuanceCostsIncurredDuringThePeriod>
    <BNZI:DebtInstrumentUnamortizedDebtIssuanceCostsIncurredDuringThePeriod
      contextRef="From2023-01-012023-12-31_custom_AdditionalSubordinatedConvertibleNotesTwoThousandAndTwentyTwoMember_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact004211"
      unitRef="USD">559390</BNZI:DebtInstrumentUnamortizedDebtIssuanceCostsIncurredDuringThePeriod>
    <us-gaap:InterestExpense
      contextRef="From2023-01-012023-12-31_custom_TwoThousandAndTwentyTwoConvertibleNotesMember"
      decimals="0"
      id="Fact004212"
      unitRef="USD">1063093</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-01-012023-12-31_custom_TwoThousandAndTwentyTwoConvertibleNotesMember"
      decimals="0"
      id="Fact004213"
      unitRef="USD">188059</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2023-01-012023-12-31_custom_TwoThousandAndTwentyTwoConvertibleNotesMember"
      decimals="0"
      id="Fact004214"
      unitRef="USD">875034</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-14_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact004216"
      unitRef="USD">3346232</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2023-12-142023-12-14_us-gaap_NonrelatedPartyMember"
      decimals="INF"
      id="Fact004218"
      unitRef="Shares">10597</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004220">&lt;p id="xdx_89B_eus-gaap--ConvertibleDebtTableTextBlock_zEtCTGwl8ruc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the Related Party and Third Party Convertible Notes, respectively, as of December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8BE_z6oOcNJaH4s4" style="display: none"&gt;Schedule of Related Party and Third Related
Party Convertible Notes&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zuUkOIsuHJSf" style="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zZttpaKCDqTg" style="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_zt0g4rAGdJ78" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;Face value of the convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;6,783,538&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;3,196,206&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--UnamortizedDebtDiscountOnConvertibleNotesPayable_iI_zRLlD9TOqE17" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Debt discount, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(131,867&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(83,688&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iI_z67p2JcEwDZ" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Carrying value of the convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,651,671&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,112,518&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--InterestPayableOnConvertibleDebt_iI_z9Wqoy7kbsZi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;619,697&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;233,714&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ConversionOfConvertibleNote_iI_zJwvejqx5cQi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Conversion of convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(7,271,368&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(3,346,232&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--ConvertibleDebtIncludingAccruedInterest_iI_zqCyps83IAmc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Total convertible notes and accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4237"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4238"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the Related Party and Third Party Convertible Notes, respectively, as of December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zQ1q31r3dVzb" style="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: center"&gt;Related Party&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_z0b2IJumKsza" style="border-bottom: Black 1pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: center"&gt;Third Party&lt;/td&gt;&lt;td style="font: italic 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_zil7JYt68Ne1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left"&gt;Face value of the convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;4,200,538&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;1,761,206&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--UnamortizedDebtDiscountOnConvertibleNotesPayable_iI_z9wf7kNbbLM" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Debt discount, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(849,656&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(398,034&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ConvertibleNotesPayable_iI_z1gAZGDjYU79" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Carrying value of the convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,350,882&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,363,172&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--InterestPayableOnConvertibleDebt_iI_z5UwPhIgEQK6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;155,626&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;45,654&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ConvertibleDebtIncludingAccruedInterest_iI_zIXer5M2ZQtg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Total convertible notes and accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,506,508&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,408,826&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact004222"
      unitRef="USD">6783538</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact004223"
      unitRef="USD">3196206</us-gaap:ConvertibleDebtFairValueDisclosures>
    <BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact004225"
      unitRef="USD">-131867</BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable>
    <BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact004226"
      unitRef="USD">-83688</BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact004228"
      unitRef="USD">6651671</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact004229"
      unitRef="USD">3112518</us-gaap:ConvertibleNotesPayable>
    <BNZI:InterestPayableOnConvertibleDebt
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact004231"
      unitRef="USD">619697</BNZI:InterestPayableOnConvertibleDebt>
    <BNZI:InterestPayableOnConvertibleDebt
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact004232"
      unitRef="USD">233714</BNZI:InterestPayableOnConvertibleDebt>
    <BNZI:ConversionOfConvertibleNote
      contextRef="AsOf2023-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact004234"
      unitRef="USD">-7271368</BNZI:ConversionOfConvertibleNote>
    <BNZI:ConversionOfConvertibleNote
      contextRef="AsOf2023-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact004235"
      unitRef="USD">-3346232</BNZI:ConversionOfConvertibleNote>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact004240"
      unitRef="USD">4200538</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="AsOf2022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact004241"
      unitRef="USD">1761206</us-gaap:ConvertibleDebtFairValueDisclosures>
    <BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact004243"
      unitRef="USD">-849656</BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable>
    <BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable
      contextRef="AsOf2022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact004244"
      unitRef="USD">-398034</BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact004246"
      unitRef="USD">3350882</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact004247"
      unitRef="USD">1363172</us-gaap:ConvertibleNotesPayable>
    <BNZI:InterestPayableOnConvertibleDebt
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact004249"
      unitRef="USD">155626</BNZI:InterestPayableOnConvertibleDebt>
    <BNZI:InterestPayableOnConvertibleDebt
      contextRef="AsOf2022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact004250"
      unitRef="USD">45654</BNZI:InterestPayableOnConvertibleDebt>
    <BNZI:ConvertibleDebtIncludingAccruedInterest
      contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact004252"
      unitRef="USD">3506508</BNZI:ConvertibleDebtIncludingAccruedInterest>
    <BNZI:ConvertibleDebtIncludingAccruedInterest
      contextRef="AsOf2022-12-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact004253"
      unitRef="USD">1408826</BNZI:ConvertibleDebtIncludingAccruedInterest>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-08-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember5467515"
      decimals="0"
      id="Fact004254"
      unitRef="USD">150000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2023-08-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact004255"
      unitRef="Pure">0.10</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-08-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember5467515"
      decimals="INF"
      id="Fact004256"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-08-302023-08-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember5467531"
      id="Fact004257">2024-04-29</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="AsOf2023-08-30_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember5467515"
      decimals="0"
      id="Fact004258"
      unitRef="USD">3711</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:InterestExpense
      contextRef="From2023-01-012023-12-31_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact004259"
      unitRef="USD">4494</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-01-012023-12-31_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact004260"
      unitRef="USD">4044</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2023-01-012023-12-31_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact004261"
      unitRef="USD">450</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember5467578"
      decimals="0"
      id="Fact004262"
      unitRef="USD">150000</us-gaap:OtherNotesPayableCurrent>
    <BNZI:InterestPayableOnOtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember5467578"
      decimals="0"
      id="Fact004263"
      unitRef="USD">4044</BNZI:InterestPayableOnOtherNotesPayableCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-09-13_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact004264"
      unitRef="USD">1500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-09-13_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember5467625"
      decimals="INF"
      id="Fact004265"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember5467640"
      id="Fact004266">2024-01-10</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="AsOf2023-09-13_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember5467625"
      decimals="0"
      id="Fact004267"
      unitRef="USD">8588</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember5467640"
      decimals="0"
      id="Fact004268"
      unitRef="USD">638808</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:InterestExpense
      contextRef="From2023-01-012023-12-31_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact004269"
      unitRef="USD">478815</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-01-012023-12-31_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact004270"
      unitRef="USD">30575</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2023-01-012023-12-31_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact004271"
      unitRef="USD">448240</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember5467687"
      decimals="0"
      id="Fact004272"
      unitRef="USD">1500000</us-gaap:OtherNotesPayableCurrent>
    <BNZI:InterestPayableOnOtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember5467687"
      decimals="0"
      id="Fact004273"
      unitRef="USD">30575</BNZI:InterestPayableOnOtherNotesPayableCurrent>
    <us-gaap:DebtConversionDescription
      contextRef="From2023-01-012023-12-31_custom_AlcoOctoberShareTransferAgreementMember_custom_AlcoSeptemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember"
      id="Fact004274">for each $500.00 in principal
borrowed under the Alco September Promissory Note, the Sponsor agreed to forfeit one share of 7GC Class B Common Stock held by the Sponsor,
in exchange for the right of Alco to receive one New Banzai Class A Share</us-gaap:DebtConversionDescription>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2023-09-13_custom_AlcoOctoberShareTransferAgreementMember_custom_AlcoSeptemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember"
      decimals="INF"
      id="Fact004275"
      unitRef="USDPShares">500.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2023-09-132023-09-13_custom_AlcoOctoberShareTransferAgreementMember_custom_AlcoSeptemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember"
      decimals="INF"
      id="Fact004276"
      unitRef="Shares">3000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <BNZI:LockUpPeriod
      contextRef="From2023-09-132023-09-13_custom_AlcoOctoberShareTransferAgreementMember_custom_AlcoSeptemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember"
      id="Fact004277">P180D</BNZI:LockUpPeriod>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-11-16_custom_AlcoAugustPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact004278"
      unitRef="USD">750000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-11-16_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember"
      decimals="INF"
      id="Fact004279"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-11-162023-11-16_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember5467796"
      id="Fact004280">2024-04-13</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="AsOf2023-11-16_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact004281"
      unitRef="USD">363905</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:InterestExpense
      contextRef="From2023-01-012023-12-31_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact004282"
      unitRef="USD">94005</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-01-012023-12-31_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact004283"
      unitRef="USD">7397</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2023-01-012023-12-31_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact004284"
      unitRef="USD">86608</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember5467843"
      decimals="0"
      id="Fact004285"
      unitRef="USD">750000</us-gaap:OtherNotesPayableCurrent>
    <BNZI:InterestPayableOnOtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_AlcoNovemberPromissoryNoteMember_custom_AlcoMember5467843"
      decimals="0"
      id="Fact004286"
      unitRef="USD">7397</BNZI:InterestPayableOnOtherNotesPayableCurrent>
    <us-gaap:DebtConversionDescription
      contextRef="From2023-01-012023-12-31_custom_AlcoNovemberShareTransferAgreementMember_custom_AlcoNovemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember"
      id="Fact004287">for
each $500.00
in principal borrowed under the Alco November Promissory Note, the Sponsor agreed to forfeit one share of 7GC Class B Common Stock
held by the Sponsor, in exchange for the right of Alco to receive one New Banzai Class A Share</us-gaap:DebtConversionDescription>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2023-09-13_custom_AlcoNovemberShareTransferAgreementMember_custom_AlcoNovemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember"
      decimals="INF"
      id="Fact004288"
      unitRef="USDPShares">500.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2023-09-132023-09-13_custom_AlcoNovemberShareTransferAgreementMember_custom_AlcoNovemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember"
      decimals="INF"
      id="Fact004289"
      unitRef="Shares">1500</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <BNZI:LockUpPeriod
      contextRef="From2023-09-132023-09-13_custom_AlcoNovemberShareTransferAgreementMember_custom_AlcoNovemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember"
      id="Fact004290">P180D</BNZI:LockUpPeriod>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-13_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact004291"
      unitRef="USD">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-12-13_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember"
      decimals="INF"
      id="Fact004292"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-12-132023-12-13_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember5467953"
      id="Fact004293">2024-12-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="AsOf2023-12-13_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact004294"
      unitRef="USD">1496252</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:InterestExpense
      contextRef="From2023-01-012023-12-31_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact004295"
      unitRef="USD">39087</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-01-012023-12-31_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact004296"
      unitRef="USD">7890</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2023-01-012023-12-31_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember"
      decimals="0"
      id="Fact004297"
      unitRef="USD">31197</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember5467984"
      decimals="0"
      id="Fact004298"
      unitRef="USD">2000000</us-gaap:OtherNotesPayableCurrent>
    <BNZI:InterestPayableOnOtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_AlcoDecemberPromissoryNoteMember_custom_AlcoMember5467984"
      decimals="0"
      id="Fact004299"
      unitRef="USD">7890</BNZI:InterestPayableOnOtherNotesPayableCurrent>
    <us-gaap:DebtConversionDescription
      contextRef="From2023-01-012023-12-31_custom_December2023ShareTransferAgreementMember_custom_AlcoNovemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember"
      id="Fact004300">for each
$500.00 in principal borrowed under the December 2023 Note, the Sponsor agreed to forfeit three shares of 7GC Class B Common Stock held
by the Sponsor, in exchange for the right of Alco to receive three New Banzai Class A Shares</us-gaap:DebtConversionDescription>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2023-09-13_custom_December2023ShareTransferAgreementMember_custom_AlcoNovemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember"
      decimals="INF"
      id="Fact004301"
      unitRef="USDPShares">500.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2023-09-132023-09-13_custom_December2023ShareTransferAgreementMember_custom_AlcoNovemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember"
      decimals="INF"
      id="Fact004302"
      unitRef="Shares">12000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <BNZI:LockUpPeriod
      contextRef="From2023-09-132023-09-13_custom_December2023ShareTransferAgreementMember_custom_AlcoNovemberPromissoryNoteMember_custom_SevenGcCoHoldingsIncMember"
      id="Fact004303">P180D</BNZI:LockUpPeriod>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="0"
      id="Fact004304"
      unitRef="USD">1000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <BNZI:HoldingPeriodForShares
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      id="Fact004305">P0Y9M7D</BNZI:HoldingPeriodForShares>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="0"
      id="Fact004306"
      unitRef="USD">1000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <BNZI:LockUpPeriod
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      id="Fact004307">P180D</BNZI:LockUpPeriod>
    <BNZI:EstimatedReLeveredEquityVolatilityRate
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact004309"
      unitRef="Pure">0.540</BNZI:EstimatedReLeveredEquityVolatilityRate>
    <BNZI:CommensurateRiskFreeRate
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact004311"
      unitRef="Pure">0.053</BNZI:CommensurateRiskFreeRate>
    <BNZI:EstimatedReLeveredEquityVolatilityRate
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MinimumMember"
      decimals="INF"
      id="Fact004313"
      unitRef="Pure">0.107</BNZI:EstimatedReLeveredEquityVolatilityRate>
    <BNZI:EstimatedReLeveredEquityVolatilityRate
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MaximumMember"
      decimals="INF"
      id="Fact004315"
      unitRef="Pure">0.160</BNZI:EstimatedReLeveredEquityVolatilityRate>
    <BNZI:PercentageOfDiscountLackOfMarketability
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_srt_WeightedAverageMember"
      decimals="INF"
      id="Fact004317"
      unitRef="Pure">0.125</BNZI:PercentageOfDiscountLackOfMarketability>
    <BNZI:ExpectedPercentageOfCompletingTheMerger
      contextRef="From2023-09-132023-09-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact004319"
      unitRef="Pure">0.80</BNZI:ExpectedPercentageOfCompletingTheMerger>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="0"
      id="Fact004320"
      unitRef="USD">500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <BNZI:HoldingPeriodForShares
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      id="Fact004321">P0Y8M19D</BNZI:HoldingPeriodForShares>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="0"
      id="Fact004322"
      unitRef="USD">500000</us-gaap:ProceedsFromIssuanceOfDebt>
    <BNZI:LockUpPeriod
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      id="Fact004323">P180D</BNZI:LockUpPeriod>
    <BNZI:EstimatedReLeveredEquityVolatilityRate
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact004325"
      unitRef="Pure">0.520</BNZI:EstimatedReLeveredEquityVolatilityRate>
    <BNZI:CommensurateRiskFreeRate
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact004327"
      unitRef="Pure">0.054</BNZI:CommensurateRiskFreeRate>
    <BNZI:EstimatedReLeveredEquityVolatilityRate
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MinimumMember"
      decimals="INF"
      id="Fact004329"
      unitRef="Pure">0.100</BNZI:EstimatedReLeveredEquityVolatilityRate>
    <BNZI:EstimatedReLeveredEquityVolatilityRate
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MaximumMember"
      decimals="INF"
      id="Fact004331"
      unitRef="Pure">0.150</BNZI:EstimatedReLeveredEquityVolatilityRate>
    <BNZI:PercentageOfDiscountLackOfMarketability
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_srt_WeightedAverageMember"
      decimals="INF"
      id="Fact004333"
      unitRef="Pure">0.115</BNZI:PercentageOfDiscountLackOfMarketability>
    <BNZI:ExpectedPercentageOfCompletingTheMerger
      contextRef="From2023-10-032023-10-03_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact004335"
      unitRef="Pure">0.80</BNZI:ExpectedPercentageOfCompletingTheMerger>
    <BNZI:HoldingPeriodForShares
      contextRef="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      id="Fact004336">P0Y7M6D</BNZI:HoldingPeriodForShares>
    <BNZI:LockUpPeriod
      contextRef="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      id="Fact004337">P180D</BNZI:LockUpPeriod>
    <BNZI:EstimatedReLeveredEquityVolatilityRate
      contextRef="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact004339"
      unitRef="Pure">0.540</BNZI:EstimatedReLeveredEquityVolatilityRate>
    <BNZI:CommensurateRiskFreeRate
      contextRef="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact004341"
      unitRef="Pure">0.052</BNZI:CommensurateRiskFreeRate>
    <BNZI:EstimatedReLeveredEquityVolatilityRate
      contextRef="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MinimumMember"
      decimals="INF"
      id="Fact004343"
      unitRef="Pure">0.095</BNZI:EstimatedReLeveredEquityVolatilityRate>
    <BNZI:EstimatedReLeveredEquityVolatilityRate
      contextRef="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MaximumMember"
      decimals="INF"
      id="Fact004345"
      unitRef="Pure">0.150</BNZI:EstimatedReLeveredEquityVolatilityRate>
    <BNZI:PercentageOfDiscountLackOfMarketability
      contextRef="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_srt_WeightedAverageMember"
      decimals="INF"
      id="Fact004347"
      unitRef="Pure">0.115</BNZI:PercentageOfDiscountLackOfMarketability>
    <BNZI:ExpectedPercentageOfCompletingTheMerger
      contextRef="From2023-11-162023-11-16_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact004349"
      unitRef="Pure">1</BNZI:ExpectedPercentageOfCompletingTheMerger>
    <BNZI:HoldingPeriodForShares
      contextRef="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      id="Fact004350">P0Y5M26D</BNZI:HoldingPeriodForShares>
    <BNZI:LockUpPeriod
      contextRef="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      id="Fact004351">P180D</BNZI:LockUpPeriod>
    <BNZI:EstimatedReLeveredEquityVolatilityRate
      contextRef="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact004353"
      unitRef="Pure">0.470</BNZI:EstimatedReLeveredEquityVolatilityRate>
    <BNZI:CommensurateRiskFreeRate
      contextRef="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact004355"
      unitRef="Pure">0.052</BNZI:CommensurateRiskFreeRate>
    <BNZI:EstimatedReLeveredEquityVolatilityRate
      contextRef="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MinimumMember"
      decimals="INF"
      id="Fact004357"
      unitRef="Pure">0.075</BNZI:EstimatedReLeveredEquityVolatilityRate>
    <BNZI:EstimatedReLeveredEquityVolatilityRate
      contextRef="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember_srt_MaximumMember"
      decimals="INF"
      id="Fact004359"
      unitRef="Pure">0.120</BNZI:EstimatedReLeveredEquityVolatilityRate>
    <BNZI:PercentageOfDiscountLackOfMarketability
      contextRef="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_srt_WeightedAverageMember"
      decimals="INF"
      id="Fact004361"
      unitRef="Pure">0.090</BNZI:PercentageOfDiscountLackOfMarketability>
    <BNZI:ExpectedPercentageOfCompletingTheMerger
      contextRef="From2023-12-132023-12-13_custom_AlcoSeptemberPromissoryNoteMember_us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember_us-gaap_PutOptionMember"
      decimals="INF"
      id="Fact004363"
      unitRef="Pure">1</BNZI:ExpectedPercentageOfCompletingTheMerger>
    <us-gaap:DebtInstrumentMaturityDateRangeEnd1
      contextRef="From2023-01-012023-12-31_custom_AlcoSeptemberPromissoryNoteMember"
      id="Fact004365">2024-09-30</us-gaap:DebtInstrumentMaturityDateRangeEnd1>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2023-12-31_custom_AlcoSeptemberPromissoryNoteMember_custom_AlcoMember5467687"
      decimals="INF"
      id="Fact004367"
      unitRef="Pure">0.10</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <BNZI:NumberOfPromissoryNotesInConnectionWithMerger
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004369"
      unitRef="Integer">2</BNZI:NumberOfPromissoryNotesInConnectionWithMerger>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-12-21_custom_DecemberTwoThousandTwentyTwoSevenGCNoteMember"
      decimals="INF"
      id="Fact004371"
      unitRef="USD">2300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-10-03_custom_DecemberTwoThousandTwentyTwoSevenGCNoteMember"
      decimals="INF"
      id="Fact004373"
      unitRef="USD">250000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-10-03_custom_SevenGCPromissoryNotesMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact004375"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2023-12-31_custom_SevenGCPromissoryNotesMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact004377"
      unitRef="USDPShares">10.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-12-31_custom_SevenGCPromissoryNotesMember"
      decimals="0"
      id="Fact004379"
      unitRef="USD">2550000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-12-31_custom_SevenGCPromissoryNotesMember"
      decimals="0"
      id="Fact004381"
      unitRef="USD">2550000</us-gaap:DebtInstrumentCarryingAmount>
    <BNZI:ModificationOfConvertibleNotesPayable
      contextRef="From2023-01-012023-12-31_custom_SevenGCPromissoryNotesMember"
      decimals="0"
      id="Fact004383"
      unitRef="USD">9909</BNZI:ModificationOfConvertibleNotesPayable>
    <us-gaap:LoansPayableCurrent
      contextRef="AsOf2023-12-31_custom_SevenGCPromissoryNotesMember"
      decimals="0"
      id="Fact004385"
      unitRef="USD">2540091</us-gaap:LoansPayableCurrent>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="From2023-12-122023-12-12_custom_SevenGCPromissoryNotesMember"
      decimals="INF"
      id="Fact004387"
      unitRef="Integer">30</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="From2023-12-122023-12-12_custom_SevenGCPromissoryNotesMember"
      decimals="INF"
      id="Fact004389"
      unitRef="Integer">30</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <BNZI:ModificationOfConvertibleNotesPayable
      contextRef="From2023-12-122023-12-12_custom_SevenGCPromissoryNotesMember"
      decimals="0"
      id="Fact004391"
      unitRef="USD">9909</BNZI:ModificationOfConvertibleNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-14_srt_MaximumMember_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact004393"
      unitRef="USD">3500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-14_custom_YorkvilleConvertibleNoteMember_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact004395"
      unitRef="USD">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-14_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember_us-gaap_CommonClassAMember"
      decimals="0"
      id="Fact004397"
      unitRef="USD">1500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-14_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember_srt_MaximumMember"
      decimals="0"
      id="Fact004399"
      unitRef="USD">7000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-02-14_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember_srt_MaximumMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact004401"
      unitRef="USD">7000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2023-12-142023-12-14_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact004403"
      unitRef="USD">1800000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-12-142023-12-14_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember"
      decimals="-5"
      id="Fact004405"
      unitRef="USD">200000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2023-12-142023-12-14_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleConvertibleNoteMember"
      id="Fact004407">2024-06-14</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-12-14_custom_YorkvilleConvertibleNoteMember_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact004409"
      unitRef="Pure">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease
      contextRef="From2023-12-142023-12-14_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleConvertibleNoteMember"
      decimals="INF"
      id="Fact004411"
      unitRef="Pure">0.18</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="From2023-12-142023-12-14_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact004413"
      unitRef="Pure">0.0999</us-gaap:DebtConversionConvertedInstrumentRate>
    <BNZI:PercentageOfPrepaymentPremium
      contextRef="AsOf2023-12-14_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact004415"
      unitRef="Pure">0.10</BNZI:PercentageOfPrepaymentPremium>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="From2023-12-142023-12-14_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember_custom_YorkvilleConvertibleNoteMember"
      decimals="0"
      id="Fact004417"
      unitRef="USD">1000000</us-gaap:RepaymentsOfConvertibleDebt>
    <BNZI:PercentageOfRepaymentOfConvertibleDebtAmount
      contextRef="AsOf2023-12-14_custom_YorkvilleConvertibleNoteMember_custom_YorkvilleAdvisorsGlobalLPMember_custom_StandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact004419"
      unitRef="Pure">0.10</BNZI:PercentageOfRepaymentOfConvertibleDebtAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-12-31_custom_YorkvilleConvertibleNoteMember"
      decimals="-6"
      id="Fact004421"
      unitRef="USD">2000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:InterestExpense
      contextRef="From2023-01-012023-12-31_custom_YorkvilleConvertibleNoteMember"
      decimals="0"
      id="Fact004423"
      unitRef="USD">0</us-gaap:InterestExpense>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-14_custom_YorkvilleConvertibleNoteMember"
      decimals="0"
      id="Fact004425"
      unitRef="USD">1800000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-12-31_custom_YorkvilleConvertibleNoteMember"
      decimals="0"
      id="Fact004427"
      unitRef="USD">1766000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:SharePrice
      contextRef="AsOf2023-12-14_custom_YorkvilleConvertibleNoteMember"
      decimals="INF"
      id="Fact004429"
      unitRef="USDPShares">10.96</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-12-142023-12-14_custom_YorkvilleConvertibleNoteMember"
      decimals="INF"
      id="Fact004431"
      unitRef="Pure">0.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-12-142023-12-14_custom_YorkvilleConvertibleNoteMember"
      id="Fact004433">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
      contextRef="From2023-12-142023-12-14_custom_YorkvilleConvertibleNoteMember"
      decimals="INF"
      id="Fact004435"
      unitRef="Pure">0.149</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-12-142023-12-14_custom_YorkvilleConvertibleNoteMember"
      decimals="INF"
      id="Fact004437"
      unitRef="Pure">0.0530</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <BNZI:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsProbabilityOptionalRedemptionRate
      contextRef="From2023-12-142023-12-14_custom_YorkvilleConvertibleNoteMember"
      decimals="INF"
      id="Fact004439"
      unitRef="Pure">0.100</BNZI:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsProbabilityOptionalRedemptionRate>
    <BNZI:ChangeInFairValueOfConvertiblePromissoryNotes
      contextRef="From2023-01-012023-12-31_custom_YorkvilleConvertibleNoteMember"
      decimals="0"
      id="Fact004441"
      unitRef="USD">34000</BNZI:ChangeInFairValueOfConvertiblePromissoryNotes>
    <us-gaap:SharePrice
      contextRef="AsOf2023-12-31_custom_YorkvilleConvertibleNoteMember"
      decimals="INF"
      id="Fact004443"
      unitRef="USDPShares">1.88</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2023-01-012023-12-31_custom_YorkvilleConvertibleNoteMember"
      decimals="INF"
      id="Fact004445"
      unitRef="Pure">0.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-12-31_custom_YorkvilleConvertibleNoteMember"
      id="Fact004447">P0Y5M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
      contextRef="From2023-01-012023-12-31_custom_YorkvilleConvertibleNoteMember"
      decimals="INF"
      id="Fact004449"
      unitRef="Pure">0.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2023-01-012023-12-31_custom_YorkvilleConvertibleNoteMember"
      decimals="INF"
      id="Fact004451"
      unitRef="Pure">0.0528</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <BNZI:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsProbabilityOptionalRedemptionRate
      contextRef="From2023-01-012023-12-31_custom_YorkvilleConvertibleNoteMember"
      decimals="INF"
      id="Fact004453"
      unitRef="Pure">0.100</BNZI:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsProbabilityOptionalRedemptionRate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-02-19_custom_CPBFLendingLLCMember"
      decimals="0"
      id="Fact004455"
      unitRef="USD">8000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-02-19_custom_CPBFLendingLLCMember_custom_TermNoteMember"
      decimals="0"
      id="Fact004457"
      unitRef="USD">6500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-02-19_custom_CPBFLendingLLCMember_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact004459"
      unitRef="USD">1500000</us-gaap:DebtInstrumentFaceAmount>
    <BNZI:DebtInstrumentAdditionalBorrowingCapacity
      contextRef="AsOf2021-02-19_custom_CPBFLendingLLCMember"
      decimals="0"
      id="Fact004461"
      unitRef="USD">7000000</BNZI:DebtInstrumentAdditionalBorrowingCapacity>
    <BNZI:PercentageOfAdditionalBorrowingPrincipalAmount
      contextRef="AsOf2021-02-19_custom_CPBFLendingLLCMember_custom_TermNoteMember"
      decimals="INF"
      id="Fact004463"
      unitRef="Pure">0.8125</BNZI:PercentageOfAdditionalBorrowingPrincipalAmount>
    <BNZI:PercentageOfAdditionalBorrowingPrincipalAmount
      contextRef="AsOf2021-02-19_custom_CPBFLendingLLCMember_us-gaap_ConvertibleDebtMember"
      decimals="INF"
      id="Fact004465"
      unitRef="Pure">0.1875</BNZI:PercentageOfAdditionalBorrowingPrincipalAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2021-02-19_custom_CPBFLendingLLCMember_custom_TermNoteMember"
      decimals="INF"
      id="Fact004467"
      unitRef="Pure">0.14</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment
      contextRef="From2021-02-192021-02-19_custom_CPBFLendingLLCMember_custom_TermNoteMember"
      id="Fact004469">monthly</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <BNZI:PaidInKindInterestRate
      contextRef="From2021-02-192021-02-19_custom_CPBFLendingLLCMember_us-gaap_ConvertibleDebtMember"
      decimals="INF"
      id="Fact004471"
      unitRef="Pure">0.155</BNZI:PaidInKindInterestRate>
    <BNZI:CashInterestDefaultPercentage
      contextRef="AsOf2021-02-19_custom_CPBFLendingLLCMember_custom_TermNoteMember"
      decimals="INF"
      id="Fact004473"
      unitRef="Pure">0.20</BNZI:CashInterestDefaultPercentage>
    <BNZI:InterestPayableInKindDefaultPercentage
      contextRef="AsOf2021-02-19_custom_CPBFLendingLLCMember_custom_TermNoteMember"
      decimals="INF"
      id="Fact004475"
      unitRef="Pure">0</BNZI:InterestPayableInKindDefaultPercentage>
    <BNZI:ExitFeePercentage
      contextRef="From2021-02-192021-02-19_custom_CPBFLendingLLCMember"
      decimals="INF"
      id="Fact004477"
      unitRef="Pure">0.010</BNZI:ExitFeePercentage>
    <us-gaap:DebtInstrumentCovenantDescription
      contextRef="From2023-01-012023-12-31_custom_CPBFLendingLLCMember"
      id="Fact004479">The
Loan Agreement contains customary covenants, including restrictions on the Company&#x2019;s ability to incur indebtedness, grant liens
or security interest on assets, make acquisitions, loans, advances or investments, or sell or otherwise transfer assets, among others.
The Loan Agreement also contains other financial covenants related to minimum gross profit margin, minimum ARR (Annual Recurring Revenue)
growth rate, and fixed charge ratio, among other financial covenants per the terms of the Loan Agreement.</us-gaap:DebtInstrumentCovenantDescription>
    <us-gaap:DebtInstrumentCovenantCompliance
      contextRef="From2023-01-012023-12-31_custom_CPBFLendingLLCMember"
      id="Fact004481">For
all respective periods presented, the Company was not in compliance with the Minimum Gross Profit Margin covenant in section 7.14.1 of
the Loan Agreement, the Minimum ARR Growth covenant in section 7.14.2 of the Loan Agreement, and the Fixed Charge Coverage Ratio covenant
in section 7.14.3 of the Loan Agreement. As a result of the Company&#x2019;s noncompliance with the financial covenants, the entire principal
amount and all unpaid and accrued interest will be classified as current on the Company&#x2019;s consolidated balance sheets.</us-gaap:DebtInstrumentCovenantCompliance>
    <BNZI:DebtIssuanceCostsCapitalized
      contextRef="From2021-02-192021-02-19_custom_CPBFLendingLLCMember_custom_TermNoteMember"
      decimals="0"
      id="Fact004483"
      unitRef="USD">310589</BNZI:DebtIssuanceCostsCapitalized>
    <BNZI:DebtIssuanceCostsCapitalized
      contextRef="From2021-02-192021-02-19_custom_CPBFLendingLLCMember_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact004485"
      unitRef="USD">71674</BNZI:DebtIssuanceCostsCapitalized>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="AsOf2021-02-19_custom_CPBFLendingLLCMember"
      decimals="0"
      id="Fact004487"
      unitRef="USD">3000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-10-10_custom_CPBFLendingLLCMember_custom_FirstAmendmentConvertibleNoteMember"
      decimals="0"
      id="Fact004489"
      unitRef="USD">321345</us-gaap:DebtInstrumentFaceAmount>
    <BNZI:DebtIssuanceCostsIncurredDuringThePeriodGross
      contextRef="From2022-01-012022-12-31_us-gaap_ConvertibleDebtMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004491"
      unitRef="USD">2000</BNZI:DebtIssuanceCostsIncurredDuringThePeriodGross>
    <us-gaap:InterestExpense
      contextRef="From2023-01-012023-12-31_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004493"
      unitRef="USD">1140106</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-01-012023-12-31_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004495"
      unitRef="USD">1058230</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2023-01-012023-12-31_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004497"
      unitRef="USD">81876</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2023-12-31_custom_CPBFLendingLLCMember_custom_TermNoteMember"
      decimals="INF"
      id="Fact004499"
      unitRef="Pure">0.16</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2022-12-31_custom_CPBFLendingLLCMember_custom_TermNoteMember"
      decimals="INF"
      id="Fact004501"
      unitRef="Pure">0.16</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestExpense
      contextRef="From2023-01-012023-12-31_us-gaap_ConvertibleDebtMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004503"
      unitRef="USD">422507</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-01-012023-12-31_us-gaap_ConvertibleDebtMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004505"
      unitRef="USD">395575</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2023-01-012023-12-31_us-gaap_ConvertibleDebtMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004507"
      unitRef="USD">26932</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2023-12-31_us-gaap_ConvertibleDebtMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="INF"
      id="Fact004509"
      unitRef="Pure">0.16</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2022-12-31_us-gaap_ConvertibleDebtMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="INF"
      id="Fact004511"
      unitRef="Pure">0.16</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestExpense
      contextRef="From2022-01-012022-12-31_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004513"
      unitRef="USD">1110296</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2022-01-012022-12-31_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004515"
      unitRef="USD">1042291</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2022-01-012022-12-31_us-gaap_MediumTermNotesMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004517"
      unitRef="USD">68006</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:InterestExpense
      contextRef="From2022-01-012022-12-31_us-gaap_ConvertibleDebtMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004519"
      unitRef="USD">319743</us-gaap:InterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="From2022-01-012022-12-31_us-gaap_ConvertibleDebtMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004521"
      unitRef="USD">303121</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="From2022-01-012022-12-31_us-gaap_ConvertibleDebtMember_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004523"
      unitRef="USD">16622</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <BNZI:AmendmentFee
      contextRef="From2023-12-142023-12-14_custom_FirstAmendmentConvertibleNoteMember"
      decimals="0"
      id="Fact004525"
      unitRef="USD">23748</BNZI:AmendmentFee>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004527">&lt;p id="xdx_897_eus-gaap--ScheduleOfDebtTableTextBlock_zsLaeqFTG5G6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the CP BF convertible notes as of December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zTSESSXAzAVk" style="display: none"&gt;Summary of Convertible Notes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20231231__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zeBcmMrC9RP5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_zJIwvJ7OBzEe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Face value of the CB BF convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;1,821,345&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--UnamortizedDebtDiscountOnConvertibleNotesPayable_iI_zukSd0ApjL5a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Debt discount, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(41,983&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ConvertibleNotesPayable_iI_zPg5M0IXIll9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Carrying value of the CB BF convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,779,362&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--InterestPayableOnConvertibleDebt_iI_zlIWGunbEzN6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;914,479&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ConvertibleDebtIncludingAccruedInterest_iI_z7NBofTirKO3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Total CB BF convertible notes and accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,693,841&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the CP BF convertible notes as of December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20221231__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zpka8r0iRLX3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--ConvertibleDebtFairValueDisclosures_iI_zq5g0iGSQflj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Face value of the CB BF convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;1,821,345&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--UnamortizedDebtDiscountOnConvertibleNotesPayable_iI_zzE6tLeb4Mz5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Debt discount, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(63,715&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--ConvertibleNotesPayable_iI_za9YaJwY6tih" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Carrying value of the CB BF convertible notes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,757,630&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--InterestPayableOnConvertibleDebt_iI_zWlgbMvl8Gl5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;518,904&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--ConvertibleDebtIncludingAccruedInterest_iI_z5nI3pWkTxG4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Total CB BF convertible notes and accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,276,534&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="AsOf2023-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004529"
      unitRef="USD">1821345</us-gaap:ConvertibleDebtFairValueDisclosures>
    <BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable
      contextRef="AsOf2023-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004531"
      unitRef="USD">-41983</BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2023-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004533"
      unitRef="USD">1779362</us-gaap:ConvertibleNotesPayable>
    <BNZI:InterestPayableOnConvertibleDebt
      contextRef="AsOf2023-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004535"
      unitRef="USD">914479</BNZI:InterestPayableOnConvertibleDebt>
    <BNZI:ConvertibleDebtIncludingAccruedInterest
      contextRef="AsOf2023-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004537"
      unitRef="USD">2693841</BNZI:ConvertibleDebtIncludingAccruedInterest>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="AsOf2022-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004539"
      unitRef="USD">1821345</us-gaap:ConvertibleDebtFairValueDisclosures>
    <BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable
      contextRef="AsOf2022-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004541"
      unitRef="USD">-63715</BNZI:UnamortizedDebtDiscountOnConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2022-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004543"
      unitRef="USD">1757630</us-gaap:ConvertibleNotesPayable>
    <BNZI:InterestPayableOnConvertibleDebt
      contextRef="AsOf2022-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004545"
      unitRef="USD">518904</BNZI:InterestPayableOnConvertibleDebt>
    <BNZI:ConvertibleDebtIncludingAccruedInterest
      contextRef="AsOf2022-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004547"
      unitRef="USD">2276534</BNZI:ConvertibleDebtIncludingAccruedInterest>
    <BNZI:TermNotesDebtTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004549">&lt;p id="xdx_89F_ecustom--TermNotesDebtTableTextBlock_zMR9Y6QKEFU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the CP BF term note as of December 31, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;span id="xdx_8B9_z7ttMYXd4Ku3" style="display: none"&gt;Summary of Term Notes&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20231231__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zh7m1TllqQ62" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OtherNotesPayableCurrent_iI_zvog5C9pH6yc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Face value of the CB BF term note&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;6,500,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--UnamortizedDebtDiscountOnOtherNotesPayable_iNI_di_zp7snBpq9Ie7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Debt discount, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(129,586&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NotesPayableFairValueDisclosure_iI_zwzUyTxIo8ib" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Carrying value of the CB BF term note&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,370,414&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccruedInterestOnNotesPayableCurrent_iI_z9dmDXaEDfY" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;289,373&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--NotesPayableIncludingAccruedInterest_iI_zvD1v3DN2Lz8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Total CB BF term note and accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,659,787&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the CP BF term note as of December 31, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20221231__us-gaap--DebtInstrumentAxis__custom--LoanAgreementWithCpbfLendingLlcMember_zu8Qtu4f1Hf5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--OtherNotesPayableCurrent_iI_zHTWr6m5a5ta" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"&gt;Face value of the CB BF term note&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;6,500,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--UnamortizedDebtDiscountOnOtherNotesPayable_iNI_di_zji1Q5d7tric" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Debt discount, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(192,911&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--NotesPayableFairValueDisclosure_iI_zahlZYOFUieb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Carrying value of the CB BF term note&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,307,089&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--AccruedInterestOnNotesPayableCurrent_iI_zZpb93u8QAJ5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;186,962&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--NotesPayableIncludingAccruedInterest_iI_zgD5SjQprCCh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Total CB BF term note and accrued interest&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,494,051&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</BNZI:TermNotesDebtTableTextBlock>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004551"
      unitRef="USD">6500000</us-gaap:OtherNotesPayableCurrent>
    <BNZI:UnamortizedDebtDiscountOnOtherNotesPayable
      contextRef="AsOf2023-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004553"
      unitRef="USD">129586</BNZI:UnamortizedDebtDiscountOnOtherNotesPayable>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="AsOf2023-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004555"
      unitRef="USD">6370414</us-gaap:NotesPayableFairValueDisclosure>
    <BNZI:AccruedInterestOnNotesPayableCurrent
      contextRef="AsOf2023-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004557"
      unitRef="USD">289373</BNZI:AccruedInterestOnNotesPayableCurrent>
    <BNZI:NotesPayableIncludingAccruedInterest
      contextRef="AsOf2023-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004559"
      unitRef="USD">6659787</BNZI:NotesPayableIncludingAccruedInterest>
    <us-gaap:OtherNotesPayableCurrent
      contextRef="AsOf2022-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004561"
      unitRef="USD">6500000</us-gaap:OtherNotesPayableCurrent>
    <BNZI:UnamortizedDebtDiscountOnOtherNotesPayable
      contextRef="AsOf2022-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004563"
      unitRef="USD">192911</BNZI:UnamortizedDebtDiscountOnOtherNotesPayable>
    <us-gaap:NotesPayableFairValueDisclosure
      contextRef="AsOf2022-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004565"
      unitRef="USD">6307089</us-gaap:NotesPayableFairValueDisclosure>
    <BNZI:AccruedInterestOnNotesPayableCurrent
      contextRef="AsOf2022-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004567"
      unitRef="USD">186962</BNZI:AccruedInterestOnNotesPayableCurrent>
    <BNZI:NotesPayableIncludingAccruedInterest
      contextRef="AsOf2022-12-31_custom_LoanAgreementWithCpbfLendingLlcMember"
      decimals="0"
      id="Fact004569"
      unitRef="USD">6494051</BNZI:NotesPayableIncludingAccruedInterest>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact004571">&lt;p id="xdx_800_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_z5hNAo4XLWX3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;15.
&lt;span id="xdx_829_zPfqhdBPOazc"&gt;Warrant Liabilities &lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Public
Warrants &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company assumed &lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_z7AKhusV5q05" title="Warrants outstanding"&gt;230,000&lt;/span&gt; Public Warrants in the Merger which remained outstanding as of December 31, 2023. &lt;span id="xdx_90C_ecustom--WarrantsExercisePriceDescription_c20230101__20231231_z9VcXYdgCFe4" title="Warrants exercise price, description"&gt;The Public Warrants have
an exercise price of $575.00 per share, subject to adjustments, and will expire &lt;span id="xdx_905_ecustom--WarrantExpirationPeriod_iI_dc_c20230331__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zaBgMkOp20e8" title="Warrant expiration period"&gt;five years&lt;/span&gt; from the Merger Closing Date. The exercise
price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including
in the event of a share dividend, or recapitalization, reorganization, merger or consolidation.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will not be obligated to deliver any shares of Class A Common Stock pursuant to the exercise of a Public Warrant and will have
no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the shares
of Class A Common Stock underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the
Company&#x2019;s satisfying its obligations described below with respect to registration, or a valid exemption from registration is available.
&lt;span id="xdx_907_ecustom--WarrantsExercisable_iI_do_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zu1JJ2NZ1V1b" title="Warrants exercisable"&gt;No&lt;/span&gt; Public Warrant will be exercisable and the Company will not be obligated to issue a share of Class A Common Stock upon exercise of
a Public Warrant unless the shares of Class A Common Stock issuable upon such Public Warrant exercise has been registered, qualified,
or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Public Warrants. In the event
that the conditions in the two immediately preceding sentences are not satisfied with respect to a Public Warrant, the holder of such
Public Warrant will not be entitled to exercise such Public Warrant and such Public Warrant may have no value and expire worthless. In
no event will the Company be required to net cash settle any Public Warrant. The Resale Registration statement went effective on February
14, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the Merger, it will
its best efforts to file with the SEC a registration statement covering the shares of Class A common stock issuable upon exercise of
the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares
of Class A common stock until the warrants expire. If a registration statement covering the shares of Class A common stock issuable upon
exercise of the warrants is not effective by the 60th business day after the closing of the Merger, the warrant holders may, until such
time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective
registration statement, exercise warrants on a &#x201c;cashless basis&#x201d; in accordance with Section 3(a)(9) of the Securities Act
and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but
it will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
In such event, each holder would pay the exercise price by surrendering the Public Warrants for that number of shares of Class A Common
Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Class A Common Stock underlying the Public
Warrants, multiplied by the excess of the &#x201c;fair market value&#x201d; (as defined below) less the exercise price of the Public Warrants
by (y) the fair market value. The &#x201c;fair market value&#x201d; as used in this paragraph shall mean the average last sale price of Class A Common Stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption
is sent to the warrant holders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Redemption
of Public Warrants When the price per Share of Class A Common Stock Equals or Exceeds $&lt;span id="xdx_908_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zvU8o13aL4Y"&gt;900.00&lt;/span&gt;. &lt;span id="xdx_903_ecustom--WarrantsExercisableDescription_c20230101__20231231_ztBmDbvGUWsi" title="Warrants exercisable description"&gt;Once the Public Warrants become exercisable,
the Company may redeem the outstanding Public Warrants:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in
                                            whole and not in part;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at
                                            a price of $&lt;span id="xdx_90C_eus-gaap--SharePrice_iI_pid_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zSJCOlqVgoe7" title="Share price warrants"&gt;0.01&lt;/span&gt; per Warrant;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;upon
                                            a minimum of 30 days&#x2019; prior written notice of redemption (the &#x201c;30-day redemption
                                            period&#x201d;); and&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if,
and only if, the closing price per share of Class A Common Stock equals or exceeds $&lt;span id="xdx_90A_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zF4NF34wbx82"&gt;900.00&lt;/span&gt; per share (as adjusted for adjustments to the
number of shares issuable upon exercise or the exercise price of a Public Warrant as described under the heading &#x201c;- Warrants-Public
Stockholder Warrants-Anti-dilution Adjustments&#x201d;) for any 20 trading days within a 30-trading day period ending three trading days
before the Company sends the notice of redemption to the warrant holders.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will not redeem the Public Warrants as described above unless a registration statement under the Securities Act covering the
issuance of shares of Class A Common Stock issuable upon exercise of the Public Warrants is then effective and a current prospectus relating
to those shares of Class A Common Stock is available throughout the 30-day redemption period. If and when the Public Warrants become
redeemable by the Company, the Company may not exercise its redemption right if the Company is unable to register or qualify the underlying
securities for sale under all applicable state securities laws.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time
of the call a significant premium to the Public Warrant exercise price. If the foregoing conditions are satisfied and the Company issues
a notice of redemption of the Public Warrants, each warrant holder will be entitled to exercise his, her or its Public Warrant prior
to the scheduled redemption date. However, the price per share of Class A Common Stock may fall below the $&lt;span id="xdx_906_ecustom--ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger_pid_c20230101__20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zbtTpVzmnYkd" title="Redemption trigger price"&gt;900.00&lt;/span&gt; redemption trigger price
(as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a Public Warrant as described under
the heading &#x201c;-Warrants-Public Stockholder Warrants-Anti-dilution Adjustments&#x201d;) as well as the $&lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember_zK7LHt4fYGL" title="Warrants price per share"&gt;575.00&lt;/span&gt; (for whole shares) Public
Warrant exercise price after the redemption notice is issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--FractionalSharesIssuedUponExerciseOfCommonStock_iI_do_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PublicWarrantsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zqRMsQNHPVOl" title="Warrants price per share"&gt;No&lt;/span&gt;
fractional shares of Class A Common Stock will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional
interest in a share, the Company will round down to the nearest whole number of the number of shares of Class A Common Stock to be issued
to the holder.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;GEM
Financing Arrangement &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
May 2022, the Company entered into a Share Purchase Agreement with GEM Global Yield LLC SCS and GEM Yield Bahamas Limited (collectively,
&#x201c;GEM&#x201d;) (the &#x201c;GEM Agreement&#x201d;) pursuant to which, among other things, upon the terms and subject to the conditions
of the GEM Agreement, GEM is to purchase from the Company (or its successor following a Reverse Merger Transaction (as defined in the
GEM Agreement)) up to the number of duly authorized, validly issued, fully paid and non-assessable shares of common stock having an aggregate
value of $&lt;span id="xdx_900_eus-gaap--CommonStockValue_iI_c20220531__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember_z3odqziyxQM" title="Common stock value"&gt;100,000,000&lt;/span&gt; (the &#x201c;GEM Financing&#x201d;). Further, in terms of the GEM Agreement, on the Public Listing Date, the Company
was required to make and execute a warrant (&#x201c;GEM Warrant&#x201d;) granting GEM the right to purchase up to the number of common
shares of the Company that would be equal to &lt;span id="xdx_90C_ecustom--PercentageOfRightToConvertWarrantToCommonShares_iI_dp_uPure_c20220531__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--GemWarrantMember_zib4T4wd9L" title="Percentage of right to convert warrant to common shares"&gt;3&lt;/span&gt;% of the total equity interests, calculated on a fully diluted basis, and at an exercise
price per share equal to the lesser of (i) the public offering price or closing bid price on the date of public listing or (ii) the quotient
obtained by dividing $&lt;span id="xdx_901_eus-gaap--WarrantsAndRightsOutstanding_iI_pn6n6_c20220531__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--GemWarrantMember_ze7rexOagAHd" title="Warrants and rights outstanding"&gt;650&lt;/span&gt; million by the total number of equity interests.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 13, 2023, the Company and GEM entered into a binding term sheet (the &#x201c;GEM Term Sheet&#x201d;) and, on December 14, 2023,
a letter agreement (the &#x201c;GEM Letter&#x201d;), agreeing to terminate in its entirety the GEM Agreement by and between the Company
and GEM, other than with respect to the Company&#x2019;s obligation (as the post-combination company in the Merger) to issue the GEM Warrant
granting the right to purchase Class A Common Stock in an amount equal to &lt;span id="xdx_906_ecustom--PercentageOfRightToConvertWarrantToCommonShares_iI_dp_uPure_c20231213__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--GemWarrantMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--TypeOfArrangementAxis__custom--GemTermSheetMember_z14pRAhJn1Z1" title="Percentage of right to convert warrant to common shares"&gt;3&lt;/span&gt;% of the total number of equity interests outstanding as of
the Closing, calculated on a fully diluted basis, at an exercise price on the terms and conditions set forth therein, in exchange for
issuance of a $&lt;span id="xdx_905_eus-gaap--ConvertibleDebt_iI_pn5n6_c20231213__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--TypeOfArrangementAxis__custom--GemTermSheetMember_zMOscwMkeE02" title="Convertible debenture"&gt;2.0 &lt;/span&gt;million convertible debenture with a&lt;span id="xdx_900_eus-gaap--DebtInstrumentTerm_dxL_c20231213__20231213__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--TypeOfArrangementAxis__custom--GemTermSheetMember_zvWWmFdsTFnk" title="Debt Instrument, Term::XDX::P5Y"&gt; &lt;span style="-sec-ix-hidden: xdx2ixbrl4603"&gt;five&lt;/span&gt;&lt;/span&gt;-year maturity and &lt;span id="xdx_907_ecustom--CouponRate_iI_dp_uPure_c20231213__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--TypeOfArrangementAxis__custom--GemTermSheetMember_zDYI5dgKbayg" title="Coupon rate"&gt;0&lt;/span&gt;% coupon. Due to the determination of the final terms
of the planned $&lt;span id="xdx_90C_eus-gaap--ConvertibleDebt_iI_pn5n6_c20231231__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--TypeOfArrangementAxis__custom--GemTermSheetMember_zUjmopUUN655" title="Convertible debt"&gt;2.0&lt;/span&gt; million convertible debenture having not been finalized, nor the final agreement related to the convertible debenture
having been executed, as of December 31, 2023, the Company recognized, concurrent with the close of the merger, a liability for the GEM
commitment fee, along with a corresponding GEM commitment fee expense, in the amount of $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentFeeAmount_iI_pn5n6_c20231231__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--TypeOfArrangementAxis__custom--GemTermSheetMember_zes13r4JtZk4" title="Debt Instrument, Fee Amount"&gt;2.0&lt;/span&gt; million. See &lt;i&gt;Note 21-Subsequent Events
&lt;/i&gt;for details related to the subsequent execution of the GEM Settlement Agreement and issuance of the final GEM convertible promissory
note, in 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
Closing, the GEM Warrant automatically became an obligation of the Company, and on December 15, 2023, the Company issued the GEM Warrant
granting GEM the right to purchase &lt;span id="xdx_900_ecustom--WarrantsPurchased_iI_c20231215__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--GemWarrantMember__us-gaap--TypeOfArrangementAxis__custom--GEMFinancingArrangementMember_zqsAwYkXrtq3" title="Warrants purchased"&gt;828,533&lt;/span&gt; shares at an exercise price of $&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20231215__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--GemWarrantMember__us-gaap--TypeOfArrangementAxis__custom--GEMFinancingArrangementMember_zPsI2CnfZDY" title="Warrants price per share"&gt;6.49&lt;/span&gt; per share. &lt;span id="xdx_90B_ecustom--WarrantsExercisePriceDescription_c20231215__20231215__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--GemWarrantMember__us-gaap--TypeOfArrangementAxis__custom--GEMFinancingArrangementMember_zRmkTc43BMa5" title="Warrants exercise price description."&gt;The exercise price will be adjusted to 105%
of the then-current exercise price if on the one-year anniversary date of the Effective Time, the GEM Warrant has not been exercised
in full and the average closing price per share of Class A Common Stock for the 10 days preceding the anniversary date is less than 90%
of the initial exercise price. GEM may exercise the GEM Warrant at any time and from time to time until December 14, 2026. The terms
of the GEM Warrant provide that the exercise price of the GEM Warrant, and the number of shares of Class A Common Stock for which the
GEM Warrant may be exercised, are subject to adjustment to account for increases or decreases in the number of outstanding shares of
New Banzai Common Stock resulting from stock splits, reverse stock splits, consolidations, combinations and reclassifications. Additionally,
the GEM Warrant contains weighted average anti-dilution provisions that provide that if the Company issues shares of common stock, or
securities convertible into or exercisable or exchange for, shares of common stock at a price per share that is less than 90% of the
exercise price then in effect or without consideration, then the exercise price of the GEM Warrant upon each such issuance will be adjusted
to the price equal to 105% of the consideration per share paid for such common stock or other securities. In the event of a Change of
Control, if the Surviving Corporation does not have registered class of equity securities and common shares listed on a U.S. national
securities exchange, then the Holder is entitled to receive one percent of the total consideration received by the Company&#x2019;s stockholders
and the GEM Warrants will expire upon payment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Warrants were not considered indexed to the issuer&#x2019;s stock pursuant to ASC 815, as the holder&#x2019;s ability to receive one percent
of the total consideration received by the Company&#x2019;s stockholders in connection with a Change of Control in lieu of the Warrant,
where the surviving corporation is not publicly traded, adjusts the settlement value based on items outside the Company&#x2019;s control
in violation of the fixed-for-fixed option pricing model. As such, the Company recorded the Warrants as liabilities initially measured
at fair value with subsequent changes in fair value recognized in earnings each reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
measurement of fair value was determined utilizing a Monte Carlo simulation considering all relevant assumptions current at the date
of issuance (i.e., share price, exercise price, term, volatility, risk-free rate, probability of dilutive term of three years, and expected
time 1to conversion). The fair value of the Warrants on the grant date, as determined by the Monte Carlo simulation option pricing model,
was $&lt;span id="xdx_900_ecustom--FairValueOfWarrants_iI_c20231215_z3hsJKwj0xzj" title="Fair value of warrants"&gt;2,448,000&lt;/span&gt; on December 15, 2023. The Company determined the Warrants were share issuance costs associated with an aborted offering.
ASC 340 notes aborted offering costs may not be deferred and charged against proceeds of a subsequent offering. As such, the Company
will record an expense for the corresponding fair value. As of December 31, 2023, the fair value of the Warrants, as determined by the
Monte Carlo simulation option pricing model, was $&lt;span id="xdx_90E_ecustom--FairValueOfWarrants_iI_c20231231_znajccWw8TF2" title="Fair value of warrants"&gt;641,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the per share market value of one share of Class A Common Stock is greater than the then-current exercise price, then GEM will have the
option to exercise the GEM Warrant on a cashless basis and receive a number of shares of Class A Common Stock equal to (x) the number
of shares of Class A Common Stock purchasable upon exercise of all of the GEM Warrant or, if only a portion of the GEM Warrant is being
exercised, the portion of the GEM Warrant being exercised, less (y) the product of the then-current exercise price and the number of
shares of Class A Common Stock purchasable upon exercise of all of the GEM Warrant or, if only a portion of the GEM Warrant is being
exercised, the portion of the GEM Warrant being exercised, divided by the per share market value of one share of Class A Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
GEM Warrant is subject to a restriction on exercise of the GEM Warrant such that the GEM Warrant may not be exercised if such exercise
would result in the beneficial ownership of the holder and its affiliates in excess of &lt;span id="xdx_90C_ecustom--ClassOfWarrantsOrRightsThresholdLimitForTheThenIssuedAndOutstandingSharesOfCommonStock_iI_dp_uPure_c20231215__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--GemWarrantMember_z8m1i5daKii" title="Class of warrants or rights threshold limit for the then issued and outstanding shares of Common Stock"&gt;9.99&lt;/span&gt;% of the then-issued and outstanding shares
of Common Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2023-12-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact004573"
      unitRef="Shares">230000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <BNZI:WarrantsExercisePriceDescription contextRef="From2023-01-012023-12-31" id="Fact004575">The Public Warrants have
an exercise price of $575.00 per share, subject to adjustments, and will expire five years from the Merger Closing Date. The exercise
price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including
in the event of a share dividend, or recapitalization, reorganization, merger or consolidation.</BNZI:WarrantsExercisePriceDescription>
    <BNZI:WarrantExpirationPeriod
      contextRef="AsOf2023-03-31_custom_PublicWarrantsMember"
      id="Fact004577">P5Y</BNZI:WarrantExpirationPeriod>
    <BNZI:WarrantsExercisable
      contextRef="AsOf2023-12-31_custom_PublicWarrantsMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact004579"
      unitRef="Shares">0</BNZI:WarrantsExercisable>
    <BNZI:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="From2023-01-012023-12-31_custom_PublicWarrantsMember5441437"
      decimals="INF"
      id="Fact004580"
      unitRef="USDPShares">900.00</BNZI:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <BNZI:WarrantsExercisableDescription contextRef="From2023-01-012023-12-31" id="Fact004582">Once the Public Warrants become exercisable,
the Company may redeem the outstanding Public Warrants:</BNZI:WarrantsExercisableDescription>
    <us-gaap:SharePrice
      contextRef="AsOf2023-12-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact004584"
      unitRef="USDPShares">0.01</us-gaap:SharePrice>
    <BNZI:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="From2023-01-012023-12-31_custom_PublicWarrantsMember5441437"
      decimals="INF"
      id="Fact004585"
      unitRef="USDPShares">900.00</BNZI:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <BNZI:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger
      contextRef="From2023-01-012023-12-31_custom_PublicWarrantsMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact004587"
      unitRef="USDPShares">900.00</BNZI:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-12-31_custom_PublicWarrantsMember"
      decimals="INF"
      id="Fact004589"
      unitRef="USDPShares">575.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <BNZI:FractionalSharesIssuedUponExerciseOfCommonStock
      contextRef="AsOf2023-12-31_custom_PublicWarrantsMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact004591"
      unitRef="Shares">0</BNZI:FractionalSharesIssuedUponExerciseOfCommonStock>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-05-31_custom_GemAgreementMember"
      decimals="0"
      id="Fact004593"
      unitRef="USD">100000000</us-gaap:CommonStockValue>
    <BNZI:PercentageOfRightToConvertWarrantToCommonShares
      contextRef="AsOf2022-05-31_custom_GemAgreementMember_custom_GemWarrantMember"
      decimals="INF"
      id="Fact004595"
      unitRef="Pure">0.03</BNZI:PercentageOfRightToConvertWarrantToCommonShares>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2022-05-31_custom_GemAgreementMember_custom_GemWarrantMember"
      decimals="-6"
      id="Fact004597"
      unitRef="USD">650000000</us-gaap:WarrantsAndRightsOutstanding>
    <BNZI:PercentageOfRightToConvertWarrantToCommonShares
      contextRef="AsOf2023-12-13_custom_GemAgreementMember_custom_GemWarrantMember_us-gaap_CommonClassAMember_custom_GemTermSheetMember"
      decimals="INF"
      id="Fact004599"
      unitRef="Pure">0.03</BNZI:PercentageOfRightToConvertWarrantToCommonShares>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2023-12-13_custom_GemAgreementMember_custom_GemTermSheetMember"
      decimals="-5"
      id="Fact004601"
      unitRef="USD">2000000.0</us-gaap:ConvertibleDebt>
    <BNZI:CouponRate
      contextRef="AsOf2023-12-13_custom_GemAgreementMember_custom_GemTermSheetMember"
      decimals="INF"
      id="Fact004605"
      unitRef="Pure">0</BNZI:CouponRate>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2023-12-31_custom_GemAgreementMember_custom_GemTermSheetMember"
      decimals="-5"
      id="Fact004607"
      unitRef="USD">2000000.0</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="AsOf2023-12-31_custom_GemAgreementMember_custom_GemTermSheetMember"
      decimals="-5"
      id="Fact004609"
      unitRef="USD">2000000.0</us-gaap:DebtInstrumentFeeAmount>
    <BNZI:WarrantsPurchased
      contextRef="AsOf2023-12-15_custom_GemAgreementMember_custom_GemWarrantMember_custom_GEMFinancingArrangementMember"
      decimals="INF"
      id="Fact004611"
      unitRef="Shares">828533</BNZI:WarrantsPurchased>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2023-12-15_custom_GemAgreementMember_custom_GemWarrantMember_custom_GEMFinancingArrangementMember"
      decimals="INF"
      id="Fact004613"
      unitRef="USDPShares">6.49</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <BNZI:WarrantsExercisePriceDescription
      contextRef="From2023-12-152023-12-15_custom_GemAgreementMember_custom_GemWarrantMember_custom_GEMFinancingArrangementMember"
      id="Fact004615">The exercise price will be adjusted to 105%
of the then-current exercise price if on the one-year anniversary date of the Effective Time, the GEM Warrant has not been exercised
in full and the average closing price per share of Class A Common Stock for the 10 days preceding the anniversary date is less than 90%
of the initial exercise price. GEM may exercise the GEM Warrant at any time and from time to time until December 14, 2026. The terms
of the GEM Warrant provide that the exercise price of the GEM Warrant, and the number of shares of Class A Common Stock for which the
GEM Warrant may be exercised, are subject to adjustment to account for increases or decreases in the number of outstanding shares of
New Banzai Common Stock resulting from stock splits, reverse stock splits, consolidations, combinations and reclassifications. Additionally,
the GEM Warrant contains weighted average anti-dilution provisions that provide that if the Company issues shares of common stock, or
securities convertible into or exercisable or exchange for, shares of common stock at a price per share that is less than 90% of the
exercise price then in effect or without consideration, then the exercise price of the GEM Warrant upon each such issuance will be adjusted
to the price equal to 105% of the consideration per share paid for such common stock or other securities. In the event of a Change of
Control, if the Surviving Corporation does not have registered class of equity securities and common shares listed on a U.S. national
securities exchange, then the Holder is entitled to receive one percent of the total consideration received by the Company&#x2019;s stockholders
and the GEM Warrants will expire upon payment.</BNZI:WarrantsExercisePriceDescription>
    <BNZI:FairValueOfWarrants
      contextRef="AsOf2023-12-15"
      decimals="0"
      id="Fact004617"
      unitRef="USD">2448000</BNZI:FairValueOfWarrants>
    <BNZI:FairValueOfWarrants
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004619"
      unitRef="USD">641000</BNZI:FairValueOfWarrants>
    <BNZI:ClassOfWarrantsOrRightsThresholdLimitForTheThenIssuedAndOutstandingSharesOfCommonStock
      contextRef="AsOf2023-12-15_custom_GemAgreementMember_custom_GemWarrantMember"
      decimals="INF"
      id="Fact004621"
      unitRef="Pure">0.0999</BNZI:ClassOfWarrantsOrRightsThresholdLimitForTheThenIssuedAndOutstandingSharesOfCommonStock>
    <BNZI:SimpleAgreementsForFutureEquityTextBlock contextRef="From2023-01-012023-12-31" id="Fact004623">&lt;p id="xdx_806_ecustom--SimpleAgreementsForFutureEquityTextBlock_zqpA1aVOFTva" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;16.
&lt;span id="xdx_827_zpLHedJayuY"&gt;Simple Agreements for Future Equity&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Simple
Agreements for Future Equity-Related Party &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2021, the Company entered into Simple Agreements for Future Equity (SAFE) arrangements with related parties Alco, DNX and William Bryant
(See &lt;i&gt;Note 14-Debt&lt;/i&gt;, for a description of the related party relationship with these entities) (the &#x201c;Related Party SAFEs&#x201d;)
pursuant to which the Company received gross proceeds in the amount of $&lt;span id="xdx_90E_ecustom--ProceedsFromSimpleAgreementForFutureEquity_c20210101__20211231_zI0Tmbuow6r8" title="Proceeds From Simple Agreement For Future Equity"&gt;3,567,000&lt;/span&gt;. In the event of an Equity Financing (as defined in
the SAFEs agreements), the Related Party SAFEs will automatically convert into shares of the Company&#x2019;s common or preferred stock
at a discount of &lt;span id="xdx_90B_ecustom--CommonAndPreferredStockDiscountPercentage_dp_uPure_c20210101__20211231_zAqC68OumDV2" title="Common or preferred stock discount"&gt;15&lt;/span&gt;% of the per share price of the shares offered in the Equity Financing (the &#x201c;Discount Price&#x201d;). In the
event of a Liquidity Event, SPAC Transaction or Dissolution Event (all terms as defined in the SAFEs agreements), the holders of the
Related Party SAFEs will be entitled to receive cash or shares of the Company&#x2019;s common or preferred stock. The Related Party SAFEs
were recorded as a liability in accordance with the applicable accounting guidance as they are redeemable for cash upon contingent events
that are outside of the Company&#x2019;s control. The initial fair value of the Related Party SAFE liability was $&lt;span id="xdx_90F_ecustom--FairValueOfSafeLiability_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlcoDNXAndWilliamBryantMember_ziAypdmOIcll" title="Fair value of SAFE liability"&gt;3,567,000&lt;/span&gt;. Subsequent
changes in fair value at each reporting period are recognized in the consolidated statement of operations. For the years ended December
31, 2023 and 2022, the Company recognized a gain of $&lt;span id="xdx_90E_ecustom--GainLossOnChangeInFairValueOfSafeLiability_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlcoDNXAndWilliamBryantMember_zfPz6Ivn2yRb" title="Gain Loss On Change in Fair Value of SAFE liability"&gt;2,752,430&lt;/span&gt; and loss of $&lt;span id="xdx_909_ecustom--GainLossOnChangeInFairValueOfSafeLiability_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlcoDNXAndWilliamBryantMember_zH23dAejHaFi" title="Gain Loss On Change in Fair Value of SAFE liability"&gt;4,078,431&lt;/span&gt;, respectively, for the change in fair value of
the Related Party SAFE liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes a combination of scenario-based methods and Monte Carlo simulation to determine the fair value of the Related Party
SAFE liability as of the valuation dates. Key inputs into these models included the timing and probability of the identified scenarios,
and for Black-Scholes option pricing models used for notes that included a valuation cap, equity values, risk-free rate and volatility.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 2, 2022, the Company modified the SAFE agreements pursuant to approval by the holders. In accordance with the modified terms,
in the event of an Equity Financing or SPAC Transaction, the Related Party SAFEs will automatically convert into shares of the Company&#x2019;s
common or preferred stock at the lesser of (a) the Discount Price for an Equity Financing (Liquidity Price (as defined in the agreements)
for a SPAC Transaction) or (b) the conversion price obtained by dividing $&lt;span id="xdx_90E_ecustom--NumeratorUsedForObtainingConversionPrice_c20220902__20220902__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlcoDNXAndWilliamBryantMember_zQv3DHeZWXA2" title="Numerator used for obtaining conversion price"&gt;50,000,000&lt;/span&gt; by the Fully Diluted Capitalization (as defined
in the agreements). Upon modification, the Company calculated the fair value of the Related Party SAFE liability immediately before and
immediately after the modification which resulted in the recognition of a loss for the change in fair value of $&lt;span id="xdx_90E_ecustom--GainLossOnChangeInFairValueOfSafeLiability_c20220902__20220902__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlcoDNXAndWilliamBryantMember_zDqHUQLwxsPh" title="Gain Loss On Change in Fair Value of SAFE liability"&gt;1,602,174&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2023, all outstanding principal related to the Related Party SAFEs at a carrying value of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_c20231214__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlcoDNXAndWilliamBryantMember_zBfwpIZtuq68" title="Outstanding principal amount"&gt;6,049,766&lt;/span&gt; converted into &lt;span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20231214__20231214__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AlcoDNXAndWilliamBryantMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zCZyKj8t1Cx4" title="Debt Conversion, Converted Instrument, Shares Issued"&gt;11,039&lt;/span&gt;
shares the Company&#x2019;s Class A Common Stock pursuant to the close of the Merger Agreement and application of the exchange ratio.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Simple
Agreements for Future Equity-Third Party &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2021, the Company entered into Simple Agreements for Future Equity (SAFE) arrangements with third party investors (the &#x201c;Third Party
SAFEs&#x201d;) pursuant to which the Company received gross proceeds in the amount of $&lt;span id="xdx_902_ecustom--ProceedsFromSimpleAgreementForFutureEquity_c20210101__20211231__srt--CounterpartyNameAxis__custom--ThirdPartySafesMember_znyo38bPBIxb" title="Proceeds From Simple Agreement For Future Equity"&gt;269,000&lt;/span&gt;. In the event of an Equity Financing (as
defined in the SAFEs agreements), the Third Party SAFEs will automatically convert into shares of the Company&#x2019;s common or preferred
stock at a discount of &lt;span id="xdx_907_ecustom--CommonAndPreferredStockDiscountPercentage_dp_uPure_c20210101__20211231__srt--CounterpartyNameAxis__custom--ThirdPartySafesMember_zIX2DuEzTuC4" title="Common or preferred stock discount"&gt;15&lt;/span&gt;% of the per share price of the shares offered in the Equity Financing (the &#x201c;Discount Price&#x201d;). In
the event of a Liquidity Event, SPAC Transaction or Dissolution Event (all terms as defined in the SAFEs agreements), the holders of
the Third Party SAFEs will be entitled to receive cash or shares of the Company&#x2019;s common or preferred stock. The Third Party SAFEs
were recorded as a liability in accordance with the applicable accounting guidance as they are redeemable for cash upon contingent events
that are outside of the Company&#x2019;s control. The initial fair value of the Third Party SAFE liability was $&lt;span id="xdx_909_ecustom--FairValueOfSafeLiability_iI_c20211231__srt--CounterpartyNameAxis__custom--ThirdPartySafesMember_z5Y1I47hxFG" title="Fair value of SAFE liability"&gt;269,000&lt;/span&gt;. Subsequent changes
in fair value at each reporting period are recognized in the Consolidated Statement of Operations. For the years ended December 31, 2023
and 2022, the Company recognized a gain of $&lt;span id="xdx_908_ecustom--GainLossOnChangeInFairValueOfSafeLiability_c20230101__20231231__srt--CounterpartyNameAxis__custom--ThirdPartySafesMember_zxilzox1Znmf" title="Gain Loss On Change in Fair Value of SAFE liability"&gt;207,570&lt;/span&gt; and a loss of $&lt;span id="xdx_90C_ecustom--GainLossOnChangeInFairValueOfSafeLiability_c20220101__20221231__srt--CounterpartyNameAxis__custom--ThirdPartySafesMember_zFZ7lLVfZfik" title="Gain Loss On Change in Fair Value of SAFE liability"&gt;307,569&lt;/span&gt;, respectively, for the change in fair value of the Third Party
SAFE liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company utilizes a combination of scenario-based methods and Monte Carlo simulation to determine the fair value of the Third Party SAFE
liability as of the valuation dates. Key inputs into these models included the timing and probability of the identified scenarios, and
for Black-Scholes option pricing models used for notes that included a valuation cap, equity values, risk-free rate and volatility.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 2, 2022, the Company modified the Third Party SAFE agreements pursuant to approval by the holders. In accordance with the modified
terms, in the event of an Equity Financing or SPAC Transaction, the Third Party SAFEs will automatically convert into shares of the Company&#x2019;s
common or preferred stock at the lesser of (a) the Discount Price for an Equity Financing (Liquidity Price (as defined in the agreements)
for a SPAC Transaction) or (b) the conversion price obtained by dividing $&lt;span id="xdx_903_ecustom--NumeratorUsedForObtainingConversionPrice_c20220902__20220902__srt--CounterpartyNameAxis__custom--ThirdPartySafesMember_zPqdU1Mpvzrj" title="Numerator used for obtaining conversion price"&gt;50,000,000&lt;/span&gt; by the Fully Diluted Capitalization (as defined
in the agreements). Upon modification, the Company calculated the fair value of the Third Party SAFE liability immediately before and
immediately after the modification which resulted in the recognition of a loss for the change in fair value of $&lt;span id="xdx_908_ecustom--GainLossOnChangeInFairValueOfSafeLiability_c20220902__20220902__srt--CounterpartyNameAxis__custom--ThirdPartySafesMember_z1As3NGF0pS2" title="Gain Loss On Change in Fair Value of SAFE liability"&gt;120,826&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2023, all outstanding principal related to the Third Party SAFEs at a carrying value of $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentCarryingAmount_iI_c20231214__srt--CounterpartyNameAxis__custom--ThirdPartySafesMember_zvk3lMlf79o1" title="Debt instrument carrying amount"&gt;456,234&lt;/span&gt; converted into &lt;span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20231214__20231214__srt--CounterpartyNameAxis__custom--ThirdPartySafesMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_znpYKuoOqDT9" title="Debt Conversion, Converted Instrument, Shares Issued"&gt;833&lt;/span&gt; shares
the Company&#x2019;s Class A Common Stock pursuant to the close of the Merger Agreement and application of the exchange ratio.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BNZI:SimpleAgreementsForFutureEquityTextBlock>
    <BNZI:ProceedsFromSimpleAgreementForFutureEquity
      contextRef="From2021-01-012021-12-31"
      decimals="0"
      id="Fact004625"
      unitRef="USD">3567000</BNZI:ProceedsFromSimpleAgreementForFutureEquity>
    <BNZI:CommonAndPreferredStockDiscountPercentage
      contextRef="From2021-01-012021-12-31"
      decimals="INF"
      id="Fact004627"
      unitRef="Pure">0.15</BNZI:CommonAndPreferredStockDiscountPercentage>
    <BNZI:FairValueOfSafeLiability
      contextRef="AsOf2021-12-31_custom_AlcoDNXAndWilliamBryantMember"
      decimals="0"
      id="Fact004629"
      unitRef="USD">3567000</BNZI:FairValueOfSafeLiability>
    <BNZI:GainLossOnChangeInFairValueOfSafeLiability
      contextRef="From2023-01-012023-12-31_custom_AlcoDNXAndWilliamBryantMember"
      decimals="0"
      id="Fact004631"
      unitRef="USD">2752430</BNZI:GainLossOnChangeInFairValueOfSafeLiability>
    <BNZI:GainLossOnChangeInFairValueOfSafeLiability
      contextRef="From2022-01-012022-12-31_custom_AlcoDNXAndWilliamBryantMember"
      decimals="0"
      id="Fact004633"
      unitRef="USD">4078431</BNZI:GainLossOnChangeInFairValueOfSafeLiability>
    <BNZI:NumeratorUsedForObtainingConversionPrice
      contextRef="From2022-09-022022-09-02_custom_AlcoDNXAndWilliamBryantMember"
      decimals="INF"
      id="Fact004635"
      unitRef="USDPShares">50000000</BNZI:NumeratorUsedForObtainingConversionPrice>
    <BNZI:GainLossOnChangeInFairValueOfSafeLiability
      contextRef="From2022-09-022022-09-02_custom_AlcoDNXAndWilliamBryantMember"
      decimals="0"
      id="Fact004637"
      unitRef="USD">1602174</BNZI:GainLossOnChangeInFairValueOfSafeLiability>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-12-14_custom_AlcoDNXAndWilliamBryantMember"
      decimals="0"
      id="Fact004639"
      unitRef="USD">6049766</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2023-12-142023-12-14_custom_AlcoDNXAndWilliamBryantMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact004641"
      unitRef="Shares">11039</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <BNZI:ProceedsFromSimpleAgreementForFutureEquity
      contextRef="From2021-01-012021-12-31_custom_ThirdPartySafesMember"
      decimals="0"
      id="Fact004643"
      unitRef="USD">269000</BNZI:ProceedsFromSimpleAgreementForFutureEquity>
    <BNZI:CommonAndPreferredStockDiscountPercentage
      contextRef="From2021-01-012021-12-31_custom_ThirdPartySafesMember"
      decimals="INF"
      id="Fact004645"
      unitRef="Pure">0.15</BNZI:CommonAndPreferredStockDiscountPercentage>
    <BNZI:FairValueOfSafeLiability
      contextRef="AsOf2021-12-31_custom_ThirdPartySafesMember"
      decimals="0"
      id="Fact004647"
      unitRef="USD">269000</BNZI:FairValueOfSafeLiability>
    <BNZI:GainLossOnChangeInFairValueOfSafeLiability
      contextRef="From2023-01-012023-12-31_custom_ThirdPartySafesMember"
      decimals="0"
      id="Fact004649"
      unitRef="USD">207570</BNZI:GainLossOnChangeInFairValueOfSafeLiability>
    <BNZI:GainLossOnChangeInFairValueOfSafeLiability
      contextRef="From2022-01-012022-12-31_custom_ThirdPartySafesMember"
      decimals="0"
      id="Fact004651"
      unitRef="USD">307569</BNZI:GainLossOnChangeInFairValueOfSafeLiability>
    <BNZI:NumeratorUsedForObtainingConversionPrice
      contextRef="From2022-09-022022-09-02_custom_ThirdPartySafesMember"
      decimals="INF"
      id="Fact004653"
      unitRef="USDPShares">50000000</BNZI:NumeratorUsedForObtainingConversionPrice>
    <BNZI:GainLossOnChangeInFairValueOfSafeLiability
      contextRef="From2022-09-022022-09-02_custom_ThirdPartySafesMember"
      decimals="0"
      id="Fact004655"
      unitRef="USD">120826</BNZI:GainLossOnChangeInFairValueOfSafeLiability>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2023-12-14_custom_ThirdPartySafesMember"
      decimals="0"
      id="Fact004657"
      unitRef="USD">456234</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2023-12-142023-12-14_custom_ThirdPartySafesMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact004659"
      unitRef="Shares">833</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact004661">&lt;p id="xdx_800_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zFUKhbSjicn6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;17.
&lt;span id="xdx_820_zPKy1Ld7KdS9"&gt;Commitments and Contingencies&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Leases
&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has operating leases for its real estate across multiple states. The operating leases have remaining lease terms of approximately
&lt;span id="xdx_909_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtY_c20231231_zvnf1HLOcFG" title="Operating leases have remaining lease terms"&gt;0.76&lt;/span&gt; years as of December 31, 2023 and consist primarily of office space.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
lease agreements generally do not provide an implicit borrowing rate. Therefore, the Company used a benchmark approach to derive an appropriate
incremental borrowing rate to discount remaining lease payments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leases
with an initial term of twelve months or less are not recorded on the balance sheet. There are no material residual guarantees associated
with any of the Company&#x2019;s leases, and there are no significant restrictions or covenants included in the Company&#x2019;s lease
agreements. Certain leases include variable payments related to common area maintenance and property taxes, which are billed by the landlord,
as is customary with these types of charges for office space. The Company has not entered into any lease arrangements with related parties.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s existing leases contain escalation clauses and renewal options. The Company is not reasonably certain that renewal options
will be exercised upon expiration of the initial terms of its existing leases. Prior to adoption of ASU 2016-02 effective January 1,
2022, the Company accounted for operating lease transactions by recording lease expense on a straight-line basis over the expected term
of the lease.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company entered into a sublease which it has identified as an operating lease prior to the adoption of ASC 842 &lt;i&gt;Leases&lt;/i&gt;. The Company
remains the primary obligor to the head lease lessor, making rental payments directly to the lessor and separately billing the sublessee.
The sublease is subordinate to the master lease, and the sublessee must comply with all applicable terms of the master lease. The Company
subleased the real estate to a third-party at a monthly rental payment amount that was less than the monthly cost that it pays on the
headlease with the lessor.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
evaluating long-lived assets for recoverability, the Company calculated the fair value of the sublease using its best estimate of future
cash flows expected to result from the use of the asset. When undiscounted cash flows to be generated through the sublease is less than
the carrying value of the underlying asset, the asset is deemed impaired. If it is determined that assets are impaired, an impairment
loss is recognized for the amount that the asset&#x2019;s book value exceeds its fair value. Based on the expected future cash flows,
the Company recognized an impairment loss upon adoption of ASC 842 &lt;i&gt;Leases&lt;/i&gt; of $&lt;span id="xdx_903_eus-gaap--OperatingLeaseImpairmentLoss_c20220101__20221231_zYQqMMwNEk56" title="Lease impairment cost"&gt;303,327&lt;/span&gt;. The impairment loss was recorded to impairment
loss on lease on the consolidated statement of operations for the year ended December 31, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--LeaseCostTableTextBlock_zFWNzkFgtaR4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of lease expense, are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span id="xdx_8B9_zzl675nz81fi" style="display: none"&gt;Schedule of Components of Lease Expense&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230101__20231231_z0PoxmdL1cIi" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220101__20221231_zkFIZHwr29Ek" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
    the Year Ended December 31,&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LeaseCostAbstract_iB_zplIcNezW3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;Components of lease expense:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseCost_i01_maLCzLvl_zfYMUrQGYLel" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 64%; text-align: left"&gt;Operating lease cost&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;199,611&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;191,483&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OperatingLeaseImpairmentLoss_i01_maLCzLvl_zZorwDLQyTE8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Lease impairment cost&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4675"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;303,327&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--SubleaseIncome_i01N_di_msLCzLvl_z1bnHur9vHPc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; text-align: left"&gt;Sublease income&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(204,324&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(177,588&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LeaseCost_i01T_mtLCzLvl_zwSsjVnXSbqe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"&gt;Total lease (income) cost&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(4,713&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;317,222&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_z51bI9uRglkj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_zGcotGyXUXG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Supplemental
cash flow information related to leases are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span id="xdx_8B3_zIYA6wctsNvj" style="display: none"&gt;Schedule of Supplemental Cash Flow Information Related to Leases&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230101__20231231_zToFA13jblz" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220101__20221231_zPm7vWzlVH0i" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
    the Year Ended December 31,&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Supplemental cash flow information:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CashFlowOperatingActivitiesLesseeAbstract_iB_zRMRb2wFoTEk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i01_zFknCcA81FNi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 64%; text-align: left"&gt;Non-cash lease expense (operating cash flow)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;173,245&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;152,018&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OperatingLeaseImpairmentLoss_i01N_di_zaVXEb3uCR2j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"&gt;Non-cash impairment of right to use assets (operating cash flow)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4692"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(303,327&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i01_z7ipF3C7pYM1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Change in lease liabilities (operating cash flow)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(284,963&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(243,596&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Operating lease right-of-use assets obtained in exchange for lease obligations:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_zohm5WHctVS6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; text-align: left"&gt;Operating leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; &lt;span style="-sec-ix-hidden: xdx2ixbrl4698"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;762,603&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zCHL0vvUxBme" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock_zqCs56vMSZJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Supplemental
balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span id="xdx_8BD_z8Da6t3pFkT2" style="display: none"&gt;Schedule of Supplemental Balance Sheet Information Related to Leases&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Operating leases:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20231231_zYVua6yLsN09" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2023&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20221231_zCUhFiViPu1e" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2022&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_zxxG7O1jDyBi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; width: 64%; text-align: left"&gt;Operating lease right-of-use assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;134,013&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;307,258&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_zQ6uXGKZEqB1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Operating lease liability, current&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;234,043&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;284,963&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_zHN6XTuKA6Jb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; text-align: left"&gt;Operating lease liability, long-term&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4709"&gt;-&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;234,043&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OperatingLeaseLiability_i01I_zmTvttVaWBr" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"&gt;Total operating lease liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;234,043&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;519,006&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Weighted-average remaining lease term:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2023&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31,&lt;br/&gt; 2022&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 64%; text-align: left"&gt;Operating leases (in years) &lt;br/&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_i01I_dtY_c20231231_zl4aMPOCbeBf" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Operating leases (in years)"&gt;0.76&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_i01I_dtY_c20221231_z1Ge4x4HiMu6" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Operating leases (in years)"&gt;1.76&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Weighted-average discount rate:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2023&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2022&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 64%; text-align: left"&gt;Operating leases &lt;br/&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_pid_dp_uPure_c20231231_zW1NRcsbMBp8" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Operating leases"&gt;6.76&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_pid_dp_uPure_c20221231_z6ZoR9xXo5y6" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Operating leases"&gt;6.74&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_z0RbfaMLk5d3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zOokf870LQD7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
minimum lease payments under non-cancellable lease as of December 31, 2023, are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8BE_zxV8dtDhXjGj" style="display: none"&gt;Schedule of Future Minimum Lease Payments Under Non-Cancellable Lease&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Maturities of lease liabilities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20231231_z93lZuQy24ca" style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Maturities of lease liabilities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_zZlFwRnwSkfe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1pt; text-align: left; width: 80%"&gt;Year Ending December 31, 2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;240,818&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_zrQjXS8vADSl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1pt; text-align: left"&gt;Total undiscounted cash flows&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;240,818&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_z9kgudVnJ1Fa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1pt; text-align: left"&gt;Less discounting&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,775&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_zr9xgH1r8CD1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 2.5pt; text-align: left"&gt;Present value of lease liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;234,043&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zEWvThz2OTJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Cantor
Fee Agreement &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Merger, 7GC previously agreed to pay Cantor an Original Deferred Fee of $&lt;span id="xdx_901_ecustom--DeferredUnderwritingFeesPayable_iI_c20231231__custom--AgreementAxis__custom--CantorFeeAgreementMember__dei--LegalEntityAxis__custom--GcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember_zVc6aJ1GJnxc" title="Deferred underwriting fees payable"&gt;8,050,000&lt;/span&gt; as deferred underwriting commissions.
On November 8, 2023, Cantor and 7GC entered into a Fee Reduction Agreement, pursuant to which Cantor agreed to forfeit $&lt;span id="xdx_900_ecustom--DeferredUnderwritingFeesForfeit_iI_c20231108__custom--AgreementAxis__custom--CantorFeeAgreementMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember_zroygEKUpG18" title="Deferred underwriting fees payable"&gt;4,050,000&lt;/span&gt; of
the $&lt;span id="xdx_904_ecustom--DeferredUnderwritingFeesPayable_iI_c20231108__custom--AgreementAxis__custom--CantorFeeAgreementMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember_zkVLp2CMxVz9" title="Deferred underwriting fees payable"&gt;8,050,000&lt;/span&gt; Original Deferred Fee, with the remaining $&lt;span id="xdx_90E_ecustom--IncreaseDecreaseInDeferredUnderwritingFees_iI_c20231108__custom--AgreementAxis__custom--CantorFeeAgreementMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember_zGUczEjG3gf6" title="Increase Decrease In Deferred Underwriting Fees"&gt;4,000,000&lt;/span&gt; Reduced Deferred Fee payable by Banzai to Cantor following the Closing
of the Merger. Pursuant to the Fee Reduction Agreement, the Reduced Deferred Fee will be payable in the form of the Cantor Fee Shares,
which will be calculated as a number of Class A Common Stock equal to the greater of (a) &lt;span id="xdx_904_ecustom--IncreaseDecreaseInDeferredUnderwritingFees_iI_c20231108__us-gaap--StatementClassOfStockAxis__custom--NewBanzaiClassASharesMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember_zxkiL2Ajq26l" title="Increase Decrease In Deferred Underwriting Fees"&gt;400,000&lt;/span&gt; or (b) the quotient obtained by dividing
(x) the Reduced Deferred Fee by (y) the dollar volume-weighted average price for Class A Common Stock on Nasdaq, over the five trading
days immediately preceding the date of filing of a resale registration statement on Form S-1, as reported by Bloomberg through its &#x201c;AQR&#x201d;
function (as adjusted for any stock dividend, split, combination, recapitalization or other similar transaction). In connection with
the merger discussed in &lt;i&gt;Note 4-Merger&lt;/i&gt;, the Company assumed the outstanding liabilities of 7GC, including the above discussed deferred
underwriting fee payable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Fee Reduction Agreement, the Company also agreed to use its reasonable best efforts to have the registration statement declared
effective by the SEC by the 120th calendar day after December 29, 2023, the date of the initial filing thereof, and to maintain the effectiveness
of such registration statement until the earliest to occur of (i) the second anniversary of the date of the effectiveness thereof, (ii)
the Cantor Fee Shares shall have been sold, transferred, disposed of or exchanged by Cantor, and (iii) the Cantor Fee Shares issued to
Cantor may be sold without registration pursuant to Rule 144 under the Securities Act (such obligations, the &#x201c;Cantor Registration
Rights Obligations&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 28, 2023, the Company and Cantor amended the Fee Reduction Agreement to provide that the Reduced Deferred Fee was payable in
the form of &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20231228__20231228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__custom--AgreementAxis__custom--CantorFeeAgreementMember_zx7QhM87EN92" title="Stock issued during period shares issued for services"&gt;22,279&lt;/span&gt; shares of Class A Common Stock and to provide that Cantor is subject to a 12-month lock-up with respect to the
Cantor Fee Shares. On December 28, 2023, the Company issued the Cantor Fee Shares to Cantor, covering the Reduced Deferred Fee in accordance
with the Fee Reduction Agreement. The fair value of the &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20231228__20231228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__custom--AgreementAxis__custom--CantorFeeAgreementMember_zwE8pgNP5PHf" title="Stock issued during period shares issued for services"&gt;22,279&lt;/span&gt; shares of Class A Common Stock was determined to be $&lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20231228__20231228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__custom--AgreementAxis__custom--CantorFeeAgreementMember_zmRm7wyJN3k2" title="Stock issued during period value issued for services"&gt;2,450,639&lt;/span&gt; on December
28, 2023 based on the Company&#x2019;s opening stock price of $&lt;span id="xdx_904_eus-gaap--SharePrice_iI_pid_c20231228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__custom--AgreementAxis__custom--CantorFeeAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z1ypQcwXeEOg" title="Stock price"&gt;110.00&lt;/span&gt;. Although the Company issued the Cantor Fee Shares, as of December
31, 2023, the Company has not satisfied its Cantor Registration Rights Obligations. As such, the Company cannot conclude that it has
settled its outstanding obligations to Cantor. Therefore, neither criteria under ASC 405 for extinguishment and derecognition of the
liability were satisfied and the $&lt;span id="xdx_90F_ecustom--IncreaseDecreaseInDeferredUnderwritingFees_iI_c20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CantorFitzgeraldMember__dei--LegalEntityAxis__custom--SevenGcCoHoldingsIncMember__custom--AgreementAxis__custom--CantorFeeAgreementMember_znQuJb5SaGm4" title="Increase decrease in deferred underwriting fees"&gt;4,000,000&lt;/span&gt; Reduced Deferred Fee remained outstanding as a current liability on the Company&#x2019;s December
31, 2023 balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
each interim period after December 31, 2023, the Company will monitor its compliance with the Cantor Registration Rights Obligations
to determine whether the entire amount of the Reduced Deferred Fee has become due and payable in cash, or the Company&#x2019;s obligations
have been satisfied and the remaining liability should be derecognized. At such time as the Company&#x2019;s obligations under the Fee
Reduction Agreement have been satisfied the relief of the liability will be recorded through equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Legal
Matters &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the regular course of business affairs and operations, we are subject to possible loss contingencies arising from third-party litigation
and federal, state, and local environmental, labor, health and safety laws and regulations. We assess the probability that we could incur
liability in connection with certain of these lawsuits. Our assessments are made in accordance with generally accepted accounting principles,
as codified in ASC 450-20, and is not an admission of any liability on the part of the Company or any of its subsidiaries. In certain
cases that are in the early stages and in light of the uncertainties surrounding them, we do not currently possess sufficient information
to determine a range of reasonably possible liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="AsOf2023-12-31" id="Fact004663">P0Y9M3D</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004665"
      unitRef="USD">303327</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004667">&lt;p id="xdx_89A_eus-gaap--LeaseCostTableTextBlock_zFWNzkFgtaR4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of lease expense, are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span id="xdx_8B9_zzl675nz81fi" style="display: none"&gt;Schedule of Components of Lease Expense&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230101__20231231_z0PoxmdL1cIi" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20220101__20221231_zkFIZHwr29Ek" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
    the Year Ended December 31,&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--LeaseCostAbstract_iB_zplIcNezW3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;Components of lease expense:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--OperatingLeaseCost_i01_maLCzLvl_zfYMUrQGYLel" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 64%; text-align: left"&gt;Operating lease cost&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;199,611&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;191,483&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OperatingLeaseImpairmentLoss_i01_maLCzLvl_zZorwDLQyTE8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Lease impairment cost&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4675"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;303,327&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--SubleaseIncome_i01N_di_msLCzLvl_z1bnHur9vHPc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; text-align: left"&gt;Sublease income&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(204,324&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(177,588&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LeaseCost_i01T_mtLCzLvl_zwSsjVnXSbqe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"&gt;Total lease (income) cost&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(4,713&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;317,222&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact004672"
      unitRef="USD">199611</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004673"
      unitRef="USD">191483</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004676"
      unitRef="USD">303327</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:SubleaseIncome
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact004678"
      unitRef="USD">204324</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004679"
      unitRef="USD">177588</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact004681"
      unitRef="USD">-4713</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004682"
      unitRef="USD">317222</us-gaap:LeaseCost>
    <BNZI:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004684">&lt;p id="xdx_89A_ecustom--ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock_zGcotGyXUXG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Supplemental
cash flow information related to leases are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span id="xdx_8B3_zIYA6wctsNvj" style="display: none"&gt;Schedule of Supplemental Cash Flow Information Related to Leases&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230101__20231231_zToFA13jblz" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220101__20221231_zPm7vWzlVH0i" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
    the Year Ended December 31,&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Supplemental cash flow information:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--CashFlowOperatingActivitiesLesseeAbstract_iB_zRMRb2wFoTEk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i01_zFknCcA81FNi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 64%; text-align: left"&gt;Non-cash lease expense (operating cash flow)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;173,245&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;152,018&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--OperatingLeaseImpairmentLoss_i01N_di_zaVXEb3uCR2j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"&gt;Non-cash impairment of right to use assets (operating cash flow)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4692"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(303,327&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i01_z7ipF3C7pYM1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Change in lease liabilities (operating cash flow)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(284,963&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(243,596&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Operating lease right-of-use assets obtained in exchange for lease obligations:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_zohm5WHctVS6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; text-align: left"&gt;Operating leases&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt; &lt;span style="-sec-ix-hidden: xdx2ixbrl4698"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;762,603&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BNZI:ScheduleOfSupplementalCashFlowInformationRelatedToLeasesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact004689"
      unitRef="USD">173245</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004690"
      unitRef="USD">152018</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004693"
      unitRef="USD">303327</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact004695"
      unitRef="USD">-284963</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004696"
      unitRef="USD">-243596</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004699"
      unitRef="USD">762603</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <BNZI:ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004701">&lt;p id="xdx_895_ecustom--ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock_zqCs56vMSZJe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Supplemental
balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span id="xdx_8BD_z8Da6t3pFkT2" style="display: none"&gt;Schedule of Supplemental Balance Sheet Information Related to Leases&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Operating leases:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20231231_zYVua6yLsN09" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2023&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20221231_zCUhFiViPu1e" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2022&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_zxxG7O1jDyBi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; width: 64%; text-align: left"&gt;Operating lease right-of-use assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;134,013&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;307,258&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_zQ6uXGKZEqB1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;Operating lease liability, current&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;234,043&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;284,963&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_zHN6XTuKA6Jb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 10pt; text-align: left"&gt;Operating lease liability, long-term&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4709"&gt;-&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;234,043&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OperatingLeaseLiability_i01I_zmTvttVaWBr" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; padding-left: 10pt; text-align: left"&gt;Total operating lease liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;234,043&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;519,006&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Weighted-average remaining lease term:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2023&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December
31,&lt;br/&gt; 2022&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 64%; text-align: left"&gt;Operating leases (in years) &lt;br/&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_i01I_dtY_c20231231_zl4aMPOCbeBf" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Operating leases (in years)"&gt;0.76&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_i01I_dtY_c20221231_z1Ge4x4HiMu6" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Operating leases (in years)"&gt;1.76&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Weighted-average discount rate:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2023&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2022&lt;/b&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 64%; text-align: left"&gt;Operating leases &lt;br/&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_pid_dp_uPure_c20231231_zW1NRcsbMBp8" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Operating leases"&gt;6.76&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_i01I_pid_dp_uPure_c20221231_z6ZoR9xXo5y6" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Operating leases"&gt;6.74&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</BNZI:ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004703"
      unitRef="USD">134013</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004704"
      unitRef="USD">307258</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004706"
      unitRef="USD">234043</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004707"
      unitRef="USD">284963</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004710"
      unitRef="USD">234043</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004712"
      unitRef="USD">234043</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004713"
      unitRef="USD">519006</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2023-12-31" id="Fact004715">P0Y9M3D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2022-12-31" id="Fact004717">P1Y9M3D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004719"
      unitRef="Pure">0.0676</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact004721"
      unitRef="Pure">0.0674</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004723">&lt;p id="xdx_89D_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zOokf870LQD7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Future
minimum lease payments under non-cancellable lease as of December 31, 2023, are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span id="xdx_8BE_zxV8dtDhXjGj" style="display: none"&gt;Schedule of Future Minimum Lease Payments Under Non-Cancellable Lease&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Maturities of lease liabilities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20231231_z93lZuQy24ca" style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;Maturities of lease liabilities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_zZlFwRnwSkfe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1pt; text-align: left; width: 80%"&gt;Year Ending December 31, 2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;240,818&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_zrQjXS8vADSl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1pt; text-align: left"&gt;Total undiscounted cash flows&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;240,818&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_di_z9kgudVnJ1Fa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1pt; text-align: left"&gt;Less discounting&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,775&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--OperatingLeaseLiability_iI_zr9xgH1r8CD1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 2.5pt; text-align: left"&gt;Present value of lease liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;234,043&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004725"
      unitRef="USD">240818</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004727"
      unitRef="USD">240818</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004729"
      unitRef="USD">6775</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004731"
      unitRef="USD">234043</us-gaap:OperatingLeaseLiability>
    <BNZI:DeferredUnderwritingFeesPayable
      contextRef="AsOf2023-12-31_custom_CantorFeeAgreementMember_custom_GcCoHoldingsIncMember_custom_CantorFitzgeraldMember"
      decimals="0"
      id="Fact004733"
      unitRef="USD">8050000</BNZI:DeferredUnderwritingFeesPayable>
    <BNZI:DeferredUnderwritingFeesForfeit
      contextRef="AsOf2023-11-08_custom_CantorFeeAgreementMember_custom_SevenGcCoHoldingsIncMember_custom_CantorFitzgeraldMember"
      decimals="0"
      id="Fact004735"
      unitRef="USD">4050000</BNZI:DeferredUnderwritingFeesForfeit>
    <BNZI:DeferredUnderwritingFeesPayable
      contextRef="AsOf2023-11-08_custom_CantorFeeAgreementMember_custom_SevenGcCoHoldingsIncMember_custom_CantorFitzgeraldMember"
      decimals="0"
      id="Fact004737"
      unitRef="USD">8050000</BNZI:DeferredUnderwritingFeesPayable>
    <BNZI:IncreaseDecreaseInDeferredUnderwritingFees
      contextRef="AsOf2023-11-08_custom_CantorFeeAgreementMember_custom_SevenGcCoHoldingsIncMember_custom_CantorFitzgeraldMember"
      decimals="0"
      id="Fact004739"
      unitRef="USD">4000000</BNZI:IncreaseDecreaseInDeferredUnderwritingFees>
    <BNZI:IncreaseDecreaseInDeferredUnderwritingFees
      contextRef="AsOf2023-11-08_custom_NewBanzaiClassASharesMember_custom_SevenGcCoHoldingsIncMember_custom_CantorFitzgeraldMember"
      decimals="0"
      id="Fact004741"
      unitRef="USD">400000</BNZI:IncreaseDecreaseInDeferredUnderwritingFees>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-12-282023-12-28_custom_CantorFitzgeraldMember_us-gaap_CommonClassAMember_custom_SevenGcCoHoldingsIncMember_custom_CantorFeeAgreementMember"
      decimals="INF"
      id="Fact004743"
      unitRef="Shares">22279</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-12-282023-12-28_custom_CantorFitzgeraldMember_us-gaap_CommonClassAMember_custom_SevenGcCoHoldingsIncMember_custom_CantorFeeAgreementMember"
      decimals="INF"
      id="Fact004745"
      unitRef="Shares">22279</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-12-282023-12-28_custom_CantorFitzgeraldMember_us-gaap_CommonClassAMember_custom_SevenGcCoHoldingsIncMember_custom_CantorFeeAgreementMember"
      decimals="0"
      id="Fact004747"
      unitRef="USD">2450639</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:SharePrice
      contextRef="AsOf2023-12-28_custom_CantorFitzgeraldMember_custom_SevenGcCoHoldingsIncMember_custom_CantorFeeAgreementMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact004749"
      unitRef="USDPShares">110.00</us-gaap:SharePrice>
    <BNZI:IncreaseDecreaseInDeferredUnderwritingFees
      contextRef="AsOf2023-12-31_custom_CantorFitzgeraldMember_custom_SevenGcCoHoldingsIncMember_custom_CantorFeeAgreementMember"
      decimals="0"
      id="Fact004751"
      unitRef="USD">4000000</BNZI:IncreaseDecreaseInDeferredUnderwritingFees>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact004753">&lt;p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zRZzfkZkJbWi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;18.
&lt;span id="xdx_82A_zga38COzULn1"&gt;Equity&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Class
A and B Common Stock &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is authorized to issue up to &lt;span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231__srt--RangeAxis__srt--MaximumMember_zC2KzklYmzDd" title="Common stock, shares authorized"&gt;275,000,000&lt;/span&gt;
shares, consisting of &lt;span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zXM0G27KVCL9" title="Common stock, shares authorized"&gt;250,000,000&lt;/span&gt;
Class A Common Stock, and &lt;span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20231231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zHudkmGmBVM5" title="Common stock, shares authorized"&gt;25,000,000&lt;/span&gt;
shares of Class B Common Stock par value $&lt;span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20231231_z4KMgoWs7lb9" title="Common stock par value"&gt;0.0001&lt;/span&gt;
per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
discussed in &lt;i&gt;Note 4-Reverse Merger Capitalization with 7GC &amp;amp; Co. Holdings Inc.&lt;/i&gt;, the Company has retroactively adjusted the
shares issued and outstanding prior to December 14, 2023 to give effect to the Exchange Ratio to determine the number of shares of Company
Common Stock into which they were converted.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--CommonStockVotingRights_c20230101__20231231_zuQ2UJw95cf9" title="Common stock voting rights"&gt;Class A Common Stock and Class B Common Stock entitle their holders to one vote per share and ten votes per share, respectively, on each
matter properly submitted to the stockholders entitled to vote thereon.&lt;/span&gt; The holders of shares of Common Stock shall be entitled to receive
dividends declared by the Board of Directors, on a pro rata basis based on the number of shares of Common Stock held by each such holder,
assuming conversion of all Class B Common Stock into Class A Common Stock at a one to one conversion ratio.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Preferred
Stock &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is authorized to issue &lt;span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20231231_zcZ4n5jZfn14" title="Preferred stock, shares authorized"&gt;75,000,000&lt;/span&gt; shares of preferred stock with a par value of $&lt;span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20231231_z5eWIQtlFZ83" title="Preferred stock, par value"&gt;0.0001&lt;/span&gt; per share. The board of directors of
the Company (the &#x201c;Board&#x201d;) has the authority to issue preferred stock and to determine the rights, privileges, preferences,
restrictions, and voting rights of those shares. As of December 31, 2023, &lt;span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20231231_zPoV4WewtcE5" title="Preferred stock, shares outstanding"&gt;no&lt;/span&gt; shares of preferred stock were outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2023, pursuant to the Merger, &lt;span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_c20231214__20231214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--BusinessAcquisitionAxis__custom--BanzaiInternationalIncMember_zeBQQb29Ds0g" title="Conversion of stock shares converted"&gt;2,328,823&lt;/span&gt; outstanding shares of Preferred Stock were automatically converted into &lt;span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_c20231214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--BusinessAcquisitionAxis__custom--BanzaiInternationalIncMember_zwUg0DyEZM2i" title="Common stock, shares outstanding"&gt;28,629&lt;/span&gt;
shares of the Company&#x2019;s Class A Common Stock pursuant to the Exchange Ratio. Refer to &lt;i&gt;Note 4-Reverse Merger Capitalization with
7GC &amp;amp; Co. Holdings Inc.&lt;/i&gt; for further details.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Restricted
Stock &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the acquisition of Demio and High Attendance, the Company issued restricted stock to the selling securityholders and founders
of Demio. &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210219__20210219__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__srt--TitleOfIndividualAxis__custom--ShareholdersAndFoundersMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--BusinessAcquisitionAxis__custom--DemioMember_ztKoRrmKCoKc" title="Stock issued during period shares new issues"&gt;14,916&lt;/span&gt; shares of the Company&#x2019;s restricted Class A common stock were issued to the selling securityholders and founders
of Demio and &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210219__20210219__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__srt--TitleOfIndividualAxis__custom--ShareholdersAndFoundersMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--BusinessAcquisitionAxis__custom--HighAttendanceMember_zIRg0D9kkjO" title="Stock issued during period shares new issues"&gt;1,638&lt;/span&gt; shares of the Company&#x2019;s restricted Class A common stock were issued to the High Attendance securityholder. All
shares issued to the selling securityholders and founders of Demio vested and are outstanding as of December 31, 2023. On July 1, 2022,
all shares issued to the High Attendance securityholder were cancelled and are not outstanding as of December 31, 2023 and 2022. Upon the
closing of the Merger, the restrictions on the outstanding shares were lifted and the shares became freely tradeable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Yorkville
Standby Equity Purchase Agreement (&#x201c;SEPA&#x201d;) &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 14, 2023, the Company entered into the SEPA with YA II PN, LTD, a Cayman Islands exempt limited partnership managed by Yorkville
Advisors Global, LP (&#x201c;Yorkville&#x201d;) in connection with the Merger. Pursuant to the SEPA, subject to certain conditions, the
Company shall have the option, but not the obligation, to sell to Yorkville, and Yorkville shall subscribe for, an aggregate amount of
up to up to $&lt;span id="xdx_905_eus-gaap--AssetAcquisitionConsiderationTransferred_c20230214__20230214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zAp2pvi0dJPj" title="Total consideration payable in shares of class A common stock"&gt;100,000,000&lt;/span&gt; of the Company&#x2019;s shares of Class A common stock, par value $&lt;span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20231214__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zAS1u68S0oI7" title="Common stock par value"&gt;0.0001&lt;/span&gt; per share, at the Company&#x2019;s request
any time during the commitment period commencing on December 14, 2023 and terminating on the 36-month anniversary of the SEPA (the &#x201c;SEPA
Option&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Each
advance (each, an &#x201c;Advance&#x201d;) the Company requests under the SEPA (notice of such request, an &#x201c;Advance Notice&#x201d;)
may be for a number of shares of Class A common stock up to the greater of (i) &lt;span id="xdx_90F_eus-gaap--InvestmentCompanyExpenseLimitationAgreementDescription_c20230101__20231231__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zSARZGqLCHy7" title="Description of equity facility financing agreement"&gt;10,000 shares or (ii) such amount as is equal to 100%
of the average daily volume traded of  Class A common stock during the five trading days immediately prior to the date the Company
requests each Advance;&lt;/span&gt; provided, in no event shall the number of shares of Class A common stock issued cause the aggregate shares of
Class A common stock held by Yorkville and its affiliates as of any such date to exceed &lt;span id="xdx_906_ecustom--PercentageOfSharesOutstandingAtTheDateOfAdvanceNotice_dp_uPure_c20230214__20230214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z7FAozNkzcUf" title="Description of equity facility financing agreement"&gt;9.99&lt;/span&gt;% of the total number of shares of Class
A common stock outstanding as of the date of the Advance Notice (less any such shares held by Yorkville and its affiliates as of such
date) (the &#x201c;Exchange Cap&#x201d;). The shares would be purchased, at the Company&#x2019;s election, at a purchase price equal to
either:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i)
&lt;span id="xdx_90E_ecustom--PercentageOfAverageDailyVolumeWeightedAveragePrice_dp_uPure_c20230214__20230214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zBJKo74mpGs" title="Percentage of average daily Volume Weighted Average Price"&gt;95&lt;/span&gt;% of the average daily Volume Weighted Average Price (&#x201c;VWAP&#x201d;) of  Class A Common Stock on the Nasdaq Stock Market (&#x201c;Nasdaq&#x201d;),
subject to certain conditions per the SEPA (the &#x201c;Option 1 Pricing Period; or&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii)
&lt;span id="xdx_903_ecustom--PercentageOfLowestDailyVolumeWeightedAveragePrice_dp_uPure_c20230214__20230214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zOv1gZqtZAic" title="Percentage of lowest daily Volume Weighted Average Price"&gt;96&lt;/span&gt;% of the lowest daily VWAP of  Class A Common Stock during the three trading days commencing on the Advance Notice date, subject
to certain conditions per the SEPA (the &#x201c;Option 2 Pricing Period&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Any
purchase under an Advance would be subject to certain limitations, including that Yorkville shall not purchase or acquire any shares
that would result in it and its affiliates beneficially owning more than &lt;span id="xdx_90C_ecustom--PurchaseOfStockPercentageOfVotingPowerOwnershipLimitation_iI_dp_uPure_c20230214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zRGOJbcVZAPj" title="Percentage of voting power"&gt;9.99&lt;/span&gt;% of the then outstanding voting power or number of shares
of Class A common stock or any shares that, aggregated with shares issued under all other earlier Advances, would exceed &lt;span id="xdx_907_ecustom--PurchaseOfStockPercentageOfOutstandingSharesOwnershipLimitation_iI_dp_uPure_c20230214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z5p9zB3ioWn8" title="Percentage of outstanding shares"&gt;&lt;span id="xdx_90C_ecustom--PurchaseOfStockPercentageOfOutstandingSharesOwnershipLimitation_iI_dp_uPure_c20230214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zEdRGJrKLltg" title="Percentage of outstanding shares"&gt;19.99&lt;/span&gt;&lt;/span&gt;% of all
shares of Class A common stock and Class B common stock of the Company, par value $&lt;span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zDv6rh5Xx7Ph" title="Common stock par value"&gt;&lt;span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zZw8S95CCYPl" title="Common stock par value"&gt;0.0001&lt;/span&gt;&lt;/span&gt; per share, outstanding on the date of the SEPA,
unless Company securityholder approval was obtained allowing for issuances in excess of such amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
SEPA Option was determined to be a freestanding financial instrument which did not meet the criteria to be accounted for as a derivative
instrument or to be recognized within equity. Pursuant to ASC 815 &lt;i&gt;Derivatives and Hedging &lt;/i&gt;(&#x201c;ASC 815&#x201d;), the Company
will therefore recognize the SEPA Option as an asset or liability, measured at fair value at the date of issuance, December 14, 2023,
and in subsequent reporting periods, with changes in fair value recognized in earnings. The SEPA Option was determined to have a fair
value of $&lt;span id="xdx_901_ecustom--FairValueOfStandbyEquityPurchaseAgreement_iI_c20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zGoEalwaKmf6" title="Fair Value Of Standby Equity Purchase Agreement"&gt;&lt;span id="xdx_905_ecustom--FairValueOfStandbyEquityPurchaseAgreement_iI_c20231231__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_z3muW9E8TOvd" title="Fair Value Of Standby Equity Purchase Agreement"&gt;0&lt;/span&gt;&lt;/span&gt; at December 14, 2023 and December 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the execution of the SEPA, the Company paid a cash structuring fee to Yorkville in the amount of $&lt;span id="xdx_909_ecustom--CashStructuringFee_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zAsgNqIks4Sj" title="Cash structuring fee"&gt;35,000&lt;/span&gt; (the &#x201c;Structuring
Fee&#x201d;). Additionally, (a) Legacy Banzai issued to Yorkville immediately prior to the Closing of the Merger on December 14, 2023
such number of shares of Legacy Banzai&#x2019;s Class A common stock such that upon the Closing, Yorkville received &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zDPegIVU0ku3" title="Stock issued during period shares acquisitions"&gt;6,000&lt;/span&gt; shares of
Class A common stock (the &#x201c;Closing Shares&#x201d;) having an aggregate fair value of $&lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z4IHYXzaScg7" title="Stock issued during period value acquisitions"&gt;3,288,000&lt;/span&gt; at issuance, as a holder of shares
of Class A common stock of Legacy Banzai, and (b) the Company agreed to pay a commitment fee of $&lt;span id="xdx_90A_ecustom--CommitmentFeePayable_iI_c20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_z7qESi6sUrSc" title="Stock issued during period value acquisitions"&gt;500,000&lt;/span&gt; to Yorkville at the earlier
of (i) March 14, 2024 or (ii) the termination of the SEPA, which will be payable, at the option of the Company, in cash or shares of
Class A common stock through an Advance (the &#x201c;Deferred Fee&#x201d;). The aggregate fair value of the Structuring Fee, the Closing
Shares, and the Deferred Fee of $&lt;span id="xdx_903_eus-gaap--GeneralAndAdministrativeExpense_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zdiGZ17DI2Ib" title="General and administrative expense"&gt;3,823,000&lt;/span&gt; was recorded to general and administrative expense upon execution of the SEPA.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the terms of the SEPA, at any time that there is a balance outstanding under the Yorkville Convertible Note, Yorkville has the right
to receive shares to pay down the principal balance, and may select the timing and delivery of such shares (via an &#x201c;Investor Notice&#x201d;),
in an amount up to the outstanding principal balance on the Yorkville Convertible Note at a purchase price equal to the lower of (i)
$&lt;span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z2lfH0EUORSb" title="Common stock price per share"&gt;10.00&lt;/span&gt; per share of Class A common stock (the &#x201c;Fixed Price&#x201d;), or (ii) &lt;span id="xdx_904_ecustom--PercentageOfLowestDailyVolumeWeightedAveragePrice_dp_uPure_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zGFnOZsYTewa" title="Percentage of lowest daily Volume Weighted Average Price"&gt;90&lt;/span&gt;% of the lowest daily Volume Weighted Average Price
(&#x201c;VWAP&#x201d;) of Class A common stock on Nasdaq during the 10 consecutive Trading Days immediately preceding the Investor
Notice date or other date of determination (the &#x201c;Variable Price&#x201d;). The Variable Price shall not be lower than $&lt;span id="xdx_90D_ecustom--MaximumFloorPrice_iI_pid_c20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__srt--RangeAxis__srt--MinimumMember_zcQshiGicxp6" title="Maximum floor price"&gt;2.00&lt;/span&gt; per share
(the &#x201c;Floor Price&#x201d;). &lt;span id="xdx_907_ecustom--FloorPriceAdjustment_pid_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zM7QpVjqKUS5" title="Floor price adjustment"&gt;The Floor Price shall be adjusted (downwards only) to equal 20% of the average VWAP for the five trading
days immediately prior to the date of effectiveness of the initial Registration Statement.&lt;/span&gt; Notwithstanding the foregoing, the Company
may reduce the Floor Price to any amount via written notice to Yorkville, provided that such amount is no more than &lt;span id="xdx_905_ecustom--MaximumPercentageOfClosingPriceOnTradingDay_pid_dp_uPure_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zPQugXPqJHh7" title="Maximum percentage of closing price on trading day"&gt;75&lt;/span&gt;% of the closing
price on the Trading Day immediately prior to the time of such reduction and no greater than $&lt;span id="xdx_903_eus-gaap--CommonStockConvertibleConversionPriceIncrease_pid_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zRqmr83GEGbj" title="Maximum conversion price"&gt;2.00&lt;/span&gt; per share of Class A common stock
(the &#x201c;Conversion Price&#x201d;). At any time that there is a balance outstanding under the Yorkville Convertible Note, the Company
is not permitted to issue Advance Notices under the SEPA unless an Amortization Event has occurred under the terms of the Yorkville Convertible
Note agreement. Refer to &lt;i&gt;Note 21 Subsequent Events&lt;/i&gt; for further details&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were no Advance Notices issued pursuant to the SEPA during the year ended December 31, 2023 or as of the date that these financial statements
were issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Cantor
Fee Agreement &lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 28, 2023, the Company issued &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231228__20231228__custom--AgreementAxis__custom--CantorFeeAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z3UZUGjKXFP6" title="Stock issued during period shares acquisitions"&gt;22,279&lt;/span&gt; shares of Class A Common Stock to Cantor pursuant to the Fee Reduction Agreement. See
&lt;i&gt;Note 17-Commitments and Contingencies &lt;/i&gt;for further details of this transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31_srt_MaximumMember"
      decimals="INF"
      id="Fact004755"
      unitRef="Shares">275000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact004757"
      unitRef="Shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-12-31_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact004759"
      unitRef="Shares">25000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004761"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockVotingRights contextRef="From2023-01-012023-12-31" id="Fact004763">Class A Common Stock and Class B Common Stock entitle their holders to one vote per share and ten votes per share, respectively, on each
matter properly submitted to the stockholders entitled to vote thereon.</us-gaap:CommonStockVotingRights>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004765"
      unitRef="Shares">75000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004767"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004769"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2023-12-142023-12-14_us-gaap_CommonClassAMember_custom_BanzaiInternationalIncMember"
      decimals="INF"
      id="Fact004771"
      unitRef="Shares">2328823</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-12-14_us-gaap_CommonClassAMember_custom_BanzaiInternationalIncMember5493359"
      decimals="INF"
      id="Fact004773"
      unitRef="Shares">28629</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-02-192021-02-19_us-gaap_CommonClassAMember_custom_ShareholdersAndFoundersMember_us-gaap_RestrictedStockMember_custom_DemioMember"
      decimals="INF"
      id="Fact004775"
      unitRef="Shares">14916</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2021-02-192021-02-19_us-gaap_CommonClassAMember_custom_ShareholdersAndFoundersMember_us-gaap_RestrictedStockMember_custom_HighAttendanceMember"
      decimals="INF"
      id="Fact004777"
      unitRef="Shares">1638</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="From2023-02-142023-02-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact004779"
      unitRef="USD">100000000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-12-14_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact004781"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:InvestmentCompanyExpenseLimitationAgreementDescription
      contextRef="From2023-01-012023-12-31_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      id="Fact004783">10,000 shares or (ii) such amount as is equal to 100%
of the average daily volume traded of  Class A common stock during the five trading days immediately prior to the date the Company
requests each Advance;</us-gaap:InvestmentCompanyExpenseLimitationAgreementDescription>
    <BNZI:PercentageOfSharesOutstandingAtTheDateOfAdvanceNotice
      contextRef="From2023-02-142023-02-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact004785"
      unitRef="Pure">0.0999</BNZI:PercentageOfSharesOutstandingAtTheDateOfAdvanceNotice>
    <BNZI:PercentageOfAverageDailyVolumeWeightedAveragePrice
      contextRef="From2023-02-142023-02-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact004787"
      unitRef="Pure">0.95</BNZI:PercentageOfAverageDailyVolumeWeightedAveragePrice>
    <BNZI:PercentageOfLowestDailyVolumeWeightedAveragePrice
      contextRef="From2023-02-142023-02-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact004789"
      unitRef="Pure">0.96</BNZI:PercentageOfLowestDailyVolumeWeightedAveragePrice>
    <BNZI:PurchaseOfStockPercentageOfVotingPowerOwnershipLimitation
      contextRef="AsOf2023-02-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact004791"
      unitRef="Pure">0.0999</BNZI:PurchaseOfStockPercentageOfVotingPowerOwnershipLimitation>
    <BNZI:PurchaseOfStockPercentageOfOutstandingSharesOwnershipLimitation
      contextRef="AsOf2023-02-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact004793"
      unitRef="Pure">0.1999</BNZI:PurchaseOfStockPercentageOfOutstandingSharesOwnershipLimitation>
    <BNZI:PurchaseOfStockPercentageOfOutstandingSharesOwnershipLimitation
      contextRef="AsOf2023-02-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact004795"
      unitRef="Pure">0.1999</BNZI:PurchaseOfStockPercentageOfOutstandingSharesOwnershipLimitation>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-02-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact004797"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-02-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_CommonClassBMember"
      decimals="INF"
      id="Fact004799"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <BNZI:FairValueOfStandbyEquityPurchaseAgreement
      contextRef="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember5493562"
      decimals="0"
      id="Fact004801"
      unitRef="USD">0</BNZI:FairValueOfStandbyEquityPurchaseAgreement>
    <BNZI:FairValueOfStandbyEquityPurchaseAgreement
      contextRef="AsOf2023-12-31_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact004803"
      unitRef="USD">0</BNZI:FairValueOfStandbyEquityPurchaseAgreement>
    <BNZI:CashStructuringFee
      contextRef="From2023-12-142023-12-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact004805"
      unitRef="USD">35000</BNZI:CashStructuringFee>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-12-142023-12-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact004807"
      unitRef="Shares">6000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2023-12-142023-12-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact004809"
      unitRef="USD">3288000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <BNZI:CommitmentFeePayable
      contextRef="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember5493562"
      decimals="0"
      id="Fact004811"
      unitRef="USD">500000</BNZI:CommitmentFeePayable>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-12-142023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="0"
      id="Fact004813"
      unitRef="USD">3823000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-12-14_us-gaap_CommonClassAMember_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact004815"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <BNZI:PercentageOfLowestDailyVolumeWeightedAveragePrice
      contextRef="From2023-12-142023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact004817"
      unitRef="Pure">0.90</BNZI:PercentageOfLowestDailyVolumeWeightedAveragePrice>
    <BNZI:MaximumFloorPrice
      contextRef="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember_srt_MinimumMember"
      decimals="INF"
      id="Fact004819"
      unitRef="USDPShares">2.00</BNZI:MaximumFloorPrice>
    <BNZI:FloorPriceAdjustment
      contextRef="From2023-12-142023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      id="Fact004821">The Floor Price shall be adjusted (downwards only) to equal 20% of the average VWAP for the five trading
days immediately prior to the date of effectiveness of the initial Registration Statement.</BNZI:FloorPriceAdjustment>
    <BNZI:MaximumPercentageOfClosingPriceOnTradingDay
      contextRef="From2023-12-142023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact004823"
      unitRef="Pure">0.75</BNZI:MaximumPercentageOfClosingPriceOnTradingDay>
    <us-gaap:CommonStockConvertibleConversionPriceIncrease
      contextRef="From2023-12-142023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact004825"
      unitRef="USDPShares">2.00</us-gaap:CommonStockConvertibleConversionPriceIncrease>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-12-282023-12-28_custom_CantorFeeAgreementMember_us-gaap_CommonClassAMember5494328"
      decimals="INF"
      id="Fact004827"
      unitRef="Shares">22279</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2023-01-012023-12-31" id="Fact004829">&lt;p id="xdx_805_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zXIQBpRfjub9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;19.
&lt;span id="xdx_82A_z4muhKEk9eBb"&gt;Stock-Based Compensation&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to the Merger, the Company established the Banzai International, Inc. 2016 Equity Incentive Plan (&#x201c;the 2016 Plan&#x201d;) on April
26, 2016, to enable the Company to attract, incentivize and retain eligible individuals through the granting of awards in the Company.
The maximum number of options that may be issued over the term of the Plan were initially set at &lt;span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20160426__us-gaap--PlanNameAxis__custom--TwoThousandAndSixteenEquityIncentivePlanMember_znNZ3iG13Vwb" title="Common stock, shares authorized"&gt;8,000&lt;/span&gt; shares of common stock. On July
19, 2017, the 2016 Plan was amended to increase the maximum number of options that may be issued to &lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease_c20170719__20170719__us-gaap--PlanNameAxis__custom--TwoThousandAndSixteenEquityIncentivePlanMember_zZQjpb4Wv6ik" title="Number of increase decrease of non-vested options"&gt;48,000&lt;/span&gt; shares of common stock.
Accordingly, the Company has reserved a sufficient number of shares to permit the exercise of options in accordance with the terms of
the 2016 Plan. The term of each award under the 2016 Plan shall be no more than ten years from the date of grant thereof. The Company&#x2019;s
Board of Directors is responsible for the administration of the 2016 Plan and has the sole discretion to determine which grantees will
be granted awards and the terms and conditions of the awards granted. As of December 31, 2023, &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20231231__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityIncentivePlanMember_z5At44iPBa1i" title="Stock options awarded"&gt;11,443&lt;/span&gt; stock options remain available
to be awarded under the 2023 Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
2023, the Company adopted the 2023 Equity Incentive Plan (the &#x201c;2023 Plan&#x201d;). The 2023 Plan permits the granting of incentive
stock options, nonstatutory stock options, SARs, restricted stock awards, RSU awards, performance awards, and other awards. to employees,
directors, and consultants. &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityIncentivePlanMember_zCsm6Z7AxM5c" title="Equity incentive plan, description"&gt;The aggregate number of shares of common stock that may be issued will not exceed approximately 12.5% of
the fully diluted common stock determined at the Close of the Merger. In addition, the aggregate number of shares of common stock will
automatically increase on January 1 of each year for a period of ten years commencing on January 1, 2024 and ending on &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20230101__20231231__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityIncentivePlanMember_zA5LxWapb1b5" title="Expiration date"&gt;January 1, 2033&lt;/span&gt;,
in an amount equal to 5% of the total number of shares of the fully diluted common stock determined as of the day prior to such increase.
The aggregate maximum number of shares of common stock that may be issued pursuant to the exercise of incentive stock options is approximately
three times the total number of shares of common stock initially reserved for issuance.&lt;/span&gt; As of December 31, 2023, no shares have been
awarded under the 2023 Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for stock-based payments pursuant to ASC 718 &lt;i&gt;Stock Compensation&lt;/i&gt; and, accordingly, the Company records compensation
expense for stock-based awards based upon an assessment of the grant date fair value for options using the Black-Scholes option pricing
model. The Company has concluded that its historical share option exercise experience does not provide a reasonable basis upon which
to estimate expected term. Therefore, the expected term was determined according to the simplified method, which is the average of the
vesting tranche dates and the contractual term. Due to the lack of company specific historical and implied volatility data, the estimate
of expected volatility is primarily based on the historical volatility of a group of similar companies that are publicly traded. For
these analyses, companies with comparable characteristics were selected, including enterprise value and position within the industry,
and with historical share price information sufficient to meet the expected life of the share-based awards. The Company computes the
historical volatility data using the daily closing prices for the selected companies&#x2019; shares during the equivalent periods of the
calculated expected term of its share-based awards. The risk-free interest rate is determined by reference to the U.S. Treasury zero-coupon
issues with remaining maturities similar to the expected term of the options. Expected dividend yield is &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dcp_c20230101__20231231_zlUNoit7oyc2" title="Expected dividend yield"&gt;zero&lt;/span&gt; based on the fact that
the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 3, 2023, the Board of Directors of Banzai approved the repricing of &lt;span id="xdx_90E_ecustom--RepricingValueOfOutstandingStockOption_c20231203__20231203_zJZuEvlzm1Gl" title="Repricing outstanding stock option"&gt;7,193&lt;/span&gt; outstanding stock options held by current employees
to an exercise price of $&lt;span id="xdx_901_ecustom--StockOptionsExercisePricePerShare_pid_c20231203__20231203_zg70WO7KQpnc" title="Exercise price"&gt;257.50&lt;/span&gt;. No other changes to the original stock option grant terms were made.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
incremental compensation cost was measured as the fair value of the stock options immediately before and immediately after the modification.
The Company determined the total incremental compensation cost from the modification to be $&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_c20231203__20231203_zSBBQuqRuN2e" title="Incremental compensation cost"&gt;113,475&lt;/span&gt;, of which $&lt;span id="xdx_90E_ecustom--VestedStockBasedCompensationExpense_c20231203__20231203_zUndw5zrDT5f" title="Vested stock based compensation expense"&gt;23,849&lt;/span&gt; related to fully
vested options and was expensed as stock-based compensation expense, and $&lt;span id="xdx_90E_ecustom--UnvestedStockBasedCompensationExpense_c20231203__20231203_zQGphraRQOud" title="Unvested stock based compensation expense"&gt;89,626&lt;/span&gt; related to unvested options and will be recognized over
the remaining service period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Merger, each option of Banzai that was outstanding and unexercised immediately prior to the Effective Time (whether
vested or unvested) was assumed by 7GC and converted into an option to acquire an adjusted number of shares of Common Stock at an adjusted
exercise price per share (the &#x201c;Substitute Options&#x201d;), based on the Option Exchange Ratio (of &lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20231214__us-gaap--AwardTypeAxis__custom--SubstituteOptionsMember_zFzfV4b2YCT" title="Exercise price per share"&gt;0.6147&lt;/span&gt;), and will continue to
be governed by substantially the same terms and conditions, including vesting, as were applicable to the former option. Each Substitute
Option will be exercisable for a number of whole shares of Common Stock equal to the product of the number of shares of Banzai common
stock underlying such Banzai option multiplied by the Option Exchange Ratio, and the per share exercise price of such Substitute Option
will be equal to the quotient determined by dividing the exercise price per share of Banzai common stock by the Option Exchange Ratio.
The percentage of total shares of Common Stock subject to each Substitute Option that is vested immediately following the Effective Time
will equal the percentage of total shares of Banzai common stock subject to each Banzai option that is vested immediately prior to the
Effective Time.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
the closing of the Merger, the outstanding and unexercised Banzai stock options became options to purchase an aggregate &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231214_zlGb2hJjPVG1" title="Option to purchase aggregate number of shares"&gt;14,962&lt;/span&gt; shares
of the Company&#x2019;s Common Stock at a weighted average exercise price of $&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20231214_z3yPPsg3I8K8" title="Exercise price per share"&gt;293.50&lt;/span&gt; per share. The Company accounted for the Substitute
Options as a modification of the existing options. Incremental compensation costs, measured as the excess, if any, of the fair value
of the modified options over the fair value of the original options immediately before its terms are modified, is measured based on the
fair value of the underlying shares and other pertinent factors at the modification date. The change to the award effected only the number
of options and strike price by the same exchange ratio, the Company determined the change would not impact the fair value of the awards.
As such, no incremental compensation costs relating to the Substitute Options was recorded at the date of modification.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zZ6NnGJJEFGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes assumptions used to compute the fair value of options granted:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zn34P8zGfa76" style="display: none"&gt;Summary of Assumptions Used to Compute Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%"&gt;Stock price&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--SharePrice_iI_c20231231__srt--RangeAxis__srt--MinimumMember_zVfW5uMVWuZc" title="Stock price"&gt;8.38&lt;/span&gt; - &lt;span id="xdx_90C_eus-gaap--SharePrice_iI_c20231231__srt--RangeAxis__srt--MaximumMember_zMPxAleXlvDg" title="Stock price"&gt;11.98&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharePrice_iI_c20221231_zmm8AanFrhl6" title="Stock price"&gt;1.54&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Exercise price&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20231231__srt--RangeAxis__srt--MinimumMember_zag7Dz5KUr5l" title="Exercise price"&gt;8.38&lt;/span&gt; - &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20231231__srt--RangeAxis__srt--MaximumMember_z5BOUJ43Awf3" title="Exercise price"&gt;11.98&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20221231_zqrpLnjYdJa6" title="Exercise price"&gt;1.04&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20230101__20231231_zUsewiqaE3ba" title="Expected volatility minimum"&gt;80.00&lt;/span&gt; - &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20230101__20231231_zhRDP497GI31" title="Expected volatility maximum"&gt;110.95&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20220101__20221231_z0zEEC9Zmfqd" title="Expected volatility minimum"&gt;53.61&lt;/span&gt;
- &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20220101__20221231_zzMLBbbHMly8" title="Expected volatility maximum"&gt;55.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zX2Xrsdgolc2" title="Time to maturity"&gt;5.00&lt;/span&gt; - &lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zsIe1wISZgg2" title="Time to maturity"&gt;6.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zyhR034sbHR9" title="Time to maturity"&gt;5.94&lt;/span&gt; - &lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zOrdjnbii6V5" title="Time to maturity"&gt;6.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_uPure_c20230101__20231231_ztEKWWX2Mak2" title="Risk-free interest rate"&gt;3.46&lt;/span&gt; - &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_uPure_c20230101__20231231_zNA69jiNG6i" title="Risk-free interest rate"&gt;4.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_uPure_c20220101__20221231_zImL3ZjVG6fc" title="Risk-free interest rate, minimum"&gt;1.95&lt;/span&gt; - &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_uPure_c20220101__20221231_zdih4cKJnGD6" title="Risk-free interest rate, maximum"&gt;2.85&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zRQZmi82YHra" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zAXNiZyxeSY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of stock option activity under the Plan is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zd6QzSqBpVm5" style="display: none"&gt;Summary of Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Shares&lt;br/&gt; Underlying&lt;br/&gt; Options&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise&lt;br/&gt; Price&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Remaining&lt;br/&gt; Contractual&lt;br/&gt; Term (in&lt;br/&gt; years)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Intrinsic&lt;br/&gt; Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 44%"&gt;Outstanding at December 31, 2021&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20211231__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z3J9EbouMMc2" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Shares Underlying Options, Beginning balanceShares Underlying Options, Beginning balance"&gt;14,634&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20211231__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zIrzqsVzw0kk" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Average Exercise Price, Beginning BalanceWeighted Average Exercise Price, Beginning Balance"&gt;57.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20211231__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBXmedbsBLS8" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Average Remaining Contractual Term (in years), Outstanding"&gt;7.20&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20211231__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zsbNKjLQMpu1" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Intrinsic Value, Outstanding, Beginning balanceIntrinsic Value, Outstanding, Ending balance"&gt;369,102&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Retroactive application of recapitalization (Note 4)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iNS_di_c20211231__20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zwlMxTVLgL22" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number"&gt;(6,024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20211231__20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zj30fYBvDFga" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price"&gt;36.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Outstanding at December 31, 2021, after effect of Merger (Note 4)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_zhSrvHEzdB24" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Option to purchase aggregate number of shares"&gt;9,610&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zTaIinWNsxZ2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price"&gt;93.55&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Granted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231_zQiGUnh2dASh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Granted"&gt;4,702&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zlJZWwj6POs8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"&gt;138.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Exercised&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20221231_zWndmfY03eQ7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Exercised"&gt;(171&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zjCDT0LYqDri" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;62.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20220101__20221231_zUs91RDYeoQi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Outstanding, Exercised"&gt;10,835&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expired&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20220101__20221231_zMbaMAmS93S4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Expired"&gt;(2,411&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zCwGPN3EYjxh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;69.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Forfeited&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220101__20221231_zNZVIN64nm46" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Forfeited"&gt;(4,310&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_ze1npNXwGIU2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;129.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Outstanding at December 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231_zBHoGWlKWh26" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Beginning balance"&gt;7,420&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231_zOciXR7hefjb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"&gt;106.44&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zND6LafTZTM6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Remaining Contractual Term (in years), Outstanding"&gt;7.95&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20230101__20231231_zh5H0fFjkUai" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Outstanding, Beginning Balance"&gt;3,433,946&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Granted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231_zeWIt5bPHtz3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Granted"&gt;16,440&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_z4B6T3yl0Dli" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"&gt;500.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Exercised&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230101__20231231_zLFrhiyPZEXb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Exercised"&gt;(353&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zj6AN683OY6h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;109.56&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20230101__20231231_zVAtYubkuaMa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Outstanding, Exercised"&gt;4,440&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expired&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20230101__20231231_zTCRjFofP58l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Expired"&gt;(258&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zs5r5f6VVlRk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;598.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Forfeited&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20231231_zSfyiTYA3gUe" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Forfeited"&gt;(8,287&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zNPw5gZwnfHl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;538.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Outstanding at December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20231231_z5SdRDvNdeP5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Ending balance"&gt;14,962&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231_zYEZg09TIC9b" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending Balance"&gt;293.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zMW5kRfHdILa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Remaining Contractual Term (in years), Outstanding"&gt;8.43&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20230101__20231231_zCHo4cGQBpcf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Outstanding, Ending balance"&gt;103,662&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Exercisable at December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20231231_zizhXccPfN8d" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Exercisable"&gt;6,900&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20231231_zKJSYdPjyzw9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercisable"&gt;211.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zhiqUOrXvqX6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Remaining Contractual Term (in years), Exercisable"&gt;7.56&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231_zCExnzVDNwlc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Exercisable"&gt;103,251&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zNiD8Mmtqqcf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with issuances under the Plan, the Company recorded stock-based compensation expense of $&lt;span id="xdx_908_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20231231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_zY1POEMiGLYe" title="Stock-based compensation expense"&gt;1,245,796&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__us-gaap--GeneralAndAdministrativeExpenseMember_z14cI4dwse5c" title="Stock-based compensation expense"&gt;770,336&lt;/span&gt;, which is
included in general and administrative expense for the years ended December 31, 2023 and 2022, respectively. The weighted-average grant-date
fair value per option granted during the years ended December 31, 2023 and 2022 was $&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230101__20231231_ziTCdG0d0vlc" title="Weighted average grant date fair value"&gt;4.86&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231_zUo18kbswFw3" title="Weighted average grant date fair value"&gt;0.77&lt;/span&gt;, respectively. As of December 31,
2023 and 2022, $&lt;span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20231231_ziso7UX18tR1" title="Unrecognized compensation expense related to unvested options"&gt;2,594,571&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20221231_zPDFTZ2s55Di" title="Unrecognized compensation expense related to unvested options"&gt;160,203&lt;/span&gt; of unrecognized compensation expense related to non-vested awards is expected to be recognized
over the weighted average period of &lt;span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231_zMzxpoOyjB9a" title="Unrecognized compensation expense related to unvested options"&gt;2.73&lt;/span&gt; and &lt;span id="xdx_90D_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20220101__20221231_zurqYV1adXKf" title="Period for unrecognized compensation expense related to unvested options yet has not been recognized"&gt;2.74&lt;/span&gt; years, respectively. The aggregate intrinsic value is calculated as the difference
between the fair value of the Company&#x2019;s stock price and the exercise price of the options.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2016-04-26_custom_TwoThousandAndSixteenEquityIncentivePlanMember"
      decimals="INF"
      id="Fact004831"
      unitRef="Shares">8000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease
      contextRef="From2017-07-192017-07-19_custom_TwoThousandAndSixteenEquityIncentivePlanMember"
      decimals="INF"
      id="Fact004833"
      unitRef="Shares">48000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2023-12-31_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember"
      decimals="INF"
      id="Fact004835"
      unitRef="Shares">11443</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms
      contextRef="From2023-01-012023-12-31_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember"
      id="Fact004837">The aggregate number of shares of common stock that may be issued will not exceed approximately 12.5% of
the fully diluted common stock determined at the Close of the Merger. In addition, the aggregate number of shares of common stock will
automatically increase on January 1 of each year for a period of ten years commencing on January 1, 2024 and ending on January 1, 2033,
in an amount equal to 5% of the total number of shares of the fully diluted common stock determined as of the day prior to such increase.
The aggregate maximum number of shares of common stock that may be issued pursuant to the exercise of incentive stock options is approximately
three times the total number of shares of common stock initially reserved for issuance.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
      contextRef="From2023-01-012023-12-31_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember"
      id="Fact004839">2033-01-01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004841"
      unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <BNZI:RepricingValueOfOutstandingStockOption
      contextRef="From2023-12-032023-12-03"
      decimals="INF"
      id="Fact004843"
      unitRef="Shares">7193</BNZI:RepricingValueOfOutstandingStockOption>
    <BNZI:StockOptionsExercisePricePerShare
      contextRef="From2023-12-032023-12-03"
      decimals="INF"
      id="Fact004845"
      unitRef="USDPShares">257.50</BNZI:StockOptionsExercisePricePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="From2023-12-032023-12-03"
      decimals="0"
      id="Fact004847"
      unitRef="USD">113475</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <BNZI:VestedStockBasedCompensationExpense
      contextRef="From2023-12-032023-12-03"
      decimals="0"
      id="Fact004849"
      unitRef="USD">23849</BNZI:VestedStockBasedCompensationExpense>
    <BNZI:UnvestedStockBasedCompensationExpense
      contextRef="From2023-12-032023-12-03"
      decimals="0"
      id="Fact004851"
      unitRef="USD">89626</BNZI:UnvestedStockBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-12-14_custom_SubstituteOptionsMember"
      decimals="INF"
      id="Fact004853"
      unitRef="USDPShares">0.6147</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-14"
      decimals="INF"
      id="Fact004855"
      unitRef="Shares">14962</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-12-14"
      decimals="INF"
      id="Fact004857"
      unitRef="USDPShares">293.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004859">&lt;p id="xdx_893_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zZ6NnGJJEFGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes assumptions used to compute the fair value of options granted:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zn34P8zGfa76" style="display: none"&gt;Summary of Assumptions Used to Compute Fair Value&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;br/&gt; 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 64%"&gt;Stock price&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--SharePrice_iI_c20231231__srt--RangeAxis__srt--MinimumMember_zVfW5uMVWuZc" title="Stock price"&gt;8.38&lt;/span&gt; - &lt;span id="xdx_90C_eus-gaap--SharePrice_iI_c20231231__srt--RangeAxis__srt--MaximumMember_zMPxAleXlvDg" title="Stock price"&gt;11.98&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--SharePrice_iI_c20221231_zmm8AanFrhl6" title="Stock price"&gt;1.54&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Exercise price&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20231231__srt--RangeAxis__srt--MinimumMember_zag7Dz5KUr5l" title="Exercise price"&gt;8.38&lt;/span&gt; - &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20231231__srt--RangeAxis__srt--MaximumMember_z5BOUJ43Awf3" title="Exercise price"&gt;11.98&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_c20221231_zqrpLnjYdJa6" title="Exercise price"&gt;1.04&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20230101__20231231_zUsewiqaE3ba" title="Expected volatility minimum"&gt;80.00&lt;/span&gt; - &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20230101__20231231_zhRDP497GI31" title="Expected volatility maximum"&gt;110.95&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20220101__20221231_z0zEEC9Zmfqd" title="Expected volatility minimum"&gt;53.61&lt;/span&gt;
- &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20220101__20221231_zzMLBbbHMly8" title="Expected volatility maximum"&gt;55.30&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expected term (in years)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zX2Xrsdgolc2" title="Time to maturity"&gt;5.00&lt;/span&gt; - &lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zsIe1wISZgg2" title="Time to maturity"&gt;6.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zyhR034sbHR9" title="Time to maturity"&gt;5.94&lt;/span&gt; - &lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zOrdjnbii6V5" title="Time to maturity"&gt;6.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_uPure_c20230101__20231231_ztEKWWX2Mak2" title="Risk-free interest rate"&gt;3.46&lt;/span&gt; - &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_uPure_c20230101__20231231_zNA69jiNG6i" title="Risk-free interest rate"&gt;4.31&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_uPure_c20220101__20221231_zImL3ZjVG6fc" title="Risk-free interest rate, minimum"&gt;1.95&lt;/span&gt; - &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_uPure_c20220101__20221231_zdih4cKJnGD6" title="Risk-free interest rate, maximum"&gt;2.85&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2023-12-31_srt_MinimumMember"
      decimals="INF"
      id="Fact004861"
      unitRef="USDPShares">8.38</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2023-12-31_srt_MaximumMember"
      decimals="INF"
      id="Fact004863"
      unitRef="USDPShares">11.98</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact004865"
      unitRef="USDPShares">1.54</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2023-12-31_srt_MinimumMember"
      decimals="INF"
      id="Fact004867"
      unitRef="USDPShares">8.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2023-12-31_srt_MaximumMember"
      decimals="INF"
      id="Fact004869"
      unitRef="USDPShares">11.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact004871"
      unitRef="USDPShares">1.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004873"
      unitRef="Pure">0.8000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004875"
      unitRef="Pure">1.1095</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004877"
      unitRef="Pure">0.5361</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004879"
      unitRef="Pure">0.5530</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-12-31_srt_MinimumMember"
      id="Fact004881">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-01-012023-12-31_srt_MaximumMember"
      id="Fact004883">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-01-012022-12-31_srt_MinimumMember"
      id="Fact004885">P5Y11M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2022-01-012022-12-31_srt_MaximumMember"
      id="Fact004887">P6Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004889"
      unitRef="Pure">0.0346</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004891"
      unitRef="Pure">0.0431</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004893"
      unitRef="Pure">0.0195</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004895"
      unitRef="Pure">0.0285</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004897">&lt;p id="xdx_89D_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zAXNiZyxeSY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
summary of stock option activity under the Plan is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zd6QzSqBpVm5" style="display: none"&gt;Summary of Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Shares&lt;br/&gt; Underlying&lt;br/&gt; Options&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise&lt;br/&gt; Price&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Remaining&lt;br/&gt; Contractual&lt;br/&gt; Term (in&lt;br/&gt; years)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Intrinsic&lt;br/&gt; Value&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 44%"&gt;Outstanding at December 31, 2021&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20211231__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_z3J9EbouMMc2" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Shares Underlying Options, Beginning balanceShares Underlying Options, Beginning balance"&gt;14,634&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20211231__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zIrzqsVzw0kk" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Average Exercise Price, Beginning BalanceWeighted Average Exercise Price, Beginning Balance"&gt;57.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20211231__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zBXmedbsBLS8" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Average Remaining Contractual Term (in years), Outstanding"&gt;7.20&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20211231__20211231__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zsbNKjLQMpu1" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Intrinsic Value, Outstanding, Beginning balanceIntrinsic Value, Outstanding, Ending balance"&gt;369,102&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Retroactive application of recapitalization (Note 4)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iNS_di_c20211231__20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zwlMxTVLgL22" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number"&gt;(6,024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20211231__20211231__srt--RestatementAxis__srt--RestatementAdjustmentMember_zj30fYBvDFga" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price"&gt;36.05&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Outstanding at December 31, 2021, after effect of Merger (Note 4)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_zhSrvHEzdB24" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Option to purchase aggregate number of shares"&gt;9,610&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zTaIinWNsxZ2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price"&gt;93.55&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Granted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20221231_zQiGUnh2dASh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Granted"&gt;4,702&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zlJZWwj6POs8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"&gt;138.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Exercised&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20220101__20221231_zWndmfY03eQ7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Exercised"&gt;(171&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zjCDT0LYqDri" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;62.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20220101__20221231_zUs91RDYeoQi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Outstanding, Exercised"&gt;10,835&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expired&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20220101__20221231_zMbaMAmS93S4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Expired"&gt;(2,411&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zCwGPN3EYjxh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;69.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Forfeited&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20220101__20221231_zNZVIN64nm46" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Forfeited"&gt;(4,310&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_ze1npNXwGIU2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;129.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Outstanding at December 31, 2022&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231_zBHoGWlKWh26" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Beginning balance"&gt;7,420&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20231231_zOciXR7hefjb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Beginning Balance"&gt;106.44&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zND6LafTZTM6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Remaining Contractual Term (in years), Outstanding"&gt;7.95&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20230101__20231231_zh5H0fFjkUai" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Outstanding, Beginning Balance"&gt;3,433,946&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Granted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231_zeWIt5bPHtz3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Granted"&gt;16,440&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_z4B6T3yl0Dli" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Granted"&gt;500.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Exercised&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230101__20231231_zLFrhiyPZEXb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Exercised"&gt;(353&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zj6AN683OY6h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;109.56&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20230101__20231231_zVAtYubkuaMa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Outstanding, Exercised"&gt;4,440&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expired&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20230101__20231231_zTCRjFofP58l" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Expired"&gt;(258&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zs5r5f6VVlRk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expired"&gt;598.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Forfeited&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20231231_zSfyiTYA3gUe" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Forfeited"&gt;(8,287&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20230101__20231231_zNPw5gZwnfHl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited"&gt;538.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;Outstanding at December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20231231_z5SdRDvNdeP5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Ending balance"&gt;14,962&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20231231_zYEZg09TIC9b" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Ending Balance"&gt;293.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zMW5kRfHdILa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Remaining Contractual Term (in years), Outstanding"&gt;8.43&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20230101__20231231_zCHo4cGQBpcf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Outstanding, Ending balance"&gt;103,662&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;Exercisable at December 31, 2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20230101__20231231_zizhXccPfN8d" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Shares Underlying Options, Exercisable"&gt;6,900&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pid_c20231231_zKJSYdPjyzw9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercisable"&gt;211.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_zhiqUOrXvqX6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Remaining Contractual Term (in years), Exercisable"&gt;7.56&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20231231_zCExnzVDNwlc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic Value, Exercisable"&gt;103,251&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-30_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      id="Fact004899"
      unitRef="Shares">14634</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-30_srt_ScenarioPreviouslyReportedMember"
      decimals="INF"
      id="Fact004901"
      unitRef="USDPShares">57.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2021-12-312021-12-31_srt_ScenarioPreviouslyReportedMember"
      id="Fact004903">P7Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2021-12-30_srt_ScenarioPreviouslyReportedMember"
      decimals="0"
      id="Fact004905"
      unitRef="USD">369102</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-30_srt_RestatementAdjustmentMember"
      decimals="INF"
      id="Fact004907"
      unitRef="Shares">6024</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-30_srt_RestatementAdjustmentMember"
      decimals="INF"
      id="Fact004909"
      unitRef="USDPShares">36.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="Fact004911"
      unitRef="Shares">9610</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2021-12-31"
      decimals="INF"
      id="Fact004913"
      unitRef="USDPShares">93.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004915"
      unitRef="Shares">4702</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004917"
      unitRef="USDPShares">138.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004919"
      unitRef="Shares">171</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004921"
      unitRef="USDPShares">62.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004923"
      unitRef="USD">10835</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004925"
      unitRef="Shares">2411</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004927"
      unitRef="USDPShares">69.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004929"
      unitRef="Shares">4310</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004931"
      unitRef="USDPShares">129.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact004933"
      unitRef="Shares">7420</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2022-12-31"
      decimals="INF"
      id="Fact004935"
      unitRef="USDPShares">106.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2022-01-012022-12-31" id="Fact004937">P7Y11M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004939"
      unitRef="USD">3433946</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004941"
      unitRef="Shares">16440</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004943"
      unitRef="USDPShares">500.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004945"
      unitRef="Shares">353</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004947"
      unitRef="USDPShares">109.56</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact004949"
      unitRef="USD">4440</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004951"
      unitRef="Shares">258</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004953"
      unitRef="USDPShares">598.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004955"
      unitRef="Shares">8287</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004957"
      unitRef="USDPShares">538.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004959"
      unitRef="Shares">14962</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004961"
      unitRef="USDPShares">293.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2023-01-012023-12-31" id="Fact004963">P8Y5M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004965"
      unitRef="USD">103662</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004967"
      unitRef="Shares">6900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact004969"
      unitRef="USDPShares">211.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2023-01-012023-12-31" id="Fact004971">P7Y6M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004973"
      unitRef="USD">103251</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-01-012023-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact004975"
      unitRef="USD">1245796</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2022-01-012022-12-31_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="0"
      id="Fact004977"
      unitRef="USD">770336</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004979"
      unitRef="USDPShares">4.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact004981"
      unitRef="USDPShares">0.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact004983"
      unitRef="USD">2594571</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact004985"
      unitRef="USD">160203</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2023-01-012023-12-31" id="Fact004987">P2Y8M23D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2022-01-012022-12-31" id="Fact004989">P2Y8M26D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2023-01-012023-12-31" id="Fact004991">&lt;p id="xdx_807_eus-gaap--IncomeTaxDisclosureTextBlock_zPFMtZiOUfc6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;20.
&lt;span id="xdx_820_zXluWbsMnqyk"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zRVyr5IWOPm" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
reconciliation of the statutory U.S. federal income tax rate to the Company&#x2019;s effective tax rate consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_zZgFH56UoUAh" style="display: none"&gt;Schedule of US Federal Income Tax Rate to the Company's Effective Tax Rate&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statutory federal income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20230101__20231231_zBSJZ1UOWFhe" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Statutory federal income tax benefit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,025,315&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_maCal1_c20230101__20231231_zr4cYRL2cjQ2" title="Statutory federal income tax benefit, percentage"&gt;21.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20220101__20221231_zpNOJH5GgEC5" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Statutory federal income tax benefit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,248,385&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_macal2_c20220101__20221231_ztebLr56ojgi" title="Statutory federal income tax benefit, percentage"&gt;21.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;State taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20230101__20231231_zhG220tPF7P1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="State taxes, net of federal tax benefit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(219,705&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_uPure_maCal1_c20230101__20231231_zJgSLiZlKe9h" title="State taxes, net of federal tax benefit, percentage"&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20220101__20221231_zcwnJXCi6tSl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="State taxes, net of federal tax benefit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(327,095&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_uPure_macal2_c20220101__20221231_zforXUPfi2q4" title="State taxes, net of federal tax benefit, percentage"&gt;2.1&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ChangeInValuationAllowanceAmount_c20230101__20231231_zZ9DEPqxjVz9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in valuation allowance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,079,231&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--ChangeInValuationAllowance_dp_uPure_maCal1_c20230101__20231231_zHqlOTdMmT61" title="Change in valuation allowance, percentage"&gt;-14.4&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ChangeInValuationAllowanceAmount_c20220101__20221231_zgszB8g9WQNi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in valuation allowance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,435,041&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--ChangeInValuationAllowance_dp_uPure_macal2_c20220101__20221231_zQDJPHWe9r44" title="Change in valuation allowance, percentage"&gt;-9.3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in state tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_c20230101__20231231_zq31eWz2PWsb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in state tax rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;462,709&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_dp_uPure_maCal1_c20230101__20231231_zH662crIzFFa" title="Change in state tax rate, percentage"&gt;-3.2&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_c20220101__20221231_zKWKfamQhtU1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in state tax rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,055&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_dp_uPure_macal2_c20220101__20221231_zIYiwjXUyZ63" title="Change in state tax rate, percentage"&gt;-0.1&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in fair value estimates&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueEstimates_c20230101__20231231_zJBcNiMDLRbg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value estimates"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,050,026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueEstimatesRate_dp_uPure_maCal1_c20230101__20231231_zPOVpsYrvVA7" title="Change in fair value estimates, percentage"&gt;14.2&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueEstimates_c20220101__20221231_z6kRmQajR2Z8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value estimates"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,610,993&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueEstimatesRate_dp_uPure_macal2_c20220101__20221231_zdwxCK6eQJf7" title="Change in fair value estimates, percentage"&gt;-10.4&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-deductible interest-IRC 163(j)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--IncomeTaxReconciliationNondeductibleInterest_c20230101__20231231_zoMa8DdqGYd1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-deductible interest-IRC 163(j)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;738,993&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--IncomeTaxReconciliationNondeductibleInterestRate_dp_uPure_maCal1_c20230101__20231231_zg2066qpGym1" title="Non-deductible interest - IRC 163(j), percentage"&gt;-5.1&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IncomeTaxReconciliationNondeductibleInterest_c20220101__20221231_zCUUo7AFnJCi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-deductible interest-IRC 163(j)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5039"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--IncomeTaxReconciliationNondeductibleInterestRate_dp_uPure_macal2_c20220101__20221231_z7HCHsowQSsg" title="Non-deductible interest - IRC 163(j), percentage"&gt;0.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-deductible transaction/restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges_c20230101__20231231_zRuX4eS9AsCe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-deductible transaction restructuring costs"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,313,792&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_dp_uPure_maCal1_c20230101__20231231_zwgqWseYA9Jc" title="Non-deductible transaction"&gt;-9.1&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges_c20220101__20221231_zXz5grsAAW4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-deductible transaction restructuring costs"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5047"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_dp_uPure_macal2_c20220101__20221231_zfhLPlY0trjc" title="Non-deductible transaction"&gt;0.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nondeductible warrant issuance expense&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IncomeTaxReconciliationNondeductibleWarrantIssuanceExpense_c20230101__20231231_zVxhpvIaE6N9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Nondeductible warrant issuance expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;552,321&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--IncomeTaxReconciliationNondeductibleWarrantIssuanceExpenseRate_dp_uPure_maCal1_c20230101__20231231_z4mAlWNHPfHa" title="Nondeductible warrant issuance expense, percentage"&gt;-3.8&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IncomeTaxReconciliationNondeductibleWarrantIssuanceExpense_c20220101__20221231_zTmxt4MAxmea" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Nondeductible warrant issuance expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5055"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--IncomeTaxReconciliationNondeductibleWarrantIssuanceExpenseRate_dp_uPure_macal2_c20220101__20221231_zwKojXRsEw9j" title="Nondeductible warrant issuance expense, percentage"&gt;0.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other non-deductible
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseOther_c20230101__20231231_zdexNYREYyNa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other non-deductible expenses"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;148,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp_uPure_maCal1_c20230101__20231231_zHeaaIEuOI4f" title="Other non-deductible expenses, percentage"&gt;-1.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseOther_c20220101__20221231_zlJQcR06oGSh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other non-deductible expenses"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;516,391&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp_uPure_macal2_c20220101__20221231_z4JdFTFtm1F9" title="Other non-deductible expenses, percentage"&gt;-3.3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20230101__20231231_znXNVWxeKC59" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Effective tax rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5067"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_dp_uPure_mtCal1_c20230101__20231231_zX43D8XOu10i" title="Effective tax rate, percentage"&gt;0.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zyVc06fbndeh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Effective tax rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5071"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_dp_uPure_mtcal2_c20220101__20221231_zXRpqyUJksWl" title="Effective tax rate, percentage"&gt;0.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_z9WkEeAnJ0x5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zgJK14to3uEf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of income tax provision (benefit) are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B1_zEx8NrEO7dT" style="display: none"&gt;Schedule of Components of Income Tax Provision (Benefit)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49C_20230101__20231231_zSBkUr9U3t96" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_490_20220101__20221231_zhlgBDrbDN2k" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="5" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
                                                                                                                                                      of December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Federal:&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CurrentFederalTaxExpenseBenefit_zeGYATht0Aa9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 64%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5077"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5078"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_zdEBUzvmu1m3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5080"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5081"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;State and Local:&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_zkvsZw9s2zoh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5083"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5084"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_zK8Ear5nfXjc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5086"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5087"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncomeTaxExpenseBenefit_zYIhEoPm0Rvk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5089"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5090"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_z6YSCDFnoeub" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zKxi272ErKzf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
income taxes reflect the net tax effects of temporary differences between the carrying value of assets and liabilities for financial
reporting purposes and amounts used for income tax purposes. The temporary differences that give rise to deferred tax assets and liabilities
are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B0_zVPifLZUbZuj" style="display: none"&gt;Schedule of Temporary Differences that Give Rise to Deferred Tax Assets and Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20231231_zW4vmL9D7GA5" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20221231_zeFT20roxmCf" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredCostsAbstract_iB_zbuPqqlVQbl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax assets (liabilities):&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTAGzi7W_zL6vGkaCTJRa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net operating
    loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,368,669&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,744,512&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsCharitableContributionCarryforwards_iI_maDTAGzi7W_zvEZgIPaQywj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Contribution carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24,626&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,837&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_maDTAGzi7W_zIBRFImRnUI5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;155,404&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,216&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxAssetsAccrualToCashAdjustment_iI_maDTAGzi7W_zwP2FI2tXMEi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrual to cash adjustment&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,299&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;482,109&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DeferredTaxAssetsTaxStartupCosts_iI_maDTAGzi7W_zcIl6Ubd0m94" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Startup costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,816,143&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5110"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--DeferredTaxAssetsLeaseLiabilities_iI_maDTAGzi7W_zGBDZWUP0Ejb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Lease Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,805&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;119,971&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DeferredTaxLiabilitiesRightOfUseAssets_iI_msDTAGzi7W_zUlAiSrbB5l8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(30,236&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(71,024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts_iI_maDTAGzi7W_zLBGxRiiTDY1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Capitalized R&amp;amp;D costs
    (Sec. 174)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;798,802&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;451,195&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsOther_iI_maDTAGzi7W_zPSkk8smOIS8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,363&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;696&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsGross_iTI_mtDTAGzi7W_maDTANzRwR_zbaIrZCBp6g6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Deferred tax assets gross&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,184,149&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,773,512&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzRwR_z4FxuenSsDRh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(9,184,149&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,773,512&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzRwR_zqzmgMPqAaH1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax assets,
    net of allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5130"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5131"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zEZJNVaso27c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2023, the Company had federal and state net operating loss carryforwards of approximately $&lt;span id="xdx_904_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_c20231231_z5W0Lj4XbW6d" title="Federal net operating loss carryforwards"&gt;26,705,200&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_c20231231_zPEnl9lIYVGe" title="State net operating loss carryforwards"&gt;13,043,900&lt;/span&gt;,
respectively. As of December 31, 2022, the Company had federal and state net operating loss carryforwards of approximately $&lt;span id="xdx_901_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_c20221231_zvS5P9o0lqz6" title="Federal net operating loss carryforwards"&gt;15,325,300&lt;/span&gt;
and $&lt;span id="xdx_90F_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_c20221231_zKMeQnGEUvJe" title="State net operating loss carryforwards"&gt;9,175,400&lt;/span&gt;, respectively. Federal losses of $&lt;span id="xdx_90B_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_z7qGy44KbWRe" title="State net operating loss carryforwards"&gt;124,500&lt;/span&gt; begin to expire in 2036 and $&lt;span id="xdx_906_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zRFZ3SJNO3z3" title="Operating loss carryforwards indefinitely"&gt;26,580,700&lt;/span&gt; of the federal losses carryforward indefinitely.
State losses of $&lt;span id="xdx_906_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zsajuCWaeaSl" title="Operating loss carryforwards to expire"&gt;10,666,100&lt;/span&gt; begin to expire in 2031 and $&lt;span id="xdx_905_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_iI_c20231231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zg8aP9th54G4" title="Operating loss carryforwards indefinitely"&gt;2,377,800&lt;/span&gt; of the state losses carryforward indefinitely. Utilization of the
net operating loss carryforwards may be subject to an annual limitation according to Section 382 of the Internal Revenue Code of 1986
as amended, and similar provisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has determined, based upon available evidence, that it is more likely than not that all the net deferred tax assets will not
be realized and, accordingly, has provided a full valuation allowance against its net deferred tax asset. Management considers the scheduled
reversal of deferred tax liabilities, projected future taxable income, net operating loss carryback potential, and tax planning strategies
in making these assessments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has determined that it had &lt;span id="xdx_902_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20231231_zxKRIRxPIrc3" title="Uncertain tax benefits"&gt;&lt;span id="xdx_907_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20221231_z0yoAIsW45qa" title="Uncertain tax benefits"&gt;no&lt;/span&gt;&lt;/span&gt; material uncertain tax benefits for the year ended December 31, 2023 and 2022. The Company recognizes
interest accrued related to unrecognized tax benefits and penalties in interest expense and penalties in operating expense. &lt;span id="xdx_90B_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20231231_zUiwPaedzxSl" title="Interest and penalties"&gt;&lt;span id="xdx_901_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestAccrued_iI_do_c20221231_zKb8xQ30jibl" title="Interest and penalties"&gt;No&lt;/span&gt;&lt;/span&gt; amounts
were accrued for the payment of interest and penalties at December 31, 2023, and 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company files tax returns as prescribed by the tax laws of the jurisdictions in which they operate. In the normal course of business,
the Company is subject to examination by federal and state jurisdictions where applicable based on the statute of limitations that apply
in each jurisdiction. As of December 31, 2023, the &lt;span id="xdx_908_eus-gaap--OpenTaxYear_c20230101__20231231_zXbTi7BhuQ2a" title="Open tax year"&gt;2016&lt;/span&gt; and subsequent tax years related to all jurisdictions remain open.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--IncomeTaxExaminationDescription_c20230101__20231231_zX70Ksfp6tc4" title="Open tax audits, description"&gt;The
Company has no open tax audits with any taxing authority as of December 31, 2023.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact004993">&lt;p id="xdx_89B_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zRVyr5IWOPm" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
reconciliation of the statutory U.S. federal income tax rate to the Company&#x2019;s effective tax rate consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B7_zZgFH56UoUAh" style="display: none"&gt;Schedule of US Federal Income Tax Rate to the Company's Effective Tax Rate&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
    the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Statutory federal income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20230101__20231231_zBSJZ1UOWFhe" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Statutory federal income tax benefit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,025,315&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_maCal1_c20230101__20231231_zr4cYRL2cjQ2" title="Statutory federal income tax benefit, percentage"&gt;21.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20220101__20221231_zpNOJH5GgEC5" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Statutory federal income tax benefit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,248,385&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_uPure_macal2_c20220101__20221231_ztebLr56ojgi" title="Statutory federal income tax benefit, percentage"&gt;21.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;State taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20230101__20231231_zhG220tPF7P1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="State taxes, net of federal tax benefit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(219,705&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_uPure_maCal1_c20230101__20231231_zJgSLiZlKe9h" title="State taxes, net of federal tax benefit, percentage"&gt;1.5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_c20220101__20221231_zcwnJXCi6tSl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="State taxes, net of federal tax benefit"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(327,095&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_uPure_macal2_c20220101__20221231_zforXUPfi2q4" title="State taxes, net of federal tax benefit, percentage"&gt;2.1&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ChangeInValuationAllowanceAmount_c20230101__20231231_zZ9DEPqxjVz9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in valuation allowance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,079,231&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--ChangeInValuationAllowance_dp_uPure_maCal1_c20230101__20231231_zHqlOTdMmT61" title="Change in valuation allowance, percentage"&gt;-14.4&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ChangeInValuationAllowanceAmount_c20220101__20221231_zgszB8g9WQNi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in valuation allowance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,435,041&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_ecustom--ChangeInValuationAllowance_dp_uPure_macal2_c20220101__20221231_zQDJPHWe9r44" title="Change in valuation allowance, percentage"&gt;-9.3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in state tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_c20230101__20231231_zq31eWz2PWsb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in state tax rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;462,709&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_dp_uPure_maCal1_c20230101__20231231_zH662crIzFFa" title="Change in state tax rate, percentage"&gt;-3.2&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeTaxReconciliationChangeInEnactedTaxRate_c20220101__20221231_zKWKfamQhtU1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in state tax rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,055&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_dp_uPure_macal2_c20220101__20221231_zIYiwjXUyZ63" title="Change in state tax rate, percentage"&gt;-0.1&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change in fair value estimates&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueEstimates_c20230101__20231231_zJBcNiMDLRbg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value estimates"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,050,026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueEstimatesRate_dp_uPure_maCal1_c20230101__20231231_zPOVpsYrvVA7" title="Change in fair value estimates, percentage"&gt;14.2&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueEstimates_c20220101__20221231_z6kRmQajR2Z8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value estimates"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,610,993&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--EffectiveIncomeTaxRateReconciliationChangeInFairValueEstimatesRate_dp_uPure_macal2_c20220101__20221231_zdwxCK6eQJf7" title="Change in fair value estimates, percentage"&gt;-10.4&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-deductible interest-IRC 163(j)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--IncomeTaxReconciliationNondeductibleInterest_c20230101__20231231_zoMa8DdqGYd1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-deductible interest-IRC 163(j)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;738,993&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--IncomeTaxReconciliationNondeductibleInterestRate_dp_uPure_maCal1_c20230101__20231231_zg2066qpGym1" title="Non-deductible interest - IRC 163(j), percentage"&gt;-5.1&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IncomeTaxReconciliationNondeductibleInterest_c20220101__20221231_zCUUo7AFnJCi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-deductible interest-IRC 163(j)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5039"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_ecustom--IncomeTaxReconciliationNondeductibleInterestRate_dp_uPure_macal2_c20220101__20221231_z7HCHsowQSsg" title="Non-deductible interest - IRC 163(j), percentage"&gt;0.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-deductible transaction/restructuring costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges_c20230101__20231231_zRuX4eS9AsCe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-deductible transaction restructuring costs"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,313,792&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_dp_uPure_maCal1_c20230101__20231231_zwgqWseYA9Jc" title="Non-deductible transaction"&gt;-9.1&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges_c20220101__20221231_zXz5grsAAW4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non-deductible transaction restructuring costs"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5047"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges_dp_uPure_macal2_c20220101__20221231_zfhLPlY0trjc" title="Non-deductible transaction"&gt;0.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Nondeductible warrant issuance expense&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IncomeTaxReconciliationNondeductibleWarrantIssuanceExpense_c20230101__20231231_zVxhpvIaE6N9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Nondeductible warrant issuance expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;552,321&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_ecustom--IncomeTaxReconciliationNondeductibleWarrantIssuanceExpenseRate_dp_uPure_maCal1_c20230101__20231231_z4mAlWNHPfHa" title="Nondeductible warrant issuance expense, percentage"&gt;-3.8&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IncomeTaxReconciliationNondeductibleWarrantIssuanceExpense_c20220101__20221231_zTmxt4MAxmea" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Nondeductible warrant issuance expense"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5055"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_ecustom--IncomeTaxReconciliationNondeductibleWarrantIssuanceExpenseRate_dp_uPure_macal2_c20220101__20221231_zwKojXRsEw9j" title="Nondeductible warrant issuance expense, percentage"&gt;0.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other non-deductible
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseOther_c20230101__20231231_zdexNYREYyNa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other non-deductible expenses"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;148,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp_uPure_maCal1_c20230101__20231231_zHeaaIEuOI4f" title="Other non-deductible expenses, percentage"&gt;-1.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseOther_c20220101__20221231_zlJQcR06oGSh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other non-deductible expenses"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;516,391&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp_uPure_macal2_c20220101__20221231_z4JdFTFtm1F9" title="Other non-deductible expenses, percentage"&gt;-3.3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeTaxExpenseBenefit_c20230101__20231231_znXNVWxeKC59" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Effective tax rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5067"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_dp_uPure_mtCal1_c20230101__20231231_zX43D8XOu10i" title="Effective tax rate, percentage"&gt;0.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_zyVc06fbndeh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Effective tax rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5071"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_dp_uPure_mtcal2_c20220101__20221231_zXRpqyUJksWl" title="Effective tax rate, percentage"&gt;0.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact004995"
      unitRef="USD">-3025315</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact004997"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact004999"
      unitRef="USD">-3248385</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact005001"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact005003"
      unitRef="USD">-219705</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact005005"
      unitRef="Pure">0.015</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact005007"
      unitRef="USD">-327095</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact005009"
      unitRef="Pure">0.021</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <BNZI:ChangeInValuationAllowanceAmount
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact005011"
      unitRef="USD">2079231</BNZI:ChangeInValuationAllowanceAmount>
    <BNZI:ChangeInValuationAllowance
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact005013"
      unitRef="Pure">-0.144</BNZI:ChangeInValuationAllowance>
    <BNZI:ChangeInValuationAllowanceAmount
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact005015"
      unitRef="USD">1435041</BNZI:ChangeInValuationAllowanceAmount>
    <BNZI:ChangeInValuationAllowance
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact005017"
      unitRef="Pure">-0.093</BNZI:ChangeInValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact005019"
      unitRef="USD">462709</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact005021"
      unitRef="Pure">-0.032</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact005023"
      unitRef="USD">13055</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact005025"
      unitRef="Pure">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <BNZI:EffectiveIncomeTaxRateReconciliationChangeInFairValueEstimates
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact005027"
      unitRef="USD">-2050026</BNZI:EffectiveIncomeTaxRateReconciliationChangeInFairValueEstimates>
    <BNZI:EffectiveIncomeTaxRateReconciliationChangeInFairValueEstimatesRate
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact005029"
      unitRef="Pure">0.142</BNZI:EffectiveIncomeTaxRateReconciliationChangeInFairValueEstimatesRate>
    <BNZI:EffectiveIncomeTaxRateReconciliationChangeInFairValueEstimates
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact005031"
      unitRef="USD">1610993</BNZI:EffectiveIncomeTaxRateReconciliationChangeInFairValueEstimates>
    <BNZI:EffectiveIncomeTaxRateReconciliationChangeInFairValueEstimatesRate
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact005033"
      unitRef="Pure">-0.104</BNZI:EffectiveIncomeTaxRateReconciliationChangeInFairValueEstimatesRate>
    <BNZI:IncomeTaxReconciliationNondeductibleInterest
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact005035"
      unitRef="USD">738993</BNZI:IncomeTaxReconciliationNondeductibleInterest>
    <BNZI:IncomeTaxReconciliationNondeductibleInterestRate
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact005037"
      unitRef="Pure">-0.051</BNZI:IncomeTaxReconciliationNondeductibleInterestRate>
    <BNZI:IncomeTaxReconciliationNondeductibleInterestRate
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact005041"
      unitRef="Pure">0.000</BNZI:IncomeTaxReconciliationNondeductibleInterestRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact005043"
      unitRef="USD">1313792</us-gaap:IncomeTaxReconciliationNondeductibleExpenseRestructuringCharges>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact005045"
      unitRef="Pure">-0.091</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact005049"
      unitRef="Pure">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseRestructuringCharges>
    <BNZI:IncomeTaxReconciliationNondeductibleWarrantIssuanceExpense
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact005051"
      unitRef="USD">552321</BNZI:IncomeTaxReconciliationNondeductibleWarrantIssuanceExpense>
    <BNZI:IncomeTaxReconciliationNondeductibleWarrantIssuanceExpenseRate
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact005053"
      unitRef="Pure">-0.038</BNZI:IncomeTaxReconciliationNondeductibleWarrantIssuanceExpenseRate>
    <BNZI:IncomeTaxReconciliationNondeductibleWarrantIssuanceExpenseRate
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact005057"
      unitRef="Pure">0.000</BNZI:IncomeTaxReconciliationNondeductibleWarrantIssuanceExpenseRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact005059"
      unitRef="USD">148000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact005061"
      unitRef="Pure">-0.010</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact005063"
      unitRef="USD">516391</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact005065"
      unitRef="Pure">-0.033</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2023-01-012023-12-31"
      decimals="INF"
      id="Fact005069"
      unitRef="Pure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2022-01-012022-12-31"
      decimals="INF"
      id="Fact005073"
      unitRef="Pure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact005075">&lt;p id="xdx_893_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zgJK14to3uEf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
components of income tax provision (benefit) are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B1_zEx8NrEO7dT" style="display: none"&gt;Schedule of Components of Income Tax Provision (Benefit)&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_49C_20230101__20231231_zSBkUr9U3t96" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_490_20220101__20221231_zhlgBDrbDN2k" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="5" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
                                                                                                                                                      of December 31,&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Federal:&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--CurrentFederalTaxExpenseBenefit_zeGYATht0Aa9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 64%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5077"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5078"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_zdEBUzvmu1m3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5080"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5081"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;State and Local:&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_zkvsZw9s2zoh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5083"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5084"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_zK8Ear5nfXjc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5086"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5087"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncomeTaxExpenseBenefit_zYIhEoPm0Rvk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5089"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5090"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2023-01-012023-12-31" id="Fact005092">&lt;p id="xdx_893_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zKxi272ErKzf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
income taxes reflect the net tax effects of temporary differences between the carrying value of assets and liabilities for financial
reporting purposes and amounts used for income tax purposes. The temporary differences that give rise to deferred tax assets and liabilities
are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8B0_zVPifLZUbZuj" style="display: none"&gt;Schedule of Temporary Differences that Give Rise to Deferred Tax Assets and Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20231231_zW4vmL9D7GA5" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20221231_zeFT20roxmCf" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--DeferredCostsAbstract_iB_zbuPqqlVQbl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax assets (liabilities):&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_maDTAGzi7W_zL6vGkaCTJRa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 64%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net operating
    loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,368,669&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,744,512&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--DeferredTaxAssetsCharitableContributionCarryforwards_iI_maDTAGzi7W_zvEZgIPaQywj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Contribution carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;24,626&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20,837&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_maDTAGzi7W_zIBRFImRnUI5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;155,404&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,216&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxAssetsAccrualToCashAdjustment_iI_maDTAGzi7W_zwP2FI2tXMEi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrual to cash adjustment&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,299&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;482,109&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--DeferredTaxAssetsTaxStartupCosts_iI_maDTAGzi7W_zcIl6Ubd0m94" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Startup costs&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,816,143&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5110"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--DeferredTaxAssetsLeaseLiabilities_iI_maDTAGzi7W_zGBDZWUP0Ejb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Lease Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;52,805&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;119,971&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--DeferredTaxLiabilitiesRightOfUseAssets_iI_msDTAGzi7W_zUlAiSrbB5l8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(30,236&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(71,024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts_iI_maDTAGzi7W_zLBGxRiiTDY1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Capitalized R&amp;amp;D costs
    (Sec. 174)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;798,802&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;451,195&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsOther_iI_maDTAGzi7W_zPSkk8smOIS8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(3,363&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;696&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsGross_iTI_mtDTAGzi7W_maDTANzRwR_zbaIrZCBp6g6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Deferred tax assets gross&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,184,149&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,773,512&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzRwR_z4FxuenSsDRh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(9,184,149&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,773,512&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DeferredTaxAssetsNet_iTI_mtDTANzRwR_zqzmgMPqAaH1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred tax assets,
    net of allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5130"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5131"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact005097"
      unitRef="USD">6368669</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact005098"
      unitRef="USD">3744512</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact005100"
      unitRef="USD">24626</us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards>
    <us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact005101"
      unitRef="USD">20837</us-gaap:DeferredTaxAssetsCharitableContributionCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact005103"
      unitRef="USD">155404</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact005104"
      unitRef="USD">25216</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <BNZI:DeferredTaxAssetsAccrualToCashAdjustment
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact005106"
      unitRef="USD">1299</BNZI:DeferredTaxAssetsAccrualToCashAdjustment>
    <BNZI:DeferredTaxAssetsAccrualToCashAdjustment
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact005107"
      unitRef="USD">482109</BNZI:DeferredTaxAssetsAccrualToCashAdjustment>
    <BNZI:DeferredTaxAssetsTaxStartupCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact005109"
      unitRef="USD">1816143</BNZI:DeferredTaxAssetsTaxStartupCosts>
    <BNZI:DeferredTaxAssetsLeaseLiabilities
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact005112"
      unitRef="USD">52805</BNZI:DeferredTaxAssetsLeaseLiabilities>
    <BNZI:DeferredTaxAssetsLeaseLiabilities
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact005113"
      unitRef="USD">119971</BNZI:DeferredTaxAssetsLeaseLiabilities>
    <BNZI:DeferredTaxLiabilitiesRightOfUseAssets
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact005115"
      unitRef="USD">-30236</BNZI:DeferredTaxLiabilitiesRightOfUseAssets>
    <BNZI:DeferredTaxLiabilitiesRightOfUseAssets
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact005116"
      unitRef="USD">-71024</BNZI:DeferredTaxLiabilitiesRightOfUseAssets>
    <BNZI:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact005118"
      unitRef="USD">798802</BNZI:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts>
    <BNZI:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact005119"
      unitRef="USD">451195</BNZI:DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact005121"
      unitRef="USD">-3363</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact005122"
      unitRef="USD">696</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact005124"
      unitRef="USD">9184149</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact005125"
      unitRef="USD">4773512</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact005127"
      unitRef="USD">9184149</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact005128"
      unitRef="USD">4773512</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact005133"
      unitRef="USD">26705200</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact005135"
      unitRef="USD">13043900</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact005137"
      unitRef="USD">15325300</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact005139"
      unitRef="USD">9175400</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2023-12-31_us-gaap_DomesticCountryMember"
      decimals="0"
      id="Fact005141"
      unitRef="USD">124500</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="AsOf2023-12-31_us-gaap_DomesticCountryMember"
      decimals="0"
      id="Fact005143"
      unitRef="USD">26580700</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="AsOf2023-12-31_us-gaap_StateAndLocalJurisdictionMember"
      decimals="0"
      id="Fact005145"
      unitRef="USD">10666100</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="AsOf2023-12-31_us-gaap_StateAndLocalJurisdictionMember"
      decimals="0"
      id="Fact005147"
      unitRef="USD">2377800</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact005149"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact005151"
      unitRef="USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact005153"
      unitRef="USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="AsOf2022-12-31"
      decimals="0"
      id="Fact005155"
      unitRef="USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:OpenTaxYear contextRef="From2023-01-012023-12-31" id="Fact005157">2016</us-gaap:OpenTaxYear>
    <us-gaap:IncomeTaxExaminationDescription contextRef="From2023-01-012023-12-31" id="Fact005159">The
Company has no open tax audits with any taxing authority as of December 31, 2023.</us-gaap:IncomeTaxExaminationDescription>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2023-01-012023-12-31" id="Fact005161">&lt;p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zOyUfyyR8T8l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;21.
&lt;span id="xdx_823_zlcsTKnMWW08"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Yorkville
SEPA Supplemental Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
previously disclosed, pursuant to the SEPA, dated December 14, 2023, between the Company and Yorkville, Yorkville agreed to advance to
the Company, in exchange for convertible promissory notes, a Pre-Paid Advance for an aggregate principal amount of up to $&lt;span id="xdx_902_ecustom--PrePaidAdvanceOnAggregatePrincipalAmount_iI_pn5n6_c20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zRmrQiOyQGga" title="Principal amount"&gt;3.5 &lt;/span&gt;million,
$&lt;span id="xdx_900_ecustom--PrePaidAdvanceFundedOnMerger_iI_pn5n6_c20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zfgeeMF5DNn3" title="Pre paid Aadvance funded on merger"&gt;2.0&lt;/span&gt; million (less a &lt;span id="xdx_906_ecustom--DiscountOnPrePaidAdvanceFundedOnMerger_dp_uPure_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zE8jMMJ1ojj7" title="Discount on pre paid advance funded on merger"&gt;10&lt;/span&gt;% discount) of which was funded at the closing of the Company&#x2019;s Merger and $&lt;span id="xdx_903_ecustom--PrePaidAdvanceFundedOnRegistration_iI_pn5n6_c20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_z3NAGunWK961" title="Pre paid advance funded on registration"&gt;1.5&lt;/span&gt; million (less a &lt;span id="xdx_901_ecustom--DiscountOnPrePaidAdvanceFundedOnRegistration_dp_uPure_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_z9cBYf3klEBg" title="Discount on pre paid advance funded on registration"&gt;10&lt;/span&gt;% discount)
of which was to be funded when the Company&#x2019;s Registration Statement on Form S-1, originally filed with the U.S. Securities and
Exchange Commission on December 29, 2023, and amended on February 5, 2024, becomes effective and the Company obtains stockholder approval
for the issuance of shares in excess of &lt;span id="xdx_909_ecustom--PercentageOfExcessShareIssuedAndOutstanding_dp_uPure_c20231214__20231214__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember_zPIUZq6HntA3" title="Percentage of excess shares issued and outstanding"&gt;19.99&lt;/span&gt;% of the aggregate number of shares of the Company&#x2019;s Class A common stock issued and
outstanding as of the date of the SEPA in accordance with the applicable rules of Nasdaq.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 5, 2024, the Company and Yorkville entered into a supplemental agreement (the &#x201c;SEPA Supplemental Agreement&#x201d;) to
increase the amount of the Pre-Paid Advance under the SEPA by $&lt;span id="xdx_90E_ecustom--IncreasedPrincipalAmountAgreedToAdvance_iI_pn5n6_c20240205__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zOs1sZ0oxJ55" title="Increased principal amount agreed to advance"&gt;1.0&lt;/span&gt; million (the &#x201c;Additional Pre-Paid Advance Amount&#x201d;), for
an aggregate principal amount of $&lt;span id="xdx_903_ecustom--AggregatePrincipalAmount_iI_pn5n6_c20240205__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zDseHiHK7iK7" title="Aggregate principal amount."&gt;4.5&lt;/span&gt; million to be advanced by Yorkville to the Company under the SEPA and SEPA Supplemental Agreement.
The Additional Pre-Paid Advance Amount (less a &lt;span id="xdx_907_ecustom--DiscountOnAdditionalPrePaidAdvanceAmountPercentage_dp_uPure_c20240205__20240205__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zvYPQn7O5Ut3" title="Discount on additional pre paid advance amount"&gt;10&lt;/span&gt;% discount) was funded on February 5, 2024 in exchange for a promissory note in the
principal amount of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20240205__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zAv2j3eJJ6H8" title="Aggregate principal amount"&gt;1.0&lt;/span&gt; million (the &#x201c;Yorkville Promissory Note&#x201d;). The Yorkville Promissory Note matures on &lt;span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20240205__20240205__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0Umlb2iGoY1" title="Debt instrument, maturity date"&gt;June 14, 2024
&lt;/span&gt;and bears interest at a rate of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240205__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zoXzlwRhsxR9" title="Debt instrument, interest rate"&gt;0&lt;/span&gt;%, subject to certain adjustments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 27, 2024, the Company and Yorkville entered into a supplemental agreement (the &#x201c;SEPA March Supplemental Agreement&#x201d;)
to increase the amount of the Pre-Paid Advance under the SEPA by $&lt;span id="xdx_90C_ecustom--IncreasedPrincipalAmountAgreedToAdvance_iI_pn5n6_c20240327__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWxekuuXQfI9" title="Increased principal amount agreed to advance"&gt;1.5&lt;/span&gt; million (the &#x201c;March Additional Pre-Paid Advance Amount&#x201d;),
for an aggregate principal amount of $&lt;span id="xdx_90D_ecustom--AggregatePrincipalAmount_iI_pn5n6_c20240327__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxlRERlF4eS6" title="Aggregate principal amount."&gt;4.5&lt;/span&gt; million to be advanced by Yorkville to the Company under the SEPA, SEPA Supplemental Agreement,
and SEPA March Supplemental Agreement. The March Additional Pre-Paid Advance Amount (less a &lt;span id="xdx_905_ecustom--DiscountOnAdditionalPrePaidAdvanceAmountPercentage_dp_uPure_c20240327__20240327__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zDOzHW0Bp8mi" title="Discount on additional pre paid advance amount"&gt;10&lt;/span&gt;% discount) was funded&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;on
March 27, 2024 in exchange for a promissory note in the principal amount of $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20240327__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zN1zvYUrQ88c" title="Aggregate principal amount"&gt;1.5&lt;/span&gt; million (the &#x201c;March Yorkville Promissory Note&#x201d;).
The March Yorkville Promissory Note matures on &lt;span id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_dd_c20240327__20240327__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zsfMB2lhnvd3" title="Debt instrument, maturity date"&gt;June 14, 2024&lt;/span&gt; and bears interest at a rate of &lt;span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240327__custom--AgreementAxis__custom--YorkvilleStandbyEquityPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5dTSeVLmVrj" title="Debt instrument, interest rate"&gt;0&lt;/span&gt;%, subject to certain adjustments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Yorkville
Advance Agreement Amortization Event Waiver&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--DebtInstrumentPaymentTerms_c20230101__20231231__custom--AgreementAxis__custom--YorkvilleConvertibleNoteAgreementMember_zOzu5gLdRv1e" title="Convertible note, term"&gt;On
January 24, 2024, Yorkville provided the Company with a waiver with respect to the triggering of an amortization event in January 2024,
in terms of the Yorkville Convertible Note Agreement, which would have required the Company to make monthly repayments of amounts outstanding
under the Yorkville Convertible Note, with each monthly repayment to be in an amount equal to the sum of (x) $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentPeriodicPayment_c20240124__20240124__custom--AgreementAxis__custom--YorkvilleConvertibleNoteAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zjOKZE2Zmjv8" title="Monthly installments"&gt;1,000,000&lt;/span&gt;, plus (y) &lt;span id="xdx_901_ecustom--PercentageOfOutstandingMonthlyRepayments_dp_uPure_c20240124__20240124__custom--AgreementAxis__custom--YorkvilleConvertibleNoteAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zAriWil6w9na" title="Percentage of outstanding monthly repayments"&gt;10&lt;/span&gt;%
in respect of such amount, and (z) all outstanding accrued and unpaid interest as of each payment date. As a result of the waiver, &lt;span id="xdx_902_eus-gaap--RepaymentsOfDebt_do_c20240124__20240124__custom--AgreementAxis__custom--YorkvilleConvertibleNoteAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zBqSDn8TUKUl" title="Repayments"&gt;no&lt;/span&gt;
repayments were required by the Company, and the floor price&lt;/span&gt; trigger underlying the amortization event was reset on February 15, 2023,
at which point the amortization event trigger was cured.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Yorkville
SEPA Advance Purchase Notices and Yorkville Deferred Fee Settlement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;In
February, 2024, Yorkville submitted two Advance Notice Investor Notices, related to the purchase of common shares of the Company, with
the aggregate purchase price of those shares offset against amounts outstanding by the Company under the Pre-Paid Yorkville Convertible
Notes. Yorkville purchased a total of &lt;span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240201__20240229__custom--AgreementAxis__custom--YorkvilleSEPAAdvancePurchaseNoticesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zX0KcElsd7Ua" title="Purchase of common shares"&gt;6,888&lt;/span&gt; shares, for a total aggregate purchase consideration of $&lt;span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240201__20240229__custom--AgreementAxis__custom--YorkvilleSEPAAdvancePurchaseNoticesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zCRvWVOHZpq1" title="Aggregate purchase consideration"&gt;300,000&lt;/span&gt;. The conversion prices
applicable to these purchases ranged from $&lt;span id="xdx_907_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240229__custom--AgreementAxis__custom--YorkvilleSEPAAdvancePurchaseNoticesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MinimumMember_zmz3TL2C8p3g" title="Debt instrument conversion price per share"&gt;38.08&lt;/span&gt; to $&lt;span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20240229__custom--AgreementAxis__custom--YorkvilleSEPAAdvancePurchaseNoticesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MaximumMember_zZjr4tLCSH5i" title="Debt instrument conversion price per share"&gt;61.15&lt;/span&gt; per share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March, 2024, Yorkville submitted six Advance Notice Investor Notices, related to the purchase of common shares of the Company, with the
aggregate purchase price of those shares offset against amounts outstanding by the Company under the Pre-Paid Yorkville Convertible Notes
and to settle the Deferred Fee payable to Yorkville. Yorkville purchased a total of &lt;span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240301__20240331__custom--AgreementAxis__custom--PrePaidYorkvilleConvertibleNotesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdVNFae9Hoy5" title="Purchase of common shares"&gt;37,787&lt;/span&gt; and &lt;span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240301__20240331__custom--AgreementAxis__custom--YorkvilleDeferredFeeSettlementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zmJDsWb1W5Wf" title="Purchase of common shares"&gt;14,201&lt;/span&gt; shares, for a total aggregate
purchase consideration of $&lt;span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240301__20240331__custom--AgreementAxis__custom--PrePaidYorkvilleConvertibleNotesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zP0zUGyi6bC1" title="Aggregate purchase consideration"&gt;1,200,000&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20240301__20240331__custom--AgreementAxis__custom--YorkvilleDeferredFeeSettlementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTKdlC3cHPG2" title="Purchase of common shares"&gt;500,000&lt;/span&gt; in settlement of the Yorkville Convertible Notes and Deferred Fee, respectively. The
conversion prices applicable to these purchases ranged from $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240331__custom--AgreementAxis__custom--YorkvilleDeferredFeeSettlementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MinimumMember_zQrdEJAmMBCg" title="Debt instrument conversion price per share"&gt;31.65&lt;/span&gt; to $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240331__custom--AgreementAxis__custom--YorkvilleDeferredFeeSettlementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--RangeAxis__srt--MaximumMember_ziRP2PNaTLJ1" title="Debt instrument conversion price per share"&gt;35.21&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Roth
Addendum to Letter Agreements&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 13, 2022, Roth and Legacy Banzai entered into the Roth Engagement Letter, pursuant to which Legacy Banzai engaged Roth as a financial
advisor in connection with the Merger and, on October 14, 2022, MKM and 7GC entered into the MKM Engagement Letter, pursuant to which
7GC engaged MKM as a financial advisor in connection with the Merger. In February 2023, Roth acquired MKM.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 2, 2024, the Company and Roth entered into an addendum to (i) the engagement letter, dated October 13, 2022, by and between
Roth and Legacy Banzai, and (ii) the engagement letter, dated October 14, 2022, by and between Roth (as successor to MKM Partners, LLC)
and 7GC (such engagement agreements, collectively, the &#x201c;Roth Engagement Agreements,&#x201d; and such addendum, the &#x201c;Roth Addendum&#x201d;).
&lt;span id="xdx_909_ecustom--AddendumToLetterAgreementsDescription_c20240202__20240202_zoNdWUDs9wjf" title="Addendum To Letter Agreements Description"&gt;Pursuant to the Roth Addendum, in lieu of payment in cash of the full amount of any advisory fees or other fees or expenses, incurred
in 2024, and owed under the Roth Engagement Agreements (collectively, the &#x201c;Roth Fee&#x201d;), the Company (i) issued to Roth &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240202__20240202__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ziknzZQrEITh" title="Shares issued, shares"&gt;3,500&lt;/span&gt;
shares (the &#x201c;Roth Shares&#x201d;) of the Company&#x2019;s Class A Common Stock, and (ii) on or before June 30, 2024, will pay to
Roth an amount in cash equal to $&lt;span id="xdx_903_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20240202__20240202__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zoMS6NtOO72a" title="Shares issued for acquisition"&gt;300,000&lt;/span&gt; or, if the Company determines that such payment should not be made in cash due to the Company&#x2019;s
cash position at such time, issue to Roth a number of shares of Class A Common Stock equal to $&lt;span id="xdx_902_ecustom--StockIssueValueIfPaymentNotMadeInCash_c20240202__20240202__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zAmmlDqj4gL8" title="Shares issued, cash"&gt;300,000&lt;/span&gt; divided by the daily VWAP for
the trading day immediately preceding June 30, 2024 (any such shares, the &#x201c;Additional Roth Shares&#x201d;). The Company registered
the Roth Shares and &lt;span id="xdx_90F_ecustom--StockIssuedDuringPeriodSharesAdditionalShares_c20240202__20240202__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrIrUXEOCwjd" title="Shares issued, shares"&gt;12,000&lt;/span&gt; shares of Class A Common Stock (in addition to the Roth Shares) on a registration statement to cover any
issuances of Additional Roth Shares&lt;/span&gt; (which may be more or less than &lt;span id="xdx_900_ecustom--StockIssuedDuringPeriodSharesAdditionalShares_c20240202__20240202__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z50NggYXX0Lk" title="Stock issued during period shares additional shares"&gt;12,000&lt;/span&gt;) that may occur pursuant to the Roth Addendum; such registration
statement became effective on February 14, 2024. The $&lt;span id="xdx_904_eus-gaap--PaymentsToAcquireBusinessesNetOfCashAcquired_c20240329__20240329__custom--AgreementAxis__custom--RothAddendumToLetterAgreementsMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpJoue3A1BFh" title="Shares issued, shares"&gt;300,000&lt;/span&gt; cash payment has not yet been made as of the date of filing of these annual
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Notice
of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 5, 2024, the Company received a letter (the &#x201c;Letter&#x201d;) from the staff at Nasdaq notifying the Company that, for the
30 consecutive business days prior to the date of the Letter, the Company&#x2019;s Minimum Value of Listed Securities (&#x201c;MVLS&#x201d;)
was below the minimum of $&lt;span id="xdx_900_ecustom--MinimumNetTangibleAssetsUponConsummationOfBusinessCombination_iI_pn6n6_c20240205__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zKpp0fiZFwA" title="Minimum net tangible assets"&gt;50 &lt;/span&gt;million required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A).
The staff at Nasdaq also noted in the Letter that the Company is not in compliance with Nasdaq Listing Rule 5450(b)(3)(A), which requires
listed companies to have total assets and total revenue of at least $&lt;span id="xdx_909_ecustom--MinimumRequirementOfNetAssetsAndNetRevenue_iI_c20240205__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zv2oJvhwryok" title="Total assets and total revenue"&gt;50,000,000&lt;/span&gt; each for the most recently completed fiscal year or for
two of the three most recently completed fiscal years. The Letter is only a notification of deficiency, not of imminent delisting, and
has no current effect on the listing or trading of the Company&#x2019;s securities on Nasdaq.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with Nasdaq listing rule 5810(c)(3)(C), the Company has 180 calendar days, or until August 5, 2024, to regain compliance.
The Letter notes that to regain compliance, the Company&#x2019;s MVLS must close at or above $&lt;span id="xdx_901_ecustom--MinimumNetTangibleAssetsUponConsummationOfBusinessCombination_iI_pn6n6_c20240205__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zM2pMwILmTij" title="Minimum net tangible assets upon consummation of business combination"&gt;50
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million for a minimum of ten consecutive business
days during the compliance period. The Letter further notes that if the Company is unable to satisfy the MVLS requirement prior to such
date, the Company may be eligible to transfer the listing of its securities to The Nasdaq Global Market (provided that the Company
then satisfies the requirements for continued listing on that market).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the Company does not regain compliance by August 5, 2024, Nasdaq staff will provide written notice to the Company that its securities
are subject to delisting. At that time, the Company may appeal any such delisting determination to a hearings panel.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company intends to actively monitor the Company&#x2019;s MVLS between now and August 5, 2024, and may, if appropriate, evaluate available
options to resolve the deficiency and regain compliance with the MVLS requirement. While the Company is exercising diligent efforts to
maintain the listing of its securities on Nasdaq, there can be no assurance that the Company will be able to regain or maintain compliance
with Nasdaq listing standards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;GEM
Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 5, 2024, the Company and GEM entered into a settlement agreement (the &#x201c;GEM Settlement Agreement&#x201d;), pursuant to which
(a) the Company and GEM agreed to (i) settle the Company&#x2019;s obligations under and terminate the binding term sheet entered into
between Legacy Banzai and GEM, dated December 13, 2023, and (ii) terminate the share repurchase agreement, dated May 27, 2022, by and
among the Company and GEM, and (b) the Company (i) agreed to pay GEM $&lt;span id="xdx_908_ecustom--DebtInstrumentCashAgreedToPay_pn5n6_c20240205__20240205__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__custom--AgreementAxis__custom--GemAgreementMember_z9rzjQ2QATph" title="Cash agreed to pay"&gt;1.2&lt;/span&gt; million in cash within three business days of the GEM Settlement
Agreement and (ii) issued to GEM, on February 5, 2024, an unsecured promissory note in the amount of $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20240205__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__custom--AgreementAxis__custom--GemAgreementMember_zSLpfoUel8gj" title="Principal amount"&gt;1.0&lt;/span&gt; million, payable in monthly
installments of $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentPeriodicPayment_c20240205__20240205__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__custom--AgreementAxis__custom--GemAgreementMember_zToaDugAsaCc" title="Monthly installments"&gt;100,000&lt;/span&gt; beginning on March 1, 2024, with the final payment to be made on December 1, 2024 (the &#x201c;GEM Promissory
Note&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
GEM Promissory Note provides that, in the event the Company fails to make a required monthly payment when due, the Company shall issue
to GEM a number of shares of Class A Common Stock equal to the monthly payment amount divided by the VWAP of Class A Common Stock
for the trading day immediately preceding the applicable payment due date. In addition, the Company agreed to register on a registration
statement &lt;span id="xdx_90D_ecustom--SharesIssuableUnderPromissoryNote_c20240205__20240205__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zInj4RLWsFxh" title="Shares issuable under the terms of promissory note"&gt;40,000&lt;/span&gt; shares of Class A Common Stock that may be issuable under the terms of the GEM Promissory Note. The GEM Promissory
Note contains customary events of default. If an event of default occurs, GEM may, at its option, demand from the Company immediate payment
of any outstanding balance under the GEM Promissory Note. As of the date of this Annual Report, we have issued an aggregate of &lt;span id="xdx_90E_ecustom--SharesIssuedUnderPromissoryNote_c20240205__20240205__us-gaap--BusinessAcquisitionAxis__custom--GemAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zDmRhRDNKNpi" title="Shares issued under the terms of promissory note"&gt;2,789&lt;/span&gt;
shares of Class A Common Stock to GEM in lieu of monthly payment obligations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Conversion
of 7GC Promissory Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
discussed per &lt;i&gt;Note 14-Debt&lt;/i&gt;, On December 12, 2023, in connection with the Merger, the Sponsor came to a non-binding agreement with
7GC to amend the 7GC Promissory Notes, to provide that 7GC has the right to elect to convert up to the full amount of the principal balance
of the 7GC Promissory Notes, in whole or in part, 30 days after the closing of the Merger at a conversion price equal to the average
daily VWAP of Class A Common Stock for the 30 trading days following the Closing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 2, 2024, pursuant to and in accordance with the First Amendment Conversion Provisions, the Sponsor exercised its right to convert
the full principal amount under each of the 7GC Notes within 30 days after the Closing, and such conversions were completed on February
2, 2024, resulting in the issuance to the Sponsor of an aggregate of &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240202__20240202__custom--AgreementAxis__custom--ConversionOf7GcPromissoryNotesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--SponsorMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zBkm87NiVDl7" title="Share issued"&gt;17,812&lt;/span&gt; shares of Class A Common Stock (collectively, the &#x201c;Conversion
and Issuance&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Forfeiture
and Cancellation of 7GC Sponsor Shares&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
January 2024, the Company and 7GC entered into an agreement whereby 7GC agreed to forfeit a total of &lt;span id="xdx_909_ecustom--ForfeitureOfCommonStockShares_iI_c20240131__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zY1Xx0sMHCka" title="Forfeiture of common stock shares"&gt;2,000&lt;/span&gt; shares held by 7GC. These
shares were transferred to the Company and subsequently cancelled.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Issuance
of Shares as Compensation for Marketing Agreement&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 16, 2024, the Company entered into a Marketing Services Agreement with a vendor. This agreement was effective February 19, 2024,
and relates to the provision of marketing and distribution services to the Company. Effective as of February 19, 2024, as compensation
for these services, the Company agreed to issued to this vendor a total of &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240219__20240219__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__custom--AgreementAxis__custom--MarketingServicesAgreementMember_z7PVchy9Lzsb" title="Ordinary shares issued"&gt;3,070&lt;/span&gt; ordinary shares, with a market value as of the valuation
date, of $&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20240219__20240219__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__custom--AgreementAxis__custom--MarketingServicesAgreementMember_zcdh8f6xaY6e" title="Ordinary shares issued value"&gt;200,000&lt;/span&gt;. As of the date of this annual report, these shares have not yet been issued to the vendor.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <BNZI:PrePaidAdvanceOnAggregatePrincipalAmount
      contextRef="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember5493562"
      decimals="-5"
      id="Fact005163"
      unitRef="USD">3500000</BNZI:PrePaidAdvanceOnAggregatePrincipalAmount>
    <BNZI:PrePaidAdvanceFundedOnMerger
      contextRef="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember5493562"
      decimals="-5"
      id="Fact005165"
      unitRef="USD">2000000.0</BNZI:PrePaidAdvanceFundedOnMerger>
    <BNZI:DiscountOnPrePaidAdvanceFundedOnMerger
      contextRef="From2023-12-142023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact005167"
      unitRef="Pure">0.10</BNZI:DiscountOnPrePaidAdvanceFundedOnMerger>
    <BNZI:PrePaidAdvanceFundedOnRegistration
      contextRef="AsOf2023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember5493562"
      decimals="-5"
      id="Fact005169"
      unitRef="USD">1500000</BNZI:PrePaidAdvanceFundedOnRegistration>
    <BNZI:DiscountOnPrePaidAdvanceFundedOnRegistration
      contextRef="From2023-12-142023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact005171"
      unitRef="Pure">0.10</BNZI:DiscountOnPrePaidAdvanceFundedOnRegistration>
    <BNZI:PercentageOfExcessShareIssuedAndOutstanding
      contextRef="From2023-12-142023-12-14_custom_YorkvilleStandbyEquityPurchaseAgreementMember"
      decimals="INF"
      id="Fact005173"
      unitRef="Pure">0.1999</BNZI:PercentageOfExcessShareIssuedAndOutstanding>
    <BNZI:IncreasedPrincipalAmountAgreedToAdvance
      contextRef="AsOf2024-02-05_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact005175"
      unitRef="USD">1000000.0</BNZI:IncreasedPrincipalAmountAgreedToAdvance>
    <BNZI:AggregatePrincipalAmount
      contextRef="AsOf2024-02-05_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact005177"
      unitRef="USD">4500000</BNZI:AggregatePrincipalAmount>
    <BNZI:DiscountOnAdditionalPrePaidAdvanceAmountPercentage
      contextRef="From2024-02-052024-02-05_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact005179"
      unitRef="Pure">0.10</BNZI:DiscountOnAdditionalPrePaidAdvanceAmountPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-02-05_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact005181"
      unitRef="USD">1000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-02-052024-02-05_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      id="Fact005183">2024-06-14</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-02-05_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact005185"
      unitRef="Pure">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <BNZI:IncreasedPrincipalAmountAgreedToAdvance
      contextRef="AsOf2024-03-27_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact005187"
      unitRef="USD">1500000</BNZI:IncreasedPrincipalAmountAgreedToAdvance>
    <BNZI:AggregatePrincipalAmount
      contextRef="AsOf2024-03-27_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact005189"
      unitRef="USD">4500000</BNZI:AggregatePrincipalAmount>
    <BNZI:DiscountOnAdditionalPrePaidAdvanceAmountPercentage
      contextRef="From2024-03-272024-03-27_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact005191"
      unitRef="Pure">0.10</BNZI:DiscountOnAdditionalPrePaidAdvanceAmountPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-03-27_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact005193"
      unitRef="USD">1500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-03-272024-03-27_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      id="Fact005195">2024-06-14</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-03-27_custom_YorkvilleStandbyEquityPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact005197"
      unitRef="Pure">0</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPaymentTerms
      contextRef="From2023-01-012023-12-31_custom_YorkvilleConvertibleNoteAgreementMember"
      id="Fact005199">On
January 24, 2024, Yorkville provided the Company with a waiver with respect to the triggering of an amortization event in January 2024,
in terms of the Yorkville Convertible Note Agreement, which would have required the Company to make monthly repayments of amounts outstanding
under the Yorkville Convertible Note, with each monthly repayment to be in an amount equal to the sum of (x) $1,000,000, plus (y) 10%
in respect of such amount, and (z) all outstanding accrued and unpaid interest as of each payment date. As a result of the waiver, no
repayments were required by the Company, and the floor price</us-gaap:DebtInstrumentPaymentTerms>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2024-01-242024-01-24_custom_YorkvilleConvertibleNoteAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact005201"
      unitRef="USD">1000000</us-gaap:DebtInstrumentPeriodicPayment>
    <BNZI:PercentageOfOutstandingMonthlyRepayments
      contextRef="From2024-01-242024-01-24_custom_YorkvilleConvertibleNoteAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact005203"
      unitRef="Pure">0.10</BNZI:PercentageOfOutstandingMonthlyRepayments>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2024-01-242024-01-24_custom_YorkvilleConvertibleNoteAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact005205"
      unitRef="USD">0</us-gaap:RepaymentsOfDebt>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-02-012024-02-29_custom_YorkvilleSEPAAdvancePurchaseNoticesMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact005207"
      unitRef="Shares">6888</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2024-02-012024-02-29_custom_YorkvilleSEPAAdvancePurchaseNoticesMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact005209"
      unitRef="USD">300000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2024-02-29_custom_YorkvilleSEPAAdvancePurchaseNoticesMember_us-gaap_SubsequentEventMember_srt_MinimumMember"
      decimals="INF"
      id="Fact005211"
      unitRef="USDPShares">38.08</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2024-02-29_custom_YorkvilleSEPAAdvancePurchaseNoticesMember_us-gaap_SubsequentEventMember_srt_MaximumMember"
      decimals="INF"
      id="Fact005213"
      unitRef="USDPShares">61.15</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-03-012024-03-31_custom_PrePaidYorkvilleConvertibleNotesMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact005215"
      unitRef="Shares">37787</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-03-012024-03-31_custom_YorkvilleDeferredFeeSettlementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact005217"
      unitRef="Shares">14201</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2024-03-012024-03-31_custom_PrePaidYorkvilleConvertibleNotesMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact005219"
      unitRef="USD">1200000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="From2024-03-012024-03-31_custom_YorkvilleDeferredFeeSettlementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact005221"
      unitRef="USD">500000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2024-03-31_custom_YorkvilleDeferredFeeSettlementMember_us-gaap_SubsequentEventMember_srt_MinimumMember"
      decimals="INF"
      id="Fact005223"
      unitRef="USDPShares">31.65</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2024-03-31_custom_YorkvilleDeferredFeeSettlementMember_us-gaap_SubsequentEventMember_srt_MaximumMember"
      decimals="INF"
      id="Fact005225"
      unitRef="USDPShares">35.21</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <BNZI:AddendumToLetterAgreementsDescription contextRef="From2024-02-022024-02-02" id="Fact005227">Pursuant to the Roth Addendum, in lieu of payment in cash of the full amount of any advisory fees or other fees or expenses, incurred
in 2024, and owed under the Roth Engagement Agreements (collectively, the &#x201c;Roth Fee&#x201d;), the Company (i) issued to Roth 3,500
shares (the &#x201c;Roth Shares&#x201d;) of the Company&#x2019;s Class A Common Stock, and (ii) on or before June 30, 2024, will pay to
Roth an amount in cash equal to $300,000 or, if the Company determines that such payment should not be made in cash due to the Company&#x2019;s
cash position at such time, issue to Roth a number of shares of Class A Common Stock equal to $300,000 divided by the daily VWAP for
the trading day immediately preceding June 30, 2024 (any such shares, the &#x201c;Additional Roth Shares&#x201d;). The Company registered
the Roth Shares and 12,000 shares of Class A Common Stock (in addition to the Roth Shares) on a registration statement to cover any
issuances of Additional Roth Shares</BNZI:AddendumToLetterAgreementsDescription>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-02-022024-02-02_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact005229"
      unitRef="Shares">3500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="From2024-02-022024-02-02_custom_RothAddendumToLetterAgreementsMember_us-gaap_CommonClassAMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact005231"
      unitRef="USD">300000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <BNZI:StockIssueValueIfPaymentNotMadeInCash
      contextRef="From2024-02-022024-02-02_custom_RothAddendumToLetterAgreementsMember_us-gaap_CommonClassAMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact005233"
      unitRef="USD">300000</BNZI:StockIssueValueIfPaymentNotMadeInCash>
    <BNZI:StockIssuedDuringPeriodSharesAdditionalShares
      contextRef="From2024-02-022024-02-02_custom_RothAddendumToLetterAgreementsMember_us-gaap_CommonClassAMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact005235"
      unitRef="Shares">12000</BNZI:StockIssuedDuringPeriodSharesAdditionalShares>
    <BNZI:StockIssuedDuringPeriodSharesAdditionalShares
      contextRef="From2024-02-022024-02-02_custom_RothAddendumToLetterAgreementsMember_us-gaap_CommonClassAMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact005237"
      unitRef="Shares">12000</BNZI:StockIssuedDuringPeriodSharesAdditionalShares>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="From2024-03-292024-03-29_custom_RothAddendumToLetterAgreementsMember_us-gaap_CommonClassAMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact005239"
      unitRef="USD">300000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <BNZI:MinimumNetTangibleAssetsUponConsummationOfBusinessCombination
      contextRef="AsOf2024-02-05_us-gaap_SubsequentEventMember"
      decimals="-6"
      id="Fact005241"
      unitRef="USD">50000000</BNZI:MinimumNetTangibleAssetsUponConsummationOfBusinessCombination>
    <BNZI:MinimumRequirementOfNetAssetsAndNetRevenue
      contextRef="AsOf2024-02-05_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact005243"
      unitRef="USD">50000000</BNZI:MinimumRequirementOfNetAssetsAndNetRevenue>
    <BNZI:MinimumNetTangibleAssetsUponConsummationOfBusinessCombination
      contextRef="AsOf2024-02-05_us-gaap_SubsequentEventMember"
      decimals="-6"
      id="Fact005245"
      unitRef="USD">50000000</BNZI:MinimumNetTangibleAssetsUponConsummationOfBusinessCombination>
    <BNZI:DebtInstrumentCashAgreedToPay
      contextRef="From2024-02-052024-02-05_us-gaap_SubsequentEventMember_custom_GemAgreementMember"
      decimals="-5"
      id="Fact005247"
      unitRef="USD">1200000</BNZI:DebtInstrumentCashAgreedToPay>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-02-05_us-gaap_SubsequentEventMember_custom_GemAgreementMember"
      decimals="-5"
      id="Fact005249"
      unitRef="USD">1000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2024-02-052024-02-05_us-gaap_SubsequentEventMember_custom_GemAgreementMember"
      decimals="0"
      id="Fact005251"
      unitRef="USD">100000</us-gaap:DebtInstrumentPeriodicPayment>
    <BNZI:SharesIssuableUnderPromissoryNote
      contextRef="From2024-02-052024-02-05_custom_GemAgreementMember_us-gaap_CommonClassAMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact005253"
      unitRef="Shares">40000</BNZI:SharesIssuableUnderPromissoryNote>
    <BNZI:SharesIssuedUnderPromissoryNote
      contextRef="From2024-02-052024-02-05_custom_GemAgreementMember_us-gaap_CommonClassAMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact005255"
      unitRef="Shares">2789</BNZI:SharesIssuedUnderPromissoryNote>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-02-022024-02-02_custom_ConversionOf7GcPromissoryNotesMember_us-gaap_SubsequentEventMember_custom_SponsorMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact005257"
      unitRef="Shares">17812</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <BNZI:ForfeitureOfCommonStockShares
      contextRef="AsOf2024-01-31_us-gaap_SubsequentEventMember_us-gaap_CommonClassAMember"
      decimals="INF"
      id="Fact005259"
      unitRef="Shares">2000</BNZI:ForfeitureOfCommonStockShares>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-02-192024-02-19_us-gaap_SubsequentEventMember_custom_MarketingServicesAgreementMember"
      decimals="INF"
      id="Fact005261"
      unitRef="Shares">3070</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-02-192024-02-19_us-gaap_SubsequentEventMember_custom_MarketingServicesAgreementMember"
      decimals="0"
      id="Fact005263"
      unitRef="USD">200000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
</xbrl>
